- Rapid Clinical Trial Patient Recruitment

NCT05224791 A Retrospective Multicenter Comparison of Laparoscopic and Robotic-Assisted Roux-en-Y Gastrectomy https://clinicaltrials.gov/study/NCT05224791 RECRUITING Laparoscopic Sleeve Gastrectomy

NCT06528691 Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors https://clinicaltrials.gov/study/NCT06528691 RECRUITING High Grade Glioma

NCT05587491 HybridAPC for Gastric Mucosal Ablation in Obese Patients. https://clinicaltrials.gov/study/NCT05587491 RECRUITING Obesity

NCT04804891 Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation https://clinicaltrials.gov/study/NCT04804891 RECRUITING Intestinal Transplantation BIOLOGICAL: Cell Therapy Columbia University Ossium Health, Inc.

NCT06614491 SCOPE - Single-Point Classification Observational Peristomal Evaluation https://clinicaltrials.gov/study/NCT06614491 NOT_YET_RECRUITING Ileostomy

NCT06120491 Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents https://clinicaltrials.gov/study/NCT06120491 RECRUITING Metastatic Castration-Sensitive Prostate Cancer DRUG: Saruparib

NCT06536491 EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema https://clinicaltrials.gov/study/NCT06536491 NOT_YET_RECRUITING Diabetic Macular Edema DRUG: EC-104 high dose

NCT05740891 AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma https://clinicaltrials.gov/study/NCT05740891 RECRUITING Multiple Myeloma DRUG: BCMA CAR-T cells injection Zhejiang University Yake Biotechnology Ltd.

NCT06674291 Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry) https://clinicaltrials.gov/study/NCT06674291 NOT_YET_RECRUITING Tuberculosis, Multidrug-Resistant DRUG: No intervention (observational study) Korea Otsuka Pharmaceutical Co., Ltd.

NCT06029491 The Pivotal Study of RapidPulseTM Aspiration System https://clinicaltrials.gov/study/NCT06029491 NOT_YET_RECRUITING Acute Ischemic Stroke DEVICE: RapidPulseTM Aspiration System RapidPulse, Inc

NCT04732962 Biomechanical Footwear as a Non-invasive Alternative and Supplement to Total Knee Replacement https://clinicaltrials.gov/study/NCT04732962 RECRUITING Osteoarthritis, Knee DEVICE: AposHealth

NCT06478862 Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy https://clinicaltrials.gov/study/NCT06478862 RECRUITING Cancer of Ovary

NCT06714591 A Multicenter, Open-Label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of BL-M11D1 in Patients with Relapsed/Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06714591 NOT_YET_RECRUITING Relapsed/Refractory Acute Myeloid Leukemia DRUG: BL-M11D1 SystImmune Inc.

NCT06134362 Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus) https://clinicaltrials.gov/study/NCT06134362 NOT_YET_RECRUITING HIV Infections DRUG: CAB LA ViiV Healthcare GlaxoSmithKline

NCT06521762 Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis https://clinicaltrials.gov/study/NCT06521762 NOT_YET_RECRUITING Immune Checkpoint Inhibitor-Related Diarrhea and Colitis DRUG: Etrasimod

NCT05290662 Registry of Patients Having Received oNKord¬Æ https://clinicaltrials.gov/study/NCT05290662 RECRUITING AML DRUG: oNKord¬Æ

NCT05366062 ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab https://clinicaltrials.gov/study/NCT05366062 NOT_YET_RECRUITING Glioma, Malignant DRUG: ERC1671

NCT04738162 Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors https://clinicaltrials.gov/study/NCT04738162 RECRUITING Brain Tumor, Pediatric DRUG: 5-Aminolevulinic Acid Hydrochloride, Oral Universit√§t M√ºnster photonamic GmbH & Co. KG

NCT04873362 A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy https://clinicaltrials.gov/study/NCT04873362 RECRUITING Breast Cancer DRUG: Atezolizumab

NCT06035991 First Clinical Evaluation of Heart Transplantation With Grafts Preserved Using an Ex-vivo Extended Perfusion System https://clinicaltrials.gov/study/NCT06035991 NOT_YET_RECRUITING Heart Transplantation PROCEDURE: Heart transplantation Assistance Publique - H√¥pitaux de Paris ICAN Nutrition Education and Research

NCT06513091 US National TOP Registry https://clinicaltrials.gov/study/NCT06513091 RECRUITING Lung Transplant DEVICE: OCS Lung TransMedics

NCT06515262 Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM https://clinicaltrials.gov/study/NCT06515262 RECRUITING Relapsed/Refractory Multiple Myeloma BIOLOGICAL: Anti-BCMA-GPRC5D CAR-T cells infusion 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China Guangzhou Bio-gene Technology Co., Ltd

NCT06010862 Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors https://clinicaltrials.gov/study/NCT06010862 RECRUITING Gastric Cancer

NCT05525091 Neoneur Feeding System Functionality in the Clinic https://clinicaltrials.gov/study/NCT05525091 RECRUITING Feeding Patterns

NCT05060991 Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients https://clinicaltrials.gov/study/NCT05060991 RECRUITING COVID-19

NCT06258291 First in Human Trial to Assess the Safety of HemoSystem REBOOT in Patients With Sepsis-induced Immunosuppression https://clinicaltrials.gov/study/NCT06258291 NOT_YET_RECRUITING Septic Shock DEVICE: Hemosystem REBOOT hemotune AG

NCT06058091 RY_SW01 Cell Injection Therapy in Systemic Sclerosis https://clinicaltrials.gov/study/NCT06058091 RECRUITING Systemic Sclerosis DRUG: RY_SW01 cell injection

NCT05467891 Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer https://clinicaltrials.gov/study/NCT05467891 RECRUITING Locoregional Recurrence

NCT05954091 OH2 Administered by Intratumoral Injection https://clinicaltrials.gov/study/NCT05954091 NOT_YET_RECRUITING Solid Tumor DRUG: OH2 Injection Binhui Biopharmaceutical Co., Ltd.

NCT05968391 Acetoacetate and Acetate Metabolism in Patients With Chronic Kidney Failure.(RENO-TEP) https://clinicaltrials.gov/study/NCT05968391 RECRUITING Kidney Failure, Chronic RADIATION: PET scan metabolic day Universit√© de Sherbrooke Nestle Health Science

NCT06256991 Potassium Correction for RAAS Optimization in Chronic Kidney Disease https://clinicaltrials.gov/study/NCT06256991 RECRUITING Chronic Kidney Diseases

NCT06336291 A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence https://clinicaltrials.gov/study/NCT06336291 NOT_YET_RECRUITING Glioblastoma DRUG: L19TNF

NCT05199662 Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT https://clinicaltrials.gov/study/NCT05199662 RECRUITING Ischemic Stroke, Acute DRUG: Intravenous tenecteplase

NCT06633562 A Study to Test the Effects of Nezavist At Different Doses in Healthy Adults https://clinicaltrials.gov/study/NCT06633562 NOT_YET_RECRUITING Healthy

NCT05652062 Prizvalve¬Æ Transcatheter Valve-in-Valve Implantation Exploratory Study https://clinicaltrials.gov/study/NCT05652062 RECRUITING Failing Bioprosthetic Valve DEVICE: Prizvalve¬Æ system Shanghai NewMed Medical Co., Ltd. Shanghai Zhongshan Hospital

NCT05451862 Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma. https://clinicaltrials.gov/study/NCT05451862 RECRUITING Hepatocellular Carcinoma DEVICE: Holmium-166 treatment

NCT05925491 Pembrolizumab in Locally Advanced Sinonasal Carcinoma https://clinicaltrials.gov/study/NCT05925491 NOT_YET_RECRUITING Sinonasal Undifferentiated Carcinoma DRUG: Pembrolizumab

NCT05285891 Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis https://clinicaltrials.gov/study/NCT05285891 RECRUITING Multiple Sclerosis DRUG: Ocrelizumab

NCT06721091 Safety, Tolerability, and Dose Response of VNA-318 in Healthy Males https://clinicaltrials.gov/study/NCT06721091 RECRUITING Healthy Volunteer DRUG: VNA-318

NCT06669091 Food-effect Study of Ecopipam Pharmacokinetics https://clinicaltrials.gov/study/NCT06669091 NOT_YET_RECRUITING Food-effect DRUG: Ecopipam tablet Emalex Biosciences Inc.

NCT06045091 To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL https://clinicaltrials.gov/study/NCT06045091 RECRUITING Multiple Myeloma

NCT06497491 An Efficacy and Safety Study of GNR-086 (canakinumab Biosimilar) and Ilaris¬Æ in Patients with Adult-onset Still's Disease https://clinicaltrials.gov/study/NCT06497491 RECRUITING Still's Disease Adult Onset BIOLOGICAL: GNR-086

NCT05177562 Reproductive Endocrinology Oxford Study (RepOx) https://clinicaltrials.gov/study/NCT05177562 RECRUITING Polycystic Ovary Syndrome OTHER: No intervention University of Oxford Bayer

NCT06470191 A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. https://clinicaltrials.gov/study/NCT06470191 RECRUITING Primary Membranous Nephropathy DRUG: B007

NCT05695391 A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM https://clinicaltrials.gov/study/NCT05695391 RECRUITING Hemophilia BIOLOGICAL: Coagulation Factor VIIa (Recombinant) Laboratoire fran√ßais de Fractionnement et de Biotechnologies

NCT06715891 Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years. https://clinicaltrials.gov/study/NCT06715891 RECRUITING Acute Respiratory Viral Infection DRUG: Raphamin

NCT04635891 Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) https://clinicaltrials.gov/study/NCT04635891 RECRUITING FSHD University of Kansas Medical Center FSHD Society, Inc.

NCT05599191 A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough https://clinicaltrials.gov/study/NCT05599191 RECRUITING Refractory Chronic Cough DRUG: BLU-5937

NCT06559891 THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS‚Ñ¢) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension https://clinicaltrials.gov/study/NCT06559891 NOT_YET_RECRUITING Hypertension DEVICE: TIVUS‚Ñ¢ Renal Denervation System

NCT05904691 Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration https://clinicaltrials.gov/study/NCT05904691 RECRUITING Neovascular Age-related Macular Degeneration (nAMD) DRUG: OCU-10-C-110 for Injection Ocugenix Corporation

NCT05398991 Coronary Covered Stents Implantation for the Treatment of Coronary Artery Perforation https://clinicaltrials.gov/study/NCT05398991 RECRUITING Coronary Artery Perforation DEVICE: the Coronary Covered Stents System manufactured by Shanghai MicroPort Medical (Group) Co., Ltd. Shanghai MicroPort Rhythm MedTech Co., Ltd.

NCT06694662 PKU EASY Microtabs Plus - Acceptability and Tolerance https://clinicaltrials.gov/study/NCT06694662 NOT_YET_RECRUITING Phenylketonuria (PKU) DIETARY_SUPPLEMENT: PKU EASY Microtabs Plus Galen Limited Birmingham Women's and Children's NHS Foundation Trust

NCT05635162 Zanubrutinib Plus Rituximab for Patients with Indolent Mantle Cell Lymphoma https://clinicaltrials.gov/study/NCT05635162 RECRUITING Mantle Cell Lymphoma DRUG: Zanubrutinib

NCT03848962 Collection and Distribution of Biospecimens for Novel Research Uses https://clinicaltrials.gov/study/NCT03848962 RECRUITING Cancer

NCT06598462 A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults with Eosinophilic Esophagitis https://clinicaltrials.gov/study/NCT06598462 RECRUITING Eosinophilic Esophagitis (EoE) DRUG: Solrikitug Low Dose

NCT02651662 A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies https://clinicaltrials.gov/study/NCT02651662 RECRUITING Relapsed/Refractory Aggressive B-Cell Lymphoma DRUG: cemiplimab

NCT06267391 Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes https://clinicaltrials.gov/study/NCT06267391 RECRUITING Type 2 Diabetes Mellitus

NCT05769491 Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials https://clinicaltrials.gov/study/NCT05769491 NOT_YET_RECRUITING Triple Negative Breast Cancer

NCT06233591 Evaluating LP-10 in Subjects With OLP https://clinicaltrials.gov/study/NCT06233591 RECRUITING Oral Lichen Planus DRUG: LP-10 (Liposomal Tacrolimus) Lipella Pharmaceuticals, Inc.

NCT05725291 AMT-116 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05725291 RECRUITING Advanced Solid Tumor DRUG: AMT-116 Multitude Therapeutics Inc.

NCT05291091 Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) https://clinicaltrials.gov/study/NCT05291091 RECRUITING Becker Muscular Dystrophy DRUG: Sevasemten 10 mg

NCT04648462 Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology https://clinicaltrials.gov/study/NCT04648462 RECRUITING Astrocytoma

NCT06585462 Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity https://clinicaltrials.gov/study/NCT06585462 RECRUITING Cardiometabolic Disease DRUG: AMG 513

NCT04984291 Zimmer Biomet Shoulder Arthroplasty PMCF https://clinicaltrials.gov/study/NCT04984291 RECRUITING Shoulder Fractures

NCT05487391 A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection. https://clinicaltrials.gov/study/NCT05487391 RECRUITING Carcinoma, Non-Small-Cell Lung DRUG: QL1706 injection

NCT06315491 A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer https://clinicaltrials.gov/study/NCT06315491 RECRUITING Platinum-resistant Ovarian Cancer

NCT06203691 Nirvana Super Pro Supplementation in Orthopedic Surgery Patients https://clinicaltrials.gov/study/NCT06203691 RECRUITING Arthropathy of Knee

NCT06159491 Pacritinib in CMML https://clinicaltrials.gov/study/NCT06159491 RECRUITING Chronic Myelomonocytic Leukemia DRUG: Pacritinib

NCT03271762 Multicentre Study of MITRACLIP¬Æ Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery https://clinicaltrials.gov/study/NCT03271762 RECRUITING Mitral Regurgitation DEVICE: percutaneous mitral valve repair with MITRACLIP NT, MITRACLIP NTR/XTR, MITRACLIP G4NT/XT, MITRACLIP G4NTW/XTW

NCT05208762 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05208762 RECRUITING Carcinoma, Non-Small-Cell Lung

NCT05766462 Allometric-Pace Study https://clinicaltrials.gov/study/NCT05766462 RECRUITING Sinus Node Dysfunction OTHER: Pacemaker lower rate setting Medtronic Cardiac Rhythm and Heart Failure

NCT06646562 Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ‚â• 60 Years for 24 https://clinicaltrials.gov/study/NCT06646562 NOT_YET_RECRUITING HIV-1 Infected Adults with Controlled Viremia DRUG: Cabotegravir LA + Rilpivirine LA Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia ViiV Healthcare

NCT05450562 Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05450562 RECRUITING Neoplasm BIOLOGICAL: SAR444200

NCT06300762 RCT Exudate Management Cutimed Sorbion Product Range https://clinicaltrials.gov/study/NCT06300762 RECRUITING Venous Leg Ulcer DEVICE: Superabsorbent dressing application BSN Medical GmbH

NCT04597476 A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck https://clinicaltrials.gov/study/NCT04597476 RECRUITING Squamous Cell Carcinomas of the Head and Neck DIETARY_SUPPLEMENT: Fucoidan

NCT06686576 A Study of Perioperative QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer https://clinicaltrials.gov/study/NCT06686576 NOT_YET_RECRUITING Colon Cancer BIOLOGICAL: QL1706

NCT06092476 Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients https://clinicaltrials.gov/study/NCT06092476 NOT_YET_RECRUITING Diabetes Mellitus, Type 2 DEVICE: Revita¬Æ DMR Treatment

NCT03851627 Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism https://clinicaltrials.gov/study/NCT03851627 RECRUITING Fatty Liver

NCT04695327 TNFŒ± and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy https://clinicaltrials.gov/study/NCT04695327 RECRUITING Solid Tumor BIOLOGICAL: TILT-123 TILT Biotherapeutics Ltd.

NCT05267327 A Prospective Post-Marketing Observational Safety Study of Verzenios¬Æ (Abemaciclib) Among Breast Cancer Patients in China Verzenios¬Æ (Abemaciclib) Among Breast https://clinicaltrials.gov/study/NCT05267327 NOT_YET_RECRUITING The Incidence of AEs and SAEs Receiving Verzenios¬Æ Over a Period of Approximately 24 Weeks OTHER: Verzenios Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Eli Lilly and Company

NCT04406727 UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection https://clinicaltrials.gov/study/NCT04406727 NOT_YET_RECRUITING HIV-1 Infection BIOLOGICAL: UB-421

NCT05936827 Gyrocardiography- A New Non-invasive Cardiac Measurement Method to Measure Exercise Capacity and Cardiorespiratory Fitness https://clinicaltrials.gov/study/NCT05936827 RECRUITING Healthy DIAGNOSTIC_TEST: Ergometry

NCT05810727 Atrial Fibrillation Data Linkage Non-Interventional Study https://clinicaltrials.gov/study/NCT05810727 NOT_YET_RECRUITING Atrial Fibrillation Pfizer

NCT05945927 A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer https://clinicaltrials.gov/study/NCT05945927 RECRUITING Breast Cancer DRUG: Trastuzumab emtansine Hoffmann-La Roche

NCT06192927 Efficacy and Safety of TenoMiR in Lateral Epicondylitis https://clinicaltrials.gov/study/NCT06192927 RECRUITING Tennis Elbow DRUG: TenoMiR

NCT05701176 A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05701176 RECRUITING Advanced Stage Non-small Cell Lung Cancer DIAGNOSTIC_TEST: [18F]F-AraG PET scan Amsterdam UMC, location VUmc Boehringer Ingelheim

NCT04982276 A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma https://clinicaltrials.gov/study/NCT04982276 RECRUITING Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma BIOLOGICAL: AK109

NCT04457076 Evaluation of the Efficacy, Safety, and Tolerability of LevoCept https://clinicaltrials.gov/study/NCT04457076 NOT_YET_RECRUITING Contraception

NCT06429176 Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis https://clinicaltrials.gov/study/NCT06429176 RECRUITING Cystic Fibrosis DRUG: SPL84

NCT06291376 Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN) https://clinicaltrials.gov/study/NCT06291376 RECRUITING Immunoglobulin A Nephropathy

NCT05793476 Therapeutic Efficacy of Erbium:YAG Laser in Postpartum Patients With Episiotomy Scars https://clinicaltrials.gov/study/NCT05793476 RECRUITING Episiotomy Wound

NCT05437276 A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS) https://clinicaltrials.gov/study/NCT05437276 RECRUITING Gait Impairment Due to Mild/Moderate Multiple Sclerosis (MS) DEVICE: PoNS¬Æ Helius Medical Inc

NCT04519476 Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy. https://clinicaltrials.gov/study/NCT04519476 RECRUITING Refractory Multiple Myeloma DRUG: Selinexor

NCT06434727 Evaluating Intuitive 3D Models in Preoperative Surgical Planning for Thoracic and Colorectal Procedures. https://clinicaltrials.gov/study/NCT06434727 RECRUITING Thoracic

NCT06265727 A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors https://clinicaltrials.gov/study/NCT06265727 RECRUITING Solid Tumor, Adult DRUG: CRB-701 Corbus Pharmaceuticals Inc. CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

NCT05357027 HPV16 E6 TCR T Cells for Cervical Carcinoma https://clinicaltrials.gov/study/NCT05357027 RECRUITING Cervical Carcinoma BIOLOGICAL: TC-E202 cells

NCT06164327 Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma https://clinicaltrials.gov/study/NCT06164327 RECRUITING Relapsed/Refractory Diffuse Large B-Cell Lymphoma DRUG: BEBT-908 for Injection

NCT06514976 Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy https://clinicaltrials.gov/study/NCT06514976 RECRUITING Stroke, Acute

NCT06504927 Biomarker Discovery in Lung Cancer - Malaysia https://clinicaltrials.gov/study/NCT06504927 RECRUITING Lung Cancer University of Malaya MiRXES Pte Ltd

NCT06607627 PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis https://clinicaltrials.gov/study/NCT06607627 NOT_YET_RECRUITING Generalized Myasthenia Gravis

NCT06157827 A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma https://clinicaltrials.gov/study/NCT06157827 RECRUITING Advanced Neuroendocrine Carcinoma DRUG: LBL-024 for Injection

NCT05600127 Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer https://clinicaltrials.gov/study/NCT05600127 RECRUITING Urothelial Carcinoma DRUG: Avelumab Erasmus Medical Center Merck KGaA, Darmstadt, Germany

NCT05906576 Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients https://clinicaltrials.gov/study/NCT05906576 RECRUITING Crohn Disease DRUG: Infliximab Taizhou Mabtech Pharmaceutical Co.,Ltd

NCT06212076 Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients https://clinicaltrials.gov/study/NCT06212076 NOT_YET_RECRUITING Solid Tumor DRUG: IPG1094 Nanjing Immunophage Biotech Co., Ltd

NCT06537076 Safety and Efficacy of AR1005 in Patients with Lewy Body Disease https://clinicaltrials.gov/study/NCT06537076 RECRUITING Lewy Body Dementia DRUG: AR1005

NCT05359276 Data Analysis of Adult and Pediatric Participants With Acid Sphingomyelinase Deficiency (ASMD) on Early Access to Olipudase Alfa in France https://clinicaltrials.gov/study/NCT05359276 RECRUITING Acid Sphingomyelinase Deficiency (ASMD) DRUG: Olipudase alfa Sanofi

NCT06091176 Assessment of Efficacy and Safety of Amicomed¬Æ, for the Management of Essential Hypertension https://clinicaltrials.gov/study/NCT06091176 NOT_YET_RECRUITING Essential Hypertension

NCT06672276 To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency https://clinicaltrials.gov/study/NCT06672276 NOT_YET_RECRUITING Resistant to Gram-positive, Gram-negative and Anaerobic Bacteria DRUG: TQD3606 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT04927676 Hormones in Hypogonadotropic Hypogonadism https://clinicaltrials.gov/study/NCT04927676 RECRUITING AMH

NCT06318676 A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment https://clinicaltrials.gov/study/NCT06318676 RECRUITING Renal Impairment DRUG: Mezigdomide Celgene

NCT05285527 MiSight 1 Day Safety Post-Approval Study https://clinicaltrials.gov/study/NCT05285527 RECRUITING Myopia DEVICE: MiSight 1 Day Coopervision, Inc.

NCT03495427 PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores https://clinicaltrials.gov/study/NCT03495427 RECRUITING Prostate Cancer

NCT04523727 Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease https://clinicaltrials.gov/study/NCT04523727 RECRUITING Hyperphosphatemia Related to Chronic Kidney Disease DRUG: ferric citrate Keryx Biopharmaceuticals

NCT06317727 PULSed Field ablAtion of coloRectal Polyps https://clinicaltrials.gov/study/NCT06317727 NOT_YET_RECRUITING Colon Polyp DEVICE: Irreversible Electroporation using EndoVE(Endoscopic Vacuum Electrode) and electrical pulses generated using ePORE(electroporation device) King's College Hospital NHS Trust Mirai Medical

NCT06689176 Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion https://clinicaltrials.gov/study/NCT06689176 RECRUITING Bladder Cancer

NCT06461676 Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients With Hypoplastic Left Heart Syndrome (HLHS) https://clinicaltrials.gov/study/NCT06461676 NOT_YET_RECRUITING Hypoplastic Left Heart Syndrome DRUG: Ventrix Bio Extracellular Matrix Emory University Ventrix, Inc.

NCT04665076 Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors https://clinicaltrials.gov/study/NCT04665076 RECRUITING Plasma Cell Tumors BIOLOGICAL: Auto CAR-T

NCT06039176 Human/Machine Interface: What the HeartMate 3 ¬Æ Device Tells Us About the Future https://clinicaltrials.gov/study/NCT06039176 NOT_YET_RECRUITING LVAD

NCT05477576 Study of RYZ101 Compared with SOC in Pts W Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy https://clinicaltrials.gov/study/NCT05477576 RECRUITING GEP-NET

NCT05840276 Cryoneurolysis Prior to Total Knee Arthroplasty https://clinicaltrials.gov/study/NCT05840276 RECRUITING Post Operative Pain

NCT06397027 A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias https://clinicaltrials.gov/study/NCT06397027 NOT_YET_RECRUITING Refractory Acute Leukemia

NCT06356727 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling https://clinicaltrials.gov/study/NCT06356727 RECRUITING Heart Failure

NCT05766527 A Study of KM602 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05766527 NOT_YET_RECRUITING Advanced Solid Tumor BIOLOGICAL: KM602 Xuanzhu Biopharmaceutical Co., Ltd.

NCT06364527 Use of Aptar Digital Health's Respiratory Disease Management Platform for Asthma https://clinicaltrials.gov/study/NCT06364527 RECRUITING Asthma Chronic DEVICE: Aptar Digital Health respiratory disease management platform CoheroHealth Aptar Digital Health

NCT04329676 directSTIM Deep Brain Stimulation System Study https://clinicaltrials.gov/study/NCT04329676 RECRUITING Parkinson Disease PROCEDURE: Deep Brain Stimulation Aleva Neurotherapeutics SA

NCT06007976 LLLT to Reduce Low Back Pain https://clinicaltrials.gov/study/NCT06007976 RECRUITING Low Back Pain DEVICE: Erchonia¬Æ Trident Mayo Clinic Erchonia Corporation

NCT06436976 The Effect of Probiotics ATG-F4 in Cancer Patients https://clinicaltrials.gov/study/NCT06436976 RECRUITING Pancreatic Cancer

NCT06030076 A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque Psoriasis https://clinicaltrials.gov/study/NCT06030076 RECRUITING Plaque Psoriasis DRUG: Tildrakizumab Almirall, S.A.

NCT06518876 A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome https://clinicaltrials.gov/study/NCT06518876 NOT_YET_RECRUITING POEMS Syndrome BIOLOGICAL: KQ-2003 CAR T-cells Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

NCT05425576 OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition https://clinicaltrials.gov/study/NCT05425576 NOT_YET_RECRUITING Malignant Pleural Mesothelioma DRUG: OT-101 Oncotelic Inc.

NCT06249776 Gravity Stent-Retriever System for Reperfusion of Large Vessel Occlusion Stroke Trial https://clinicaltrials.gov/study/NCT06249776 RECRUITING Ischemic Stroke

NCT05556876 Effect of Oral Nutritional Supplements to Older Patients Discharged with a Rehabilitation Plan https://clinicaltrials.gov/study/NCT05556876 RECRUITING Nutritional Risk

NCT06441227 Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects https://clinicaltrials.gov/study/NCT06441227 RECRUITING Lipoprotein Disorder Disease DRUG: HRS-5346 tablets

NCT05957276 Global Patient Registry of Inherited Retinal Diseases https://clinicaltrials.gov/study/NCT05957276 RECRUITING Inherited Retinal Diseases OTHER: Standard of Care Janssen Research & Development, LLC

NCT01524276 Product Surveillance Registry https://clinicaltrials.gov/study/NCT01524276 RECRUITING Cardiac Rhythm Disorders

NCT05894876 A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature https://clinicaltrials.gov/study/NCT05894876 RECRUITING Idiopathic Short Stature OTHER: No treatment is given Novo Nordisk A/S

NCT04104776 A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas https://clinicaltrials.gov/study/NCT04104776 RECRUITING Advanced Solid Tumor

NCT04720976 JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04720976 RECRUITING Solid Tumor

NCT06539676 A Study to Compare Nighttime Aligners to Daytime Aligners https://clinicaltrials.gov/study/NCT06539676 RECRUITING Teeth Straightening

NCT06699576 ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma. https://clinicaltrials.gov/study/NCT06699576 NOT_YET_RECRUITING Osteosarcoma

NCT05091476 OcuDyne System in the Treatment of AMD https://clinicaltrials.gov/study/NCT05091476 RECRUITING Age-Related Macular Degeneration DEVICE: OPTiC System OcuDyne, Inc.

NCT05310227 Nerivio Device for Treatment of New Daily Headache Persistence (NDHP) https://clinicaltrials.gov/study/NCT05310227 RECRUITING New Daily Persistent Headache (NDPH) DEVICE: Nerivio Children's National Research Institute Theranica

NCT05645276 A Study of AK129 in Patients With Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT05645276 RECRUITING Advanced Malignant Tumors(Stage IA-IB) DRUG: AK129 IV infusion Akeso

NCT06550076 A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis https://clinicaltrials.gov/study/NCT06550076 RECRUITING Plaque Psoriasis DRUG: TAK-279 Takeda

NCT05970276 Non-Invasive At-Home Sleep Therapy System https://clinicaltrials.gov/study/NCT05970276 RECRUITING Sleep

NCT06357676 Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma https://clinicaltrials.gov/study/NCT06357676 NOT_YET_RECRUITING Mantle Cell Lymphoma PROCEDURE: Biospecimen Collection

NCT03150576 Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer https://clinicaltrials.gov/study/NCT03150576 RECRUITING Breast Cancer DRUG: Olaparib

NCT06430827 Clinical Study of Irinotecan Hydrochloride Liposome Combined With Capecitabine for Second-line Treatment in Patients With Advanced or Metastatic Biliary Tract Carcinoma https://clinicaltrials.gov/study/NCT06430827 NOT_YET_RECRUITING Biliary Tract Carcinoma DRUG: irinotecan hydrochloride liposome injection

NCT04691427 Effectiveness of Virtual Reality Vision Therapy - VERVE https://clinicaltrials.gov/study/NCT04691427 RECRUITING Convergence Insufficiency DEVICE: Virtual Eye Rotation Vision Exercises (VERVE) OculoMotor Technologies New Jersey Institute of Technology

NCT06205576 ACOART AVF RENEW: A Post Market Clinical Study https://clinicaltrials.gov/study/NCT06205576 RECRUITING Stenosis of Native Hemodialysis Arteriovenous Fistulas DEVICE: DCB catheter Acotec Scientific Co., Ltd

NCT04609176 Study of Camrelizumab (SHR-1210) and Apatinb Based Therapies for Alpha-fetoprotein (AFP)-Producing Gastric Cancer or Gastroesophageal Junction Adenocarcinoma https://clinicaltrials.gov/study/NCT04609176 RECRUITING Gastric Cancer DRUG: Camrelizumab plus Apatinib and SOX

NCT05682976 Ophthalmological Adverse Events of Tralokinumab in AD https://clinicaltrials.gov/study/NCT05682976 NOT_YET_RECRUITING Atopic Dermatitis Nantes University Hospital LEO Pharma

NCT03651076 Traxi Panniculus Retractor for Cesarean Delivery https://clinicaltrials.gov/study/NCT03651076 RECRUITING Obesity, Morbid

NCT05133076 Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based Medications https://clinicaltrials.gov/study/NCT05133076 RECRUITING Opioid-Induced Constipation BIOLOGICAL: Lactobacillus gasseri BGP345A

NCT06100276 Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS) https://clinicaltrials.gov/study/NCT06100276 RECRUITING Amyotrophic Lateral Sclerosis DRUG: AMT-162 UniQure Biopharma B.V.

NCT05322876 Feasibility of Reducing Cardiovascular Disease Risk Factors in Hispanics Through a Family-Based Community Intervention https://clinicaltrials.gov/study/NCT05322876 RECRUITING Cardiovascular Diseases

NCT06627127 A Study to Investigate the Feasibility and Respiratory Effects of Stimulating Two Functional Targets (neural And/or Muscular) for the Treatment of Obstructive Sleep Apnea https://clinicaltrials.gov/study/NCT06627127 RECRUITING Sleep Apnea

NCT05518227 Patient Satisfaction and Visual Outcomes After Bilateral PanOptix Implantation in Patients With Previous Multifocal Contact Lens https://clinicaltrials.gov/study/NCT05518227 RECRUITING Cataract DEVICE: The Clareon‚Ñ¢ PanOptix‚Ñ¢ Trifocal (toric and non-toric models) Vivid Laser Center Sengi

NCT06514027 Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations https://clinicaltrials.gov/study/NCT06514027 NOT_YET_RECRUITING Non Small Cell Lung Cancer DRUG: BEBT-109 Capsules

NCT05594927 Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP) https://clinicaltrials.gov/study/NCT05594927 RECRUITING Hepatocellular Carcinoma DRUG: Icaritin

NCT05387031 Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease https://clinicaltrials.gov/study/NCT05387031 RECRUITING Crohn Disease

NCT05772182 Non-invasive Tool to Assess Electrophysiological Mechanisms in Cardiac Arrhythmias https://clinicaltrials.gov/study/NCT05772182 RECRUITING Cardiac Arrhythmia DEVICE: ACORYS MAPPING SYSTEM Corify Care S.L. Hospital General Universitario Gregorio Mara√±on

NCT05902182 Study to Demonstrate the Efficacy and Safety of Convatec ConvaFoam‚Ñ¢ Silicone, ConvaFoam‚Ñ¢ Border and ConvaFoam‚Ñ¢ Non-adhesive Dressings to Protect Against Skin Breakdown https://clinicaltrials.gov/study/NCT05902182 NOT_YET_RECRUITING Skin Breakdown DEVICE: ConvaFoam ConvaTec Inc.

NCT04713982 Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease https://clinicaltrials.gov/study/NCT04713982 RECRUITING Huntington Disease DRUG: Deutetrabenazine Vanderbilt University Medical Center Teva Branded Pharmaceutical Products R&D, Inc.

NCT04056520 Clinical and Radiological Outcomes of Posterior Cervical Fusion With Medtronic Infinity Occipitocervical-Upper Thoracic (OCT) System https://clinicaltrials.gov/study/NCT04056520 RECRUITING Degenerative Disc Disease DEVICE: Medtronic Infinity Occipitocervical-Upper Thoracic System using the O-arm Imaging System and StealthStation Navigation system Ohio State University Medtronic

NCT06150820 A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease https://clinicaltrials.gov/study/NCT06150820 RECRUITING Pompe Disease (Late-onset) OTHER: No Intervention Astellas Gene Therapies

NCT06369831 HER2 Targeted Molecular Imaging in MBC Using 68Ga-ABS011 https://clinicaltrials.gov/study/NCT06369831 RECRUITING Metastatic Breast Cancer DIAGNOSTIC_TEST: 68Ga-NOTA-ABSCINT-HER2 PET/CT ABSCINT NV/SA

NCT06295731 INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS‚â•20 HNSCC https://clinicaltrials.gov/study/NCT06295731 RECRUITING Head and Neck Squamous Cell Carcinoma (HNSCC) DRUG: INBRX-106

NCT06255782 An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency (OTC-HOPE) https://clinicaltrials.gov/study/NCT06255782 RECRUITING Ornithine Transcarbamylase Deficiency

NCT01733082 The Mycophenolate Pregnancy Registry https://clinicaltrials.gov/study/NCT01733082 RECRUITING Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases Genentech, Inc. Accord Healthcare, Inc.

NCT05300282 Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients https://clinicaltrials.gov/study/NCT05300282 RECRUITING Relapsed or Refractory Hodgkin's Lymphoma DRUG: Atezolizumab

NCT05872282 Percutaneous Endovascular Arch Repair Trial (PEART) Study https://clinicaltrials.gov/study/NCT05872282 RECRUITING Aortic Diseases DEVICE: ZIPPER aortic arch stentgraft system Hangzhou Endonom Medtech Co., Ltd. Wayne W.Zhang , SeattleÔºåWashingtonÔºåUSA

NCT06418282 Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema https://clinicaltrials.gov/study/NCT06418282 RECRUITING Phlebolymphedema

NCT06567782 A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer https://clinicaltrials.gov/study/NCT06567782 NOT_YET_RECRUITING Neoplasms, Colon BIOLOGICAL: Dostarlimab

NCT05147220 Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) https://clinicaltrials.gov/study/NCT05147220 RECRUITING Relapsing Multiple Sclerosis DRUG: Remibrutinib

NCT06637631 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. https://clinicaltrials.gov/study/NCT06637631 NOT_YET_RECRUITING Crohn's Disease DRUG: SAR441566

NCT06441682 A Safety and Efficacy Study of ARGX-119 in Adult Patients with Amyotrophic Lateral Sclerosis (ALS) https://clinicaltrials.gov/study/NCT06441682 RECRUITING Amyotrophic Lateral Sclerosis BIOLOGICAL: ARGX-119

NCT05558982 BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma https://clinicaltrials.gov/study/NCT05558982 RECRUITING Metastatic Pancreatic Ductal Adenocarcinoma DRUG: BXCL701

NCT06543082 MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study https://clinicaltrials.gov/study/NCT06543082 RECRUITING Acute Coronary Syndrome DRUG: Colchicine 0.6 mg CHA University Biotronik SE & Co. KG

NCT04340882 Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade https://clinicaltrials.gov/study/NCT04340882 RECRUITING Metastatic Non-Small Lung Cell Cancer

NCT06701682 JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab https://clinicaltrials.gov/study/NCT06701682 NOT_YET_RECRUITING Acute Respiratory Distress Syndrome (ARDS)

NCT02819882 A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC) https://clinicaltrials.gov/study/NCT02819882 RECRUITING Breast Neoplasms OTHER: No intervention Spanish Breast Cancer Research Group Hoffmann-La Roche

NCT02773082 DBS for Obsessive-Compulsive Disorder https://clinicaltrials.gov/study/NCT02773082 RECRUITING Obsessive-Compulsive Disorder (OCD) DEVICE: Reclaim‚Ñ¢ DBS Therapy Northwell Health Medtronic

NCT06465420 A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine https://clinicaltrials.gov/study/NCT06465420 RECRUITING Haemophilus Influenzae Meningitis

NCT05489120 Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD) https://clinicaltrials.gov/study/NCT05489120 RECRUITING Chronic Kidney Disease Stage 3B

NCT06016920 Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT06016920 RECRUITING HPV Positive Oropharyngeal Squamous Cell Carcinoma

NCT05972720 A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma https://clinicaltrials.gov/study/NCT05972720 RECRUITING Cancer

NCT06121882 Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis https://clinicaltrials.gov/study/NCT06121882 RECRUITING Knee Osteoarthritis

NCT03767582 Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas. https://clinicaltrials.gov/study/NCT03767582 RECRUITING Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05007782 Study of GS-1811 Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05007782 RECRUITING Advanced Solid Tumor DRUG: GS-1811

NCT06120582 Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN) https://clinicaltrials.gov/study/NCT06120582 RECRUITING Hemophilia B GENETIC: ANB-002, dose 1

NCT05606120 H-35 CL TRAUMA Cemented Femoral Stem https://clinicaltrials.gov/study/NCT05606120 RECRUITING Arthroplasty

NCT06548620 A Study of RD06-04 in Patients With Active Autoimmune Diseases https://clinicaltrials.gov/study/NCT06548620 NOT_YET_RECRUITING SLE (Systemic Lupus)

NCT06572982 Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients https://clinicaltrials.gov/study/NCT06572982 NOT_YET_RECRUITING Acute Myeloid Leukemia DRUG: Azacitidine Hikma Pharmaceuticals LLC

NCT05486182 Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT05486182 RECRUITING Metastatic Breast Cancer DRUG: 18F Fluoroestradiol Radiopharmaceutical with PET/CT Zionexa GE Healthcare

NCT06384131 A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection https://clinicaltrials.gov/study/NCT06384131 RECRUITING Chronic Hepatitis B DRUG: ABI-4334

NCT03616782 Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL) https://clinicaltrials.gov/study/NCT03616782 RECRUITING Mantle Cell Lymphoma DRUG: Ixazomib Ho Sup Lee Takeda

NCT04686682 A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors https://clinicaltrials.gov/study/NCT04686682 RECRUITING NSCLC

NCT05596682 Prospective Multicenter Clinical Study on the Visual and Refractive Outcomes and Safety Outcomes Following Implantation of an AddOn Intraocular Lens in Previously Pseudophakic Eyes https://clinicaltrials.gov/study/NCT05596682 RECRUITING Presbyopia

NCT04919382 Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT04919382 RECRUITING Extensive Stage Lung Small Cell Carcinoma

NCT04058782 Impact of Peripheral Vascular Stiffness Assessment on Risk Prediction in Patients With Myocardial Infarction https://clinicaltrials.gov/study/NCT04058782 RECRUITING Myocardial Infarction

NCT06333782 Evaluation of the Safety and Efficacy of Hyaluronic Acid Injection in Labia Majora Augmentation https://clinicaltrials.gov/study/NCT06333782 RECRUITING Vulvar Atrophy DEVICE: Experimental- Genefill Contour¬Æ

NCT06479382 Study of the ETX-4143 2.0 Device in Subjects With Eye Pain https://clinicaltrials.gov/study/NCT06479382 NOT_YET_RECRUITING Eye Pain DEVICE: ETX-4143 2.0 EyeCool Therapeutics, Inc.

NCT06146920 Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation https://clinicaltrials.gov/study/NCT06146920 RECRUITING Melanoma

NCT04881682 Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) https://clinicaltrials.gov/study/NCT04881682 RECRUITING CIDP DEVICE: Immunoadsorption

NCT05324982 Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants https://clinicaltrials.gov/study/NCT05324982 RECRUITING Behavioral Pharmacology of Cannabis DRUG: Oral Placebo

NCT06389682 Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients https://clinicaltrials.gov/study/NCT06389682 RECRUITING Clear Cell Renal Cell Carcinoma Metastatic DRUG: 68Ga-NYM005 injection Norroy Bioscience Co., LTD

NCT06439082 A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) https://clinicaltrials.gov/study/NCT06439082 RECRUITING Sickle Cell Disease BIOLOGICAL: Crizanlizumab

NCT05692882 A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China https://clinicaltrials.gov/study/NCT05692882 RECRUITING Intracranial Arteriosclerosis

NCT05966220 Post Market Clinical Follow-up of Hip Surgery Using FH ORTHO Company Medical Devices. https://clinicaltrials.gov/study/NCT05966220 NOT_YET_RECRUITING Hip Surgery DEVICE: Hip surgery with FH Ortho devices FH ORTHO

NCT06149520 A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis https://clinicaltrials.gov/study/NCT06149520 RECRUITING Thrombolysis

NCT05029882 Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab https://clinicaltrials.gov/study/NCT05029882 RECRUITING Non-Small Cell Lung Cancer

NCT06679582 Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age with Relapsed/Refractory CBFA2T3::GLIS2 AML https://clinicaltrials.gov/study/NCT06679582 RECRUITING Acute Myeloid Leukemia (AML) DRUG: Luveltamab tazevibulin Sutro Biopharma, Inc. Children's Oncology Group (COG)

NCT05687682 Safety of AM-928 Infusion in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05687682 RECRUITING Advanced Solid Tumor BIOLOGICAL: AM-928 AcadeMab Biomedical Inc.

NCT06550882 A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea https://clinicaltrials.gov/study/NCT06550882 NOT_YET_RECRUITING Acquired Hemophilia A DRUG: OBIZUR Takeda

NCT04604782 A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients https://clinicaltrials.gov/study/NCT04604782 RECRUITING Myocardial Ischemia

NCT04652882 Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) https://clinicaltrials.gov/study/NCT04652882 RECRUITING Sleep Wake Disorders

NCT05967520 JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT05967520 RECRUITING Lupus Erythematosus, Systemic DRUG: JMKX000189

NCT06558682 Neoadjuvant Therapy in Cervical Cancer https://clinicaltrials.gov/study/NCT06558682 NOT_YET_RECRUITING Uterine Cervical Neoplasms DRUG: Disitamab Vedotin and Cisplatin Qilu Hospital of Shandong University RemeGen Co., Ltd.

NCT05417282 MW151 and Whole-brain Radiotherapy in Patients With Intracranial Metastases https://clinicaltrials.gov/study/NCT05417282 RECRUITING Cognitive Dysfunction, Cognitive Disorder DRUG: MW151 ImmunoChem Therapeutics, LLC National Cancer Institute (NCI)

NCT05661682 Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Adult Patients Requiring Long-term Parenteral Nutrition https://clinicaltrials.gov/study/NCT05661682 NOT_YET_RECRUITING Manganese Safety in Adults DRUG: Tralement

NCT03631420 Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants https://clinicaltrials.gov/study/NCT03631420 RECRUITING Bronchopulmonary Dysplasia BIOLOGICAL: Human Umbilical Cord Derived-Mesenchymal Stem Cells Meridigen Biotech Co., Ltd.

NCT05669482 Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer https://clinicaltrials.gov/study/NCT05669482 RECRUITING KRAS Activating Mutation

NCT06007482 A Study of ES009 in Subjects With Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06007482 RECRUITING Advanced Solid Tumor DRUG: ES009 Elpiscience Biopharma Australia Pty. Ltd.

NCT05133882 A Phase ‚Ö†b/‚Ö° Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML https://clinicaltrials.gov/study/NCT05133882 NOT_YET_RECRUITING Acute Myeloid Leukemia, Adult DRUG: Clifutinib Besylate Sunshine Lake Pharma Co., Ltd.

NCT03537482 APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies https://clinicaltrials.gov/study/NCT03537482 RECRUITING Hematologic Malignancies DRUG: APG-2575 Ascentage Pharma Group Inc.

NCT06293482 Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population https://clinicaltrials.gov/study/NCT06293482 RECRUITING Hearing Loss, Sensorineural

NCT06539182 DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8) https://clinicaltrials.gov/study/NCT06539182 RECRUITING Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma DRUG: DZD8586

NCT05955482 Pragmatic Assessment of the NuvoAir Clinical Service in the Management of Patients With Chronic Obstructive Pulmonary Disease https://clinicaltrials.gov/study/NCT05955482 RECRUITING COPD

NCT06413420 SUNOSI¬Æ (Solriamfetol) Pregnancy Registry https://clinicaltrials.gov/study/NCT06413420 RECRUITING Narcolepsy

NCT05898620 A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children with Rett Syndrome https://clinicaltrials.gov/study/NCT05898620 RECRUITING Rett Syndrome GENETIC: NGN-401 Neurogene Inc.

NCT04957329 Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells https://clinicaltrials.gov/study/NCT04957329 RECRUITING Glaucoma

NCT06199180 Pulsed Field Ablation Versus Conventional Radiofrequency Catheter Ablation for Repeat PVI in Patients With Paroxysmal AF https://clinicaltrials.gov/study/NCT06199180 NOT_YET_RECRUITING Atrial Fibrillation Recurrent DEVICE: pulmonary vein isolation with RFA

NCT05551780 Treatment of Calcific Total Occlusions in Peripheral Artery Disease https://clinicaltrials.gov/study/NCT05551780 RECRUITING Chronic Total Occlusion of Artery of the Extremities DEVICE: SoundBite Crossing System SoundBite Medical Solutions, Inc.

NCT06208280 F01 in the Treatment of Autoimmune Diseases https://clinicaltrials.gov/study/NCT06208280 RECRUITING Autoimmune Diseases DRUG: After preconditioning with Fludarabine and Cyclophosphamide, F01 will be evaluated. RenJi Hospital Shanghai Simnova Biotechnology Co.,Ltd.

NCT06236880 A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD https://clinicaltrials.gov/study/NCT06236880 RECRUITING Major Depressive Disorder DRUG: GM-2505 Gilgamesh Pharmaceuticals

NCT06347380 Usability Study of the FemPulse System https://clinicaltrials.gov/study/NCT06347380 RECRUITING Overactive Bladder DEVICE: FemPulse System FemPulse Corporation

NCT06229080 SEGWAY(Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization) https://clinicaltrials.gov/study/NCT06229080 RECRUITING Liver Cancer (Primary and Metastatic) DEVICE: NexGel Next Biomedical Co., Ltd.

NCT06413680 A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies https://clinicaltrials.gov/study/NCT06413680 RECRUITING Melanoma

NCT06363162 Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery https://clinicaltrials.gov/study/NCT06363162 RECRUITING Glioma DIAGNOSTIC_TEST: Immunohistochemistry or genetic test Beijing Tiantan Hospital West China Hospital

NCT04879329 A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 https://clinicaltrials.gov/study/NCT04879329 RECRUITING Urothelial Carcinoma DRUG: disitamab vedotin

NCT04528680 Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma https://clinicaltrials.gov/study/NCT04528680 RECRUITING Glioblastoma

NCT04052880 Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM https://clinicaltrials.gov/study/NCT04052880 RECRUITING Newly Diagnosed Multiple Myeloma DRUG: Daratumumab

NCT06031480 Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors https://clinicaltrials.gov/study/NCT06031480 NOT_YET_RECRUITING Hepatocellular Carcinoma DRUG: Anlotinib and TQB2450 Shanghai Zhongshan Hospital Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT06648980 Effect of a Nutritional Supplement with Phytoglycogen on Gut-brain Axis with Focus to Perceived Stress, Mood and Sleep https://clinicaltrials.gov/study/NCT06648980 NOT_YET_RECRUITING Perceived Stress DIETARY_SUPPLEMENT: Placebo

NCT06440980 A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or Overweight https://clinicaltrials.gov/study/NCT06440980 RECRUITING Healthy

NCT06321562 Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma https://clinicaltrials.gov/study/NCT06321562 RECRUITING Primary Open-angle Glaucoma DRUG: TimoD implant

NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2 https://clinicaltrials.gov/study/NCT06346392 RECRUITING Gastric Cancer

NCT05433792 To Evaluate the Effectiveness of New Specially Designed Fitlens Soft Lens. https://clinicaltrials.gov/study/NCT05433792 RECRUITING Myopia DEVICE: Myolens CN (Central-Near) soft contact lens

NCT06216392 Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis https://clinicaltrials.gov/study/NCT06216392 NOT_YET_RECRUITING Atopic Dermatitis BIOLOGICAL: GR1802 injection

NCT05086692 A Beta-only IL-2 ImmunoTherapY Study https://clinicaltrials.gov/study/NCT05086692 RECRUITING Advanced Solid Tumor

NCT05890092 Vulvar Disease in Nigeria Observational Study https://clinicaltrials.gov/study/NCT05890092 RECRUITING Vulvar Diseases

NCT04882592 Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy https://clinicaltrials.gov/study/NCT04882592 RECRUITING Cerebral Palsy DEVICE: SCiP SpineX Inc.

NCT05846789 Phase II Trial of Carboplatin +/- Tocilizumab for Metastatic Triple Negative and ER-low Breast Cancers https://clinicaltrials.gov/study/NCT05846789 RECRUITING Metastatic Breast Cancer

NCT05796089 Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy https://clinicaltrials.gov/study/NCT05796089 RECRUITING Extensive-Stage Small-Cell Lung Cancer RADIATION: Thoracic Radiotherapy

NCT05515289 Study of SHR6390 in Renal Insufficiency and Healthy Subjects https://clinicaltrials.gov/study/NCT05515289 RECRUITING Breast Cancer DRUG: SHR6390 Jiangsu HengRui Medicine Co., Ltd.

NCT04562129 IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients https://clinicaltrials.gov/study/NCT04562129 RECRUITING Melanoma Stage III

NCT04695080 ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis https://clinicaltrials.gov/study/NCT04695080 RECRUITING Advanced Multiple Sclerosis

NCT06323980 INHANCE Stemless Reverse Shoulder IDE https://clinicaltrials.gov/study/NCT06323980 NOT_YET_RECRUITING Arthroplasty

NCT05978180 Safety of Use and Efficacy of Pandora for Patients Suffering From Gonarthrosis (PANDORA2) https://clinicaltrials.gov/study/NCT05978180 RECRUITING Knee Osteoarthritis DEVICE: Medical Device : HO-1

NCT05517980 Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis https://clinicaltrials.gov/study/NCT05517980 NOT_YET_RECRUITING Glomerulonephritis DRUG: KP104 Kira Pharmacenticals (US), LLC.

NCT06209580 AMT-253 in Patients With Advanced Solid Tumours https://clinicaltrials.gov/study/NCT06209580 RECRUITING Malignant Melanoma

NCT04398680 A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic Function https://clinicaltrials.gov/study/NCT04398680 RECRUITING Multiple Myeloma DRUG: Belantamab mafodotin GlaxoSmithKline

NCT03945162 Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients https://clinicaltrials.gov/study/NCT03945162 RECRUITING Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG COMBINATION_PRODUCT: Ruvidar¬Æ (TLD-1433) Bladder infusion and PDT Theralase¬Æ Technologies Inc.

NCT06497062 Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06497062 NOT_YET_RECRUITING Acute Myeloid Leukemia DRUG: sonrotoclax

NCT05819580 Studying the Clinical Trial Experiences of Patients With Mesothelioma https://clinicaltrials.gov/study/NCT05819580 NOT_YET_RECRUITING Mesothelioma Power Life Sciences Inc.

NCT06253780 Multidisciplinary Study to Verify Blood Pressure Documentation and Response to Titration of Intravenous Medications https://clinicaltrials.gov/study/NCT06253780 RECRUITING Blood Pressure University of Texas Southwestern Medical Center Chiesi USA, Inc.

NCT03727880 Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma https://clinicaltrials.gov/study/NCT03727880 RECRUITING Resectable Pancreatic Ductal Adenocarcinoma (PDAC)

NCT04679662 EXPLORE DMR: Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation https://clinicaltrials.gov/study/NCT04679662 NOT_YET_RECRUITING Degenerative Mitral Valve Disease DEVICE: Transcatheter mitral valve repair (PLAR Implant and Delivery System) Polares Medical SA Polares Medical, Inc.

NCT04163562 Oral Immunotherapy for Peanut Allergic Patients https://clinicaltrials.gov/study/NCT04163562 RECRUITING Peanut Allergy DRUG: INP20

NCT06087289 A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer https://clinicaltrials.gov/study/NCT06087289 RECRUITING Epithelial Ovarian Cancer

NCT06193889 KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Refractory Generalized Myasthenia Gravis https://clinicaltrials.gov/study/NCT06193889 RECRUITING Myasthenia Gravis

NCT05538689 Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) https://clinicaltrials.gov/study/NCT05538689 RECRUITING Metrorrhagia

NCT06719089 Evaluation of the Safety and Performance of the Hydrustent¬Æ Biodegradable Hydrogel Ureteral Stent https://clinicaltrials.gov/study/NCT06719089 NOT_YET_RECRUITING Urinary Lithiasis DEVICE: Biodegradable double loop ureteral stent

NCT05400980 Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross(TM) Expander System & Retrieval Sheath https://clinicaltrials.gov/study/NCT05400980 RECRUITING Benign Prostatic Hyperplasia DEVICE: Urocross implant

NCT05568680 SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma https://clinicaltrials.gov/study/NCT05568680 RECRUITING Ovarian Cancer

NCT04789980 Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY https://clinicaltrials.gov/study/NCT04789980 RECRUITING Locally Advanced Pancreatic Cancer

NCT06014762 P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies https://clinicaltrials.gov/study/NCT06014762 RECRUITING Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

NCT06442462 Study of SPG302 in Adults With Schizophrenia https://clinicaltrials.gov/study/NCT06442462 RECRUITING Schizophrenia DRUG: SPG302

NCT05625529 ExoLuminate Study for Early Detection of Pancreatic Cancer https://clinicaltrials.gov/study/NCT05625529 RECRUITING Pancreas Cancer

NCT05960929 InfasurfAero‚Ñ¢ Versus Sham Treatment in Preterm Newborns With RDS https://clinicaltrials.gov/study/NCT05960929 NOT_YET_RECRUITING Respiratory Distress Syndrome (Neonatal)

NCT04419480 Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial https://clinicaltrials.gov/study/NCT04419480 RECRUITING Cardiogenic Shock

NCT05576480 SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer https://clinicaltrials.gov/study/NCT05576480 NOT_YET_RECRUITING Rectal Cancer

NCT05926180 Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients With EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19) https://clinicaltrials.gov/study/NCT05926180 RECRUITING Non-small Cell Lung Cancer DRUG: DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin) Dizal Pharmaceuticals

NCT06049680 Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD And/or PNAC in Pediatric and Adult Patients https://clinicaltrials.gov/study/NCT06049680 RECRUITING Malnutrition, Child

NCT03776162 A Comparison of ACL Repair With BEAR Device vs. Autograft Patellar Tendon ACL Reconstruction https://clinicaltrials.gov/study/NCT03776162 RECRUITING Anterior Cruciate Ligament Tear PROCEDURE: ACL Reconstruction (Bone Patellar Tendon Bone Graft)

NCT06257680 A Phase I Study on ReT01 ACT for the Treatment of Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06257680 RECRUITING Advanced Solid Tumor BIOLOGICAL: ReT01 ACT Aeonvital Biomedicine

NCT05393180 CONVERGE Post-Approval Study (PAS) https://clinicaltrials.gov/study/NCT05393180 RECRUITING Chronic Atrial Fibrillation DEVICE: Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF AtriCure, Inc.

NCT03423680 A Study of Abilify¬Æ Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression https://clinicaltrials.gov/study/NCT03423680 RECRUITING Depression, Bipolar DRUG: Abilify 2, 5, 10, 15mg (Tablet)

NCT04801680 Mpact 3D Metal Cup PMS https://clinicaltrials.gov/study/NCT04801680 RECRUITING Total Hip Arthroplasty DEVICE: Mpact 3D metal cup Medacta International SA

NCT04566380 ONO-4538 Phase II Rollover Study (ONO-4538-98) https://clinicaltrials.gov/study/NCT04566380 RECRUITING Pan-tumor DRUG: ONO-4538

NCT06097780 Efficacy and Safety of NestaCell¬Æ in Huntington's Disease https://clinicaltrials.gov/study/NCT06097780 NOT_YET_RECRUITING Huntington Disease GENETIC: NestaCell¬Æ Azidus Brasil Cellavita Pesquisa Cient√≠fica Ltda

NCT03892980 Robotic-Assisted da Vinci System Prophylactic Nipple-Sparing Mastectomy https://clinicaltrials.gov/study/NCT03892980 RECRUITING Nipple Sparing Mastectomy DEVICE: Nipple-Sparing Mastectomy Intuitive Surgical

NCT06581380 JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT06581380 NOT_YET_RECRUITING Small Cell Lung Cancer DRUG: JK-1201I

NCT05807880 Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma https://clinicaltrials.gov/study/NCT05807880 NOT_YET_RECRUITING Nasopharyngeal Neoplasms DRUG: The combination treatment of anlotinib, penpulimab and capecitabine. Sun Yat-sen University Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT06251180 Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT06251180 RECRUITING B-cell Non-Hodgkin Lymphoma DRUG: Rocbrutinib

NCT05692180 A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA) https://clinicaltrials.gov/study/NCT05692180 RECRUITING Asthma DRUG: Benralizumab

NCT04404062 Serological and PCR Testing for COVID-19 https://clinicaltrials.gov/study/NCT04404062 RECRUITING COVID-19 DIAGNOSTIC_TEST: Membrane-based immunoassay kit

NCT06073873 A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea https://clinicaltrials.gov/study/NCT06073873 RECRUITING Ulcerative Colitis DRUG: Ozanimod Bristol-Myers Squibb

NCT05882773 Asian Myeloproliferative Neoplasm (MPN) Registry https://clinicaltrials.gov/study/NCT05882773 RECRUITING Myeloproliferative Neoplasm

NCT06319573 The Impact of Personalized Prognostic Counseling on IVF Patient's Experience and Treatment Utilization https://clinicaltrials.gov/study/NCT06319573 RECRUITING Infertility OTHER: Counseling Supported by Univfy¬Æ Report

NCT06177431 An Open Label Extension Study of Monepantel in Individuals With Motor Neurone Disease https://clinicaltrials.gov/study/NCT06177431 RECRUITING Motor Neuron Disease DRUG: Monepantel Neurizon Therapeutics Limited Calvary Health Care Bethlehem

NCT04023331 67Cu-SARTATE‚Ñ¢ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma https://clinicaltrials.gov/study/NCT04023331 RECRUITING Neuroblastoma

NCT06473831 MagDI Australia Study https://clinicaltrials.gov/study/NCT06473831 RECRUITING Obesity

NCT05883631 RESOLVE-AF: Clinical Evaluation of the Ablacath‚Ñ¢ Mapping Catheter and Ablamap¬Æ System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. https://clinicaltrials.gov/study/NCT05883631 RECRUITING Atrial Fibrillation

NCT06021431 Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT https://clinicaltrials.gov/study/NCT06021431 RECRUITING Opioid Use Disorder DEVICE: MORE-VR

NCT05133531 A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment https://clinicaltrials.gov/study/NCT05133531 RECRUITING Paroxysmal Nocturnal Hemoglobinuria DRUG: Ravulizumab

NCT00567073 Pompe Pregnancy Sub-Registry https://clinicaltrials.gov/study/NCT00567073 RECRUITING Glycogen Storage Disease Type II (GSD-II)

NCT03654573 The MOCA I Study - Microvascular Obstruction With CoFI‚Ñ¢ System Assessment https://clinicaltrials.gov/study/NCT03654573 RECRUITING STEMI - ST Elevation Myocardial Infarction

NCT05750173 The EASE-IT CT Registry https://clinicaltrials.gov/study/NCT05750173 RECRUITING Transcatheter Aortic Valve Implantation (TAVI) OTHER: Streamlining of the pre-procedural patient pathway Institut f√ºr Pharmakologie und Pr√§ventive Medizin Edwards Lifesciences

NCT06456073 E-CEL UVEC Treatment for Anal Fissures https://clinicaltrials.gov/study/NCT06456073 RECRUITING Chronic Anal Fissure BIOLOGICAL: E-CEL UVEC cells (AB-207) Weill Medical College of Cornell University Angiocrine Bioscience

NCT06502873 Setting up a Cohort of Patients With Crohn's Disease and a Cohort of Patients Without Chronic Inflammatory Bowel Disease https://clinicaltrials.gov/study/NCT06502873 RECRUITING Crohn Disease PROCEDURE: biological samples collection Artialis

NCT06690931 Neurofeedback Rehabilitation with FES and VR for PD https://clinicaltrials.gov/study/NCT06690931 RECRUITING Parkinson Disease DEVICE: Brain-Computer Interface with FES and VR

NCT06122831 A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF) https://clinicaltrials.gov/study/NCT06122831 RECRUITING Myelofibrosis DRUG: TQ05105 Tablets

NCT06072131 To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL https://clinicaltrials.gov/study/NCT06072131 RECRUITING Peripheral T Cell Lymphoma DRUG: Belinostat Injection

NCT06688331 Treatment of Pre-diabetic State in Pediatric Population with Treg Cell Preparations and Rituximab https://clinicaltrials.gov/study/NCT06688331 NOT_YET_RECRUITING Presymptomatic Diabetes Type 1 (stage 1)

NCT06104631 A Prospective Trial in Patients With Crohn's Disease in Remission and Having Irritable Bowel Syndrome-like Symptoms https://clinicaltrials.gov/study/NCT06104631 NOT_YET_RECRUITING Irritable Bowel Syndrome-like Symptoms

NCT05294731 Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader https://clinicaltrials.gov/study/NCT05294731 RECRUITING B-cell Malignancy

NCT06318273 A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT06318273 RECRUITING Metastatic Castration-Resistant Prostate Cancer DRUG: ABBV-969 AbbVie

NCT06311773 Pivotal Trial of the Boomerang Catheter for pDVA https://clinicaltrials.gov/study/NCT06311773 NOT_YET_RECRUITING Chronic Limb-Threatening Ischemia DEVICE: Boomerang Catheter Aveera Medical, Inc.

NCT05172973 ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves https://clinicaltrials.gov/study/NCT05172973 RECRUITING Aortic Valve Insufficiency

NCT05845073 The Efficacy of a Probiotic for Antibiotic Associated Gastrointestinal Symptoms https://clinicaltrials.gov/study/NCT05845073 RECRUITING Antibiotic-associated Diarrhea DIETARY_SUPPLEMENT: Probiotic

NCT06662773 Drug-Drug Interaction (DDI) Study for TQB3616 https://clinicaltrials.gov/study/NCT06662773 NOT_YET_RECRUITING Healthy DRUG: TQB3616 capsule + itraconazole

NCT04581473 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection https://clinicaltrials.gov/study/NCT04581473 RECRUITING Gastric Adenocarcinoma

NCT05319873 Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer https://clinicaltrials.gov/study/NCT05319873 RECRUITING Anatomic Stage II Breast Cancer AJCC v8

NCT06556173 Phase 2a Study of VTX3232 in Parkinson's Disease https://clinicaltrials.gov/study/NCT06556173 RECRUITING Idiopathic Parkinson Disease DRUG: VTX3232 Zomagen Biosciences Ltd.

NCT04353973 Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Metastatic Cancer Patients https://clinicaltrials.gov/study/NCT04353973 RECRUITING Cancer OTHER: Pre-Test Intervention

NCT05597631 G-IVF and Sperm Parameters https://clinicaltrials.gov/study/NCT05597631 NOT_YET_RECRUITING Infertility, Male DEVICE: G-IVF PLUS Vitrolife

NCT05762731 Screening for Lung Cancer in Subjects With Family History of Lung Cancer https://clinicaltrials.gov/study/NCT05762731 RECRUITING Lung Cancer DIAGNOSTIC_TEST: Low dose CT thorax

NCT06246331 Evaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection https://clinicaltrials.gov/study/NCT06246331 RECRUITING Reversal of Neuromuscular Blockade Hanlim Pharm. Co., Ltd.

NCT05676931 Study With Immunotherapy Combinations in Participants With Metastatic Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05676931 RECRUITING Advanced Non-Small Cell Lung Cancer DRUG: Domvanalimab

NCT04347473 ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis. https://clinicaltrials.gov/study/NCT04347473 RECRUITING Psoriasis DRUG: Ilumya Injectable Product Psoriasis Treatment Center of Central New Jersey Sun Pharmaceutical Industries Limited

NCT06435273 A Randomised, Double-blind, Parallel Group, Placebo Controlled, 4-Week, Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma https://clinicaltrials.gov/study/NCT06435273 RECRUITING Asthma DRUG: AZD4604

NCT05301673 ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence https://clinicaltrials.gov/study/NCT05301673 RECRUITING Attention Deficit Hyperactivity Disorder

NCT05272631 Depuy Synthes Lower Extremity Shaft Nail Registry https://clinicaltrials.gov/study/NCT05272631 RECRUITING Femoral Fractures

NCT06519331 Development of a New Method for Liver Stiffness Measurement Using FibroScan https://clinicaltrials.gov/study/NCT06519331 NOT_YET_RECRUITING Liver Diseases DEVICE: Research FibroScan (FS) Echosens

NCT06321731 Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide/Glycopyrronium/Formoterol) in Spain. https://clinicaltrials.gov/study/NCT06321731 RECRUITING Chronic Obstructive Pulmonary Disease (COPD) AstraZeneca

NCT05011331 The Effect of a Custom Pillow on Sleep Quality in Patients With Nonoperative Rotator Cuff Syndrome https://clinicaltrials.gov/study/NCT05011331 RECRUITING Rotator Cuff Injuries DEVICE: MedCline Shoulder Relief System Rhode Island Hospital Amenity Health, Inc.

NCT05731973 Intercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum https://clinicaltrials.gov/study/NCT05731973 RECRUITING Pectus Excavatum

NCT04116073 INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer https://clinicaltrials.gov/study/NCT04116073 RECRUITING Pancreatic Cancer Non-resectable

NCT06661473 Interventional Study Exploring the Occurrence of Surgical Site Infections. https://clinicaltrials.gov/study/NCT06661473 RECRUITING Total Knee Arthroplasty

NCT05800873 Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001 https://clinicaltrials.gov/study/NCT05800873 RECRUITING Primary Membranous Nephropathy DRUG: EVER001 Everest Medicines (China) Co.,Ltd.

NCT05601973 Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI https://clinicaltrials.gov/study/NCT05601973 RECRUITING Non Small Cell Lung Cancer DRUG: Amivantamab

NCT06393673 A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women https://clinicaltrials.gov/study/NCT06393673 NOT_YET_RECRUITING Vasomotor Symptoms DRUG: HS-10384 tablet Dose 1

NCT04433273 Electrical Vestibular Stimulation (VeNS): Assessment of AMPK & SIRT1 Following Repeated Usage https://clinicaltrials.gov/study/NCT04433273 NOT_YET_RECRUITING Overweight and Obesity DEVICE: Electrical vestibular nerve stimulation Neurovalens Ltd. Compliance Solutions Ltd.

NCT03549273 Evaluation Glizigen¬Æ and Ocoxin¬Æ-Viusid¬Æ in High-grade Cervical Intraepithelial Lesions https://clinicaltrials.gov/study/NCT03549273 RECRUITING Carcinoma

NCT02880631 BAROSTIM THERAPY‚Ñ¢ In Resistant Hypertension https://clinicaltrials.gov/study/NCT02880631 RECRUITING Hypertension DEVICE: BAROSTIM NEO‚Ñ¢ System CVRx, Inc.

NCT05338931 Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT05338931 RECRUITING B-cell Non Hodgkin Lymphoma DRUG: AT101(Anti-CD19 Chimeric Antigen Receptor T cell) AbClon

NCT06494631 Xeltis Hemodialysis Access Graft (aXess) US Study https://clinicaltrials.gov/study/NCT06494631 NOT_YET_RECRUITING End Stage Renal Disease DEVICE: Xeltis Hemodialysis Access (aXess) graft Xeltis

NCT05327127 Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis https://clinicaltrials.gov/study/NCT05327127 RECRUITING NASH DRUG: K-877-ER

NCT06239727 Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response https://clinicaltrials.gov/study/NCT06239727 RECRUITING Nasopharyngeal Carcinoma DRUG: PD-1 blocking antibody

NCT04471727 A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001) https://clinicaltrials.gov/study/NCT04471727 RECRUITING Small-Cell Lung Cancer

NCT06605573 Lay User Evaluation of the Panbio‚Ñ¢ HCV Self-Test https://clinicaltrials.gov/study/NCT06605573 NOT_YET_RECRUITING HEPATITIS C (HCV) DIAGNOSTIC_TEST: Panbio‚Ñ¢ HCV Self Test Abbott Rapid Dx Aga Khan University

NCT05456373 Intraoperative Use of ClearEdge Device in Breast Conserving Surgery https://clinicaltrials.gov/study/NCT05456373 RECRUITING Breast Cancer DEVICE: ClearEdge device LS BioPath

NCT06671873 Study on Mass Balance of [14C]HMPL-306ÔºàIsocitrate Dehydrogenase InhibitorÔºâ in Healthy Chinese Adult Male Subjects https://clinicaltrials.gov/study/NCT06671873 RECRUITING Mass Balance Study DRUG: 100 ¬µCi [14C] HMPL-306 Hutchmed

NCT05250973 A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis https://clinicaltrials.gov/study/NCT05250973 RECRUITING Amyloidosis DRUG: Daratumumab

NCT06649773 The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients https://clinicaltrials.gov/study/NCT06649773 RECRUITING Type 2 Diabetes DRUG: Noiiglutide Injection

NCT05786573 A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre) https://clinicaltrials.gov/study/NCT05786573 RECRUITING Warm Autoimmune Hemolytic Anemia DRUG: Obexelimab

NCT06423573 A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez https://clinicaltrials.gov/study/NCT06423573 NOT_YET_RECRUITING Epidermolysis Bullosa, Dystrophic

NCT05988073 A Prospective Longitudinal Study in Adults with Multifocal Motor Neuropathy https://clinicaltrials.gov/study/NCT05988073 RECRUITING Multifocal Motor Neuropathy argenx

NCT05941273 A Study of the SING IMT in an Israeli Cohort https://clinicaltrials.gov/study/NCT05941273 NOT_YET_RECRUITING Age-Related Macular Degeneration

NCT06506773 Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF) https://clinicaltrials.gov/study/NCT06506773 RECRUITING Cystic Fibrosis Vertex Pharmaceuticals Incorporated

NCT05309473 Acoustic Stimulation During Restricted Sleep After Sleep Deprivation https://clinicaltrials.gov/study/NCT05309473 RECRUITING Sleep Deprivation

NCT03672773 Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT03672773 RECRUITING Recurrent Extensive Stage Small Cell Lung Carcinoma

NCT06415773 Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin https://clinicaltrials.gov/study/NCT06415773 RECRUITING T2DM (Type 2 Diabetes Mellitus) DRUG: HTD1801

NCT03486873 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) https://clinicaltrials.gov/study/NCT03486873 RECRUITING Solid Tumors

NCT05515367 A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study) https://clinicaltrials.gov/study/NCT05515367 RECRUITING Chronic Kidney Diseases

NCT06431373 A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis https://clinicaltrials.gov/study/NCT06431373 RECRUITING Uveitis, Posterior

NCT05606367 Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis(CREST) https://clinicaltrials.gov/study/NCT05606367 RECRUITING Coronary Artery Stenosis DEVICE: Non-slip Balloon Catheter of Shanghai MicroPort Rhythm

NCT04977167 Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma https://clinicaltrials.gov/study/NCT04977167 RECRUITING Solid Tumor

NCT05660967 Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma https://clinicaltrials.gov/study/NCT05660967 RECRUITING Diffuse Large B-Cell Lymphoma BIOLOGICAL: Epcoritamab

NCT01623167 Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia https://clinicaltrials.gov/study/NCT01623167 RECRUITING Severe Aplastic Anemia DRUG: Cohort 1: hATG, CsA, EPAG Day 14 to Month 6

NCT06548867 Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib https://clinicaltrials.gov/study/NCT06548867 RECRUITING Metastatic Renal Cell Carcinoma DRUG: Cabozantinib Gruppo Oncologico Italiano di Ricerca Clinica Yghea

NCT04501367 Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker. https://clinicaltrials.gov/study/NCT04501367 RECRUITING Vitrectomy

NCT06673667 First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants https://clinicaltrials.gov/study/NCT06673667 RECRUITING Healthy Participants Study DRUG: KT-621

NCT06521567 A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer https://clinicaltrials.gov/study/NCT06521567 NOT_YET_RECRUITING Melanoma DRUG: Cobolimab

NCT03947567 Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients. https://clinicaltrials.gov/study/NCT03947567 RECRUITING Hemophilia A DRUG: Recombinant Human Coagulation FVIII Sinocelltech Ltd.

NCT06063967 A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. https://clinicaltrials.gov/study/NCT06063967 RECRUITING Crohn's Disease DRUG: Risankizumab SC

NCT04918667 Effect of Gamma-cyclodextrin on the Bioavailability of Berberine https://clinicaltrials.gov/study/NCT04918667 NOT_YET_RECRUITING Drug Absorption COMBINATION_PRODUCT: Berberine incorporated in gamma cyclodextrin

NCT06346067 A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) https://clinicaltrials.gov/study/NCT06346067 RECRUITING Advanced or Metastatic NRAS-mutant Melanoma DRUG: Naporafenib

NCT06444867 A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968 https://clinicaltrials.gov/study/NCT06444867 RECRUITING Joint Pain

NCT06305767 A Clinical Study of V940 Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005) https://clinicaltrials.gov/study/NCT06305767 RECRUITING Bladder Cancer BIOLOGICAL: Pembrolizumab

NCT06310967 A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease https://clinicaltrials.gov/study/NCT06310967 NOT_YET_RECRUITING Hyperuricemia

NCT06422767 Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers https://clinicaltrials.gov/study/NCT06422767 NOT_YET_RECRUITING Hepatitis B DRUG: Bepirovirsen

NCT05337540 A Study to Evaluate the Efficacy, Safety and Tolerability of EVI-01 Intra-Articular Injection in Osteoarthritis of the Knee https://clinicaltrials.gov/study/NCT05337540 RECRUITING Osteoarthritis

NCT05701540 A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn https://clinicaltrials.gov/study/NCT05701540 RECRUITING Gastroesophageal Reflux Disease DRUG: Tegoprazan

NCT06333067 Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators https://clinicaltrials.gov/study/NCT06333067 RECRUITING Lax Skin DEVICE: Sofwave Sofwave Medical LTD

NCT04982367 Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis https://clinicaltrials.gov/study/NCT04982367 RECRUITING Peripheral Artery Disease DEVICE: Sirolimus-eluting balloon catheter

NCT03127267 Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients https://clinicaltrials.gov/study/NCT03127267 RECRUITING Amyotrophic Lateral Sclerosis DRUG: Masitinib (6.0)

NCT06018467 Senolytics to Improve Osteoporosis Therapy https://clinicaltrials.gov/study/NCT06018467 RECRUITING Osteopenia, Osteoporosis DRUG: Dasatinib 100 Mg Oral Tablet

NCT06383767 A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer https://clinicaltrials.gov/study/NCT06383767 RECRUITING Metastatic Breast Cancer DRUG: ESG401

NCT06394167 A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults https://clinicaltrials.gov/study/NCT06394167 RECRUITING Pain DRUG: VX-993

NCT04579367 Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia https://clinicaltrials.gov/study/NCT04579367 RECRUITING Hypercholesterolemia

NCT06109467 Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer https://clinicaltrials.gov/study/NCT06109467 RECRUITING GastroEsophageal Cancer

NCT05234567 A Prospective Sub-Study of the Global Hypophosphatasia Registry https://clinicaltrials.gov/study/NCT05234567 RECRUITING Hypophosphatasia BIOLOGICAL: Asfotase Alfa Alexion Pharmaceuticals, Inc.

NCT06528067 Mindful Motivation for Reducing Binge Eating https://clinicaltrials.gov/study/NCT06528067 NOT_YET_RECRUITING Binge Eating

NCT06262867 Early Allergen System Experience https://clinicaltrials.gov/study/NCT06262867 NOT_YET_RECRUITING Food Allergy in Infants DIETARY_SUPPLEMENT: Ready. Set. Food! Stage 1 Mix ins Prollergy dba Ready Set Food ObvioHealth

NCT05287867 Trial for Treating Painful Degenerative Disc Disease https://clinicaltrials.gov/study/NCT05287867 RECRUITING Degenerative Disc Disease BIOLOGICAL: Platelet-rich plasma (PRP), Platelet lysate (PL), and Platelet Poor Plasma (PPP)

NCT05330767 DermaClose DUKE Fasciotomy and Wound Study https://clinicaltrials.gov/study/NCT05330767 RECRUITING Wound of Skin DEVICE: DermaClose Continuous External Tissue Expander Device

NCT04942067 APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT04942067 RECRUITING Multiple Myeloma

NCT05460767 Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma https://clinicaltrials.gov/study/NCT05460767 RECRUITING Solid Tumors or Lymphoma BIOLOGICAL: IBI363 Innovent Biologics (Suzhou) Co. Ltd.

NCT06071767 Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1 https://clinicaltrials.gov/study/NCT06071767 RECRUITING HIV-1-infection BIOLOGICAL: ChAdOx1.tHIVconsv1

NCT05105867 CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies https://clinicaltrials.gov/study/NCT05105867 RECRUITING Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

NCT05090267 The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study https://clinicaltrials.gov/study/NCT05090267 RECRUITING Cognition

NCT06368167 A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma https://clinicaltrials.gov/study/NCT06368167 NOT_YET_RECRUITING Follicular Lymphoma DRUG: SHR2554 Jiangsu HengRui Medicine Co., Ltd.

NCT06035367 SKAMo-2: the Real-life Test of Continuous Photoacoustic Signal by Neogly in Patients With Type I Diabetes https://clinicaltrials.gov/study/NCT06035367 RECRUITING Diabetes DEVICE: Non-invasive continuous monitoring device to record photoacoustic signal Eclypia

NCT04405167 Tasquinimod for the Treatment of Relapsed or Refractory Myeloma https://clinicaltrials.gov/study/NCT04405167 RECRUITING Multiple Myeloma DRUG: Tasquinimod

NCT06716801 Real-world Clinical Response to Cenobamate Early Add-on in France, Germany and Spain https://clinicaltrials.gov/study/NCT06716801 NOT_YET_RECRUITING Focal Epilepsy with and Without Secondary Generalization DRUG: Cenobamate Aziende Chimiche Riunite Angelini Francesco S.p.A Iqvia Pty Ltd

NCT06643767 Evaluation of the Bexa Breast Examination https://clinicaltrials.gov/study/NCT06643767 RECRUITING Breast Cancer DEVICE: Bexa and focus ultrasound Sure, Inc. Hendrick Medical Center

NCT06153667 Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE) https://clinicaltrials.gov/study/NCT06153667 RECRUITING Uterine Fibroid DEVICE: Bearing nsPVA Merit Medical Systems, Inc.

NCT06326567 Comprehensive Connected Cancer Care (C4): Intervention Evaluation https://clinicaltrials.gov/study/NCT06326567 RECRUITING Cancer

NCT06717867 Long-Term PEA Safety Study https://clinicaltrials.gov/study/NCT06717867 NOT_YET_RECRUITING Healthy

NCT06052267 A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations https://clinicaltrials.gov/study/NCT06052267 RECRUITING Asthma DRUG: TEV-56248

NCT06385067 Treatment of Primary Coronary Artery Vascular Lesions With Biolimus Coated Coronary Balloon Dilation Catheter https://clinicaltrials.gov/study/NCT06385067 NOT_YET_RECRUITING Coronary Artery Disease DEVICE: Biolimus Coated Coronary Artery Balloon Dilation Catheter JW Medical Systems Ltd

NCT06651567 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia https://clinicaltrials.gov/study/NCT06651567 RECRUITING Agitation Associated With Alzheimer's Dementia DRUG: ITI-1284

NCT05872867 Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) https://clinicaltrials.gov/study/NCT05872867 RECRUITING Advanced Solid Tumor

NCT05797740 Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA) https://clinicaltrials.gov/study/NCT05797740 RECRUITING Multiple Sclerosis DRUG: Mavenclad Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

NCT05988840 Acquisition and Analysis of Relationships Between Longitudinal Emotional Signals Produced by an Artificial Intelligence Algorithm and Self-questionnaires Used in the Psychiatric Follow-up of Patients With Mood and/or Anxiety Disorders: a Real-Environment Study. https://clinicaltrials.gov/study/NCT05988840 NOT_YET_RECRUITING Anxiety Disorders

NCT05507827 Safety of Myeloablative Conditioning, Orca-T, and Allogeneic, Donor-Derived CD19/CD22-CAR (Chimeric Antigen Receptor) T Cells in Adults With B-cell Acute Lymphoblastic Leukemia (ALL) https://clinicaltrials.gov/study/NCT05507827 RECRUITING Lymphoid Leukemia DRUG: Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)

NCT06079827 Impact of Therapeutic Plasma Exchange on RNA Biomarker Expression Levels in Alzheimer's Patients https://clinicaltrials.gov/study/NCT06079827 RECRUITING Alzheimer Disease MaxWell Clinic, PLC

NCT06554873 Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders https://clinicaltrials.gov/study/NCT06554873 RECRUITING Smoking Cessation

NCT05311527 UroLift System With SAbR for Prostate Cancer and BPH https://clinicaltrials.gov/study/NCT05311527 RECRUITING Prostate Cancer DEVICE: Urolift

NCT06593327 NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study https://clinicaltrials.gov/study/NCT06593327 NOT_YET_RECRUITING Type 2 Diabetes

NCT05812027 A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05812027 RECRUITING Head and Neck Cancer

NCT06690827 Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN https://clinicaltrials.gov/study/NCT06690827 RECRUITING AML (Acute Myeloid Leukemia)

NCT06224673 ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT06224673 NOT_YET_RECRUITING HER2 Low Breast Carcinoma

NCT03072927 MILD¬Æ Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study https://clinicaltrials.gov/study/NCT03072927 RECRUITING Lumbar Spinal Stenosis DEVICE: MILD

NCT05393427 A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors https://clinicaltrials.gov/study/NCT05393427 RECRUITING Locally Advanced or Metastatic Urinary Tumors

NCT05983627 Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells in Patients With Acute Respiratory Distress Syndrome https://clinicaltrials.gov/study/NCT05983627 NOT_YET_RECRUITING Acute Respiratory Distress Syndrome BIOLOGICAL: Human Umbilical Cord Mesenchymal Stem Cells Asia Cell Therapeutics (Shanghai) Co., Ltd.

NCT06202027 Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA¬Æ in S. Korean Patients https://clinicaltrials.gov/study/NCT06202027 RECRUITING FGF23-related Hypophosphataemic Rickets and Osteomalacia DRUG: FGF23-related hypophosphataemic rickets and osteomalacia Kyowa Kirin Korea Co., Ltd.

NCT06048627 Anti-gingivitis Mouthrinse https://clinicaltrials.gov/study/NCT06048627 RECRUITING Gingivitis DRUG: Amine/zinc lactate/fluoride system

NCT05525273 Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma https://clinicaltrials.gov/study/NCT05525273 RECRUITING Craniopharyngioma DRUG: Oral dabrafenib and trametinib Eva Marie Erfurth, MD, PhD Novartis

NCT05678673 Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma https://clinicaltrials.gov/study/NCT05678673 RECRUITING Non-Clear Cell Renal Cell Carcinoma DRUG: XL092

NCT06352073 Dupilumab for Eosinophilic Esophagitis With Severe Strictures https://clinicaltrials.gov/study/NCT06352073 RECRUITING Eosinophilic Esophagitis

NCT06501573 A Study of SGB-9768 in Adult Healthy Volunteers https://clinicaltrials.gov/study/NCT06501573 NOT_YET_RECRUITING Healthy Volunteer DRUG: SGB-9768

NCT06145373 A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab https://clinicaltrials.gov/study/NCT06145373 RECRUITING Hemophilia A DRUG: Fitusiran (SAR439774)

NCT05564273 Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions https://clinicaltrials.gov/study/NCT05564273 RECRUITING Metabolic Health COMBINATION_PRODUCT: VIOME Precision Nutrition Program

NCT05879627 To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05879627 RECRUITING Advanced Solid Tumors DRUG: BAT8007 for injection Bio-Thera Solutions Zhejiang Tumor Hospital

NCT05917327 Performance and Safety of MEX-CD1 Low-volume Continuous Veno-venous Haemodialysis Medical Device for Copper-extraction in Patients With Wilson's Disease https://clinicaltrials.gov/study/NCT05917327 RECRUITING Hepatolenticular Degeneration; Wilson DEVICE: Low-volume continuous veno-venous haemodialysis Mexbrain Integrated Scientific Services (ISS) AG

NCT05822427 A Long-term Follow-up Study of Participants Who Received an Allogeneic CAR T-Cell Product https://clinicaltrials.gov/study/NCT05822427 RECRUITING Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study Precision BioSciences, Inc.

NCT04175327 Prospective and Non-randomized Registry of CardioCel 3D https://clinicaltrials.gov/study/NCT04175327 RECRUITING Intracardiac and Septal Defects

NCT03897127 Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagnosed AML and Intermediate- or Adverse Genetics https://clinicaltrials.gov/study/NCT03897127 RECRUITING Acute Myeloid Leukemia DRUG: Cytarabine

NCT06445127 Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging) https://clinicaltrials.gov/study/NCT06445127 RECRUITING Lupus Nephritis

NCT05735327 A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY https://clinicaltrials.gov/study/NCT05735327 RECRUITING Non-small Cell Lung Cancer (NSCLC) DRUG: No intervention Takeda

NCT06031727 CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I) https://clinicaltrials.gov/study/NCT06031727 RECRUITING Neovascular Age-related Macular Degeneration(nAMD) GENETIC: HG202 HuidaGene Therapeutics Co., Ltd. Tianjin Medical University Eye Hospital

NCT05479773 Safety and Usability of the LUMENA Non-invasive Ventilation Mask https://clinicaltrials.gov/study/NCT05479773 RECRUITING Respiratory Failure DEVICE: Standard NIV mask

NCT06141473 Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis https://clinicaltrials.gov/study/NCT06141473 RECRUITING Multiple Sclerosis DRUG: Frexalimab

NCT05869773 A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy https://clinicaltrials.gov/study/NCT05869773 RECRUITING Narcolepsy DRUG: JZP258 Jazz Pharmaceuticals

NCT05656573 CART-PSMA Cells for Advanced Prostate Cancer https://clinicaltrials.gov/study/NCT05656573 RECRUITING Prostate Cancer DRUG: CART-PSMA cells Nova Therapeutics LLC Chinese PLA General Hospital

NCT06634927 Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ¬Æ Injection in Healthy Subjects. https://clinicaltrials.gov/study/NCT06634927 RECRUITING Type 2 Diabetes DRUG: Ozempic¬Æ

NCT06483373 A Clinical Study of SPH7854 Granules in Healthy Subjects. https://clinicaltrials.gov/study/NCT06483373 RECRUITING Inflammatory Bowel Disease DRUG: SPH7854

NCT06651073 ATTR-CM: A Multi-country, Non-interventional Disease Registry https://clinicaltrials.gov/study/NCT06651073 NOT_YET_RECRUITING Transthyretin Amyloid Cardiopathy OTHER: Observational Pfizer

NCT05430373 GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors https://clinicaltrials.gov/study/NCT05430373 RECRUITING Solid Tumors, Adult BIOLOGICAL: GT101 Grit Biotechnology

NCT05711927 Sleep in SNOO Smart Sleeper Bassinet in Preterm Infants https://clinicaltrials.gov/study/NCT05711927 RECRUITING Prematurity

NCT06581627 A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants https://clinicaltrials.gov/study/NCT06581627 RECRUITING Healthy Volunteers

NCT06351527 Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 in Mature B-cell Malignancies https://clinicaltrials.gov/study/NCT06351527 NOT_YET_RECRUITING Mature B-cell Malignancies DRUG: ICP-248 InnoCare Pharma Inc.

NCT06212427 Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs) https://clinicaltrials.gov/study/NCT06212427 RECRUITING Premature Infant

NCT05866627 A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants https://clinicaltrials.gov/study/NCT05866627 RECRUITING Healthy Volunteers DRUG: Famotidine

NCT06314373 A Study for HSK39775 in Participants With Solid Tumors https://clinicaltrials.gov/study/NCT06314373 RECRUITING Advanced Solid Tumors DRUG: HSK39775 Monotherapy Xizang Haisco Pharmaceutical Co., Ltd

NCT05973773 REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) https://clinicaltrials.gov/study/NCT05973773 RECRUITING Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation DRUG: TAS6417 Taiho Oncology, Inc.

NCT05193227 Sustained Release Lidocaine for the Treatment of Postoperative Pain https://clinicaltrials.gov/study/NCT05193227 RECRUITING Postoperative Pain

NCT05431127 High Dose Inspiratory Muscle Training in LOPD https://clinicaltrials.gov/study/NCT05431127 RECRUITING Late-Onset Pompe Disease

NCT06487273 Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis https://clinicaltrials.gov/study/NCT06487273 NOT_YET_RECRUITING Non-cystic Fibrosis Bronchiectasis DEVICE: SIMEOX

NCT04647227 SEVENFACT¬Æ for Bleeding Events in Hemophilia With Inhibitors https://clinicaltrials.gov/study/NCT04647227 RECRUITING Hemophilia A With Inhibitor

NCT03985527 Janus Feasibility Study https://clinicaltrials.gov/study/NCT03985527 RECRUITING Sleep Apnea Syndromes DEVICE: Transvenous nerve stimulation Respicardia, Inc.

NCT04714827 Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT04714827 RECRUITING Multiple Myeloma BIOLOGICAL: KQ-2003 CAR-T cells Shanxi Province Cancer Hospital Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

NCT05162573 EBRT + Lu-PSMA for N1M0 Prostate Cancer https://clinicaltrials.gov/study/NCT05162573 RECRUITING Prostatic Neoplasm DRUG: 177Lu-PSMA-617

NCT05542173 Efficacy and Safety of BALI Association in the Treatment of Aphthous Ulcerations https://clinicaltrials.gov/study/NCT05542173 NOT_YET_RECRUITING Aphthous Stomatitis DRUG: BALI association

NCT05007873 ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase https://clinicaltrials.gov/study/NCT05007873 RECRUITING Chronic Phase Chronic Myelogenous Leukemia

NCT04792073 Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma https://clinicaltrials.gov/study/NCT04792073 RECRUITING Merkel Cell Carcinoma DRUG: Avelumab

NCT06282289 Elicitation of Steady-state Audiovisual Responses in 6- and 10-month-old Infants https://clinicaltrials.gov/study/NCT06282289 NOT_YET_RECRUITING Speech BEHAVIORAL: Magnetoencephalography (MEG)

NCT05629689 A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies https://clinicaltrials.gov/study/NCT05629689 RECRUITING Malignant Solid Tumor

NCT06080789 A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants with Acute Pancreatitis https://clinicaltrials.gov/study/NCT06080789 RECRUITING Acute Pancreatitis DRUG: RABI-767 Panafina, Inc.

NCT06629389 Clinical Trial with Cannabidiol (Kanbis¬Æ) for Parkinson Disease Symptoms https://clinicaltrials.gov/study/NCT06629389 RECRUITING Parkinson Disease DRUG: Cannabidiol 100 mg/ml

NCT05264389 Post-market Clinical Follow-up (PMCF) Study of the Poly-Tape Device for Medial Patellofemoral Ligament (MPFL) Reconstruction https://clinicaltrials.gov/study/NCT05264389 RECRUITING Medial Patellofemoral Dislocation DEVICE: Poly-Tape Xiros Ltd

NCT06646289 A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP) https://clinicaltrials.gov/study/NCT06646289 NOT_YET_RECRUITING X-Linked Retinitis Pigmentosa BIOLOGICAL: AAV5-hRKp.RPGR

NCT06058689 A Pilot Bioequivalence Study of Pomalidomide https://clinicaltrials.gov/study/NCT06058689 NOT_YET_RECRUITING Bioequivalence Study DRUG: Pomalidomide 4 MG Oral Capsule Megalabs

NCT00404989 Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women. https://clinicaltrials.gov/study/NCT00404989 RECRUITING HIV Infections

NCT05646589 A Person-centred Care Transition Support for People With Stroke/TIA https://clinicaltrials.gov/study/NCT05646589 RECRUITING Stroke

NCT05924789 Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America https://clinicaltrials.gov/study/NCT05924789 RECRUITING Gastric Cancer

NCT06171789 PRO1107 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06171789 RECRUITING Endometrial Cancer

NCT05142189 Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients with Advanced Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05142189 RECRUITING Non-Small Cell Lung Cancer BIOLOGICAL: BNT116

NCT06654089 A Study Evaluating Quality of Life Parameters Following Use of Emergen-C https://clinicaltrials.gov/study/NCT06654089 RECRUITING Dietary Supplements DIETARY_SUPPLEMENT: Emergen-C Core Super Orange Powder

NCT05417789 Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) https://clinicaltrials.gov/study/NCT05417789 RECRUITING TGCT DRUG: Emactuzumab

NCT06535789 Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes https://clinicaltrials.gov/study/NCT06535789 NOT_YET_RECRUITING Diabetes, Gestational

NCT05455489 GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the MitraClip G4 https://clinicaltrials.gov/study/NCT05455489 RECRUITING Mitral Valve Regurgitation Fondazione GISE Onlus University of Padova

NCT05498389 EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer https://clinicaltrials.gov/study/NCT05498389 NOT_YET_RECRUITING Metastatic Lung Non-Small Cell Carcinoma

NCT05850689 Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder https://clinicaltrials.gov/study/NCT05850689 RECRUITING Major Depressive Disorder DRUG: Lumateperone

NCT04801589 Goal-Directed Sedation in Mechanically Ventilated Infants and Children https://clinicaltrials.gov/study/NCT04801589 RECRUITING Delirium

NCT06547489 GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder https://clinicaltrials.gov/study/NCT06547489 NOT_YET_RECRUITING Major Depressive Disorder DRUG: zelquistinel Gate Neurosciences, Inc

NCT05095389 Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers https://clinicaltrials.gov/study/NCT05095389 NOT_YET_RECRUITING Diabetic Foot Ulcer DEVICE: ADRCs

NCT00571389 A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells. https://clinicaltrials.gov/study/NCT00571389 RECRUITING Solid Tumor, Adult

NCT06440889 A Clinical Study to Determine the Safety and Efficacy of Bio-Ray Knee Guard in Panelists With Varicose Vein and Knee Pain. https://clinicaltrials.gov/study/NCT06440889 NOT_YET_RECRUITING Varicose Veins With Self-declared Knee Pain DEVICE: Bio-Ray Knee Guard NovoBliss Research Pvt Ltd Winnox Cosmeceutics Sdn. Bhd

NCT05669989 International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab https://clinicaltrials.gov/study/NCT05669989 RECRUITING Plasma Cell Myeloma DRUG: Isatuximab intravenous (IV)

NCT06483789 Efficacy and Safety of HB-1 for Panic Disorder https://clinicaltrials.gov/study/NCT06483789 NOT_YET_RECRUITING Panic Disorder

NCT06552689 Sutra Hemi-valve First-in-Human Study https://clinicaltrials.gov/study/NCT06552689 NOT_YET_RECRUITING Mitral Regurgitation DEVICE: Sutra Hemi-valve Transcatheter Mitral Valve Replacement (TMVR) System Sutra Medical, Inc.

NCT06183489 Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma https://clinicaltrials.gov/study/NCT06183489 RECRUITING Smoldering Multiple Myeloma DRUG: Elranatamab Stichting European Myeloma Network Pfizer

NCT03736889 Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors https://clinicaltrials.gov/study/NCT03736889 RECRUITING MSI-H/dMMR Solid Tumors DRUG: Tislelizumab (BGB-A317) BeiGene

NCT06448689 Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and Psoriasis https://clinicaltrials.gov/study/NCT06448689 RECRUITING Atopic Dermatitis

NCT04850989 Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia https://clinicaltrials.gov/study/NCT04850989 RECRUITING Social Anxiety Disorder DEVICE: Pico Goblin VR headset Penn State University Limbix Health, Inc.

NCT06695689 An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours https://clinicaltrials.gov/study/NCT06695689 RECRUITING Solid Tumor DRUG: LM303 Suzhou BlueHorse Therapeutics Co., Ltd.

NCT06420089 CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL) https://clinicaltrials.gov/study/NCT06420089 RECRUITING T Cell Non-Hodgkin Lymphoma DRUG: Senza5 CART5 Vittoria Biotherapeutics University of Pennsylvania

NCT06539689 A Trail of Sperstent¬Æ Used for Residual Lesions of Femoropopliteal Arteries https://clinicaltrials.gov/study/NCT06539689 RECRUITING Peripheral Arterial Disease

NCT06278389 Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants https://clinicaltrials.gov/study/NCT06278389 RECRUITING Healthy Adult Participants DRUG: ACC017 tablets

NCT06633289 Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy https://clinicaltrials.gov/study/NCT06633289 NOT_YET_RECRUITING Cow's Milk Protein Allergy OTHER: Experimental formula

NCT05268289 Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V https://clinicaltrials.gov/study/NCT05268289 RECRUITING Lupus Nephritis DRUG: Iptacopan (part 1)

NCT05727189 A Study of Idazoxan in Healthy Participants https://clinicaltrials.gov/study/NCT05727189 RECRUITING Healthy DRUG: TR-01-XRR (1)

NCT06694389 Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ‚â•50 Years of Age https://clinicaltrials.gov/study/NCT06694389 RECRUITING COVID-19

NCT05701189 Evaluating Efgartigimod in Patients With Guillain-Barr√© Syndrome https://clinicaltrials.gov/study/NCT05701189 RECRUITING Guillain-Barre Syndrome DRUG: Efgartigimod Alfa-Fcab

NCT05395689 Efficacy and Safety Assessment of Beltavac¬Æ With Polymerized Extract of HDM https://clinicaltrials.gov/study/NCT05395689 RECRUITING House Dust Mite Allergy BIOLOGICAL: House dust mites allergoid from Dermatophagoides pteronyssinus and Dermatophagoides farinae

NCT02630589 Implantation of an Auditory Brainstem Implant for the Treatment of Incapacitating Unilateral Tinnitus https://clinicaltrials.gov/study/NCT02630589 RECRUITING Tinnitus DEVICE: Auditory brainstem implant University Medical Center Groningen MED-EL Elektromedizinische Ger√§te GesmbH

NCT06637189 Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A. https://clinicaltrials.gov/study/NCT06637189 NOT_YET_RECRUITING Stimulation in the Ovary

NCT03567889 Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients https://clinicaltrials.gov/study/NCT03567889 RECRUITING Melanoma Stage IIIB/C DRUG: Daromun

NCT06222489 Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT https://clinicaltrials.gov/study/NCT06222489 NOT_YET_RECRUITING Non-Small Cell Lung Carcinoma

NCT05409989 MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED‚Ñ¢ X‚Ñ¢) Post-Approval Study https://clinicaltrials.gov/study/NCT05409989 RECRUITING Intracranial Aneurysm DEVICE: FRED‚Ñ¢ X‚Ñ¢ Microvention-Terumo, Inc.

NCT05489289 A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection https://clinicaltrials.gov/study/NCT05489289 NOT_YET_RECRUITING Hepatocellular Carcinoma BIOLOGICAL: AK104

NCT06378489 The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study https://clinicaltrials.gov/study/NCT06378489 NOT_YET_RECRUITING Endometrial Hyperplasia Without Atypia DRUG: Etonogestrel implant University of the Philippines Organon

NCT06486467 Reliability of Minimally Trained Operator's Velocity-Time Integral Measurement Guided by Artificial Intelligence VTI https://clinicaltrials.gov/study/NCT06486467 NOT_YET_RECRUITING Velocity-time Integral Measurement

NCT05966467 Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies https://clinicaltrials.gov/study/NCT05966467 RECRUITING Neuromyelitis Optica Spectrum Disorder

NCT05087667 Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) ) https://clinicaltrials.gov/study/NCT05087667 RECRUITING Femoral Fracture DEVICE: Implantation of Ortholoop cerclage

NCT04347967 Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS) https://clinicaltrials.gov/study/NCT04347967 NOT_YET_RECRUITING Acute Respiratory Distress Syndrome BIOLOGICAL: UMC119-06 Meridigen Biotech Co., Ltd.

NCT05452889 PET Image in PAH Patients https://clinicaltrials.gov/study/NCT05452889 RECRUITING Pulmonary Arterial Hypertension DIAGNOSTIC_TEST: 18F-FGLN PET Imaging

NCT03865589 Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome https://clinicaltrials.gov/study/NCT03865589 RECRUITING Bone Marrow Transplant Complications

NCT06202989 Multiprofen-CC‚Ñ¢ to Reduce Pain After Total Knee Arthroplasty https://clinicaltrials.gov/study/NCT06202989 RECRUITING Postsurgical Pain DRUG: Multiprofen-CC‚Ñ¢ plus standard treatment

NCT05828589 A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies https://clinicaltrials.gov/study/NCT05828589 RECRUITING Relapsed Non-Hodgkin Lymphoma

NCT06452589 The Field PULSE Study https://clinicaltrials.gov/study/NCT06452589 RECRUITING Atrial Arrhythmias DEVICE: FieldForce Ablation System Field Medical

NCT06279689 Echography Study_Anthropometric Measurements https://clinicaltrials.gov/study/NCT06279689 RECRUITING Healthy Subjects OTHER: Ultrasound scans Crossject

NCT05894889 Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC https://clinicaltrials.gov/study/NCT05894889 RECRUITING Stage IIIB(N2) Non-small Cell Lung Cancer

NCT03805789 The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant https://clinicaltrials.gov/study/NCT03805789 RECRUITING Acute-graft-versus-host Disease BIOLOGICAL: Alpha-1 antitrypsin (AAT)

NCT06651489 Efficacy of Guselkumab in Treating Hailey Hailey Disease https://clinicaltrials.gov/study/NCT06651489 NOT_YET_RECRUITING Hailey Hailey Disease DRUG: Guselkumab Yale University Janssen Scientific Affairs, LLC

NCT05296889 Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate¬Æ Cervical https://clinicaltrials.gov/study/NCT05296889 RECRUITING Spine Fracture

NCT05972967 Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab https://clinicaltrials.gov/study/NCT05972967 RECRUITING Paroxysmal Nocturnal Hemoglobinuria DRUG: OMS906 Study Drug - 3 mg/kg

NCT06436092 Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry) https://clinicaltrials.gov/study/NCT06436092 RECRUITING Stable Angina

NCT05692492 A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH) https://clinicaltrials.gov/study/NCT05692492 RECRUITING Nonalcoholic Steatohepatitis (NASH) DRUG: ZSP1601

NCT06072989 Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors https://clinicaltrials.gov/study/NCT06072989 RECRUITING Advanced Solid Tumor BIOLOGICAL: B4T2-001 autologous CAR-T Shanghai East Hospital Bio4T2 LLC

NCT04644289 WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC https://clinicaltrials.gov/study/NCT04644289 RECRUITING Epithelial Ovarian Cancer DRUG: olaparib

NCT06399289 Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy https://clinicaltrials.gov/study/NCT06399289 RECRUITING Hemophilia B BIOLOGICAL: Recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) CSL Behring

NCT06717789 Compex SP8.0 - Symptomatic Treatment of Musculoskeletal Pain https://clinicaltrials.gov/study/NCT06717789 NOT_YET_RECRUITING Musculoskeletal Conditions

NCT06180889 Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty https://clinicaltrials.gov/study/NCT06180889 RECRUITING Knee Arthroplasty, Total DRUG: Enoxaparin

NCT06201689 Radicle Energy 24: a Study of Health and Wellness Products on Fatigue and Related Health Outcomes https://clinicaltrials.gov/study/NCT06201689 RECRUITING Fatigue

NCT05740189 CBAS180 De-escalation Study https://clinicaltrials.gov/study/NCT05740189 RECRUITING Barrett's Esophagus

NCT03913689 StimRouter Registry Clinical Protocol https://clinicaltrials.gov/study/NCT03913689 RECRUITING Chronic Pain

NCT06369389 Real-life Management of Patients Eligible for CAR-T Cell Therapy https://clinicaltrials.gov/study/NCT06369389 NOT_YET_RECRUITING Hemopathy OTHER: Patients eligible for CAR-T treatment University Hospital, Toulouse Ligue contre le cancer, France

NCT06045689 A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants https://clinicaltrials.gov/study/NCT06045689 RECRUITING Myelodysplastic Syndromes DRUG: Luspatercept Bristol-Myers Squibb

NCT06084689 Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures https://clinicaltrials.gov/study/NCT06084689 NOT_YET_RECRUITING Adult Soft Tissue Sarcoma

NCT06542289 Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve Palsy https://clinicaltrials.gov/study/NCT06542289 NOT_YET_RECRUITING Bell's Palsy

NCT06362889 Evaluating Microneedling With CBD and Hempseed Oil for Acne Vulgaris Safety and Efficacy https://clinicaltrials.gov/study/NCT06362889 NOT_YET_RECRUITING Acne Vulgaris (Disorder) COMBINATION_PRODUCT: Microneedling with CBD Rejuva Medical Aesthetics HealMD, LLC

NCT06035289 Register Schweres Asthma - German Asthma Net e.V. https://clinicaltrials.gov/study/NCT06035289 RECRUITING Severe Asthma German Asthma Net e.V. AstraZeneca

NCT06100289 A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease https://clinicaltrials.gov/study/NCT06100289 NOT_YET_RECRUITING Ulcerative Colitis

NCT06625489 A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib https://clinicaltrials.gov/study/NCT06625489 NOT_YET_RECRUITING Idiopathic Pulmonary Fibrosis DRUG: Part A: Placebo

NCT06292689 A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer https://clinicaltrials.gov/study/NCT06292689 RECRUITING Vulvar and Vaginal Cancer DRUG: Cardunolizumab Zhejiang Cancer Hospital Akeso

NCT06044389 Observational Study on the Safety and Efficacy of the Medical Product Fructosin. https://clinicaltrials.gov/study/NCT06044389 NOT_YET_RECRUITING Fructose Intolerance DEVICE: Fructosin Sciotec Diagnostic Technologies GmbH

NCT04657289 A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome) https://clinicaltrials.gov/study/NCT04657289 RECRUITING Neovascular Age-related Macular Degeneration (nAMD) DRUG: Ranibizumab

NCT05773092 A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC https://clinicaltrials.gov/study/NCT05773092 RECRUITING NSCLC DRUG: Oral S-1 + Oral Osimertinib National Cancer Centre, Singapore Taiho Pharmaceutical Co., Ltd.

NCT06501092 To Assess the Utility of the Point Mini in a Clinical Take-home Study https://clinicaltrials.gov/study/NCT06501092 NOT_YET_RECRUITING Amputation; Traumatic, Hand

NCT06114992 Servo-n HFOV Study: Safety and Performance in Neonates and Infants https://clinicaltrials.gov/study/NCT06114992 RECRUITING Elective HFOV for Respiratory Failure in Neonates/Infants

NCT05971589 A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05971589 NOT_YET_RECRUITING Solid Tumor BIOLOGICAL: LM103 Suzhou BlueHorse Therapeutics Co., Ltd.

NCT05634889 The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases. https://clinicaltrials.gov/study/NCT05634889 RECRUITING Breast Cancer RADIATION: De-escalation Region Skane Exact Sciences Corporation

NCT03592472 A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV) https://clinicaltrials.gov/study/NCT03592472 RECRUITING Renal Cell Carcinoma DRUG: Pazopanib

NCT05641272 Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract https://clinicaltrials.gov/study/NCT05641272 NOT_YET_RECRUITING Allergic Rhinitis

NCT05383872 Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors https://clinicaltrials.gov/study/NCT05383872 RECRUITING Glioblastoma

NCT04794972 A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT04794972 RECRUITING Recurrent Glioma

NCT06101472 Rotational Stability and Clinical Response of the ASQELIO Toric Biaspheric Monofocal Lens. https://clinicaltrials.gov/study/NCT06101472 RECRUITING Cataract DEVICE: ASQELIO Toric Biaspheric Monofocal Lens AST Products, Inc.

NCT04189172 MiDura-Study (Neuro-Patch in Duraplasty) https://clinicaltrials.gov/study/NCT04189172 RECRUITING Meningioma

NCT05386472 A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19 https://clinicaltrials.gov/study/NCT05386472 RECRUITING COVID-19 DRUG: nirmatrelvir

NCT05924672 Efficacy of Ra-223 in PSMA PET Optimally Selected Patients https://clinicaltrials.gov/study/NCT05924672 RECRUITING Castration-Resistant Prostate Carcinoma

NCT06324604 Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients https://clinicaltrials.gov/study/NCT06324604 NOT_YET_RECRUITING Healthy Volunteers

NCT05880472 Percutaneous Holmium Injection in Pancreatic Cancer https://clinicaltrials.gov/study/NCT05880472 RECRUITING Pancreas Cancer DEVICE: Intratumoral Radboud University Medical Center Quirem Medical B.V.

NCT06637072 A Study to Assess Adults with CIDP Transitioning from IVIg to Efgartigimod PH20 SC https://clinicaltrials.gov/study/NCT06637072 NOT_YET_RECRUITING Chronic Inflammatory Demyelinating Polyneuropathy BIOLOGICAL: Efgartigimod PH20 SC argenx

NCT06221072 A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid https://clinicaltrials.gov/study/NCT06221072 NOT_YET_RECRUITING Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors DRUG: JMT103

NCT06548672 A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer https://clinicaltrials.gov/study/NCT06548672 RECRUITING Advanced Cancer

NCT04606472 A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04606472 RECRUITING Solid Tumor DRUG: SI-B003 Sichuan Baili Pharmaceutical Co., Ltd. SystImmune Inc.

NCT06049472 Patient Perspectives in Mantle Cell Lymphoma Clinical Research https://clinicaltrials.gov/study/NCT06049472 NOT_YET_RECRUITING Mantle Cell Lymphoma Power Life Sciences Inc.

NCT06289504 A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight https://clinicaltrials.gov/study/NCT06289504 RECRUITING Obesity DRUG: Cagrilintide

NCT06344572 Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia https://clinicaltrials.gov/study/NCT06344572 RECRUITING Myopia DEVICE: SAT-001

NCT05630872 Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis https://clinicaltrials.gov/study/NCT05630872 RECRUITING HIV-associated Tuberculosis DRUG: Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC

NCT02392572 ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome https://clinicaltrials.gov/study/NCT02392572 RECRUITING Recurrent Acute Lymphoblastic Leukemia

NCT06598072 Comparative Study to Evaluate the Efficacy of an Alcohol-free Mouthwash Regimen with CPC+Zn, Flossing and Brushing, and an Alcohol-based Mouthwash Regimen with Essential Oils in Reducing Plaque and Gingivitis. https://clinicaltrials.gov/study/NCT06598072 NOT_YET_RECRUITING Gingival Bleeding

NCT06399172 OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy https://clinicaltrials.gov/study/NCT06399172 NOT_YET_RECRUITING Locally Advanced Pancreatic Adenocarcinoma DEVICE: OncoSil OncoSil Medical Limited

NCT06527872 Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN https://clinicaltrials.gov/study/NCT06527872 RECRUITING Lupus Nephritis OTHER: None (Observational study) GlaxoSmithKline

NCT06165172 Early Feasibility Study of the MyoRegulator¬Æ for Treatment of ALS https://clinicaltrials.gov/study/NCT06165172 RECRUITING Amyotrophic Lateral Sclerosis DEVICE: MyoRegulator¬Æ PathMaker Neurosystems Inc. Spaulding Rehabilitation Hospital

NCT05012072 Reducing Pregnancy Risks: The Mastery Lifestyle Intervention https://clinicaltrials.gov/study/NCT05012072 RECRUITING Mental Health Wellness 1

NCT04958772 Biosimilarity Study of Subcutaneous Filgrastim in Healthy Volunteers https://clinicaltrials.gov/study/NCT04958772 NOT_YET_RECRUITING Healthy BIOLOGICAL: Filgrastim Megalabs

NCT05575804 GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT05575804 RECRUITING Advanced/ Metastatic Her-2 Positive Breast Cancer DRUG: GQ1001+pyrotinib

NCT04971772 SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries https://clinicaltrials.gov/study/NCT04971772 RECRUITING Peripheral Arterial Disease

NCT06687980 A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2) https://clinicaltrials.gov/study/NCT06687980 NOT_YET_RECRUITING Lichen Simplex Chronicus DRUG: Dupilumab

NCT06385262 TOP 2301: Neoadjuvant Chemo for NSCLC https://clinicaltrials.gov/study/NCT06385262 RECRUITING Non Small Cell Lung Cancer DRUG: Alirocumab

NCT06628362 A Study of CT-388 in Participants Who Are Overweight or Obese with Type 2 Diabetes Mellitus https://clinicaltrials.gov/study/NCT06628362 RECRUITING Overweight or Obese

NCT06386289 Safety, Performance of CEREGLIDE 92 Intermediate Catheter in Treatment of Acute Ischemic Stroke https://clinicaltrials.gov/study/NCT06386289 NOT_YET_RECRUITING Acute Ischemic Stroke DEVICE: Cereglide 92 Cerenovus, Part of DePuy Synthes Products, Inc.

NCT04440189 Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis https://clinicaltrials.gov/study/NCT04440189 RECRUITING Osteoarthritis, Knee DEVICE: GID SVF-2 Device System GID BIO, Inc.

NCT04672889 Use Babyguard¬Æ Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis https://clinicaltrials.gov/study/NCT04672889 RECRUITING Intestinal Bacteria Flora Disturbance DIETARY_SUPPLEMENT: Placebo

NCT05248789 OH2 Oncolytic Viral Therapy in Advanced Bladder Cancer https://clinicaltrials.gov/study/NCT05248789 RECRUITING Advanced Bladder Carcinoma BIOLOGICAL: OH2 injection Binhui Biopharmaceutical Co., Ltd.

NCT05421689 Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia https://clinicaltrials.gov/study/NCT05421689 RECRUITING Oropharyngeal Dysphagia BIOLOGICAL: Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR)

NCT06525389 Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST) https://clinicaltrials.gov/study/NCT06525389 NOT_YET_RECRUITING Talaromycosis DRUG: Liposomal Amphotericin B (LAmB)

NCT05469789 A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) https://clinicaltrials.gov/study/NCT05469789 RECRUITING Hereditary Angioedema (HAE) OTHER: No Intervention Takeda

NCT06050980 Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation https://clinicaltrials.gov/study/NCT06050980 RECRUITING NSCLC DRUG: HSK40118 Haisco Pharmaceutical Group Co., Ltd.

NCT05684380 Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER) https://clinicaltrials.gov/study/NCT05684380 NOT_YET_RECRUITING Allergic Rhinitis DRUG: MAZ-101association

NCT02977780 INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) https://clinicaltrials.gov/study/NCT02977780 RECRUITING Glioblastoma DRUG: Temozolomide

NCT06491862 RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platinum-based Chemotherapy in Brazil https://clinicaltrials.gov/study/NCT06491862 RECRUITING Non-squamous Non-Small Cell Lung Cancer AstraZeneca

NCT05088889 Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer https://clinicaltrials.gov/study/NCT05088889 RECRUITING Stage IV Pancreatic Cancer DRUG: Nivolumab

NCT05728840 Virtual-reality Exercises for Alleviating Attention Deficits in Patients with Acquired Brain Injury https://clinicaltrials.gov/study/NCT05728840 RECRUITING Stroke

NCT06709040 A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters https://clinicaltrials.gov/study/NCT06709040 NOT_YET_RECRUITING Growth Hormone Deficiency

NCT06641362 Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED) https://clinicaltrials.gov/study/NCT06641362 NOT_YET_RECRUITING Bradycardia

NCT06074562 A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain https://clinicaltrials.gov/study/NCT06074562 RECRUITING Diabetic Peripheral Neuropathy DRUG: LY3556050

NCT06203262 Ventricular Catheter Ablation Study (VCAS) https://clinicaltrials.gov/study/NCT06203262 RECRUITING Ventricular Tachyarrhythmia

NCT04954989 Biosimilarity Study of Intravenous Recombinant Human Erythropoietin in Healthy Volunteers https://clinicaltrials.gov/study/NCT04954989 NOT_YET_RECRUITING Healthy BIOLOGICAL: Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU

NCT05169489 A Study of bbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL) https://clinicaltrials.gov/study/NCT05169489 RECRUITING Diffuse Large B Cell Lymphoma (DLBCL) BIOLOGICAL: bbT369 2seventy bio

NCT01429389 Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy https://clinicaltrials.gov/study/NCT01429389 RECRUITING Down Syndrome

NCT05733962 Evaluation of the Efficacy and Safety of DBL-4pen Mobile Application in Patients With Type 2 Diabetes https://clinicaltrials.gov/study/NCT05733962 NOT_YET_RECRUITING Diabetes Mellitus, Type 2 DEVICE: Use of the device DBL-4pen Diabeloop Icadom

NCT05665062 Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies https://clinicaltrials.gov/study/NCT05665062 RECRUITING CLL/SLL

NCT05996562 Study for Evaluation of Safety and Efficacy of PADN to Treat Combined Post- and Pre- Capillary Pulmonary Hypertension Associated with Chronic Heart FailureÔºàPADN-CpcPH-PILOTÔºâ https://clinicaltrials.gov/study/NCT05996562 RECRUITING Pulmonary Hypertension

NCT06081062 Evaluate the Safety and Efficacy of Fabagal¬Æ (Agalsidase Beta) in Patients With Fabry Disease https://clinicaltrials.gov/study/NCT06081062 RECRUITING Fabry Disease BIOLOGICAL: Fabagal¬Æ (Agalsidase beta)

NCT06682962 Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma https://clinicaltrials.gov/study/NCT06682962 NOT_YET_RECRUITING Glaucoma

NCT05537662 External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) https://clinicaltrials.gov/study/NCT05537662 RECRUITING Chronic Pain DEVICE: Standard of care neuromodulation therapy (SCS or DRG) Abbott Medical Devices

NCT02836262 Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty https://clinicaltrials.gov/study/NCT02836262 RECRUITING Osteoarthritis of Hip DEVICE: HIT Hip Replacement System Hip Innovation Technology

NCT05063162 A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD) https://clinicaltrials.gov/study/NCT05063162 RECRUITING Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD) DRUG: Rozanolixizumab

NCT05778162 RISC Panel Remnant Sample Collection https://clinicaltrials.gov/study/NCT05778162 RECRUITING Arthritis, Inflammatory DIAGNOSTIC_TEST: Synovasure¬Æ RISC‚Ñ¢ Panel Zimmer Biomet

NCT05883462 Paclitaxel-Coated Nasal Balloon for the Treatment of Recurrent Chronic Rhinosinusitis With or Without Nasal Polyps (FIH) https://clinicaltrials.gov/study/NCT05883462 RECRUITING Chronic Rhinosinusitis COMBINATION_PRODUCT: Airiver Nasal Drug Coated Balloon (DCB) Catheter. Airiver Medical, Inc.

NCT06714162 A Dietary Supplement Examined for Anti-ageing Effects https://clinicaltrials.gov/study/NCT06714162 NOT_YET_RECRUITING Ageing Signs DIETARY_SUPPLEMENT: Longevity pill Prenetics Global San Francisco Research Institute

NCT06434662 Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AML https://clinicaltrials.gov/study/NCT06434662 RECRUITING Relapsed/Refractory Acute Myeloid Leukaemia

NCT05668962 Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC https://clinicaltrials.gov/study/NCT05668962 RECRUITING Thyroid Cancer

NCT04786262 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes https://clinicaltrials.gov/study/NCT04786262 RECRUITING Diabetes Mellitus, Type 1

NCT04307862 Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis https://clinicaltrials.gov/study/NCT04307862 RECRUITING Atopic Dermatitis DRUG: ZEP-3Na 0.1%

NCT06333262 Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia https://clinicaltrials.gov/study/NCT06333262 RECRUITING Chronic Lymphocytic Leukemia

NCT06632262 A Phase 2 Clinical Study of ABSK061 and ABSK043 https://clinicaltrials.gov/study/NCT06632262 RECRUITING HER2-Gastric/Gastroesophageal Junction Cancer

NCT06455462 Patient Characteristics, Treatment Patterns and Outcomes of Patients Enrolled in the Tezepelumab Patient Access Programme; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma Centres https://clinicaltrials.gov/study/NCT06455462 RECRUITING Severe Asthma DRUG: Tezepelumab AstraZeneca

NCT02469662 Clinical Outcomes Study of the Nexel Total Elbow https://clinicaltrials.gov/study/NCT02469662 RECRUITING Elbow Joint Destruction

NCT06715462 Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy https://clinicaltrials.gov/study/NCT06715462 NOT_YET_RECRUITING Painful Diabetic Peripheral Neuropathy (PDPN) DRUG: N0750

NCT06042062 Clinical Evaluation of Infection Control to Knee Periprosthetic Joint Infection (PJI) -United Cellbrick Knee Spacer https://clinicaltrials.gov/study/NCT06042062 RECRUITING Knee; Infection, Joint DEVICE: Novel spacer

NCT06590740 Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA Patients. https://clinicaltrials.gov/study/NCT06590740 NOT_YET_RECRUITING Cough-Variant Asthma DRUG: Budesonide-Formoterol treatment AstraZeneca

NCT06360640 A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults https://clinicaltrials.gov/study/NCT06360640 RECRUITING Healthy Subjects DRUG: APC148 and Placebo AdjuTec Pharma AS CTC Clinical Trial Consultants AB

NCT06104644 A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany (DELPHIN) https://clinicaltrials.gov/study/NCT06104644 RECRUITING Plaque Psoriasis DRUG: Deucravacitinib Bristol-Myers Squibb

NCT02833792 Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease https://clinicaltrials.gov/study/NCT02833792 RECRUITING Alzheimer Dementia DRUG: Human Mesenchymal Stem Cells and Lactated Riunger's Solution

NCT06261892 Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine https://clinicaltrials.gov/study/NCT06261892 RECRUITING Cervical Cancer DIAGNOSTIC_TEST: Collect HPV DNA from urine WomenX Biotech Limited Hong Kong Science and Technology Parks Corporation

NCT05665192 A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib https://clinicaltrials.gov/study/NCT05665192 RECRUITING Myelofibrosis Bristol-Myers Squibb

NCT06434792 Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease https://clinicaltrials.gov/study/NCT06434792 RECRUITING Chronic Obstructive Pulmonary Disease DRUG: Bronpass Tab.

NCT06705192 Study in Asymptomatic GRN-FTD Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 https://clinicaltrials.gov/study/NCT06705192 NOT_YET_RECRUITING Dementia

NCT03621592 VLU Dressing Study https://clinicaltrials.gov/study/NCT03621592 RECRUITING Venous Leg Ulcer DEVICE: Cutimed¬Æ Sorbact¬Æ

NCT05913089 A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05913089 RECRUITING Non Small Cell Lung Cancer DRUG: TQB2450 injection + Chemotherapy

NCT05027776 Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years https://clinicaltrials.gov/study/NCT05027776 RECRUITING HPV Infections

NCT05334576 Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA https://clinicaltrials.gov/study/NCT05334576 RECRUITING Sickle Cell Disease OTHER: Crizanlizumab Andria Ford Novartis Pharmaceuticals

NCT06431776 Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP). https://clinicaltrials.gov/study/NCT06431776 NOT_YET_RECRUITING Autoimmune Pulmonary Alveolar Proteinosis DRUG: Molgramostim Savara Inc.

NCT03827876 Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis https://clinicaltrials.gov/study/NCT03827876 RECRUITING Psoriasis DRUG: Enstilar 0.005%-0.064% Topical Foam Psoriasis Treatment Center of Central New Jersey LEO Pharma

NCT02777476 Clinical Performance of B-Lite¬Æ Light Weight Breast Implant https://clinicaltrials.gov/study/NCT02777476 RECRUITING Breast Implants DEVICE: B-Lite- Light Weight Breast Implants G&G Biotechnology Ltd.

NCT04146376 Von Willebrand Factor in Pregnancy (VIP) Study https://clinicaltrials.gov/study/NCT04146376 RECRUITING Von Willebrand Diseases OTHER: Use of a postpartum diary and additional blood draws

NCT05831176 A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis https://clinicaltrials.gov/study/NCT05831176 RECRUITING Eosinophilic Gastritis

NCT06721676 Study of Transcatheter Aortic Valve Replacement With A¬≤ Flex and Commissural Alignment Technology in Severe Aortic Stenosis https://clinicaltrials.gov/study/NCT06721676 NOT_YET_RECRUITING Aortic Stenosis Symptomatic DEVICE: transcatheter aortic valve replacement in severe aortic stenosis Peijia Medical Technology (Suzhou) Co., Ltd. Shanghai Zhongshan Hospital

NCT06633627 Neurological Responses in Patients with Dentine Hypersensitivity https://clinicaltrials.gov/study/NCT06633627 RECRUITING Dentine Hypersensitivity OTHER: Recording of brain activity using electroencephalography (EEG) Sheffield Teaching Hospitals NHS Foundation Trust University of Sheffield

NCT06415227 The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina Pectoris https://clinicaltrials.gov/study/NCT06415227 NOT_YET_RECRUITING Vasospastic Angina DRUG: Vericiguat Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Bayer

NCT05804227 Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Low-Grade Gliomas in Adults https://clinicaltrials.gov/study/NCT05804227 RECRUITING Gliomas DRUG: Ulixertinib M.D. Anderson Cancer Center BioMed Valley Discoveries, Inc

NCT04813627 Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy https://clinicaltrials.gov/study/NCT04813627 RECRUITING Colorectal Cancer Stage II

NCT03040973 Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone https://clinicaltrials.gov/study/NCT03040973 RECRUITING Advanced Solid Tumors Which Are cMET-dependent DRUG: Capmatinib

NCT05354973 ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy https://clinicaltrials.gov/study/NCT05354973 RECRUITING Patient Reported Outcome Measures

NCT04941573 Hyperpolarized MRI of Lung Transplants https://clinicaltrials.gov/study/NCT04941573 RECRUITING Lung Transplant Rejection COMBINATION_PRODUCT: Hyperpolarized 129-Xenon (MagniXene) MRI of the lung Xemed LLC University of Pennsylvania

NCT04201873 Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma https://clinicaltrials.gov/study/NCT04201873 RECRUITING Recurrent Glioblastoma BIOLOGICAL: Dendritic Cell Tumor Cell Lysate Vaccine

NCT06638073 Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC https://clinicaltrials.gov/study/NCT06638073 NOT_YET_RECRUITING Surgical Procedure, Unspecified

NCT06335173 A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants with Early Alzheimer's Disease (ALTITUDE-AD) https://clinicaltrials.gov/study/NCT06335173 RECRUITING Alzheimer Disease DRUG: sabirnetug

NCT05971576 A Clinical Study on TILs for the Treatment of Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05971576 NOT_YET_RECRUITING Solid Tumor BIOLOGICAL: LM103 Suzhou BlueHorse Therapeutics Co., Ltd.

NCT05813327 Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma https://clinicaltrials.gov/study/NCT05813327 RECRUITING Soft Tissue Sarcoma

NCT06391827 A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly Participants https://clinicaltrials.gov/study/NCT06391827 NOT_YET_RECRUITING Healthy DRUG: DA-7503 Single dose

NCT05705427 The COMBAT HBV Feasibility Trial https://clinicaltrials.gov/study/NCT05705427 RECRUITING Hepatitis B

NCT05776927 A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma. https://clinicaltrials.gov/study/NCT05776927 NOT_YET_RECRUITING Asthma DRUG: QVM149

NCT04064827 A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD) https://clinicaltrials.gov/study/NCT04064827 RECRUITING Chronic Kidney Disease (CKD)

NCT05171673 Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury https://clinicaltrials.gov/study/NCT05171673 RECRUITING Soft Tissue Injuries DRUG: Licart‚Ñ¢ (diclofenac epolamine) topical system IBSA Institut Biochimique SA

NCT05923073 A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease https://clinicaltrials.gov/study/NCT05923073 RECRUITING Crohn's Disease DRUG: Guselkumab

NCT06210373 Assessment of Efficacy and Safety of the Use of Two Eye Gel Products Containing 5% Dexpanthenol in Patients With Moderate to Severe Dry Eye Syndrome https://clinicaltrials.gov/study/NCT06210373 RECRUITING Dry Eye Disease DEVICE: Myrialen Gel

NCT06717373 Point-of-Care Echocardiography in Patients with Known or Suspected Aortic Stenosis https://clinicaltrials.gov/study/NCT06717373 NOT_YET_RECRUITING Patients with an Indication for an Echocardiographic Examination with Suspicion of Valcular Heart Disease DEVICE: AutoAS Caption Health, Inc.

NCT05040373 Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program https://clinicaltrials.gov/study/NCT05040373 RECRUITING Hereditary Transthyretin-mediated (hATTR) Amyloidosis

NCT05685173 A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Participants With Aggressive B-cell Non-Hodgkin Lymphomas https://clinicaltrials.gov/study/NCT05685173 RECRUITING B-cell Non-Hodgkins Lymphoma (B-NHL) DRUG: Odronextamab

NCT04709276 A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer https://clinicaltrials.gov/study/NCT04709276 RECRUITING Metastatic Prostate Neuroendocrine Carcinoma

NCT06326476 A Study to Demonstrate the Safety and Efficacy of Siplizumab in the Treatment of Hidradenitis Suppurativa https://clinicaltrials.gov/study/NCT06326476 NOT_YET_RECRUITING Hidradenitis Suppurativa DRUG: Siplizumab University of Alabama at Birmingham ITB-Med LLC

NCT05233527 Novosyn¬Æ Quick in Patients Undergoing Episiotomy Closure https://clinicaltrials.gov/study/NCT05233527 RECRUITING Episiotomy Wound PROCEDURE: Episiotomy Closure Aesculap AG B.Braun Surgical SA

NCT05048927 Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe Sepsis https://clinicaltrials.gov/study/NCT05048927 RECRUITING Severe Sepsis Bluejay Diagnostics, Inc.

NCT06368427 Change in Patient-repOrted Outcomes in COPD Patients Newly Initiated on TRIXEO AEROSPHERE in Real worlD https://clinicaltrials.gov/study/NCT06368427 RECRUITING Chronic Obstructive Pulmonary Disease (COPD) DRUG: budesonide / glycopyrronium / formoterol AstraZeneca

NCT05910827 Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers, and HMBD-001 + Cetuximab in Advanced Squamous Cell Cancers https://clinicaltrials.gov/study/NCT05910827 RECRUITING Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

NCT05483673 Analyzing Orthopedic Patient Experience Patterns in Medical Trials https://clinicaltrials.gov/study/NCT05483673 NOT_YET_RECRUITING Orthopedic Disorder Power Life Sciences Inc.

NCT05535673 Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma https://clinicaltrials.gov/study/NCT05535673 NOT_YET_RECRUITING Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL DRUG: ThisCART19A Zhengzhou University Fundamenta Therapeutics, Ltd.

NCT04649073 Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT04649073 RECRUITING Multiple Myeloma (MM) BIOLOGICAL: OPC-415 Otsuka Pharmaceutical Co., Ltd.

NCT06573073 Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation https://clinicaltrials.gov/study/NCT06573073 RECRUITING Non Small Cell Lung Cancer

NCT05705973 Ultimaster Nagomi‚Ñ¢ Sirolimus Eluting Coronary Stent System in Complex PCI Patients https://clinicaltrials.gov/study/NCT05705973 RECRUITING Cardiovascular Disease

NCT04034173 Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation https://clinicaltrials.gov/study/NCT04034173 NOT_YET_RECRUITING Treatment Related Cancer DRUG: Panitumumab

NCT05772273 PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT https://clinicaltrials.gov/study/NCT05772273 RECRUITING Acute Myeloid Leukemia DRUG: Azacitidine

NCT05196373 Safety, Tolerability, Pharmacokinetics, Immunogenicity and Efficacy of STP705 in Adult Patients With Hypertrophic Scars https://clinicaltrials.gov/study/NCT05196373 NOT_YET_RECRUITING Hypertrophic Scar DRUG: STP705 Sirnaomics

NCT05914376 Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors https://clinicaltrials.gov/study/NCT05914376 RECRUITING Advanced Solid Tumors BIOLOGICAL: Recombinant human IL-21-expressing oncolytic vaccinia virus injection Hangzhou Converd Co., Ltd.

NCT06715527 Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A Comparison https://clinicaltrials.gov/study/NCT06715527 RECRUITING Polycystic Ovarian Syndrome (PCOS) DIETARY_SUPPLEMENT: Myo-Inositol and D-Chiro-Inositol (40:1)

NCT06043427 Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma https://clinicaltrials.gov/study/NCT06043427 RECRUITING Gastroesophageal Adenocarcinoma DRUG: Paclitaxel

NCT06361927 A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients https://clinicaltrials.gov/study/NCT06361927 RECRUITING NSCLC DRUG: SSGJ-707 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

NCT05515627 Atezolizumab for Idiopathic Pulmonary Fibrosis https://clinicaltrials.gov/study/NCT05515627 RECRUITING Idiopathic Pulmonary Fibrosis DRUG: Atezolizumab Cedars-Sinai Medical Center Genentech, Inc.

NCT05975073 A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors https://clinicaltrials.gov/study/NCT05975073 RECRUITING MTAP-null Non-Small-Cell Lung Cancer

NCT05265273 A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis https://clinicaltrials.gov/study/NCT05265273 RECRUITING Myasthenia Gravis DRUG: Nipocalimab Janssen Research & Development, LLC

NCT05832073 Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1 https://clinicaltrials.gov/study/NCT05832073 NOT_YET_RECRUITING Rabies Virus Infection DRUG: Natural full human monoclonal antibody CBB 1 injection

NCT06448273 A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects https://clinicaltrials.gov/study/NCT06448273 RECRUITING Systemic Lupus Erythematosus DRUG: TQB3702 tablets

NCT05507073 A Comparison of Impingement Free Range of Motion With CT Scan After Manual and Robotic Total Hip Replacement https://clinicaltrials.gov/study/NCT05507073 RECRUITING Hip Osteoarthritis

NCT06719427 QEEG Brain Signature of Depression & Neuromodulation-induced Recovery https://clinicaltrials.gov/study/NCT06719427 NOT_YET_RECRUITING Major Depressive Diorder DEVICE: Transcranial Magnetic Stimulation Sunnybrook Health Sciences Centre Mitacs

NCT05422027 Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma https://clinicaltrials.gov/study/NCT05422027 RECRUITING Multiple Myeloma DRUG: Selinexor

NCT06718127 Description of the Immune Response to Yellow Fever Vaccination https://clinicaltrials.gov/study/NCT06718127 RECRUITING Immunization

NCT06385327 A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes https://clinicaltrials.gov/study/NCT06385327 RECRUITING Recurrent Genital Herpes Simplex Type 2 DRUG: ABI-5366

NCT06620627 Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection https://clinicaltrials.gov/study/NCT06620627 RECRUITING Colorectal Cancer Screening Natera, Inc.

NCT05900973 A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer https://clinicaltrials.gov/study/NCT05900973 RECRUITING Prostate Cancer DRUG: Darolutamide Oral Tablet [Nubeqa] D'Or Institute for Research and Education Bayer

NCT03958773 Cardiovalve Transfemoral System - FIM Study https://clinicaltrials.gov/study/NCT03958773 RECRUITING Mitral Regurgitation DEVICE: Cardiovalve transfemoral Mitral valve system Cardiovalve Ltd. Meditrial Europe Ltd.

NCT06099873 Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents with Influenza https://clinicaltrials.gov/study/NCT06099873 RECRUITING Respiratory Viral Infection DRUG: ZX-7101A

NCT06402773 A Safety Study in Human Subjects Evaluating the Use of the Signati System for Vasectomy https://clinicaltrials.gov/study/NCT06402773 RECRUITING Vasectomy DEVICE: The Signati Separo‚Ñ¢ Vessel Sealing System Signati Medical Inc

NCT06383273 A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR) https://clinicaltrials.gov/study/NCT06383273 RECRUITING Cataract DRUG: MELT-300 sublingual tablet

NCT06040827 A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension https://clinicaltrials.gov/study/NCT06040827 RECRUITING Knee Osteoarthritis DEVICE: Total Knee Arthroplasty Canary Medical

NCT05060627 Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide https://clinicaltrials.gov/study/NCT05060627 RECRUITING Relapsed Multiple Myeloma DRUG: Belantamab mafodotin

NCT06224127 Treating Stress and Anxiety in Individuals With Alcohol Use Disorder (AUD) https://clinicaltrials.gov/study/NCT06224127 NOT_YET_RECRUITING Anxiety Disorders

NCT06545227 Early Versus Late Monitoring Among Pregnant Women With a History of Gestational Diabetes https://clinicaltrials.gov/study/NCT06545227 RECRUITING Pregnancy Complications

NCT06553027 To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications https://clinicaltrials.gov/study/NCT06553027 RECRUITING Parkinson Disease DRUG: CVN424 75 mg

NCT06542627 Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study https://clinicaltrials.gov/study/NCT06542627 RECRUITING PreDiabetes

NCT02942927 Team Approach to Polypharmacy Evaluation and Reduction https://clinicaltrials.gov/study/NCT02942927 RECRUITING Multi-morbidity

NCT05702073 To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin. https://clinicaltrials.gov/study/NCT05702073 RECRUITING Type 2 Diabetes Mellitus DRUG: INS068 injection

NCT06232473 Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder https://clinicaltrials.gov/study/NCT06232473 RECRUITING Functional Disorder BEHAVIORAL: Patient Education

NCT05338073 KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models https://clinicaltrials.gov/study/NCT05338073 RECRUITING Cancer

NCT05349227 Comprehensive Outcomes for After Cancer Health https://clinicaltrials.gov/study/NCT05349227 RECRUITING Ovarian Cancer

NCT04216927 NO During CPB in Neonates to Reduce Risk of AKI https://clinicaltrials.gov/study/NCT04216927 RECRUITING AKI

NCT06277427 Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells https://clinicaltrials.gov/study/NCT06277427 RECRUITING Lupus Nephritis

NCT04534127 Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia https://clinicaltrials.gov/study/NCT04534127 RECRUITING Skin Cancer

NCT05095727 A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a) https://clinicaltrials.gov/study/NCT05095727 RECRUITING Glycogen Storage Disease DRUG: mRNA-3745 ModernaTX, Inc.

NCT05579327 Withdrawal of Tiratricol Treatment in Males with Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency) https://clinicaltrials.gov/study/NCT05579327 RECRUITING Monocarboxylate Transporter 8 Deficiency

NCT05583227 Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis https://clinicaltrials.gov/study/NCT05583227 RECRUITING Eosinophilic Esophagitis BIOLOGICAL: Tezepelumab

NCT05106127 Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem https://clinicaltrials.gov/study/NCT05106127 NOT_YET_RECRUITING Advanced Endometrial Cancer DRUG: EG-007

NCT05002127 A Study of Evorpacept (ALX148) in Patients with Advanced HER2+ Gastric Cancer (ASPEN-06) https://clinicaltrials.gov/study/NCT05002127 RECRUITING Gastric Cancer

NCT05051527 Study to Evaluate the Effectiveness of Legalon¬Æ https://clinicaltrials.gov/study/NCT05051527 RECRUITING Non-alcoholic Fatty Liver Disease (NAFLD) DRUG: Legalon¬Æ 140 mg Mylan Inc. Meda Pharma S.p.A.

NCT06470373 A Phase 3 Clinical Trial to Compare RBS-001 to Eylea¬Æ in Subjects with Neovascular Age-Related Macular Degeneration https://clinicaltrials.gov/study/NCT06470373 NOT_YET_RECRUITING Neovascular Age-related Macular Degeneration (nAMD) DRUG: RBS-001 Solution for intravitreal injection

NCT04069273 Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma https://clinicaltrials.gov/study/NCT04069273 RECRUITING Gastric Cancer

NCT04173273 A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease https://clinicaltrials.gov/study/NCT04173273 RECRUITING Crohn's Disease DRUG: Etrasimod

NCT06492876 Gene Therapy for DME https://clinicaltrials.gov/study/NCT06492876 RECRUITING Diabetic Macular Edema GENETIC: FT-003 Frontera Therapeutics

NCT05417776 Collagen-targeted PET Imaging for Early Interstitial Lung Disease https://clinicaltrials.gov/study/NCT05417776 RECRUITING Interstitial Lung Disease DRUG: [68Ga]CBP8

NCT05850676 Disentangling the Role of Depression in Hypersomnia https://clinicaltrials.gov/study/NCT05850676 RECRUITING Hypersomnia DIAGNOSTIC_TEST: Sleep study University of Pennsylvania Jazz Pharmaceuticals

NCT05672576 A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT05672576 RECRUITING Lupus Erythematosus, Systemic DRUG: Cenerimod

NCT06234527 Efficacy and Tolerability of the Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins https://clinicaltrials.gov/study/NCT06234527 NOT_YET_RECRUITING Hyperpigmentation OTHER: tested product Cosmetique Active International

NCT06560827 CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection https://clinicaltrials.gov/study/NCT06560827 RECRUITING HCC BIOLOGICAL: CT011 CAR-GPC3 T Cells Injection CARsgen Therapeutics Co., Ltd. Shanghai Zhongshan Hospital

NCT05103527 Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain https://clinicaltrials.gov/study/NCT05103527 RECRUITING Knee Osteoarthritis

NCT05188573 EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients https://clinicaltrials.gov/study/NCT05188573 NOT_YET_RECRUITING Pancreatic Cancer DEVICE: Early detection pancreatic cancer test

NCT05471973 CIED Infection Quality Initiative Demonstration Project https://clinicaltrials.gov/study/NCT05471973 RECRUITING Infections OTHER: Multidisciplinary Team

NCT02438631 Placental Passage and Disposition of Drugs: A Physiology-based Approach https://clinicaltrials.gov/study/NCT02438631 RECRUITING Pregnancy Radboud University Medical Center Janssen Pharmaceuticals

NCT05797831 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer https://clinicaltrials.gov/study/NCT05797831 RECRUITING Endometrial Cancer DRUG: Navtemadlin

NCT03665831 Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults https://clinicaltrials.gov/study/NCT03665831 RECRUITING Major Depressive Disorder

NCT05052931 Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer https://clinicaltrials.gov/study/NCT05052931 RECRUITING Gastric Cancer DRUG: Nab-paclitaxel combined with oxaliplatin and S-1 Jianjun Yang CSPC Ouyi Pharmaceutical Co., Ltd.

NCT04113382 Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy https://clinicaltrials.gov/study/NCT04113382 RECRUITING Bowel Preparation DRUG: CLENPIQ

NCT05330182 LMN-201 for Prevention of C. Difficile Infection Recurrence https://clinicaltrials.gov/study/NCT05330182 RECRUITING Clostridioides Difficile Infection DRUG: LMN-201

NCT05045482 Hepatic Impairment with Cirrhosis Due to Cholestatic Liver Disease https://clinicaltrials.gov/study/NCT05045482 RECRUITING Hepatic Impairment

NCT06676982 Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT06676982 NOT_YET_RECRUITING Advanced Hepatocellular Carcinoma BIOLOGICAL: anti-CD19 CAR-T Zhejiang University Juventas Cell Therapy Ltd.

NCT05271682 A Study Evaluating Safety, Tolerability and Clinical Activity of FHND6091 in Patients With Multiple Myeloma https://clinicaltrials.gov/study/NCT05271682 RECRUITING Multiple Myeloma DRUG: FHND6091 Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.

NCT06357182 Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06357182 RECRUITING Acute Myeloid Leukemia

NCT05834582 Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer https://clinicaltrials.gov/study/NCT05834582 RECRUITING TNBC - Triple-Negative Breast Cancer DRUG: Fluzoparib+Paclitaxel

NCT04637282 Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3 https://clinicaltrials.gov/study/NCT04637282 NOT_YET_RECRUITING Juvenile Neuronal Ceroid Lipofuscinosis DRUG: PLX-200

NCT05410782 Power Prenatal Supplements for Sperm Quality https://clinicaltrials.gov/study/NCT05410782 RECRUITING Spermatogenesis and Semen Disorders

NCT06142682 Dexamethasone Eluting Cochlear Implant: a Pivotal Study https://clinicaltrials.gov/study/NCT06142682 RECRUITING Cochlear Implant DEVICE: Cochlear Implant MED-EL Elektromedizinische Ger√§te GesmbH

NCT04755920 SGM-101 in Colorectal Brain Metastases. https://clinicaltrials.gov/study/NCT04755920 RECRUITING Rectal Neoplasms

NCT05901831 A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes https://clinicaltrials.gov/study/NCT05901831 RECRUITING Chronic Kidney Disease

NCT04521231 A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients https://clinicaltrials.gov/study/NCT04521231 RECRUITING B Cell Precursor Acute Lymphoblastic Leukemia DRUG: Blinatumomab Amgen

NCT06351631 A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) https://clinicaltrials.gov/study/NCT06351631 RECRUITING Thrombocythemia, Essential

NCT05735431 Non-Inferiority,Combination Formoterol/FluticasonexAlenia¬ÆFormoterol/Budesonide for Asthma in Brazil https://clinicaltrials.gov/study/NCT05735431 NOT_YET_RECRUITING Moderate Asthma DRUG: Administration of investigation drug

NCT06391931 A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective Surgery https://clinicaltrials.gov/study/NCT06391931 RECRUITING Anesthesia DRUG: Cipepofol

NCT03161431 SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab https://clinicaltrials.gov/study/NCT03161431 RECRUITING Melanoma Stage III

NCT06113731 A Phase‚Ö° Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine https://clinicaltrials.gov/study/NCT06113731 RECRUITING SARS-CoV-2 Infection BIOLOGICAL: COVID-19 mRNA Vaccine (ZSVG-02-O)

NCT04402931 Randomized Trial of Transcatheter Valve-in-Valve vs Redo Surgery for Bioprosthetic Mitral Dysfunction https://clinicaltrials.gov/study/NCT04402931 RECRUITING Mitral Prosthetic Valve Stenosis and Regurgitation PROCEDURE: Transcatheter Valve-in-Valve Intervention

NCT06003231 A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 https://clinicaltrials.gov/study/NCT06003231 RECRUITING Carcinoma, Squamous Cell of Head and Neck

NCT05933031 Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients https://clinicaltrials.gov/study/NCT05933031 RECRUITING Helicobacter Pylori Infection DRUG: Tegoprazan 50 mg Triple Therapy

NCT06213831 A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream https://clinicaltrials.gov/study/NCT06213831 RECRUITING Prurigo Nodularis DRUG: Ruxolitinib Cream 1.5% Incyte Corporation

NCT05731882 First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder https://clinicaltrials.gov/study/NCT05731882 RECRUITING Nonvalvular Atrial Fibrillation DEVICE: E-SeaLA, CardioPulse PFA system Hangzhou Dinova EP Technology Co., Ltd

NCT06687382 Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis https://clinicaltrials.gov/study/NCT06687382 NOT_YET_RECRUITING Diverticulitis

NCT05623982 Phase Ib/II Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT05623982 RECRUITING Non-hodgkin's Lymphoma DRUG: GNC-038 Sichuan Baili Pharmaceutical Co., Ltd. SystImmune Inc.

NCT05656482 Ability of a Cat Food to Reduce Respiratory Symptoms in Cat Allergic Patients https://clinicaltrials.gov/study/NCT05656482 RECRUITING Rhinitis, Allergic OTHER: Cats fed with PRO PLAN¬Æ LIVECLEAT¬Æ MASK-air SAS

NCT02451982 Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas https://clinicaltrials.gov/study/NCT02451982 RECRUITING Pancreatic Cancer DRUG: Cyclophosphamide

NCT05525182 Efficacy and Safety of ES16001 in Patients With COVID-19 https://clinicaltrials.gov/study/NCT05525182 RECRUITING COVID-19 DRUG: ES16001 40 mg

NCT05825131 Natural History Study of Participants With Sanfilippo Syndrome Type IIIC https://clinicaltrials.gov/study/NCT05825131 RECRUITING Sanfilippo Syndrome Type C Phoenix Nest Vaincres Les Maladies Lysosomales

NCT06545331 Study of XB010 in Subjects With Solid Tumors https://clinicaltrials.gov/study/NCT06545331 RECRUITING Locally Advanced or Metastatic Solid Tumors DRUG: XB010

NCT06441331 Phase I Trial to Determine the Dose and Evaluate the PK of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors https://clinicaltrials.gov/study/NCT06441331 NOT_YET_RECRUITING NET

NCT04965831 Furmonertinib as Perioperation Therapy in Stage IIIA-IIIB (N1-N2) Resectable EGFR Mutated Lung Adenocarcinoma (FRONT) https://clinicaltrials.gov/study/NCT04965831 NOT_YET_RECRUITING Lung Adenocarcinoma DRUG: Furmonertinib Tianjin Medical University Cancer Institute and Hospital Allist Pharmaceuticals, Inc.

NCT06072482 A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis https://clinicaltrials.gov/study/NCT06072482 RECRUITING Antineutrophil Cytoplasmic Antibody-associated Vasculitis DRUG: Avacopan

NCT06636682 FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer https://clinicaltrials.gov/study/NCT06636682 RECRUITING Prostate Cancer (Adenocarcinoma)

NCT05700682 Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee https://clinicaltrials.gov/study/NCT05700682 RECRUITING Osteoarthritis, Knee

NCT05409482 A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT05409482 RECRUITING Hepatocellular Carcinoma Meng Chao Hepatobiliary Hospital of Fujian Medical University Suzhou Suncadia Biopharmaceuticals Co., Ltd.

NCT06587282 PREEMIE: Study for Treatment of PDA in Premature Infants https://clinicaltrials.gov/study/NCT06587282 NOT_YET_RECRUITING Patent Ductus Arteriosus (PDA) DEVICE: Bloom Micro Occluder System Merit Medical Systems, Inc.

NCT06068582 Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis https://clinicaltrials.gov/study/NCT06068582 RECRUITING Multiple Sclerosis BEHAVIORAL: Strenghtening the brain

NCT06419582 BHV-7000 Acute Treatment of Bipolar Mania https://clinicaltrials.gov/study/NCT06419582 RECRUITING Bipolar Disorder DRUG: BHV-7000

NCT05313282 A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification https://clinicaltrials.gov/study/NCT05313282 RECRUITING C-staged Hepatocellular Carcinoma in BCLC Classification COMBINATION_PRODUCT: Hepatic Arterial Infusion combined with Apatinib and Camrelizumab

NCT04651673 Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA) https://clinicaltrials.gov/study/NCT04651673 RECRUITING Knee Osteoarthritis OTHER: This is a non interventional registry √ñssur Iceland ehf Region Skane

NCT05572073 Otoferlin Gene-mediated Hearing Loss Natural History Study https://clinicaltrials.gov/study/NCT05572073 RECRUITING Sensorineural Hearing Loss, Bilateral OTHER: Natural History Study Akouos, Inc. Eli Lilly and Company

NCT06495931 Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human https://clinicaltrials.gov/study/NCT06495931 NOT_YET_RECRUITING Type 2 Diabetes Mellitus DRUG: HRS-1780 tablets

NCT06310031 Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure https://clinicaltrials.gov/study/NCT06310031 RECRUITING Cardiovascular Diseases

NCT03767231 ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing https://clinicaltrials.gov/study/NCT03767231 NOT_YET_RECRUITING Hepatitis C DIAGNOSTIC_TEST: Xpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid) Johns Hopkins University Cepheid

NCT03784131 Tissue Engineered Veins in Patients With Chronic Venous Insufficiency https://clinicaltrials.gov/study/NCT03784131 RECRUITING Chronic Venous Insufficiency DRUG: P-TEV Verigraft AB

NCT06583031 Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years https://clinicaltrials.gov/study/NCT06583031 RECRUITING RSV Infection

NCT06299982 An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO https://clinicaltrials.gov/study/NCT06299982 NOT_YET_RECRUITING Plaque Psoriasis Patients DRUG: 608 Q2W

NCT06367582 Spine Bone Cements Outcomes - Post Market Follow-up https://clinicaltrials.gov/study/NCT06367582 RECRUITING Vertebral Fracture

NCT03270982 Comprehensive Segmental Revision System https://clinicaltrials.gov/study/NCT03270982 RECRUITING Degenerative Disease

NCT06244082 Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants with Mutations Amenable to Exon44 Skipping https://clinicaltrials.gov/study/NCT06244082 RECRUITING DMD

NCT03455582 Cognition Evolution and MRI Markers in PPMS Patients on 2 Years https://clinicaltrials.gov/study/NCT03455582 RECRUITING Multiple Sclerosis, Primary Progressive OTHER: Clinical assessment

NCT05079282 Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma https://clinicaltrials.gov/study/NCT05079282 RECRUITING Relapsed or Refractory T Cell Lymphoma DRUG: ONO-4685 Ono Pharmaceutical Co. Ltd

NCT05214482 A Study of AK112 in Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT05214482 RECRUITING Advanced Malignant Tumors DRUG: AK112

NCT05897320 A Study of Eptinezumab in Pediatric Participants With Episodic Migraine https://clinicaltrials.gov/study/NCT05897320 RECRUITING Episodic Migraine DRUG: Eptinezumab

NCT06072820 Analytical Evaluation of the Endotest¬Æ Diagnostic https://clinicaltrials.gov/study/NCT06072820 NOT_YET_RECRUITING Endometriosis

NCT04880473 Evaluation of the PrevisEA Device for Predicting Gastrointestinal Impairment https://clinicaltrials.gov/study/NCT04880473 RECRUITING Gastrointestinal Complication DEVICE: PrevisEA device Entac Medical Inc.

NCT06619873 A Phase 1, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects https://clinicaltrials.gov/study/NCT06619873 NOT_YET_RECRUITING Breast Cancer DRUG: HRS-8080 Shandong Suncadia Medicine Co., Ltd.

NCT05994131 IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC https://clinicaltrials.gov/study/NCT05994131 RECRUITING NSCLC DRUG: IN10018

NCT04747431 A Study of PBFT02 in Patients With Frontotemporal Dementia and Progranulin Mutations (FTD-GRN) https://clinicaltrials.gov/study/NCT04747431 RECRUITING Frontotemporal Dementia

NCT06598631 Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease https://clinicaltrials.gov/study/NCT06598631 RECRUITING Chronic Kidney Disease DRUG: Volenrelaxin

NCT05478382 Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects https://clinicaltrials.gov/study/NCT05478382 NOT_YET_RECRUITING Postoperative Pain

NCT03957382 Evaluation of Safety and Efficacy of the Accero¬Æ (Heal) Stent for Intracranial Aneurysm Treatment https://clinicaltrials.gov/study/NCT03957382 RECRUITING Intracranial Aneurysm DEVICE: Accero¬Æ (heal) Stent Acandis GmbH

NCT04260282 Microbiome and Exacerbations in Neutrophilic Asthma https://clinicaltrials.gov/study/NCT04260282 RECRUITING Asthma

NCT06537882 Evaluate the Effect of Synbiotics on MAFLD https://clinicaltrials.gov/study/NCT06537882 RECRUITING Metabolic Dysfunction-Associated Fatty Liver Disease DIETARY_SUPPLEMENT: G-NiiB synbiotics formula (SLP07)

NCT06625931 Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition https://clinicaltrials.gov/study/NCT06625931 NOT_YET_RECRUITING Parenteral Nutrition DRUG: NTCB01-1

NCT05117931 A Study of Amivantamab in People with Esophagogastric Cancer https://clinicaltrials.gov/study/NCT05117931 RECRUITING Esophagogastric Cancer DRUG: Amivantamab Memorial Sloan Kettering Cancer Center Janssen Pharmaceuticals

NCT06373731 ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) https://clinicaltrials.gov/study/NCT06373731 RECRUITING Age Related Macular Degeneration (ARMD) DRUG: Elamipretide

NCT05808231 Effectiveness and Safety of Quinine Sulfate as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia ( DEAL-COVID19 ) https://clinicaltrials.gov/study/NCT05808231 RECRUITING COVID-19 DRUG: Standard of Care + Quinine Sulfate

NCT06710431 A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder https://clinicaltrials.gov/study/NCT06710431 NOT_YET_RECRUITING Alcohol Abuse

NCT05223231 Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT05223231 RECRUITING Advanced Malignant Tumors DRUG: LBL-019 Injection

NCT05083182 A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis https://clinicaltrials.gov/study/NCT05083182 RECRUITING Arthritis, Juvenile DRUG: Ustekinumab

NCT05738382 Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures https://clinicaltrials.gov/study/NCT05738382 NOT_YET_RECRUITING Assisted Reproductive Technology

NCT06421831 Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 3 Patients https://clinicaltrials.gov/study/NCT06421831 RECRUITING Spinal Muscular Atrophy Type 3 GENETIC: GC101 GeneCradle Inc

NCT04675931 To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria https://clinicaltrials.gov/study/NCT04675931 RECRUITING Severe Malaria DRUG: KAE609

NCT05870631 Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT ) https://clinicaltrials.gov/study/NCT05870631 NOT_YET_RECRUITING Vaccine Reaction BIOLOGICAL: vaccinate with DTaP

NCT06701331 Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06701331 NOT_YET_RECRUITING Atopic Dermatitis DRUG: Placebo

NCT06311682 A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06311682 RECRUITING Atopic Dermatitis DRUG: Tralokinumab + TCS

NCT06111482 Clinical Study to Evaluate Different Energy-based Devices for Aesthetic Treatments. https://clinicaltrials.gov/study/NCT06111482 RECRUITING Dermatologic Conditions DEVICE: Intense pulsed light.

NCT06359782 Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH) https://clinicaltrials.gov/study/NCT06359782 NOT_YET_RECRUITING Subarachnoid Hemorrhage, Aneurysmal DRUG: C1 Esterase Inhibitor Injection [Cinryze]

NCT06171282 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors https://clinicaltrials.gov/study/NCT06171282 RECRUITING Osteosarcoma

NCT05210582 A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face https://clinicaltrials.gov/study/NCT05210582 RECRUITING Vitiligo DRUG: Afamelanotide Clinuvel, Inc.

NCT05023382 A Study of Teduglutide in Japanese People With Short Bowel Syndrome https://clinicaltrials.gov/study/NCT05023382 RECRUITING Short Bowel Syndrome DRUG: Teduglutide Takeda

NCT06585982 Synbiotics Impact on Insulin and TNF-Œ± in MAFLD: a Gut Microbiota Profile Analysis https://clinicaltrials.gov/study/NCT06585982 RECRUITING Fatty Liver Disease DIETARY_SUPPLEMENT: Treatment

NCT06049082 A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency https://clinicaltrials.gov/study/NCT06049082 RECRUITING Alpha 1-Antitrypsin Deficiency DRUG: KB408 (Nebulization) Krystal Biotech, Inc.

NCT06048120 A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection) https://clinicaltrials.gov/study/NCT06048120 RECRUITING Pulmonary Hypertension Due to Left Heart Disease DRUG: BAY2701250 IV

NCT06269120 SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary https://clinicaltrials.gov/study/NCT06269120 NOT_YET_RECRUITING Type 2 Diabetes DRUG: Oral Semaglutide Novo Nordisk A/S

NCT06665620 Optimizing a Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents https://clinicaltrials.gov/study/NCT06665620 NOT_YET_RECRUITING Suicide

NCT05324631 A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis https://clinicaltrials.gov/study/NCT05324631 RECRUITING Non-radiographic Axial Spondyloarthritis DRUG: SHR0302

NCT06541431 Analytical Validation of Stream‚Ñ¢ Platform https://clinicaltrials.gov/study/NCT06541431 NOT_YET_RECRUITING Gastrointestinal Diseases OTHER: Abdominal Drainage Fluid Collection FluidAI Medical Hamilton Health Sciences Corporation

NCT06470282 Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer https://clinicaltrials.gov/study/NCT06470282 NOT_YET_RECRUITING Bladder Cancer

NCT03655782 Retraining Neural Pathways Improves Cognitive Skills After A Mild Traumatic Brain Injury https://clinicaltrials.gov/study/NCT03655782 RECRUITING MTBI - Mild Traumatic Brain Injury BEHAVIORAL: PATH neurotraining

NCT06098482 An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App https://clinicaltrials.gov/study/NCT06098482 RECRUITING Hearing Loss DEVICE: Mobile Research App (MRA)

NCT05676320 Investigating Bone Cement With or Without Inossia‚Ñ¢ Cement Softener for Vertebral Compression Fractures https://clinicaltrials.gov/study/NCT05676320 RECRUITING Vertebral Compression Fracture DEVICE: V-Flex

NCT06075420 Evaluating Efficacy and Safety of Short Duration of DAPT After Genoss DES Stent Implantation in Patients https://clinicaltrials.gov/study/NCT06075420 RECRUITING Acute Coronary Syndrome

NCT06660173 A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) https://clinicaltrials.gov/study/NCT06660173 RECRUITING Type 2 Diabetes Mellitus (T2DM) DRUG: Maridebart Cafraglutide

NCT03513731 Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint https://clinicaltrials.gov/study/NCT03513731 RECRUITING Osteoarthritis of Facet Joint of Lumbar Spine DEVICE: Adipose-derived stem cell injection

NCT05319431 A Phase II Study of AK104 Plus Lenvatinib and TACE in HCC https://clinicaltrials.gov/study/NCT05319431 RECRUITING Unresectable, Non-metastatic Hepatocellular Carcinoma BIOLOGICAL: AK104

NCT05732831 Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors https://clinicaltrials.gov/study/NCT05732831 RECRUITING Locally Advanced Solid Tumor DRUG: TNG462 Tango Therapeutics, Inc.

NCT05610631 Pulmonary Hypertension Registry Switzerland https://clinicaltrials.gov/study/NCT05610631 RECRUITING Pulmonary Hypertension University of Zurich Actelion

NCT06428331 A Study of SKB518 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06428331 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: SKB518 for injection Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

NCT06492031 Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients https://clinicaltrials.gov/study/NCT06492031 RECRUITING Chronic Renal Failure DRUG: Icodextrin Peritoneal Dialysis Solution

NCT05821231 Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma https://clinicaltrials.gov/study/NCT05821231 RECRUITING Soft Tissue Sarcoma COMBINATION_PRODUCT: SBRT + MEDI5752 Institut Claudius Regaud National Cancer Institute, France

NCT05770882 Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC) https://clinicaltrials.gov/study/NCT05770882 RECRUITING Hepatocellular Carcinoma (HCC) DRUG: Chidamide

NCT06526182 A Study of of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06526182 RECRUITING Dermatitis, Atopic

NCT05769582 Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients https://clinicaltrials.gov/study/NCT05769582 RECRUITING BK Viremia; BKV DNAemia BIOLOGICAL: Anti-BK polyomavirus (AntiBKV) Memo Therapeutics AG

NCT06610682 Feasibility of CSF and Plasma ctDNA in BRAF-altered Glioma During Treatment With Plixorafenib https://clinicaltrials.gov/study/NCT06610682 NOT_YET_RECRUITING BRAF V600E Mutation DRUG: Plixorafenib Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Fore Biotherapeutics

NCT06114082 TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients With Hepatocellular Carcinoma (IDADOX) https://clinicaltrials.gov/study/NCT06114082 RECRUITING Hepatocellular Carcinoma

NCT06670482 The Effect of Mask Design on Transcutaneous Carbon Dioxide in Healthy Volunteers: a Pilot Clinical Investigation https://clinicaltrials.gov/study/NCT06670482 NOT_YET_RECRUITING Healthy Volunteers

NCT06314282 INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use https://clinicaltrials.gov/study/NCT06314282 NOT_YET_RECRUITING Systemic Lupus Erythematosus (SLE) AstraZeneca

NCT05727176 Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement https://clinicaltrials.gov/study/NCT05727176 RECRUITING Advanced Cholangiocarcinoma

NCT06041776 Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations https://clinicaltrials.gov/study/NCT06041776 RECRUITING Non-Small Cell Lung Cancer

NCT06500676 A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations https://clinicaltrials.gov/study/NCT06500676 RECRUITING KRAS G12D Mutations

NCT05961176 Exploratory Study on Bio-signal Telemonitoring Using Electronic Textiles in a Pediatric Acute and Critical Care Setting https://clinicaltrials.gov/study/NCT05961176 RECRUITING Heart Failure DEVICE: Skiin pediatric band and Skiin biometric pod The Hospital for Sick Children Myant Medical Corp.

NCT06125327 SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) https://clinicaltrials.gov/study/NCT06125327 RECRUITING Idiopathic Pulmonary Fibrosis DRUG: SC1011

NCT06233227 Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule https://clinicaltrials.gov/study/NCT06233227 NOT_YET_RECRUITING Healthy Subjects DRUG: Dutasteride-Test product

NCT05990127 A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05990127 NOT_YET_RECRUITING Locally Advanced or Metastatic NSCLC DRUG: AK104

NCT05145127 Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors https://clinicaltrials.gov/study/NCT05145127 RECRUITING Hemophilia A

NCT06285227 Study of CM313 in Healthy Subjects https://clinicaltrials.gov/study/NCT06285227 RECRUITING Healthy BIOLOGICAL: CM313 injection Keymed Biosciences Co.Ltd

NCT06680427 Siegel‚Ñ¢ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study https://clinicaltrials.gov/study/NCT06680427 NOT_YET_RECRUITING Aortic Stenosis Symptomatic DEVICE: Siegel Transcatheter Aortic Valve (TAVR) MiRus

NCT05864573 Study of ZGGS15 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05864573 RECRUITING Advanced Solid Tumors BIOLOGICAL: ZGGS15 Suzhou Zelgen Biopharmaceuticals Co.,Ltd

NCT06454773 To Evaluate the Impact of Consumption of Bioactive Compounds Extracted From Hemp Hull and Black Pepper on Fasting Blood Glucose Levels in People With Pre-diabetes: A Randomized Placebo-Controlled Parallel Arm Trial https://clinicaltrials.gov/study/NCT06454773 RECRUITING Intervention DIETARY_SUPPLEMENT: NCT/NFT Diabetes Foundation, India Brightseed

NCT06087276 Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET) https://clinicaltrials.gov/study/NCT06087276 RECRUITING Essential Tremor DRUG: 60 mg ulixacaltamide

NCT04701476 TATE and Pembrolizumab (MK3475) in mCRC and NSCLC https://clinicaltrials.gov/study/NCT04701476 RECRUITING Colorectal Cancer; Lung Cancer DRUG: TATE and pembrolizumab

NCT05773976 An Interventional, Confirmative, Post Marketing Clinical Followup (PMCF) Study to Evaluate Performance and Safety of Ophthalmic Solutions Used to Relieve Dry Eyes Like Symptoms in Glaucoma Patients. https://clinicaltrials.gov/study/NCT05773976 RECRUITING Opthalomology/Dry Eye DEVICE: Afomill Refreshing Soothing, Afomill Anti-redness Eye Drops, Iridil Montefarmaco OTC SpA

NCT06169527 A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab https://clinicaltrials.gov/study/NCT06169527 RECRUITING Atopic Dermatitis DRUG: Dupilumab Sanofi Regeneron Pharmaceuticals

NCT06449027 Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects. https://clinicaltrials.gov/study/NCT06449027 NOT_YET_RECRUITING Breast Cancer Subjects DRUG: T Leuprolide Injectable Emulsion

NCT03363373 Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow https://clinicaltrials.gov/study/NCT03363373 RECRUITING Neuroblastoma BIOLOGICAL: GM-CSF + Naxitamab Y-mAbs Therapeutics

NCT05318573 A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05318573 RECRUITING Advanced Urothelial Carcinoma

NCT06384573 DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease https://clinicaltrials.gov/study/NCT06384573 RECRUITING Alzheimer's Disease

NCT06014073 TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL https://clinicaltrials.gov/study/NCT06014073 RECRUITING Non Hodgkin's Lymphoma BIOLOGICAL: TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)

NCT06596473 A Study of BG-C477 in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06596473 RECRUITING Advanced Solid Tumors DRUG: BG-C477

NCT06080776 SH-1028 Tablets Versus Placebo as Adjuvant Therapy in Resected Stage II-IIIB NSCLC With Sensitizing EGFR Mutations https://clinicaltrials.gov/study/NCT06080776 RECRUITING Non-small Cell Lung Cancer DRUG: SH-1028 tablets

NCT06316076 Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases https://clinicaltrials.gov/study/NCT06316076 RECRUITING Systemic Lupus Erythematosus

NCT06251076 Plan Development for Giving Teclistamab in the Outpatient Setting https://clinicaltrials.gov/study/NCT06251076 NOT_YET_RECRUITING Multiple Myeloma

NCT06174376 Clinical Outcomes of the Gore Synthetic Cornea Device https://clinicaltrials.gov/study/NCT06174376 RECRUITING Corneal Opacity DEVICE: GORE Synthetic Cornea Device W.L.Gore & Associates

NCT06312176 A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010) https://clinicaltrials.gov/study/NCT06312176 RECRUITING Breast Neoplasms DRUG: Sacituzumab tirumotecan

NCT05442827 A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibroids https://clinicaltrials.gov/study/NCT05442827 RECRUITING Uterine Fibroids With Menorrhagia DRUG: SHR7280 tablets

NCT05844527 Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients https://clinicaltrials.gov/study/NCT05844527 RECRUITING Wound of Skin

NCT06419127 Embryo Assessment Utilizing Timelapse Imaging in Conjunction With Preimplantation Genetic Testing for Aneuploidy With Next Generation Sequencing https://clinicaltrials.gov/study/NCT06419127 RECRUITING Infertility, Female

NCT05636527 Further Evaluation of Safety and Performance of the NEXUS Aortic Arch Stent Graft System and the Custom-Made NEXUS DUO‚Ñ¢ Aortic Arch Stent Graft System https://clinicaltrials.gov/study/NCT05636527 RECRUITING AAT9 Endospan Ltd.

NCT06010173 Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children https://clinicaltrials.gov/study/NCT06010173 RECRUITING Lesion in Body Region

NCT04903873 A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04903873 RECRUITING Solid Tumor

NCT06500273 Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL https://clinicaltrials.gov/study/NCT06500273 RECRUITING Large B-cell Lymphoma GENETIC: cemacabtagene ansegedleucel

NCT03059173 Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome https://clinicaltrials.gov/study/NCT03059173 RECRUITING Polycystic Ovary Syndrome

NCT06613373 An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer https://clinicaltrials.gov/study/NCT06613373 NOT_YET_RECRUITING Breast Cancer DRUG: Dalpiciclib Jiangsu Famous Medical Technology Co., Ltd.

NCT06407973 A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Pseudophakic Eyes https://clinicaltrials.gov/study/NCT06407973 RECRUITING Primary Open Angle Glaucoma DEVICE: OMNI Surgical System

NCT06347731 Varian ProBeam360¬∞ Proton Therapy System China Clinical Trial (Wuhan) https://clinicaltrials.gov/study/NCT06347731 RECRUITING Tumor, Solid DEVICE: Proton Radiation Therapy Varian, a Siemens Healthineers Company

NCT06243731 A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation https://clinicaltrials.gov/study/NCT06243731 NOT_YET_RECRUITING Cytomegalovirus (CMV)

NCT06267482 Using ROSA for Challenging The TKA Standard of Care https://clinicaltrials.gov/study/NCT06267482 RECRUITING Knee Osteoarthritis PROCEDURE: ROSA PSA Parapatellar Approach

NCT05881382 Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction https://clinicaltrials.gov/study/NCT05881382 NOT_YET_RECRUITING ST Elevation Myocardial Infarction DRUG: Dutogliptin + Filgrastim

NCT03547973 Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread https://clinicaltrials.gov/study/NCT03547973 RECRUITING Metastatic Urothelial Cancer DRUG: Sacituzumab Govitecan-hziy

NCT04533373 Sensory Restoration After DIEP Flap Neurotization https://clinicaltrials.gov/study/NCT04533373 RECRUITING Breast Cancer

NCT05741073 Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients With Advanced NMSC https://clinicaltrials.gov/study/NCT05741073 RECRUITING Basal Cell Carcinoma

NCT06159231 FAME II-10-year Follow-Up https://clinicaltrials.gov/study/NCT06159231 RECRUITING Coronary Artery Disease CoreAalst BV Abbott Medical Devices

NCT06427031 Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients https://clinicaltrials.gov/study/NCT06427031 RECRUITING Dry Eye

NCT05349682 Bayer OA Knee Pain Pilot https://clinicaltrials.gov/study/NCT05349682 RECRUITING Osteoarthritis, Knee DIAGNOSTIC_TEST: dynamic contrast enhanced MRI

NCT04737382 Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. https://clinicaltrials.gov/study/NCT04737382 RECRUITING Non-small-cell Lung Carcinoma DIAGNOSTIC_TEST: biopsy

NCT05141682 Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia https://clinicaltrials.gov/study/NCT05141682 RECRUITING T-Cell Large Granular Lymphocyte Leukemia DRUG: Oral Azacitidine Jonathan Brammer Bristol-Myers Squibb

NCT05660382 Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis https://clinicaltrials.gov/study/NCT05660382 RECRUITING Otomycosis DRUG: Miconazole (2%) oil and mineral oil

NCT05642182 Study of SFA002 in Patients With Mild to Moderate Psoriasis Plaques https://clinicaltrials.gov/study/NCT05642182 RECRUITING Psoriasis DRUG: Drug (SFA002) Vitamin D, Magnesium

NCT05889182 A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy https://clinicaltrials.gov/study/NCT05889182 RECRUITING Hidradenitis Suppurativa DRUG: Upadacitinib

NCT04092673 Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies https://clinicaltrials.gov/study/NCT04092673 RECRUITING Solid Tumor, Adult DRUG: eFT226

NCT06111131 Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures https://clinicaltrials.gov/study/NCT06111131 RECRUITING Small Bowel Disease DEVICE: Enteroscopy Aspero Medical, Inc. National Institutes of Health (NIH)

NCT05143931 Avoid and Resist Strategies for Weight Management https://clinicaltrials.gov/study/NCT05143931 RECRUITING Obesity

NCT06077331 A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis https://clinicaltrials.gov/study/NCT06077331 RECRUITING Psoriasis DRUG: HS-10374 tablets 1mg

NCT05777031 Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease https://clinicaltrials.gov/study/NCT05777031 RECRUITING Peyronie Disease

NCT04897282 Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients. https://clinicaltrials.gov/study/NCT04897282 RECRUITING Ulcerative Colitis DIAGNOSTIC_TEST: UCRI Glycominds, LLC University of California, Davis

NCT06387082 A Clinical Study of HMPL-506 in Patients With Hematological Malignancies https://clinicaltrials.gov/study/NCT06387082 RECRUITING Hematological Malignancies DRUG: HMPL-506 Hutchmed

NCT03546582 SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma https://clinicaltrials.gov/study/NCT03546582 RECRUITING Head and Neck Squamous Cell Carcinoma (HNSCC) DRUG: Pembrolizumab

NCT04335682 Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide https://clinicaltrials.gov/study/NCT04335682 RECRUITING Metastatic Prostate Cancer

NCT04541082 Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms https://clinicaltrials.gov/study/NCT04541082 RECRUITING Central Nervous System Neoplasms

NCT06529731 Interferon-Œ≥ (IFN-Œ≥) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation https://clinicaltrials.gov/study/NCT06529731 RECRUITING Acute Myeloid Leukemia

NCT06531031 Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples https://clinicaltrials.gov/study/NCT06531031 NOT_YET_RECRUITING Bloodstream Infection

NCT06475131 A Study of BL-B16D1 in Patients With Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06475131 RECRUITING Solid Tumor DRUG: BL-B16D1 Sichuan Baili Pharmaceutical Co., Ltd. Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

NCT06455982 Reduced Carbohydrates + Ketogenic Supplement on Energy Metabolism https://clinicaltrials.gov/study/NCT06455982 NOT_YET_RECRUITING Healthy Aging DIETARY_SUPPLEMENT: reduced carbohydrate menu combined with ketogenic supplement Universit√© de Sherbrooke Nestl√© Health Science

NCT05194982 A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor https://clinicaltrials.gov/study/NCT05194982 RECRUITING Locally Advanced or Metastatic Solid Tumor DRUG: BL-B01D1 Sichuan Baili Pharmaceutical Co., Ltd. SystImmune Inc.

NCT05492682 START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer https://clinicaltrials.gov/study/NCT05492682 RECRUITING Melanoma (Skin)

NCT06319482 The Adherence of Proactive Sleep Apnea Therapy https://clinicaltrials.gov/study/NCT06319482 RECRUITING Obstructive Sleep Apnea DEVICE: Proactive CPAP Therapy

NCT05789082 A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation https://clinicaltrials.gov/study/NCT05789082 RECRUITING Non-Small Cell Lung Cancer DRUG: Divarasib

NCT05354882 Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology https://clinicaltrials.gov/study/NCT05354882 RECRUITING Breast Cancer

NCT05774431 Disparities in the Proportion of Ticagrelor and Prasugrel-eligible Patients With Acute Coronary Syndrome in a Real-world Registry https://clinicaltrials.gov/study/NCT05774431 RECRUITING Acute Myocardial Infarction OTHER: There was no intervention necessary. University Hospital Heidelberg AstraZeneca

NCT06146231 Motiva Flora¬Æ Aesthetic Breast Recon¬Æ Clinical Study https://clinicaltrials.gov/study/NCT06146231 RECRUITING Mammaplasty

NCT06186531 PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health https://clinicaltrials.gov/study/NCT06186531 RECRUITING Menopause

NCT06256731 ETNA-MS Device Validation Study https://clinicaltrials.gov/study/NCT06256731 RECRUITING Multiple Sclerosis DEVICE: Eye-Tracking Innodem Neurosciences Syneos Health

NCT05862831 Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT05862831 RECRUITING Advanced Solid Tumors BIOLOGICAL: PM1003 Injection Biotheus Inc.

NCT06095531 A Pilot Study to Evidence Improved Cranial Flap Fixation With a Bioresorbable Bone Adhesive https://clinicaltrials.gov/study/NCT06095531 RECRUITING Craniotomy DEVICE: Tetranite for Cranial Flap Fixation (TN-CFF) RevBio

NCT06642831 Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study https://clinicaltrials.gov/study/NCT06642831 RECRUITING Polycystic Ovarian Syndrome (PCOS) University Hospital Erlangen Roche Diagnostics International AG

NCT05661331 VIATORR Device Registry https://clinicaltrials.gov/study/NCT05661331 RECRUITING Chronic Liver Disease DEVICE: Transjugular intrahepatic portosystemic shunt W.L.Gore & Associates

NCT06270082 Study of IK-595 in RAS- or RAF-altered Advanced Tumors https://clinicaltrials.gov/study/NCT06270082 RECRUITING Solid Tumor, Adult

NCT05907382 Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects https://clinicaltrials.gov/study/NCT05907382 RECRUITING Safety and Tolerability DRUG: JMKX003002 will be administered orally

NCT06345482 A Study of MHB039A for Advanced Solid Tumor https://clinicaltrials.gov/study/NCT06345482 NOT_YET_RECRUITING Advanced Solid Tumor DRUG: MHB039A Minghui Pharmaceutical (Hangzhou) Ltd

NCT05812482 Treatment of Urethral Stricture With Urethral Drug Ball https://clinicaltrials.gov/study/NCT05812482 RECRUITING Urethral Stricture Less Than 2 cm PROCEDURE: Drug balloon dilatation

NCT06263231 A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) https://clinicaltrials.gov/study/NCT06263231 RECRUITING Sarcoma,Soft Tissue DRUG: INT230-6

NCT04631731 Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity https://clinicaltrials.gov/study/NCT04631731 RECRUITING Lung Cancer, Nonsmall Cell

NCT06307431 A Study of Adjuvant V940 and Pembrolizumab in Renal Cell Carcinoma (V940-004) https://clinicaltrials.gov/study/NCT06307431 RECRUITING Renal Cell Carcinoma BIOLOGICAL: V940

NCT06419231 Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated Symptoms https://clinicaltrials.gov/study/NCT06419231 RECRUITING Gut Health DIETARY_SUPPLEMENT: Butyrate Formulation

NCT05908682 Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes https://clinicaltrials.gov/study/NCT05908682 RECRUITING Vulvovaginal Candidiasis

NCT06384482 SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma https://clinicaltrials.gov/study/NCT06384482 RECRUITING Recurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma DRUG: SNC115 injection Shanghai Simnova Biotechnology Co.,Ltd. Shanghai Chest Hospital

NCT05653882 A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors https://clinicaltrials.gov/study/NCT05653882 RECRUITING Solid Tumor

NCT03887273 Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis https://clinicaltrials.gov/study/NCT03887273 RECRUITING Transverse Myelitis BIOLOGICAL: Q-Cells Q Therapeutics, Inc.

NCT04450173 Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma https://clinicaltrials.gov/study/NCT04450173 RECRUITING Ann Arbor Stage II Follicular Lymphoma

NCT06028373 A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas https://clinicaltrials.gov/study/NCT06028373 RECRUITING Advanced Solid Tumors

NCT04696731 Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma https://clinicaltrials.gov/study/NCT04696731 RECRUITING Advanced/Metastatic Clear Cell Renal Cell Carcinoma GENETIC: ALLO-316

NCT04123431 ACE Acetabular Cup UK Multi-centre PMCF Study https://clinicaltrials.gov/study/NCT04123431 NOT_YET_RECRUITING Hip Disease DEVICE: Total Hip Replacement JRI Orthopaedics

NCT05384431 Can we Achieve 'High-quality' Weight Loss Through Supplementation and Exercise? The TRIM MUSCLE Study https://clinicaltrials.gov/study/NCT05384431 RECRUITING Overweight

NCT05643131 Hyivy Device as Non-hormonal Therapy in Endometriosis https://clinicaltrials.gov/study/NCT05643131 NOT_YET_RECRUITING Endometriosis

NCT06199531 Safety and Efficacy of GS-100 Gene Therapy in Patients With NGLY1 Deficiency https://clinicaltrials.gov/study/NCT06199531 RECRUITING NGLY1 Deficiency GENETIC: GS-100 Grace Science, LLC

NCT06048731 Enlighten Study: The EV-ICD Post Approval Registry https://clinicaltrials.gov/study/NCT06048731 RECRUITING Ventricular Arrhythmia

NCT05481931 Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines https://clinicaltrials.gov/study/NCT05481931 RECRUITING Glabellar Frown Lines DRUG: prabotulinumtoxinA Evolus, Inc. Avania

NCT06703931 Performance Study of the Thermodiag Solution for Body Temperature Measurement https://clinicaltrials.gov/study/NCT06703931 NOT_YET_RECRUITING Temperature Change, Body

NCT06511882 Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD https://clinicaltrials.gov/study/NCT06511882 RECRUITING Acute Myeloid Leukemia DRUG: Azacitidine

NCT05816382 A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions https://clinicaltrials.gov/study/NCT05816382 RECRUITING Narcolepsy Type 1 DRUG: TAK-861 Takeda

NCT06639282 Repurposing Siponimod for Alzheimer's Disease https://clinicaltrials.gov/study/NCT06639282 NOT_YET_RECRUITING Alzheimer Disease

NCT05849727 A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT05849727 RECRUITING Rheumatoid Arthritis DRUG: TQH3821 tablets 200 mg

NCT04396327 SM-1 vs. an Active Comparator in A Model of Transient Insomnia https://clinicaltrials.gov/study/NCT04396327 NOT_YET_RECRUITING Transient Insomnia DRUG: SM-1

NCT05579873 Double Plating Versus Single Plating Techniques in Midshaft Clavicle Fractures https://clinicaltrials.gov/study/NCT05579873 NOT_YET_RECRUITING Clavicle Fracture PROCEDURE: Clavicle plating Luzerner Kantonsspital Kantonsspital Obwalden

NCT06108973 Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients https://clinicaltrials.gov/study/NCT06108973 NOT_YET_RECRUITING Chronic Obstructive Pulmonary Disease DEVICE: Capnography Employee's State Insurance Corporation, New Delhi Medtronic Spine LLC

NCT06644573 Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy‚Ñ¢ in Patients With Sleep Deprivation and Chronic Insomnia https://clinicaltrials.gov/study/NCT06644573 NOT_YET_RECRUITING Chronic Insomnia

NCT06270173 Post-Market Study of The Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures https://clinicaltrials.gov/study/NCT06270173 RECRUITING Osteoporotic Vertebral Compression Fractures DEVICE: Tripod-Fix Vertebral Body Augmentation System (Tripod-Fix) Wiltrom Co., Ltd. Maxis Medical GmbH

NCT06159673 ACP-204 in Adults With Alzheimer's Disease Psychosis https://clinicaltrials.gov/study/NCT06159673 RECRUITING Alzheimer's Disease Psychosis DRUG: ACP-204

NCT05206773 A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ‚â•16 Years of Age With Fabry Disease https://clinicaltrials.gov/study/NCT05206773 RECRUITING Fabry Disease DRUG: Venglustat (GZ402671)

NCT03810573 Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis https://clinicaltrials.gov/study/NCT03810573 RECRUITING Degenerative Disc Disease

NCT06199973 Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan https://clinicaltrials.gov/study/NCT06199973 RECRUITING Advanced Colorectal Cancer DRUG: SHR-A1811

NCT06580873 Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT) https://clinicaltrials.gov/study/NCT06580873 NOT_YET_RECRUITING HIV-1-infection

NCT02861573 Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) https://clinicaltrials.gov/study/NCT02861573 RECRUITING Metastatic Castration-Resistant Prostate Cancer BIOLOGICAL: Pembrolizumab 200 mg

NCT05985473 Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement https://clinicaltrials.gov/study/NCT05985473 RECRUITING Deafness Neurosensory OTHER: audiological measurements

NCT06077773 Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria https://clinicaltrials.gov/study/NCT06077773 RECRUITING Chronic Spontaneous Urticaria DRUG: Oral EP262

NCT05712473 An Observational Registry Assessing the Impact of PYLARIFY¬Æ (Piflufolastat F18) PET in Patients With Prostate Cancer https://clinicaltrials.gov/study/NCT05712473 NOT_YET_RECRUITING Prostate Cancer DIAGNOSTIC_TEST: PYLARIFY Specialty Networks Research. Lantheus Medical Imaging

NCT04965220 HLX208 (BRAF V600E Inhibitor) in Combination With Trametinib in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04965220 RECRUITING Solid Tumor DRUG: HLX 208 Shanghai Henlius Biotech

NCT05896020 A Study of SHR-A1811 in Subjects With Gynaecologic Oncology https://clinicaltrials.gov/study/NCT05896020 RECRUITING Gynaecological Malignancies DRUG: SHR- A1811 Jiangsu HengRui Medicine Co., Ltd.

NCT05534620 Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics https://clinicaltrials.gov/study/NCT05534620 RECRUITING Acute Myeloid Leukaemia (AML)

NCT05984420 Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis https://clinicaltrials.gov/study/NCT05984420 RECRUITING Atopic Dermatitis DEVICE: LimpiAD 2,5% plus cream

NCT04073420 Medtronic Cardiac Surgery PMCF Registry https://clinicaltrials.gov/study/NCT04073420 RECRUITING Valve Disease, Heart DEVICE: Surgical Heart Valve Repair Products

NCT04510220 9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis https://clinicaltrials.gov/study/NCT04510220 RECRUITING Relapsing Multiple Sclerosis DRUG: Ofatumumab

NCT06265220 AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT06265220 RECRUITING Lupus Nephritis - WHO Class III

NCT06708520 Pharmacokinetics and Safety of Rupatadine in Participants With Renal Impairment Compared to Control Participants https://clinicaltrials.gov/study/NCT06708520 RECRUITING Renal Impairment DRUG: Rupatadine Noucor Health S.A.

NCT06239220 PD-L1 T-haNK, N-803 IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC https://clinicaltrials.gov/study/NCT06239220 RECRUITING Head and Neck Cancer

NCT06552520 To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06552520 NOT_YET_RECRUITING Atopic Dermatitis DRUG: TQH2722 injection

NCT04490720 The Efficacy Evaluation of Buckwheat Husk Extract on Cardiovascular Disease Risk Factors https://clinicaltrials.gov/study/NCT04490720 RECRUITING Cardiovascular Diseases DIETARY_SUPPLEMENT: Placebo

NCT05326620 National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC) https://clinicaltrials.gov/study/NCT05326620 RECRUITING Renal Cancer

NCT06035120 An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema https://clinicaltrials.gov/study/NCT06035120 RECRUITING Emphysema, Pulmonary

NCT06210620 Pro APP Prosthetic Outcome Registry https://clinicaltrials.gov/study/NCT06210620 RECRUITING Amputation √ñssur Iceland ehf

NCT06282120 Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV¬± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer https://clinicaltrials.gov/study/NCT06282120 RECRUITING Metastatic Biliary Tract Cancer DRUG: Irinotecan Hydrochloride Liposome Injection ÔºõFluorouracil ÔºõLeucovorinÔºõimmunotherapy Tianjin Medical University Cancer Institute and Hospital CSPC Ouyi Pharmaceutical Co., Ltd.

NCT06657820 Optical Brain Pulse Monitor: Validation of Cerebral Oximetry Monitoring (OBPM:VOCOM) Study. https://clinicaltrials.gov/study/NCT06657820 NOT_YET_RECRUITING Hypoxia PROCEDURE: Hypoxia in healthy individuals

NCT05821920 A Safety Study on Posterior Pedicle Screw System https://clinicaltrials.gov/study/NCT05821920 RECRUITING Degenerative Disc Disease

NCT05799820 QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC https://clinicaltrials.gov/study/NCT05799820 RECRUITING Colorectal Carcinoma DRUG: QL1706

NCT05847920 Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy https://clinicaltrials.gov/study/NCT05847920 RECRUITING Primary IgA Nephropathy DRUG: SHR-2010 Injection

NCT06042920 A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis https://clinicaltrials.gov/study/NCT06042920 RECRUITING Palmoplantar Psoriasis

NCT05077774 Harmony TPV Post-Approval Study https://clinicaltrials.gov/study/NCT05077774 RECRUITING Congenital Heart Disease

NCT06627673 MultiCenter IDE Study of the PEEK-OPTIMA‚Ñ¢ Femoral Component vs a CoCr Alloy TKA Femoral Component of Similar Design https://clinicaltrials.gov/study/NCT06627673 NOT_YET_RECRUITING Knee Osteoarthritis DEVICE: Total Knee Arthroplasty Maxx Orthopedics Inc

NCT06103773 A Study of Single and Multiple Oral Doses of TollB-001 https://clinicaltrials.gov/study/NCT06103773 RECRUITING Rheumatoid Arthritis DRUG: TollB-001 tablets

NCT06106373 iotaSOFT Pediatric Study https://clinicaltrials.gov/study/NCT06106373 RECRUITING Hearing Loss, Sensorineural

NCT06328673 A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06328673 RECRUITING Advanced Solid Tumor DRUG: DM919

NCT06268873 A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. https://clinicaltrials.gov/study/NCT06268873 RECRUITING Chronic Kidney Disease and Hypertension DRUG: Baxdrostat/dapagliflozin

NCT06072573 Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy https://clinicaltrials.gov/study/NCT06072573 RECRUITING Pain

NCT04012073 Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome https://clinicaltrials.gov/study/NCT04012073 RECRUITING Respiratory Distress Syndrome, Adult DEVICE: Invasive Mechanical ventilation

NCT06471673 A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer https://clinicaltrials.gov/study/NCT06471673 RECRUITING Breast Cancer

NCT06645873 Exploration of Continuous Glucose Monitoring on the Intensive Care Unit https://clinicaltrials.gov/study/NCT06645873 NOT_YET_RECRUITING Hypoglycemia, Hyperglycemia DEVICE: Continuous glucose monitoring (CGM) device Kim Kamphorst DexCom, Inc.

NCT05776173 Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Œ≤-thalassemia https://clinicaltrials.gov/study/NCT05776173 RECRUITING Œ≤-thalassemia Major GENETIC: BD211 Shanghai BDgene Co., Ltd. Ruijin Hospital

NCT04909073 Observational Study of Afatinib 30 mg Daily https://clinicaltrials.gov/study/NCT04909073 RECRUITING Non-Small Cell Lung Cancer

NCT05972473 A Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With nAMD https://clinicaltrials.gov/study/NCT05972473 RECRUITING Neovascular Age-related Macular Degeneration DRUG: Aflibercept Ophthalmic

NCT06494020 Task Practice and Spinal Cord Stimulation https://clinicaltrials.gov/study/NCT06494020 RECRUITING Spinal Cord Injury Cervical

NCT04546620 Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL) https://clinicaltrials.gov/study/NCT04546620 RECRUITING Diffuse Large B Cell Lymphoma DRUG: R-CHOP

NCT05867420 A Study of ASKG915 in Patients With Selected Advanced Solid Tumors. https://clinicaltrials.gov/study/NCT05867420 RECRUITING Advanced Solid Tumors BIOLOGICAL: ASKG915 AskGene Pharma, Inc. Jiangsu Aosaikang Pharmaceutical Co., Ltd.

NCT06046820 The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency https://clinicaltrials.gov/study/NCT06046820 RECRUITING Ectonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency

NCT05455320 A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment https://clinicaltrials.gov/study/NCT05455320 RECRUITING Relapsed or Refractory Multiple Myeloma DRUG: Talquetamab

NCT05316220 A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis https://clinicaltrials.gov/study/NCT05316220 NOT_YET_RECRUITING Ulcerative Colitis (UC) DRUG: Mesalamine

NCT06274320 Effect of Lipikar Urea 30% Before Actinic Keratoses Treatment https://clinicaltrials.gov/study/NCT06274320 RECRUITING Actinic Keratoses OTHER: Group A: holistic approach

NCT05097820 Prospective Observational Study on SEBBIN Silicone Gel-filled Testicular Implants https://clinicaltrials.gov/study/NCT05097820 RECRUITING Testicular Cancer

NCT05322720 HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy https://clinicaltrials.gov/study/NCT05322720 NOT_YET_RECRUITING Solid Tumor, Adult BIOLOGICAL: EOC202

NCT05893420 A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning https://clinicaltrials.gov/study/NCT05893420 RECRUITING Sepsis

NCT05283720 A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT05283720 RECRUITING Non-Hodgkin Lymphoma DRUG: Epcoritamab

NCT06062420 A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202 https://clinicaltrials.gov/study/NCT06062420 RECRUITING Neoplasms, Head and Neck DRUG: Dostarlimab

NCT06634420 HAELO: a Phase 3 Study to Evaluate NTLA-2002 in Participants with Hereditary Angioedema (HAE) https://clinicaltrials.gov/study/NCT06634420 RECRUITING Hereditary Angioedema BIOLOGICAL: NTLA-2002

NCT04396574 A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine https://clinicaltrials.gov/study/NCT04396574 RECRUITING Migraine DRUG: Lasmiditan Eli Lilly and Company

NCT06419374 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants with Compensated Cirrhosis Due to MASH https://clinicaltrials.gov/study/NCT06419374 RECRUITING Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) with Compensated Cirrhosis BIOLOGICAL: Pegozafermin

NCT05040074 SQ-Kyrin TMVr FIM Study https://clinicaltrials.gov/study/NCT05040074 RECRUITING Mitral Regurgitation DEVICE: SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System Shanghai Shenqi Medical Technology Co., Ltd

NCT04449874 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation https://clinicaltrials.gov/study/NCT04449874 RECRUITING Non-Small Cell Lung Cancer

NCT03897374 Strategic Targeting for Optimal Prevention of Cancer https://clinicaltrials.gov/study/NCT03897374 RECRUITING Early Detection of Cancer DIAGNOSTIC_TEST: Genetic Testing ClinLogic LLC MDGlobal

NCT06670274 A Dose Escalating Study of HC002 in Healthy Adult Volunteers https://clinicaltrials.gov/study/NCT06670274 NOT_YET_RECRUITING Inflammatory Disease

NCT06255665 A Study of JNJ-79032421 Targeting Mesothelin for Advanced Stage Solid Tumors https://clinicaltrials.gov/study/NCT06255665 RECRUITING Advanced Stage Solid Tumors DRUG: JNJ-79032421

NCT05865665 Registry Of Best Up-titration STrategies in Acute Heart Failure https://clinicaltrials.gov/study/NCT05865665 NOT_YET_RECRUITING Acute Heart Failure Heart Initiative INSERM UMR-942, Paris, France

NCT05948865 A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05948865 RECRUITING Cancer

NCT05159765 Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial https://clinicaltrials.gov/study/NCT05159765 RECRUITING Myopia DEVICE: Single vision contact lenses

NCT05307965 RETRIEVE-AMI Study https://clinicaltrials.gov/study/NCT05307965 RECRUITING Myocardial Infarction

NCT06001320 De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients https://clinicaltrials.gov/study/NCT06001320 RECRUITING Kidney Transplant; Complications

NCT06373120 Interventional Ventricular Assist System for PCI in CHIP Patients https://clinicaltrials.gov/study/NCT06373120 RECRUITING High-Risk Percutaneous Coronary Intervention (High-risk PCI)

NCT03546374 Medtronic Terminate AF Study https://clinicaltrials.gov/study/NCT03546374 RECRUITING Persistent Atrial Fibrillation

NCT06107374 Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG https://clinicaltrials.gov/study/NCT06107374 RECRUITING Advanced Non Small Cell Lung Cancer DRUG: [18F]F-AraG CellSight Technologies, Inc.

NCT05631574 Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer https://clinicaltrials.gov/study/NCT05631574 RECRUITING Non Small Cell Lung Cancer

NCT06225674 Clinical Investigation on the Outcome of Episealer Talus Post-operation for Treatment of Focal Osteochondral Defects https://clinicaltrials.gov/study/NCT06225674 RECRUITING Osteochondral Defect DEVICE: Episealer Talus implant Episurf Medical Inc.

NCT06111274 A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer https://clinicaltrials.gov/study/NCT06111274 RECRUITING Advanced Pancreatic Cancer DRUG: Pimicotinib (ABSK021) Abbisko Therapeutics Co, Ltd

NCT05844774 Post Anaesthesia Care Hypotension Prevention https://clinicaltrials.gov/study/NCT05844774 NOT_YET_RECRUITING Hypotension During Surgery DEVICE: HPI (using HemoSphere) - guided algorithm

NCT03143374 PET Tau - Neurodegenerative Disease Imaging https://clinicaltrials.gov/study/NCT03143374 RECRUITING Neurodegenerative Disease DRUG: 18F-AV-1451 University of Pennsylvania Avid Radiopharmaceuticals

NCT06633965 Safety and Feasibility Testing of a Smaller Network Version of AIDANET https://clinicaltrials.gov/study/NCT06633965 RECRUITING Type 1 Diabetes DEVICE: AIDANET

NCT06568965 Clinical Study of De-Stress & Happy Gut Powder for Stress and Indigestion in Adults. https://clinicaltrials.gov/study/NCT06568965 NOT_YET_RECRUITING Stress

NCT05272865 Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Œî9-THC https://clinicaltrials.gov/study/NCT05272865 NOT_YET_RECRUITING Nausea Post Chemotherapy

NCT06686420 Investigation of the Effects of a Bifidobacterial Strain on Bowel Movement in Healthy Adults https://clinicaltrials.gov/study/NCT06686420 RECRUITING Infrequent Bowel Movements DIETARY_SUPPLEMENT: B. longum

NCT05565820 A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation https://clinicaltrials.gov/study/NCT05565820 RECRUITING Pediculosis Capitis

NCT05798520 A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS) https://clinicaltrials.gov/study/NCT05798520 RECRUITING Relapsing Forms of Multiple Sclerosis DRUG: BIIB091

NCT06041620 Safety and Efficacy Evaluation of Autologous CRISPR-Cas12b Edited Hematopoietic Stem Cells https://clinicaltrials.gov/study/NCT06041620 RECRUITING Thalassemia, Beta

NCT06312020 A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome https://clinicaltrials.gov/study/NCT06312020 RECRUITING Sjogren's Syndrome DRUG: HZN-1116

NCT05772520 The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis https://clinicaltrials.gov/study/NCT05772520 RECRUITING Plaque Psoriasis DRUG: TLL018 tablets Hangzhou Highlightll Pharmaceutical Co., Ltd

NCT06678074 Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI https://clinicaltrials.gov/study/NCT06678074 NOT_YET_RECRUITING STEMI

NCT05779774 WayToServePlus: Improving Responsible Alcohol Service Ph II https://clinicaltrials.gov/study/NCT05779774 RECRUITING Alcohol Drinking

NCT06687174 Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN) https://clinicaltrials.gov/study/NCT06687174 NOT_YET_RECRUITING IgA Nephropathy (IgAN) DRUG: MY008211A tablets

NCT05588674 The Effect of Probiotics on Exercise Performance and Recovery https://clinicaltrials.gov/study/NCT05588674 RECRUITING Probiotics

NCT06632574 A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06632574 RECRUITING Advanced Solid Tumor DRUG: paclitaxel cationic liposomes CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

NCT05121974 Tebipenem Trial in Children With Shigellosis https://clinicaltrials.gov/study/NCT05121974 RECRUITING Shigellosis DRUG: Tebipenem Pivoxil

NCT05744674 Phase ‚Ö° Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management https://clinicaltrials.gov/study/NCT05744674 RECRUITING Thoracoscopic Lobectomy DRUG: HR18034

NCT04014374 Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab https://clinicaltrials.gov/study/NCT04014374 RECRUITING Leukemia/Lymphoma

NCT04154774 A Study of Apalutamide in Participants With Severe Hepatic Impairment Compared With Participants With Normal Hepatic Function https://clinicaltrials.gov/study/NCT04154774 RECRUITING Hepatic Impairment DRUG: Apalutamide Janssen Research & Development, LLC

NCT05198674 SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN https://clinicaltrials.gov/study/NCT05198674 RECRUITING Hypertension

NCT06461065 Evaluation of Neurodevelopmental Trajectories in Children According to the Glycemic Profile Associated With Different Early Treatment Modalities in Children With Type 1 Diabetes (T1DM) https://clinicaltrials.gov/study/NCT06461065 NOT_YET_RECRUITING Diabetes DEVICE: AIDS

NCT05848765 Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy https://clinicaltrials.gov/study/NCT05848765 RECRUITING Relapsed Follicular Lymphoma

NCT03870620 Metastatic Breast Cancer in Austria https://clinicaltrials.gov/study/NCT03870620 RECRUITING Breast Cancer

NCT06055920 The PEERLESS II Study https://clinicaltrials.gov/study/NCT06055920 RECRUITING Pulmonary Embolism DEVICE: FlowTriever System

NCT05315674 Markers of COPD Exacerbations https://clinicaltrials.gov/study/NCT05315674 RECRUITING COPD

NCT05648474 Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure https://clinicaltrials.gov/study/NCT05648474 RECRUITING Intervertebral Disc Degeneration

NCT06449274 RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial https://clinicaltrials.gov/study/NCT06449274 RECRUITING Acute Coronary Syndrome (ACS) DEVICE: Drug-coated balloon

NCT04546074 Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma https://clinicaltrials.gov/study/NCT04546074 RECRUITING Melanoma DRUG: Pembrolizumab and Imatinib mesylate

NCT06175065 Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease https://clinicaltrials.gov/study/NCT06175065 RECRUITING Acute Exacerbation of Chronic Obstructive Pulmonary Disease DRUG: RLS-0071

NCT06536465 The Clostridioides Difficile Trial of REC-3964 https://clinicaltrials.gov/study/NCT06536465 RECRUITING Recurrent Clostridioides Difficile Infection DRUG: REC-3964 Recursion Pharmaceuticals Inc.

NCT05587465 Evaluation of Safety and Effectiveness of Lobster Dynamic Interspinous Spacer in Lumbar Spinal Stenosis https://clinicaltrials.gov/study/NCT05587465 RECRUITING Spinal Lumbar Stenosis

NCT06099665 Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR Platform https://clinicaltrials.gov/study/NCT06099665 RECRUITING Aortic Valve Stenosis

NCT06622174 Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer https://clinicaltrials.gov/study/NCT06622174 NOT_YET_RECRUITING Non Small Cell Lung Cancer

NCT05586074 HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML https://clinicaltrials.gov/study/NCT05586074 RECRUITING Leukemia, Acute Myeloid (AML) DRUG: Clifutinib

NCT05900765 A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT05900765 RECRUITING Classical Hodgkin Lymphoma DRUG: Zimberelimab 240mg Sun Yat-sen University Guangzhou Gloria Biosciences Co., Ltd.

NCT06544265 SynKIR-310 for Relapsed/Refractory B-NHL https://clinicaltrials.gov/study/NCT06544265 RECRUITING B Cell Lymphoma

NCT06693765 A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants https://clinicaltrials.gov/study/NCT06693765 NOT_YET_RECRUITING Renal Impairment

NCT04015765 Hybrid-APC Margin Ablation to Prevent Post EMR Adenoma Recurrence https://clinicaltrials.gov/study/NCT04015765 RECRUITING Colorectal Cancer

NCT06557265 NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With Autoimmune Disease (Ntrust-1) https://clinicaltrials.gov/study/NCT06557265 RECRUITING Lupus Nephritis

NCT06392165 Evaluation of Adhesion Properties in Wound Care Devices https://clinicaltrials.gov/study/NCT06392165 NOT_YET_RECRUITING Adhesion Properties of Wound Care Devices OTHER: self-adhesive device Molnlycke Health Care AB

NCT06293365 Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease https://clinicaltrials.gov/study/NCT06293365 RECRUITING Sj√∂grens Disease

NCT06264674 Comparison Between CHF5993 pMDI 200/6/12.5 ¬µg HFA-152a VS CHF5993 pMDI 200/6/12.5 ¬µg HFA-134a in Subjects With Asthma (TRECOS). https://clinicaltrials.gov/study/NCT06264674 RECRUITING Asthma DRUG: CHF5993 200/6/12.5 Œºg pMDI HFA-152a

NCT05679674 Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer https://clinicaltrials.gov/study/NCT05679674 RECRUITING Pancreas Cancer

NCT05388474 A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab https://clinicaltrials.gov/study/NCT05388474 RECRUITING HIV Infections

NCT06700174 Lifetech AcuMark‚Ñ¢ Sizing Balloon Post-Market Clinical Follow-up Study https://clinicaltrials.gov/study/NCT06700174 RECRUITING Atrial Septal Defect (ASD) Lifetech Scientific (Shenzhen) Co., Ltd.

NCT05644665 A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC) https://clinicaltrials.gov/study/NCT05644665 RECRUITING Ulcerative Colitis DRUG: Ozanimod

NCT06277765 Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis https://clinicaltrials.gov/study/NCT06277765 NOT_YET_RECRUITING Atopic Dermatitis BIOLOGICAL: CM310

NCT06463665 Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer https://clinicaltrials.gov/study/NCT06463665 RECRUITING Advanced Non-squamous Non-small-cell Lung Cancer

NCT05795465 A Study of GEn-1124 in Subjects with Acute Respiratory Distress Syndrome (ARDS) https://clinicaltrials.gov/study/NCT05795465 RECRUITING Respiratory Distress Syndrome, Acute DRUG: GEn-1124

NCT06308120 A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB https://clinicaltrials.gov/study/NCT06308120 RECRUITING Pulmonary Nodule, Solitary

NCT06304220 Comparison of Two PPOS Models for Pituitary Suppression https://clinicaltrials.gov/study/NCT06304220 NOT_YET_RECRUITING Infertility, Female

NCT06252220 First in Human Study in Subjects With Obesity, But Otherwise Healthy https://clinicaltrials.gov/study/NCT06252220 RECRUITING Obesity DRUG: DA-1726

NCT05850520 A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) https://clinicaltrials.gov/study/NCT05850520 RECRUITING Macular Edema Secondary to Retinal Vein Occlusion DRUG: Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose

NCT06709274 Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC https://clinicaltrials.gov/study/NCT06709274 NOT_YET_RECRUITING Non-Small Cell Lung Cancer DRUG: Osimertinib

NCT05102474 Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis https://clinicaltrials.gov/study/NCT05102474 RECRUITING Psoriasis Vulgaris OTHER: Polysomnography (PSG) University of California, San Francisco Novartis Pharmaceuticals

NCT02696265 CFAE/Spatiotemporal Dispersion Guided Ablation Versus PVI Guided Ablation in Persistent AF https://clinicaltrials.gov/study/NCT02696265 RECRUITING Chronic Atrial Fibrillation PROCEDURE: CFAE guided ablation

NCT04205565 Study on Clinical Effectiveness of L-Oxiracetam Injection https://clinicaltrials.gov/study/NCT04205565 RECRUITING Craniocerebral Injury DRUG: Test group: L-oxiracetam Injection

NCT05112965 An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C) https://clinicaltrials.gov/study/NCT05112965 RECRUITING Neoplasms DRUG: Atezolizumab

NCT06188065 Eosinopenia in Severe COPD Exacerbation https://clinicaltrials.gov/study/NCT06188065 RECRUITING Chronic Obstructive Pulmonary Disease DIAGNOSTIC_TEST: Blood eosinophil count Northumbria Healthcare NHS Foundation Trust Newcastle University

NCT04976920 Metabolomics Non Selection Study - Vitrolife Media https://clinicaltrials.gov/study/NCT04976920 RECRUITING Infertility DIAGNOSTIC_TEST: Overture Metabolomics Embryo Selection Overture Life Clinica Juana Crespo

NCT06642220 Ablative Radioembolization of Renal Cell Carcinoma Trial https://clinicaltrials.gov/study/NCT06642220 NOT_YET_RECRUITING Renal Cell Carcinoma (RCC)

NCT05276674 ZNN Bactiguard Retrograde Femoral Nails PMCF Study https://clinicaltrials.gov/study/NCT05276674 RECRUITING Femoral Fracture DEVICE: ZNN Bactiguard Retrograde Femoral Nail Zimmer Biomet

NCT06332274 tislelizUMaB in canceR Patients With molEcuLar residuaL Disease https://clinicaltrials.gov/study/NCT06332274 NOT_YET_RECRUITING Cancer

NCT06376474 To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage https://clinicaltrials.gov/study/NCT06376474 RECRUITING Psoriasis DRUG: Hemay005 Ganzhou Hemay Pharmaceutical Co., Ltd

NCT06297174 Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions https://clinicaltrials.gov/study/NCT06297174 NOT_YET_RECRUITING Healthy Vollunteer DRUG: Racecadotril 100 mg Capsules

NCT06527274 Effect of Defocus in Soft Contact Lenses on Internal Retinal Vascularization https://clinicaltrials.gov/study/NCT06527274 RECRUITING Nearsightedness DEVICE: Experimental: Myopic defocus soft lens design (MDSL)

NCT05799274 Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer https://clinicaltrials.gov/study/NCT05799274 RECRUITING Healthy Volunteers

NCT03994874 Peritoneal Ultrafiltration in Cardio Renal Syndrome. https://clinicaltrials.gov/study/NCT03994874 NOT_YET_RECRUITING Congestive Heart Failure DRUG: PolyCore (Polydextrin, L-Carnitine, D-xylitol) Iperboreal Pharma Srl

NCT05952674 Treatment Resistant Depression and Vagus Nerve Stimulation https://clinicaltrials.gov/study/NCT05952674 NOT_YET_RECRUITING Treatment Resistant Depression (TRD) DEVICE: Vagus Nerve Stimulation (VNS)

NCT04162665 Pre-operative Adaptive Short Court Radiation Therapy in Gastric Cancer https://clinicaltrials.gov/study/NCT04162665 RECRUITING Gastric Adenocarcinoma RADIATION: Adaptive short course radiation therapy

NCT06414265 Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral Regurgitation https://clinicaltrials.gov/study/NCT06414265 RECRUITING Heart Failure DEVICE: Transcatheter mitral valve replacement InnovHeart MAXIS, LLC

NCT05713565 A Digital Care Solution for Coronary Artery Disease Patients https://clinicaltrials.gov/study/NCT05713565 RECRUITING Coronary Artery Disease DEVICE: A digital care solution for patients with Coronary Artery Disease

NCT06228365 Minimally Invasive Superficial Venous Insufficiency Surgery and Digital Sedation https://clinicaltrials.gov/study/NCT06228365 RECRUITING Superficial Venous Insufficiency DEVICE: use of a device incorporating virtual reality software

NCT06685965 Double-Blind, Placebo-Controlled, Crossover Study With Roll-over Extension of Two RE03 Doses for PTSD Sleep Disturbances https://clinicaltrials.gov/study/NCT06685965 NOT_YET_RECRUITING Posttraumatic Stress Disorder (PTSD)

NCT02102165 AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer. https://clinicaltrials.gov/study/NCT02102165 RECRUITING Metastatic Breast Cancer PROCEDURE: metastatic lesion biopsy Breast International Group Jules Bordet Institute

NCT06351020 LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma. https://clinicaltrials.gov/study/NCT06351020 RECRUITING Locally Advanced or Metastatic GC and GCJ Adenocarcinoma DRUG: LM-302

NCT05943574 PMCF Study on the Safety, Performance and Clinical Benefits Data of the XtraFix¬Æ Small External Fixation System https://clinicaltrials.gov/study/NCT05943574 RECRUITING Wrist Fracture

NCT05405374 OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study https://clinicaltrials.gov/study/NCT05405374 RECRUITING Lumbar Spine Disease

NCT06503965 Tunisian Registry of Trans Catheter Aortic Valve Implantation https://clinicaltrials.gov/study/NCT06503965 RECRUITING Tunisian Patients Already Implanted With a TAVI Les Laboratoires des M√©dicaments St√©riles Tunisian Society of Cardiology and Cardiovascular Surgery

NCT06116565 A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06116565 NOT_YET_RECRUITING Atopic Dermatitis BIOLOGICAL: CM310 Keymed Biosciences Co.Ltd

NCT05216965 A Clinical Study of 9MW2821 in Subjects With Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT05216965 RECRUITING Solid Tumors DRUG: 9MW2821 Mabwell (Shanghai) Bioscience Co., Ltd.

NCT04414865 VitaFlow‚Ñ¢ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study https://clinicaltrials.gov/study/NCT04414865 RECRUITING Aortic Valve Stenosis DEVICE: VitaFlow‚Ñ¢ Transcatheter Aortic Valve System Shanghai MicroPort CardioFlow Medtech Co., Ltd.

NCT06541665 Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL https://clinicaltrials.gov/study/NCT06541665 RECRUITING Primary Central Nervous System Lymphoma DRUG: ONO-4059

NCT05435365 Investigating The Experiences of Patients In Immunotherapy Clinical Trials https://clinicaltrials.gov/study/NCT05435365 NOT_YET_RECRUITING Immunotherapy

NCT06532565 Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06532565 RECRUITING Advanced Solid Tumors DRUG: GS-2121

NCT06697665 An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours https://clinicaltrials.gov/study/NCT06697665 RECRUITING Solid Cancer BIOLOGICAL: LM103 Suzhou BlueHorse Therapeutics Co., Ltd.

NCT04563520 SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis https://clinicaltrials.gov/study/NCT04563520 RECRUITING Hemophilia A DRUG: aPCC-emicizumab

NCT05498220 Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma https://clinicaltrials.gov/study/NCT05498220 RECRUITING Diffuse Large B-cell Lymphoma DRUG: Polatuzumab vedotin (PV)

NCT05073120 Survey Among Healthcare Professionals Treating Patients With Metastatic Breast Cancer in Selected European Countries to Evaluate Their Knowledge on Management of Hyperglycemia When Using Alpelisib https://clinicaltrials.gov/study/NCT05073120 RECRUITING Breast Cancer OTHER: Piqray Prescriber's/HCP guide for hyperglycemia Novartis Pharmaceuticals

NCT06490874 Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT https://clinicaltrials.gov/study/NCT06490874 NOT_YET_RECRUITING Gestational Diabetes Mellitus

NCT05320874 A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors. https://clinicaltrials.gov/study/NCT05320874 NOT_YET_RECRUITING Advanced Solid Tumor BIOLOGICAL: KM257 Bispecific antibody Xuanzhu Biopharmaceutical Co., Ltd.

NCT04608474 Lipid Management in Renal Transplant Recipients Using Evolocumab. https://clinicaltrials.gov/study/NCT04608474 RECRUITING Hyperlipidemias DRUG: Evolocumab

NCT06486974 Efficacy of Manual Toothbrushes in Removing Tooth Stains https://clinicaltrials.gov/study/NCT06486974 RECRUITING Tooth Discoloration DRUG: NaF

NCT04919265 Mother-Infant Cohort Study in Malaysia and China https://clinicaltrials.gov/study/NCT04919265 RECRUITING Gut Microbiota

NCT06059365 Clinical Trial for a Outpatient Clinical Management for Complicated Acute Appendicitis https://clinicaltrials.gov/study/NCT06059365 NOT_YET_RECRUITING Acute Appendicitis

NCT06372665 Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization https://clinicaltrials.gov/study/NCT06372665 RECRUITING Japanese Encephalitis Liaoning Chengda Biotechnology CO., LTD

NCT05313165 PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia https://clinicaltrials.gov/study/NCT05313165 RECRUITING Critical Limb Ischemia

NCT06719531 SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients with Type 1 and Type 2 Diabetes https://clinicaltrials.gov/study/NCT06719531 NOT_YET_RECRUITING Type 1 Diabetes Mellitus

NCT06505031 A Study of TAK-861in People With Narcolepsy Type 1 https://clinicaltrials.gov/study/NCT06505031 RECRUITING Narcolepsy Type 1 DRUG: TAK-861

NCT02766231 Physica CR and Physica PS Clinical Trial https://clinicaltrials.gov/study/NCT02766231 RECRUITING Knee Osteoarthritis DEVICE: Physica CR

NCT05790382 Single and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101 https://clinicaltrials.gov/study/NCT05790382 NOT_YET_RECRUITING Parkinson Disease DRUG: NM-101

NCT06683482 A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in Spain https://clinicaltrials.gov/study/NCT06683482 NOT_YET_RECRUITING Breast Cancer OTHER: No intervention Gilead Sciences

NCT06124482 Performance and Safety Evaluation of the FHK¬Æ-CK Knee Prosthesis https://clinicaltrials.gov/study/NCT06124482 RECRUITING Total Knee Arthroplasty DEVICE: Total Knee arthroplasty FH ORTHO Slb Pharma

NCT05751382 Evaluation of Self-adhesive Hybrid Resin Composite Compared to a Traditional Composite Resin in Restorations of NCCLs https://clinicaltrials.gov/study/NCT05751382 RECRUITING Tooth Restoration DEVICE: Surefil one

NCT06641882 Retrospective Chart Review of Patients with Acanthamoeba Keratitis Who Have Received 0.8 Mg/ml Polihexanide https://clinicaltrials.gov/study/NCT06641882 RECRUITING Acanthamoeba Keratitis SIFI SpA

NCT05438420 Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05438420 RECRUITING Esophageal Cancer

NCT04963920 A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock https://clinicaltrials.gov/study/NCT04963920 RECRUITING Septic Shock DEVICE: Cytosorb¬Æ 300 ml CytoSorbents Europe GmbH BRAHMS GmbH

NCT06639620 Study To Assess Effectiveness and Adverse Events of Foscarbidopa/ Foslevodopa in Adult Participants With Advanced Parkinson Disease in Real Life Setting https://clinicaltrials.gov/study/NCT06639620 RECRUITING Advanced Parkinson Disease AbbVie

NCT06254820 Dose, Safety, and Pathogenicity of a New Influenza B Strain https://clinicaltrials.gov/study/NCT06254820 RECRUITING Influenza B BIOLOGICAL: influenza B/Connecticut/1/21 virus part a dose arm 1

NCT06473974 Open-label, Single-arm, Proof of Concept Study in Subjects With Mild-to-moderate Facial Hyperpigmentation https://clinicaltrials.gov/study/NCT06473974 NOT_YET_RECRUITING Facial Hyperpigmentation DRUG: Test cosmetic product Kayuraeffect, LLP COD Research

NCT06095674 ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study https://clinicaltrials.gov/study/NCT06095674 NOT_YET_RECRUITING Cervical Cancer DRUG: Anti-PD-1 antibody balstilimab Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Dutch Cancer Society

NCT02325674 MEASuRE: Metreleptin Effectiveness And Safety Registry https://clinicaltrials.gov/study/NCT02325674 RECRUITING Generalised Lipodystrophy

NCT06717074 A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants with Stable Coronary Artery Disease https://clinicaltrials.gov/study/NCT06717074 RECRUITING Stable Coronary Artery Disease CAD DRUG: RBD4059

NCT06122974 Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia https://clinicaltrials.gov/study/NCT06122974 NOT_YET_RECRUITING Critical Limb Ischemia DEVICE: Drug Eluting Temporary Spur Stent System

NCT05938465 Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) https://clinicaltrials.gov/study/NCT05938465 RECRUITING Ileal Pouch BIOLOGICAL: EXE-346

NCT04421820 BOLD-100 in Combination with FOLFOX for the Treatment of Advanced Solid Tumours https://clinicaltrials.gov/study/NCT04421820 RECRUITING Colorectal Cancer

NCT05129020 Neurostimulation to Improve NOWS Outcomes https://clinicaltrials.gov/study/NCT05129020 RECRUITING Neonatal Opioid Withdrawal Syndrome

NCT06637020 Phase Ib Clinical Study of HDM1005 Injection https://clinicaltrials.gov/study/NCT06637020 RECRUITING Overweight and Obesity DRUG: HDM1005 injection or placebo Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

NCT05902520 Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors https://clinicaltrials.gov/study/NCT05902520 RECRUITING HNSCC

NCT03850574 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT03850574 RECRUITING Leukemia, Myeloid, Acute

NCT02720874 Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT02720874 NOT_YET_RECRUITING Arthritis, Rheumatoid BEHAVIORAL: Rheumatoid arthritis educational booklet

NCT06510374 Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer https://clinicaltrials.gov/study/NCT06510374 RECRUITING Intermediate Risk Non-Muscle Invasive Bladder Cancer DRUG: Nadofaragene Firadenovec Ferring Pharmaceuticals

NCT05808374 Clinical Study to Evaluate the Safety, Tolerance and Pharmacokinetic Characteristics of Single Administration of HRS-5635 Injection in Chinese Healthy Subjects and the Safety, Tolerance, Pharmacokinetics and Antiviral Effect of Multiple Administration in Patients With Chronic Hepatitis B https://clinicaltrials.gov/study/NCT05808374 RECRUITING Chronic Hepatitis B DRUG: HRS-5635

NCT06171074 Study of CM310 in Subjects With Seasonal Allergic Rhinitis https://clinicaltrials.gov/study/NCT06171074 NOT_YET_RECRUITING Seasonal Allergic Rhinitis BIOLOGICAL: CM310 Keymed Biosciences Co.Ltd

NCT06492174 A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort https://clinicaltrials.gov/study/NCT06492174 RECRUITING In-Stent Restenosis DEVICE: AGENT DCB 40 mm Boston Scientific Corporation

NCT06594874 A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06594874 NOT_YET_RECRUITING Non-Small Cell Lung Cancer

NCT04117074 Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery https://clinicaltrials.gov/study/NCT04117074 RECRUITING Surgery

NCT06442774 MamaConecta: Digital Tool for Maternal Mental Health https://clinicaltrials.gov/study/NCT06442774 NOT_YET_RECRUITING Pregnancy Related

NCT04986865 A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas https://clinicaltrials.gov/study/NCT04986865 RECRUITING Advanced Solid Tumor

NCT06480565 A Phase 1/2 Trial of ADI-270 in CcRCC https://clinicaltrials.gov/study/NCT06480565 RECRUITING Clear Cell Renal Cell Carcinoma DRUG: ADI-270

NCT04657965 LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies https://clinicaltrials.gov/study/NCT04657965 NOT_YET_RECRUITING Infectious Diseases

NCT06488365 In Vivo Liquid Biopsy of Melanoma (Cytophone) https://clinicaltrials.gov/study/NCT06488365 NOT_YET_RECRUITING Melanoma

NCT05369065 Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities https://clinicaltrials.gov/study/NCT05369065 RECRUITING Diabetes Mellitus, Type 2

NCT05699265 Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing https://clinicaltrials.gov/study/NCT05699265 RECRUITING Fabry Disease DIAGNOSTIC_TEST: Measures of arterial stiffness and endothelial function

NCT06412120 Study Evaluating Safety, Tolerability, and Metabolism of Niraparib https://clinicaltrials.gov/study/NCT06412120 NOT_YET_RECRUITING Ovarian Cancer DRUG: Niraparib University of Miami GlaxoSmithKline

NCT06700720 YN001-004 in Patients With Coronary Atherosclerosis in Australia https://clinicaltrials.gov/study/NCT06700720 NOT_YET_RECRUITING Coronary Artery Disease

NCT06319820 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer https://clinicaltrials.gov/study/NCT06319820 RECRUITING Non-Muscle Invasive Bladder Cancer COMBINATION_PRODUCT: TAR-210

NCT03255174 The EVARREST¬Æ Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study https://clinicaltrials.gov/study/NCT03255174 RECRUITING Controlling Mild to Moderate Bleeding During Surgery BIOLOGICAL: EVARREST¬Æ Fibrin Sealant Patch Ethicon, Inc.

NCT06642974 Development, Validation and Testing of an Education Program for Identification of Learning Disabilities Among School Children by Primary School Teachers in Qatar https://clinicaltrials.gov/study/NCT06642974 NOT_YET_RECRUITING Learning Disabilities, Child OTHER: Education module on learning disabilities

NCT05435274 Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05435274 RECRUITING Advanced Non-Small-Cell Lung Cancer DRUG: HS-10376 Jiangsu Hansoh Pharmaceutical Co., Ltd.

NCT04471974 ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT04471974 RECRUITING Castration-Resistant Prostate Carcinoma

NCT06268574 Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML https://clinicaltrials.gov/study/NCT06268574 RECRUITING Acute Myeloid Leukemia (AML)

NCT05652374 Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study https://clinicaltrials.gov/study/NCT05652374 RECRUITING Recurrent Urinary Tract Infection DEVICE: Ialuril 50ml Prefill

NCT00438074 A Pilot Study To Evaluate the Effectiveness of Pulsed Time-Domain Optical Spectroscopy for Monitoring the Responses in Neoadjuvant Treatments of Locally-Advanced Breast Cancer https://clinicaltrials.gov/study/NCT00438074 RECRUITING Breast Cancer Sunnybrook Health Sciences Centre ART Advanced Research Technologies Inc.

NCT06485674 Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT06485674 RECRUITING Long-Term Organ Damage in Adult Patients With Active Systemic Lupus Erythematosus AstraZeneca IQVIA Pvt. Ltd

NCT06590974 A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants with Congenital Protein C Deficiency https://clinicaltrials.gov/study/NCT06590974 RECRUITING Protein C Deficiency DRUG: Freeze-dried Human Protein C Concentrate Takeda

NCT06298565 A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa https://clinicaltrials.gov/study/NCT06298565 NOT_YET_RECRUITING Myasthenia Gravis BIOLOGICAL: efgartigimod argenx

NCT02895165 PREgnancy and FERtility Registry https://clinicaltrials.gov/study/NCT02895165 RECRUITING Breast Neoplasms

NCT03383965 CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas https://clinicaltrials.gov/study/NCT03383965 RECRUITING Hodgkin Lymphoma

NCT05740631 The Effect of Obeticholic Acid in Healthy Volunteers https://clinicaltrials.gov/study/NCT05740631 RECRUITING Healthy DRUG: Ocaliva

NCT06463782 Clinical Study of 68Ga-LNC1007 Injection PET/CT https://clinicaltrials.gov/study/NCT06463782 NOT_YET_RECRUITING Healthy Volunteers

NCT04762082 A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers https://clinicaltrials.gov/study/NCT04762082 NOT_YET_RECRUITING Erectile Dysfunction DRUG: Tadalafil 10 MG Seattle Gummy Company

NCT04814082 Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot Versus Single Radius Design for Total Knee Arthroplasty https://clinicaltrials.gov/study/NCT04814082 RECRUITING Osteoarthritis, Knee

NCT05187182 CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer https://clinicaltrials.gov/study/NCT05187182 RECRUITING Gastric Cancer

NCT06678282 JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia https://clinicaltrials.gov/study/NCT06678282 RECRUITING B-NHL

NCT05245682 Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer https://clinicaltrials.gov/study/NCT05245682 RECRUITING Head and Neck Carcinoma of Unknown Primary

NCT04856982 A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation https://clinicaltrials.gov/study/NCT04856982 RECRUITING Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation DRUG: Tofersen

NCT06300320 A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease https://clinicaltrials.gov/study/NCT06300320 RECRUITING Chronic Graft Versus Host Disease DRUG: TQ05105 tablets Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT06178120 Disease Progression in Women With X-linked Adrenoleukodystrophy https://clinicaltrials.gov/study/NCT06178120 RECRUITING X-linked Adrenoleukodystrophy Minoryx Therapeutics, S.L.

NCT06301074 The Phase I Study of HS-10509 in Chinese Adult Subjects https://clinicaltrials.gov/study/NCT06301074 NOT_YET_RECRUITING Schizophrenia DRUG: HS-10509

NCT04764474 A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH https://clinicaltrials.gov/study/NCT04764474 RECRUITING Isocitrate Dehydrogenase Gene Mutation DRUG: HMPL-306 Hutchmed

NCT03941574 A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy https://clinicaltrials.gov/study/NCT03941574 RECRUITING MSI-H Solid Malignant Tumor DRUG: HLX10 Shanghai Henlius Biotech

NCT06304974 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT06304974 RECRUITING Esophageal Squamous Cell Carcinoma DRUG: BL-B01D1

NCT05933265 Study of LP-184 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05933265 RECRUITING Advanced Solid Tumor DRUG: LP-184 Lantern Pharma Inc.

NCT06549465 Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT06549465 RECRUITING PSMA PET-Positive Castration-Resistant Prostate Cancer BIOLOGICAL: In-111 rosopatamab tetraxetan

NCT05578976 A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) https://clinicaltrials.gov/study/NCT05578976 RECRUITING Diffuse Large B-Cell Lymphoma DRUG: Epcoritamab

NCT05782127 Oral Azacitidine Combined with Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes https://clinicaltrials.gov/study/NCT05782127 RECRUITING Untreated Myelodysplastic Syndrome DRUG: Onureg + Venetoclax Groupe Francophone des Myelodysplasies Bristol-Myers Squibb

NCT06567327 A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese https://clinicaltrials.gov/study/NCT06567327 RECRUITING Obesity DRUG: Danuglipron

NCT05412927 AngelMed Guardian¬Æ System PMA Post Approval Study https://clinicaltrials.gov/study/NCT05412927 RECRUITING Acute Coronary Syndrome DEVICE: PMA P150009 AngelMed Guardian¬Æ System Angel Medical Systems

NCT05501327 Dose Regimen Study of SLI-F06 in Healthy Volunteers https://clinicaltrials.gov/study/NCT05501327 RECRUITING Scar

NCT04715373 LISA in the Delivery Room for Extremely Preterm Infants https://clinicaltrials.gov/study/NCT04715373 RECRUITING Extreme Prematurity

NCT05362773 A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies https://clinicaltrials.gov/study/NCT05362773 RECRUITING Leukemia, Acute Myeloid

NCT05983276 Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer https://clinicaltrials.gov/study/NCT05983276 RECRUITING Ovarian Cancer DRUG: Decitabine

NCT05868876 A Phase Ia/Ib Open LabelÔºåClinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT05868876 RECRUITING Advanced Malignant Tumors DRUG: AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion Akeso

NCT06110676 A Study to Evaluate the Efficacy and Safety of LZM012 https://clinicaltrials.gov/study/NCT06110676 RECRUITING Psoriasis BIOLOGICAL: LZM012

NCT05763576 A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection https://clinicaltrials.gov/study/NCT05763576 RECRUITING Chronic Hepatitis B DRUG: RO7565020

NCT06074276 The Effects of Almond on Facial Skin Collagen and Wrinkles https://clinicaltrials.gov/study/NCT06074276 RECRUITING Collagen Degeneration

NCT06694727 A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure https://clinicaltrials.gov/study/NCT06694727 NOT_YET_RECRUITING Heart Failure DIETARY_SUPPLEMENT: Coenzyme Q10 100 Milligrams Oral Capsule

NCT06576427 Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-II https://clinicaltrials.gov/study/NCT06576427 RECRUITING Pulmonary Embolism DEVICE: Vertex Pulmonary Embolectomy System Neptune Medical

NCT05745727 A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels https://clinicaltrials.gov/study/NCT05745727 RECRUITING Gout DRUG: PRX-115

NCT05815927 Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer https://clinicaltrials.gov/study/NCT05815927 NOT_YET_RECRUITING Oligometastatic Squamous Cell Carcinoma of the Head and Neck DRUG: Pembrolizumab

NCT06637527 The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain https://clinicaltrials.gov/study/NCT06637527 RECRUITING Neuropathic Pain DRUG: OK-101 0.05%

NCT06719973 Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521) https://clinicaltrials.gov/study/NCT06719973 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: M9466

NCT05774873 IBI334 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05774873 RECRUITING Solid Tumors DRUG: IBI334 D

NCT06447376 Study of Cytokine Release Syndrome Prophylaxis and Treatment with Siltuximab Prior to Epcoritamab https://clinicaltrials.gov/study/NCT06447376 NOT_YET_RECRUITING Non-Hodgkin Lymphoma

NCT05707676 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid TumorsÔºàMEETCD8-001Ôºâ https://clinicaltrials.gov/study/NCT05707676 RECRUITING Solid Tumor DRUG: LB4330 L & L biopharma Co., Ltd., Shanghai China

NCT03965676 Evolution of Tophus and Erosions of Hands and Feet at DECT https://clinicaltrials.gov/study/NCT03965676 RECRUITING Tophaceous Gout OTHER: Dual-Energy Computed Tomography examination Assistance Publique - H√¥pitaux de Paris Canon U.S.A., Inc.

NCT05348876 A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) https://clinicaltrials.gov/study/NCT05348876 RECRUITING Non-metastatic Castration-resistant Prostate Cancer DRUG: Darolutamide (Nubeqa, BAY1841788) Bayer

NCT04126876 A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma https://clinicaltrials.gov/study/NCT04126876 RECRUITING Malignant Melanoma DRUG: Tilsotolimod

NCT06019676 Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients https://clinicaltrials.gov/study/NCT06019676 RECRUITING Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Royal Marsden NHS Foundation Trust Janssen, LP

NCT05318976 A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation https://clinicaltrials.gov/study/NCT05318976 RECRUITING Alzheimer Disease

NCT05724576 Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients https://clinicaltrials.gov/study/NCT05724576 RECRUITING Safety Issues BIOLOGICAL: OmniMSC-AMI Taiwan Bio Therapeutics Inc.

NCT04921527 Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer https://clinicaltrials.gov/study/NCT04921527 RECRUITING Ovarian Cancer

NCT05254327 Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001 https://clinicaltrials.gov/study/NCT05254327 RECRUITING Rectal Cancer DRUG: BMX-001 University of Nebraska BioMimetix JV, LLC

NCT05419427 Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis https://clinicaltrials.gov/study/NCT05419427 RECRUITING Osteoporosis, Postmenopausal DRUG: Denosumab

NCT05744427 To Evaluate the Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05744427 RECRUITING Advanced Solid Tumor DRUG: JSKN003 Jiangsu Alphamab Biopharmaceuticals Co., Ltd

NCT06322927 PatIent exPeRiences and prEFerence of trEatment foR Multiple Myeloma https://clinicaltrials.gov/study/NCT06322927 NOT_YET_RECRUITING Multiple Myeloma OTHER: Patient Interview The Christie NHS Foundation Trust CellCentric Ltd.

NCT05729373 A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder https://clinicaltrials.gov/study/NCT05729373 RECRUITING Generalized Anxiety Disorder DRUG: SEP-363856

NCT06186076 A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients https://clinicaltrials.gov/study/NCT06186076 RECRUITING Carcinoma, Non-Small-Cell Lung

NCT05516576 Endoscopic Sutured Gastroplasty With Endomina¬Æ Device Versus Standard of Care in Patients With Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial https://clinicaltrials.gov/study/NCT05516576 RECRUITING Diabetes Mellitus, Type 2

NCT05701527 A Study of EBC-129 in Advanced Solid Tumours https://clinicaltrials.gov/study/NCT05701527 RECRUITING Advanced Solid Tumours DRUG: EBC-129

NCT04389827 Global Kidney Patient Trials Network https://clinicaltrials.gov/study/NCT04389827 RECRUITING Kidney Diseases The George Institute George Clinical Pty Ltd

NCT06144827 A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer https://clinicaltrials.gov/study/NCT06144827 NOT_YET_RECRUITING Cancer, Hepatocellular

NCT06558227 Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT06558227 NOT_YET_RECRUITING Hepatocellular Carcinoma BIOLOGICAL: ZG005 for Injection

NCT04856176 A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy https://clinicaltrials.gov/study/NCT04856176 RECRUITING Advanced Lung Non-Small Cell Carcinoma

NCT05552976 A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2) https://clinicaltrials.gov/study/NCT05552976 RECRUITING Relapsed or Refractory Multiple Myeloma DRUG: Mezigdomide

NCT06118827 A Study of HS-10518 in Healthy Female Participants https://clinicaltrials.gov/study/NCT06118827 NOT_YET_RECRUITING Endometriosis DRUG: HS-10518

NCT06094127 Zenith Thoracic Alpha (ZTA) Post-Market Data Collection https://clinicaltrials.gov/study/NCT06094127 RECRUITING Thoracic Aortic Aneurysm

NCT04307927 Lifetech LAmbre‚Ñ¢ Left Atrial Appendage Closure System Post-Market Registry https://clinicaltrials.gov/study/NCT04307927 RECRUITING Atrial Fibrillation Lifetech Scientific (Shenzhen) Co., Ltd.

NCT06463327 ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AML https://clinicaltrials.gov/study/NCT06463327 NOT_YET_RECRUITING Acute Myeloid Leukemia

NCT05944627 Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis https://clinicaltrials.gov/study/NCT05944627 NOT_YET_RECRUITING Knee Osteoarthritis BIOLOGICAL: FURESTEM-OA Kit Inj.

NCT04469127 A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients. https://clinicaltrials.gov/study/NCT04469127 NOT_YET_RECRUITING Breast Cancer Stage IV DRUG: Lutetium-177-DOTAGA-IAC Advanced Imaging Projects, LLC University of Witwatersrand, South Africa

NCT06040476 Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS) https://clinicaltrials.gov/study/NCT06040476 NOT_YET_RECRUITING Acute Ischemic Stroke BIOLOGICAL: hUCB StemCyte International, Ltd. StemCyte Taiwan Co., Ltd.

NCT06472076 A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) https://clinicaltrials.gov/study/NCT06472076 RECRUITING Lung Cancer, Non-Small Cell BIOLOGICAL: Dostarlimab

NCT06435676 A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects https://clinicaltrials.gov/study/NCT06435676 RECRUITING Overweight or Obesity; Type 2 Diabetes DRUG: HRS9531

NCT05038527 ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery https://clinicaltrials.gov/study/NCT05038527 RECRUITING Spine Deformity

NCT06494527 A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in Healthy Adults https://clinicaltrials.gov/study/NCT06494527 NOT_YET_RECRUITING Safety Issues DRUG: RG002C0106 Rigerna Therapeutics, BeijingÔºõ Rigerna Therapeutics, SuzhouÔºõ Rigerna OA Therapeutics Pty Ltd

NCT06577727 A Study to Collect Data to Build Artificial Intelligence Derived Algorithms for Estimating Iron Status of Children https://clinicaltrials.gov/study/NCT06577727 NOT_YET_RECRUITING Iron Deficiency OTHER: Gold standard blood test

NCT04934527 Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection https://clinicaltrials.gov/study/NCT04934527 RECRUITING Kidney Transplantation

NCT05034627 Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer https://clinicaltrials.gov/study/NCT05034627 RECRUITING Locally Advanced Pancreatic Adenocarcinoma

NCT05867927 GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications https://clinicaltrials.gov/study/NCT05867927 RECRUITING GYN Disorders DEVICE: Robotic-assisted surgery (da Vinci)

NCT05856227 Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age https://clinicaltrials.gov/study/NCT05856227 RECRUITING Neonatal Sepsis DRUG: Ceftobiprole medocaril Basilea Pharmaceutica

NCT06038227 Lung cAncer Robotic Comparative Study https://clinicaltrials.gov/study/NCT06038227 RECRUITING Lung Cancer PROCEDURE: Robotic Assisted Thoracic Surgery

NCT06066476 Evaluating Efficacy and Safety of GENOSS Stent in Patients With Coronary Artery Disease https://clinicaltrials.gov/study/NCT06066476 RECRUITING Coronary Artery Disease DEVICE: Genoss DES Genoss Co., Ltd.

NCT05812976 Novel Index (PIMR) in PAH https://clinicaltrials.gov/study/NCT05812976 RECRUITING Pulmonary Hypertension OTHER: Pulmonary Index of Microcirculatory Resistance

NCT05117476 A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05117476 RECRUITING Advanced Solid Tumor DRUG: CLN-619

NCT06052176 Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement https://clinicaltrials.gov/study/NCT06052176 RECRUITING Cirrhosis

NCT05690776 PMCF Study on the Safety, Performance and Clinical Benefits Data of the Quattro X Broadband https://clinicaltrials.gov/study/NCT05690776 RECRUITING Rotator Cuff Tears

NCT06254027 Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment https://clinicaltrials.gov/study/NCT06254027 NOT_YET_RECRUITING Onychomycosis DEVICE: Forte

NCT06087627 A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine https://clinicaltrials.gov/study/NCT06087627 RECRUITING Prurigo Nodularis DRUG: Dupilumab SAR231893 (REGN668) Sanofi

NCT06543576 External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer https://clinicaltrials.gov/study/NCT06543576 NOT_YET_RECRUITING Cervical Adenocarcinoma

NCT06326827 In'Oss‚Ñ¢ (MBCP¬Æ Putty) Ortho https://clinicaltrials.gov/study/NCT06326827 NOT_YET_RECRUITING Orthopedic Disorder

NCT06568627 A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE) https://clinicaltrials.gov/study/NCT06568627 NOT_YET_RECRUITING Venous Leg Ulcer (VLU) DRUG: EscharEx (EX-03)

NCT05537727 Robotic MIS With Dexter https://clinicaltrials.gov/study/NCT05537727 RECRUITING Hysterectomy

NCT05347927 Observational Study to Evaluate the Influence of Undercast Material Types on Skin Microbiome https://clinicaltrials.gov/study/NCT05347927 RECRUITING Skin Microbiome

NCT05288127 Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature https://clinicaltrials.gov/study/NCT05288127 RECRUITING HRD 100 Gene Expression High

NCT06497127 A Study in Patients With Mixed Dyslipidemia https://clinicaltrials.gov/study/NCT06497127 NOT_YET_RECRUITING Mixed Dyslipidemia DRUG: BW-00112 Shanghai Argo Biopharmaceutical Co., Ltd.

NCT06065176 The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection https://clinicaltrials.gov/study/NCT06065176 RECRUITING COVID-19

NCT05997576 A Study of TG103 Injection in Non-diabetic Overweight or Obesity https://clinicaltrials.gov/study/NCT05997576 NOT_YET_RECRUITING Overweight or Obesity DRUG: TG103 22.5 mg

NCT05872776 BEAT AF - Braking Ectopic Atrial Trends In Atrial Fibrillation https://clinicaltrials.gov/study/NCT05872776 RECRUITING Paroxysmal Atrial Fibrillation DEVICE: Neuromodulation with RR2 device

NCT06706076 A Study of BH-30643 in Subjects with Locally Advanced or Metastatic NSCLC Harboring EGFR And/or HER2 Mutations https://clinicaltrials.gov/study/NCT06706076 RECRUITING NSCLC (advanced Non-small Cell Lung Cancer) DRUG: BH-30643

NCT05920876 A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT05920876 RECRUITING Relapsed or Refractory Multiple Myeloma DRUG: QLS32015 Qilu Pharmaceutical Co., Ltd.

NCT05542576 AMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy https://clinicaltrials.gov/study/NCT05542576 RECRUITING Parkinson Disease

NCT05996627 Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease https://clinicaltrials.gov/study/NCT05996627 RECRUITING Chronic Graft Versus Host Disease DRUG: Belumosudil

NCT05984927 NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration https://clinicaltrials.gov/study/NCT05984927 RECRUITING Age-Related Macular Degeneration GENETIC: NG101 AAV gene therapy Neuracle Genetics, Inc ORA, Inc.

NCT03916627 Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients https://clinicaltrials.gov/study/NCT03916627 RECRUITING Non-small Cell Lung Cancer

NCT06662227 Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors https://clinicaltrials.gov/study/NCT06662227 RECRUITING B Cell Lymphoma

NCT05561127 Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel https://clinicaltrials.gov/study/NCT05561127 RECRUITING Bowel; Stricture COMBINATION_PRODUCT: GIE Medical ProTractX3 TTS DCB

NCT06397976 The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study https://clinicaltrials.gov/study/NCT06397976 RECRUITING Eyes With Normal Anterior Segment

NCT06135376 E-PAUse: Encouraging Proper Antibiotic Use in Outpatient Setting https://clinicaltrials.gov/study/NCT06135376 RECRUITING Drug Use BEHAVIORAL: comprehensive multi-component interventions Hamad Medical Corporation Primary Health Care Corporation, Qatar

NCT04338776 Comparing UroLift Experience Against Rez≈´m https://clinicaltrials.gov/study/NCT04338776 RECRUITING Benign Prostatic Hyperplasia DEVICE: UroLift

NCT05248776 Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes https://clinicaltrials.gov/study/NCT05248776 RECRUITING Type 2 Diabetes DRUG: CPL207280

NCT06629376 Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia https://clinicaltrials.gov/study/NCT06629376 RECRUITING Gout

NCT04802876 Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors https://clinicaltrials.gov/study/NCT04802876 RECRUITING MSI-H Colorectal Cancer

NCT04855227 A Prospective Evaluation of Pain After Non-complex Ventral Hernia Repair https://clinicaltrials.gov/study/NCT04855227 RECRUITING Ventral Hernia PROCEDURE: robotic-assisted ventral hernia repair Intuitive Surgical

NCT06315127 The CanDo (Canadian Donor Milk) Trial https://clinicaltrials.gov/study/NCT06315127 RECRUITING Small for Gestational Age at Delivery

NCT06036927 A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps https://clinicaltrials.gov/study/NCT06036927 RECRUITING Chronic Sinusitis

NCT05814627 Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT05814627 RECRUITING Rheumatoid Arthritis DRUG: Upadacitinib

NCT06559527 A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function https://clinicaltrials.gov/study/NCT06559527 NOT_YET_RECRUITING Diabetes Mellitus, Type 2

NCT06248827 Creation of a Clinical Database of Lumbar Spine MRI https://clinicaltrials.gov/study/NCT06248827 NOT_YET_RECRUITING Low Back Pain OTHER: Data Collection Caerus Medical Centre hospitalier de l'Universit√© de Montr√©al (CHUM)

NCT05832827 First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis) https://clinicaltrials.gov/study/NCT05832827 RECRUITING Untreated Advanced or Recurrent Thymic Carcinomas DRUG: MK-3475

NCT05540327 The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) https://clinicaltrials.gov/study/NCT05540327 RECRUITING Systemic Lupus Erythematosus DRUG: M5049 low dose

NCT06608927 Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma https://clinicaltrials.gov/study/NCT06608927 RECRUITING Metastatic Pancreatic Ductal Adenocarcinoma DRUG: Quemliclustat

NCT06559176 A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants with P47phox Autosomal Recessive Chronic Granulomatous Disease (CGD ) https://clinicaltrials.gov/study/NCT06559176 RECRUITING Chronic Granulomatous Disease

NCT04307576 A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia https://clinicaltrials.gov/study/NCT04307576 RECRUITING Leukemia, Acute Lymphoblastic DRUG: Omitted Doxorubicin

NCT06578676 To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults https://clinicaltrials.gov/study/NCT06578676 RECRUITING Type 2 Diabetes

NCT06663176 Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients with Pseudomonas Aeruginosa (Pa) https://clinicaltrials.gov/study/NCT06663176 RECRUITING Non-Cystic Fibrosis Bronchiectasis DRUG: RESP302

NCT05797376 Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation https://clinicaltrials.gov/study/NCT05797376 RECRUITING Atherosclerosis of Artery

NCT05636176 A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation https://clinicaltrials.gov/study/NCT05636176 RECRUITING Heart Failure DRUG: Ziltivekimab

NCT06284876 Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer https://clinicaltrials.gov/study/NCT06284876 NOT_YET_RECRUITING Peptic Ulcer DRUG: Ilaprazole

NCT06093776 Rib Fracture Cryoanalgesia https://clinicaltrials.gov/study/NCT06093776 RECRUITING Pain Management Improvement DEVICE: iovera¬∫ system Methodist Health System Pacira Pharmaceuticals, Inc

NCT03050476 Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase https://clinicaltrials.gov/study/NCT03050476 RECRUITING Systemic Inflammation

NCT05924776 Plasmodium Immunotherapy for Advanced Ovarian Cancer https://clinicaltrials.gov/study/NCT05924776 NOT_YET_RECRUITING Advanced Ovarian Cancer BIOLOGICAL: Plasmodium immunotherapy CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. The Third Affiliated Hospital of Southern Medical University

NCT06172127 PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT06172127 RECRUITING HER2-positive Breast Cancer DRUG: Trastuzumab deruxtecan

NCT05004727 Multi-Center PAMPA Study https://clinicaltrials.gov/study/NCT05004727 RECRUITING Psoriasis DRUG: Guselkumab

NCT04110327 An All-Comers Observational Study of the MicroStent‚Ñ¢ Peripheral Vascular Stent System in Subjects with Peripheral Arterial Disease https://clinicaltrials.gov/study/NCT04110327 RECRUITING Peripheral Arterial Disease

NCT05330520 Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients Who Completed 12 Months of Follow-Up Post Implantation (Continuation Study for Study BM-011-IL) https://clinicaltrials.gov/study/NCT05330520 RECRUITING BPH

NCT04580420 Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD https://clinicaltrials.gov/study/NCT04580420 RECRUITING Primary Hyperoxaluria Type 1

NCT05685420 Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia https://clinicaltrials.gov/study/NCT05685420 NOT_YET_RECRUITING Immune Thrombocytopenia DRUG: Herombopag Jiangsu HengRui Medicine Co., Ltd.

NCT06393920 PulseSelect‚Ñ¢ PFA Global Registry https://clinicaltrials.gov/study/NCT06393920 RECRUITING Atrial Fibrillation Medtronic Cardiac Rhythm and Heart Failure

NCT06397274 Stemchymal¬Æ for Polyglutamine Spinocerebellar Ataxia https://clinicaltrials.gov/study/NCT06397274 NOT_YET_RECRUITING Spinocerebellar Ataxias BIOLOGICAL: Stemchymal

NCT06523374 A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer https://clinicaltrials.gov/study/NCT06523374 NOT_YET_RECRUITING Barrett's Esophagus

NCT05800574 Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer https://clinicaltrials.gov/study/NCT05800574 RECRUITING Oropharynx Cancer RADIATION: Radiation therapy (5 days for 7 weeks)

NCT06096974 Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS https://clinicaltrials.gov/study/NCT06096974 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: YL-17231 Shanghai YingLi Pharmaceutical Co. Ltd.

NCT06284265 Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis https://clinicaltrials.gov/study/NCT06284265 RECRUITING Cystitis Chronic

NCT06433765 A Study Evaluating the Effect of BRIUMVI¬Æ (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS) https://clinicaltrials.gov/study/NCT06433765 RECRUITING Multiple Sclerosis OTHER: No intervention TG Therapeutics, Inc.

NCT05941065 Study of Skin Balancing Gel Cream Safety and Influence of Skin Microbiome on Acne Prone Skin https://clinicaltrials.gov/study/NCT05941065 RECRUITING Skin Microboime

NCT06645665 A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above https://clinicaltrials.gov/study/NCT06645665 RECRUITING Respiratory Syncytial Virus Infections BIOLOGICAL: Bivalent RSV Vaccine (IN006)

NCT04721665 German SLD-Registry (Deutsches SLD-Register) https://clinicaltrials.gov/study/NCT04721665 RECRUITING Steatotic Liver Disease Leberstiftungs-GmbH Deutschland

NCT06246565 A Study of HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC) https://clinicaltrials.gov/study/NCT06246565 NOT_YET_RECRUITING Cough DRUG: HS-10383

NCT05483465 The Effect of NAD Supplementation on Brain Vascular Health in Aging https://clinicaltrials.gov/study/NCT05483465 RECRUITING Aging DRUG: Nicotinamide riboside

NCT06078865 FX Shoulder Prospective Clinical Study https://clinicaltrials.gov/study/NCT06078865 RECRUITING Osteoarthritis Shoulder

NCT06402565 NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers https://clinicaltrials.gov/study/NCT06402565 NOT_YET_RECRUITING Diabetic Foot Ulcer DRUG: NOX1416 plus SOC

NCT06189365 Amplatzer Amulet China Post Market Study (PMS) https://clinicaltrials.gov/study/NCT06189365 RECRUITING Non-Valvular Atrial Fibrillation DEVICE: Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder Abbott Medical Devices

NCT05452720 MASA Valve Early Feasibility Study https://clinicaltrials.gov/study/NCT05452720 RECRUITING Tetrology of Fallot

NCT06591520 AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer https://clinicaltrials.gov/study/NCT06591520 NOT_YET_RECRUITING Biliary Tract Cancer DRUG: AK112, Gemcitabine, Cisplatin

NCT06368674 Bridging the Gap: Creating a Continuum of Care https://clinicaltrials.gov/study/NCT06368674 NOT_YET_RECRUITING Frailty

NCT06117774 Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) https://clinicaltrials.gov/study/NCT06117774 RECRUITING Limited Stage Small Cell Lung Cancer

NCT05865574 A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection https://clinicaltrials.gov/study/NCT05865574 NOT_YET_RECRUITING Healthy Men DRUG: BAT1706 Injection Bio-Thera Solutions

NCT06554574 A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants https://clinicaltrials.gov/study/NCT06554574 RECRUITING Healthy DRUG: LTG-305 Latigo Biotherapeutics

NCT06147674 Evaluation of VQm PHM on Pulmonary Health Parameters for ICU https://clinicaltrials.gov/study/NCT06147674 NOT_YET_RECRUITING Ventilators, Mechanical

NCT06393374 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) https://clinicaltrials.gov/study/NCT06393374 RECRUITING Triple-Negative Breast Cancer BIOLOGICAL: Pembrolizumab

NCT06558474 Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation https://clinicaltrials.gov/study/NCT06558474 RECRUITING Coronary Artery Disease BEHAVIORAL: Liberal post-dilatation strategy during PCI Cathreine BV Medtronic

NCT03433274 Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation https://clinicaltrials.gov/study/NCT03433274 RECRUITING Mitral Regurgitation

NCT03812874 A Study of PTX-9908 Injection for Non-resectable HCC with TACE https://clinicaltrials.gov/study/NCT03812874 RECRUITING Carcinoma, Hepatocellular DRUG: PTX-9908 Injection

NCT06052865 Serial Brain MRI in Hospitalized Preterm Infants https://clinicaltrials.gov/study/NCT06052865 RECRUITING Preterm Birth Complication BEHAVIORAL: SENSE-plus: The Supporting and Enhancing NICU Sensory Experiences 2nd Edition (SENSE II) program

NCT05824065 Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss https://clinicaltrials.gov/study/NCT05824065 NOT_YET_RECRUITING Female Pattern Baldness DRUG: OMA102

NCT05501665 Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer https://clinicaltrials.gov/study/NCT05501665 RECRUITING Lung Non-Small Cell Carcinoma

NCT06698965 Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin https://clinicaltrials.gov/study/NCT06698965 RECRUITING Lung Cancer, Small Cell DRUG: Chemotherapy ÔºàEtoposide and CarboplatinÔºâ

NCT05566665 Nosocomial Infections in ECMO Patients https://clinicaltrials.gov/study/NCT05566665 RECRUITING Acute Respiratory Distress Syndrome

NCT06081465 A Phase I Study of Single and Multiple Doses of VG290131 in Healthy Subjects https://clinicaltrials.gov/study/NCT06081465 RECRUITING Healthy Volunteers DRUG: VG290131 Zhejiang Vimgreen Pharmaceuticals, Ltd. Tigermed Consulting Co., Ltd

NCT03394365 Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy https://clinicaltrials.gov/study/NCT03394365 RECRUITING Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

NCT05790265 Assessing Innovative Wireless and Wearable Sensors for Continuous Blood Pressure Measurement in Obese Pregnant Women https://clinicaltrials.gov/study/NCT05790265 NOT_YET_RECRUITING Blood Pressure DEVICE: ANNE One Sibel Health Inc. University of North Carolina

NCT06024265 The Safety and Tolerability Study With ER2001 Intravenous Injection in Adults With Early Manifest Huntington's Disease https://clinicaltrials.gov/study/NCT06024265 RECRUITING Huntington Disease DRUG: ER2001 injection ExoRNA Bioscience

NCT05716165 Effect of Proprioceptive Knee Braces on the Performance and Endurance of Recreational Soccer Players Aged 60-80 Years https://clinicaltrials.gov/study/NCT05716165 RECRUITING Healthy Volunteers DEVICE: proprioceptive knee braces

NCT06389474 Efficacy of INM004 in Children With STEC-HUS https://clinicaltrials.gov/study/NCT06389474 RECRUITING Hemolytic-Uremic Syndrome BIOLOGICAL: INM004

NCT05706974 Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials https://clinicaltrials.gov/study/NCT05706974 NOT_YET_RECRUITING Bile Duct Cancer Power Life Sciences Inc.

NCT06180174 Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma https://clinicaltrials.gov/study/NCT06180174 RECRUITING B Cell Lymphoma

NCT06172374 A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials https://clinicaltrials.gov/study/NCT06172374 RECRUITING Primary Ciliary Dyskinesia GENETIC: Sano Genetics Testing Kit ReCode Therapeutics Sano Genetics

NCT06542874 A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes https://clinicaltrials.gov/study/NCT06542874 RECRUITING Type 2 Diabetes (T2D) DRUG: NNC0487-0111 subcutanous

NCT03288974 Post Marketing Surveillance on Safety Evaluation of POMALYST¬Æ (Pomalidomide) Treatment of Multiple Myeloma in Korea https://clinicaltrials.gov/study/NCT03288974 RECRUITING Multiple Myeloma DRUG: POMALYST¬Æ (Pomalidomide) Celgene

NCT05920174 Clinical Trial to Evaluate the Safety and Efficacy of an Implantable Neural Acquisitor & Stimulator System in Patients With Motor Disability https://clinicaltrials.gov/study/NCT05920174 RECRUITING Tetraplegia DEVICE: NEO Neuracle Medical Technology(Shanghai) Co.,Ltd. Xuanwu Hospital, Beijing

NCT06537674 Pyrotinib Combined With Trastuzumab Subcutaneously Compared Intravenous Administration in the Treatment of HER2-positive Early Breast Cancer https://clinicaltrials.gov/study/NCT06537674 NOT_YET_RECRUITING HER2+ Breast Cancer DRUG: Trastuzumab intravenous drip/Trastuzumab Subcutaneous Injection Jiangsu Famous Medical Technology Co., Ltd.

NCT06151574 Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment https://clinicaltrials.gov/study/NCT06151574 RECRUITING Lung Cancer, Non-squamous, Non-small Cell DRUG: zongertinib

NCT06213974 A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Argentina https://clinicaltrials.gov/study/NCT06213974 RECRUITING Cytomegalovirus (CMV) OTHER: No Intervention Takeda

NCT05361174 A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer https://clinicaltrials.gov/study/NCT05361174 RECRUITING Unresectable Melanoma

NCT05729074 A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients https://clinicaltrials.gov/study/NCT05729074 NOT_YET_RECRUITING Mild to Moderate Atopic Dermatitis DRUG: IN-A002 Ointment 0.3% or IN-A002 Placebo Ointment

NCT05067374 Hepatitis C Screening Paired With Mammography https://clinicaltrials.gov/study/NCT05067374 RECRUITING Hepatitis C

NCT06416865 Efficacy and Safety of AJU-C52 in Essential Hypertension Patients https://clinicaltrials.gov/study/NCT06416865 RECRUITING Essential Hypertension DRUG: AJU-C52L, AJU-C52

NCT06657365 Safety and Efficacy Evaluation of the Monopolar Radiofrequency Device for the Improvement of Facial Wrinkles https://clinicaltrials.gov/study/NCT06657365 RECRUITING Facial Wrinkles

NCT06625320 Phase 3 Study of RMC-6236 in Patients with Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) https://clinicaltrials.gov/study/NCT06625320 RECRUITING Pancreatic Cancer

NCT05003674 A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation in Adult Cochlear Implant Recipients https://clinicaltrials.gov/study/NCT05003674 RECRUITING Hearing Impairment DEVICE: Focused stimulation strategy

NCT03308474 Myeloma Registry Platform (MYRIAM) https://clinicaltrials.gov/study/NCT03308474 RECRUITING Multiple Myeloma OTHER: Routine care as per site standard. iOMEDICO AG Deutsche Studiengruppe Multiples Myelom (DSMM)

NCT06028074 Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies https://clinicaltrials.gov/study/NCT06028074 RECRUITING Advanced Solid Malignancies DRUG: GIM122 Georgiamune Inc

NCT05566574 A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer https://clinicaltrials.gov/study/NCT05566574 RECRUITING Solid Tumor

NCT06564974 Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE¬Æ) in Patients with Duchenne Muscular Dystrophy. https://clinicaltrials.gov/study/NCT06564974 RECRUITING Duchenne Muscular Dystrophy DRUG: Vamorolone Catalyst Pharmaceuticals, Inc.

NCT05357274 A System to Classify Treatable Traits in Primary Care https://clinicaltrials.gov/study/NCT05357274 NOT_YET_RECRUITING Respiratory Disease

NCT06245174 A Smartphone Application for Neurology and Telemedicine https://clinicaltrials.gov/study/NCT06245174 RECRUITING Parkinson Disease(PD) Altec Inc. National Institute of Neurological Disorders and Stroke (NINDS)

NCT04988074 Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca https://clinicaltrials.gov/study/NCT04988074 RECRUITING HPV-Related Squamous Cell Carcinoma DRUG: Cemiplimab Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Regeneron Pharmaceuticals

NCT05501574 An Open Label Trial Evaluating Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients https://clinicaltrials.gov/study/NCT05501574 RECRUITING Lung Transplant Rejection DRUG: Tacrolimus Inhalation Powder TFF Pharmaceuticals, Inc.

NCT06387420 A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06387420 NOT_YET_RECRUITING ACUTE MYELOID LEUKEMIA; AML DRUG: AK117

NCT05756920 This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants https://clinicaltrials.gov/study/NCT05756920 RECRUITING Healthy DRUG: ABL301

NCT06323174 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise https://clinicaltrials.gov/study/NCT06323174 RECRUITING Type 2 Diabetes DRUG: Cagrilintide

NCT05505474 Use of a Subcutaneous Catheter for Controlled Ovarian Stimulation https://clinicaltrials.gov/study/NCT05505474 RECRUITING Infertility, Female DEVICE: IVF with the Neria‚Ñ¢ Guard Subcutaneous Catheter University of Southern California ConvaTec Inc.

NCT05687474 Baby Detect : Genomic Newborn Screening https://clinicaltrials.gov/study/NCT05687474 RECRUITING Congenital Adrenal Hyperplasia

NCT06210074 Performance of Tampons as a Biospecimen Collection Tool for the Detection of Human Papillomavirus in a Colposcopy Setting https://clinicaltrials.gov/study/NCT06210074 NOT_YET_RECRUITING CIN2 DEVICE: Daye Diagnostic Tampon Tampon Innovations Ltd University of Edinburgh

NCT06043674 A Ph 2 Study of Glofitamab Alone or in Combination With Polatuzumab Vedotin or Atezolizumab in Richter's Transformation https://clinicaltrials.gov/study/NCT06043674 RECRUITING Chronic Lymphocytic Leukemia

NCT04912674 Evaluation of Symphony‚Ñ¢ Posterior Cervical System for Surgical Treatment of Adult Cervical Deformity https://clinicaltrials.gov/study/NCT04912674 RECRUITING Cervical Deformity DEVICE: Symphony OCT System International Spine Study Group Foundation DePuy Synthes

NCT06202274 Clinical Study to Evaluate the Safety and Efficacy of Candela Technology https://clinicaltrials.gov/study/NCT06202274 RECRUITING Hair Reduction

NCT06233474 Study of Intra-articular Allocetra in Knee Osteoarthritis https://clinicaltrials.gov/study/NCT06233474 RECRUITING Osteoarthritis, Knee DRUG: Allocetra

NCT06675565 A Study to Evaluate ALN-AGT01 RVR in Adult Healthy Volunteers https://clinicaltrials.gov/study/NCT06675565 NOT_YET_RECRUITING Healthy Volunteers DRUG: ALN-AGT01 RVR

NCT06260865 A Confirmatory Trial of Multidisciplinary Digital Therapeutics for Patellofemoral Pain Syndrome https://clinicaltrials.gov/study/NCT06260865 RECRUITING Patellofemoral Pain Syndrome DEVICE: MORA Cure

NCT05350865 Thailand HDV Cohort https://clinicaltrials.gov/study/NCT05350865 RECRUITING HDV The HIV Netherlands Australia Thailand Research Collaboration King Chulalongkorn Memorial Hospital

NCT06153420 Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D). https://clinicaltrials.gov/study/NCT06153420 RECRUITING Irritable Bowel Syndrome With Diarrhea DRUG: CIN-103

NCT06592820 Shear Wave Elastography Registry Study https://clinicaltrials.gov/study/NCT06592820 NOT_YET_RECRUITING MASLD

NCT04292574 UK SMA Patient Registry https://clinicaltrials.gov/study/NCT04292574 RECRUITING Spinal Muscular Atrophy

NCT05485974 A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation https://clinicaltrials.gov/study/NCT05485974 RECRUITING Lung Cancer

NCT06143774 Study of TRX-920 for Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06143774 RECRUITING Advanced Solid Tumor DRUG: TRX-920 Oral Gel (10 mg and 30 mg) TaiRx, Inc.

NCT06260774 Study of TTX-MC138 in Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06260774 RECRUITING Advanced Solid Tumor DRUG: TTX-MC138 TransCode Therapeutics

NCT04893174 Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA). https://clinicaltrials.gov/study/NCT04893174 RECRUITING Osteoarthritis, Knee BIOLOGICAL: UMC119-06-05

NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry https://clinicaltrials.gov/study/NCT03452774 RECRUITING Cancer, Metastatic

NCT04655365 Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer. https://clinicaltrials.gov/study/NCT04655365 RECRUITING Prostate Cancer DRUG: Enzalutamide capsule CHU de Quebec-Universite Laval Astellas Pharma Europe Ltd.

NCT05444465 Use of the REGENETEN‚Ñ¢ Bioinductive Implant System in High Grade Partial-thickness Tears https://clinicaltrials.gov/study/NCT05444465 RECRUITING Rotator Cuff Injuries DEVICE: Isolated Bioinductive Repair

NCT06117020 Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals https://clinicaltrials.gov/study/NCT06117020 RECRUITING Muscle Spasticity

NCT04761120 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study https://clinicaltrials.gov/study/NCT04761120 RECRUITING Mitral Regurgitation

NCT04705220 Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome https://clinicaltrials.gov/study/NCT04705220 RECRUITING Mild Cognitive Impairment DIETARY_SUPPLEMENT: MERIVA¬Æ Tablets

NCT05764720 Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach https://clinicaltrials.gov/study/NCT05764720 RECRUITING Pancreatic Cancer RADIATION: Daily Adaptive External Beam Radiation Therapy Varian, a Siemens Healthineers Company Washington University School of Medicine

NCT06520774 Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases https://clinicaltrials.gov/study/NCT06520774 NOT_YET_RECRUITING Aortic Arch Aneurysm

NCT05107674 A Study of NX-1607 in Adults With Advanced Malignancies https://clinicaltrials.gov/study/NCT05107674 RECRUITING Ovarian Cancer, Epithelial

NCT05517174 A Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Older Adults https://clinicaltrials.gov/study/NCT05517174 RECRUITING Influenza BIOLOGICAL: High-Dose Quadrivalent Influenza Vaccine

NCT05691374 Evaluation of Functional and Biomechanical Outcome by Shear-wave Elastography in the Short to Intermediate Follow-up After Arthroscopic Rotator Cuff Repair https://clinicaltrials.gov/study/NCT05691374 RECRUITING Arthroscopic Rotator Cuff Repair (ARCR) PROCEDURE: Ultrasound (US) examination

NCT05358574 PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder Bipolar System https://clinicaltrials.gov/study/NCT05358574 RECRUITING Revision of a Shoulder Prosthesis Zimmer Biomet

NCT06343220 Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research https://clinicaltrials.gov/study/NCT06343220 RECRUITING Huntington Disease Huntington Study Group Roche Products Limited

NCT05959720 Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil https://clinicaltrials.gov/study/NCT05959720 RECRUITING Acute Lymphoid Leukemia

NCT05775874 A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC https://clinicaltrials.gov/study/NCT05775874 RECRUITING Urothelial Carcinoma DRUG: AZD4547

NCT05461274 Determining Patterns In Trial Experiences of Diabetic Neuropathy Patients https://clinicaltrials.gov/study/NCT05461274 NOT_YET_RECRUITING Diabetic Neuropathies

NCT00540774 Optical Sensor for Photodynamic Detection of Oral Pathology https://clinicaltrials.gov/study/NCT00540774 RECRUITING Mouth Diseases DEVICE: detection of oral pathology University of California, Irvine National Institutes of Health (NIH)

NCT06206174 TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies https://clinicaltrials.gov/study/NCT06206174 RECRUITING Hematologic Malignancy

NCT06091774 Clinical Study for the Investigation and Validation of a Therapy Procedure for the Adjustment of Risk Factors in Patients With Coronary Heart Disease by Means of Digital Therapy Control https://clinicaltrials.gov/study/NCT06091774 RECRUITING Coronary Artery Disease

NCT05458674 Tucatinib+Trastuzumab+Eribulin in HER2+ MBC https://clinicaltrials.gov/study/NCT05458674 RECRUITING Breast Cancer DRUG: Tucatinib

NCT05839873 Abbott Ventricular Tachycardia PAS https://clinicaltrials.gov/study/NCT05839873 RECRUITING Ventricular Tachycardia DEVICE: FlexAbility SE Ablation Catheter Abbott Medical Devices

NCT06571331 A Clinical Trial of De-Stress & Snooze Gummies in Reducing Stress and Insomnia Disorder https://clinicaltrials.gov/study/NCT06571331 NOT_YET_RECRUITING Stress

NCT05258331 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis https://clinicaltrials.gov/study/NCT05258331 RECRUITING Moderate to Severe Plaque Psoriasis GENETIC: CT303 GC Cell Corporation

NCT06085131 Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study https://clinicaltrials.gov/study/NCT06085131 RECRUITING Cataract DEVICE: Argos Shammas Eye Medical Center Sengi

NCT06141031 Trial of Radiotherapy in Combination with TTI-101 in Patients with Borderline Resectable Pancreatic Cancer https://clinicaltrials.gov/study/NCT06141031 RECRUITING Pancreatic Cancer DRUG: TTI-101 University of Colorado, Denver Tvardi Therapeutics, Incorporated

NCT06169631 The Effects of Noninvasive Neuromodulation on Mental Wellness, Behavior, and Electrophysiology https://clinicaltrials.gov/study/NCT06169631 RECRUITING Anxiety Disorders DEVICE: Gen0b Sanmai Technologies PBC dba Sanmai

NCT05736731 A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants with Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression https://clinicaltrials.gov/study/NCT05736731 RECRUITING Solid Tumor, Adult

NCT05893082 Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR https://clinicaltrials.gov/study/NCT05893082 RECRUITING Aortic Stenosis DEVICE: F2 Filter and Delivery System EnCompass Technologies, Inc.

NCT05995782 A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418 https://clinicaltrials.gov/study/NCT05995782 RECRUITING Parkinson Disease Psychosis

NCT06185673 A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia https://clinicaltrials.gov/study/NCT06185673 RECRUITING Oculopharyngeal Muscular Dystrophy GENETIC: BB-301: Dose escalation phase 1b cohort 1

NCT06678373 Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas https://clinicaltrials.gov/study/NCT06678373 NOT_YET_RECRUITING Japanese Encephalitis BIOLOGICAL: Liaoning Chengda Inactivated Japanese Encephalitis Vaccine

NCT06267131 Transcutaneous Pulse Oximetry Brain Monitoring Study (US) https://clinicaltrials.gov/study/NCT06267131 RECRUITING Acute Brain Injury DEVICE: Brain Pulse Oximeter Cyban Pty Ltd

NCT06397131 A Study to Determine the Safety and Efficacy of NT-501 With MHFM https://clinicaltrials.gov/study/NCT06397131 NOT_YET_RECRUITING Macular Telangiectasia Type 2 COMBINATION_PRODUCT: NT-501 CNTF Implant Neurotech Pharmaceuticals

NCT05838131 Study of CT071 Injection in RRMM or PPCL https://clinicaltrials.gov/study/NCT05838131 RECRUITING Multiple Myeloma

NCT06038331 Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis https://clinicaltrials.gov/study/NCT06038331 RECRUITING Osteoarthritis Hand BIOLOGICAL: SclerFIX-IP TBF Genie Tissulaire

NCT05856331 Study of INBRX-101 Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema https://clinicaltrials.gov/study/NCT05856331 RECRUITING Alpha 1-Antitrypsin Deficiency

NCT06180382 Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. https://clinicaltrials.gov/study/NCT06180382 RECRUITING Crohn's Disease DRUG: Adalimumab

NCT06703073 JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record) https://clinicaltrials.gov/study/NCT06703073 NOT_YET_RECRUITING Acute Respiratory Distress Syndrome (ARDS)

NCT03399773 Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes https://clinicaltrials.gov/study/NCT03399773 RECRUITING Acute Biphenotypic Leukemia

NCT05852431 To Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Severe Hypertriglyceridemia https://clinicaltrials.gov/study/NCT05852431 RECRUITING Severe Hypertriglyceridemia DRUG: Pegozafermin

NCT05611931 Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma https://clinicaltrials.gov/study/NCT05611931 RECRUITING Endometrial Cancer DRUG: Selinexor

NCT06503731 A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients with Antibody-Mediated Rejection (AMR) https://clinicaltrials.gov/study/NCT06503731 RECRUITING Antibody-mediated Rejection COMBINATION_PRODUCT: Efgartigimod PH20 SC - prefilled syringe

NCT06346431 Efficacy of Digital Problem Solving Application in Reduction of Anxiety, Depression and Substance Use Disorder Symptoms https://clinicaltrials.gov/study/NCT06346431 NOT_YET_RECRUITING Anxiety

NCT06532331 A Phase‚Ö†Study of ONO-7475 in Combination With ONO-4538 and Gemcitabine Plus Nab-paclitaxel (GnP), the Standard of Care, and ONO-7475 in Combination With GnP in Patients With Pancreatic Cancer https://clinicaltrials.gov/study/NCT06532331 RECRUITING Metastatic Pancreatic Cancer DRUG: ONO-7475

NCT06218082 Vitiligo Registry for Adults and Children in the UK https://clinicaltrials.gov/study/NCT06218082 RECRUITING Dermatologic Disease

NCT05844982 Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 Mg) Intravitreal Implants Vs Observation for Prevention of VA Loss Due to Radiation Retinopathy https://clinicaltrials.gov/study/NCT05844982 RECRUITING Radiation Retinopathy

NCT06364631 CARE1 Pragmatic Clinical Trial https://clinicaltrials.gov/study/NCT06364631 RECRUITING Metastatic Kidney Cancer

NCT05493631 A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patient https://clinicaltrials.gov/study/NCT05493631 RECRUITING Hemophilia BIOLOGICAL: MG1113 GC Biopharma Corp

NCT04175431 Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study https://clinicaltrials.gov/study/NCT04175431 RECRUITING Prostate Adenocarcinoma PROCEDURE: Positron Emission Tomography

NCT06173531 Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome https://clinicaltrials.gov/study/NCT06173531 RECRUITING Hyperphagia in Prader-Willi Syndrome DRUG: Carbetocin

NCT05934331 A LM-302 Combined With Toripalimab Phase II Study https://clinicaltrials.gov/study/NCT05934331 RECRUITING Gastric Cancer

NCT05709431 A Study Evaluating the French Version of the CIQoL-35 Quality of Life Questionnaire in Adult Cochlear Implant Use. https://clinicaltrials.gov/study/NCT05709431 RECRUITING PROM

NCT06650631 The Effectiveness of Heat Treatment on Knee Pain in Patients with Osteoarthritis - an International, Multicenter Clinical Investigation https://clinicaltrials.gov/study/NCT06650631 RECRUITING Pain Management

NCT06160531 Influenza Viral Challenge Study of CC-42344 in Healthy Participants https://clinicaltrials.gov/study/NCT06160531 RECRUITING Influenza A DRUG: CC-42344

NCT05394831 A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC https://clinicaltrials.gov/study/NCT05394831 RECRUITING EGFR Mutant Advanced Non-small Cell Lung Cancer DRUG: JIN-A02 J Ints Bio

NCT05708131 Outcomes of Functional Substrate Mapping of Ventricular Tachycardia https://clinicaltrials.gov/study/NCT05708131 RECRUITING Ventricular Tachycardia Mid and South Essex NHS Foundation Trust Abbott

NCT06648031 Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants https://clinicaltrials.gov/study/NCT06648031 NOT_YET_RECRUITING Type2diabetes DRUG: Arm 1 - DehydraTECH-CBD alone

NCT04991831 A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease https://clinicaltrials.gov/study/NCT04991831 RECRUITING Tremor Associated With Tremor Dominant Parkinson's Disease DEVICE: Unilateral thalamotomy InSightec

NCT06525831 Rein 3D PRINT MECHANICS https://clinicaltrials.gov/study/NCT06525831 NOT_YET_RECRUITING Kidney Cancer DIAGNOSTIC_TEST: MR-elastography exam

NCT06602531 Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults https://clinicaltrials.gov/study/NCT06602531 NOT_YET_RECRUITING Influenza, Human BIOLOGICAL: ARCT-2304

NCT06377982 Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy https://clinicaltrials.gov/study/NCT06377982 NOT_YET_RECRUITING Cerebral Palsy BIOLOGICAL: hUCB StemCyte International, Ltd. StemCyte Taiwan Co., Ltd.

NCT06508931 Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With Relapsed or Refractory B-Cell Neoplasms https://clinicaltrials.gov/study/NCT06508931 NOT_YET_RECRUITING B-Cell Neoplasm DRUG: zamtocabtagene autoleucel (MB-CART2019.1) Miltenyi Biomedicine GmbH

NCT03734731 Cannabis Vs Opioids Pain Management Objective Testing Comparisons https://clinicaltrials.gov/study/NCT03734731 NOT_YET_RECRUITING Chronic Pain

NCT06521931 A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients https://clinicaltrials.gov/study/NCT06521931 RECRUITING Thrombocytopenia DRUG: PN20 Chongqing Peg-Bio Biopharm Co., Ltd.

NCT03319082 Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery https://clinicaltrials.gov/study/NCT03319082 RECRUITING Corneal Ectasia COMBINATION_PRODUCT: Corneal Collagen Cross-linking Glaukos Corporation

NCT03867682 Venetoclax and Lintuzumab-Ac225 in AML Patients https://clinicaltrials.gov/study/NCT03867682 RECRUITING Acute Myeloid Leukemia

NCT05655182 A Study of BLB-201 RSV Vaccine in Infants and Children https://clinicaltrials.gov/study/NCT05655182 RECRUITING Respiratory Syncytial Virus Infections BIOLOGICAL: PIV5-vectored RSV Vaccine (BLB-201) Low Dose

NCT05859373 To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer. https://clinicaltrials.gov/study/NCT05859373 NOT_YET_RECRUITING Non-small Cell Lung Cancer COMBINATION_PRODUCT: TQB3728 tablets, TQB2450 injection, sequential or concurrent chemoradiation

NCT03746431 A Phase 1/2 Study of [225Ac]-FPI-1434 Injection https://clinicaltrials.gov/study/NCT03746431 RECRUITING Advanced Solid Tumours

NCT04772131 Desara ¬Æ One Single Incision Sling 522 Study https://clinicaltrials.gov/study/NCT04772131 RECRUITING Stress Urinary Incontinence DEVICE: Desara¬Æ One Single Incision Sling

NCT05502731 Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT05502731 NOT_YET_RECRUITING Rheumatoid Arthritis DRUG: Filgotinib

NCT06693531 A U.S. Registry of Eosinophilic Esophagitis Adolescent and Adult Patients Treated With DUPIXENT¬Æ As Standard of Care https://clinicaltrials.gov/study/NCT06693531 NOT_YET_RECRUITING Eosinophilic Esophagitis (EoE) DRUG: dupilumab Regeneron Pharmaceuticals Sanofi

NCT06410131 Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16 https://clinicaltrials.gov/study/NCT06410131 NOT_YET_RECRUITING Solid Tumors DRUG: FTL008.16 Sound Biopharmaceuticals Ltd.

NCT05860231 Comparative Study Between Foley and T-Control¬Æ Catheter in Patients With Long-term Catheterization https://clinicaltrials.gov/study/NCT05860231 RECRUITING Catheter-Associated Urinary Tract Infection

NCT06557031 Clinical Performance Study of the ABTest Card¬Æ Device. https://clinicaltrials.gov/study/NCT06557031 NOT_YET_RECRUITING Transfusion Reaction DIAGNOSTIC_TEST: ABTest Card¬ÆREF and ABTest Card¬ÆNEW Diagast Soladis

NCT06294431 Radicle Clarity 24: A Study of Health and Wellness Products on Cognitive Function and Related Health Outcomes https://clinicaltrials.gov/study/NCT06294431 RECRUITING Cognitive Function DIETARY_SUPPLEMENT: Placebo Control Form 1

NCT05123482 A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies https://clinicaltrials.gov/study/NCT05123482 RECRUITING Breast Cancer

NCT00001373 Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics https://clinicaltrials.gov/study/NCT00001373 RECRUITING Familial Mediterranean Fever (FMF)

NCT04812431 Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI https://clinicaltrials.gov/study/NCT04812431 RECRUITING Spinal Cord Injury, Acute

NCT06402331 FPI-2265 (225Ac-PSMA-I&T) for Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) https://clinicaltrials.gov/study/NCT06402331 RECRUITING Metastatic Castration-resistant Prostate Cancer DRUG: FPI-2265 Fusion Pharmaceuticals Inc.

NCT06047431 A Study of QL1706H in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06047431 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: QL1706H Qilu Pharmaceutical Co., Ltd.

NCT04725331 A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04725331 RECRUITING Metastatic Cancer

NCT05522231 Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2) https://clinicaltrials.gov/study/NCT05522231 RECRUITING Advanced Renal Cell Carcinoma DRUG: fruquintinib+sintilimab

NCT06316531 A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer https://clinicaltrials.gov/study/NCT06316531 RECRUITING HER2-positive Breast Cancer DRUG: BL-M07D1

NCT04109131 A Brain Metastases Research Platform to Tackle the Challenge of CNS Metastases in Solid Tumours https://clinicaltrials.gov/study/NCT04109131 RECRUITING CNS Metastases OTHER: Samples collection: Plasma

NCT06294873 Stool Sample Collection Study https://clinicaltrials.gov/study/NCT06294873 RECRUITING Colorectal Cancer DIAGNOSTIC_TEST: A screening device for the detection of colorectal and other aerodigestive tract cancers Innovis LLC Exact Sciences Corporation

NCT05257473 Defining Endpoints in Becker Muscular Dystrophy https://clinicaltrials.gov/study/NCT05257473 RECRUITING Becker Muscular Dystrophy

NCT06220773 A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy https://clinicaltrials.gov/study/NCT06220773 RECRUITING Essential Hypertension

NCT06315673 Digital Assessment of Speech and Fine Motor Control in ALS https://clinicaltrials.gov/study/NCT06315673 RECRUITING Amyotrophic Lateral Sclerosis

NCT04844073 A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer https://clinicaltrials.gov/study/NCT04844073 RECRUITING Squamous Cell Cancer of Head and Neck (SCCHN)

NCT04918173 Efficacy of Atenativ in Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Delivery https://clinicaltrials.gov/study/NCT04918173 RECRUITING Congenital Antithrombin Deficiency DRUG: Atenativ Octapharma

NCT06375031 Comparison of HR011408 and NovoRapid¬Æ in Subjects With Diabetics https://clinicaltrials.gov/study/NCT06375031 RECRUITING Diabetes DRUG: HR011408 injection; HR011408 injection Placebo

NCT05485831 Epidyolex¬Æ in Lennox Gastaut and Dravet Syndrome: an Observational Study in ITALY https://clinicaltrials.gov/study/NCT05485831 NOT_YET_RECRUITING Lennox Gastaut Syndrome

NCT04558931 Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma https://clinicaltrials.gov/study/NCT04558931 RECRUITING Multiple Myeloma DRUG: CellProtect

NCT04716231 Atacicept in Subjects with IgA Nephropathy https://clinicaltrials.gov/study/NCT04716231 RECRUITING IgA Nephropathy

NCT06564831 Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care https://clinicaltrials.gov/study/NCT06564831 RECRUITING Diabetic Foot Ulcer

NCT06183931 Study of ALXN2220 Versus Placebo in Adults With ATTR-CM https://clinicaltrials.gov/study/NCT06183931 RECRUITING Transthyretin Amyloid Cardiomyopathy DRUG: ALXN2220

NCT06433531 A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP) https://clinicaltrials.gov/study/NCT06433531 RECRUITING Generalized Pustular Psoriasis DRUG: TQH2929 Injection Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

NCT04278131 BS01 in Patients With Retinitis Pigmentosa https://clinicaltrials.gov/study/NCT04278131 RECRUITING Retinitis Pigmentosa DRUG: BS01 Bionic Sight LLC

NCT05748873 Promising ROd-cone DYstrophy Gene TherapY https://clinicaltrials.gov/study/NCT05748873 RECRUITING Retinitis Pigmentosa DRUG: SPVN06 SparingVision

NCT06459973 A Clinical Study of YL205 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06459973 RECRUITING Advanced Solid Tumors DRUG: intravenous (IV) infusion MediLink Therapeutics (Suzhou) Co., Ltd.

NCT05834673 VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) https://clinicaltrials.gov/study/NCT05834673 RECRUITING Atherosclerotic Cardiovascular Disease (ASCVD)

NCT06523231 Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants. https://clinicaltrials.gov/study/NCT06523231 NOT_YET_RECRUITING Shigellosis BIOLOGICAL: Shigella4V2

NCT05693831 myCare-102: Clinical Utility and Usability of Cellworks Singula‚Ñ¢ and Cellworks Ventura‚Ñ¢ Reports https://clinicaltrials.gov/study/NCT05693831 RECRUITING Cancer

NCT05123131 Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma https://clinicaltrials.gov/study/NCT05123131 RECRUITING Multiple Myeloma DRUG: Isatuximab

NCT06237231 Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third Molars https://clinicaltrials.gov/study/NCT06237231 NOT_YET_RECRUITING Moderate Pain

NCT04282031 A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer https://clinicaltrials.gov/study/NCT04282031 RECRUITING Advanced Solid Tumor

NCT05799131 Safety and Efficacy of the QBX Peripheral Balloon Expandable Stent System in Peripheral Artery Disease (PAD) https://clinicaltrials.gov/study/NCT05799131 NOT_YET_RECRUITING Peripheral Arterial Disease DEVICE: QBX (5F/6F) Peripheral Balloon Expandable Stent System QualiMed Innovative Medizinprodukte GmbH

NCT05397431 A Survey of Lanadelumab in Participants With Hereditary Angioedema https://clinicaltrials.gov/study/NCT05397431 RECRUITING Hereditary Angioedema (HAE) DRUG: Lanadelumab Takeda

NCT05575973 Mitoxantrone Hydrochloride Liposome Combined With Rituximab and Lenalidomide (M+R2) in Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma https://clinicaltrials.gov/study/NCT05575973 NOT_YET_RECRUITING Diffuse Large B-cell Lymphoma DRUG: Mitoxantrone Hydrochloride Liposome

NCT05024773 Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) https://clinicaltrials.gov/study/NCT05024773 RECRUITING Bladder Carcinoma in Situ (CIS) DRUG: ONCOFID P-B (PACLITAXEL-HYALURONIC ACID) Fidia Farmaceutici s.p.a.

NCT04892173 NBTXR3 With or Without Cetuximab in LA-HNSCC https://clinicaltrials.gov/study/NCT04892173 RECRUITING Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT06579573 ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures. https://clinicaltrials.gov/study/NCT06579573 RECRUITING Epilepsy, Generalized DRUG: Cenobamate Ono Pharmaceutical Co. Ltd

NCT05888831 A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05888831 RECRUITING Advanced Solid Tumors DRUG: BMS-986449

NCT04562831 The NO-ALS Study: a Trial of Nicotinamide/pterostilbene Supplement in ALS. https://clinicaltrials.gov/study/NCT04562831 RECRUITING Amyotrophic Lateral Sclerosis DIETARY_SUPPLEMENT: EH301 (Nicotinamide Riboside/Pterostilbene) Haukeland University Hospital Elysium Health

NCT05908331 MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions https://clinicaltrials.gov/study/NCT05908331 RECRUITING In-Stent Restenosis

NCT06069531 Effect of Lactobacillus Johnsonii or White Pomegranate Extract on the Vaginal Health https://clinicaltrials.gov/study/NCT06069531 RECRUITING Vaginitis Bacterial

NCT06372431 PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of Russia https://clinicaltrials.gov/study/NCT06372431 RECRUITING Arterial Hypertension, Chronic Kidney Disease AstraZeneca

NCT04969731 Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer https://clinicaltrials.gov/study/NCT04969731 RECRUITING Pancreatic Ductal Adenocarcinoma DRUG: Immuncell-LC

NCT04886531 Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers https://clinicaltrials.gov/study/NCT04886531 RECRUITING Breast Cancer

NCT06355531 A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) https://clinicaltrials.gov/study/NCT06355531 RECRUITING Progressive Supranuclear Palsy DRUG: FNP-223

NCT05302531 Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome https://clinicaltrials.gov/study/NCT05302531 RECRUITING Short Bowel Syndrome

NCT04547231 Impact of Coronary CT Angiography, Physiologic Assessment and Pharmacotherapy on the Clinical Outcomes https://clinicaltrials.gov/study/NCT04547231 RECRUITING Coronary Artery Disease DIAGNOSTIC_TEST: Fractional flow reserve, Coronary CT angiography Seoul National University Hospital Seoul National University Bundang Hospital

NCT06233266 Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg https://clinicaltrials.gov/study/NCT06233266 NOT_YET_RECRUITING Healthy Subjects DRUG: Ticagrelor-Test product

NCT04677166 Coupling Negative Pressure Wound Therapy With Instillation https://clinicaltrials.gov/study/NCT04677166 RECRUITING Wound

NCT06377566 A Study of BV-AVD in People With Bulky Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT06377566 RECRUITING Hodgkin Lymphoma DRUG: Brentuximab vedotin

NCT04562766 Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) https://clinicaltrials.gov/study/NCT04562766 RECRUITING Immune Thrombocytopenia DRUG: Rilzabrutinib

NCT05329766 A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies https://clinicaltrials.gov/study/NCT05329766 RECRUITING Gastrointestinal Tract Malignancies DRUG: Domvanalimab

NCT04872166 A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer https://clinicaltrials.gov/study/NCT04872166 RECRUITING Advanced Solid Tumor

NCT04417166 Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma https://clinicaltrials.gov/study/NCT04417166 RECRUITING Lymphoma, Extranodal NK-T-Cell DRUG: Pembrolizumab

NCT06448026 Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC). https://clinicaltrials.gov/study/NCT06448026 NOT_YET_RECRUITING Locally Recurrent Oral Cavity Squamous Cell Carcinoma DRUG: Cemiplimab

NCT06698926 A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants https://clinicaltrials.gov/study/NCT06698926 RECRUITING Healthy Volunteer DRUG: ABBV-CLS-616

NCT05179226 Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age with Iron Deficiency Anemia https://clinicaltrials.gov/study/NCT05179226 RECRUITING Iron Deficiency, Anaemia in Children DRUG: Ferric Derisomaltose Pharmacosmos A/S

NCT06656026 PharmacokineticsÔºåSafety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A https://clinicaltrials.gov/study/NCT06656026 NOT_YET_RECRUITING Influenza a DRUG: ZSP1273 granules Guangdong Raynovent Biotech Co., Ltd

NCT05287126 A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis https://clinicaltrials.gov/study/NCT05287126 RECRUITING Ulcerative Colitis DRUG: Etrasimod Pfizer Arena is a wholly owned subsidiary of Pfizer

NCT05753566 Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer https://clinicaltrials.gov/study/NCT05753566 RECRUITING Prostate Cancer

NCT06133166 A Study for the Treatment of Dry Eye in Postmenopausal Women https://clinicaltrials.gov/study/NCT06133166 RECRUITING Postmenopausal Women With DED DRUG: EG017 ointment

NCT06257966 A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin https://clinicaltrials.gov/study/NCT06257966 RECRUITING Type2 Diabetes Mellitus DRUG: Exendin-4 Fc fusion protein injection(1.2mgÔºâ

NCT04262466 Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors https://clinicaltrials.gov/study/NCT04262466 RECRUITING Select Advanced Solid Tumors DRUG: Brenetafusp

NCT06008366 A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06008366 RECRUITING Advanced Solid Tumor DRUG: 7MW3711 for injection

NCT06387966 A Randomized, Double-blind,Dose-escalating, Single-dose, Oral Phase I Clinical Study of Flunotinib Healthy People https://clinicaltrials.gov/study/NCT06387966 RECRUITING Healthy Person DRUG: flunotinib

NCT05618366 Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT05618366 RECRUITING Lymphoma, Non-Hodgkin

NCT04609566 Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT04609566 RECRUITING Melanoma

NCT06602466 A Clinical Study Investigating the Effect of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival Health https://clinicaltrials.gov/study/NCT06602466 RECRUITING Dental Plaque

NCT05674526 A Phase 1b Study of WU-NK-101 in Combination With Cetuximab https://clinicaltrials.gov/study/NCT05674526 RECRUITING Colorectal Cancer Metastatic

NCT05696626 Evaluation of Lasofoxifene Combined with Abemaciclib Compared with Fulvestrant Combined with Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer with an ESR1 Mutation https://clinicaltrials.gov/study/NCT05696626 RECRUITING Metastatic Breast Cancer DRUG: Lasofoxifene in combination with abemaciclib

NCT05934526 Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) https://clinicaltrials.gov/study/NCT05934526 RECRUITING Pulmonary Arterial Hypertension DRUG: Placebo

NCT06701526 A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications https://clinicaltrials.gov/study/NCT06701526 NOT_YET_RECRUITING Migraine DRUG: Eptinezumab H. Lundbeck A/S

NCT06212466 MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2) https://clinicaltrials.gov/study/NCT06212466 RECRUITING Ischemic Heart Disease

NCT05831566 Expertise Asthma COPD Program With Digital Support https://clinicaltrials.gov/study/NCT05831566 RECRUITING Asthma DRUG: Budesonide/Formoterol fumarate dihydrate Franciscus Gasthuis Teva Pharmaceuticals USA

NCT06118866 A Study to Assess the Efficacy and Safety of HMI-115 in Male Subjects with Androgenetic Alopecia https://clinicaltrials.gov/study/NCT06118866 RECRUITING Androgenetic Alopecia DRUG: placebo-Q2W

NCT05996666 Primary Liver Cancer Early Detection https://clinicaltrials.gov/study/NCT05996666 RECRUITING Liver Cancer DEVICE: Liver-cancer early detection test The First Hospital of Jilin University Guangzhou Burning Rock Dx Co., Ltd.

NCT05709626 PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction https://clinicaltrials.gov/study/NCT05709626 RECRUITING ST-segment Elevation Myocardial Infarction (STEMI) DRUG: No aspirin (Prasugurel monotherapy)

NCT04756726 Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma https://clinicaltrials.gov/study/NCT04756726 RECRUITING Multiple Myeloma

NCT06188026 A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children. https://clinicaltrials.gov/study/NCT06188026 RECRUITING Healthy Volunteers (Non-alcoholic Steatohepatitis) DRUG: NNC0194-0499

NCT05432466 Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome https://clinicaltrials.gov/study/NCT05432466 RECRUITING Vascular Ehlers-Danlos Syndrome DRUG: ACER-002 (celiprolol) 200 mg BID

NCT05584566 Ridge Augmentation Treatment Using OSSIX¬Æ BREEZE vs Jason¬Æ https://clinicaltrials.gov/study/NCT05584566 RECRUITING Ridge Augmentation DEVICE: OSSIX Breeze

NCT05366166 Pembrolizumab Plus Olaparib in LA-HNSCC https://clinicaltrials.gov/study/NCT05366166 RECRUITING Squamous Cell Carcinoma of Head and Neck BIOLOGICAL: Pembrolizumab

NCT06094426 Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06094426 RECRUITING Solid Tumor

NCT05280626 First-line Treatment of P53 Mutation With PD-L1 Expression in DLBCL With Anti-PD-1 Mab and R-CHOP https://clinicaltrials.gov/study/NCT05280626 NOT_YET_RECRUITING Diffuse Large B-Cell Lymphoma DRUG: Sintilimab

NCT06432166 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients https://clinicaltrials.gov/study/NCT06432166 NOT_YET_RECRUITING Alzheimer Disease

NCT04097366 Breast Screening - Risk Adaptive Imaging for Density https://clinicaltrials.gov/study/NCT04097366 RECRUITING Breast Cancer DIAGNOSTIC_TEST: ABUS

NCT06645366 Device for Improving Skin Quality and Texture on the Face and Neck https://clinicaltrials.gov/study/NCT06645366 RECRUITING Wrinkle

NCT04670666 Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus https://clinicaltrials.gov/study/NCT04670666 NOT_YET_RECRUITING Type 2 Diabetes Mellitus DRUG: MADALENA ASSOCIATION

NCT06296966 A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye https://clinicaltrials.gov/study/NCT06296966 RECRUITING Dry Eye DRUG: VSJ-110

NCT04422366 Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females https://clinicaltrials.gov/study/NCT04422366 RECRUITING Cervical Cancer

NCT05839626 A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA) https://clinicaltrials.gov/study/NCT05839626 RECRUITING Relapsed/Refractory Multiple Myeloma

NCT04275726 LANDMARK Trial: a Randomised Controlled Trial of Myval THV https://clinicaltrials.gov/study/NCT04275726 RECRUITING Aortic Valve Stenosis DEVICE: Myval THV Series

NCT05579626 Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM) https://clinicaltrials.gov/study/NCT05579626 RECRUITING Pre Diabetes

NCT06372626 Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma. https://clinicaltrials.gov/study/NCT06372626 RECRUITING Neuroendocrine Carcinoma BIOLOGICAL: ZG005

NCT05968326 A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC https://clinicaltrials.gov/study/NCT05968326 RECRUITING Adenocarcinoma, Pancreatic Ductal DRUG: Autogene cevumeran

NCT05324826 Effectiveness of Handheld Ultrasound for Diagnosing Patients With TMD https://clinicaltrials.gov/study/NCT05324826 RECRUITING Temporomandibular Joint Disorders

NCT04869826 Calibration of a Wrist Cuff Blood Pressure Device, According to the AAMI/ESH/ISO Universal Standard https://clinicaltrials.gov/study/NCT04869826 RECRUITING Hypertension DEVICE: Pulsewave Health Monitor (PAD-2A) Device Cardiovascular Research New Brunswick Cloud DX Inc.

NCT05829226 A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS) https://clinicaltrials.gov/study/NCT05829226 RECRUITING AML, Adult Recurrent

NCT05844826 Evaluation of the Microbiome in Multiple Sclerosis https://clinicaltrials.gov/study/NCT05844826 RECRUITING Multiple Sclerosis DEVICE: SIMBA Capsule Nimble Science Ltd. IGY Life Sciences

NCT06604026 Investigational Study with the BD PosiFlush‚Ñ¢ SafeScrub on NADs https://clinicaltrials.gov/study/NCT06604026 NOT_YET_RECRUITING Prevention of Catheter-related Blood Stream Infections (CRBSI) DEVICE: BD PosiFlush‚Ñ¢ SafeScrub

NCT06078566 Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201 https://clinicaltrials.gov/study/NCT06078566 RECRUITING Microtia COMBINATION_PRODUCT: AUR-201 Auregen Biotherapeutics, SA

NCT05498766 Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients https://clinicaltrials.gov/study/NCT05498766 NOT_YET_RECRUITING Gastric Cancer DRUG: Huaier granule

NCT06216366 Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers https://clinicaltrials.gov/study/NCT06216366 NOT_YET_RECRUITING Decompression Sickness DRUG: Sodium Chloride 0.9% Inj pre-exposure

NCT06254066 Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer https://clinicaltrials.gov/study/NCT06254066 NOT_YET_RECRUITING Female Breast Cancer Patients

NCT05848466 Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients https://clinicaltrials.gov/study/NCT05848466 RECRUITING Advanced or Metastatic Solid Tumors DRUG: BAT8010 for Injection Bio-Thera Solutions

NCT06043466 A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT06043466 RECRUITING Colorectal Cancer

NCT06174766 A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients https://clinicaltrials.gov/study/NCT06174766 NOT_YET_RECRUITING Hypertension DRUG: HGP2102-1

NCT06299826 A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure https://clinicaltrials.gov/study/NCT06299826 RECRUITING Chronic Heart Failure DRUG: AZD5462

NCT05904626 Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA https://clinicaltrials.gov/study/NCT05904626 NOT_YET_RECRUITING Intestinal Malabsorption DRUG: ELGN-2112

NCT05942066 Feasibility Study Aiming at Pre-Analytical Standardization of Whole Blood Processing for Liquid Biopsy Applications https://clinicaltrials.gov/study/NCT05942066 RECRUITING Healthy Participants Tethis S.p.A.

NCT05866666 Cardiac Performance System Data Collection Study https://clinicaltrials.gov/study/NCT05866666 RECRUITING Cardiac Disease DEVICE: Cardiac Performance System (NSR) Sensydia Corporation Orlando Health, Inc.

NCT06586866 JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases https://clinicaltrials.gov/study/NCT06586866 NOT_YET_RECRUITING Triple Negative Breast Cancer (TNBC)

NCT04703166 Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy. https://clinicaltrials.gov/study/NCT04703166 NOT_YET_RECRUITING Atrial Fibrillation DEVICE: Samsung Galaxy Watch Active2 Tulane University School of Medicine Samsung

NCT06430866 Pharmacokinetic Similarity Between ABP 234 and Keytruda¬Æ (Pembrolizumab) https://clinicaltrials.gov/study/NCT06430866 RECRUITING Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC) DRUG: ABP 234

NCT06307626 A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults with Thyroid Eye Disease. https://clinicaltrials.gov/study/NCT06307626 RECRUITING Thyroid Eye Disease COMBINATION_PRODUCT: Efgartigimod PH20 SC

NCT06659926 The Radium-select Study https://clinicaltrials.gov/study/NCT06659926 NOT_YET_RECRUITING mCRPC

NCT05827666 The Effect of Dairy and Dairy-Free Alternative Beverages on Post-Exercise Anabolism in Active Youth https://clinicaltrials.gov/study/NCT05827666 RECRUITING Dietary Proteins

NCT06308666 Performance of DAILIES TOTAL1 Daily Disposable Contact Lenses in Habitual Soft Lens Wearers Who Report Substantial Digital Device Use https://clinicaltrials.gov/study/NCT06308666 RECRUITING Myopia DEVICE: Delefilcon A contact lenses University of Waterloo Alcon Research

NCT05485766 Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer https://clinicaltrials.gov/study/NCT05485766 RECRUITING Triple Negative Breast Neoplasms

NCT06117566 A Study of WX390 Combined With Toripalimab in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06117566 RECRUITING Solid Tumor DRUG: WX390

NCT06641466 A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine https://clinicaltrials.gov/study/NCT06641466 NOT_YET_RECRUITING Menstrual Migraine DRUG: Rimegepant

NCT05282966 Assessment of QSant‚Ñ¢ for Underlying Allograft Rejection https://clinicaltrials.gov/study/NCT05282966 NOT_YET_RECRUITING Kidney Transplant Failure and Rejection DIAGNOSTIC_TEST: QSant-TM Urine Test NephroSant

NCT05732766 To Evaluate Safety of Oral Cholera Vaccine Hillchol¬Æ (BBV131) https://clinicaltrials.gov/study/NCT05732766 RECRUITING Cholera BIOLOGICAL: Hillchol vaccine Bharat Biotech International Limited

NCT05988866 Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels https://clinicaltrials.gov/study/NCT05988866 NOT_YET_RECRUITING Hypercholesterolemia

NCT05592626 A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants with Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05592626 RECRUITING Advanced Solid Tumors

NCT05292326 Safety and Efficiency of the PacePress to Prevent Hemorrhagic Complications in Patients Undergoing CIED Implantation. https://clinicaltrials.gov/study/NCT05292326 RECRUITING Hemorrhagic Complications

NCT06111326 BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT06111326 NOT_YET_RECRUITING Hepatocellular Carcinoma DRUG: BC3402 injection

NCT05325866 A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression https://clinicaltrials.gov/study/NCT05325866 RECRUITING Solid Tumors DRUG: Bemarituzumab Amgen

NCT04985266 A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer https://clinicaltrials.gov/study/NCT04985266 RECRUITING ER+ Breast Cancer

NCT04079166 SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study) https://clinicaltrials.gov/study/NCT04079166 RECRUITING Malignant Melanoma

NCT06013566 SSVEP Evaluation of Brain Function (PRO) https://clinicaltrials.gov/study/NCT06013566 RECRUITING Mild Traumatic Brain Injury DEVICE: SSVEP Headsafe MFG

NCT06622226 A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT06622226 RECRUITING Non Hodgkin Lymphoma DRUG: ONO-7018 Ono Pharmaceutical Co. Ltd

NCT05318326 A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets https://clinicaltrials.gov/study/NCT05318326 RECRUITING Type 2 Diabetes DRUG: placebo group

NCT06259526 A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression https://clinicaltrials.gov/study/NCT06259526 RECRUITING Depression DRUG: Placebo group

NCT05738226 EpiCare@Home Validation Study for Focal Onset Seizures https://clinicaltrials.gov/study/NCT05738226 RECRUITING Epilepsy

NCT06680726 Research Collaboration for a Precision Oncology Program (POP) https://clinicaltrials.gov/study/NCT06680726 RECRUITING Cancer OTHER: Matching with RWD

NCT05835466 Reparixin in Patients with Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) https://clinicaltrials.gov/study/NCT05835466 RECRUITING Myelofibrosis (PMF)

NCT06540066 A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06540066 RECRUITING Advanced Cancer

NCT06126666 A Study With ABL103 in Subjects With Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06126666 RECRUITING Advanced Solid Tumor DRUG: ABL103 ABL Bio, Inc.

NCT05074420 A Study of Baricitinib (LY3009104) in Children With COVID-19 https://clinicaltrials.gov/study/NCT05074420 RECRUITING Covid19

NCT06492720 A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS‚Ñ¢ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy https://clinicaltrials.gov/study/NCT06492720 RECRUITING Drug Resistant Epilepsy

NCT05332574 A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor https://clinicaltrials.gov/study/NCT05332574 RECRUITING NSCLC

NCT06298474 The BRAIN App (Phase 2 SBIR) https://clinicaltrials.gov/study/NCT06298474 NOT_YET_RECRUITING Dementia

NCT05868174 Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors https://clinicaltrials.gov/study/NCT05868174 RECRUITING Solid Tumor, Adult

NCT05947474 ORB-011 In Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05947474 RECRUITING Advanced Solid Cancer DRUG: ORB-011 Orionis Biosciences Inc

NCT06038474 Descartes-08 for Patients With Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT06038474 RECRUITING Systemic Lupus Erythematosus (SLE) DRUG: Descartes-08 Cartesian Therapeutics

NCT06399874 Pilot Trial Comparing Nightmare Deconstruction and Reprocessing vs. NightWare Wristband https://clinicaltrials.gov/study/NCT06399874 RECRUITING Nightmares Associated With Chronic Post-Traumatic Stress Disorder BEHAVIORAL: Nightmare Deconstruction and Reprocessing

NCT06161974 Study of Olutasidenib and Temozolomide in HGG https://clinicaltrials.gov/study/NCT06161974 NOT_YET_RECRUITING High Grade Glioma

NCT04680065 GDNF Gene Therapy for Multiple System Atrophy https://clinicaltrials.gov/study/NCT04680065 RECRUITING Multiple System Atrophy BIOLOGICAL: AAV2-GDNF gene therapy

NCT06232720 User Site Testing Study to Evaluate Usability of the Q300‚Ñ¢ Device Under "Real-life Conditions" in a Reproductive Laboratory Environment Use https://clinicaltrials.gov/study/NCT06232720 RECRUITING to Aid in Sperm Selection for ICSI DEVICE: Q300 QART Medical QART Medical

NCT06462820 SAINT for MDD in an Inpatient Setting Follow-on https://clinicaltrials.gov/study/NCT06462820 RECRUITING Major Depressive Disorder

NCT05655520 A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease https://clinicaltrials.gov/study/NCT05655520 RECRUITING Huntington's Disease DRUG: SAGE-718 Sage Therapeutics

NCT05703620 REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions. https://clinicaltrials.gov/study/NCT05703620 RECRUITING Chronic Kidney Diseases

NCT05735574 Determining Cost of Explant of Neurmodulation Device Due to Infection https://clinicaltrials.gov/study/NCT05735574 NOT_YET_RECRUITING Neuropathic Pain

NCT06475274 A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery https://clinicaltrials.gov/study/NCT06475274 RECRUITING Kidney Injury Following Open-Chest Cardiac Surgery DRUG: RMC-035

NCT05787574 A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition https://clinicaltrials.gov/study/NCT05787574 RECRUITING Primary Immune Regulatory Disorder

NCT05583474 OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects https://clinicaltrials.gov/study/NCT05583474 RECRUITING Open Angle Glaucoma or Ocular Hypertension DRUG: OPC-1085EL

NCT05489874 A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient https://clinicaltrials.gov/study/NCT05489874 RECRUITING COVID-19 Patient Shanghai Vinnerna Biosciences Co., Ltd.

NCT05860374 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05860374 RECRUITING Sarcoma

NCT06005220 SBD121, a Synbiotic Medical Food for RA Management https://clinicaltrials.gov/study/NCT06005220 RECRUITING Rheumatoid Arthritis OTHER: SBD121

NCT05290220 HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT05290220 NOT_YET_RECRUITING Advanced Hepatocellular Carcinoma DRUG: HLX07

NCT05886920 Study of D3S-002 as Monotherapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations https://clinicaltrials.gov/study/NCT05886920 RECRUITING Advanced Solid Tumors With MAPK Pathway Mutations DRUG: D3S-002 D3 Bio (Wuxi) Co., Ltd

NCT06386874 EMAGINE 2.0 - Electromagnetic Field Ischemic Stroke - Novel Subacute Treatment https://clinicaltrials.gov/study/NCT06386874 NOT_YET_RECRUITING Ischemic Stroke DEVICE: BQ 3.0 system

NCT06189274 Anatomy Based Selection of CI Array for SSD Patients https://clinicaltrials.gov/study/NCT06189274 NOT_YET_RECRUITING Single-Sided Deafness OTHER: Anatomy-Based Electrode Array Selection

NCT06327074 Testing the Engaged Approach to Lung Cancer Screening https://clinicaltrials.gov/study/NCT06327074 RECRUITING Lung Cancer BEHAVIORAL: Engaged Approach to Lung Cancer Screening University of Colorado, Denver Bristol-Myers Squibb

NCT06466174 Determination of the Safety and Efficacy of Two Probiotic Strains https://clinicaltrials.gov/study/NCT06466174 NOT_YET_RECRUITING Gastrointestinal Dysfunction DIETARY_SUPPLEMENT: Placebo 1 to Probiotic A

NCT06412874 Assessment of Supportive Care and Educational Needs to Guide Quality Care Improvements for Patients With Locally Advanced and Metastatic Bladder Cancer https://clinicaltrials.gov/study/NCT06412874 RECRUITING Screening Tool

NCT06267274 A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes https://clinicaltrials.gov/study/NCT06267274 RECRUITING Open-angle Glaucoma

NCT06390774 A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT06390774 RECRUITING Locally Advanced, Recurrent or Metastatic Malignancies DRUG: SSGJ-705 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

NCT05275374 XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation https://clinicaltrials.gov/study/NCT05275374 NOT_YET_RECRUITING Cancer

NCT05383274 Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters https://clinicaltrials.gov/study/NCT05383274 RECRUITING Urethral Stricture COMBINATION_PRODUCT: Optilume Urethral DCB Urotronic Inc. Laborie Medical Technologies Inc.

NCT05840120 Studying the Clinical Research Experiences of Patients With PTSD https://clinicaltrials.gov/study/NCT05840120 NOT_YET_RECRUITING PTSD Power Life Sciences Inc.

NCT03107520 Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH https://clinicaltrials.gov/study/NCT03107520 RECRUITING Developmental Dysplasia of the Hip DIAGNOSTIC_TEST: Intraoperative contrast-enhanced ultrasound (CEUS)

NCT05652920 Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC https://clinicaltrials.gov/study/NCT05652920 RECRUITING Hepatocellular Carcinoma BIOLOGICAL: Ori-C101 OriCell Therapeutics Co., Ltd.

NCT06188520 A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06188520 RECRUITING ER+ HER2- Advanced Breast Cancer

NCT06206720 A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV https://clinicaltrials.gov/study/NCT06206720 RECRUITING Respiratory Syncytial Virus Infection DRUG: Deuremidevir Hydrobromide for Suspension

NCT06586320 Quantification of Parkinson's Disease Patients as a Biomarker for Classification, Prediction and Response to Treatment https://clinicaltrials.gov/study/NCT06586320 RECRUITING Parkinson Disease DRUG: 150% of their routine home dopaminergic medications dose right in the clinic

NCT05995873 A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders. https://clinicaltrials.gov/study/NCT05995873 RECRUITING Opioid Use Disorder, Moderate

NCT05884320 Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers https://clinicaltrials.gov/study/NCT05884320 RECRUITING Gland

NCT03390920 Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions https://clinicaltrials.gov/study/NCT03390920 NOT_YET_RECRUITING Osteoarthritis

NCT05886374 A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT05886374 RECRUITING Advanced Malignant Solid Tumors DRUG: HMPL-415S1 Hutchmed

NCT06585774 A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease https://clinicaltrials.gov/study/NCT06585774 RECRUITING Chronic Graft-versus-host-disease DRUG: INCA034176

NCT06026774 Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms https://clinicaltrials.gov/study/NCT06026774 RECRUITING Digestive System Neoplasms BIOLOGICAL: iNeo-Vac-R01 in combination with standard adjuvant therapy Sir Run Run Shaw Hospital Hangzhou Neoantigen Therapeutics Co., Ltd.

NCT06706674 Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients https://clinicaltrials.gov/study/NCT06706674 RECRUITING Irritability Associated With Autism Spectrum Disorder DRUG: Lumateperone high dose

NCT06512974 NeuroTrainer Cognitive Training For Academic Focus https://clinicaltrials.gov/study/NCT06512974 NOT_YET_RECRUITING ADHD - Combined Type

NCT06538974 Adherence to Long-term Exoskeleton Rehabilitation to Treat Lower Limb Weakness and / or Deficiencies in Adult Population https://clinicaltrials.gov/study/NCT06538974 RECRUITING Motor Disorders

NCT05680220 40 Hz Light Neurostimulation for Patients With Depression (FELIX) https://clinicaltrials.gov/study/NCT05680220 RECRUITING Major Depressive Disorder

NCT05686720 Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Advanced Triple Negative Breast Cancer https://clinicaltrials.gov/study/NCT05686720 NOT_YET_RECRUITING Advanced Triple Negative Breast Cancer DRUG: SZ011 CAR-NK First Affiliated Hospital of Shantou University Medical College Guangdong ProCapZoom Biosciences Co., Ltd.

NCT06336720 PoNS¬Æ Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study https://clinicaltrials.gov/study/NCT06336720 RECRUITING Chronic Stroke Survivors DEVICE: Portable Neuromodulation Stimulator (PoNS) Helius Medical Inc

NCT05792020 Safety, Parameterization, and Mechanism of Transcranial Focused Ultrasound https://clinicaltrials.gov/study/NCT05792020 NOT_YET_RECRUITING Healthy DEVICE: Focused Ultrasound Stimulation Medical University of South Carolina BRAINBox Solutions Inc

NCT05963074 A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia https://clinicaltrials.gov/study/NCT05963074 RECRUITING Leukemia, Lymphocytic, Chronic, B-Cell

NCT04365374 Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study) https://clinicaltrials.gov/study/NCT04365374 RECRUITING Brain Metastases DEVICE: Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)

NCT05192174 Study of NIB101 in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05192174 RECRUITING Solid Tumor BIOLOGICAL: NIB101 Noile-Immune Biotech, Inc

NCT03818620 Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer https://clinicaltrials.gov/study/NCT03818620 RECRUITING Skin Cancer

NCT04832620 Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas https://clinicaltrials.gov/study/NCT04832620 RECRUITING Bone Neoplasm of Vertebral Column

NCT03702920 Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% https://clinicaltrials.gov/study/NCT03702920 RECRUITING Acute-On-Chronic Liver Failure BIOLOGICAL: SMT + PE-A 5%

NCT06496620 A Study to Evaluate Solrikitug in Participants With COPD (ZION) https://clinicaltrials.gov/study/NCT06496620 RECRUITING COPD DRUG: Biological: Solrikitug low dose

NCT05585320 A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05585320 RECRUITING Advanced Solid Tumor

NCT05903274 JSP191 (Briquilimab) in Subjects With LR-MDS https://clinicaltrials.gov/study/NCT05903274 RECRUITING Lower-risk Myelodysplastic Syndrome DRUG: JSP191 Jasper Therapeutics, Inc.

NCT05714774 Evaluation of Different Methods of Ultrasound Image Analysis for Real-time Monitoring of HIFU Prostate Cancer Treatment https://clinicaltrials.gov/study/NCT05714774 RECRUITING Prostatic Neoplasms DEVICE: HIFU treatment of prostate cancer Hospices Civils de Lyon EDAP TMS S.A.

NCT06488274 Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula https://clinicaltrials.gov/study/NCT06488274 NOT_YET_RECRUITING Functional Gastrointestinal Disorders DIETARY_SUPPLEMENT: New infant formula United Pharmaceuticals Axiodis CRO

NCT06156774 SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project https://clinicaltrials.gov/study/NCT06156774 RECRUITING Non-hodgkin Lymphoma,B Cell OTHER: Chimeric Antigen Receptor T-cells (CAR-T) therapy Fondazione Italiana Linfomi - ETS Kite, A Gilead Company

NCT06022874 The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis https://clinicaltrials.gov/study/NCT06022874 RECRUITING Atopic Dermatitis OTHER: Phoilex Releaf Gel Phoilex Ltd. Phoenix Medical Spa X Peak Human

NCT05873374 Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19 https://clinicaltrials.gov/study/NCT05873374 NOT_YET_RECRUITING COVID-19 Vaccine

NCT06592274 A Phase 2 Study to Explore the Efficacy and Safety of HB0017 Longer Dose Interval in Psoriasis Patients https://clinicaltrials.gov/study/NCT06592274 NOT_YET_RECRUITING Psoriasis (PsO) BIOLOGICAL: HB0017

NCT04779320 A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) https://clinicaltrials.gov/study/NCT04779320 RECRUITING Crohn's Disease (CD) DRUG: Vedolizumab IV Takeda

NCT06087120 Investigate the Prognostic and Predictive Value of ctDNA During Neoadjuvant Chemotherapy for Breast Cancer. https://clinicaltrials.gov/study/NCT06087120 RECRUITING Breast Cancer Female

NCT06237920 Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab https://clinicaltrials.gov/study/NCT06237920 RECRUITING Urologic Neoplasms

NCT06678620 Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine https://clinicaltrials.gov/study/NCT06678620 RECRUITING Pneumococcal Infectious Disease BIOLOGICAL: Reinovax PCV24 formulation 1

NCT04895020 Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years https://clinicaltrials.gov/study/NCT04895020 RECRUITING HPV Infections

NCT05989074 All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve https://clinicaltrials.gov/study/NCT05989074 NOT_YET_RECRUITING Aortic Stenosis, Severe DEVICE: ALLEGRA TAVI System TF

NCT04815720 Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck https://clinicaltrials.gov/study/NCT04815720 RECRUITING Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) DRUG: pepinemab + pembrolizumab Vaccinex Inc. Merck Sharp & Dohme LLC

NCT06709820 A Study of LY4060874 in Healthy Participants https://clinicaltrials.gov/study/NCT06709820 NOT_YET_RECRUITING Healthy Participants DRUG: LY4060874

NCT06616974 A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) https://clinicaltrials.gov/study/NCT06616974 RECRUITING Pulmonary Hypertension

NCT05001074 Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients https://clinicaltrials.gov/study/NCT05001074 RECRUITING Lung Transplant; Complications DRUG: Extended release tacrolimus

NCT05307874 Phase 1/2a Study of ICT01 Plus Low Dose SC IL-2 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05307874 RECRUITING Solid Tumor, Adult DRUG: ICT01

NCT03539874 Sperm Oxidative Stress and Pregnancy Success During IUI and IVF https://clinicaltrials.gov/study/NCT03539874 RECRUITING Oxidative Stress Fertilys

NCT05245474 Neoadjuvant Long-course Chemoradiation Plus PD-1 Blockade for Mid-low Locally Advanced Rectal Cancer https://clinicaltrials.gov/study/NCT05245474 RECRUITING Locally Advanced Rectal Cancer COMBINATION_PRODUCT: Long-course chemoradiation, with or without Tislelizumab (PD-1 inhibitor) Beijing Friendship Hospital Beijing Chao Yang Hospital

NCT05895474 Safety Assessment of Central Medial Thalamus Stimulation Using Transcranial Focused Ultrasound https://clinicaltrials.gov/study/NCT05895474 RECRUITING Healthy DEVICE: Transcranial Focused Ultrasound Medical University of South Carolina Attune Neurosciences Inc

NCT04567420 DNA-Guided Second Line Adjuvant Therapy For High Residual Risk, Stage II-III, Hormone Receptor Positive, HER2 Negative Breast Cancer https://clinicaltrials.gov/study/NCT04567420 RECRUITING Breast Cancer DRUG: Palbociclib

NCT06091020 A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury https://clinicaltrials.gov/study/NCT06091020 RECRUITING Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury BIOLOGICAL: IncobotulinumtoxinA

NCT05170074 Post-market Clinical Follow-up of the SRS Implant https://clinicaltrials.gov/study/NCT05170074 RECRUITING Pelvic Organ Prolapse pfm medical gmbh

NCT05235074 OH2 Oncolytic Viral Therapy in Central Nervous System Tumors https://clinicaltrials.gov/study/NCT05235074 RECRUITING Central Nervous System Tumors BIOLOGICAL: OH2 injection Binhui Biopharmaceutical Co., Ltd.

NCT05465174 Nivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults https://clinicaltrials.gov/study/NCT05465174 RECRUITING Craniopharyngioma, Child

NCT06100874 A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) https://clinicaltrials.gov/study/NCT06100874 RECRUITING Her 2 Positive Breast Cancer

NCT06238622 A Follow-up Study to Test Long-term Treatment With BI 1015550 in People With Pulmonary Fibrosis Who Took Part in a Previous Study With BI 1015550 https://clinicaltrials.gov/study/NCT06238622 RECRUITING Idiopathic Pulmonary Fibrosis

NCT05197322 NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer https://clinicaltrials.gov/study/NCT05197322 RECRUITING Adenocarcinoma of the Colon DRUG: Pembrolizumab University College, London Merck Sharp & Dohme LLC

NCT06661122 A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer https://clinicaltrials.gov/study/NCT06661122 RECRUITING Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT06225622 Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer https://clinicaltrials.gov/study/NCT06225622 RECRUITING Metastatic Colorectal Cancer DRUG: Irinotecan Liposome

NCT05345522 A Study of Anti-IL-6R mAb Injection in Patients With iMCD https://clinicaltrials.gov/study/NCT05345522 RECRUITING Idiopathic Multicentric Castleman's Disease BIOLOGICAL: Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg

NCT06628622 A Study to Test Whether BI 1356225 Improves Impulsive Behavior in Men With Opioid Use Disorder Who Are Taking Buprenorphine https://clinicaltrials.gov/study/NCT06628622 NOT_YET_RECRUITING Opioid Use Disorder DRUG: BI 1356225

NCT06548022 Rare Group Problem Management Plus https://clinicaltrials.gov/study/NCT06548022 RECRUITING Anxiety

NCT04198922 Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease https://clinicaltrials.gov/study/NCT04198922 RECRUITING Recurrent Moderate-Severe Chronic Graft Versus Host Disease

NCT06706622 A Trial of Lu AF82422 in Participants With Multiple System Atrophy (MSA) https://clinicaltrials.gov/study/NCT06706622 RECRUITING Multiple System Atrophy DRUG: Lu AF82422

NCT06250322 A Multicenter, Observational, Single Arm Study of the TECNIS Presbyopia-correcting Intraocular Lens https://clinicaltrials.gov/study/NCT06250322 RECRUITING Cataracts DEVICE: Intervention Johnson & Johnson Surgical Vision, Inc.

NCT04529122 A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test https://clinicaltrials.gov/study/NCT04529122 RECRUITING Solid Tumours Hoffmann-La Roche

NCT04362722 Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients https://clinicaltrials.gov/study/NCT04362722 RECRUITING Carcinoma, Basal Cell

NCT05680922 DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05680922 RECRUITING Small Cell Lung Cancer Extensive Stage

NCT06704022 The Impact of an Oral Nutrition Supplement on the Gut Microbiome in Diabetic Patients https://clinicaltrials.gov/study/NCT06704022 NOT_YET_RECRUITING Type 2 Diabetes DIETARY_SUPPLEMENT: Oral nutritional supplement Nimble Science Ltd. Abbott Nutrition

NCT06129422 Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer https://clinicaltrials.gov/study/NCT06129422 RECRUITING Pancreatic Cancer DRUG: NMK89 Nihon Medi-Physics Co., Ltd.

NCT04998422 A Study of HG381 Administered to Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04998422 RECRUITING Advanced Solid Tumor DRUG: HG381 HitGen Inc.

NCT04588922 Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies https://clinicaltrials.gov/study/NCT04588922 RECRUITING Hematologic Malignancies DRUG: SLS009

NCT06449222 Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination with Chemotherapy https://clinicaltrials.gov/study/NCT06449222 RECRUITING Locally Advanced Breast Cancer

NCT06368622 Evolve China PMCF Study https://clinicaltrials.gov/study/NCT06368622 RECRUITING Intracranial Aneurysm DEVICE: Surpass Evolve Flow Diverter System Stryker Neurovascular Stryker (Beijing) Healthcare Products Co., Ltd

NCT05973422 Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 Diabetes https://clinicaltrials.gov/study/NCT05973422 NOT_YET_RECRUITING Type 1 Diabetes DEVICE: SIGI Insulin Management System Tandem Diabetes Care, Inc.

NCT05853822 FirmTech User Research Trial https://clinicaltrials.gov/study/NCT05853822 RECRUITING Erectile Function OTHER: FirmTech Tech Ring

NCT06086522 Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06086522 RECRUITING Solid Tumor DRUG: QN-302 Qualigen Theraputics, Inc. Translational Drug Development

NCT05940922 RWE-based Treatment Patterns and Outcomes in CIDP https://clinicaltrials.gov/study/NCT05940922 NOT_YET_RECRUITING Chronic Inflammatory Demyelinating Polyneuropathy

NCT06117722 TorasEmide Induced Effect on QoL and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone. https://clinicaltrials.gov/study/NCT06117722 RECRUITING Chronic Heart Failure OTHER: Eplerenone torasemide in chronic heart failure Elpen Pharmaceutical Co. Inc.

NCT04674722 HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody https://clinicaltrials.gov/study/NCT04674722 RECRUITING Breast Cancer

NCT05970822 Study of BC3402 in Combination With Azacitidine in Patients With MDS and CMML https://clinicaltrials.gov/study/NCT05970822 RECRUITING Myelodysplastic Syndromes

NCT04044222 A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy https://clinicaltrials.gov/study/NCT04044222 RECRUITING Classic Hodgkin's Lymphoma BIOLOGICAL: Sintilimab

NCT05678322 Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy https://clinicaltrials.gov/study/NCT05678322 RECRUITING Prostate Cancer DRUG: 18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent

NCT05870722 An In Depth Study Evaluating The Experiences of Patients In Schizophrenia Research https://clinicaltrials.gov/study/NCT05870722 NOT_YET_RECRUITING Schizophrenia Power Life Sciences Inc.

NCT04357522 Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers https://clinicaltrials.gov/study/NCT04357522 NOT_YET_RECRUITING Pneumonia, Pneumococcal BIOLOGICAL: 15-Valent Pneumococcal Conjugate Vaccine

NCT04838522 A Study of Prucalopride in Breastfeeding Women With Constipation https://clinicaltrials.gov/study/NCT04838522 RECRUITING Chronic Idiopathic Constipation (CIC) OTHER: No Intervention Takeda UC San Diego Human Milk Research Biorepository

NCT04528082 Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Beh√ßet's Disease https://clinicaltrials.gov/study/NCT04528082 RECRUITING Beh√ßet Disease DRUG: Apremilast

NCT06712082 A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants https://clinicaltrials.gov/study/NCT06712082 NOT_YET_RECRUITING Healthy DRUG: PF-07264660

NCT04794582 Prevention of Incisional Hernia After Renal Transplantation https://clinicaltrials.gov/study/NCT04794582 RECRUITING Incisional Hernia

NCT05838482 Clinical Feasibility and Evaluation of Silicon Photon Counting CT https://clinicaltrials.gov/study/NCT05838482 RECRUITING CT Photon-Counting DEVICE: CT Photon-Counting GE Healthcare Stanford University

NCT06416020 Integrating MOUD in African American Community Settings (Better Together) https://clinicaltrials.gov/study/NCT06416020 NOT_YET_RECRUITING Opioid Use Disorder BEHAVIORAL: HC-MOUD Only

NCT05650320 To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD https://clinicaltrials.gov/study/NCT05650320 RECRUITING Atopic Dermatitis (AD) DRUG: 0.3% OPA-15406 Ointment

NCT05576220 Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell Therapy https://clinicaltrials.gov/study/NCT05576220 NOT_YET_RECRUITING Febrile Neutropenia DEVICE: IDION iTempShield IDION Inc.

NCT05821374 Deucravacitinib in PG https://clinicaltrials.gov/study/NCT05821374 NOT_YET_RECRUITING Pyoderma Gangrenosum DRUG: Deucravacitinib Dartmouth-Hitchcock Medical Center Bristol-Myers Squibb

NCT06091865 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma https://clinicaltrials.gov/study/NCT06091865 RECRUITING Diffuse Large B-cell Lymphoma (DLBCL) DRUG: Odronextamab

NCT05547165 Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants https://clinicaltrials.gov/study/NCT05547165 RECRUITING Ductus Arteriosus, Patent DEVICE: Percutaneous Patent Ductus Arteriosus Closure (PPC)

NCT06362265 A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus https://clinicaltrials.gov/study/NCT06362265 RECRUITING Type 2 Diabetes Mellitus DRUG: LY3209590 Eli Lilly and Company

NCT05387265 A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05387265 RECRUITING Solid Tumors DRUG: CX-904 CytomX Therapeutics

NCT06592482 A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780 https://clinicaltrials.gov/study/NCT06592482 RECRUITING Renal Impairment DRUG: AZD0780 AstraZeneca

NCT05482282 Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma) https://clinicaltrials.gov/study/NCT05482282 NOT_YET_RECRUITING Diphtheria Vaccine Adverse Reaction

NCT05948982 Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis https://clinicaltrials.gov/study/NCT05948982 NOT_YET_RECRUITING Decompensated Liver Cirrhosis BIOLOGICAL: Human Umbilical Cord Mesenchymal Stem Cells Asia Cell Therapeutics (Shanghai) Co., Ltd.

NCT06600282 Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions https://clinicaltrials.gov/study/NCT06600282 NOT_YET_RECRUITING Post-operative Pain

NCT06370182 Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA5 Device https://clinicaltrials.gov/study/NCT06370182 NOT_YET_RECRUITING Acute Ischemic Stroke From Large Vessel Occlusion DEVICE: ANA Funnel Catheter

NCT04011020 Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes https://clinicaltrials.gov/study/NCT04011020 RECRUITING Type 1 Diabetes COMBINATION_PRODUCT: Stem Cell Educator therapy Throne Biotechnologies Inc. Hackensack Meridian Health

NCT06466265 Study of DNP002 in Patients With Solid Tumors https://clinicaltrials.gov/study/NCT06466265 RECRUITING Advanced Solid Tumor DRUG: DNP002 Kumho HT Inc.

NCT06271265 Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery https://clinicaltrials.gov/study/NCT06271265 RECRUITING Postoperative Pain DRUG: EXPAREL

NCT04964765 The Basel CardioInsightTM - 3D Mapping Study https://clinicaltrials.gov/study/NCT04964765 RECRUITING New-onset Atrial Fibrillation (NOAF) DIAGNOSTIC_TEST: Mapping

NCT05480865 SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation https://clinicaltrials.gov/study/NCT05480865 RECRUITING Solid Tumor, Adult

NCT06424665 A Study of FZ-AD005 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06424665 RECRUITING Advanced Solid Tumor, SCLC(Small Cell Lung Cancer) or LCNEC (Large Cell Neuroendocrine Carcinoma) DRUG: FZ-AD005 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

NCT06276465 Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging https://clinicaltrials.gov/study/NCT06276465 RECRUITING Prostatic Cancer, Castration-Resistant DRUG: Darolutamide 300 mg

NCT05955365 Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation https://clinicaltrials.gov/study/NCT05955365 RECRUITING Percutaneous Coronary Intervention (PCI)

NCT06516965 A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) https://clinicaltrials.gov/study/NCT06516965 RECRUITING Prurigo Nodularis DRUG: Povorcitinib

NCT04756765 Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer https://clinicaltrials.gov/study/NCT04756765 RECRUITING Breast Cancer

NCT05008965 Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma https://clinicaltrials.gov/study/NCT05008965 RECRUITING Allergic Asthma BIOLOGICAL: FB825

NCT06307665 Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma https://clinicaltrials.gov/study/NCT06307665 RECRUITING Asthma COMBINATION_PRODUCT: BDA MDI

NCT01246765 National Pregnancy Registry for Psychiatric Medications https://clinicaltrials.gov/study/NCT01246765 RECRUITING Pregnant Women

NCT06637865 A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers https://clinicaltrials.gov/study/NCT06637865 RECRUITING Healthy DRUG: IMP761

NCT05966480 Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT05966480 RECRUITING SLE DRUG: ESK-001

NCT05919680 A Study of NST-6179 in Adult Subjects With Intestinal Failure-Associated Liver Disease (IFALD). https://clinicaltrials.gov/study/NCT05919680 RECRUITING Intestinal Failure Associated Liver Disease DRUG: NST-6179 Part A

NCT05137262 A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder https://clinicaltrials.gov/study/NCT05137262 RECRUITING Urothelial Carcinoma

NCT04706962 TH1902 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04706962 RECRUITING Solid Tumor

NCT05064280 Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases https://clinicaltrials.gov/study/NCT05064280 RECRUITING Brain Metastases

NCT05358080 Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy https://clinicaltrials.gov/study/NCT05358080 RECRUITING Non Proliferative Diabetic Retinopathy DRUG: Entelon Tab. 50mg

NCT04107662 Biomarkers of Traumatic Brain Injury With Tbit System https://clinicaltrials.gov/study/NCT04107662 NOT_YET_RECRUITING Brain Injuries, Traumatic DEVICE: Tbit system BioDirection Inc

NCT05529862 Trans-RosaLEE Study: a Biomarker-directed, Translational Study https://clinicaltrials.gov/study/NCT05529862 RECRUITING Advanced or Metastatic Breast Cancer (BC) GENETIC: Pre-treatment biopsy

NCT05257980 Evaluation of Four New Ready to Drink Oral Nutritional Supplements: Adult ONS Trial https://clinicaltrials.gov/study/NCT05257980 RECRUITING Malnutrition DIETARY_SUPPLEMENT: Dietary supplement (ONS) Nutricia UK Ltd

NCT06047080 An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma https://clinicaltrials.gov/study/NCT06047080 RECRUITING Large B-Cell Lymphoma DRUG: Glofitamab

NCT05456880 BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease https://clinicaltrials.gov/study/NCT05456880 RECRUITING Sickle Cell Disease BIOLOGICAL: BEAM-101 Beam Therapeutics Inc.

NCT04797780 Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome https://clinicaltrials.gov/study/NCT04797780 RECRUITING Myelodysplastic Syndromes DRUG: Tamibarotene

NCT06607562 Effectiveness and Safety of Probiotics in Protecting Liver Function https://clinicaltrials.gov/study/NCT06607562 RECRUITING Alcohol Abuse DIETARY_SUPPLEMENT: Probiotic group

NCT06302062 Phase I Clinical Study of Tumor-associated Lymph Node T Cell Therapy for Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06302062 RECRUITING Advanced Solid Tumor

NCT06008080 Post-Market Clinical Follow Up Study with Navitor Valve https://clinicaltrials.gov/study/NCT06008080 RECRUITING Aortic Stenosis DEVICE: Navitor Transcatheter Aortic Valve, FlexNav Delivery System, Navitor Loading System Abbott Medical Devices

NCT06522880 Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study https://clinicaltrials.gov/study/NCT06522880 RECRUITING Cytomegalovirus Infections DIAGNOSTIC_TEST: CMV PCR on saliva University of Massachusetts, Worcester ModernaTX, Inc.

NCT06092580 Phase 1 Study of AWT020 in Advanced Cancer https://clinicaltrials.gov/study/NCT06092580 RECRUITING Advanced Cancer BIOLOGICAL: AWT020 Anwita Biosciences

NCT05753462 Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy https://clinicaltrials.gov/study/NCT05753462 RECRUITING Duchenne Muscular Dystrophy DRUG: Phase 1, SQY51

NCT05895162 Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis. https://clinicaltrials.gov/study/NCT05895162 RECRUITING Vulvovaginal Candidiasis

NCT06545162 Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101 https://clinicaltrials.gov/study/NCT06545162 NOT_YET_RECRUITING Overweight and Obesity BIOLOGICAL: CPX101 or placebo 80mg single dose

NCT05642780 SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors https://clinicaltrials.gov/study/NCT05642780 RECRUITING Solid Tumor DRUG: SKB264

NCT04648280 Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their CART and Have Dual- or Triple-class Antiretroviral Resistance https://clinicaltrials.gov/study/NCT04648280 RECRUITING HIV Infections with Multi Drug Resistant Virus DRUG: Fostemsavir PENTA Foundation ViiV Healthcare

NCT04835480 A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites https://clinicaltrials.gov/study/NCT04835480 RECRUITING Cirrhotic Ascites DRUG: OrsHSA

NCT06204380 An Observational Study on the Identification of Prescription Patterns of STAFEN Cap https://clinicaltrials.gov/study/NCT06204380 RECRUITING Mixed Dyslipidemia Hanlim Pharm. Co., Ltd.

NCT05843162 A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome https://clinicaltrials.gov/study/NCT05843162 NOT_YET_RECRUITING Essential Hypertension

NCT06702462 A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma https://clinicaltrials.gov/study/NCT06702462 NOT_YET_RECRUITING Asthma OTHER: HFA-152A propellant

NCT04869280 Post-Marketing Study of Prucalopride Safety In Pregnancy https://clinicaltrials.gov/study/NCT04869280 RECRUITING Chronic Idiopathic Constipation (CIC) OTHER: No Intervention Takeda The Organization of Teratology Information Specialists

NCT06695780 Food Typologies and Multidimensional Phenotyping of Elderly in Auvergne-Rh√¥ne-Alpes (Part'AGE) https://clinicaltrials.gov/study/NCT06695780 NOT_YET_RECRUITING Nutritional Assessment

NCT05688280 Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS https://clinicaltrials.gov/study/NCT05688280 RECRUITING Metastatic Solid Tumor

NCT05094089 Assessment of GORE¬Æ SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application https://clinicaltrials.gov/study/NCT05094089 RECRUITING Hernia, Ventral

NCT05829460 Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia https://clinicaltrials.gov/study/NCT05829460 NOT_YET_RECRUITING Endometrial Hyperplasia DRUG: Semaglutide

NCT06359860 A Study of ST-1898 for Unresectable or Metastatic Melanoma https://clinicaltrials.gov/study/NCT06359860 RECRUITING Unresectable or Metastatic Melanoma DRUG: ST-1898 tablets Beijing Scitech-Mq Pharmaceuticals Limited

NCT04805060 A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors https://clinicaltrials.gov/study/NCT04805060 RECRUITING Terminal Malignant Tumors DRUG: TQB2858 injection Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT04811560 A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia https://clinicaltrials.gov/study/NCT04811560 RECRUITING Acute Leukemias

NCT06224660 Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy https://clinicaltrials.gov/study/NCT06224660 NOT_YET_RECRUITING DMD-Associated Dilated Cardiomyopathy GENETIC: SRD-001 Sardocor Corp.

NCT06552260 A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma https://clinicaltrials.gov/study/NCT06552260 NOT_YET_RECRUITING Glioblastoma

NCT06079060 Evaluation of Synthetic Nitrile Male Condom Compared to Standard Latex Male Condom https://clinicaltrials.gov/study/NCT06079060 RECRUITING Sexually Transmitted Diseases DEVICE: Synthetic Nitrile Condom (61mm)

NCT05037760 Study to Evaluate KER-050 as a Monotherapy or in Combination With Ruxolitinib in Myelofibrosis https://clinicaltrials.gov/study/NCT05037760 RECRUITING Myelofibrosis DRUG: KER-050 monotherapy

NCT06354660 Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1) https://clinicaltrials.gov/study/NCT06354660 RECRUITING Diabetes Type 2 DRUG: Retatrutide

NCT06691360 AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT06691360 NOT_YET_RECRUITING Advanced Malignant Tumors DRUG: AK137 Akeso

NCT06571760 Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-I https://clinicaltrials.gov/study/NCT06571760 RECRUITING Pulmonary Embolism DEVICE: Vertex Pulmonary Embolectomy System Neptune Medical

NCT06625060 A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults https://clinicaltrials.gov/study/NCT06625060 RECRUITING Episodic Migraine

NCT06144060 A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute Pyelonephritis https://clinicaltrials.gov/study/NCT06144060 NOT_YET_RECRUITING Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP) DRUG: HRS -8427

NCT04878276 Comparative Head Lice Therapy With Dimet 5¬Æ vs. Hedrin¬Æ Once https://clinicaltrials.gov/study/NCT04878276 RECRUITING Head Lice Infestation

NCT05508360 "Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nulcectomy" (LOPAIN2) https://clinicaltrials.gov/study/NCT05508360 RECRUITING Degenerative Disc Disease

NCT05737160 Study of Telitacicept in Generalized Myasthenia Gravis https://clinicaltrials.gov/study/NCT05737160 RECRUITING Myasthenia Gravis, Generalized BIOLOGICAL: Telitacicept

NCT06430060 The Clinical Investigation of Colgate Dual Zinc Toothpaste as Compared to Colgate Cavity Protection Toothpaste in Controlling Established Plaque and Gingivitis https://clinicaltrials.gov/study/NCT06430060 NOT_YET_RECRUITING Plaque, Dental

NCT03141060 Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB https://clinicaltrials.gov/study/NCT03141060 RECRUITING Tuberculosis

NCT06067360 Evaluation of Performance of New IFIS Sleeve https://clinicaltrials.gov/study/NCT06067360 NOT_YET_RECRUITING Cataract DEVICE: IFIS sleeve Medicel AG

NCT06498960 Evaluation of the Safety and Effectiveness of the CereVasc¬Æ EShunt¬Æ System in Normal Pressure Hydrocephalus https://clinicaltrials.gov/study/NCT06498960 RECRUITING Normal Pressure Hydrocephalus DEVICE: CereVasc eShunt System

NCT04316676 The MATCH Investigation: CT Myocardial Perfusion and CT-FFR vs PET MPI https://clinicaltrials.gov/study/NCT04316676 RECRUITING Coronary Artery Disease DIAGNOSTIC_TEST: PET-MPI Protocol

NCT06560476 OPtilume‚Ñ¢ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH https://clinicaltrials.gov/study/NCT06560476 RECRUITING Benign Prostatic Hyperplasia OTHER: Data collection Urotronic Inc.

NCT04676360 Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma https://clinicaltrials.gov/study/NCT04676360 RECRUITING Relapsed Plasmablastic Lymphoma

NCT05833360 Prospective Study of OncRNA Stratification of Cancer by Size and Stage https://clinicaltrials.gov/study/NCT05833360 RECRUITING Cancer DEVICE: Exai oncRNA blood test Exai Bio Inc.

NCT06619860 Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy https://clinicaltrials.gov/study/NCT06619860 RECRUITING Diabetic Peripheral Neuropathic Pain DRUG: VX-993

NCT06077760 A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) https://clinicaltrials.gov/study/NCT06077760 RECRUITING Non-small Cell Lung Cancer BIOLOGICAL: V940

NCT06654960 Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects https://clinicaltrials.gov/study/NCT06654960 RECRUITING Type 2 Diabetes DRUG: HRS9531 injection

NCT04615260 Rate of Bony Fusion Using NanoBone¬Æ Synthetic Bone Graft Versus Local Autologous Bone Graft. https://clinicaltrials.gov/study/NCT04615260 RECRUITING Degenerative Disc Disease

NCT05781360 A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05781360 RECRUITING Locally Advanced Unresectable or Metastatic Solid Tumor DRUG: SIM0237 Jiangsu Simcere Pharmaceutical Co., Ltd. Shanghai Xianxiang Medical Technology Co., Ltd.

NCT05123989 Evaluating the Impact of Personalized Move Goals on Physical Activity https://clinicaltrials.gov/study/NCT05123989 NOT_YET_RECRUITING Sedentary Lifestyle

NCT06603740 Nanoscope Cost Analysis Study https://clinicaltrials.gov/study/NCT06603740 NOT_YET_RECRUITING Meniscal Tear DEVICE: Arthrex Nanoscope

NCT04647240 Dermacyte¬Æ Amniotic Wound Care Liquid for the Treatment of Non-Healing Venous Stasis Ulcers https://clinicaltrials.gov/study/NCT04647240 RECRUITING Venous Stasis Ulcer

NCT06439940 Oncoliq: Early Breast Cancer Detection Based on Liquid Biopsies and microRNAs https://clinicaltrials.gov/study/NCT06439940 RECRUITING Breast Cancer Female

NCT05349240 C2 Esophageal Squamous Epithelium Dysplasia https://clinicaltrials.gov/study/NCT05349240 NOT_YET_RECRUITING Esophageal Squamous Epithelium Dysplasia DEVICE: C2 CryoBalloonTM Ablation System. Pentax Medical

NCT06012240 A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata https://clinicaltrials.gov/study/NCT06012240 RECRUITING Alopecia Areata DRUG: Upadacitinib

NCT06629740 A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication https://clinicaltrials.gov/study/NCT06629740 RECRUITING Substance Use Disorder (SUD) DEVICE: Measurements with a eHealth system Kontigo Care AB

NCT05661240 Phase ‚Ö°/‚Ö¢ Clinical Study of Tumor Treating Fields ÔºàEFE-P100ÔºâCombined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1ÔºàPD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment https://clinicaltrials.gov/study/NCT05661240 NOT_YET_RECRUITING Non-small Cell Lung Cancer (NSCLC) DEVICE: Tumor treating fieldsÔºàEFE-P100Ôºâ

NCT05393440 First-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer https://clinicaltrials.gov/study/NCT05393440 RECRUITING Uterine Cervical Neoplasms BIOLOGICAL: BS-006 Zhongnan Hospital Binhui Biopharmaceutical Co., Ltd.

NCT05936840 Quantum Menstrual Health Monitoring Study https://clinicaltrials.gov/study/NCT05936840 RECRUITING Menstrual Cycle Abnormal

NCT05000840 Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA https://clinicaltrials.gov/study/NCT05000840 RECRUITING Diabetes Mellitus, Type 2

NCT05870540 BPL-003 Efficacy and Safety in Treatment Resistant Depression https://clinicaltrials.gov/study/NCT05870540 RECRUITING Treatment Resistant Depression DRUG: BPL-003 Beckley Psytech Limited

NCT06243640 Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD https://clinicaltrials.gov/study/NCT06243640 RECRUITING Generalized Anxiety Disorder DRUG: Buagafuran capsules, 15mg/ capsule

NCT06163040 A Study to Evaluate the Safety of Empliciti¬Æ (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan https://clinicaltrials.gov/study/NCT06163040 RECRUITING Relapsed or Refractory Multiple Myeloma DRUG: Elotuzumab in combination with pomalidomide and dexamethasone

NCT06047340 Feasibility Study of Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease https://clinicaltrials.gov/study/NCT06047340 NOT_YET_RECRUITING Dementia Alzheimers DEVICE: G:DATA, dementia screen videogame Ascentys Ltd

NCT04409340 Viscoelasticity Imaging to Assess Liver Cancer https://clinicaltrials.gov/study/NCT04409340 RECRUITING Liver Cancer DEVICE: Magnetic Resonance Viscoelastography

NCT06328140 Sleep Quality, Cognitive Performance, and Computerized Cognitive Training https://clinicaltrials.gov/study/NCT06328140 NOT_YET_RECRUITING Bipolar Disorder

NCT06517940 A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP) https://clinicaltrials.gov/study/NCT06517940 RECRUITING Retinitis Pigmentosa Sumitomo Pharma America, Inc.

NCT05774340 A Study of CM326 in Subjects With Moderate to Severe Asthma https://clinicaltrials.gov/study/NCT05774340 RECRUITING Moderate to Severe Asthma DRUG: CM326

NCT04907240 Observational GORE¬Æ VIABAHN¬Æ Endoprosthesis With PROPATEN Bioactive Surface Global Registry https://clinicaltrials.gov/study/NCT04907240 RECRUITING Peripheral Artery Disease

NCT06299540 Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia https://clinicaltrials.gov/study/NCT06299540 RECRUITING Leukemia, Lymphocytic, Chronic, B-Cell BEHAVIORAL: Individual Physical Activity Intervention (IPAI)

NCT05241340 Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer https://clinicaltrials.gov/study/NCT05241340 RECRUITING Urothelial Carcinoma Bladder DRUG: Sasanlimab

NCT06705140 A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers https://clinicaltrials.gov/study/NCT06705140 RECRUITING RSV Immunisation BIOLOGICAL: Low Dose (LD) RSVt vaccine

NCT06688240 A Multi-center, Single-arm, Prospective Non-interventional Study to Investigate the Safety Profiles and Effectiveness of Liposomal Irinotecan (ONIVYDE¬Æ) in Combination with 5-fluorouracil (5-FU) and Leucovorin (LV) in Chinese Patients with Metastatic Pancreatic Cancer As Approval Condition (SEOPAC) https://clinicaltrials.gov/study/NCT06688240 NOT_YET_RECRUITING Metastatic Pancreatic Cancer Servier (Tianjin) Pharmaceutical Co. LTD. Les Laboratoires Servier

NCT05514340 Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy https://clinicaltrials.gov/study/NCT05514340 RECRUITING Hypoxic-Ischemic Encephalopathy

NCT05419765 Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver Disease https://clinicaltrials.gov/study/NCT05419765 RECRUITING Non-Alcoholic Fatty Liver Disease DIAGNOSTIC_TEST: Peripheral blood withdrawn University of Roma La Sapienza Alexion Pharmaceuticals, Inc.

NCT05851066 A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers https://clinicaltrials.gov/study/NCT05851066 NOT_YET_RECRUITING Dyslipidemias

NCT02472665 Efficacy and Safety of Fanhdi¬Æ, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease https://clinicaltrials.gov/study/NCT02472665 RECRUITING Von Willebrand Disease DRUG: plasma-derived FVIII/VWF concentrate Grifols Therapeutics LLC Instituto Grifols, S.A.

NCT05660265 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years https://clinicaltrials.gov/study/NCT05660265 RECRUITING Hematologic Diseases

NCT05765266 ACP Max‚Ñ¢ PRP System for Knee Osteoarthritis: A Feasibility Trial https://clinicaltrials.gov/study/NCT05765266 RECRUITING Knee Osteoarthritis DEVICE: ACP Max‚Ñ¢

NCT06556966 A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects https://clinicaltrials.gov/study/NCT06556966 NOT_YET_RECRUITING Schizophrenia

NCT05098665 PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY https://clinicaltrials.gov/study/NCT05098665 NOT_YET_RECRUITING Cardiac Amyloidosis COMBINATION_PRODUCT: Telemonitoring service Dr Jorg Taubel Richmond Pharmacology Limited

NCT05838066 Efficacy and Safety of KN026 in Combination With HB1801 in the First-line Treatment of Subjects With HER2-positive Recurrent or Metastatic Breast Cancer. https://clinicaltrials.gov/study/NCT05838066 NOT_YET_RECRUITING First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer DRUG: KN026

NCT06462365 Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) https://clinicaltrials.gov/study/NCT06462365 RECRUITING Hematologic Malignancy

NCT04912765 Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC https://clinicaltrials.gov/study/NCT04912765 RECRUITING Hepatocellular Carcinoma

NCT04205266 IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding https://clinicaltrials.gov/study/NCT04205266 RECRUITING Anemia, Iron Deficiency

NCT06050265 Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome https://clinicaltrials.gov/study/NCT06050265 RECRUITING PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

NCT05176665 EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers https://clinicaltrials.gov/study/NCT05176665 RECRUITING Neoplasms

NCT05101265 Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment https://clinicaltrials.gov/study/NCT05101265 RECRUITING Advanced Solid Tumor

NCT04860765 COMPASSION S3 Post-Approval Study https://clinicaltrials.gov/study/NCT04860765 RECRUITING Complex Congenital Heart Defect

NCT06060665 IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA) https://clinicaltrials.gov/study/NCT06060665 RECRUITING Primary Biliary Cholangitis DRUG: Seladelpar 10 mg

NCT05950165 A Study to Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT05950165 RECRUITING Non-Hodgkin Lymphoma DRUG: CHO-H01

NCT05860465 Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT05860465 RECRUITING Locally Advanced or Metastatic Breast Cancer DRUG: SPH4336 Tablets

NCT04937166 A Study of Dual-SIgnaling Protein 107 (DSP107) for Patients with Hematological Malignancies https://clinicaltrials.gov/study/NCT04937166 RECRUITING Acute Myeloid Leukemia

NCT06155565 Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research https://clinicaltrials.gov/study/NCT06155565 NOT_YET_RECRUITING Anxiety Disorder Power Life Sciences Inc.

NCT06226766 JSKN033 in Patients With Advanced or Metastatic Solid Malignant Tumors https://clinicaltrials.gov/study/NCT06226766 RECRUITING Advanced Solid Tumor DRUG: JSKN033 Injection Jiangsu Alphamab Biopharmaceuticals Co., Ltd

NCT05607966 A Post-market Observational ORIGIN¬Æ CR Clinical Study https://clinicaltrials.gov/study/NCT05607966 RECRUITING Total Knee Replacement DEVICE: ORIGIN¬Æ CR devices Symbios Orthopedie SA

NCT03773965 A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis https://clinicaltrials.gov/study/NCT03773965 RECRUITING Juvenile Idiopathic Arthritis DRUG: Baricitinib Eli Lilly and Company

NCT05268666 A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05268666 RECRUITING Locally Advanced Solid Tumor

NCT05948566 Strategy for Improving Stroke Treatment Response https://clinicaltrials.gov/study/NCT05948566 RECRUITING Ischemic Stroke BIOLOGICAL: TS23 Translational Sciences, Inc. University of Cincinnati

NCT06571266 A Study to Assess the Relative Bioavailability of Two Formulations of Risankizumab Following Subcutaneous Administration With Prefilled Syringes in Healthy Adult Participants https://clinicaltrials.gov/study/NCT06571266 RECRUITING Healthy Volunteers DRUG: Risankizumab AbbVie

NCT06106672 Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis https://clinicaltrials.gov/study/NCT06106672 RECRUITING Myasthenia Gravis

NCT05905172 Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis https://clinicaltrials.gov/study/NCT05905172 RECRUITING Liver Fibrosis DRUG: Hydronidone capsules

NCT05418972 A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma https://clinicaltrials.gov/study/NCT05418972 RECRUITING Stage II Melanoma DRUG: Relatlimab and nivolumab fixed dose combination (FDC) Melanoma Institute Australia Bristol-Myers Squibb

NCT04771572 Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. https://clinicaltrials.gov/study/NCT04771572 RECRUITING Non Hodgkin Lymphoma

NCT06176872 Cardiac CT Angiography in Patients With Acute Ischemic Stroke https://clinicaltrials.gov/study/NCT06176872 NOT_YET_RECRUITING Acute Ischemic Stroke

NCT05365672 Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation https://clinicaltrials.gov/study/NCT05365672 RECRUITING Kidney Transplantation BIOLOGICAL: MIC

NCT06122272 An Exploratory Trial in Hong Kong to Explore the Effect of a New Formula https://clinicaltrials.gov/study/NCT06122272 RECRUITING Healthy Subjects OTHER: Test Formula

NCT05633446 Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19) https://clinicaltrials.gov/study/NCT05633446 NOT_YET_RECRUITING Coronavirus

NCT06581146 A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition https://clinicaltrials.gov/study/NCT06581146 NOT_YET_RECRUITING X-Linked Myotubular Myopathy OTHER: No Intervention Astellas Gene Therapies

NCT05296746 Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer https://clinicaltrials.gov/study/NCT05296746 RECRUITING Breast Cancer Stage II DRUG: Ribociclib (neoadjuvant)

NCT05714072 A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis https://clinicaltrials.gov/study/NCT05714072 RECRUITING Myelofibrosis Due to and Following Polycythemia Vera DRUG: Ruxolitinib

NCT05694572 Post-market Surveillance of Micorport CRM Cardiac Implantable Electronic Devices https://clinicaltrials.gov/study/NCT05694572 RECRUITING Cardiac Rhythm Disorder

NCT05408546 Novel Œ±2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial https://clinicaltrials.gov/study/NCT05408546 RECRUITING Pulmonary Embolism DRUG: TS23

NCT05572346 Digital App for Telerehabilitation in Respiratory Diseases https://clinicaltrials.gov/study/NCT05572346 RECRUITING Respiratory Disease

NCT05400369 A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease https://clinicaltrials.gov/study/NCT05400369 RECRUITING COPD Exacerbation Acute DRUG: Sitafloxacin

NCT04134169 Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202) https://clinicaltrials.gov/study/NCT04134169 RECRUITING Rheumatoid Arthritis OTHER: Not applicable(observational study) Kang Stem Biotech Co., Ltd.

NCT05194072 A Study of SGN-B7H4V in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05194072 RECRUITING Ovarian Neoplasms

NCT06704672 Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus https://clinicaltrials.gov/study/NCT06704672 NOT_YET_RECRUITING Type 1 Diabetes Mellitus

NCT06295172 A Study Comparing Lafullen15 and Lafullen for Temporary Nasolabial Fold Improvement https://clinicaltrials.gov/study/NCT06295172 NOT_YET_RECRUITING Nasolabial Folds DEVICE: Lafullen15

NCT06603220 A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults with Chronic Inducible Urticaria https://clinicaltrials.gov/study/NCT06603220 RECRUITING Chronic Inducible Urticaria DRUG: Oral EVO756 Evommune, Inc.

NCT06291220 A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) https://clinicaltrials.gov/study/NCT06291220 RECRUITING Chronic Lymphocytic Leukemia

NCT06534320 Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of DA-302168S Tablets https://clinicaltrials.gov/study/NCT06534320 RECRUITING Overweight and Obesity DRUG: DA-302168S

NCT04453020 Deep Brain Stimulation Effects in Patients With Chronic Refractory Obesity https://clinicaltrials.gov/study/NCT04453020 RECRUITING Obesity DEVICE: DBS of the LHA donald whiting Boston Scientific Corporation

NCT04708782 Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis https://clinicaltrials.gov/study/NCT04708782 RECRUITING Idiopathic Pulmonary Fibrosis

NCT05575882 Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin. https://clinicaltrials.gov/study/NCT05575882 RECRUITING Atopic Dermatitis

NCT06369220 A Study of the Cobas¬Æ Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections https://clinicaltrials.gov/study/NCT06369220 RECRUITING Chlamydia Trachomatis Infection

NCT06334120 An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea https://clinicaltrials.gov/study/NCT06334120 RECRUITING Non-metastatic Castration-resistant Prostate Cancer

NCT05623020 A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, Lenalidomide or Elranatamab and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant https://clinicaltrials.gov/study/NCT05623020 RECRUITING Multiple Myeloma DRUG: Elranatamab

NCT06525220 A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab Vs Pembrolizumab in First-line Treatment of Head and Neck Cancer https://clinicaltrials.gov/study/NCT06525220 RECRUITING Head and Neck Squamous Cell Carcinoma DRUG: Petosemtamab

NCT05015920 A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in Œ≤-Thalassemia Major Participants https://clinicaltrials.gov/study/NCT05015920 RECRUITING Hematologic Diseases GENETIC: BD211 Drug Product Shanghai BDgene Co., Ltd. 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

NCT04501120 Study of APG2575 Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML https://clinicaltrials.gov/study/NCT04501120 RECRUITING Relapsed/Refractory Acute Myeloid Leukaemia

NCT05607420 Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT05607420 RECRUITING B-cell Non-Hodgkin Lymphoma (B-NHL) BIOLOGICAL: UCART20x22

NCT06422520 A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06422520 RECRUITING Advanced Solid Tumor DRUG: BGB-C354

NCT06317220 Vedolizumab for the Treatment of Collagenous Gastritis https://clinicaltrials.gov/study/NCT06317220 NOT_YET_RECRUITING Collagenous Gastritis BIOLOGICAL: Vedolizumab Massachusetts General Hospital Takeda

NCT06588257 Acceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study https://clinicaltrials.gov/study/NCT06588257 RECRUITING HPV BIOLOGICAL: Non-infectious adjuvanted recombinant nonavalent HPV vaccine Fundaci√≥n Hu√©sped MSD Pharmaceuticals LLC

NCT05511922 PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial https://clinicaltrials.gov/study/NCT05511922 RECRUITING Hereditary Angioedema DRUG: KVD900 600 mg KalVista Pharmaceuticals, Ltd.

NCT06429722 To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder. https://clinicaltrials.gov/study/NCT06429722 RECRUITING Major Depressive Episode Associated With Bipolar II Disorder DRUG: NMRA-335140 80 mg

NCT06367426 A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People https://clinicaltrials.gov/study/NCT06367426 RECRUITING Alzheimer Disease DRUG: DDN-A-0101 (SAD)

NCT05496426 A Study of KL130008 in Adults With Severe Alopecia Areata https://clinicaltrials.gov/study/NCT05496426 NOT_YET_RECRUITING Alopecia Areata DRUG: KL130008/Placebo Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

NCT06547957 A First-in-Human Study of EOS301984 as Monotherapy or Combination Therapy in Adult Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06547957 RECRUITING Advanced Solid Tumors DRUG: EOS301984

NCT04835857 Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices https://clinicaltrials.gov/study/NCT04835857 RECRUITING Hypertension

NCT03455725 CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial https://clinicaltrials.gov/study/NCT03455725 RECRUITING Refractory Angina

NCT05990725 Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT05990725 RECRUITING Atopic Dermatitis

NCT05033522 Immunotherapy for Advanced Liver Cancer https://clinicaltrials.gov/study/NCT05033522 RECRUITING Hepatocellular Carcinoma BIOLOGICAL: AlloStim¬Æ immunotherapy

NCT06630325 A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced, Recurrent Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer https://clinicaltrials.gov/study/NCT06630325 NOT_YET_RECRUITING Advanced Breast Carcinoma

NCT05926622 Clinical and Radiological Outcomes of Medacta Shoulder System FR https://clinicaltrials.gov/study/NCT05926622 RECRUITING Primary Osteoarthritis

NCT04859725 HyperSpectral Imaging in Low Grade Glioma https://clinicaltrials.gov/study/NCT04859725 RECRUITING Low Grade Glioma of Brain DEVICE: Hyperspectral Imaging with Snapscan camera Universitaire Ziekenhuizen KU Leuven Imec

NCT06334822 Randomised Controlled Trial for Assessing the Effectiveness of an Inclusive Heart Failure Monitoring and TRACKing Solution in the UK. https://clinicaltrials.gov/study/NCT06334822 RECRUITING Heart Failure DEVICE: Heartfelt Device installed

NCT04442022 A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) with or Without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma https://clinicaltrials.gov/study/NCT04442022 RECRUITING Relapsed/refractory Diffuse Large B-cell Lymphoma DRUG: Selinexor (combination therapy)

NCT06017622 Observational Study of THC Concentrations in Acute Cannabinoid Intoxication https://clinicaltrials.gov/study/NCT06017622 RECRUITING Acute Cannabinoid Intoxication Anebulo Pharmaceuticals

NCT05521022 Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis https://clinicaltrials.gov/study/NCT05521022 RECRUITING Amyloidosis; Systemic DRUG: AT-02

NCT06230822 Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF) https://clinicaltrials.gov/study/NCT06230822 RECRUITING Idiopathic Pulmonary Fibrosis DRUG: VUM02 Injection Wuhan Optics Valley Vcanbiopharma Co., Ltd.

NCT05423522 Clinical Safety and Efficacy Evaluation of NanoLithium¬Æ NP03 in Patients With Mild-to-severe Alzheimer's Disease https://clinicaltrials.gov/study/NCT05423522 RECRUITING Alzheimer's Disease DRUG: NanoLithium¬Æ NP03

NCT06127225 Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD) https://clinicaltrials.gov/study/NCT06127225 RECRUITING Non-Alcoholic Fatty Liver Disease (NAFLD) DRUG: Proliverenol

NCT06425926 Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06425926 RECRUITING Melanoma Stage IV

NCT06682572 A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese Patients https://clinicaltrials.gov/study/NCT06682572 RECRUITING Low Grade Serous Ovarian Cancer

NCT06687304 Light in Healthcare Environment (Ljus i sjukhusmilj√∂) https://clinicaltrials.gov/study/NCT06687304 NOT_YET_RECRUITING Sleep Quality

NCT05327972 DEgenerative ROtator Cuff Disease and Botulinum TOXin https://clinicaltrials.gov/study/NCT05327972 RECRUITING Degenerative Rotator Cuff Disease DRUG: The investigational medicinal product is incobotulinumtoxinA (XEOMIN¬Æ).

NCT06148272 A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension https://clinicaltrials.gov/study/NCT06148272 RECRUITING Healthy

NCT05952804 IVIG for Infection Prevention After CAR-T-Cell Therapy https://clinicaltrials.gov/study/NCT05952804 RECRUITING Lymphoma BIOLOGICAL: Immune Globulin Infusion (Human), 10% Solution

NCT06592872 Using Digital Health Technology to Prevent Bullying and Cyberbullying Among Elementary School Students https://clinicaltrials.gov/study/NCT06592872 NOT_YET_RECRUITING Bullying

NCT06065072 Comparative Study of the Tomey OA-2000, Tomey CASIA2, and the LenStar LS900 https://clinicaltrials.gov/study/NCT06065072 RECRUITING Cataract

NCT05203172 The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials https://clinicaltrials.gov/study/NCT05203172 RECRUITING Solid Tumors DRUG: Binimetinib only treatment

NCT03049072 Ion Therapy Patient Registry https://clinicaltrials.gov/study/NCT03049072 RECRUITING Ion Beam Radiation Therapy for Tumor Patients RADIATION: Protons and Carbon Ions EBG MedAustron GmbH

NCT04165772 Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors https://clinicaltrials.gov/study/NCT04165772 RECRUITING Rectal Adenocarcinoma

NCT04888104 Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients https://clinicaltrials.gov/study/NCT04888104 RECRUITING Adult Spinal Deformity

NCT06524804 A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined With Radiotherapy in Patients With Malignant Solid Tumors https://clinicaltrials.gov/study/NCT06524804 RECRUITING Solid Tumor, Adult DRUG: BY101298 Capsules

NCT04302272 STRIVE Post-Market Registry Study https://clinicaltrials.gov/study/NCT04302272 RECRUITING Emphysema DEVICE: Spiration Valve System (SVS) Olympus Corporation of the Americas

NCT06029972 Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis https://clinicaltrials.gov/study/NCT06029972 RECRUITING Ulcerative Colitis DRUG: Tilpisertib Fosmecarbil

NCT06493604 A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease https://clinicaltrials.gov/study/NCT06493604 RECRUITING Dry Eye Disease DRUG: Reproxalap Ophthalmic Solution (0.25%)

NCT01366404 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention https://clinicaltrials.gov/study/NCT01366404 RECRUITING Coronary Artery Disease Seung-Jung Park CardioVascular Research Foundation, Korea

NCT05649904 AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis https://clinicaltrials.gov/study/NCT05649904 RECRUITING Intraventricular Hemorrhage

NCT04829604 ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) https://clinicaltrials.gov/study/NCT04829604 RECRUITING HER2 Positive Metastatic Breast Cancer DRUG: ARX788 Ambrx, Inc.

NCT06424444 A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease https://clinicaltrials.gov/study/NCT06424444 RECRUITING Dry Eye Disease DRUG: Reproxalap ophthalmic solution (0.25%)

NCT06650644 A Study to Evaluate the Efficacy and Safety of Lactococcus Lactis KD10 Powder for Improving Autism Spectrum Symptoms in Children with Autism Spectrum Symptoms. https://clinicaltrials.gov/study/NCT06650644 RECRUITING Autism Spectrum Disorder OTHER: Placebo of Lactococcus lactis KD10

NCT06447844 OsteoGen Plug vs. Freeze-dried Bone Allograft With Collagen Barrier https://clinicaltrials.gov/study/NCT06447844 RECRUITING Nonterminal Premolar Needing Extraction DEVICE: OsteoGen Plug

NCT04042844 A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD) https://clinicaltrials.gov/study/NCT04042844 RECRUITING Lumbar Disc Disease BIOLOGICAL: BRTX-100

NCT06603844 First-in-human Study of CRB-601-01 to Treat Patients with Advanced Solid Tumor. https://clinicaltrials.gov/study/NCT06603844 NOT_YET_RECRUITING Solid Tumor DRUG: CRB-601 monoclonal antibody

NCT06597344 A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis) https://clinicaltrials.gov/study/NCT06597344 RECRUITING Urinary Tract Infections DRUG: Gepotidacin GlaxoSmithKline

NCT06668792 An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients with Relapsed/Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT06668792 NOT_YET_RECRUITING Relapsed/Refractory Multiple Myeloma DRUG: BCD-248 Biocad

NCT06631092 Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer https://clinicaltrials.gov/study/NCT06631092 RECRUITING Triple Negative Breast Cancer BIOLOGICAL: Oral DNA Vaccine NEC Bio B.V NEC Bio Therapeutics

NCT05838092 Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III) https://clinicaltrials.gov/study/NCT05838092 RECRUITING Epidermolysis Bullosa DRUG: allo-APZ2-OTS

NCT06524492 Flow Measurements in Functional CSF Shunts and Off-Shunt Locations With a Second-Generation Thermal Device https://clinicaltrials.gov/study/NCT06524492 RECRUITING Hydrocephalus DEVICE: FlowSense Rhaeos, Inc.

NCT06485492 Aneurysm Embolization System for Intracranial Aneurysms https://clinicaltrials.gov/study/NCT06485492 NOT_YET_RECRUITING Ruptured Cerebral Aneurysm PROCEDURE: Implant an aneurysm embolization system Jiangsu CED Medtech Co., Ltd

NCT05779592 A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma https://clinicaltrials.gov/study/NCT05779592 NOT_YET_RECRUITING Muscle-invasive Urothelial Carcinoma Bristol-Myers Squibb Ono Pharmaceutical Co. Ltd

NCT05563844 Study of Purinostat Mesylate for Injection in the Treatment of Diffuse Large B-cell Lymphoma (DLBCL) https://clinicaltrials.gov/study/NCT05563844 RECRUITING Diffuse Large B Cell LymphomaÔºåDLBCL DRUG: PM 8.4 mg/m2

NCT05632744 Evaluation of CG-100 Intraluminal Bypass Device https://clinicaltrials.gov/study/NCT05632744 RECRUITING Colorectal Cancer DEVICE: CG-100 Intraluminal Bypass Device Colospan Ltd.

NCT06442644 Live Music in the Intensive Care Unit https://clinicaltrials.gov/study/NCT06442644 NOT_YET_RECRUITING Stress

NCT03557944 Team Approach to Polypharmacy Evaluation and Reduction (Pharmacy) https://clinicaltrials.gov/study/NCT03557944 RECRUITING Multi-morbidity

NCT05771844 Home Sleep Therapy for Older Adults With MCI https://clinicaltrials.gov/study/NCT05771844 RECRUITING Mild Cognitive Impairment

NCT05882344 Cholinergic Deep Brain Stimulation for Alzheimer's Disease https://clinicaltrials.gov/study/NCT05882344 NOT_YET_RECRUITING Alzheimer Disease, Early Onset

NCT05682144 ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I https://clinicaltrials.gov/study/NCT05682144 RECRUITING Mucopolysaccharidosis IH/S

NCT05450744 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) https://clinicaltrials.gov/study/NCT05450744 RECRUITING Neoplastic Disease

NCT06579092 Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity https://clinicaltrials.gov/study/NCT06579092 RECRUITING Obesity or Overweight DRUG: AZD5004

NCT05918692 A Phase 1, Study of BMF-500 in Adults With Acute Leukemia https://clinicaltrials.gov/study/NCT05918692 RECRUITING Acute Myeloid Leukemia

NCT06081192 Partially-guided Protocol for Maxillary Overdentures Retained by Ti-Zr One-piece Mini Implants https://clinicaltrials.gov/study/NCT06081192 NOT_YET_RECRUITING Edentulous Jaw

NCT05399992 Study Evaluating Effectiveness and Adherence of Inclisiran Plus Standard of Care (SoC) Lipid-lowering Therapy Compared to SoC in ASCVD https://clinicaltrials.gov/study/NCT05399992 RECRUITING Primary Hypercholesterolemia

NCT02786589 Plasmodium Immunotherapy for Lung Cancer https://clinicaltrials.gov/study/NCT02786589 RECRUITING Lung Cancer, Nonsmall Cell BIOLOGICAL: Blood-stage infection of P. vivax State Key Laboratory of Respiratory Disease CAS Lamvac Biotech Co., Ltd.

NCT06648889 Isatuximab in Adult Patients with Cytologic or Molecular Relapsed/refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia https://clinicaltrials.gov/study/NCT06648889 RECRUITING T-ALL DRUG: Isatuximab

NCT06095089 A Study of JNJ-87189401 Plus JNJ-78278343 for Advanced Prostate Cancer https://clinicaltrials.gov/study/NCT06095089 RECRUITING Advanced Prostate Cancer DRUG: JNJ-78278343

NCT06703489 Safety and Performance Assessment of the Sphere-9‚Ñ¢ Catheter and Affera‚Ñ¢ Ablation System for the Treatment of Ventricular Tachycardia https://clinicaltrials.gov/study/NCT06703489 NOT_YET_RECRUITING Ventricular Tachycardia (VT) DEVICE: Sphere-9 Catheter with the Affera Mapping and Ablation System Medtronic Cardiac Rhythm and Heart Failure

NCT05851040 Observe the Effect of Wheatgrass and Tulsi Formulation or Individuals Taken With Other Allopathic Drugs https://clinicaltrials.gov/study/NCT05851040 NOT_YET_RECRUITING Blood Pressure, High

NCT06185244 Efficacy of Internet-delivered Trauma-focused CBT for Young People With PTSD https://clinicaltrials.gov/study/NCT06185244 RECRUITING Posttraumatic Stress Disorder BEHAVIORAL: Therapist-supported internet-delivered trauma-focused CBT

NCT06501144 Real-world Longitudinal Follow-up Study of a Digital Health Application in Erectile Dysfunction https://clinicaltrials.gov/study/NCT06501144 RECRUITING Erectile Dysfunction

NCT06644144 P4O2 ILD Extension https://clinicaltrials.gov/study/NCT06644144 NOT_YET_RECRUITING Interstitial Lung Disease

NCT06562192 Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers https://clinicaltrials.gov/study/NCT06562192 RECRUITING Pancreatic Ductal Adenocarcinoma

NCT04335292 Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge https://clinicaltrials.gov/study/NCT04335292 RECRUITING Non-Small Cell Lung Cancer DRUG: Osimertinib First-Line

NCT06464692 Study to Assess Adverse Events and How Intravenously (IV) Infused ABBV-400 Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal Cancer https://clinicaltrials.gov/study/NCT06464692 RECRUITING Colorectal Cancer DRUG: ABBV-400 AbbVie

NCT05986292 A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain https://clinicaltrials.gov/study/NCT05986292 RECRUITING Osteoarthritis, Knee

NCT06062992 Contrast-Enhanced Stereotactic Biopsy https://clinicaltrials.gov/study/NCT06062992 RECRUITING Breast Cancer

NCT05843292 Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer https://clinicaltrials.gov/study/NCT05843292 NOT_YET_RECRUITING Triple-negative Breast Cancer DRUG: Taxane and Carboplatin

NCT06264492 Delving Into Participation Trends of Scleroderma Clinical Trials https://clinicaltrials.gov/study/NCT06264492 NOT_YET_RECRUITING Scleroderma Power Life Sciences Inc.

NCT06575192 Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants https://clinicaltrials.gov/study/NCT06575192 RECRUITING Breast Reconstruction DEVICE: ARTIA Reconstructive Tissue Matrix

NCT06035744 CLN-617 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06035744 RECRUITING Advanced Solid Tumor DRUG: CLN-617

NCT06649344 A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes https://clinicaltrials.gov/study/NCT06649344 RECRUITING Type 2 Diabetes DRUG: HRS9531 Injection

NCT05844644 The Effects of the GOLO for Life¬Æ Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes https://clinicaltrials.gov/study/NCT05844644 RECRUITING Type 2 Diabetes

NCT02701244 A Registry Study of Breast Microseed Treatment https://clinicaltrials.gov/study/NCT02701244 RECRUITING Breast Neoplasms RADIATION: Permanent Breast Seed Implant (PBSI) Concure Oncology-Breast Microseed Inc.

NCT06398444 A Clinical Study to Evaluate the Safety and Efficacy of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms https://clinicaltrials.gov/study/NCT06398444 NOT_YET_RECRUITING Advanced Neuroendocrine Neoplasm DRUG: Lutetium[177Lu] Oxodotreotide Injection Sinotau Pharmaceutical Group

NCT05912244 A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma https://clinicaltrials.gov/study/NCT05912244 RECRUITING Melanoma DRUG: IO102/IO103

NCT05691244 Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke https://clinicaltrials.gov/study/NCT05691244 NOT_YET_RECRUITING Acute Ischemic Stroke

NCT04591392 Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD https://clinicaltrials.gov/study/NCT04591392 RECRUITING Heart Septal Defect

NCT06432192 A Prospective, Monocentric Clinical Study for the Validation of in Vitro Diagnostic Tests Developed by Firalis https://clinicaltrials.gov/study/NCT06432192 RECRUITING Genetic Health Risks DIAGNOSTIC_TEST: APO-Easy Firalis SA

NCT04972292 Fixed Dose Combination of COdeine + DIpyrone to Mitigate Moderate to Intense Pain Post-impacted Third Lower Molar Extraction https://clinicaltrials.gov/study/NCT04972292 RECRUITING Pain DRUG: FDC of codeine 30 mg/dipyrone 500 mg

NCT06601192 A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults https://clinicaltrials.gov/study/NCT06601192 RECRUITING RSV Infection

NCT03564340 Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers https://clinicaltrials.gov/study/NCT03564340 RECRUITING Recurrent Ovarian Cancer

NCT05918640 Lurbinectedin in FET-Fused Tumors https://clinicaltrials.gov/study/NCT05918640 RECRUITING Ewing Sarcoma

NCT06463340 Study of SGR-3515 In Participants With Advanced Solid Tumors. https://clinicaltrials.gov/study/NCT06463340 RECRUITING Advanced Solid Tumor DRUG: SGR-3515 Schr√∂dinger, Inc.

NCT03851640 A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC). https://clinicaltrials.gov/study/NCT03851640 RECRUITING MCRPC DRUG: HC-1119

NCT06637644 Impella RP Flex with Smart Assist https://clinicaltrials.gov/study/NCT06637644 RECRUITING Right Ventricular (RV) Dysfunction DEVICE: Right-sided ventricular assist device Abiomed Inc.

NCT06564844 A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Standard of Care, Following Complete Tumour Resection, in Participants With Stage I Adenocarcinoma NSCLC Who Are ctDNA-positive or Have High-risk Pathological Features https://clinicaltrials.gov/study/NCT06564844 RECRUITING Non-small Cell Lung Cancer DRUG: Datopotamab Deruxtecan

NCT06607744 Determine the Bioavailability of Selegiline TDS 6mg/24 Hours vs EMSAM in Healthy Subjects https://clinicaltrials.gov/study/NCT06607744 NOT_YET_RECRUITING MDD DRUG: Pharmacokinetic profiles of Selegiline TDS and EMSAM Corium Innovations, Inc.

NCT06527144 A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease https://clinicaltrials.gov/study/NCT06527144 RECRUITING Pulmonary Disease, Chronic Obstructive DRUG: 3mg TQC3721 Suspension for Inhalation

NCT06616844 IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers https://clinicaltrials.gov/study/NCT06616844 NOT_YET_RECRUITING Wound Heal

NCT05458544 [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application https://clinicaltrials.gov/study/NCT05458544 RECRUITING Metastatic Castration-resistant Prostate Cancer DRUG: [177Lu]Ludotadipep 3.7 GBq FutureChem

NCT04807244 Treatment of Deep Carious Lesions With Selective Caries Removal, Partial or Full Pulpotomy https://clinicaltrials.gov/study/NCT04807244 NOT_YET_RECRUITING Irreversible Pulpitis

NCT06363292 Study to Evaluate the Safety and Tolerability of PRO-231 Ophthalmic Solution Versus VIGAMOXI¬Æ on the Ocular Surface of Healthy Subjects. https://clinicaltrials.gov/study/NCT06363292 RECRUITING Ophthalmological Agent Toxicity

NCT05320692 A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT05320692 RECRUITING Hepatocellular Carcinoma DRUG: TACE+Camrelizumab+Apatinib mesylate

NCT04987892 Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH https://clinicaltrials.gov/study/NCT04987892 RECRUITING BPH DEVICE: UroLift System

NCT05670392 Laser and High Intensity Tesla Magnetic Stimulation (HITS) for Stress Urinary Incontinence (SUI) https://clinicaltrials.gov/study/NCT05670392 NOT_YET_RECRUITING Stress Urinary Incontinence DEVICE: laser and High intensity Tesla magnetic stimulation

NCT05923892 Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type https://clinicaltrials.gov/study/NCT05923892 RECRUITING Irritable Bowel Syndrome of Diarrhea Type (IBS-D) DRUG: OPS-2071

NCT03465592 Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma https://clinicaltrials.gov/study/NCT03465592 RECRUITING Sarcoma

NCT04655092 Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients https://clinicaltrials.gov/study/NCT04655092 RECRUITING Polycythemia Vera (PV) BIOLOGICAL: P1101 (Ropeginterferon alfa-2b) PharmaEssentia Japan K.K.

NCT04059640 PMCF Study of LiquiBand FIX8¬Æ OHMF Device https://clinicaltrials.gov/study/NCT04059640 RECRUITING Inguinal Hernia DEVICE: LiquiBand FIX8 Open Hernia Mesh Fixation Device Advanced Medical Solutions Ltd. Imarc Research, Inc.

NCT06655740 Safety, Tolerability, and Effectiveness of Duodenal Mucosal RF Vapor Ablation for Insulin Elimination in Type-2 Diabetes https://clinicaltrials.gov/study/NCT06655740 RECRUITING Diabetes Mellitus, Type 2 DEVICE: RF Vapor Ablation Aqua Medical, Inc.

NCT05995340 ELAPR002f Injectable Gel in the Treatment of Atrophic Acne Scars https://clinicaltrials.gov/study/NCT05995340 RECRUITING Atrophic Acne Scars DEVICE: ELAPR002f Injectable Gel

NCT06680440 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASC30 Tablets in Participants With Obesity https://clinicaltrials.gov/study/NCT06680440 RECRUITING Weight Management DRUG: ASC30

NCT06579144 Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A https://clinicaltrials.gov/study/NCT06579144 NOT_YET_RECRUITING Hemophilia A DRUG: Efanesoctocog alfa Swedish Orphan Biovitrum PSI CRO

NCT04907344 Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) https://clinicaltrials.gov/study/NCT04907344 NOT_YET_RECRUITING Triple Negative Breast Cancer DRUG: Camrelizumab

NCT03804944 Converting HR+ Breast Cancer Into an Individualized Vaccine https://clinicaltrials.gov/study/NCT03804944 RECRUITING Breast Cancer RADIATION: Focal Radiation therapy

NCT05947344 A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML) https://clinicaltrials.gov/study/NCT05947344 RECRUITING AML, Adult DRUG: STI-8591 Zhejiang ACEA Pharmaceutical Co. Ltd.

NCT05948592 Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection https://clinicaltrials.gov/study/NCT05948592 RECRUITING Diabetic Foot Infection BIOLOGICAL: TP-102

NCT06394492 SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer https://clinicaltrials.gov/study/NCT06394492 RECRUITING Ovarian Cancer DRUG: SHR-A1921

NCT06101992 Mesoglycan for Acute Hemorrhoidal Disease https://clinicaltrials.gov/study/NCT06101992 NOT_YET_RECRUITING Hemorrhoids DRUG: Mesoglycan

NCT04579692 MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia https://clinicaltrials.gov/study/NCT04579692 RECRUITING Trigeminal Neuralgia DEVICE: ExAblate Transcranial treatment University of Maryland, Baltimore Focused Ultrasound Foundation

NCT05733689 Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) https://clinicaltrials.gov/study/NCT05733689 NOT_YET_RECRUITING Gastroesophageal Adenocarcinoma DEVICE: ctDNA Blood Test

NCT04792489 DALY II USA/ MB-CART2019.1 for DLBCL https://clinicaltrials.gov/study/NCT04792489 RECRUITING Refractory Diffuse Large B Cell Lymphoma (DLBCL)

NCT04469140 Non Exudative AMD Imaged With SS-OCT- Extension https://clinicaltrials.gov/study/NCT04469140 RECRUITING Dry Macular Degeneration DEVICE: SS-OCT imaging Boston Image Reading Center

NCT05671640 Feasibility Study of the DragonFly-T System for Severe Tricuspid Regurgitation https://clinicaltrials.gov/study/NCT05671640 RECRUITING Tricuspid Regurgitation DEVICE: DragonFly-T Transcatheter Tricuspid Valve Repair System Hangzhou Valgen Medtech Co., Ltd

NCT04282044 Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies https://clinicaltrials.gov/study/NCT04282044 RECRUITING Solid Tumor, Adult

NCT06410092 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001 https://clinicaltrials.gov/study/NCT06410092 RECRUITING Solid Tumor DRUG: FTL001 Sound Biopharmaceuticals Ltd.

NCT06627244 Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma https://clinicaltrials.gov/study/NCT06627244 NOT_YET_RECRUITING Metastatic Uveal Melanoma

NCT06104592 Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL https://clinicaltrials.gov/study/NCT06104592 RECRUITING Large B-cell Lymphoma

NCT03919292 Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca https://clinicaltrials.gov/study/NCT03919292 RECRUITING Solid Tumor, Adult DRUG: Neratinib

NCT05197192 A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL https://clinicaltrials.gov/study/NCT05197192 RECRUITING Chronic Lymphocytic Leukemia DRUG: Obinutuzumab

NCT06566092 Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants https://clinicaltrials.gov/study/NCT06566092 RECRUITING Soft Tissue Sarcoma

NCT06244992 PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06244992 RECRUITING Locally Advanced or Metastatic Solid Tumors DRUG: PTT-936

NCT06377592 Development and Accuracy Evaluation of Gram Staining Analysis AI https://clinicaltrials.gov/study/NCT06377592 RECRUITING Bacterial Infections OTHER: Sample collection without intervention GramEye

NCT05880940 Comparing Different Rehabilitation Exercise Strategies for Improving Arm Recovery After Stroke https://clinicaltrials.gov/study/NCT05880940 RECRUITING Stroke DEVICE: Boost - Moveable Wheelchair Armrest

NCT06698640 A Trial of Text-Message-Based Engagement for Well-Child Visits https://clinicaltrials.gov/study/NCT06698640 NOT_YET_RECRUITING Well Child Visit

NCT04031040 A Post-market Clinical Follow up of the Genio‚Ñ¢ System for the Treatment of Obstructive Sleep Apnea in Adults https://clinicaltrials.gov/study/NCT04031040 RECRUITING Obstructive Sleep Apnea DEVICE: Genio(TM) system therapy Nyxoah S.A.

NCT05449444 Masitinib for the Treatment of Severe Mast Cell Activation Syndrome https://clinicaltrials.gov/study/NCT05449444 RECRUITING Mast Cell Activation Syndrome DRUG: Masitinib 4.5 mg/kg/day

NCT05830344 Effects of Multi Radiance Medical¬Æ Super Pulsed Laser on Chronic Knee Pain https://clinicaltrials.gov/study/NCT05830344 RECRUITING Knee Pain Chronic DEVICE: Placebo Multi Radiance Medical¬Æ Super Pulsed Laser

NCT06631144 A Spanish-language Caregiver-Enabled Care Program https://clinicaltrials.gov/study/NCT06631144 RECRUITING Dementia

NCT06029244 Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE) https://clinicaltrials.gov/study/NCT06029244 RECRUITING Delirium

NCT04271644 BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT04271644 RECRUITING Multiple Myeloma

NCT04900844 Safety and Efficacy of the CGuard‚Ñ¢ Carotid Stent System in Carotid Artery Stenting https://clinicaltrials.gov/study/NCT04900844 RECRUITING Carotid Artery Stenosis DEVICE: CGuard Carotid Stent implantation InspireMD

NCT06700044 Probiotic Supplementation During Pregnancy in Women With High-Risk Pregnancies https://clinicaltrials.gov/study/NCT06700044 NOT_YET_RECRUITING Preeclampsia

NCT06108492 A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC) https://clinicaltrials.gov/study/NCT06108492 RECRUITING Intermediate and High-risk Non-muscle Invasive Bladder Cancer DRUG: SHR-2005 Shanghai Hengrui Pharmaceutical Co., Ltd.

NCT04153292 The ENCIRCLE Trial https://clinicaltrials.gov/study/NCT04153292 RECRUITING Mitral Regurgitation

NCT04150640 Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma https://clinicaltrials.gov/study/NCT04150640 RECRUITING Esophageal Adenocarcinoma

NCT05620940 A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects. https://clinicaltrials.gov/study/NCT05620940 RECRUITING Opioid Dependence

NCT05715840 Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ¬± Bevacizumab Versus Placebo Plus Chemotherapy ¬±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS‚â•1) https://clinicaltrials.gov/study/NCT05715840 NOT_YET_RECRUITING Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS‚â•1) DRUG: SG001 injection

NCT05219240 Evaluation of Body Composition Improvement With Visceral Adiposity-Focused Anti-Obesity Telehealth Program https://clinicaltrials.gov/study/NCT05219240 RECRUITING Obesity

NCT05328440 Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02) https://clinicaltrials.gov/study/NCT05328440 RECRUITING Breast Neoplasms DRUG: Pyrotinib Maleate

NCT06555744 A Study of ZW191 in Participants With Solid Tumors https://clinicaltrials.gov/study/NCT06555744 RECRUITING Advanced Solid Tumors DRUG: ZW191 Zymeworks BC Inc.

NCT06667544 A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation https://clinicaltrials.gov/study/NCT06667544 NOT_YET_RECRUITING KRAS G12D Mutation DRUG: RNK08954-01 Ranok Therapeutics (Hangzhou) Co., Ltd.

NCT06312644 Study of Ultomiris¬Æ (Ravulizumab) Safety in Pregnancy https://clinicaltrials.gov/study/NCT06312644 RECRUITING Ultomiris-exposed Pregnant/ Postpartum

NCT04885244 Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery https://clinicaltrials.gov/study/NCT04885244 RECRUITING Adult Spinal Deformity

NCT06081244 NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III) https://clinicaltrials.gov/study/NCT06081244 RECRUITING Triple Negative Breast Cancer DRUG: Sacituzumab govitecan

NCT05964244 Impact of Noninvasive With Expiratory Washout on Respiratory Rate of Patients With Acute Hypercapnic Respiratory Failure https://clinicaltrials.gov/study/NCT05964244 NOT_YET_RECRUITING Noninvasive Ventilation DEVICE: Vela Investigational Mask

NCT06570044 Evaluation of PerioMonitor for Detection of Oral Inflammatory (OI) in Human Subjects in Medical Practice https://clinicaltrials.gov/study/NCT06570044 RECRUITING Oral Inflammation DIAGNOSTIC_TEST: PerioMonitor Oral Science International Inc.

NCT06503692 Scoring Balloon and High Pressure Balloon in the Treatment of Arteriovenous Graft Stenosis https://clinicaltrials.gov/study/NCT06503692 NOT_YET_RECRUITING Arteriovenous Graft Stenosis DEVICE: DKutting PTA Scoring Balloon Dilatation Catheter

NCT06238544 Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria https://clinicaltrials.gov/study/NCT06238544 RECRUITING Paroxysmal Nocturnal Hemoglobinuria DRUG: HRS-5965 tablets Chengdu Suncadia Medicine Co., Ltd.

NCT05688592 Usefulness of PET-CT for Invasive Fungal Infection https://clinicaltrials.gov/study/NCT05688592 RECRUITING Invasive Fungal Infections PROCEDURE: PET-CT Puerta de Hierro University Hospital Gilead Sciences

NCT05715892 Examining Patterns in the Involvement of Gastric Bypass Patients in Clinical Studies https://clinicaltrials.gov/study/NCT05715892 NOT_YET_RECRUITING Gastric Bypass

NCT06672692 A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients https://clinicaltrials.gov/study/NCT06672692 RECRUITING Influenza a

NCT05819892 Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer https://clinicaltrials.gov/study/NCT05819892 RECRUITING Endometrial Cancer DRUG: Paclitaxel

NCT06343792 Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease https://clinicaltrials.gov/study/NCT06343792 RECRUITING Steroid Refractory GVHD DRUG: RLS-0071 ReAlta Life Sciences, Inc. CTI Clinical Trial and Consulting Services

NCT06186492 A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1) https://clinicaltrials.gov/study/NCT06186492 RECRUITING Alpha-1 Antitrypsin Deficiency DRUG: WVE-006 Wave Life Sciences Ltd.

NCT05385692 A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors or Other Solid Tumors https://clinicaltrials.gov/study/NCT05385692 RECRUITING Locally Advanced or Metastatic Digestive Tract Tumors

NCT05774392 An Observational Study of Patients With Chronic Kidney Disease https://clinicaltrials.gov/study/NCT05774392 NOT_YET_RECRUITING Kidney Disease, Chronic

NCT05960292 Laparoscopic Versus Vaginal Approach Closure Complications https://clinicaltrials.gov/study/NCT05960292 RECRUITING Vaginal Vault Prolapse PROCEDURE: Laparoscopic and Vaginal Hysterectomy Egymedicalpedia

NCT06517992 Collaborative cOMMUNIty Care for Metastatic breAsT cancEr Patients in inDonesia (Communicated) https://clinicaltrials.gov/study/NCT06517992 NOT_YET_RECRUITING Metastatic Breast Cancer

NCT03825289 Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer https://clinicaltrials.gov/study/NCT03825289 RECRUITING Metastatic Pancreatic Carcinoma

NCT05704829 NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer https://clinicaltrials.gov/study/NCT05704829 RECRUITING HER2-positive Early Breast Cancer DRUG: Trastuzumab deruxtecan

NCT04354129 Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients with Primary and Secondary Immunodeficiency. https://clinicaltrials.gov/study/NCT04354129 RECRUITING Primary Immune Deficiency Disorder

NCT06239480 SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations https://clinicaltrials.gov/study/NCT06239480 RECRUITING Microcystic Lymphatic Malformation DRUG: QTORIN 3.9% Rapamycin Anhydrous Gel Palvella Therapeutics, Inc. FDA Office of Orphan Products Development

NCT04662580 ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer https://clinicaltrials.gov/study/NCT04662580 RECRUITING Metastatic Prostate Cancer DRUG: ARX517

NCT05992480 REVIVE (Response to the Ebola Virus Vaccine) https://clinicaltrials.gov/study/NCT05992480 NOT_YET_RECRUITING Ebola Virus Disease BIOLOGICAL: rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO) Tulane University Kenema Government Hospital

NCT05387980 A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis. https://clinicaltrials.gov/study/NCT05387980 RECRUITING Atopic Dermatitis DRUG: CIBINQO Pfizer

NCT05555680 Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients https://clinicaltrials.gov/study/NCT05555680 RECRUITING PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries OTHER: Ferriman-Gallwey Score Clinique Ovo

NCT06582589 HEALSea Nasal Spray for Prevention of Infections in Children https://clinicaltrials.gov/study/NCT06582589 NOT_YET_RECRUITING Healthy Subjects DEVICE: Healsea Children Lallemand Pharma AG

NCT05757089 Efficacy of the Dietary Food Supplement ALCOFILTRUM in Alleviating Alcohol Hangover Symptoms https://clinicaltrials.gov/study/NCT05757089 RECRUITING Alcohol Drinking

NCT06435429 A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer https://clinicaltrials.gov/study/NCT06435429 RECRUITING Metastatic HER2-positive Breast Cancer DRUG: Zanidatamab

NCT06617429 Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With AS https://clinicaltrials.gov/study/NCT06617429 NOT_YET_RECRUITING Angelman Syndrome DRUG: GTX-102

NCT06130280 A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer https://clinicaltrials.gov/study/NCT06130280 RECRUITING Colorectal Cancer

NCT06459180 A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20) https://clinicaltrials.gov/study/NCT06459180 RECRUITING Cervical Cancer BIOLOGICAL: Sacituzumab Tirumotecan

NCT06360380 Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System https://clinicaltrials.gov/study/NCT06360380 RECRUITING Chronic Heart Failure

NCT06064929 A Study of Felzartamab in Participants With Lupus Nephritis https://clinicaltrials.gov/study/NCT06064929 RECRUITING Lupus Nephritis DRUG: Felzartamab HI-Bio, A Biogen Company

NCT06677229 Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord Injury https://clinicaltrials.gov/study/NCT06677229 NOT_YET_RECRUITING Acute Spinal Cord Injury (SCI) DRUG: Eletriptan HBr 40 mg Technophage, SA VectorB2B

NCT05622929 Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control https://clinicaltrials.gov/study/NCT05622929 RECRUITING Cardiovascular Diseases

NCT06655129 Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder https://clinicaltrials.gov/study/NCT06655129 RECRUITING Excessive Hairiness

NCT05989529 Delving Into Borderline Personality Disorder Clinical Trial Experiences https://clinicaltrials.gov/study/NCT05989529 NOT_YET_RECRUITING Borderline Personality Disorder Power Life Sciences Inc.

NCT05895929 The Role of IL5 in Epithelial Cell Integrity https://clinicaltrials.gov/study/NCT05895929 RECRUITING Chronic Rhinosinusitis With Nasal Polyps

NCT05736029 Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics https://clinicaltrials.gov/study/NCT05736029 RECRUITING Non Small Cell Lung Cancer

NCT05698329 Effect of AIV007 by Periocular Administration in Subjects With nAMD or DME https://clinicaltrials.gov/study/NCT05698329 RECRUITING Neovascular Age-related Macular Degeneration

NCT04965129 Supplementation of n-3 PUFA in the Modulation of Lean Mass in Patients With Lung Cancer Receiving a High-protein Diet https://clinicaltrials.gov/study/NCT04965129 RECRUITING Lung Cancer DRUG: Placebo

NCT05686629 An Efficacy and Safety Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia https://clinicaltrials.gov/study/NCT05686629 NOT_YET_RECRUITING Novel COVID-19-Infected Pneumonia DRUG: Jaktinib hydrochloride tablets Suzhou Zelgen Biopharmaceuticals Co.,Ltd

NCT06183229 Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza https://clinicaltrials.gov/study/NCT06183229 RECRUITING Influenza

NCT05366829 Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT05366829 RECRUITING Carcinoma, Hepatocellular

NCT05505929 eUltra 10k - Biofreedom Ultra https://clinicaltrials.gov/study/NCT05505929 RECRUITING Post Market Clinical Follow up (PMCF) DEVICE: Biofreedom Ultra Biosensors Europe SA European Cardiovascular Research Center

NCT05050929 RAPid SimPLE Targeted Radiation Treatment for Brain Metastases https://clinicaltrials.gov/study/NCT05050929 RECRUITING Brain Metastases, Adult RADIATION: Targeting All Brain Metastases British Columbia Cancer Agency Varian Medical Systems

NCT03094429 An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen¬Æ, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults https://clinicaltrials.gov/study/NCT03094429 RECRUITING Refractory Schizophrenia DRUG: NaBen¬Æ

NCT04035629 129Xe MRI in Pediatric Population With BPD https://clinicaltrials.gov/study/NCT04035629 NOT_YET_RECRUITING Bronchopulmonary Dysplasia COMBINATION_PRODUCT: MagniXene, hyperpolarized 129Xe MRI Xemed LLC Children's Hospital of Philadelphia

NCT05982080 A Study to Investigate FP002 in Subjects With Advanced Malignancies https://clinicaltrials.gov/study/NCT05982080 RECRUITING Advanced Solid Tumor DRUG: FP002 Injection Guangdong Fapon Biopharma Inc.

NCT06338280 Remotely Observed Methadone Evaluation II https://clinicaltrials.gov/study/NCT06338280 NOT_YET_RECRUITING Opioid Use Disorder OTHER: Sonara Sonara Health

NCT06495229 Study of CM310 in Adolescent Subjects With Atopic Dermatis https://clinicaltrials.gov/study/NCT06495229 NOT_YET_RECRUITING Atopic Dermatitis BIOLOGICAL: CM310 Keymed Biosciences Co.Ltd

NCT06379529 The COPD CARE Study: Evaluating the Impact of a Virtual-First COPD Service on Major Cardiac and Respiratory Events https://clinicaltrials.gov/study/NCT06379529 NOT_YET_RECRUITING COPD Exacerbation

NCT05632380 ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM) https://clinicaltrials.gov/study/NCT05632380 RECRUITING Multiple Myeloma PROCEDURE: Autologous hematopoietic stem cell transplantation

NCT06712680 A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes https://clinicaltrials.gov/study/NCT06712680 RECRUITING Solid Tumor DRUG: Test Product HYP-6589 Sichuan Huiyu Pharmaceutical Co., Ltd

NCT06613880 Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia https://clinicaltrials.gov/study/NCT06613880 RECRUITING Aplastic Anemia

NCT04918680 Prospective Post-market Study Examining the Effectiveness of the EcoFit¬Æ https://clinicaltrials.gov/study/NCT04918680 NOT_YET_RECRUITING Degenerative Joint Disease

NCT06349980 A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 With or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients. https://clinicaltrials.gov/study/NCT06349980 NOT_YET_RECRUITING Carcinoma, Hepatocellular DRUG: HLX53 (1000mg)

NCT06014580 Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil https://clinicaltrials.gov/study/NCT06014580 RECRUITING Endometrial Cancer OTHER: Observational study Latin American Cooperative Oncology Group GlaxoSmithKline

NCT06213480 Next-Generation Synbiotic in Individuals With Overweight or Obesity https://clinicaltrials.gov/study/NCT06213480 NOT_YET_RECRUITING Overweight and Obesity DIETARY_SUPPLEMENT: Synbiotic Group

NCT05936580 Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery https://clinicaltrials.gov/study/NCT05936580 RECRUITING Hemophilia A DRUG: Nuwiq Octapharma

NCT06030180 CLUE: CLinical Utility Study of EsoGuard https://clinicaltrials.gov/study/NCT06030180 RECRUITING Barrett Esophagus

NCT06122389 SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma https://clinicaltrials.gov/study/NCT06122389 RECRUITING Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy DRUG: SHR2554; Chidamide analog tablets

NCT05438329 First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05438329 RECRUITING Advanced Solid Tumor DRUG: DB-1305/BNT325

NCT06290089 Pre-Study of Wild Type Enterotoxigenic E. Coli (ETEC) Strain for Verification of a Planned Challenge Dose https://clinicaltrials.gov/study/NCT06290089 RECRUITING ETEC Diarrhea OTHER: Enterotoxigenic E. coli (ETEC) strain Scandinavian Biopharma AB Johns Hopkins Bloomberg School of Public Health

NCT00825929 Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women. https://clinicaltrials.gov/study/NCT00825929 RECRUITING HIV Infections Radboud University Medical Center PENTA Foundation

NCT06608329 A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects https://clinicaltrials.gov/study/NCT06608329 NOT_YET_RECRUITING Healthy Adult Subject DRUG: HDM1002 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

NCT05223829 Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder https://clinicaltrials.gov/study/NCT05223829 RECRUITING PTSD

NCT04919980 TVMR With the Innovalve System Trial - Early Feasibility Study https://clinicaltrials.gov/study/NCT04919980 RECRUITING Mitral Valve Regurgitation (Degenerative or Functional) DEVICE: Innovalve MR system Innovalve Bio Medical Ltd.

NCT05680480 A Study of Telitacicept in Lupus Nephritis https://clinicaltrials.gov/study/NCT05680480 RECRUITING Lupus Nephritis BIOLOGICAL: Telitacicept 240 mg

NCT04263480 Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenstr√∂m's Macroglobulinemia https://clinicaltrials.gov/study/NCT04263480 RECRUITING Waldenstrom Macroglobulinemia DRUG: Carfilzomib + Ibrutinib

NCT05784480 Relevance of Reversible Causes During OHCA (Rebecca Study) https://clinicaltrials.gov/study/NCT05784480 RECRUITING Out-Of-Hospital Cardiac Arrest

NCT06314880 Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli) https://clinicaltrials.gov/study/NCT06314880 RECRUITING Healthy Volunteers BIOLOGICAL: Recombinant Meningococcal Group B Vaccine (E. Coli) (low-dose)

NCT05269680 STAR-LIFE: a Post-market Registry on MINIject https://clinicaltrials.gov/study/NCT05269680 RECRUITING Open Angle Glaucoma iSTAR Medical

NCT06569680 Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma https://clinicaltrials.gov/study/NCT06569680 RECRUITING Extranodal Marginal Zone Lymphoma DRUG: Mosunetuzumab Izidore Lossos, MD Genentech, Inc.

NCT06264180 VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3) https://clinicaltrials.gov/study/NCT06264180 RECRUITING Advanced Melanoma BIOLOGICAL: Vusolimogene Oderparepvec

NCT05651529 Acute Oral Ketones or Carbohydrate Supplement Modify Heart Function in Heart Failure? https://clinicaltrials.gov/study/NCT05651529 NOT_YET_RECRUITING Heart Failure DIETARY_SUPPLEMENT: exogenous ketone salt supplement

NCT06651229 A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms https://clinicaltrials.gov/study/NCT06651229 NOT_YET_RECRUITING Leukemia, Myeloid, Acute

NCT06375629 ES-HIFU, Prospective Data Collection of Patients Treated With Partial Gland HIFU Ablation for Prostate Cancer https://clinicaltrials.gov/study/NCT06375629 RECRUITING Prostate Cancer DEVICE: FocalOne EDAP TMS S.A.

NCT06137729 A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults https://clinicaltrials.gov/study/NCT06137729 RECRUITING Healthy DRUG: PF-07899895

NCT06378229 Psilocybin for Hospitalized Patients with Treatment-resistant Depression https://clinicaltrials.gov/study/NCT06378229 RECRUITING Treatment Resistant Depression DRUG: Psilocybin University Hospital, Ghent Filament Health Corp.

NCT06101329 Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) https://clinicaltrials.gov/study/NCT06101329 RECRUITING Pre-Exposure Prophylaxis of HIV Infection DRUG: Lenacapavir Tablet

NCT06022029 A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination with Cemiplimab in Patients with Advanced Solid Tumors and Lymphomas. https://clinicaltrials.gov/study/NCT06022029 RECRUITING Triple Negative Breast Cancer

NCT03692429 alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells https://clinicaltrials.gov/study/NCT03692429 RECRUITING Unresectable Metastatic Colorectal Cancer DRUG: CYAD-101

NCT03514329 Vapor Ablation for Localized Cancer Lesions https://clinicaltrials.gov/study/NCT03514329 NOT_YET_RECRUITING Non Small Cell Lung Cancer

NCT05892380 The Clinical Value of an Artificial Intelligence System Using Abbreviated Protocol of Breast MRI Facilitates Classification of Breast Lessions https://clinicaltrials.gov/study/NCT05892380 NOT_YET_RECRUITING Breast Cancer Fudan University Bayer

NCT05735080 Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer https://clinicaltrials.gov/study/NCT05735080 RECRUITING Breast Cancer

NCT06156280 A Clinical Study of TQH2929 in Healthy Adult Subjects https://clinicaltrials.gov/study/NCT06156280 RECRUITING Psoriasis DRUG: TQH2929 injection

NCT05599789 Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004) https://clinicaltrials.gov/study/NCT05599789 RECRUITING Non Small Cell Lung Cancer Metastatic DRUG: Pembrolizumab in Combination with Plinabulin and Docetaxel Peking Union Medical College Hospital BeyondSpring Pharmaceuticals Inc.

NCT05581589 Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer https://clinicaltrials.gov/study/NCT05581589 RECRUITING Muscle Invasive Bladder Carcinoma

NCT03671889 ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease https://clinicaltrials.gov/study/NCT03671889 RECRUITING Alzheimer Disease DEVICE: Blood Brain Barrier (BBB) Disruption InSightec

NCT06345729 A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant, Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ‚â•50% (MK-1084-004) https://clinicaltrials.gov/study/NCT06345729 RECRUITING Non-small Cell Lung Cancer DRUG: MK-1084

NCT05773729 Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia https://clinicaltrials.gov/study/NCT05773729 RECRUITING Œ≤-thalassemia GENETIC: BD211 Shanghai BDgene Co., Ltd. Shanghai Children's Medical Center

NCT06521229 Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study https://clinicaltrials.gov/study/NCT06521229 RECRUITING Uncontrolled Asthma AstraZeneca

NCT06249529 Airway Bypass - Safety and Feasibility Study https://clinicaltrials.gov/study/NCT06249529 RECRUITING Emphysema or COPD DEVICE: Airway Bypass Zoar Engelman

NCT05885529 Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to Exclude Lesions Linked to Significant Traumatic Brain Injuries https://clinicaltrials.gov/study/NCT05885529 NOT_YET_RECRUITING Traumatic Brain Injury OTHER: UCH-L1 GFAP Centre Hospitalier Princesse Grace BioM√©rieux

NCT05329129 OssDsign¬Æ Spine Registry Study ("Propel") https://clinicaltrials.gov/study/NCT05329129 RECRUITING Degenerative Disc Disease

NCT05069129 Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above https://clinicaltrials.gov/study/NCT05069129 RECRUITING COVID-19 Pneumonia

NCT04991129 The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer https://clinicaltrials.gov/study/NCT04991129 RECRUITING Advanced Hematologic Malignancies

NCT06306729 Computational Assessment of Bioprosthetic Aortic Valve Function https://clinicaltrials.gov/study/NCT06306729 NOT_YET_RECRUITING CFD

NCT06426680 A Study of the ILB-3101 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06426680 RECRUITING Advanced Solid Tumor BIOLOGICAL: ILB-3101 Innolake Biopharm

NCT05458180 CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma https://clinicaltrials.gov/study/NCT05458180 NOT_YET_RECRUITING Peripheral T-cell Lymphoma DRUG: Lposomal mitoxantrone hydrochloride,Cyclophosphamide,Vincristine,Etoposide and Prednisone(CMOEP) Tianjin Medical University Cancer Institute and Hospital CSPC Ouyi Pharmaceutical Co., Ltd.

NCT04121780 Growth Hormone Replacement Therapy for Retried Professional Football Players https://clinicaltrials.gov/study/NCT04121780 RECRUITING TBI (Traumatic Brain Injury)

NCT04212780 Dual Lead Thalamic Deep Brain Recording (DBR)-DBS Interface for Closed Loop Control of Severe Essential Tremor https://clinicaltrials.gov/study/NCT04212780 RECRUITING Essential Tremor DEVICE: Medtronic Summit Rechargable (RC)+S

NCT05681689 PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study https://clinicaltrials.gov/study/NCT05681689 RECRUITING Helicobacter Pylori Infection

NCT05693129 Pediatric Patients Aged 1 to 6 Years With APDS https://clinicaltrials.gov/study/NCT05693129 RECRUITING APDS DRUG: Leniolisib Pharming Technologies B.V. CMIC Co, Ltd. Japan

NCT06062329 SYMPHONY-PE Study for Treatment of Pulmonary Embolism https://clinicaltrials.gov/study/NCT06062329 RECRUITING Acute Pulmonary Embolism

NCT06140329 Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation https://clinicaltrials.gov/study/NCT06140329 RECRUITING Autosomal Dominant Optic Atrophy

NCT05829629 Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women https://clinicaltrials.gov/study/NCT05829629 RECRUITING HPV Infection

NCT06201429 A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscitation‚Ñ¢ (MTR‚Ñ¢) Therapy System for Removal of Excess Fluid in Subjects Who Have Had a Portion of Their Skull Removed to Expose the Dura/Brain and Require Drainage for Fluid Removal. https://clinicaltrials.gov/study/NCT06201429 NOT_YET_RECRUITING Clinical Need for Craniotomy or Craniectomy DEVICE: Mechanical Tissue Resuscitation (MTR‚Ñ¢) Renovo Concepts, Inc.

NCT06532929 Sport Surgery Products Outcomes - A Post-market Follow-up https://clinicaltrials.gov/study/NCT06532929 RECRUITING Sport Surgery DEVICE: Orthopaedic surgeries (ankle)

NCT05052229 Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF). https://clinicaltrials.gov/study/NCT05052229 RECRUITING Idiopathic Pulmonary Fibrosis DRUG: Nitric Oxide

NCT05972629 A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria https://clinicaltrials.gov/study/NCT05972629 RECRUITING Phenylketonuria DRUG: SAR444836 Sanofi

NCT06702280 Assessing the Safety of an IGY Supplement on the Gut Microbiome https://clinicaltrials.gov/study/NCT06702280 NOT_YET_RECRUITING Healthy

NCT05901480 An Investigator Initiated Study for OTOV101N+OTOV101C Injection https://clinicaltrials.gov/study/NCT05901480 RECRUITING DFNB9 GENETIC: OTOV101N+OTOV101C Injections Otovia Therapeutics

NCT06682780 A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours https://clinicaltrials.gov/study/NCT06682780 NOT_YET_RECRUITING Advanced Solid Tumor DRUG: LM-2417

NCT05650580 TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05650580 RECRUITING Non-Hodgkin's Lymphoma, Relapsed

NCT05733780 To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M https://clinicaltrials.gov/study/NCT05733780 NOT_YET_RECRUITING COVID-19

NCT06320080 Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma. https://clinicaltrials.gov/study/NCT06320080 RECRUITING Advanced Hepatocellular Carcinoma DRUG: TQB2223 injection

NCT06567080 JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases https://clinicaltrials.gov/study/NCT06567080 NOT_YET_RECRUITING B-cell Tumors

NCT06270680 Carotenoids for Collision Athletes https://clinicaltrials.gov/study/NCT06270680 NOT_YET_RECRUITING Head Injury

NCT06487429 Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer https://clinicaltrials.gov/study/NCT06487429 RECRUITING Gastric Cancer DRUG: Short range radiotherapy with sequential Disitamab Vedotin combined with S-1 and xindilizumab Wuhan Union Hospital, China RemeGen Co., Ltd.

NCT06388629 Epicardial Access Study With Rook https://clinicaltrials.gov/study/NCT06388629 RECRUITING Arrythmia DEVICE: Rook Epicardial Access Kit Circa Scientific, Inc.

NCT06317129 Clinical Feasibility Study of the BariTon‚Ñ¢ System in Obese Patients https://clinicaltrials.gov/study/NCT06317129 RECRUITING Obesity DEVICE: Endoscopic gastric restriction and biliodigestive diversion BariaTek Medical

NCT06128629 MAGNITUDE: a Phase 3 Study of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM) https://clinicaltrials.gov/study/NCT06128629 RECRUITING Transthyretin Amyloidosis (ATTR) with Cardiomyopathy BIOLOGICAL: NTLA-2001

NCT05706129 A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05706129 RECRUITING Clear Cell Renal Cell Cancer (ccRCC)

NCT06314529 Long-term Follow-up Study of BHC001 for TDT https://clinicaltrials.gov/study/NCT06314529 RECRUITING Thalassemia, Beta OTHER: Assessments Bioray Laboratories The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army

NCT05669729 A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velaglucerase Alfa (VPRIV) Home Infusion https://clinicaltrials.gov/study/NCT05669729 NOT_YET_RECRUITING Gaucher Disease Takeda

NCT05868629 Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05868629 RECRUITING Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors OTHER: Non-investigational Novartis Pharmaceuticals

NCT06313580 Spices for Cultivating a Healthy Gut Microbiome and Cardiometabolic Profile https://clinicaltrials.gov/study/NCT06313580 RECRUITING Cardiometabolic Syndrome OTHER: Yogurt with added Spices

NCT06248580 Find HDV and Determine Its Status in Turkey https://clinicaltrials.gov/study/NCT06248580 RECRUITING Chronic Hepatitis D Infection

NCT06300580 Study of Oral ABBV-932 Capsules to Evaluate Dopamine D2 and D3 Receptor Occupancy in Brain in Adult Healthy Volunteers https://clinicaltrials.gov/study/NCT06300580 RECRUITING Healthy Volunteers DRUG: ABBV-932 AbbVie

NCT05750589 Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections https://clinicaltrials.gov/study/NCT05750589 RECRUITING Retinal Disease DRUG: IRX-101

NCT05987189 Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung https://clinicaltrials.gov/study/NCT05987189 RECRUITING Lung Cancer DIAGNOSTIC_TEST: miLungDx Hummingbird Diagnostics

NCT04987489 A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease https://clinicaltrials.gov/study/NCT04987489 RECRUITING Sickle Cell Disease

NCT06422689 Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care https://clinicaltrials.gov/study/NCT06422689 RECRUITING Asthma DRUG: Albuterol and budesonide inhalation aerosol AstraZeneca Premier HealthCare Solutions Inc.

NCT06243029 A Study to Assess Multidomain Endpoints of an ECG Patch https://clinicaltrials.gov/study/NCT06243029 RECRUITING Acute Decompensated Heart Failure DEVICE: ECG Patch AstraZeneca

NCT05890729 A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis https://clinicaltrials.gov/study/NCT05890729 RECRUITING Pulmonary Sarcoidosis DRUG: XTMAB-16 or Placebo Xentria, Inc.

NCT05572229 Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma https://clinicaltrials.gov/study/NCT05572229 RECRUITING Multiple Myeloma DRUG: Teclistamab

NCT06007729 ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors https://clinicaltrials.gov/study/NCT06007729 RECRUITING Head and Neck Squamous Cell Carcinoma DRUG: HS-20093 Hansoh BioMedical R&D Company

NCT06046729 A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa https://clinicaltrials.gov/study/NCT06046729 RECRUITING Hidradenitis Suppurativa DRUG: Eltrekibart

NCT06062680 Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects https://clinicaltrials.gov/study/NCT06062680 NOT_YET_RECRUITING Adult Patients With Chronic Primary ITP

NCT04464980 Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD) https://clinicaltrials.gov/study/NCT04464980 RECRUITING Opioid Use Disorder (OUD) DRUG: SL-BUP

NCT06385080 A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck Cancer https://clinicaltrials.gov/study/NCT06385080 RECRUITING Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma BIOLOGICAL: Amivantamab

NCT00315380 Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis https://clinicaltrials.gov/study/NCT00315380 RECRUITING Eosinophilic Granulomatosis With Polyangiitis

NCT06373380 A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC) https://clinicaltrials.gov/study/NCT06373380 RECRUITING HPV16+ Squamous Cell Carcinoma DRUG: HB-200

NCT06292780 A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) https://clinicaltrials.gov/study/NCT06292780 RECRUITING Relapsed/Refractory Systemic Light Chain Amyloidosis DRUG: Linvoseltamab Regeneron Pharmaceuticals

NCT05996380 A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes https://clinicaltrials.gov/study/NCT05996380 RECRUITING T2DM DRUG: SHR-3167

NCT04803929 Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5) https://clinicaltrials.gov/study/NCT04803929 RECRUITING AML M4

NCT06675929 A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH https://clinicaltrials.gov/study/NCT06675929 NOT_YET_RECRUITING Compensated Liver Cirrhosis

NCT03340129 Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) https://clinicaltrials.gov/study/NCT03340129 RECRUITING Melanoma Stage Iv DRUG: Ipilimumab

NCT06382129 A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT06382129 RECRUITING Non-small Cell Lung Cancer DRUG: BL-B01D1

NCT06596980 Examining the Effect of a Digital Medical Device for Cognitive and Musical Training in Children with Reading Disabilities https://clinicaltrials.gov/study/NCT06596980 RECRUITING Learning Disorders, Specific

NCT05494580 Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer https://clinicaltrials.gov/study/NCT05494580 RECRUITING Ovarian Cancer

NCT05954780 Selinexor (Nexpovio¬Æ) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT05954780 RECRUITING Multiple Myeloma DRUG: Selinexor iOMEDICO AG Stemline Switzerland GmbH

NCT06175780 Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06175780 RECRUITING Neoplasms

NCT01542580 A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee https://clinicaltrials.gov/study/NCT01542580 RECRUITING Osteoarthritis

NCT06721962 Treatment of Moderate to Severe Refractory Crohn's Disease https://clinicaltrials.gov/study/NCT06721962 NOT_YET_RECRUITING Crohns Disease BIOLOGICAL: TRX103

NCT04391062 Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma https://clinicaltrials.gov/study/NCT04391062 RECRUITING Glioblastoma DRUG: Gliolan

NCT05526989 Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma https://clinicaltrials.gov/study/NCT05526989 RECRUITING Penile Carcinoma DRUG: Dostarlimab

NCT06453629 RCT to Evaluate Social Skills in Children with Autism Using VR Technology (SoCaVR) https://clinicaltrials.gov/study/NCT06453629 RECRUITING Autism Spectrum Disorder

NCT06539429 Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L https://clinicaltrials.gov/study/NCT06539429 NOT_YET_RECRUITING Osteoarthritis, Knee BIOLOGICAL: ANT-301 Anterogen Co., Ltd.

NCT06185829 Evaluating the Benefit of Hypnoanalgesia Versus Neuroleptanalgesia During Hand Surgery https://clinicaltrials.gov/study/NCT06185829 RECRUITING Hand Surgery DRUG: Neurloeptanalgesic treatment

NCT06331780 Refractive Status and Accommodation Response Under Different Experimental Conditions. https://clinicaltrials.gov/study/NCT06331780 RECRUITING Accommodation Disorder

NCT05169580 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FTX-6058 https://clinicaltrials.gov/study/NCT05169580 RECRUITING Sickle Cell Disease

NCT05546580 Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+) https://clinicaltrials.gov/study/NCT05546580 RECRUITING Acute Myeloid Leukemia, in Relapse

NCT05953480 A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke https://clinicaltrials.gov/study/NCT05953480 RECRUITING Acute Ischemic Stroke BIOLOGICAL: Redasemtide

NCT05655780 The Role of the Tumor Molecular Profile (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of the Intestinal Microbiota for Treatment Efficiency, Toxicity, Survival and Quality of Life in Patients With Metastatic or Unresectable Colorectal Cancer During Irinotecan-based Systemic Treatment https://clinicaltrials.gov/study/NCT05655780 RECRUITING Colorectal Neoplasms Maastricht University Medical Center Maastricht University

NCT04541680 Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis https://clinicaltrials.gov/study/NCT04541680 RECRUITING SARS-Cov-2 Induced Pulmonary Fibrosis DRUG: Nintedanib 150 MG [Ofev]

NCT06429280 Clinical Data Registry of Amblyopia Patients on Luminopia Treatment https://clinicaltrials.gov/study/NCT06429280 RECRUITING Amblyopia DEVICE: N/A this is an observational study of Standard of Care Luminopia

NCT06565780 Evaluation of the Performance and Safety of the Aktiia Spot-check Optical Blood Pressure Monitoring Device At Wrist Against Double Auscultation https://clinicaltrials.gov/study/NCT06565780 RECRUITING Hypertension DEVICE: Device under test evaluation against references Aktiia SA

NCT06262880 Dietary Supplementation on Gastrointestinal Barrier Function https://clinicaltrials.gov/study/NCT06262880 RECRUITING Intestinal Permeability DIETARY_SUPPLEMENT: plant derived phenolics

NCT05907980 A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors https://clinicaltrials.gov/study/NCT05907980 RECRUITING Solid Tumor DRUG: ROSE12

NCT05191680 TherApeutics in Early ProState Cancer (TAPS02) https://clinicaltrials.gov/study/NCT05191680 RECRUITING Prostate Cancer DRUG: Apalutamide Oral Tablet [Erleada]

NCT04640480 Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors https://clinicaltrials.gov/study/NCT04640480 NOT_YET_RECRUITING Colorectal Cancer

NCT04257162 HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a) https://clinicaltrials.gov/study/NCT04257162 RECRUITING Metastatic Cancer OTHER: Tumor and Blood sample collection SOLTI Breast Cancer Research Group Daiichi Sankyo

NCT05624580 A Study to Look at Safety and Tolerability of NNC0582-0001, How it is Transported Throughout the Body and How it Works in Healthy Adults https://clinicaltrials.gov/study/NCT05624580 RECRUITING Healthy Volunteers DRUG: NNC0582-0001

NCT06600789 A Modular Phase 1/2 Study with CT7439 in Participants with Solid Malignancies https://clinicaltrials.gov/study/NCT06600789 RECRUITING Solid Malignancies DRUG: CT7439 Capsules (0.5 mg, 1mg, 3mg) Carrick Therapeutics Limited

NCT06065189 Base-edited Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With Œ≤-thalassemia Major https://clinicaltrials.gov/study/NCT06065189 RECRUITING Beta-Thalassemia BIOLOGICAL: CS-101 injection Children's Hospital of Fudan University CorrectSequence Therapeutics Co., Ltd

NCT05193929 A Clinical Investigation Evaluating Wound Closure With OptiPulse‚Ñ¢ Versus SOC in the Treatment of Non-Healing DFU's https://clinicaltrials.gov/study/NCT05193929 RECRUITING Diabetic Foot Ulcer DEVICE: OptiPulse‚Ñ¢

NCT06010329 A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC https://clinicaltrials.gov/study/NCT06010329 RECRUITING Non-small Cell Lung Cancer DRUG: Sutetinib Maleate Capsule Teligene US

NCT06471829 A Trial of Lu AG13909 in Adult Participants With Cushing's Disease https://clinicaltrials.gov/study/NCT06471829 RECRUITING Cushing's Disease DRUG: Lu AG13909 H. Lundbeck A/S

NCT04356729 A Phase II Trial of PD-L1 Therapy Combined with Anti-VEGF Therapy in Unresectable or Metastatic Melanoma https://clinicaltrials.gov/study/NCT04356729 RECRUITING Clinical Stage III Cutaneous Melanoma AJCC V8

NCT03821129 GORE¬Æ CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study https://clinicaltrials.gov/study/NCT03821129 RECRUITING Stroke

NCT06093880 Observational, Prospective Clinical Investigation on Mini 4 Ready Intraocular Lens https://clinicaltrials.gov/study/NCT06093880 RECRUITING Cataract DEVICE: monofocal intraocular lens SIFI SpA

NCT02555280 Coflex PS3 Actual Conditions for Use Study https://clinicaltrials.gov/study/NCT02555280 RECRUITING Spinal Stenosis Lumbar DEVICE: coflex¬Æ Interlaminar Technology

NCT05363280 Phase 2 Safety and Efficacy Evaluation of AL8326 in ‚â•2nd Line SCLC https://clinicaltrials.gov/study/NCT05363280 RECRUITING Small Cell Lung Cancer DRUG: AL8326 low dose group

NCT06223880 A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms https://clinicaltrials.gov/study/NCT06223880 RECRUITING Major Depressive Disorder DRUG: AXS-05

NCT05217680 Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema https://clinicaltrials.gov/study/NCT05217680 RECRUITING Diabetic Macular Edema BIOLOGICAL: Bevacizumab

NCT05457829 Doxorubicin Hydrochloride Liposome Combined With Irinotecan Versus VIT Regimen in the Treatment of Pediatric Rhabdomyosarcoma https://clinicaltrials.gov/study/NCT05457829 NOT_YET_RECRUITING Rhabdomyosarcoma, Child DRUG: Doxorubicin Hydrochloride Liposome+Irinotecan

NCT02675829 Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers https://clinicaltrials.gov/study/NCT02675829 RECRUITING Solid Tumor Cancers

NCT06659029 Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users https://clinicaltrials.gov/study/NCT06659029 NOT_YET_RECRUITING Systemic Lupus Erythematosus DRUG: Anifrolumab AstraZeneca PPD DEVELOPMENT, LP

NCT05544929 A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers https://clinicaltrials.gov/study/NCT05544929 RECRUITING Carcinoma, Non-Small-Cell Lung

NCT05838729 Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer https://clinicaltrials.gov/study/NCT05838729 RECRUITING Head Neck Cancer

NCT04875429 Zenith¬Æ Fenestrated+ Clinical Study https://clinicaltrials.gov/study/NCT04875429 RECRUITING Aortic Aneurysm, Abdominal

NCT04412629 Cabozantinib in High Grade Neuroendocrine Neoplasms https://clinicaltrials.gov/study/NCT04412629 RECRUITING High Grade Neuroendocrine Neoplasms DRUG: Cabozantinib

NCT04558229 RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users https://clinicaltrials.gov/study/NCT04558229 RECRUITING Birth Control

NCT03168529 Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit https://clinicaltrials.gov/study/NCT03168529 RECRUITING Heart Failure DRUG: Ivabradine

NCT05465629 Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Conditions https://clinicaltrials.gov/study/NCT05465629 RECRUITING Gastrointestinal Health COMBINATION_PRODUCT: VIOME Precision Nutrition Program

NCT05232929 Long-Term Follow-Up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) https://clinicaltrials.gov/study/NCT05232929 RECRUITING Spinal Muscular Atrophy DRUG: Risdiplam Genentech, Inc.

NCT06674980 Randomized Trial Assessing Human Placental Membrane Products and Standard of Care (SOC) vs SOC Alone in Nonhealing Diabetic Foot Ulcers https://clinicaltrials.gov/study/NCT06674980 NOT_YET_RECRUITING Pathologic Processes

NCT06377280 En Evaluation of Navina Mini, a New Low-volume Transanal Irrigation Device. https://clinicaltrials.gov/study/NCT06377280 RECRUITING Bowel Dysfunction DEVICE: Navina Mini Wellspect HealthCare

NCT05361980 Pediatric Orthopaedic Implant Safety & Efficacy https://clinicaltrials.gov/study/NCT05361980 RECRUITING Fracture

NCT06178289 Effectiveness of 3M Cavilon Advanced Skin Protectant in the Treatment of Moisture-associated Skin Damage in Hospitals https://clinicaltrials.gov/study/NCT06178289 NOT_YET_RECRUITING Irritant Dermatitis

NCT06533189 Developing a Whole-body MRI and Diffusion-weighted Imaging State-of-the-art Protocol: a Pilot Study https://clinicaltrials.gov/study/NCT06533189 NOT_YET_RECRUITING Whole Body Imaging

NCT04369729 Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache https://clinicaltrials.gov/study/NCT04369729 RECRUITING Post-Traumatic Headache Mayo Clinic University of Arizona

NCT05971329 Pilot Study of ZetaFuse‚Ñ¢ Bone Graft for the Treatment of Cervical Degenerative Disc Disease https://clinicaltrials.gov/study/NCT05971329 RECRUITING Radiculopathy, Cervical

NCT06462729 LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF) https://clinicaltrials.gov/study/NCT06462729 RECRUITING Degenerative Disc Disease

NCT05802329 Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME) https://clinicaltrials.gov/study/NCT05802329 NOT_YET_RECRUITING Center Involved Diabetic Macular Edema

NCT05252429 Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT05252429 RECRUITING Effect of Drug DRUG: Docetaxel

NCT05556629 A Survey to Assess Participants' and Physicians' Knowledge, Attitudes and Behavior When Using NATPARA https://clinicaltrials.gov/study/NCT05556629 RECRUITING Hypoparathyroidism OTHER: No Intervention Shire Takeda Development Center Americas, Inc.

NCT06545929 Study of Sunobinop on Craving in Alcohol Use Disorder https://clinicaltrials.gov/study/NCT06545929 NOT_YET_RECRUITING Alcohol Use Disorder DRUG: Sunobinop

NCT06614829 Patient Reported Experiences and Outcomes Associated with Standard C-Section Wound Closure Versus STRATAFIX/DERMABOND PRINEO Wound Closure (CS-PREO) https://clinicaltrials.gov/study/NCT06614829 RECRUITING Cesarean Section; Complications, Wound, Infection (Following Delivery) DEVICE: Stratafix Suture

NCT05673629 Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer https://clinicaltrials.gov/study/NCT05673629 RECRUITING Breast Cancer DRUG: Utidelone Injection in combination with AC

NCT05946629 SELUTION 4 De Novo Small Vessel IDE Trial https://clinicaltrials.gov/study/NCT05946629 RECRUITING Coronary Artery Disease DEVICE: PCI with SELUTION SLR DCB

NCT06115980 Safety and Preliminary Performance of Xtrac O.S. System for Lead Extraction. https://clinicaltrials.gov/study/NCT06115980 RECRUITING Bradycardia DEVICE: lead extraction (Xtrac O.S. system) Xtrac O.S. KCRI

NCT05884580 Neuflo System for the Treatment of BPH https://clinicaltrials.gov/study/NCT05884580 RECRUITING Benign Prostatic Hyperplasia

NCT06694480 Study of FID-022 in Participants with Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06694480 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: FID-022 Fulgent Pharma LLC.

NCT05004129 Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy https://clinicaltrials.gov/study/NCT05004129 RECRUITING Congenital Myotonic Dystrophy DRUG: Tideglusib AMO Pharma Limited

NCT05919329 Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy https://clinicaltrials.gov/study/NCT05919329 RECRUITING Castration Resistant Prostate Cancer

NCT06496880 A Study to Evaluate the Efficacy of OxyjunTM on Cardiac Pumping Capacity as Well as Work Productivity in Individuals With Metabolic Risk. https://clinicaltrials.gov/study/NCT06496880 NOT_YET_RECRUITING Metabolic Disorder DIETARY_SUPPLEMENT: Oxyjun TM

NCT06444880 Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies https://clinicaltrials.gov/study/NCT06444880 RECRUITING SMARCB1-Deficient Malignancies DRUG: Ubamatamab

NCT06391580 A Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit https://clinicaltrials.gov/study/NCT06391580 NOT_YET_RECRUITING Jawline Contour Deficit DEVICE: Poly-L-lactin Acid (PLLA) Based Facial Injectable Sinclair Pharmaceuticals Limited

NCT05771480 Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) https://clinicaltrials.gov/study/NCT05771480 RECRUITING Biliary Tract Cancer BIOLOGICAL: Durvalumab

NCT04409080 REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy https://clinicaltrials.gov/study/NCT04409080 RECRUITING Severe Aplastic Anemia (SAA) DRUG: REGN7257 Regeneron Pharmaceuticals

NCT05035862 Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma https://clinicaltrials.gov/study/NCT05035862 RECRUITING Asthma DRUG: Albuterol Sulfate

NCT04557462 A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy https://clinicaltrials.gov/study/NCT04557462 RECRUITING Primary IgA Nephropathy DRUG: LNP023 Novartis Pharmaceuticals

NCT02586389 Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay https://clinicaltrials.gov/study/NCT02586389 RECRUITING Non-hematologic Cancer Sequenom, Inc.

NCT05062889 Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients https://clinicaltrials.gov/study/NCT05062889 RECRUITING Stage II Colon Cancer

NCT06661889 OM2 Low Saturation Verification https://clinicaltrials.gov/study/NCT06661889 NOT_YET_RECRUITING Hypoxia Medtronic - MITG

NCT03399929 Traumatic Brain Injury and Stroke Long Term Outcome https://clinicaltrials.gov/study/NCT03399929 RECRUITING Traumatic Brain Injury

NCT04888429 Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma https://clinicaltrials.gov/study/NCT04888429 RECRUITING Sarcomatoid Carcinoma of Lung DRUG: Camrelizumab

NCT06551129 Real-world Patient Reported Outcomes Among Patients Treated With Camzyos https://clinicaltrials.gov/study/NCT06551129 RECRUITING Obstructive Hypertrophic Cardiomyopathy DRUG: Mavacamten Bristol-Myers Squibb

NCT06041529 Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension https://clinicaltrials.gov/study/NCT06041529 RECRUITING Essential Hypertension DRUG: Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg

NCT04477629 Belatacept in De Novo Heart Transplantation https://clinicaltrials.gov/study/NCT04477629 RECRUITING Heart Transplantation DRUG: Belatacept

NCT06417229 Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants https://clinicaltrials.gov/study/NCT06417229 RECRUITING Healthy Participants DRUG: BMS-986365

NCT05795829 Ultrasound Ablation for Essential HypertensionÔºàFIMÔºâ https://clinicaltrials.gov/study/NCT05795829 RECRUITING Uncontrolled Essential Hypertension DEVICE: disposable intravascular ultrasound ablation catheter and ultrasound ablation instrument Lepu Medical Technology (Beijing) Co., Ltd.

NCT06633029 Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry https://clinicaltrials.gov/study/NCT06633029 NOT_YET_RECRUITING Acute Renal Failure (ARF)

NCT05801029 A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations https://clinicaltrials.gov/study/NCT05801029 RECRUITING Non-Small Cell Lung Cancer (NSCLC) DRUG: Osimertinib

NCT06194929 Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma https://clinicaltrials.gov/study/NCT06194929 RECRUITING Melanoma DRUG: Defactinib

NCT04743180 European All-comers' Multicentric Prospective REGISTRY on LUMINOR¬© Drug Eluting Balloon in the Superficial Femoral Artery and Popliteal Artery With 5 Years Follow-up. https://clinicaltrials.gov/study/NCT04743180 RECRUITING Angioplasty

NCT06481280 Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA. https://clinicaltrials.gov/study/NCT06481280 NOT_YET_RECRUITING Cow's Milk Allergy DIETARY_SUPPLEMENT: Test Formula

NCT05653180 IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract Cancer https://clinicaltrials.gov/study/NCT05653180 RECRUITING Advanced Biliary Tract Cancer DRUG: IBI310

NCT06054880 Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency https://clinicaltrials.gov/study/NCT06054880 RECRUITING Ureter Injury DRUG: Indigotindisulfonate sodium 0.8%

NCT04836780 DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia https://clinicaltrials.gov/study/NCT04836780 RECRUITING COVID-19

NCT05251480 Examining the Effectiveness of DermGEN‚Ñ¢ in the Treatment of Diabetic Foot Ulcers in First Nations People https://clinicaltrials.gov/study/NCT05251480 NOT_YET_RECRUITING Diabetes Mellitus

NCT06662162 Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration https://clinicaltrials.gov/study/NCT06662162 NOT_YET_RECRUITING Age-Related Macular Degeneration

NCT02703662 Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction https://clinicaltrials.gov/study/NCT02703662 RECRUITING Ventral Hernia DEVICE: Strattice biologic mesh

NCT03886662 A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) https://clinicaltrials.gov/study/NCT03886662 RECRUITING Myelodysplastic Syndromes DRUG: LB-100 Lixte Biotechnology Holdings, Inc.

NCT05906862 AMT-253 in Patients With Selected Advanced Solid Tumours https://clinicaltrials.gov/study/NCT05906862 RECRUITING Advanced Solid Tumor DRUG: AMT-253 Multitude Therapeutics (Australia) Pty Ltd

NCT05406362 Assess Safety and Efficacy of VAD044 in HHT Patients https://clinicaltrials.gov/study/NCT05406362 RECRUITING Hereditary Hemorrhagic Telangiectasia (HHT) DRUG: VAD044 Vaderis Therapeutics AG

NCT05464329 Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Autologous Stem Cell Transplant-Eligible Patients With Relapsed/Refractory Aggressive B Cell Lymphoma https://clinicaltrials.gov/study/NCT05464329 RECRUITING Diffuse Large B Cell Lymphoma

NCT03368729 Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer https://clinicaltrials.gov/study/NCT03368729 RECRUITING Metastatic Breast Cancer

NCT05702229 Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma https://clinicaltrials.gov/study/NCT05702229 RECRUITING Gastric Cancer DRUG: Rilvegostomig

NCT06141980 Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus https://clinicaltrials.gov/study/NCT06141980 NOT_YET_RECRUITING T2DM (Type 2 Diabetes Mellitus) DRUG: DWP16001 0.3 mg Daewoong Pharmaceutical Co. LTD.

NCT03619980 A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death https://clinicaltrials.gov/study/NCT03619980 RECRUITING Prostate Cancer OTHER: No intervention Astellas Pharma Europe Ltd.

NCT06121180 Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma https://clinicaltrials.gov/study/NCT06121180 RECRUITING Metastatic Uveal Melanoma DRUG: ZIV-Aflibercept

NCT06699680 Phase 1 Study of PRX019 in Healthy Adult Volunteers https://clinicaltrials.gov/study/NCT06699680 RECRUITING Healthy Participants Study DRUG: PRX019

NCT06001580 A Phase I Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06001580 RECRUITING Advanced Solid Tumor DRUG: BR101 BioRay Pharmaceutical Co., Ltd.

NCT06455280 A Study of SIPLIZUMAB in AILD and LT Patients https://clinicaltrials.gov/study/NCT06455280 RECRUITING Autoimmune Liver Disease

NCT05263180 A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors. https://clinicaltrials.gov/study/NCT05263180 RECRUITING Advanced Solid Tumor BIOLOGICAL: EMB-09 Shanghai EpimAb Biotherapeutics Co., Ltd.

NCT06208462 Neoadjuvant Therapy of HAICÔºàGEMOXÔºâ Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors https://clinicaltrials.gov/study/NCT06208462 RECRUITING Intrahepatic Cholangiocarcinoma DRUG: Adebrelimab

NCT05204862 Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05204862 RECRUITING Advanced Solid Tumor DRUG: TU2218

NCT06066346 A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy https://clinicaltrials.gov/study/NCT06066346 RECRUITING Multiple Myeloma DRUG: Talquetamab Memorial Sloan Kettering Cancer Center Janssen Pharmaceuticals

NCT06612346 Minimally Invasive Nasal Trabeculostomy: Long-Term Follow-Up Extension Study https://clinicaltrials.gov/study/NCT06612346 RECRUITING Open Angle Glaucoma DEVICE: Minimally Invasive Micro Trabeculostomy Sanoculis Ltd

NCT06414746 Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in Russia https://clinicaltrials.gov/study/NCT06414746 RECRUITING Hereditary Transthyretin Amyloidosis

NCT05801146 Evaluate the Safety and Efficacy of HG102 as Compared to Botox¬Æ in Subject With Moderate to Severe Glabellar Lines https://clinicaltrials.gov/study/NCT05801146 RECRUITING Glabellar Lines DRUG: Botulinum Toxin Type A Injection [HG102]

NCT06055946 Symmcora¬Æ Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy https://clinicaltrials.gov/study/NCT06055946 RECRUITING Prostate Cancer DEVICE: robotic assisted radical prostatectomy Aesculap AG B.Braun Surgical SA

NCT05938569 Computer-Assisted Hair Restoration Study Using ARTAS System https://clinicaltrials.gov/study/NCT05938569 RECRUITING Androgenic Alopecia DEVICE: Hair restoration Venus Concept

NCT06067269 Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients with Prostate Cancer, HEATWAVE Trial https://clinicaltrials.gov/study/NCT06067269 RECRUITING Prostate Adenocarcinoma

NCT05441046 Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT05441046 RECRUITING Malignant Solid Tumors DRUG: Genakumab Changchun GeneScience Pharmaceutical Co., Ltd.

NCT04912869 A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD). https://clinicaltrials.gov/study/NCT04912869 RECRUITING Sickle Cell Disease DRUG: Crovalimab

NCT06143046 A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers https://clinicaltrials.gov/study/NCT06143046 RECRUITING Respiratory Syncytial Virus BIOLOGICAL: mRNA-1345

NCT04906746 Ruxolitinib for Cancer Cachexia https://clinicaltrials.gov/study/NCT04906746 RECRUITING Stage IV Non-small Cell Lung Cancer

NCT05823246 Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma https://clinicaltrials.gov/study/NCT05823246 RECRUITING Melanoma

NCT06271746 Treatment of Fibromyalgia With the FibroNova Neuromodulation Device https://clinicaltrials.gov/study/NCT06271746 RECRUITING Fibromyalgia DEVICE: FibroNova (Active mode)

NCT05615246 Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP) https://clinicaltrials.gov/study/NCT05615246 RECRUITING Osteoarthritis Shoulder

NCT04591938 FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study https://clinicaltrials.gov/study/NCT04591938 RECRUITING Percutaneous Coronary Intervention

NCT06502938 A Clinical Trial Evaluating the Pan-vascular Interventional Robotic System for Panvascularization Interventional Surgery https://clinicaltrials.gov/study/NCT06502938 NOT_YET_RECRUITING Percutaneous Coronary Intervention DEVICE: Pan-vascular interventional robotic system

NCT04486638 Dengvaxia US Pregnancy Registry https://clinicaltrials.gov/study/NCT04486638 RECRUITING Dengue Virus Infection BIOLOGICAL: Dengue Tetravalent Vaccine, Live Sanofi Pasteur, a Sanofi Company

NCT04407338 Efficacy and Tolerance Study of B-DYN Versus Conventional Fusion in the Treatment of Lumbar Stenosis on the Degree of Post-operative Functional Incapacity (BDYNCLIN) https://clinicaltrials.gov/study/NCT04407338 RECRUITING Degenerative Lumbar Spinal Stenosis DEVICE: B-DYN

NCT04827238 Standardized Invasive Hemodynamics for Elevated Gradients Post TAVR (DISCORDANCE TAVR) https://clinicaltrials.gov/study/NCT04827238 RECRUITING Aortic Stenosis

NCT06470438 A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT06470438 RECRUITING Lymphoma, Non-Hodgkin

NCT05726838 The Belgian REAL (BE.REAL) Registry https://clinicaltrials.gov/study/NCT05726838 RECRUITING Atherosclerotic Cardiovascular Disease OTHER: Inclisiran Novartis Pharmaceuticals

NCT06276738 The LINFU¬Æ U.S. Registry in Patients With Clinical Signs and/or Symptoms of Disease https://clinicaltrials.gov/study/NCT06276738 NOT_YET_RECRUITING Pancreatic Cancer

NCT06521190 ACOU085 for Hearing Loss Prevention in Testicular Cancer Patients Receiving Cisplatin https://clinicaltrials.gov/study/NCT06521190 RECRUITING Cisplatin-induced Hearing Loss DRUG: ACOU085 (bimokalner)

NCT06547138 Pilot Study on the Effectiveness and Safety of OPTILENE¬Æ SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH) https://clinicaltrials.gov/study/NCT06547138 NOT_YET_RECRUITING Abdominal Aortic Aneurysm

NCT06718738 Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer https://clinicaltrials.gov/study/NCT06718738 RECRUITING Colorectal Cancer (CRC) BIOLOGICAL: IM96 CAR-T Cells Beijing Immunochina Medical Science & Technology Co., Ltd. Peking University Cancer Hospital & Institute

NCT04065438 Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER¬Æ LA-15 System https://clinicaltrials.gov/study/NCT04065438 RECRUITING Focal Segmental Glomerulosclerosis DEVICE: LIPOSORBER¬Æ LA-15 Kaneka Medical America LLC

NCT06228638 CognivAiD Real-World Evidence Clinical Registry (CONNECT Registry) https://clinicaltrials.gov/study/NCT06228638 RECRUITING Memory Impairment

NCT06674538 Clinical Trial to Treat Stage IV Cancer Patients https://clinicaltrials.gov/study/NCT06674538 NOT_YET_RECRUITING Soft Tissue Cancer DRUG: Moonshot antibodies Moonshot Antibodies

NCT05314738 Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus https://clinicaltrials.gov/study/NCT05314738 RECRUITING Progressive Keratoconus COMBINATION_PRODUCT: NXL Energy 1

NCT05625438 Telerehabilitation Early After Stroke https://clinicaltrials.gov/study/NCT05625438 RECRUITING Cerebral Stroke DEVICE: HandyMotion Treatment Program TRCare, Inc. Providence St. Jude Medical Center

NCT04922138 Aumolertinib Adjuvant Therapy of Resectable Stage I EGFRm+ NSCLC With High-grade Patterns https://clinicaltrials.gov/study/NCT04922138 RECRUITING Lung Cancer DRUG: Aumolertinib Baohui Han Jiangsu Hansoh Pharmaceutical Co., Ltd.

NCT06393738 A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. https://clinicaltrials.gov/study/NCT06393738 RECRUITING Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)

NCT03606538 MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function https://clinicaltrials.gov/study/NCT03606538 NOT_YET_RECRUITING Pharmacokinetics

NCT06170138 Study to Assess PK, PD, Nicotine Extraction, Palatability, Subjective Effects of Nicotine Pouches - Daily Nicotine Users https://clinicaltrials.gov/study/NCT06170138 RECRUITING Nicotine Use Disorder OTHER: Test product 1 - Test product 2 - Comparator product Amplicon AB

NCT05478538 Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform https://clinicaltrials.gov/study/NCT05478538 RECRUITING Non Small Cell Lung Cancer

NCT06265038 Confirmatory Investigation to Evaluate the Performance and Safety of ReSpace TiCell Cage Implants in TLIF https://clinicaltrials.gov/study/NCT06265038 RECRUITING Degenerative Instability

NCT06038838 Feasibility Study of the Tioga TMVR System https://clinicaltrials.gov/study/NCT06038838 NOT_YET_RECRUITING Mitral Regurgitation DEVICE: Tioga TMVR System Tioga Cardiovascular, Inc.

NCT05522738 Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer https://clinicaltrials.gov/study/NCT05522738 RECRUITING Metastatic Colorectal Cancer DRUG: Combination: Fruquintinib + FOLFIRI Chinese PLA General Hospital Hutchison Medipharma Limited

NCT04263038 Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism https://clinicaltrials.gov/study/NCT04263038 RECRUITING Pulmonary Embolism

NCT03626038 Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System https://clinicaltrials.gov/study/NCT03626038 RECRUITING Osteoarthritis

NCT05994638 Polyphenol Rich Aerosol as a Support for Cancer Patients in Minimizing Side Effects After a Radiation Therapy https://clinicaltrials.gov/study/NCT05994638 RECRUITING Oral Mucositis DIETARY_SUPPLEMENT: Aerosol (Polyphenol-rich plant extracts, Hyaluronic Acid, Cetraria Islandica, Vitamin B3) AronPharma Sp. z o. o.

NCT04194138 Complex Adult Deformity Surgery (CADS) https://clinicaltrials.gov/study/NCT04194138 RECRUITING Adult Spinal Deformity

NCT05365438 Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia https://clinicaltrials.gov/study/NCT05365438 RECRUITING Dyslipidemias

NCT02804438 Establishing Normative Data for Pupillometer Assessments in Neuro-Intensive Care https://clinicaltrials.gov/study/NCT02804438 RECRUITING Critical Illness

NCT06700538 Study of ARO-INHBE in Adults With Obesity With and Without Diabetes Mellitus https://clinicaltrials.gov/study/NCT06700538 NOT_YET_RECRUITING Obesity DRUG: ARO-INHBE

NCT04563338 An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE) https://clinicaltrials.gov/study/NCT04563338 RECRUITING Hepatocellular Carcinoma

NCT06034938 DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road) https://clinicaltrials.gov/study/NCT06034938 NOT_YET_RECRUITING Hiv DRUG: Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO] University Hospital, Caen Merck Sharp & Dohme LLC

NCT04894838 DIStal gastriC Bypass OUtcome in Revision SurgEry After Roux-en-y Gastric Bypass https://clinicaltrials.gov/study/NCT04894838 RECRUITING Obesity, Morbid

NCT05890638 Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients https://clinicaltrials.gov/study/NCT05890638 RECRUITING COPD DRUG: Ipratropium / Levosalbutamol Fixed Dose Combination

NCT06710938 Thoracoabdominal Artery Stent Graft System Exploratory Study https://clinicaltrials.gov/study/NCT06710938 NOT_YET_RECRUITING Thoracoabdominal Aortic Aneurysms DEVICE: The system includes the G-Branch‚Ñ¢ thoracoabdominal aortic stent graft system, the peripheral vascular stent graft system, and the aortic extension stent graft system Lifetech Scientific (Shenzhen) Co., Ltd.

NCT06671938 Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients with Parkinson's Disease https://clinicaltrials.gov/study/NCT06671938 RECRUITING Parkinson Disease DRUG: exidavnemab

NCT05845138 A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression. https://clinicaltrials.gov/study/NCT05845138 RECRUITING Breast Cancer DRUG: SHR-A1811 for injection ; capecitabine Suzhou Suncadia Biopharmaceuticals Co., Ltd.

NCT06220838 Study SC-101 in Subjects with Advanced Malignancies https://clinicaltrials.gov/study/NCT06220838 RECRUITING Advanced Solid Tumor DRUG: SC-101 Tianjin ConjuStar Biologics Co., Ltd.

NCT06127238 Study of ST-1898 in Advanced Renal Cell Carcinoma https://clinicaltrials.gov/study/NCT06127238 RECRUITING Advanced Renal Cell Carcinoma DRUG: ST-1898 tablets Beijing Scitech-Mq Pharmaceuticals Limited

NCT06673238 A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants https://clinicaltrials.gov/study/NCT06673238 RECRUITING Healthy Volunteer DRUG: ABBV-722

NCT04562740 ABLUMINUS DES BTK Registry - FIM https://clinicaltrials.gov/study/NCT04562740 RECRUITING Peripheral Artery Disease

NCT04482140 Post Approval Study to Evaluate the Safety and Performance of GENTA-FOIL Resorb¬Æ in Hand Surgery https://clinicaltrials.gov/study/NCT04482140 NOT_YET_RECRUITING Tissue Adhesions, Surgery-Induced DEVICE: Genta-Foil resorb¬Æ Advanced Medical Solutions Ltd.

NCT04578340 Long Term Outcomes Following Hernia Repair With Mesh https://clinicaltrials.gov/study/NCT04578340 RECRUITING Abdominal Hernia NorthShore University HealthSystem Medtronic

NCT06170840 A Study of QY101 Ointment in Subjects With Plaque Psoriasis https://clinicaltrials.gov/study/NCT06170840 RECRUITING Psoriasis DRUG: QY101Placebo/QY101 ointment E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

NCT06196840 Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS) https://clinicaltrials.gov/study/NCT06196840 RECRUITING Neovascular Age-Related Macular Degeneration GENETIC: LX102 subretinal injection

NCT05314140 Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes: TOSCANA Study https://clinicaltrials.gov/study/NCT05314140 NOT_YET_RECRUITING Diabetes Mellitus

NCT04510740 Liver Cancer Registry Platform https://clinicaltrials.gov/study/NCT04510740 RECRUITING Hepatocellular Carcinoma (HCC)

NCT05745740 A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation https://clinicaltrials.gov/study/NCT05745740 NOT_YET_RECRUITING Non-small Cell Lung Cancer DRUG: RC48-ADC

NCT06523140 Management of COPD Patients With BoraCare¬Æ Remote Monitoring Solution Including BVS3 Early Detection Score for COPD Exacerbations https://clinicaltrials.gov/study/NCT06523140 NOT_YET_RECRUITING COPD DEVICE: Boracare remote monitoring solution Biosency Assistance Publique - H√¥pitaux de Paris

NCT06515340 Effect of Allulose on Diet-induced Thermogenesis https://clinicaltrials.gov/study/NCT06515340 RECRUITING Diet Induced Thermogenesis OTHER: Allulose Dose 1

NCT04781140 Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD https://clinicaltrials.gov/study/NCT04781140 RECRUITING Attention-Deficit/Hyperactivity Disorder DRUG: 100mg SPN-812

NCT05705440 A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control https://clinicaltrials.gov/study/NCT05705440 RECRUITING Respiratory Syncytial Virus Infections BIOLOGICAL: RSVPreF3 vaccine

NCT04679740 Resorbable Magnesium Scaffolds Registry https://clinicaltrials.gov/study/NCT04679740 RECRUITING Coronary Artery Disease DEVICE: Magmaris Biotronik AG

NCT04599140 SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial https://clinicaltrials.gov/study/NCT04599140 RECRUITING Metastatic Colon Adenocarcinoma

NCT05986240 Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML https://clinicaltrials.gov/study/NCT05986240 RECRUITING AML/MDS

NCT06711640 A Pharmacokinetic, Safety, and Tolerability Study of LUCEMYRA in the Treatment of Opioid Withdrawal Management in Adolescent Subjects https://clinicaltrials.gov/study/NCT06711640 NOT_YET_RECRUITING Opioid Withdrawal (Disorder)

NCT06075940 Evaluation of the MAGNITUDE¬Æ Bioresorbable Drug-Eluting Scaffold in the Treatment of Patients With Below the Knee Disease in Australia https://clinicaltrials.gov/study/NCT06075940 RECRUITING Critical Limb-Threatening Ischemia

NCT05913440 HER2-low Unresectable and/or Metastatic Breast Cancer in Russia https://clinicaltrials.gov/study/NCT05913440 RECRUITING Breast Cancer AstraZeneca

NCT06126640 A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy https://clinicaltrials.gov/study/NCT06126640 NOT_YET_RECRUITING HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy DRUG: SHR-A1811

NCT06127940 K-SAB Trial - Sotorasib Followed by SBRT to 1-3 Lesions in Advanced NSCLC With KRASG12C Mutation https://clinicaltrials.gov/study/NCT06127940 RECRUITING Non-small Cell Lung Cancer Metastatic RADIATION: Stereotactic body radiation therapy (SBRT)

NCT05299840 Impact of Using the Oncogramme¬Æ Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer https://clinicaltrials.gov/study/NCT05299840 RECRUITING Metastatic Colorectal Cancer DIAGNOSTIC_TEST: Oncogramme results available

NCT05215340 Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations https://clinicaltrials.gov/study/NCT05215340 RECRUITING Metastatic Non Small Cell Lung Cancer DRUG: Datopotamab Deruxtecan

NCT06556940 G.I. Pharmacokinetics of LMN-401 in Individuals With Ileostomies https://clinicaltrials.gov/study/NCT06556940 NOT_YET_RECRUITING Travelers Diarrhea BIOLOGICAL: LMN-401 Lumen Bioscience, Inc.

NCT05987644 Delayed or Upfront Brain RAdiotherapy in Treatment na√Øve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements https://clinicaltrials.gov/study/NCT05987644 RECRUITING Lung Cancer

NCT06640244 The Effect of Cosmetic Face Care Products on Facial Skin Tone and Spot Brightening https://clinicaltrials.gov/study/NCT06640244 RECRUITING Pigment Spots OTHER: Sunscreen

NCT05770544 DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. https://clinicaltrials.gov/study/NCT05770544 RECRUITING Solid Tumor

NCT02523092 Use of CXCL9 as a Biomarker of Acthar Efficacy https://clinicaltrials.gov/study/NCT02523092 RECRUITING Sarcoidosis DRUG: Acthar gel University of California, San Francisco Mallinckrodt

NCT04970992 A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma https://clinicaltrials.gov/study/NCT04970992 RECRUITING Solid Tumor

NCT05269992 Childrens Real Food Tolerance Study https://clinicaltrials.gov/study/NCT05269992 RECRUITING Malnutrition, Child OTHER: Real food products Nutricia UK Ltd

NCT04573192 A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression https://clinicaltrials.gov/study/NCT04573192 RECRUITING Glioblastoma DRUG: L19TNF

NCT06351592 First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS) https://clinicaltrials.gov/study/NCT06351592 RECRUITING Amyotrophic Lateral Sclerosis (ALS)

NCT06481592 A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. https://clinicaltrials.gov/study/NCT06481592 RECRUITING Endometrial Cancer BIOLOGICAL: Lifileucel Iovance Biotherapeutics, Inc.

NCT05350592 Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock https://clinicaltrials.gov/study/NCT05350592 RECRUITING Acute Myocardial Infarction

NCT06534892 An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study https://clinicaltrials.gov/study/NCT06534892 RECRUITING Respiratory Syncytial Virus Infections BIOLOGICAL: RSVPreF3 OA vaccine GlaxoSmithKline

NCT05419492 A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children with SCN1A-Positive Dravet Syndrome https://clinicaltrials.gov/study/NCT05419492 RECRUITING Dravet Syndrome DRUG: ETX101 Encoded Therapeutics

NCT06580392 CCM and Implementation of Guideline-Directed Medical Therapy in Patients With Heart Failure (Fix-GDMT-HF) https://clinicaltrials.gov/study/NCT06580392 NOT_YET_RECRUITING Heart Failure Impulse Dynamics

NCT05783089 MSLN-targeted CAR-T Cells in Solid Tumors. https://clinicaltrials.gov/study/NCT05783089 NOT_YET_RECRUITING Mesothelin-positive Advanced Malignant Solid Tumors BIOLOGICAL: Anti-mesothelin CAR-T cells Cancer Institute and Hospital, Chinese Academy of Medical Sciences UTC Therapeutics Inc.

NCT06565689 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012 https://clinicaltrials.gov/study/NCT06565689 RECRUITING Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma DRUG: YK012 Excyte Biopharma Ltd

NCT06275789 Mix of Demineralized Freeze-Dried Bone Allograft and Deproteinized Bovine Bone Mineral: a Possible Solution for Alveolar Ridge Preservation? https://clinicaltrials.gov/study/NCT06275789 RECRUITING Alveolar Ridge Preservation

NCT06059989 inDuctIon tREatment With subCuTaneous Infliximab for Crohn's Disease https://clinicaltrials.gov/study/NCT06059989 RECRUITING Inflammatory Disease

NCT05367440 Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer https://clinicaltrials.gov/study/NCT05367440 RECRUITING Metastatic Prostate Cancer DRUG: AZD5305

NCT06424340 MB-dNPM1-TCR.1 in Relapsed/refractory AML https://clinicaltrials.gov/study/NCT06424340 RECRUITING Leukemia, Myeloid, Acute BIOLOGICAL: MB-dNPM1-TCR.1 Miltenyi Biomedicine GmbH

NCT04631744 Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) https://clinicaltrials.gov/study/NCT04631744 RECRUITING Prostate Cancer DRUG: Cabozantinib Weill Medical College of Cornell University Exelixis

NCT06624644 A Trial of LNS8801 with or Without Pembrolizumab in Patients with Refractory Melanoma https://clinicaltrials.gov/study/NCT06624644 NOT_YET_RECRUITING Melanoma (Skin Cancer)

NCT06362044 A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ¬± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan https://clinicaltrials.gov/study/NCT06362044 RECRUITING Chronic Lymphocytic Leukemia AbbVie

NCT06685692 A Clinical Trial Investigating the Safety and Efficacy of Subjects with Alcoholic Hepatitis (Part 1) https://clinicaltrials.gov/study/NCT06685692 RECRUITING Alcoholic Hepatitis DRUG: ADX-629

NCT05576792 A 24-week Study Evaluating the Effectiveness and Safety of Lucentis¬Æ 0.2mg in Retinopathy of Prematurity Participants in China https://clinicaltrials.gov/study/NCT05576792 RECRUITING Retinopathy of Prematurity OTHER: Ranibizumab Novartis Pharmaceuticals

NCT04800692 The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication https://clinicaltrials.gov/study/NCT04800692 RECRUITING Claudication, Intermittent

NCT05260892 Incisors Single-Unit Rehabilitation With Narrow GM Implants https://clinicaltrials.gov/study/NCT05260892 RECRUITING Edentulous Alveolar Ridge DEVICE: Narrow GM implants Neodent

NCT05903092 MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05903092 RECRUITING Small Cell Lung Cancer

NCT06660992 A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis https://clinicaltrials.gov/study/NCT06660992 RECRUITING Non-cystic Fibrosis Bronchiectasis DRUG: HSK31858, tablet

NCT05557292 RMC-5552 Monotherapy in Adult Subjects with Recurrent Glioblastoma https://clinicaltrials.gov/study/NCT05557292 RECRUITING Glioblastoma

NCT06157892 A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors https://clinicaltrials.gov/study/NCT06157892 RECRUITING Breast Neoplasms

NCT04773392 Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR https://clinicaltrials.gov/study/NCT04773392 RECRUITING Kidney Transplantation

NCT05870592 Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients Using the CyPath Lung Assay https://clinicaltrials.gov/study/NCT05870592 NOT_YET_RECRUITING Lung Cancer bioAffinity Technologies Inc. Brooke Army Medical Center

NCT06150040 Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX] https://clinicaltrials.gov/study/NCT06150040 RECRUITING Acute Myeloid Leukemia Refractory DRUG: NP137

NCT05977140 CDI-988 Safety Study in Healthy Participants https://clinicaltrials.gov/study/NCT05977140 RECRUITING Healthy Volunteers DRUG: CDI-988

NCT05697640 Study to Investigate Improvement in Physical Function in SF-36 with Vericiguat Compared with Placebo in Participants with Post-COVID-19 Syndrome https://clinicaltrials.gov/study/NCT05697640 RECRUITING Post-COVID ME/CFS DRUG: Vericiguat Oral Tablet Charite University, Berlin, Germany Bayer

NCT05830240 A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer https://clinicaltrials.gov/study/NCT05830240 RECRUITING Head and Neck Cancer

NCT06131840 A Study of PF-08046050 (SGN-CEACAM5C) in Adults With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06131840 RECRUITING Colorectal Neoplasms

NCT05987540 SHARPEN - Parkinson's Disease Dementia https://clinicaltrials.gov/study/NCT05987540 RECRUITING Parkinson Disease Dementia DEVICE: Non-invasive brainstem stimulation Scion NeuroStim National Institute of Neurological Disorders and Stroke (NINDS)

NCT06218940 HY1272 in Patients With Locally Advanced or Metastatic Solid Tumors or Locally Advanced or Metastatic EGFRm+ NSCLC https://clinicaltrials.gov/study/NCT06218940 NOT_YET_RECRUITING NSCLC Stage IV DRUG: HY1272 Newsoara Biopharma Co., Ltd.

NCT06113744 A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine https://clinicaltrials.gov/study/NCT06113744 RECRUITING SARS-CoV-2 Infection BIOLOGICAL: Placebo

NCT05901844 Evaluate the Accuracy of Raman IVD Analyzer in the Diagnosis of Gliomas During Surgery https://clinicaltrials.gov/study/NCT05901844 NOT_YET_RECRUITING Glioma DIAGNOSTIC_TEST: Paraffin pathological diagnosis Beijing Tiantan Hospital West China Hospital

NCT05883644 Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC) https://clinicaltrials.gov/study/NCT05883644 RECRUITING Advanced Hepatocellular Carcinoma DRUG: Durvalumab

NCT06400992 Investigation of Sky Automatic Technologies in Pediatrics https://clinicaltrials.gov/study/NCT06400992 NOT_YET_RECRUITING Hearing Loss DEVICE: Cochlear implant processor Sky CITM M90 (CI-5295)

NCT05484492 Alveolar Ridge Preservation With Putty Allograft vs. Putty Alloplast Graft https://clinicaltrials.gov/study/NCT05484492 RECRUITING Alveolar Bone Resorption BIOLOGICAL: demineralized and mineralized combination putty bone allograft

NCT05601492 Adherence to Otezla https://clinicaltrials.gov/study/NCT05601492 NOT_YET_RECRUITING Psoriasis DRUG: Otezla - Standard Care

NCT05064540 JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization https://clinicaltrials.gov/study/NCT05064540 RECRUITING AAA

NCT06112340 A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) https://clinicaltrials.gov/study/NCT06112340 RECRUITING Thyroid Eye Disease

NCT06454240 A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps https://clinicaltrials.gov/study/NCT06454240 RECRUITING Chronic Rhinosinusitis With Nasal Polyps DRUG: lunsekimig

NCT05955144 Clinical Validation of the Screening Tool Picterus JP Using Different Smartphones https://clinicaltrials.gov/study/NCT05955144 RECRUITING Neonatal Jaundice DEVICE: Picterus JP Picterus AS

NCT05787444 Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B) https://clinicaltrials.gov/study/NCT05787444 NOT_YET_RECRUITING SARS-CoV-2

NCT06451744 Cellular and Molecular Biomarkers in Patients With Lichen Planus https://clinicaltrials.gov/study/NCT06451744 RECRUITING Lichen Planus OTHER: Blood samples collection

NCT06225544 Lumasiran in Hyperoxalaemic Patients on Haemodialysis https://clinicaltrials.gov/study/NCT06225544 RECRUITING Haemodialysis

NCT05619744 A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas https://clinicaltrials.gov/study/NCT05619744 RECRUITING Small Cell Lung Cancer

NCT04028492 Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis https://clinicaltrials.gov/study/NCT04028492 RECRUITING Idiopathic Gastroparesis

NCT05039892 Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma https://clinicaltrials.gov/study/NCT05039892 NOT_YET_RECRUITING Cholangiocarcinoma,Adult DRUG: 3D185 3D Medicines (Beijing) Co., Ltd.

NCT06593392 Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis with Moderate-to-Severe Pruritus https://clinicaltrials.gov/study/NCT06593392 NOT_YET_RECRUITING Pruritus

NCT06696092 Safety and Efficacy of WoundClot Surgical https://clinicaltrials.gov/study/NCT06696092 RECRUITING Surgical Bleeding DEVICE: Hemostatic Agent Core Scientific Creations Ltd.

NCT05874492 Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Postoperative Radiotherapy for Breast Cancer https://clinicaltrials.gov/study/NCT05874492 RECRUITING Fibrosis

NCT06614192 A Randomized Trial Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Over-Expressed Refractory Metastatic Colorectal Cancer https://clinicaltrials.gov/study/NCT06614192 RECRUITING Metastatic Colorectal Cancer DRUG: ABBV-400

NCT04239092 9-ING-41 in Pediatric Patients with Refractory Malignancies. https://clinicaltrials.gov/study/NCT04239092 RECRUITING Refractory Cancer

NCT06274801 Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) https://clinicaltrials.gov/study/NCT06274801 RECRUITING Pulmonary Arterial Hypertension DRUG: Seralutinib

NCT06159101 A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX13 With YERVOY in Male Subjects https://clinicaltrials.gov/study/NCT06159101 RECRUITING Healthy Male Volunteers DRUG: HLX13

NCT05659901 A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher Disease https://clinicaltrials.gov/study/NCT05659901 RECRUITING Pelizaeus-Merzbacher Disease Ionis Pharmaceuticals, Inc.

NCT06235801 A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06235801 RECRUITING Myeloid Leukemia DRUG: Gilteritinib

NCT05992701 Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease https://clinicaltrials.gov/study/NCT05992701 RECRUITING Parkinson's Disease DEVICE: Directional deep brain stimualtion Beijing Pins Medical Co., Ltd Beijing Tiantan Hospital

NCT06024967 A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency https://clinicaltrials.gov/study/NCT06024967 NOT_YET_RECRUITING GHD DRUG: PEG-somatropin Changchun GeneScience Pharmaceutical Co., Ltd.

NCT05846867 Study of AK119 and AK 112 With or Without Chemotherapy for Colorectal Cancer Patients https://clinicaltrials.gov/study/NCT05846867 NOT_YET_RECRUITING Colorectal Cancer DRUG: AK119

NCT04384367 Efficacy and Safety of Rizatriptan-Naproxen (10/550 mg) in the Acute Treatment of Migraine https://clinicaltrials.gov/study/NCT04384367 RECRUITING Migraine DRUG: Rizatriptan 10 mg + Naproxen 550mg

NCT05718167 TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer. https://clinicaltrials.gov/study/NCT05718167 NOT_YET_RECRUITING Advanced Squamous Non-Small Cell Lung Carcinoma DRUG: TQB2450

NCT06379867 A Study to Evaluate the Effects of HSK3486 Administration on Cardiac Repolarization in Healthy Subjects https://clinicaltrials.gov/study/NCT06379867 RECRUITING Anesthesia DRUG: HSK3486

NCT06585267 Development of a New Patient Reported Outcome Measure (PROM) to Assess Patient's Emotional Wellbeing, and Perceptions of Total Knee Replacement Surgery for the Treatment of Knee Arthritis https://clinicaltrials.gov/study/NCT06585267 NOT_YET_RECRUITING Complete Questionnaires Following TKR Surgery Invibio Ltd Oxford University Innovation

NCT05650567 Study of M5049 in DM and PM Participants (NEPTUNIA) https://clinicaltrials.gov/study/NCT05650567 RECRUITING Dermatomyositis

NCT05502367 A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia https://clinicaltrials.gov/study/NCT05502367 RECRUITING Cervical Intraepithelial Neoplasia DRUG: ABI-2280 Vaginal Tablet/Insert Antiva Biosciences

NCT06456567 A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2) https://clinicaltrials.gov/study/NCT06456567 RECRUITING Systemic Lupus Erythematosus BIOLOGICAL: Telitacicept

NCT06679140 A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease https://clinicaltrials.gov/study/NCT06679140 NOT_YET_RECRUITING COVID-19 SARS-CoV-2 Infection DRUG: ibuzatrelvir

NCT04027140 MDR - M/L Taper With Kinectiv Technology Stems and Necks https://clinicaltrials.gov/study/NCT04027140 RECRUITING Hip Disease

NCT06654440 A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy https://clinicaltrials.gov/study/NCT06654440 NOT_YET_RECRUITING Advanced Gynecological Malignancy DRUG: SHR-A2102 for injection Shanghai Hengrui Pharmaceutical Co., Ltd.

NCT05557240 Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients https://clinicaltrials.gov/study/NCT05557240 RECRUITING Glioma, Malignant

NCT05028140 Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus https://clinicaltrials.gov/study/NCT05028140 NOT_YET_RECRUITING Type II Diabetes DRUG: PIEMONTE

NCT06477640 Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension https://clinicaltrials.gov/study/NCT06477640 RECRUITING Pulmonary Arterial Hypertension PAH BEHAVIORAL: Exercise

NCT06130540 Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR https://clinicaltrials.gov/study/NCT06130540 RECRUITING Giant Cell Arteritis

NCT05068440 Treatment of CD79B Mutant Relapsed/Refractory Diffuse Large B-Cell Lymphoma With Bruton Tyrosine Kinase Inhibitor Zanubrutinib https://clinicaltrials.gov/study/NCT05068440 RECRUITING Relapsed Diffuse Large B-cell Lymphoma

NCT06486844 An Observational Study Called ROVER to Learn More About How Well Vericiguat Works in People Who Were Newly Treated With Vericiguat in Routine Medical Care in Germany https://clinicaltrials.gov/study/NCT06486844 RECRUITING Chronic Heart Failure With Reduced Ejection Fraction DRUG: Vericiguat (Verquvo, BAY1021189) Bayer

NCT06222944 Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA https://clinicaltrials.gov/study/NCT06222944 NOT_YET_RECRUITING Gastric Cancer

NCT01927744 Study of Chemotherapy with Cisplatin/Carboplatin, and Docetaxel with or Without Erlotinib in Patients with Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection https://clinicaltrials.gov/study/NCT01927744 RECRUITING Head and Neck Cancer DRUG: Docetaxel

NCT03969329 A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis https://clinicaltrials.gov/study/NCT03969329 RECRUITING Secondary Hyperparathyroidism DRUG: Etelcalcetide Amgen

NCT06219629 Parkinson's Disease Progression Study https://clinicaltrials.gov/study/NCT06219629 RECRUITING Parkinson Disease Koneksa Health Merck Sharp & Dohme LLC

NCT06356129 Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma https://clinicaltrials.gov/study/NCT06356129 RECRUITING Large B-cell Lymphoma DRUG: Golcadomide

NCT05949580 Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis https://clinicaltrials.gov/study/NCT05949580 NOT_YET_RECRUITING Relapsing Remitting Multiple Sclerosis DEVICE: MS Care Platform (icobrain ms and icompanion ms) Hoffmann-La Roche icometrix

NCT06456580 A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (RemeMG) https://clinicaltrials.gov/study/NCT06456580 RECRUITING Generalized Myasthenia Gravis BIOLOGICAL: Telitacicept

NCT05701280 Pilot/Pivotal Study of DBS+Rehab After Stroke https://clinicaltrials.gov/study/NCT05701280 RECRUITING Stroke

NCT06538480 Confirmatory Study of PRGN-2012 in Patients with RRP https://clinicaltrials.gov/study/NCT06538480 RECRUITING Recurrent Respiratory Papillomatosis

NCT05880680 SEAL‚Ñ¢ ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry https://clinicaltrials.gov/study/NCT05880680 NOT_YET_RECRUITING Aneurysm

NCT00271180 Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products https://clinicaltrials.gov/study/NCT00271180 RECRUITING Arrhythmia

NCT06641180 Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age https://clinicaltrials.gov/study/NCT06641180 RECRUITING Influenza BIOLOGICAL: High-Dose trivalent influenza vaccine (Split virion, Inactivated)

NCT05658562 A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL https://clinicaltrials.gov/study/NCT05658562 RECRUITING Diffuse Large B-Cell Lymphoma DRUG: MT-2111 Mitsubishi Tanabe Pharma Corporation

NCT06568562 XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT06568562 NOT_YET_RECRUITING Metastatic Castration-resistant Prostate Cancer DRUG: XL092 University of Utah Exelixis

NCT06047262 Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia https://clinicaltrials.gov/study/NCT06047262 RECRUITING Diabetes Mellitus, Type 2 DRUG: Dapansutrile

NCT05967494 Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences https://clinicaltrials.gov/study/NCT05967494 NOT_YET_RECRUITING Chronic Fatigue Syndrome Power Life Sciences Inc.

NCT06464094 Vitaliti Continuous Vital Signs Monitor User-Testing Protocol: VERDICT-2 https://clinicaltrials.gov/study/NCT06464094 NOT_YET_RECRUITING Surgery OTHER: User-testing of Vitaliti Continuous Vital Sign Monitor Model CVSM-1A Hamilton Health Sciences Corporation McMaster University

NCT05435794 Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients https://clinicaltrials.gov/study/NCT05435794 RECRUITING OSA DEVICE: CPAP

NCT04777994 A Phase 1 Study With ABBV-CLS-484 in Subjects With Locally Advanced or Metastatic Tumors https://clinicaltrials.gov/study/NCT04777994 RECRUITING Advanced Solid Tumor Cancer DRUG: ABBV-CLS-484

NCT04562194 NeVa ONE Registry Study https://clinicaltrials.gov/study/NCT04562194 RECRUITING Acute Ischemic Stroke DEVICE: NeVa Stent Retriever Vesalio

NCT05223894 Treating Heart Failure With hiPSC-CMs https://clinicaltrials.gov/study/NCT05223894 RECRUITING Heart Failure BIOLOGICAL: hiPSC-CM therapy

NCT04114994 Longitudinal Cognitive Assessment by BoCA https://clinicaltrials.gov/study/NCT04114994 RECRUITING Alzheimer Disease

NCT05966194 RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer https://clinicaltrials.gov/study/NCT05966194 RECRUITING Oral Mucositis DRUG: RRx-001

NCT06480994 Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support https://clinicaltrials.gov/study/NCT06480994 RECRUITING Venous Thromboembolism

NCT06674694 The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia. https://clinicaltrials.gov/study/NCT06674694 RECRUITING Schizophrenia Disorders DRUG: Brexpiprazole long-acting injection Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

NCT05417594 Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies https://clinicaltrials.gov/study/NCT05417594 RECRUITING Advanced Solid Malignancies DRUG: AZD9574

NCT03789162 Blood and Stool Sample Collection in Subjects with a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast https://clinicaltrials.gov/study/NCT03789162 RECRUITING Colorectal Cancer Exact Sciences Corporation

NCT06510062 Comparative Evaluation of Sustained Acoustic Medicine Device on Circulation https://clinicaltrials.gov/study/NCT06510062 RECRUITING Measurement of Circulation on Anatomical Locations of the Body DEVICE: Sustained Acoustic Medicine

NCT06226662 Study of NM8074 in Patients With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) https://clinicaltrials.gov/study/NCT06226662 NOT_YET_RECRUITING Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis DRUG: NM8074

NCT05802862 A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China https://clinicaltrials.gov/study/NCT05802862 NOT_YET_RECRUITING Diabetes DRUG: Insulin Degludec and Insulin Aspart Sunshine Lake Pharma Co., Ltd.

NCT03065062 Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors https://clinicaltrials.gov/study/NCT03065062 RECRUITING Lung Cancer Squamous Cell

NCT05631262 SKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05631262 RECRUITING Selected Subjects With Advanced Solid Tumors DRUG: SKB264

NCT05021562 A Study of Niraparib in Patients with Ovarian Cancer in Clinical Practice https://clinicaltrials.gov/study/NCT05021562 RECRUITING Ovarian Cancer DRUG: Niraparib Takeda

NCT06655662 Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Œí-thalassaemia Patients. https://clinicaltrials.gov/study/NCT06655662 RECRUITING Œí-thalassemia OTHER: Œ≤-globin restored autologous hematopoietic stem cells Shenzhen Hemogen

NCT05758662 The Effect of Subclinical Leaflet Thrombosis and Prosthesis Type on Transcatheter Aortic Valve Degeneration (POPular PET TAVI) https://clinicaltrials.gov/study/NCT05758662 RECRUITING Aortic Valve Stenosis DIAGNOSTIC_TEST: 18F-sodium fluoride Positron Emission Tomography (18F-NaF PET), Cardiac Computed Tomography (CT), Transthoracic Echocardiography (TTE) St. Antonius Hospital St. Antonius Research Fund

NCT05389462 A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors https://clinicaltrials.gov/study/NCT05389462 RECRUITING Advanced Solid Tumors DRUG: ADCT-601

NCT06538662 An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations https://clinicaltrials.gov/study/NCT06538662 RECRUITING Ocular Redness

NCT05926362 Capillary-Venous Paired Data Collection https://clinicaltrials.gov/study/NCT05926362 NOT_YET_RECRUITING Oncology Entia Ltd

NCT04222062 A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease https://clinicaltrials.gov/study/NCT04222062 RECRUITING Brain Tumor - Metastatic DRUG: Carmustine 7.7Mg Wafer University of Nebraska Arbor Pharmaceuticals, Inc.

NCT04417062 Olaparib With Ceralasertib in Recurrent Osteosarcoma https://clinicaltrials.gov/study/NCT04417062 RECRUITING Osteosarcoma

NCT05944562 Tulmimetostat (CPI-0209) in Patients With Mycosis Fungoides and S√©zary Syndrome https://clinicaltrials.gov/study/NCT05944562 RECRUITING Mycosis Fungoides

NCT03682289 Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors https://clinicaltrials.gov/study/NCT03682289 RECRUITING Clear Cell Renal Cell Carcinoma

NCT06366789 Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated Relapsed or Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06366789 NOT_YET_RECRUITING AML With Gene Mutations DRUG: ZE46-0134 Eilean Therapeutics

NCT06274489 A Study to Evaluate Setanaxib in Patients With Alport Syndrome https://clinicaltrials.gov/study/NCT06274489 RECRUITING Alport Syndrome DRUG: Setanaxib

NCT05348889 First-in-Human (FIH) Trial of 1A46 in Subjects With Advanced CD20 and/or CD19 Positive B-cell Hematologic Malignancies https://clinicaltrials.gov/study/NCT05348889 RECRUITING Non-Hodgkin's Lymphoma (Disorder)

NCT05662462 Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching https://clinicaltrials.gov/study/NCT05662462 RECRUITING Pre-Gestational Diabetes

NCT05747391 Assessment of Rosacea Patients' Clinical Trial Experiences https://clinicaltrials.gov/study/NCT05747391 NOT_YET_RECRUITING Rosacea Power Life Sciences Inc.

NCT04452591 Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin https://clinicaltrials.gov/study/NCT04452591 RECRUITING Non Muscle Invasive Bladder Cancer

NCT04842591 Characteristics of Pulmonary Vascular Changes in Patients With Kidney Transplantation https://clinicaltrials.gov/study/NCT04842591 RECRUITING Pulmonary Hypertension

NCT05948891 Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow¬Æ in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study https://clinicaltrials.gov/study/NCT05948891 RECRUITING COPD DRUG: Beclometasone/Formoterol/Glycopyrronium 88 ¬µg/5 ¬µg/9 ¬µg DPI (Trimbow¬Æ 88 ¬µg/5 ¬µg/9 ¬µg in NEXThaler device) Chiesi SAS Kappa Sant√©

NCT02043691 Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies https://clinicaltrials.gov/study/NCT02043691 RECRUITING Juxtarenal Aortic Aneurysm

NCT06586294 A Study of Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma https://clinicaltrials.gov/study/NCT06586294 NOT_YET_RECRUITING Gastric Adenocarcinoma

NCT05985694 AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma https://clinicaltrials.gov/study/NCT05985694 RECRUITING Eosinophilic Asthma DRUG: AD17002

NCT05673694 To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer. https://clinicaltrials.gov/study/NCT05673694 RECRUITING Breast Cancer DRUG: EG017 Changchun GeneScience Pharmaceutical Co., Ltd.

NCT05707494 Lipopolysaccharide Adsorption (Efferon LPS NEO) in Children With Sepsis https://clinicaltrials.gov/study/NCT05707494 RECRUITING Sepsis

NCT06093594 Investigating Participation Patterns Among Stage IV Melanoma Patients https://clinicaltrials.gov/study/NCT06093594 NOT_YET_RECRUITING Stage IV Melanoma Power Life Sciences Inc.

NCT06656494 ICP-248 in Combination with Azacitidine in Treatment-Na√Øve Subjects with Acute Myelogenous Leukemia(AML) or Previously Treated Relapsed/Refractory Subjects with Acute Myelogenous Leukemia(R/R AML). https://clinicaltrials.gov/study/NCT06656494 NOT_YET_RECRUITING Acute Myelogenous Leukemia DRUG: ICP-248

NCT05447494 Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease https://clinicaltrials.gov/study/NCT05447494 RECRUITING Gaucher Disease, Type 1

NCT06596291 Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults with Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization https://clinicaltrials.gov/study/NCT06596291 RECRUITING Neurogenic Detrusor Overactivity

NCT04299191 Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04299191 RECRUITING High-grade Glioma

NCT05801991 Neurolens and Contact Lens Discomfort https://clinicaltrials.gov/study/NCT05801991 NOT_YET_RECRUITING Contact Lens Discomfort DEVICE: Neurolens

NCT05363891 Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT05363891 RECRUITING Rheumatoid Arthritis DRUG: Natrunix

NCT05062291 Merit WRAPSODY‚Ñ¢ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP) https://clinicaltrials.gov/study/NCT05062291 RECRUITING Venous Stenosis

NCT04721691 Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES). https://clinicaltrials.gov/study/NCT04721691 RECRUITING Electrical Status Epilepticus of Slow-Wave Sleep DRUG: Epidiolex 100 mg/mL Oral Solution

NCT05006794 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies https://clinicaltrials.gov/study/NCT05006794 RECRUITING Solid Malignancies DRUG: GS-9716

NCT05732194 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers https://clinicaltrials.gov/study/NCT05732194 RECRUITING Healthy Volunteers DRUG: ITI-333

NCT06651294 Efficacy of Neorenal Forte for the Complete Elimination of Residual Fragments https://clinicaltrials.gov/study/NCT06651294 NOT_YET_RECRUITING Urolithiasis DIETARY_SUPPLEMENT: Neorenal Forte

NCT04833894 Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children with Generalized Myasthenia Gravis https://clinicaltrials.gov/study/NCT04833894 RECRUITING Generalized Myasthenia Gravis BIOLOGICAL: Efgartigimod IV argenx

NCT06655194 A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different Chewable Tablets on an Empty Stomach by Healthy Participants https://clinicaltrials.gov/study/NCT06655194 NOT_YET_RECRUITING Bioequivalence

NCT06363994 A Global Phase 3 Study of Orelabrutinib+BR vs.BR in Pts With TN MCL https://clinicaltrials.gov/study/NCT06363994 NOT_YET_RECRUITING Mantle Cell Lymphoma DRUG: Orelabrutinib

NCT05430360 Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/Recurrent Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05430360 RECRUITING Solid Tumor BIOLOGICAL: GT201 Grit Biotechnology

NCT06377462 Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection https://clinicaltrials.gov/study/NCT06377462 RECRUITING VEXAS Syndrome Technische Universit√§t Dresden Bristol-Myers Squibb

NCT05902962 SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects https://clinicaltrials.gov/study/NCT05902962 RECRUITING Retinal Dystrophy

NCT06143891 A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. https://clinicaltrials.gov/study/NCT06143891 RECRUITING Chronic Graft Versus Host Disease DRUG: Belumosudil

NCT06000891 A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570 https://clinicaltrials.gov/study/NCT06000891 RECRUITING Safety and Tolerability DRUG: ZP7570

NCT06249191 Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma https://clinicaltrials.gov/study/NCT06249191 RECRUITING Diffuse Large B-Cell Lymphoma

NCT06280391 A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis https://clinicaltrials.gov/study/NCT06280391 RECRUITING Bronchiectasis DRUG: Itepekimab (SAR440340)

NCT05852691 A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer https://clinicaltrials.gov/study/NCT05852691 RECRUITING Breast Cancer DRUG: Tobemstomig

NCT06288191 Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT06288191 NOT_YET_RECRUITING Cutaneous Squamous Cell Carcinoma DRUG: Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination Melanoma Institute Australia Bristol-Myers Squibb

NCT05396391 A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT05396391 RECRUITING Advanced Malignant Tumors DRUG: IAP0971 SUNHOÔºàChinaÔºâBioPharmaceutical CO., Ltd.

NCT06600191 Capstan Medical TMVR Study: FIH https://clinicaltrials.gov/study/NCT06600191 NOT_YET_RECRUITING Mitral Regurgitation DEVICE: Capstan System transcatheter mitral valve replacement Capstan Medical

NCT06387394 A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence https://clinicaltrials.gov/study/NCT06387394 RECRUITING Masseter Muscle Prominence DRUG: BOTOX

NCT06503094 CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors https://clinicaltrials.gov/study/NCT06503094 RECRUITING B-Cell Lymphoblastic Leukemia/Lymphoma DRUG: CD19&CD20 bispecific CAR-T cells Wuhan Union Hospital, China Hebei Taihe Chunyu Biotechnology Co., Ltd

NCT03657394 Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries https://clinicaltrials.gov/study/NCT03657394 RECRUITING Hypoxic-Ischemic Encephalopathy

NCT06305962 177Lu-anti-PD-L1 SdAb in Metastatic Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT06305962 RECRUITING PDL1 Gene Mutation

NCT05610891 Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG https://clinicaltrials.gov/study/NCT05610891 RECRUITING High-Grade Glioma DRUG: CLR 131 Cellectar Biosciences, Inc. National Cancer Institute (NCI)

NCT06160791 Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) https://clinicaltrials.gov/study/NCT06160791 RECRUITING Hemophagocytic Lymphohistiocytoses DRUG: Ruxolitinib

NCT06169891 A Study of Recombinant Anti-IL-1Œ≤ Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout https://clinicaltrials.gov/study/NCT06169891 NOT_YET_RECRUITING Acute Gout DRUG: Recombinant Anti-IL-1Œ≤ Humanized Monoclonal Antibody Injection 200 mg

NCT03260491 U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT03260491 RECRUITING Non-Small Cell Lung Cancer (NSCLC) DRUG: HER3-DXd (FL-DP)

NCT05648591 Safety and Tolerability of Open-Labeled Iloperidone in Adolescents https://clinicaltrials.gov/study/NCT05648591 RECRUITING Schizophrenia

NCT06011694 The Jinling Cohort https://clinicaltrials.gov/study/NCT06011694 RECRUITING Cancer

NCT06500494 To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment https://clinicaltrials.gov/study/NCT06500494 NOT_YET_RECRUITING Advanced Breast Cancer DRUG: Vinorelbine Tartrate Oral Pierre Fabre Medicament

NCT04662294 CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases https://clinicaltrials.gov/study/NCT04662294 RECRUITING Acute Myeloid Leukemia

NCT05248594 Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A https://clinicaltrials.gov/study/NCT05248594 RECRUITING Hemophilia A DRUG: HEMLIBRA Montefiore Medical Center Genentech, Inc.

NCT05712694 Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC) https://clinicaltrials.gov/study/NCT05712694 RECRUITING Soft Tissue Sarcoma DRUG: ADI PEG20

NCT06434194 Serrantor OCT Study https://clinicaltrials.gov/study/NCT06434194 NOT_YET_RECRUITING Critical Limb Ischemia DEVICE: Serranator PTA Serration Catheter

NCT04974294 PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2) https://clinicaltrials.gov/study/NCT04974294 RECRUITING Streptococcus Pneumonia BIOLOGICAL: PPV23

NCT03884660 Remedƒì System Therapy Study https://clinicaltrials.gov/study/NCT03884660 RECRUITING Central Sleep Apnea DEVICE: remede System Respicardia, Inc.

NCT06146660 A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy https://clinicaltrials.gov/study/NCT06146660 RECRUITING Obstructive Hypertrophic Cardiomyopathy DRUG: Mavacamten Bristol-Myers Squibb

NCT04754191 Enfortumab Vedotin As Monotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT04754191 RECRUITING Metastatic Castration-resistant Prostate Cancer DRUG: Enfortumab vedotin University of Utah Astellas Pharma Inc

NCT05959694 A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) . https://clinicaltrials.gov/study/NCT05959694 RECRUITING Chronic Lymphocytic Leukemia

NCT05895994 Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies https://clinicaltrials.gov/study/NCT05895994 RECRUITING Neoplasms

NCT06167694 Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT06167694 RECRUITING Unresectable or Metastatic Breast Cancer DRUG: HRS-8080; Dalpiciclib Isethionate Tablets Shandong Suncadia Medicine Co., Ltd.

NCT05999994 A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer https://clinicaltrials.gov/study/NCT05999994 RECRUITING Neoplasms

NCT06562894 Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients https://clinicaltrials.gov/study/NCT06562894 NOT_YET_RECRUITING Severe Alopecia Areata DRUG: SYHX1901

NCT06660394 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults with Dravet Syndrome (DS) https://clinicaltrials.gov/study/NCT06660394 RECRUITING Dravet Syndrome DRUG: LP352

NCT06042894 A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer https://clinicaltrials.gov/study/NCT06042894 RECRUITING Breast Cancer DRUG: BL-B01D1

NCT06048094 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery https://clinicaltrials.gov/study/NCT06048094 RECRUITING Brain Metastases

NCT04961060 Drivers of Eosinophilic COPD Exacerbations https://clinicaltrials.gov/study/NCT04961060 RECRUITING COPD Exacerbation

NCT05101460 An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant https://clinicaltrials.gov/study/NCT05101460 RECRUITING Lung Transplant DEVICE: XVIVO Perfusion System (XPS‚Ñ¢) with STEEN Solution‚Ñ¢ XVIVO Perfusion

NCT05570760 Clinical Study to Evaluate Adaptos¬ÆOrtho Wedge Bone Graft Substitute in High Tibial Osteotomy https://clinicaltrials.gov/study/NCT05570760 RECRUITING Knee Deformity DEVICE: Adaptos¬ÆOrtho Wedge (bone grafting surgery)

NCT04375891 Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation https://clinicaltrials.gov/study/NCT04375891 RECRUITING Oncology

NCT06176794 Immediate Release Torsemide Versus Extended Release Torsemide After Salty Meal https://clinicaltrials.gov/study/NCT06176794 RECRUITING Heart Failure DRUG: Immediate release torsemide 20mg tablet

NCT04317794 Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium) https://clinicaltrials.gov/study/NCT04317794 RECRUITING Muscular Atrophy, Spinal DRUG: Nusinersen Sodium Injection Biogen

NCT06454994 Clinical Study to Evaluate Safety and Effectiveness of Noble Lift¬Æ Lifting Threads https://clinicaltrials.gov/study/NCT06454994 NOT_YET_RECRUITING Aesthetic DEVICE: Eyebrow lift

NCT06630494 Phase I Study to Evaluate rhTPO in Healthy Caucasian Volunteers https://clinicaltrials.gov/study/NCT06630494 RECRUITING Healthy Subjects DRUG: Recombinant human thrombopoietin for injection (rhTPO) Shenyang Sunshine Pharmaceutical Co., LTD.

NCT05958394 Evaluation of Skillflix for Parents of Youth With ASD https://clinicaltrials.gov/study/NCT05958394 NOT_YET_RECRUITING Autism Spectrum Disorder BEHAVIORAL: SkillFlix for Parents Ashley Philliber dfusion Inc

NCT05616494 A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic Cancer https://clinicaltrials.gov/study/NCT05616494 RECRUITING Pancreatic Cancer DRUG: Docetaxel for injection (Albumin-bound) CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

NCT05747794 Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy https://clinicaltrials.gov/study/NCT05747794 RECRUITING Breast Carcinoma BIOLOGICAL: eftilagimod alpha

NCT05921994 Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa. https://clinicaltrials.gov/study/NCT05921994 RECRUITING Hidradenitis Suppurativa OTHER: secukinumab Novartis Pharmaceuticals

NCT05711394 A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine https://clinicaltrials.gov/study/NCT05711394 RECRUITING Episodic Migraine DRUG: Atogepant

NCT05362994 Selution Sirolimus-eluting Balloon for Internal Pudendal-penile Artery Disease-related Erectile Dysfunction https://clinicaltrials.gov/study/NCT05362994 RECRUITING Erectile Dysfunction

NCT02954094 A Longitudinal Observational Study of the Natural History and Management of Patients With HCC https://clinicaltrials.gov/study/NCT02954094 RECRUITING Hepatocellular Cancer Target PharmaSolutions, Inc.

NCT06322394 BXOS110 Injection in the Treatment of Acute Ischaemic Stroke https://clinicaltrials.gov/study/NCT06322394 RECRUITING Acute Ischemic Stroke DRUG: high-dose BXOS110

NCT04092894 Suvorexant and Sleep/Delirium in ICU Patients https://clinicaltrials.gov/study/NCT04092894 RECRUITING Insomnia

NCT06596694 Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) https://clinicaltrials.gov/study/NCT06596694 RECRUITING Gastrointestinal Cancer BIOLOGICAL: Patritumab deruxtecan Merck Sharp & Dohme LLC Daiichi Sankyo

NCT06360094 A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis https://clinicaltrials.gov/study/NCT06360094 RECRUITING Idiopathic Pulmonary Fibrosis

NCT06239194 Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06239194 RECRUITING Biliary Tract Cancer

NCT05906394 b.Spine Clinical Trial https://clinicaltrials.gov/study/NCT05906394 RECRUITING Degenerative Spinal Conditions PROCEDURE: Posterolateral Fusion GreenBone Ortho S.p.A.

NCT03383094 Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer https://clinicaltrials.gov/study/NCT03383094 RECRUITING Head and Neck Squamous Cell Carcinoma

NCT06675994 In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme https://clinicaltrials.gov/study/NCT06675994 NOT_YET_RECRUITING Healthy

NCT06509360 How do You Feelee? Emotion-based Smartphone App in the Forensic Outpatient Setting https://clinicaltrials.gov/study/NCT06509360 RECRUITING Emotion Regulation

NCT06342960 KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis https://clinicaltrials.gov/study/NCT06342960 RECRUITING Lupus Nephritis

NCT06491160 Performance and fMRI BOLD Signal Changes in Impulsive Patients https://clinicaltrials.gov/study/NCT06491160 NOT_YET_RECRUITING Attention Deficit Hyperactivity Disorder

NCT06353360 TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma. https://clinicaltrials.gov/study/NCT06353360 RECRUITING Glioblastoma Multiforme DEVICE: Tumor Treating Fields

NCT06038760 Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO) https://clinicaltrials.gov/study/NCT06038760 RECRUITING Brain Tumor

NCT03813862 Observational Pharmaco-Epidemiology Research & Analysis https://clinicaltrials.gov/study/NCT03813862 RECRUITING Chronic Disease

NCT06237062 Migraine Survey in Gulf Region https://clinicaltrials.gov/study/NCT06237062 RECRUITING Migraine OTHER: erenumab Novartis Pharmaceuticals

NCT06555562 Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthritis https://clinicaltrials.gov/study/NCT06555562 RECRUITING Psoriatic Arthritis

NCT05181462 Nadunolimab in Combination with Gemcitabine Plus Carboplatin in Patients with Advanced Triple Negative Breast Cancer. https://clinicaltrials.gov/study/NCT05181462 RECRUITING Triple Negative Breast Cancer DRUG: Carboplatin

NCT06196762 Phase I of XKH002 Injection in Patients https://clinicaltrials.gov/study/NCT06196762 RECRUITING Advanced or Metastatic Solid Tumors DRUG: XKH002 Injection Zhejiang Kanova Biopharmaceutical Co., LTD

NCT05962762 Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Ankylosing Spondylitis https://clinicaltrials.gov/study/NCT05962762 NOT_YET_RECRUITING Ankylosing Spondylitis BIOLOGICAL: Human Umbilical Cord Mesenchymal Stem Cells Asia Cell Therapeutics (Shanghai) Co., Ltd. RenJi Hospital

NCT05299762 A Post Market Surveillance on INFUSE Bone Graft https://clinicaltrials.gov/study/NCT05299762 RECRUITING Intervertebral Disc Degeneration

NCT04006262 Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma. https://clinicaltrials.gov/study/NCT04006262 RECRUITING Localized Oesogastric Adenocarcimona

NCT05966662 Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO) https://clinicaltrials.gov/study/NCT05966662 RECRUITING Coronary Artery Disease

NCT06659562 Clinical Study of HER-096 in Healthy Volunteer Subjects and Patients with Parkinson's Disease https://clinicaltrials.gov/study/NCT06659562 RECRUITING Parkinson Disease, Idiopathic DRUG: HER-096

NCT05327062 Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment https://clinicaltrials.gov/study/NCT05327062 RECRUITING Cardiac Resynchronization Therapy

NCT06424262 Performance and Hearing-related Outcomes in Adults Implanted With the CI622D Dexamethasone-eluting Cochlear Implant Compared to Those Implanted With a Standard Cochlear Implant (CI622) https://clinicaltrials.gov/study/NCT06424262 RECRUITING Hearing Loss, Bilateral Sensorineural

NCT05353062 Bipolar Hemostatic Forceps Versus Standard Therapy in Acute Non-variceal Upper GI Bleeding https://clinicaltrials.gov/study/NCT05353062 RECRUITING Gastrointestinal Hemorrhage PROCEDURE: Hemostatic therapy

NCT06034262 Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of PIP Joint Osteoarthritis https://clinicaltrials.gov/study/NCT06034262 RECRUITING Osteoarthritis Hand BIOLOGICAL: SclerFIX-IP TBF Genie Tissulaire

NCT05061862 Cardiac Implantable Electronic Device (CIED) Research Study https://clinicaltrials.gov/study/NCT05061862 RECRUITING Arrhythmias, Cardiac

NCT06560762 Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) https://clinicaltrials.gov/study/NCT06560762 NOT_YET_RECRUITING Heart Failure With Preserved Ejection Fraction (HFpEF) DRUG: STM01 Secretome Therapeutics

NCT05646862 A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy https://clinicaltrials.gov/study/NCT05646862 RECRUITING Breast Cancer DRUG: Inavolisib

NCT05717062 Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO) https://clinicaltrials.gov/study/NCT05717062 RECRUITING Snakebite

NCT06588491 KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person Syndrome https://clinicaltrials.gov/study/NCT06588491 RECRUITING Stiff-Person Syndrome

NCT05190991 Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever https://clinicaltrials.gov/study/NCT05190991 RECRUITING Familial Mediterranean Fever

NCT05262491 A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor https://clinicaltrials.gov/study/NCT05262491 RECRUITING Gastrointestinal Tumor DRUG: BL-B01D1 Sichuan Baili Pharmaceutical Co., Ltd. SystImmune Inc.

NCT06358391 To Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Puncture for Left Atrial Access. https://clinicaltrials.gov/study/NCT06358391 RECRUITING Arrhythmias, Cardiac

NCT04894591 To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) https://clinicaltrials.gov/study/NCT04894591 RECRUITING Extensive-stage Small-cell Lung Cancer DRUG: Zepzelca Jazz Pharmaceuticals

NCT05384691 Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions https://clinicaltrials.gov/study/NCT05384691 RECRUITING Myelodysplastic Syndromes

NCT06237491 The Safety and Dosimetry Study of 177Lu-LNC1003 Injection https://clinicaltrials.gov/study/NCT06237491 NOT_YET_RECRUITING Metastatic Castration-resistant Prostate Cancer, mCRPC DRUG: 177Lu-LNC1003 Injection group 1

NCT03682991 Reversal of Atrial Substrate to Prevent Atrial https://clinicaltrials.gov/study/NCT03682991 RECRUITING Atrial Fibrillation OTHER: Aggressive Risk Factor Control

NCT06081894 Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM https://clinicaltrials.gov/study/NCT06081894 RECRUITING Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy DRUG: Aficamten

NCT06594094 An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE) https://clinicaltrials.gov/study/NCT06594094 RECRUITING Duchenne Muscular Dystrophin (DMD) GENETIC: HG302 HuidaGene Therapeutics Co., Ltd.

NCT04678362 TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma https://clinicaltrials.gov/study/NCT04678362 RECRUITING Urothelial Carcinoma DRUG: Talazoparib + Avelumab Centre Francois Baclesse Pfizer

NCT06447662 A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. https://clinicaltrials.gov/study/NCT06447662 RECRUITING Carcinoma, Pancreatic Ductal

NCT04176562 Prospective SPINE Registry https://clinicaltrials.gov/study/NCT04176562 RECRUITING Sacroiliac; Fusion

NCT06163391 A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer https://clinicaltrials.gov/study/NCT06163391 RECRUITING Advanced Solid Tumor

NCT05609994 ViCToRy: Vorasidenib in Combination with Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas https://clinicaltrials.gov/study/NCT05609994 NOT_YET_RECRUITING Low Grade Glioma of Brain DRUG: PEPIDH1M vaccine + vorasidenib Katy Peters, MD, PhD Servier

NCT06516094 Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain https://clinicaltrials.gov/study/NCT06516094 RECRUITING Chronic Low-back Pain DRUG: Celecoxib+Pregabalin+Vitamin B fixed dose

NCT06465862 Development of a Silica Microparticle Taggant System to Measure ART Adherence https://clinicaltrials.gov/study/NCT06465862 NOT_YET_RECRUITING Hiv

NCT05840562 Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy https://clinicaltrials.gov/study/NCT05840562 RECRUITING Chemotherapy-induced Peripheral Neuropathy DRUG: Capsaicin

NCT05028062 Naltrexone in AUD Reward Drinkers https://clinicaltrials.gov/study/NCT05028062 RECRUITING Alcohol Use Disorder

NCT05483491 KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer https://clinicaltrials.gov/study/NCT05483491 RECRUITING Gastric Cancer

NCT05036291 A Study of NB004 as Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05036291 RECRUITING Advanced Solid Tumor DRUG: NB004 tablets Ningbo Newbay Technology Development Co., Ltd

NCT04767594 First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting. https://clinicaltrials.gov/study/NCT04767594 RECRUITING Breast Neoplasms DRUG: Palbociclib + endocrine therapy Pfizer

NCT05903794 A Study of EXG102-031 in Patients With wAMD (Everest) https://clinicaltrials.gov/study/NCT05903794 RECRUITING Neovascular (Wet) Age-related Macular Degeneration (nAMD) BIOLOGICAL: EXG102-031 Exegenesis Bio

NCT06622694 CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia https://clinicaltrials.gov/study/NCT06622694 NOT_YET_RECRUITING Severe Aplastic Anemia

NCT06431594 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06431594 RECRUITING Solid Tumors

NCT05841862 Intravitreal Quantum Dots (QD) for Advanced Retinitis Pigmentosa (RP) (QUANTUM) https://clinicaltrials.gov/study/NCT05841862 NOT_YET_RECRUITING Retinitis Pigmentosa DEVICE: 2C-QD

NCT05112991 Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer https://clinicaltrials.gov/study/NCT05112991 RECRUITING Advanced Endometrial Cancer DRUG: Envafolimab+Lenvatinib

NCT06510491 Epcoritamab in Previously Treated WM https://clinicaltrials.gov/study/NCT06510491 NOT_YET_RECRUITING Waldenstrom Macroglobulinemia

NCT05444491 Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer https://clinicaltrials.gov/study/NCT05444491 RECRUITING Colorectal Cancer Singlera Genomics Inc. Cancer Institute and Hospital, Chinese Academy of Medical Sciences

NCT06204991 To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma https://clinicaltrials.gov/study/NCT06204991 NOT_YET_RECRUITING Melanoma Stage III

NCT05376891 Met Non Small Cell Cancer Registry (MOMENT) https://clinicaltrials.gov/study/NCT05376891 RECRUITING Cancer EMD Serono Research & Development Institute, Inc. Merck KGaA, Darmstadt, Germany

NCT06046391 Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult https://clinicaltrials.gov/study/NCT06046391 RECRUITING Seasonal Allergic Rhinitis BIOLOGICAL: LP-003 dose 1

NCT05714891 Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05714891 RECRUITING NSCLC DRUG: JDQ443 Canadian Cancer Trials Group Novartis

NCT06189391 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CN201 https://clinicaltrials.gov/study/NCT06189391 RECRUITING Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma DRUG: CN201 Curon Biopharmaceutical (Shanghai) Co.,Ltd

NCT06573294 Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors https://clinicaltrials.gov/study/NCT06573294 RECRUITING Advanced Malignant Solid Tumor

NCT04736394 A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in na√Øve Intermediate-risk NMIBC Patients https://clinicaltrials.gov/study/NCT04736394 RECRUITING Non-muscle Invasive Bladder Cancer DRUG: APL-1202

NCT04027894 Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years https://clinicaltrials.gov/study/NCT04027894 NOT_YET_RECRUITING Traveler's Diarrhea DRUG: Rifamycin SV MMX

NCT05164094 A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults https://clinicaltrials.gov/study/NCT05164094 RECRUITING Epstein-Barr Virus Infection BIOLOGICAL: mRNA-1189

NCT06175494 A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) https://clinicaltrials.gov/study/NCT06175494 RECRUITING COVID-19 BIOLOGICAL: Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell)

NCT03624062 MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes https://clinicaltrials.gov/study/NCT03624062 RECRUITING Type 1 Diabetes Mellitus DRUG: MAS-1 adjuvanted Insulin B-chain University of Colorado, Denver The Leona M. and Harry B. Helmsley Charitable Trust

NCT05603091 Pressure Wave Guided Atrial Fibrillation Cryoablation https://clinicaltrials.gov/study/NCT05603091 RECRUITING Atrial Fibrillation PROCEDURE: cryoablation of pulmonary veins Hospital Universitario 12 de Octubre Boston Scientific Corporation

NCT06540391 A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients https://clinicaltrials.gov/study/NCT06540391 NOT_YET_RECRUITING Melanoma BIOLOGICAL: MB097

NCT05967091 Ryme Medical TLD Pilot Study https://clinicaltrials.gov/study/NCT05967091 NOT_YET_RECRUITING Chronic Obstructive Pulmonary Disease DEVICE: Targeted Lung Denervation Ryme Medical, Inc.

NCT06571591 Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin with Metformin https://clinicaltrials.gov/study/NCT06571591 RECRUITING T2DM DRUG: CT-L03 Group 1

NCT06678191 Investigation of Fixed Triple Inhaled Combination in Asthmatic Patients, in a Real-life Setting https://clinicaltrials.gov/study/NCT06678191 RECRUITING Asthma, Chronic Obstructive Pulmonary Disease (COPD)

NCT05453591 Investigation of Urinary Biomarkers for the Detection of Breast Cancer https://clinicaltrials.gov/study/NCT05453591 RECRUITING Breast Cancer

NCT05593094 A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05593094 RECRUITING Advanced Solid Tumors

NCT05860894 Post Intensive Care Unit Atrial Fibrillation https://clinicaltrials.gov/study/NCT05860894 RECRUITING Atrial Fibrillation

NCT06025994 Standardizing the Management of Patients With Coronary Microvascular Dysfunction https://clinicaltrials.gov/study/NCT06025994 RECRUITING Coronary Artery Disease

NCT05613894 Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT05613894 RECRUITING Metastatic Castration-resistant Prostate Cancer DRUG: Cabozantinib University of Utah Exelixis

NCT06561594 To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection https://clinicaltrials.gov/study/NCT06561594 NOT_YET_RECRUITING Idiopathic Hypogonadotropic Hypogonadism DRUG: recombinant human follicle-stimulating hormone-CTP Fusion protein injection

NCT06504394 A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Hyaluronidase (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65) https://clinicaltrials.gov/study/NCT06504394 RECRUITING Classical Hodgkin Lymphoma Recurrent

NCT05914194 A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 https://clinicaltrials.gov/study/NCT05914194 NOT_YET_RECRUITING Narcolepsy Type 1

NCT06084962 A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma https://clinicaltrials.gov/study/NCT06084962 RECRUITING Relapse/Refractory Multiple Myeloma BIOLOGICAL: DeepTag-GPRC5D Targeted CAR T-cells He Huang Yake Biotechnology Ltd.

NCT06636162 Window of Opportunity Study of DSP-0390 in Gliomas https://clinicaltrials.gov/study/NCT06636162 NOT_YET_RECRUITING Glioma, Malignant

NCT06233162 Febuxostat 80 mg Tablets Relative to Feburic¬Æ 80 mg Tablets https://clinicaltrials.gov/study/NCT06233162 NOT_YET_RECRUITING Healthy Subjects DRUG: Febuxostat-Test product

NCT06276491 Phase 1, Safety and Tolerability Study of XmAb¬Æ541 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06276491 RECRUITING Ovarian Cancer

NCT05382091 Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons https://clinicaltrials.gov/study/NCT05382091 NOT_YET_RECRUITING Opioid Use Disorder DRUG: naltrexone implant Go Medical Industries Pty Ltd National Institute on Drug Abuse (NIDA)

NCT04614194 Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib https://clinicaltrials.gov/study/NCT04614194 RECRUITING Breast Cancer DRUG: Letrozole

NCT05304962 FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT05304962 RECRUITING Breast Cancer DRUG: RGT-419B

NCT05180162 Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286 https://clinicaltrials.gov/study/NCT05180162 RECRUITING Liver Fibrosis

NCT04839991 Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours. https://clinicaltrials.gov/study/NCT04839991 RECRUITING Advanced and/or Metastatic Solid Tumours DRUG: CB307 Crescendo Biologics Ltd.

NCT05538091 Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer https://clinicaltrials.gov/study/NCT05538091 RECRUITING Platinum-Resistant Fallopian Tube Carcinoma

NCT06117891 An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery https://clinicaltrials.gov/study/NCT06117891 RECRUITING Unresectable Hepatocellular Carcinoma DRUG: Atezolizumab

NCT05829291 Alpha Radiation Emitters Device for the Treatment of Liver Metastases (DaRT) https://clinicaltrials.gov/study/NCT05829291 RECRUITING Liver Metastases DEVICE: Diffusing Alpha Radiation Emitters Therapy (DaRT) Alpha Tau Medical LTD.

NCT05198791 Stratified Medicine of Eplerenone in Acute MI/injury (StratMed-MINOCA) https://clinicaltrials.gov/study/NCT05198791 RECRUITING Myocardial Infarction, Acute

NCT06617091 A Phase 1 Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and with HIV https://clinicaltrials.gov/study/NCT06617091 NOT_YET_RECRUITING HIV DRUG: GRAdHIVNE1 Vaccine

NCT04192591 A 5-year Superion‚Ñ¢ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE) https://clinicaltrials.gov/study/NCT04192591 RECRUITING Lumbar Spinal Stenosis DEVICE: Superion‚Ñ¢ IDS device Boston Scientific Corporation

NCT05971394 IBS Titan‚Ñ¢ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial https://clinicaltrials.gov/study/NCT05971394 RECRUITING Infrapopliteal Lesions

NCT06289894 A Study of BRY805 in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06289894 NOT_YET_RECRUITING Advanced Solid Tumor DRUG: BRY805 injection BioRay Pharmaceutical Co., Ltd.

NCT02928094 Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia https://clinicaltrials.gov/study/NCT02928094 NOT_YET_RECRUITING Angina, Stable BIOLOGICAL: Ad5FGF-4

NCT00144794 Mucopolysaccharidosis I (MPS I) Registry https://clinicaltrials.gov/study/NCT00144794 RECRUITING Mucopolysaccharidosis I (MPS I) Genzyme, a Sanofi Company

NCT06445062 Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors https://clinicaltrials.gov/study/NCT06445062 RECRUITING Colorectal Cancer

NCT04275362 Gait Analysis of a Lateral-Pivot Design Total Knee Replacement https://clinicaltrials.gov/study/NCT04275362 RECRUITING Knee Osteoarthritis DEVICE: DJO Empowr PS Knee System

NCT05303662 Prevalence of Multidrug Resistant Micro-organism Carriage in Patients Undergoing an ERCP in Four Different Countries https://clinicaltrials.gov/study/NCT05303662 RECRUITING Drug Resistance, Multiple, Bacterial

NCT06570291 Allogenic Adipose-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis https://clinicaltrials.gov/study/NCT06570291 NOT_YET_RECRUITING Knee Osteoarthritis DRUG: Mesenchymal progenitor cells

NCT04486391 Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT04486391 RECRUITING Classical Hodgkin Lymphoma DRUG: Tislelizumab

NCT04052191 MCRcI¬Æ Stem Cell Treatment for Diffuse Coronary Artery Disease https://clinicaltrials.gov/study/NCT04052191 NOT_YET_RECRUITING Coronary Artery Disease BIOLOGICAL: MCRcI¬Æ stem cells Honya Medical Inc Chang Gung Memorial Hospital

NCT06396091 A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer https://clinicaltrials.gov/study/NCT06396091 RECRUITING Metastatic Pancreatic Adenocarcinoma DRUG: zolbetuximab

NCT05597891 Endovascular Engineering ENGULF Study https://clinicaltrials.gov/study/NCT05597891 RECRUITING Pulmonary Embolism DEVICE: Hƒìlo PE Thombectomy System Endovascular Engineering

NCT06344091 A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients https://clinicaltrials.gov/study/NCT06344091 RECRUITING Local Analgesia Via Infiltration DRUG: Bupivacaine Liposome Injection Jiangsu HengRui Medicine Co., Ltd.

NCT06308094 320-detector Computed Tomography to Assess Myocardial Extracellular Volume Fraction in Patients With Atrial Fibrillation Before AF Ablation. https://clinicaltrials.gov/study/NCT06308094 NOT_YET_RECRUITING Atrial Fibrillation DIAGNOSTIC_TEST: CT Johns Hopkins University Canon Medical Systems, USA

NCT05357794 Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides https://clinicaltrials.gov/study/NCT05357794 RECRUITING Mycosis Fungoides DRUG: Brentuximab vedotin M.D. Anderson Cancer Center Seagen Inc.

NCT05565794 Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements https://clinicaltrials.gov/study/NCT05565794 RECRUITING Intrahepatic Cholangiocarcinoma

NCT06661694 A Study to Learn How Different Tablets of the Study Medicine Mevrometostat Are Taken up Into the Blood in Healthy Adults https://clinicaltrials.gov/study/NCT06661694 NOT_YET_RECRUITING Healthy DRUG: Treatment A

NCT06110962 Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor https://clinicaltrials.gov/study/NCT06110962 NOT_YET_RECRUITING OSA DEVICE: Sleeptracker-AI Woolcock Institute of Medical Research Fullpower Technologies, Inc.

NCT05498662 An Observational Study of the T3 Pro Dental Implant System https://clinicaltrials.gov/study/NCT05498662 RECRUITING Tooth Loss DEVICE: T3 Pro dental implant system ZimVie

NCT06071962 Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain https://clinicaltrials.gov/study/NCT06071962 RECRUITING Pain

NCT06084091 Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery https://clinicaltrials.gov/study/NCT06084091 RECRUITING Coronary Artery Disease

NCT06297291 Global Paradise System US Post Approval Study https://clinicaltrials.gov/study/NCT06297291 RECRUITING Hypertension

NCT04725994 Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination with XELOX or Irinotecan in Patients with Advanced Gastric Cancer https://clinicaltrials.gov/study/NCT04725994 RECRUITING Gastric Cancer DRUG: IDX-1197+XELOX

NCT06506994 A Study of HRS-9057 in Patients With Heart Failure and Volume Overload https://clinicaltrials.gov/study/NCT06506994 NOT_YET_RECRUITING Heart Failure With Volume Overload DRUG: HRS-9057

NCT06450444 The RECLAIM Study. https://clinicaltrials.gov/study/NCT06450444 RECRUITING Chronic Migraine

NCT05864144 A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05864144 RECRUITING Solid Tumor, Adult

NCT06329544 High Fructose Diet, the Gut Microbiome, and Metabolic Health https://clinicaltrials.gov/study/NCT06329544 RECRUITING MASLD

NCT03033992 Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG https://clinicaltrials.gov/study/NCT03033992 RECRUITING Malignant Glioma

NCT06160492 Phase III Clinical Trial Evaluating the Efficacy and Safety of 5-aminolevulinic Acid (5-ALAÔºâ https://clinicaltrials.gov/study/NCT06160492 NOT_YET_RECRUITING 5-aminolevulinic Acid

NCT06224192 A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe AD https://clinicaltrials.gov/study/NCT06224192 RECRUITING Atopic Dermatitis COMBINATION_PRODUCT: Rocatinlimab Prefilled Syringe

NCT06659692 Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA. https://clinicaltrials.gov/study/NCT06659692 RECRUITING Ovarian Stimulation

NCT05883592 A Real-World Study on Distal Aortic Remodeling for Stanford Type B Aortic Dissection With Fabulous Thoracic Aortic Stent System https://clinicaltrials.gov/study/NCT05883592 NOT_YET_RECRUITING Aortic Dissection DEVICE: Fabulous Thoracic Aortic Stent System Hangzhou Endonom Medtech Co., Ltd.

NCT05181592 Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome. https://clinicaltrials.gov/study/NCT05181592 RECRUITING Myelodysplastic Syndromes DRUG: Luspatercept GWT-TUD GmbH Celgene

NCT05866692 A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05866692 RECRUITING Solid Tumor, Adult DRUG: TY-2699a TYK Medicines, Inc

NCT05944692 Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG) https://clinicaltrials.gov/study/NCT05944692 NOT_YET_RECRUITING Epilepsy DEVICE: Tripolar electroencephalography CREmedical Boston Children's Hospital

NCT06309992 A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight https://clinicaltrials.gov/study/NCT06309992 RECRUITING Obesity

NCT06555289 Outcomes of Clareon PanOptix in Patients With Prior Myopic Refractive Surgery https://clinicaltrials.gov/study/NCT06555289 RECRUITING Cataract DEVICE: Clareon PanOptix IOL Juliette Eye Institute Research Center Sengi

NCT06641089 Evaluation of Sonelokimab in Patients with Active Psoriatic Arthritis and Anti-TNFŒ± Inadequate Response https://clinicaltrials.gov/study/NCT06641089 RECRUITING Arthritis, Psoriatic DRUG: Sonelokimab

NCT03770429 AZD6738 for Patients With Progressive MDS or CMML https://clinicaltrials.gov/study/NCT03770429 RECRUITING Leukemia

NCT06396429 To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese https://clinicaltrials.gov/study/NCT06396429 RECRUITING Overweight or Obesity DRUG: HRS9531 injection

NCT06344429 Stellest Lenses and Low-concentration Atropine Myopia Control Among Children https://clinicaltrials.gov/study/NCT06344429 RECRUITING Myopia DEVICE: Stellest Lenses

NCT05768529 Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT05768529 RECRUITING Relapsed or Refractory Non-Hodgkin's Lymphoma DRUG: U16 Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

NCT05629429 Olaparib Maintenance Therapy in Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT05629429 RECRUITING Metastatic Breast Cancer DRUG: Olaparib

NCT06399029 Topical Ruxolitinib Evaluation in Immune-related Lichenoid Skin-Toxicities https://clinicaltrials.gov/study/NCT06399029 NOT_YET_RECRUITING Exanthema

NCT06114329 Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease https://clinicaltrials.gov/study/NCT06114329 RECRUITING Fabry Disease DRUG: AL01211 AceLink Therapeutics, Inc.

NCT06006689 Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis) https://clinicaltrials.gov/study/NCT06006689 RECRUITING Diabetic Kidney Disease DRUG: Qishen Yiqi Dripping Pills placebo 3 bags

NCT05166889 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations https://clinicaltrials.gov/study/NCT05166889 RECRUITING Chronic Obstructive Pulmonary Disease (COPD) DRUG: Tozorakimab

NCT06631989 A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients with EGFRm+ Advanced Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT06631989 RECRUITING EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer DRUG: WSD0922-FU Wayshine Biopharm, Inc.

NCT05642429 Study of AV-1959D, an Amyloid Beta Vaccine https://clinicaltrials.gov/study/NCT05642429 RECRUITING Alzheimer Disease BIOLOGICAL: AV-1959D

NCT05593029 A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder https://clinicaltrials.gov/study/NCT05593029 RECRUITING Major Depressive Disorder DRUG: SEP-363856

NCT06652529 Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06652529 NOT_YET_RECRUITING Solid Tumors (Phase 1)

NCT06484829 Puesta Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT06484829 NOT_YET_RECRUITING Relapsed or Refractory Multiple Myeloma (RRMM) DRUG: Purinostat Mesylate 3mg/m2

NCT05305729 Metabolic FingerPrinting https://clinicaltrials.gov/study/NCT05305729 RECRUITING Genetic Disease OTHER: No intervention Arcensus GmbH

NCT05143229 Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer https://clinicaltrials.gov/study/NCT05143229 RECRUITING Breast Cancer DRUG: Alpelisib

NCT06544629 Imjudo & Imfinzi PMS https://clinicaltrials.gov/study/NCT06544629 NOT_YET_RECRUITING Hepatocellular Carcinoma AstraZeneca

NCT05460780 First-in-human, Study of MATTISSE¬Æ Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer https://clinicaltrials.gov/study/NCT05460780 RECRUITING Breast Cancer Female

NCT04239144 Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas Disease https://clinicaltrials.gov/study/NCT04239144 RECRUITING Chagas Cardiomyopathy

NCT05255744 Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol https://clinicaltrials.gov/study/NCT05255744 NOT_YET_RECRUITING Obstructive Sleep Apnea DEVICE: Positive Airway Pressure (PAP) Therapy ResMed Singapore General Hospital

NCT04609592 Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery https://clinicaltrials.gov/study/NCT04609592 RECRUITING Gastroenteropancreatic Neuroendocrine Tumor DRUG: Lutathera

NCT06568692 A Phase 2 Study of PCS6422 with Capecitabine in Patients with Advanced or Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT06568692 RECRUITING Breast Cancer

NCT05969392 Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain https://clinicaltrials.gov/study/NCT05969392 NOT_YET_RECRUITING Pain, Cervical

NCT06182592 A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06182592 NOT_YET_RECRUITING High-risk (Secondary) Acute Myeloid Leukemia DRUG: Liposomal cytarabine-daunorubicin for injection

NCT05961592 R-2487 in Patients with Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT05961592 RECRUITING Arthritis, Rheumatoid DRUG: R-2487 Rise Therapeutics LLC

NCT05271292 Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. https://clinicaltrials.gov/study/NCT05271292 RECRUITING Small Cell Lung Cancer

NCT06298292 Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies https://clinicaltrials.gov/study/NCT06298292 NOT_YET_RECRUITING Tyrosinemia, Type I

NCT03734692 Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer https://clinicaltrials.gov/study/NCT03734692 RECRUITING Ovarian Cancer Recurrent DRUG: Rintatolimod

NCT05522192 Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT05522192 RECRUITING Relapsed or Refractory Acute Myeloid Leukemia DRUG: Mitoxantrone liposome

NCT05500092 An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05500092 RECRUITING Resectable Stage IIA to IIIB Non-small Cell Lung Cancer DRUG: Nivolumab

NCT06439589 Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06439589 RECRUITING Advanced Solid Tumors DRUG: HRS2398

NCT05508789 A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) https://clinicaltrials.gov/study/NCT05508789 RECRUITING Alzheimer Disease

NCT05555589 Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 https://clinicaltrials.gov/study/NCT05555589 RECRUITING Neurotrophic Keratopathy DRUG: RGN-259

NCT06616389 Study of ODX (OsteoDex) in Multiple Myeloma https://clinicaltrials.gov/study/NCT06616389 RECRUITING Multiple Myeloma DRUG: ODX (Osteodex) DexTech Medical AB

NCT04106492 Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04106492 RECRUITING Cancer DRUG: SQ3370 Shasqi, Inc.

NCT01954992 Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer https://clinicaltrials.gov/study/NCT01954992 RECRUITING Metastatic Pancreatic Adenocarcinoma DRUG: Glufosfamide

NCT05767892 YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations https://clinicaltrials.gov/study/NCT05767892 NOT_YET_RECRUITING Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) DRUG: YK-209A tablet

NCT06233292 A Study of ZG005 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06233292 RECRUITING Solid Tumors BIOLOGICAL: ZG005 Powder for Injection

NCT06185192 Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c https://clinicaltrials.gov/study/NCT06185192 RECRUITING Diabetes DIETARY_SUPPLEMENT: Viome's Precision Nutrition Program (VPNP) Viome

NCT05142592 IPG7236 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05142592 RECRUITING Safety Issues

NCT04171492 Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules https://clinicaltrials.gov/study/NCT04171492 RECRUITING Nodule Solitary Pulmonary

NCT06023589 A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma https://clinicaltrials.gov/study/NCT06023589 RECRUITING Asthma BIOLOGICAL: Tezepelumab

NCT06609889 A Safety and Efficacy of Intrathecally Administered ION283 in Patients with Lafora Disease https://clinicaltrials.gov/study/NCT06609889 RECRUITING Lafora Disease GENETIC: ION283 Berge Minassian Elpida Therapeutics SPC

NCT06218589 Non-Invasive Diagnostic Tests for MASLD in Pediatric Population https://clinicaltrials.gov/study/NCT06218589 RECRUITING Metabolic Dysfunction Associated Steatotic Liver Disease

NCT04821089 A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines https://clinicaltrials.gov/study/NCT04821089 RECRUITING Moderate to Severe Upper Facial Lines BIOLOGICAL: IPN10200

NCT04458389 A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas https://clinicaltrials.gov/study/NCT04458389 RECRUITING Locally Advanced /Metastatic Solid Tumors

NCT03737929 Hybrid Therapy and Heart Team for Atrial Fibrillation https://clinicaltrials.gov/study/NCT03737929 RECRUITING Atrial Fibrillation PROCEDURE: Hybrid ablation

NCT03882229 Middle East MED-EL Observatory Study https://clinicaltrials.gov/study/NCT03882229 RECRUITING Cochlear Implants DEVICE: MED-EL CI systems MED-EL Elektromedizinische Ger√§te GesmbH

NCT05685329 Determining Patterns In Trial Experiences of Parkinson's Disease Patients https://clinicaltrials.gov/study/NCT05685329 NOT_YET_RECRUITING Parkinson Disease Power Life Sciences Inc.

NCT04510129 A Multicenter Cancer Biospecimen Collection Study https://clinicaltrials.gov/study/NCT04510129 RECRUITING Cancer of Head and Neck

NCT05231629 Sequential Therapy in Multiple Myeloma Guided by MRD Assessments https://clinicaltrials.gov/study/NCT05231629 RECRUITING Multiple Myeloma DRUG: Dara-VRd intensification, Dara-R maintenance

NCT04423029 A Study of DF6002 Alone and in Combination With Nivolumab https://clinicaltrials.gov/study/NCT04423029 RECRUITING Solid Tumors DRUG: DF6002

NCT05091229 A Blood Test to Diagnose Kawasaki Disease https://clinicaltrials.gov/study/NCT05091229 NOT_YET_RECRUITING Kawasaki Disease HBI Solutions Inc. Shanghai Children's Medical Center

NCT03992729 Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With Tildrakizumab https://clinicaltrials.gov/study/NCT03992729 RECRUITING Pregnancy Related DRUG: Pregnant women exposed to tildrakizumab

NCT05157529 AQUABEAM¬Æ Robotic System and Ultrasound Accessories https://clinicaltrials.gov/study/NCT05157529 RECRUITING Benign Prostatic Hyperplasia

NCT06401629 Outcomes After Unified Versus Standard GDM Diagnosis https://clinicaltrials.gov/study/NCT06401629 NOT_YET_RECRUITING Gestational Diabetes

NCT05222529 Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma https://clinicaltrials.gov/study/NCT05222529 RECRUITING Asthma DRUG: Glycopyrronium bromide 25ug

NCT06508489 A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies https://clinicaltrials.gov/study/NCT06508489 RECRUITING Acute Myeloid Leukemia BIOLOGICAL: SAR443579

NCT06552429 Peginterferon Œ±-2b Injection for Hydroxyurea Resistant or Intolerant ET https://clinicaltrials.gov/study/NCT06552429 RECRUITING Essential Thrombocythemia DRUG: Peginterferon Œ±-2b injection

NCT06227429 A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients https://clinicaltrials.gov/study/NCT06227429 RECRUITING Hereditary Tyrosinemia, Type I DRUG: Nitisinone Swedish Orphan Biovitrum

NCT04801329 Korean Post-marketing Surveillance Vyndamax¬Æ Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy https://clinicaltrials.gov/study/NCT04801329 RECRUITING ATTR-CM (Transthyretin Amyloid Cardiomyopathy) DRUG: Vyndamax (tafamidis 61mg) Pfizer

NCT06012929 A Study of ONC201 for Refractory Meningioma https://clinicaltrials.gov/study/NCT06012929 NOT_YET_RECRUITING Meningioma

NCT06620029 BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer https://clinicaltrials.gov/study/NCT06620029 NOT_YET_RECRUITING Ovarian Neoplasms

NCT04878029 Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer https://clinicaltrials.gov/study/NCT04878029 RECRUITING Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation

NCT05421429 KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia https://clinicaltrials.gov/study/NCT05421429 RECRUITING Hemophilia BIOLOGICAL: KN057 dose‚Ö†

NCT06363929 Continuous Glucose Monitoring in Neonatal Hyperinsulinism https://clinicaltrials.gov/study/NCT06363929 RECRUITING Hyperinsulinism

NCT05893992 fNIRS, Listening Effort, and Motivation https://clinicaltrials.gov/study/NCT05893992 NOT_YET_RECRUITING Hearing Loss DEVICE: Hearing aids (omnidirectional)

NCT03899792 A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors https://clinicaltrials.gov/study/NCT03899792 RECRUITING Medullary Thyroid Cancer

NCT05480592 A Study of HS-10380 in Chinese Participants https://clinicaltrials.gov/study/NCT05480592 RECRUITING Schizophrenia DRUG: HS-10380

NCT04600492 THERAPY-HYBRID-BPA Trial https://clinicaltrials.gov/study/NCT04600492 RECRUITING Hypertension, Pulmonary DRUG: Riociguat Oral Tablet National Hospital Organization Okayama Medical Center Bayer Yakuhin, Ltd.

NCT06476392 Melatonin for CHronic BAck Pain (The MOCHA Trial) https://clinicaltrials.gov/study/NCT06476392 RECRUITING Back Pain Lower Back Chronic

NCT05533892 Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC https://clinicaltrials.gov/study/NCT05533892 RECRUITING Hepatocellular Carcinoma DRUG: Nocardia rubra cell wall skeleton

NCT06118892 MISHA¬Æ Post-Market Clinical Study https://clinicaltrials.gov/study/NCT06118892 RECRUITING Osteo Arthritis Knee DEVICE: MISHA Knee System Moximed

NCT05684692 Screening Trial for Pain Relief in Schwannomatosis (STARFISH) https://clinicaltrials.gov/study/NCT05684692 RECRUITING Schwannomatosis

NCT06677892 A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium https://clinicaltrials.gov/study/NCT06677892 NOT_YET_RECRUITING Cytomegalovirus (CMV) OTHER: No Intervention Takeda

NCT01817192 Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT01817192 RECRUITING Non-Small Cell Lung Cancer DRUG: Adjuvant Chemotherapy

NCT04936789 Clinical Feasibility of the IMES Transradial Prosthesis https://clinicaltrials.gov/study/NCT04936789 RECRUITING Amputation DEVICE: IMES √ñssur Iceland ehf

NCT06564389 FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients https://clinicaltrials.gov/study/NCT06564389 RECRUITING Healthy Participants

NCT04856189 Selinexor and Pembrolizumab for the Treatment of Cisplatin-Ineligible or Cisplatin-Refractory Locally Advanced or Metastatic Urothelial Carcinoma https://clinicaltrials.gov/study/NCT04856189 RECRUITING Advanced Urothelial Carcinoma

NCT04191889 A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification https://clinicaltrials.gov/study/NCT04191889 RECRUITING C-staged Hepatocellular Carcinoma in BCLC Classification COMBINATION_PRODUCT: Hepatic Arterial Infusion combined with Apatinib and Camrelizumab Sun Yat-sen University Jiangsu HengRui Medicine Co., Ltd.

NCT02998229 Artisse‚Ñ¢ Intrasaccular Device IDE https://clinicaltrials.gov/study/NCT02998229 RECRUITING Intracranial Aneurysm DEVICE: Artisse‚Ñ¢ Intrasaccular Device Medtronic Neurovascular Clinical Affairs

NCT05161429 BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes https://clinicaltrials.gov/study/NCT05161429 RECRUITING Diabetes Mellitus, Type 2 DRUG: DPP4

NCT06071429 Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease https://clinicaltrials.gov/study/NCT06071429 NOT_YET_RECRUITING Chronic Limb-Threatening Ischemia DEVICE: MAGNITUDE Sirolimus-eluting Bioresorbable Scaffold

NCT05450029 Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer https://clinicaltrials.gov/study/NCT05450029 RECRUITING Rectal Cancer DRUG: Sintilimab Yanhong Deng GeneCast Biotechnology Co., Ltd.

NCT06465329 A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC) https://clinicaltrials.gov/study/NCT06465329 RECRUITING Non-Small Cell Lung Cancer DRUG: Cemiplimab

NCT05150691 A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05150691 RECRUITING HER2-positive Advanced Solid Tumor BIOLOGICAL: DB-1303/BNT323

NCT06119594 Contribution of the Evaluation of Body Composition by Connected Scale in the Effectiveness of a Reconditioning Program Through Physical Activity Adapted for Patients Suffering From Chronic Diseases https://clinicaltrials.gov/study/NCT06119594 RECRUITING Chronic Disease DEVICE: Body Comp Pro connected scale (Withings manufacturer) Assistance Publique - H√¥pitaux de Paris H√¥pital Lariboisi√®re Fernand Widal

NCT06041594 Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) https://clinicaltrials.gov/study/NCT06041594 NOT_YET_RECRUITING Pulmonary Embolism DEVICE: Laguna Thrombectomy System Innova Vascular, Inc.

NCT05824494 Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors https://clinicaltrials.gov/study/NCT05824494 NOT_YET_RECRUITING Uterine Cervical Neoplasms

NCT05444894 EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) https://clinicaltrials.gov/study/NCT05444894 RECRUITING Transfusion Dependent Beta Thalassemia

NCT05867160 Adjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) Study https://clinicaltrials.gov/study/NCT05867160 RECRUITING Epilepsy OTHER: ASM as adjunctive therapy Aziende Chimiche Riunite Angelini Francesco S.p.A Hippocrates Research

NCT06021860 A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients https://clinicaltrials.gov/study/NCT06021860 NOT_YET_RECRUITING Edema Due to Heart Failure or Cirrhosis DRUG: Spironolactone Oral Suspension CMP Development, LLC

NCT06462560 Live and Interactive Fitness Training Program (Vivo Knee OA) https://clinicaltrials.gov/study/NCT06462560 RECRUITING Knee Osteoarthritis OTHER: Vivo Online Exercise Program

NCT06072560 Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain https://clinicaltrials.gov/study/NCT06072560 RECRUITING Pain

NCT06228560 Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment https://clinicaltrials.gov/study/NCT06228560 RECRUITING Chronic Spontaneous Urticaria BIOLOGICAL: LP-003

NCT06340360 A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA) https://clinicaltrials.gov/study/NCT06340360 RECRUITING Alopecia Areata DRUG: Rezpegaldesleukin

NCT04064060 A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials https://clinicaltrials.gov/study/NCT04064060 RECRUITING Myelodysplastic Syndromes (MDS)

NCT06657560 Pharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Renal Function https://clinicaltrials.gov/study/NCT06657560 RECRUITING Contrast-Enhanced Magnetic Resonance Imaging Detection DRUG: HRS-9231 Shanghai Shengdi Pharmaceutical Co., Ltd

NCT03237494 TRAMmoniTTR Study Genetic Screening of an At-risk Population for HATTR and Monitoring of TTR Positive Subjects https://clinicaltrials.gov/study/NCT03237494 RECRUITING Transthyretin Amyloidosis

NCT04885894 An Examination of Cognitive Fatigue Using Functional Neuroimaging https://clinicaltrials.gov/study/NCT04885894 RECRUITING Multiple Sclerosis, Relapsing-Remitting DRUG: Zeposia Kessler Foundation Celgene

NCT06008691 A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice https://clinicaltrials.gov/study/NCT06008691 RECRUITING Non-Hodgkin Lymphoma, B-cell DRUG: "novel" MAB (alone or in combination) Fondazione Italiana Linfomi - ETS Roche Pharma AG

NCT04829994 Post-Market Clinical Follow-Up onTVT EXACT¬Æ Continence System https://clinicaltrials.gov/study/NCT04829994 RECRUITING Stress Urinary Incontinence DEVICE: Intervention Ethicon, Inc.

NCT06319794 Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis https://clinicaltrials.gov/study/NCT06319794 RECRUITING Actinic Keratosis DRUG: Bimiralisib

NCT05901194 Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT05901194 NOT_YET_RECRUITING Hepatocellular Carcinoma Non-resectable DRUG: Lenvatinib Assistance Publique - H√¥pitaux de Paris Laboratoire EISAI

NCT05790694 A Trial of HBM9378 in Healthy Chinese Subjects https://clinicaltrials.gov/study/NCT05790694 RECRUITING Asthma DRUG: HBM9378 (SKB378) Injection

NCT06597994 Augmenting Urinary Reflex Activity: Study 3 https://clinicaltrials.gov/study/NCT06597994 NOT_YET_RECRUITING Urinary Incontinence DEVICE: Amber UI system Amber Therapeutics Ltd

NCT06699160 Refobacin Revision-3 Bone Cement Post-Market Study https://clinicaltrials.gov/study/NCT06699160 NOT_YET_RECRUITING Revision Arthroplasty DEVICE: Revision arthroplasty Zimmer Biomet

NCT06241560 A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood https://clinicaltrials.gov/study/NCT06241560 NOT_YET_RECRUITING Idiopathic Pulmonary Fibrosis DRUG: BI 1015550

NCT04554160 Arrhythmias in Pulmonary Hypertension Assessed by Continuous Long-term Cardiac Monitoring https://clinicaltrials.gov/study/NCT04554160 RECRUITING Pulmonary Hypertension

NCT05090891 To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva https://clinicaltrials.gov/study/NCT05090891 RECRUITING Fibrodysplasia Ossificans Progressiva (FOP) DRUG: INCB000928

NCT04676594 Genentech Validation Tool for Pulmonary Fibrosis https://clinicaltrials.gov/study/NCT04676594 RECRUITING Interstitial Lung Disease Columbia University Genentech, Inc.

NCT06616194 A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine https://clinicaltrials.gov/study/NCT06616194 RECRUITING Migraine DRUG: Rimegepant

NCT06148194 Efficacy of Probiotics (LiveSpo Navax) in Preventing Respiratory Diseases in Children https://clinicaltrials.gov/study/NCT06148194 RECRUITING Respiratory Disease

NCT06373094 A Single Dose Escalation Study of HHT201 in Healthy Subjects https://clinicaltrials.gov/study/NCT06373094 NOT_YET_RECRUITING Alzheimer Disease DRUG: Donepezil Dihydroxynaphthalate for Injection Shanghai Synergy Pharmaceutical Sciences Co., Ltd.

NCT06568094 A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer https://clinicaltrials.gov/study/NCT06568094 RECRUITING Prostate Cancer DRUG: HRS-5041 tablets

NCT05452694 OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults https://clinicaltrials.gov/study/NCT05452694 RECRUITING Lumbar Spine Stenosis

NCT06564194 A Phase 1 Study to Evaluate JCXH-108, an MRNA-based Vaccine Against RSV https://clinicaltrials.gov/study/NCT06564194 RECRUITING Respiratory Syncytial Virus (RSV)

NCT06296160 A Simplified Lung Ultrasound Guided Management Protocol Of Pulmonary Congestion in Hemodialysis https://clinicaltrials.gov/study/NCT06296160 RECRUITING End Stage Renal Disease OTHER: Intervention Group Hamad Medical Corporation Brugmann University Hospital

NCT06453694 Efgartigimod for the Treatment of Acute Optic Neuritis https://clinicaltrials.gov/study/NCT06453694 NOT_YET_RECRUITING Optic Neuritis DRUG: Efgartigimod Alfa

NCT05889260 Speech Accessibility Project https://clinicaltrials.gov/study/NCT05889260 RECRUITING Parkinson Disease

NCT05815160 Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy https://clinicaltrials.gov/study/NCT05815160 RECRUITING Small Cell Lung Cancer Recurrent DRUG: Debio 0123

NCT02402660 Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease https://clinicaltrials.gov/study/NCT02402660 RECRUITING Stargardt Disease

NCT06638060 Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Older Adults Department PHC https://clinicaltrials.gov/study/NCT06638060 NOT_YET_RECRUITING Aging Medtronic - MITG Excelar

NCT05115760 Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy https://clinicaltrials.gov/study/NCT05115760 RECRUITING Locally Advanced Head and Neck Carcinoma DIETARY_SUPPLEMENT: Dietary Supplement

NCT05864560 Ankura‚Ñ¢ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up https://clinicaltrials.gov/study/NCT05864560 RECRUITING Abdominal Aortic Aneurysm DEVICE: Ankura‚Ñ¢ AAA Stent Graft System; Ankura‚Ñ¢ Cuff Stent Graft System; Ankura‚Ñ¢ AUI Stent Graft System Lifetech Scientific (Shenzhen) Co., Ltd.

NCT05713994 Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT05713994 RECRUITING Hepatocellular Carcinoma Non-resectable PROCEDURE: HAIC

NCT06149494 RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection https://clinicaltrials.gov/study/NCT06149494 RECRUITING COPD Exacerbation Acute

NCT06462794 First In Human Study of CX-801 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06462794 RECRUITING Solid Tumor, Adult DRUG: CX-801

NCT06553794 Protein Digestion and Amino Acid Absorption in the Aging Gastrointestinal Tract https://clinicaltrials.gov/study/NCT06553794 NOT_YET_RECRUITING Protein Malabsorption OTHER: Gastroscopy with duodenal mucosal tissue biopsies Maastricht University Medical Center FrieslandCampina

NCT05076760 MEM-288 Oncolytic Virus Alone and in Combination With Nivolumab in Solid Tumors Including Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05076760 RECRUITING Solid Tumor

NCT05362760 Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management https://clinicaltrials.gov/study/NCT05362760 RECRUITING Hormone Receptor-positive Metastatic Breast Cancer

NCT05442060 To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05442060 RECRUITING Non-small Cell Lung Cancer BIOLOGICAL: 30 Œºg OBI-833/100 Œºg OBI-821

NCT06508060 Bimodal Stimulation Using Auditory and Vibrotactile Stimuli for the Mitigation of Tinnitus https://clinicaltrials.gov/study/NCT06508060 NOT_YET_RECRUITING Tinnitus DEVICE: Neosensory Wristband

NCT04404894 Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris¬Æ Testing https://clinicaltrials.gov/study/NCT04404894 RECRUITING Prostate Cancer Myriad Genetic Laboratories, Inc.

NCT05317494 A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece https://clinicaltrials.gov/study/NCT05317494 RECRUITING Acute Myeloid Leukemia AbbVie

NCT02038660 Drug-Eluting Balloon Registry in Routine Clinical Practice https://clinicaltrials.gov/study/NCT02038660 RECRUITING Coronary Artery Disease

NCT05494060 XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma https://clinicaltrials.gov/study/NCT05494060 RECRUITING Carcinoma

NCT05028660 AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study https://clinicaltrials.gov/study/NCT05028660 RECRUITING Muscle-Invasive Bladder Carcinoma DIAGNOSTIC_TEST: GAG score Elypta Lund University

NCT06291194 Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients https://clinicaltrials.gov/study/NCT06291194 RECRUITING Dry Eye Syndromes DRUG: AJU-S56 5%

NCT05492994 A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease https://clinicaltrials.gov/study/NCT05492994 RECRUITING Lung Diseases, Interstitial DIAGNOSTIC_TEST: Spirometry

NCT06344494 Cardiac Interventional ICE Imaging Trial https://clinicaltrials.gov/study/NCT06344494 NOT_YET_RECRUITING Structural Heart Diseases

NCT06721494 A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine https://clinicaltrials.gov/study/NCT06721494 NOT_YET_RECRUITING Methamphetamine Intoxication

NCT06098560 A Biomarker Study for Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H Colorectal Patients https://clinicaltrials.gov/study/NCT06098560 RECRUITING Colorectal Cancer Geneplus-Beijing Co. Ltd.

NCT06463860 Multi-Center Study to Evaluate the Performance of DermDx for Primary Care Physicians in the Detection of Skin Cancers https://clinicaltrials.gov/study/NCT06463860 NOT_YET_RECRUITING Skin Cancer DEVICE: DermDx MetaOptima Technology Inc.

NCT06666660 Daily Intake of Multivitamin & Mineral Supplementation Effects on Biological Age of Relatively Healthy Middle-aged Individuals https://clinicaltrials.gov/study/NCT06666660 RECRUITING Relatively Healthy Volunteers DIETARY_SUPPLEMENT: Multivitamin/Mineral supplements

NCT05224960 Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2) https://clinicaltrials.gov/study/NCT05224960 RECRUITING Decompensated Cirrhosis BIOLOGICAL: UC-MSCs

NCT05627960 First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies https://clinicaltrials.gov/study/NCT05627960 RECRUITING Triple Negative Breast Cancer

NCT06643260 A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy https://clinicaltrials.gov/study/NCT06643260 NOT_YET_RECRUITING Plaque Psoriasis DRUG: piclidenoson

NCT05263960 A Study of CM350 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05263960 RECRUITING Advanced Solid Tumor DRUG: CM350_group 1

NCT06372860 DPP Feasibility Study of Breastfeeding - eMOMS 2.0 https://clinicaltrials.gov/study/NCT06372860 RECRUITING Overweight or Obesity

NCT06029660 AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion https://clinicaltrials.gov/study/NCT06029660 RECRUITING Aortic Aneurysm, Abdominal DEVICE: IMPEDE-FX RapidFill Implants

NCT05666960 R-3750 in Patients With Mild to Moderate Ulcerative Colitis https://clinicaltrials.gov/study/NCT05666960 RECRUITING Ulcerative Colitis Chronic Mild

NCT06205160 Evaluation of New Flexible High-density Intra-operative ECoG Electrodes for Epilepsy Surgery. ( EpiGrid ) https://clinicaltrials.gov/study/NCT06205160 NOT_YET_RECRUITING Focal Epilepsy

NCT06548360 A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo https://clinicaltrials.gov/study/NCT06548360 RECRUITING NonSegmental Vitiligo DRUG: Ruxolitinib Cream

NCT06176560 Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis. https://clinicaltrials.gov/study/NCT06176560 NOT_YET_RECRUITING Colitis, Ulcerative DRUG: Mesalazine Faes Farma, S.A.

NCT06667960 Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer https://clinicaltrials.gov/study/NCT06667960 RECRUITING Solid Tumor DRUG: JK06 Salubris Biotherapeutics Inc

NCT05286060 Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer https://clinicaltrials.gov/study/NCT05286060 RECRUITING Head and Neck Squamous Cell Carcinoma DRUG: GX-188E, GX-I7, Pembrolizumab

NCT05878860 ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis https://clinicaltrials.gov/study/NCT05878860 RECRUITING X-linked Retinoschisis BIOLOGICAL: ATSN-201 Atsena Therapeutics Inc.

NCT06665776 HLA-A*02:01 Allele Frequency and the NY-ESO-1 Expression Status in Cancer Patients in Taiwan https://clinicaltrials.gov/study/NCT06665776 RECRUITING Solid Tumor Malignancy PharmaEssentia

NCT06409494 Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years https://clinicaltrials.gov/study/NCT06409494 RECRUITING Varicella Zoster Virus Infection

NCT06544694 A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease https://clinicaltrials.gov/study/NCT06544694 RECRUITING Dry Eye Disease DRUG: 0.003% AR-15512

NCT06292494 Focused Ultrasound for Drug-resistant Epilepsy https://clinicaltrials.gov/study/NCT06292494 RECRUITING Focused Ultrasound

NCT06232460 An Open Label, Dose-escalation Study, Assessing the Safety and Tolerability of a Collagen Peptide https://clinicaltrials.gov/study/NCT06232460 NOT_YET_RECRUITING Tolerance DIETARY_SUPPLEMENT: H80 Rousselot BVBA

NCT05643560 An Observational Study Called JOIHA to Learn More About How Well the Treatment With Jivi Works to Prevent Problems With Joints in Adults With Hemophilia A. https://clinicaltrials.gov/study/NCT05643560 RECRUITING Hemophilia A

NCT05629260 The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation https://clinicaltrials.gov/study/NCT05629260 RECRUITING Hematological Malignancy DRUG: ATG

NCT05595460 Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC https://clinicaltrials.gov/study/NCT05595460 RECRUITING SCLC,Extensive Stage DRUG: RYZ101 Dose Level 1

NCT06630260 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours https://clinicaltrials.gov/study/NCT06630260 RECRUITING Glioblastoma Multiforme (GBM)

NCT05047094 A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC https://clinicaltrials.gov/study/NCT05047094 RECRUITING Head and Neck Squamous Cell Carcinoma

NCT04413994 Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC) https://clinicaltrials.gov/study/NCT04413994 RECRUITING Prematurity

NCT05000294 Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types https://clinicaltrials.gov/study/NCT05000294 RECRUITING Bile Duct Cancer

NCT06107894 TIL Therapy for Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06107894 NOT_YET_RECRUITING Advanced Breast Cancer

NCT01374360 Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry https://clinicaltrials.gov/study/NCT01374360 RECRUITING Paroxysmal Nocturnal Hemoglobinuria Alexion Pharmaceuticals, Inc.

NCT05423860 Phase I Human Analytics (HALO) Study https://clinicaltrials.gov/study/NCT05423860 RECRUITING Cardiovascular Diseases

NCT05633160 64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) https://clinicaltrials.gov/study/NCT05633160 RECRUITING Prostatic Neoplasms

NCT05956860 Radial Access for Abdominopelvic Vascular Intervention https://clinicaltrials.gov/study/NCT05956860 RECRUITING Vascular Access Device Complications PROCEDURE: abdominopelvic vascular intervention through the radial artery access Zhongda Hospital Terumo Medical Corporation

NCT06438562 Evaluation of Vitamin A Absorption From Fortified Bouillon https://clinicaltrials.gov/study/NCT06438562 RECRUITING Healthy Volunteers

NCT06016062 A Study of RC148 in Patients With Locally Advanced Unresectable or Metastatic Malignant Solid Tumors https://clinicaltrials.gov/study/NCT06016062 RECRUITING Solid Tumor DRUG: RC148 RemeGen Co., Ltd.

NCT06382662 Assess the Effect of Metaxalone 640 mg (M640) Compared to Tizanidine 8 mg on Truck Driving Ability and Cognition https://clinicaltrials.gov/study/NCT06382662 RECRUITING Cognitive Impairment DRUG: metaxalone m640

NCT02815891 A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD) https://clinicaltrials.gov/study/NCT02815891 RECRUITING Nonalcoholic Fatty Liver

NCT05055791 A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies https://clinicaltrials.gov/study/NCT05055791 NOT_YET_RECRUITING Acute Myeloid Leukemia

NCT06151691 Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics Approach https://clinicaltrials.gov/study/NCT06151691 NOT_YET_RECRUITING Pancreatic Ductal Adenocarcinoma OTHER: Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test Fudan University Shanghai Weihe Medical Laboratory Co., Ltd.

NCT05223491 En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer https://clinicaltrials.gov/study/NCT05223491 RECRUITING Non-muscle Invasive Bladder Cancer PROCEDURE: En Bloc resection

NCT05838391 Adaptive Radiation in Anal Cancer https://clinicaltrials.gov/study/NCT05838391 RECRUITING Anal Squamous Cell Carcinoma RADIATION: Artificial Intelligence Guided Daily Radiotherapy Treatment Planning and Delivery

NCT03740191 Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer https://clinicaltrials.gov/study/NCT03740191 RECRUITING Low Risk Prostate Cancer

NCT06373991 A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT06373991 NOT_YET_RECRUITING Lupus Erythematosus, Systemic BIOLOGICAL: ATHENA CAR-T

NCT06112691 ARTIFICIAL INTELLIGENCE FOR MASS SCREENING OF THE DIABETIC RETINOPATHY IN THE CHERNIVTSI REGION (Pilot Study) https://clinicaltrials.gov/study/NCT06112691 RECRUITING Diabetic Retinopathy DEVICE: taking fundus photos using non-mydriatic fundus camera - FundusScope Rodenstock The Filatov Institute of Eye Diseases and Tissue Therapy Komisarenko Institute of Endocrinology and Metobolism

NCT06492291 Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension https://clinicaltrials.gov/study/NCT06492291 RECRUITING Hypercholesterolemia DRUG: Enlicitide Decanoate Merck Sharp & Dohme LLC

NCT06187194 Efficacy and Safety of an Irreversible Electroporation (IRE) System for Tonsil Reduction for The Treatment of Chronic Symptomatic Tonsillar Hypertrophy https://clinicaltrials.gov/study/NCT06187194 RECRUITING Tonsillar Hypertrophy DEVICE: IRE System ENTire Medical Ltd.

NCT05667194 Phase 1 Trial of KH617 https://clinicaltrials.gov/study/NCT05667194 RECRUITING Advanced Solid Tumors DRUG: KH617 Sichuan Honghe Biotechnology Co., Ltd.

NCT04190862 E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas https://clinicaltrials.gov/study/NCT04190862 RECRUITING Anal Fistula DRUG: E-CEL UVEC Weill Medical College of Cornell University Angiocrine Bioscience

NCT05116462 Neoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer https://clinicaltrials.gov/study/NCT05116462 RECRUITING Non-Small Cell Lung Cancer DRUG: Pemetrexed

NCT06581562 Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. https://clinicaltrials.gov/study/NCT06581562 RECRUITING Rheumatoid Arthritis

NCT06310291 VTP-1000 in Adults With Celiac Disease https://clinicaltrials.gov/study/NCT06310291 RECRUITING Celiac Disease BIOLOGICAL: VTP-1000

NCT05955391 TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC) https://clinicaltrials.gov/study/NCT05955391 RECRUITING Non-small Cell Lung Cancer DRUG: TGRX-326 Shenzhen TargetRx, Inc. Sun Yat-sen University

NCT05664191 Levosimendan as Treatment of Aneurysmal SubArachnoid Haemorrhage https://clinicaltrials.gov/study/NCT05664191 RECRUITING Sub-arachnoid Haemorrhage DRUG: Levosimendan

NCT05556291 Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study https://clinicaltrials.gov/study/NCT05556291 RECRUITING Efficacy

NCT06334991 Study for Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT06334991 NOT_YET_RECRUITING Non-Hodgkin Lymphoma Refractory/ Relapsed BIOLOGICAL: CD19 t-haNK ImmunityBio, Inc.

NCT04761991 CMR Versus CT in Coronary Artery Disease https://clinicaltrials.gov/study/NCT04761991 RECRUITING Coronary Artery Disease DIAGNOSTIC_TEST: CMR and CTCA with CT-FFR University of Leicester HeartFlow, Inc.

NCT05671991 Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease https://clinicaltrials.gov/study/NCT05671991 RECRUITING End Stage Renal Disease on Dialysis DRUG: Empagliflozin 25 mg vs Placebo

NCT04045691 Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment https://clinicaltrials.gov/study/NCT04045691 RECRUITING Melanoma Stage IV

NCT05570591 Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy https://clinicaltrials.gov/study/NCT05570591 RECRUITING Central Serous Chorioretinopathy DEVICE: 2RT subthreshold nanosecond laser - active

NCT05907291 Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn) https://clinicaltrials.gov/study/NCT05907291 RECRUITING Congenital Adrenal Hyperplasia

NCT05051891 A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-na—óve Mantle Cell Lymphoma https://clinicaltrials.gov/study/NCT05051891 RECRUITING Treatment-na—óve Mantle Cell Lymphoma DRUG: Orelabrutinib and R-CHOP

NCT06464991 A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03) https://clinicaltrials.gov/study/NCT06464991 RECRUITING Multiple Myeloma DRUG: Equecabtagene Autoleucel Injection

NCT06316791 Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases https://clinicaltrials.gov/study/NCT06316791 RECRUITING Lupus Erythematosus, Systemic BIOLOGICAL: single dose of CNCT19 Juventas Cell Therapy Ltd.

NCT06181591 A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB) https://clinicaltrials.gov/study/NCT06181591 NOT_YET_RECRUITING Overactive Bladder DRUG: Mirabegron 50 MG

NCT06302491 A Study of Safety and Efficiency of AND017 in Patients With Œ≤-thalassemia https://clinicaltrials.gov/study/NCT06302491 RECRUITING Œ≤ -Thalassemia DRUG: AND017 capsules

NCT05358691 A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants https://clinicaltrials.gov/study/NCT05358691 NOT_YET_RECRUITING Lung Cancer Stage III DRUG: AN0025 Rutgers, The State University of New Jersey Adlai Nortye Biopharma Co., Ltd.

NCT03474094 Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy https://clinicaltrials.gov/study/NCT03474094 RECRUITING Sarcoma,Soft Tissue COMBINATION_PRODUCT: Pre-operative radiotherapy followed by 2 cycles of atezolizumab then surgery

NCT05902494 HER2 and LA/mUC: A Multi-country Chart Review Cohort Study https://clinicaltrials.gov/study/NCT05902494 RECRUITING Urothelial Carcinoma Seagen Inc.

NCT06514794 A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy inT-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma https://clinicaltrials.gov/study/NCT06514794 NOT_YET_RECRUITING T-cell Acute Lymphoblastic Leukemia

NCT04904562 Angiotensin II for Distributive Shock https://clinicaltrials.gov/study/NCT04904562 RECRUITING Distributive Shock DRUG: Angiotensin II

NCT05805462 The Euro-CRAFT Registry https://clinicaltrials.gov/study/NCT05805462 RECRUITING Coronary Microvascular Disease CoreAalst BV Hexacath, France

NCT02880891 Effects of Splinted or Non-splinted Single-unit Crowns on Marginal Bone-level Alterations Around Implants https://clinicaltrials.gov/study/NCT02880891 RECRUITING Jaw, Edentulous, Partially PROCEDURE: prothetic procedure Peking University Dentsply Sirona Implants and Consumables

NCT05577091 Tris-CAR-T Cell Therapy for Recurrent Glioblastoma https://clinicaltrials.gov/study/NCT05577091 RECRUITING Recurrent Glioblastoma GENETIC: Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes. Beijing Tiantan Hospital Beijing Neurosurgical Institute

NCT06656091 A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT06656091 NOT_YET_RECRUITING Advanced Oesophageal Squamous Cell Carcinoma DRUG: simmitinib

NCT05557591 A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1) https://clinicaltrials.gov/study/NCT05557591 RECRUITING Advanced Non-Small Cell Lung Cancer DRUG: BNT116

NCT06056791 Study of INKmune in Patients With mCRPC (CaRe Prostate) https://clinicaltrials.gov/study/NCT06056791 RECRUITING Cancer

NCT06425991 A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT06425991 RECRUITING Relapsed or Refractory Multiple Myeloma DRUG: Teclistamab Janssen Research & Development, LLC

NCT05564091 Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma https://clinicaltrials.gov/study/NCT05564091 RECRUITING Primary Open Angle Glaucoma DEVICE: Cataract surgery combined with ab-interno canaloplasty utililzing the iTrack Advance canaloplasty device

NCT06695494 Enabling Genomic Testing in Cancer of Unknown Primary https://clinicaltrials.gov/study/NCT06695494 RECRUITING Cancer of Unknown Primary

NCT04359394 International Rare And Severe Psoriasis Expert Network https://clinicaltrials.gov/study/NCT04359394 RECRUITING Pustular Psoriasis (PP) OTHER: biological sampling

NCT05394662 Safety and Effectiveness of Juveena‚Ñ¢ Hydrogel System Following TCGP At High-Risk for Intrauterine Adhesions https://clinicaltrials.gov/study/NCT05394662 RECRUITING Intrauterine Adhesion DEVICE: Juveena Hydrogel System Rejoni Inc.

NCT06097962 Safety and Efficacy of NK510 to Treat NSCLC https://clinicaltrials.gov/study/NCT06097962 RECRUITING NSCLC DRUG: NK510

NCT05651191 To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL https://clinicaltrials.gov/study/NCT05651191 RECRUITING B-cell Acute Lymphoblastic Leukemia DRUG: Human CD19 Targeted DASH CAR-T Cells Injection Hrain Biotechnology Co., Ltd. Second Affiliated Hospital of Nanchang University

NCT04543591 Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant https://clinicaltrials.gov/study/NCT04543591 RECRUITING Thrombotic Microangiopathy BIOLOGICAL: Ravulizumab

NCT06411691 KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer https://clinicaltrials.gov/study/NCT06411691 RECRUITING Colorectal Cancer

NCT05608291 A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery https://clinicaltrials.gov/study/NCT05608291 RECRUITING Melanoma DRUG: Fianlimab

NCT05294991 Wellness App for Sleep Disturbance in Hematological Cancer Patients https://clinicaltrials.gov/study/NCT05294991 RECRUITING Cancer

NCT03797391 A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT03797391 RECRUITING Neoplasms

NCT04270591 Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT04270591 RECRUITING C-Met Exon 14 Mutation DRUG: Glumetinib Haihe Biopharma Co., Ltd.

NCT03914794 A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors https://clinicaltrials.gov/study/NCT03914794 RECRUITING Bladder Cancer

NCT05100862 A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma https://clinicaltrials.gov/study/NCT05100862 RECRUITING Relapsed/Refractory Follicular Lymphoma

NCT05267262 Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis https://clinicaltrials.gov/study/NCT05267262 RECRUITING Alport Syndrome

NCT06122662 AMX0035 and Progressive Supranuclear Palsy https://clinicaltrials.gov/study/NCT06122662 RECRUITING Progressive Supranuclear Palsy

NCT03897491 PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma https://clinicaltrials.gov/study/NCT03897491 RECRUITING Glioblastoma DRUG: 5-aminolevulinic acid photonamic GmbH & Co. KG

NCT05106491 Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients https://clinicaltrials.gov/study/NCT05106491 NOT_YET_RECRUITING Cardiogenic Shock

NCT06565091 Clinical Investigation for a Multifunction Ophthalmic Measurement Device https://clinicaltrials.gov/study/NCT06565091 RECRUITING Accommodation Disorder

NCT04878991 Overture Metabolomics Non-Selection Study https://clinicaltrials.gov/study/NCT04878991 RECRUITING Infertility DIAGNOSTIC_TEST: Overture Metabolomics Embryo Selection Overture Life New Hope Fertility Center

NCT06481891 A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy https://clinicaltrials.gov/study/NCT06481891 RECRUITING Obstructive Cardiomyopathy, Hypertrophic

NCT06511791 An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation. https://clinicaltrials.gov/study/NCT06511791 RECRUITING Infertility DRUG: FE 999302

NCT05960591 Usability of the ADEPTH Sensor for Bore Depth Measurements in Plate Osteosynthesis Procedures https://clinicaltrials.gov/study/NCT05960591 RECRUITING Fractures, Bone

NCT06011291 A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer https://clinicaltrials.gov/study/NCT06011291 RECRUITING Solid Tumors

NCT05314491 Multigen Plus CCK and AMF TT Cones Follow Up Study https://clinicaltrials.gov/study/NCT05314491 RECRUITING Total Knee Arthroplasty

NCT05886491 A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT05886491 RECRUITING Leukemia DRUG: GDX012

NCT06018194 ELUCIDATE FFRct Study https://clinicaltrials.gov/study/NCT06018194 RECRUITING Coronary Artery Disease DEVICE: ElucidVivo Elucid Bioimaging Inc. Lundquist Institute at Harbor-UCLA Medical Center

NCT05596591 Focused Extracorporeal Shockwave Therapy for Knee Arthritis https://clinicaltrials.gov/study/NCT05596591 RECRUITING Bone Marrow Edema

NCT06463262 Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma https://clinicaltrials.gov/study/NCT06463262 RECRUITING Chordoma of Spine

NCT04500262 Comparison Trial of Open-tip Pulsed Needle Biopsy and Conventional Core Biopsy in Axillary Lymph Nodes https://clinicaltrials.gov/study/NCT04500262 RECRUITING Breast Cancer DEVICE: Open-tip pulsed needle biopsy (NeoNavia Biopsy System)

NCT04327791 COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1) https://clinicaltrials.gov/study/NCT04327791 RECRUITING Influenza DRUG: Baloxavir

NCT06581991 Liquid Valine and Isoleucine in Maple Syrup Urine Disease https://clinicaltrials.gov/study/NCT06581991 NOT_YET_RECRUITING Maple Syrup Urine Disease DIETARY_SUPPLEMENT: Valine oral solution (50mg/ml) and isoleucine oral solution (25mg/ml) Meta Healthcare Ltd Birmingham Women's and Children's NHS Foundation Trust

NCT04075591 Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia https://clinicaltrials.gov/study/NCT04075591 RECRUITING Refractive Error DEVICE: iDesign Refractive Studio with STAR S4 IR¬Æ Excimer laser System AMO Development, LLC

NCT05916391 Gene Therapy for Diabetic Macular Edema https://clinicaltrials.gov/study/NCT05916391 RECRUITING Diabetic Macular Edema GENETIC: FT-003 Frontera Therapeutics Tianjin Medical University Eye Hospital

NCT05521191 A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease https://clinicaltrials.gov/study/NCT05521191 RECRUITING Autosomal Dominant Polycystic Kidney Disease

NCT05381662 CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment https://clinicaltrials.gov/study/NCT05381662 RECRUITING Acute Lymphoblastic Leukemia in Remission BIOLOGICAL: CD19 CAR-T cells and CD19 positive feeder T cells Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd The First Affiliated Hospital of Soochow University

NCT05580562 ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) https://clinicaltrials.gov/study/NCT05580562 RECRUITING H3 K27M

NCT06383962 Post-Market Data Collection to Evaluate the Performance of the Synergy Disc¬Æ https://clinicaltrials.gov/study/NCT06383962 NOT_YET_RECRUITING Cervical Degenerative Disc Disease DEVICE: Synergy cervical spine disc replacement Synergy Spine Solutions MCRA

NCT06649162 A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy https://clinicaltrials.gov/study/NCT06649162 RECRUITING Type 2 Diabetes Boryung Pharmaceutical Co., Ltd

NCT04620291 Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation in HIV Infected Adults https://clinicaltrials.gov/study/NCT04620291 NOT_YET_RECRUITING HIV-1-infection BIOLOGICAL: UB-421 SC United BioPharma

NCT05683691 Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer https://clinicaltrials.gov/study/NCT05683691 RECRUITING Prostate Cancer DEVICE: Vanquish System Francis Medical Inc.

NCT05423691 Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs https://clinicaltrials.gov/study/NCT05423691 RECRUITING Myelofibrosis DRUG: CK0804 Cellenkos, Inc.

NCT06594991 A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma https://clinicaltrials.gov/study/NCT06594991 RECRUITING Advanced Melanoma DRUG: Fianlimab

NCT05818891 Multicenter Mpact DM France https://clinicaltrials.gov/study/NCT05818891 RECRUITING Total Hip Arthroplasty

NCT05629091 An Investigation of Performance and Safety of the Wound Dressing FibDex in Patients With Superficial Dermal Burns https://clinicaltrials.gov/study/NCT05629091 RECRUITING Burns DEVICE: FibDex

NCT06076291 An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06076291 RECRUITING Advanced Solid Tumors DRUG: SG1827 Hangzhou Sumgen Biotech Co., Ltd.

NCT04426591 Red Blood Cell Survival in Sickle Cell Disease https://clinicaltrials.gov/study/NCT04426591 RECRUITING Sickle Cell Disease DRUG: Biotin Labeled Red Blood Cells

NCT05135091 FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy https://clinicaltrials.gov/study/NCT05135091 RECRUITING Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis BIOLOGICAL: NRTX-1001

NCT06546891 Using an Adaptive Rower for People Using Motorized Wheelchairs https://clinicaltrials.gov/study/NCT06546891 NOT_YET_RECRUITING People Who Use Motorized Wheelchairs for Mobility BEHAVIORAL: Adaptive Rowing University of South Carolina Foundation for Physical Therapy, Inc.

NCT05424562 A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada https://clinicaltrials.gov/study/NCT05424562 RECRUITING Acute Myeloid Leukemia AbbVie

NCT05932862 A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05932862 RECRUITING Advanced Solid Tumor DRUG: XL309 (ISM3091)

NCT04622462 Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment https://clinicaltrials.gov/study/NCT04622462 RECRUITING Oral Neoplasm PROCEDURE: Standard of Care Histopathology

NCT04149691 Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies https://clinicaltrials.gov/study/NCT04149691 RECRUITING Gastric Cancer

NCT05687591 Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast Asia Observational Study https://clinicaltrials.gov/study/NCT05687591 RECRUITING Atrial Fibrillation DEVICE: Amplatzer Amulet Left Atrial Appendage Occlusion Device Sarawak Heart Centre InnoSignum

NCT06711991 A Clinical Trial of TQC3927 Powder for Inhalation in Chronic Obstructive Pulmonary Disease https://clinicaltrials.gov/study/NCT06711991 NOT_YET_RECRUITING Chronic Obstructive Pulmonary Disease DRUG: TQC3927 powder for inhalation

NCT06154291 FIH XON7 in Advanced/Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06154291 RECRUITING Advanced Solid Tumor

NCT06500091 TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors https://clinicaltrials.gov/study/NCT06500091 NOT_YET_RECRUITING Soft Tissue Sarcoma

NCT06666491 An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older https://clinicaltrials.gov/study/NCT06666491 NOT_YET_RECRUITING Malaria, Vivax DRUG: Tafenoquine

NCT05234762 Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors https://clinicaltrials.gov/study/NCT05234762 RECRUITING Tremor, Essential DRUG: ES-481

NCT05292794 Use of CereGate Therapy for Freezing of Gait in PD https://clinicaltrials.gov/study/NCT05292794 RECRUITING Parkinson Disease

NCT05604560 A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer https://clinicaltrials.gov/study/NCT05604560 RECRUITING Pancreatic Cancer DRUG: Tislelizumab

NCT06615960 Safety and Effectiveness of PANAF-Premium TM Snake Venom Antiserum As Standard Treatment for Snakebites https://clinicaltrials.gov/study/NCT06615960 RECRUITING Snake Bites Premium Serums & Vaccines Pvt.Ltd.

NCT04183660 A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial https://clinicaltrials.gov/study/NCT04183660 RECRUITING Cardiac Failure

NCT05192460 Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver Cancer https://clinicaltrials.gov/study/NCT05192460 RECRUITING Gastric Cancer

NCT06717360 A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R https://clinicaltrials.gov/study/NCT06717360 NOT_YET_RECRUITING Hypercholesterolemia DRUG: AG2304T

NCT06380660 Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06380660 RECRUITING Solid Tumor, Adult

NCT06172894 PBMC-based Leukocyte Immunotherapy https://clinicaltrials.gov/study/NCT06172894 RECRUITING Advanced Solid Tumor DRUG: APN401 invIOs GmbH

NCT06590194 PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) https://clinicaltrials.gov/study/NCT06590194 NOT_YET_RECRUITING Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) DRUG: PH009-1 tablet Suzhou Puhe Pharmaceutical Technology Co., LTD

NCT05226494 Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma https://clinicaltrials.gov/study/NCT05226494 RECRUITING Glioma, Malignant DRUG: fb-PMT NanoPharmaceuticals LLC

NCT06128694 Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients https://clinicaltrials.gov/study/NCT06128694 RECRUITING Malnutrition; Protein

NCT06132360 the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C https://clinicaltrials.gov/study/NCT06132360 RECRUITING To Reduce the LDL-C Level in Hypercholesteremia Patients DRUG: RN0191 Shanghai Rona Therapeutics Co., Ltd.

NCT06050460 SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19 https://clinicaltrials.gov/study/NCT06050460 RECRUITING COVID-19 DRUG: SA55 Injection

NCT06103760 Positioning of Esketamine Treatment in the Real-world Management of Depression https://clinicaltrials.gov/study/NCT06103760 RECRUITING Major Depressive Disorder DRUG: Esketamine Nasal Spray [Spravato] Royal North Shore Hospital Janssen-Cilag Pty Ltd

NCT05556460 Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation https://clinicaltrials.gov/study/NCT05556460 RECRUITING Tricuspid Regurgitation DEVICE: DragonFly-T Transcatheter Tricuspid Valve Repair System

NCT06141460 Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) https://clinicaltrials.gov/study/NCT06141460 RECRUITING Neovascular Age-related Macular Degeneration DRUG: RRG001 Shanghai Refreshgene Technology Co., Ltd.

NCT06087094 A Trial of HRS-7450 in Chinese Healthy Volunteers https://clinicaltrials.gov/study/NCT06087094 NOT_YET_RECRUITING Cerebral Stroke DRUG: HRS-7450 ÔºõPlacebo Fujian Shengdi Pharmaceutical Co., Ltd.

NCT06592794 A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ‚â•18 Years of Age for the Prevention of Acute Gastroenteritis https://clinicaltrials.gov/study/NCT06592794 RECRUITING Acute Gastroenteritis

NCT05626894 Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors https://clinicaltrials.gov/study/NCT05626894 NOT_YET_RECRUITING Stroke

NCT05158894 Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy https://clinicaltrials.gov/study/NCT05158894 RECRUITING Migraine AbbVie

NCT06277960 Septal Ablation for Obstructive HCM https://clinicaltrials.gov/study/NCT06277960 RECRUITING Hypertrophic Obstructive Cardiomyopathy (HOCM) DEVICE: percutaneous intramyocardial septal radiofrequency ablation system SuZhou Sinus Medical Technologies Co.,Ltd

NCT06708260 A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME https://clinicaltrials.gov/study/NCT06708260 NOT_YET_RECRUITING Diabetic Macular Edema (DME) DRUG: ENN0403, low dose

NCT05709860 An Electronic Health Record-based Approach to Increase PrEP Knowledge and Uptake: the EMC2 PrEP Strategy https://clinicaltrials.gov/study/NCT05709860 RECRUITING HIV Infections

NCT06368960 BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06368960 RECRUITING Advanced Solid Tumors RADIATION: Radiotherapy

NCT05769660 A Study to Evaluate Safety and Efficacy of BEY1107 in Combination With Temozolomide in Patients With Recurrent or Progressive Glioblastoma Multiforme (GBM) https://clinicaltrials.gov/study/NCT05769660 RECRUITING Glioblastoma Multiforme DRUG: BEY1107

NCT05916560 A Study of LY3437943 in Participants With Impaired and Normal Liver Function https://clinicaltrials.gov/study/NCT05916560 RECRUITING Healthy

NCT05208060 Study to Evaluate the Ability of Sublingual MV130 to Induce the Expression of Trained Immunity in Peripheral Blood Cells https://clinicaltrials.gov/study/NCT05208060 RECRUITING Immune Response BIOLOGICAL: MV130

NCT05172960 ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve https://clinicaltrials.gov/study/NCT05172960 RECRUITING Aortic Stenosis, Severe DEVICE: SAPIEN X4 THV Edwards Lifesciences

NCT05767060 BAT7104 Injection in Patients With Advanced Malignant Tumors. https://clinicaltrials.gov/study/NCT05767060 RECRUITING Advanced Malignant Tumor DRUG: BAT7104 injection Bio-Thera Solutions Sun Yat-sen University

NCT06557460 A PHASE IIB, RANDOMIZED, ASSESSOR-MASKED, MULTICENTER CLINICAL TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SUBRETINAL IMPLANTATION OF THE CPCB-RPE1 IMPLANT IN SUBJECTS WITH ADVANCED, DRY AMD (GEOGRAPHIC ATROPHY) https://clinicaltrials.gov/study/NCT06557460 NOT_YET_RECRUITING Dry Age-related Macular Degeneration

NCT06493760 A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients https://clinicaltrials.gov/study/NCT06493760 RECRUITING Metastatic Colorectal Cancer DRUG: SSGJ-707

NCT06465160 A Study to Evaluate the MNV-201 in Patients With Low Risk MDS https://clinicaltrials.gov/study/NCT06465160 RECRUITING Myelodysplastic Syndromes BIOLOGICAL: MNV-201 (Autologous CD34+ Cells Enriched with allogenic Placenta Derived Mitochondria) Minovia Therapeutics Ltd.

NCT05195294 Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC https://clinicaltrials.gov/study/NCT05195294 NOT_YET_RECRUITING Hepatocellular Carcinoma

NCT05438394 Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM https://clinicaltrials.gov/study/NCT05438394 RECRUITING Multiple Myeloma DRUG: melphalan hydrochloride for injection Peking University People's Hospital CASI Pharmaceuticals, Inc.

NCT06452160 A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06452160 RECRUITING Mesothelioma

NCT06179160 A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation https://clinicaltrials.gov/study/NCT06179160 RECRUITING Solid Tumors DRUG: INCB161734

NCT04424394 DualStim Therapy With or Without Umbilical Cord Derived Wharton's Jelly for Erectile Dysfunction https://clinicaltrials.gov/study/NCT04424394 NOT_YET_RECRUITING Erectile Dysfunction DEVICE: DualStim Therapy

NCT01499394 Caris Biorepository Research Protocol https://clinicaltrials.gov/study/NCT01499394 RECRUITING Cancer Caris Science, Inc.

NCT05130294 Unrefined Salmon Oil as Dietary Supplement in Patient With Chronic Obstructive Pulmonary Disease https://clinicaltrials.gov/study/NCT05130294 NOT_YET_RECRUITING Chronic Obstructive Pulmonary Disease DIETARY_SUPPLEMENT: CARDIO¬Æ

NCT06662994 High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy https://clinicaltrials.gov/study/NCT06662994 NOT_YET_RECRUITING Diabetic Macular Edema (DME) DRUG: Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321) Retina Consultants of Orange County Regeneron Pharmaceuticals

NCT04945460 A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16) https://clinicaltrials.gov/study/NCT04945460 RECRUITING Hypertension, Pulmonary DRUG: Sotatercept 0.3 mg/kg

NCT05897060 Braindex Cerebral Tissue Oxygen Saturation (SctO2) Measurement Algorithm Assessment and Improvement https://clinicaltrials.gov/study/NCT05897060 RECRUITING Post-Operative Confusion DEVICE: Venus Jugular O2 Saturation optical fiber Braindex

NCT06561360 A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People with Hairy Cell Leukemia (HCL) https://clinicaltrials.gov/study/NCT06561360 RECRUITING Hairy Cell Leukemia DRUG: Vemurafenib

NCT06652360 Chemical Debridement and Leg Ulcers https://clinicaltrials.gov/study/NCT06652360 RECRUITING Venous Leg Ulcers

NCT05738694 Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma https://clinicaltrials.gov/study/NCT05738694 RECRUITING Renal Cell Carcinoma

NCT04898894 Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT04898894 RECRUITING Acute Leukemia of Ambiguous Lineage in Relapse

NCT05171894 A Study to Evaluate Efficacy and Safety of Light Dose in Subjects with PWB Treated with Hemoporfin PDT https://clinicaltrials.gov/study/NCT05171894 RECRUITING Port-wine Birthmarks

NCT05669794 An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World https://clinicaltrials.gov/study/NCT05669794 RECRUITING Atopic Dermatitis AbbVie

NCT04421560 Pembrolizumab, Ibrutinib and Rituximab in PCNSL https://clinicaltrials.gov/study/NCT04421560 RECRUITING Primary Central Nervous System Lymphoma

NCT06414460 Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06414460 NOT_YET_RECRUITING Locally Advanced/Metastatic Solid Tumors DRUG: ISM3412 InSilico Medicine Hong Kong Limited

NCT06400160 Clinical Trial of TB511 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06400160 NOT_YET_RECRUITING NSCLC

NCT04586660 Study of XGEVA¬Æ (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone https://clinicaltrials.gov/study/NCT04586660 RECRUITING Giant Cell Tumor of Bone DRUG: XGEVA¬Æ Amgen

NCT04272060 Ultra-high-resolution CT vs. Conventional Angiography for Detecting Coronary Heart Disease https://clinicaltrials.gov/study/NCT04272060 RECRUITING Coronary Artery Disease DIAGNOSTIC_TEST: CT angiography

NCT05009160 DreaMS - Validation Study 1 https://clinicaltrials.gov/study/NCT05009160 RECRUITING Multiple Sclerosis DEVICE: dreaMS App R2.1 Research Center for Clinical Neuroimmunology and Neuroscience Basel Healios AG

NCT06073860 A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or Œ≤-thalassemia https://clinicaltrials.gov/study/NCT06073860 RECRUITING Myelodysplastic Syndrome

NCT06603194 Benefit of Bovine or Marine Collagen Vs. Placebo on Skin, Hair, Nails and Whole Body Health in Healthy Adults https://clinicaltrials.gov/study/NCT06603194 RECRUITING Skin Laxity

NCT05652894 A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer https://clinicaltrials.gov/study/NCT05652894 NOT_YET_RECRUITING Metastatic Colorectal Cancer DRUG: HX008

NCT05888194 The Effect of Mucogyne¬Æ Gel on Wound Healing https://clinicaltrials.gov/study/NCT05888194 RECRUITING Perineal Tear and Episiotomy DEVICE: Mucogyne¬Æ gel Biocodex

NCT06534060 MB-105 in Patients With CD5 Positive T-cell Lymphoma https://clinicaltrials.gov/study/NCT06534060 NOT_YET_RECRUITING Lymphoma, T-Cell BIOLOGICAL: Genetic: MB-105 March Biosciences Inc

NCT06082960 Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors https://clinicaltrials.gov/study/NCT06082960 RECRUITING Solid Tumors DRUG: GS-9911

NCT06188494 UNFOLD Study Egypt https://clinicaltrials.gov/study/NCT06188494 RECRUITING Breast Cancer AstraZeneca

NCT06660160 Group Exercise Program Supported by Audiovisual Media During Hemodialysis https://clinicaltrials.gov/study/NCT06660160 NOT_YET_RECRUITING Chronic Kidney Failure

NCT06602960 Nextsense Brain-sensing Buds Study https://clinicaltrials.gov/study/NCT06602960 RECRUITING Sleep

NCT06467760 Thumb Hemi-Arthroplasty With Natural Kinematics; a Prospective Multicenter Study to Confirm the Safety and Efficacy of the InDx Implant https://clinicaltrials.gov/study/NCT06467760 NOT_YET_RECRUITING CMC Joint Arthritis DEVICE: InDx CMC Implant Loci Orthopaedics

NCT06609460 Study of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications https://clinicaltrials.gov/study/NCT06609460 RECRUITING Influenza COMBINATION_PRODUCT: CD388 Injection

NCT03918460 ANEUFIX for Endoleak Type II Repair https://clinicaltrials.gov/study/NCT03918460 RECRUITING Abdominal Aortic Aneurysm

NCT05360160 A Phase I-II Study Investigating the All Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE) https://clinicaltrials.gov/study/NCT05360160 RECRUITING Acute Myeloid Leukemia DRUG: SNDX-5613

NCT03193476 Registry for Patients With X-Linked Hypophosphatemia https://clinicaltrials.gov/study/NCT03193476 RECRUITING X-Linked Hypophosphatemia Kyowa Kirin Pharmaceutical Development Ltd Iqvia Pty Ltd

NCT06550960 Evaluation of SureCore Plus Biopsy System https://clinicaltrials.gov/study/NCT06550960 NOT_YET_RECRUITING BPH DEVICE: Evaluation of two biopsy systems Uro-1 Medical

NCT06677060 Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin https://clinicaltrials.gov/study/NCT06677060 NOT_YET_RECRUITING Heart Failure DRUG: Baxdrostat and dapagliflozin

NCT05339360 ZNN Bactiguard Antegrade Femoral Nails PMCF Study https://clinicaltrials.gov/study/NCT05339360 RECRUITING Femur Fracture

NCT06504160 Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2) https://clinicaltrials.gov/study/NCT06504160 NOT_YET_RECRUITING Atopic Dermatitis DRUG: ShA9 Topical Gel

NCT04829357 Post Market Clinical Follow-up Study on TVT ABBREVO¬Æ Continence System https://clinicaltrials.gov/study/NCT04829357 RECRUITING Stress Urinary Incontinence DEVICE: Intervention Ethicon, Inc.

NCT05114148 Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT05114148 RECRUITING Hepatocellular Carcinoma Non-resectable DEVICE: Holmium-166 radioembolization UMC Utrecht Erasmus Medical Center

NCT04011748 Clinical Application of Stem Cell Educator Therapy in Alopecia Areata https://clinicaltrials.gov/study/NCT04011748 RECRUITING Alopecia Areata

NCT04651348 A Clinical Study of MIL95 in Advanced Malignancies. https://clinicaltrials.gov/study/NCT04651348 RECRUITING Advanced Malignancies DRUG: Recombinant Humanized Monoclonal Antibody MIL95 Beijing Mabworks Biotech Co., Ltd.

NCT05947448 Efficacy and Safety of Mexartan Potassium Tablets (AZL-M) and Calcium Channel Blockers (CCB) in the Treatment of Adults With Essential Hypertension in Chinese Population: a National Multicenter, Prospective, Observational Study https://clinicaltrials.gov/study/NCT05947448 RECRUITING Essential Hypertension DRUG: Azilsartan Medoxomil Potassium Tablet

NCT03555448 Once Daily Immunosuppression Regimen https://clinicaltrials.gov/study/NCT03555448 RECRUITING Kidney Transplant; Complications DRUG: Once daily immunosuppression regimen

NCT05985148 A Study of Stereotactic Radiosurgery (SRS) to Treat Pain in the Chest and/or Stomach Wall https://clinicaltrials.gov/study/NCT05985148 RECRUITING Thoracoabdominal Wall Pain

NCT05236348 Performance of the Aktiia Optical Blood Pressure Monitoring Device Against Double Auscultation https://clinicaltrials.gov/study/NCT05236348 RECRUITING Hypertension

NCT06649630 A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy Men https://clinicaltrials.gov/study/NCT06649630 RECRUITING Haemophilia A DRUG: NNC0442-0344 A

NCT06121830 Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) https://clinicaltrials.gov/study/NCT06121830 RECRUITING Non-erosive Reflux Disease

NCT06643130 Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia https://clinicaltrials.gov/study/NCT06643130 NOT_YET_RECRUITING Hypertension

NCT05467930 CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2 https://clinicaltrials.gov/study/NCT05467930 RECRUITING COVID-19

NCT05140226 Cognitive and Physical Training in Patients With Chronic Obstructive Pulmonary Disease Patients https://clinicaltrials.gov/study/NCT05140226 RECRUITING Pulmonary Disease, Chronic Obstructive BEHAVIORAL: Physical Training

NCT06250426 Effect of a Cooling Sensation Flavor on the Swallow Response in Post-stroke Patients With Oropharyngeal Dysphagia https://clinicaltrials.gov/study/NCT06250426 RECRUITING Oropharyngeal Dysphagia

NCT01665326 Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease https://clinicaltrials.gov/study/NCT01665326 RECRUITING Pompe Disease OTHER: Observational Duke University Genzyme, a Sanofi Company

NCT06637657 Guided Optimisation of Long-term Disease rEduction in secoNdary Prevention of CVD https://clinicaltrials.gov/study/NCT06637657 RECRUITING Acute Coronary Syndrome OTHER: No intervention (observational study) Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Dutch Network for Cardiovascular Research (WCN), Utrecht

NCT05000957 Pelvic Organs Prolapse Treatment Using Neodymium Laser https://clinicaltrials.gov/study/NCT05000957 RECRUITING Pelvic Organ Prolapse

NCT06510257 Safety and Efficacy Reconyl for Cough With/Without Sore Throat https://clinicaltrials.gov/study/NCT06510257 NOT_YET_RECRUITING Cough DRUG: Reconyl

NCT05829148 The Effect of Dexmedetomidine, Melatonin and Pregabalin https://clinicaltrials.gov/study/NCT05829148 NOT_YET_RECRUITING Endoscopic Sinus Surgery DRUG: Dexmedetomidine

NCT03659448 Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer https://clinicaltrials.gov/study/NCT03659448 RECRUITING Colorectal Neoplasms DRUG: SGM-101 Surgimab

NCT04167748 Preimplantation Genetic Testing in Women of Advanced Maternal Age https://clinicaltrials.gov/study/NCT04167748 RECRUITING Infertility, Female PROCEDURE: Preimplantation genetic testing for aneuploidy (PGT-A) Genomic Prediction Inc.

NCT06087848 A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events https://clinicaltrials.gov/study/NCT06087848 RECRUITING Cardiovascular Diseases BIOLOGICAL: Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte) Cellcolabs Clinical LTD.

NCT04010448 A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India https://clinicaltrials.gov/study/NCT04010448 RECRUITING Rotavirus Infection of Children BIOLOGICAL: TV P2-VP8

NCT06302348 A Study of Sepiapterin in Participants With Phenylketonuria (PKU) https://clinicaltrials.gov/study/NCT06302348 RECRUITING Phenylketonuria DRUG: Sepiapterin PTC Therapeutics

NCT04915248 Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients. https://clinicaltrials.gov/study/NCT04915248 RECRUITING Plasmablastic Lymphoma DRUG: Daratumumab

NCT05781048 A Phase I Clinical Study of the SafetyÔºå TolerabilityÔºåPharmacokinetics, and Initial Efficacy of HRS-6209 Monotherapy in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05781048 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: HRS-6209 Jiangsu HengRui Medicine Co., Ltd.

NCT05085548 ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies https://clinicaltrials.gov/study/NCT05085548 RECRUITING Advanced Pancreatic Cancer

NCT06263348 A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes https://clinicaltrials.gov/study/NCT06263348 RECRUITING Type2diabetes DRUG: Dorzagliatin tablets Hua Medicine Limited Shanghai Branch, KunTuo Medical Research and Development (Beijing) Co., Ltd.

NCT05875948 Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome https://clinicaltrials.gov/study/NCT05875948 RECRUITING Hepatorenal Syndrome

NCT04841148 Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer https://clinicaltrials.gov/study/NCT04841148 RECRUITING Breast Cancer DRUG: HCQ

NCT06511648 Erdafitinib Monotherapy or in Combination With Cetrelimab in Muscle-invasive Bladder Cancer Patients With Fibroblast Growth Factor Receptor (FGFR ) Gene Alterations https://clinicaltrials.gov/study/NCT06511648 RECRUITING Muscle-invasive Bladder Cancer DRUG: Erdafitinib monotherapy

NCT06510348 Achieving nuTritional Target in criticAlly Ill patieNts With iMpairEd gastroiNtesTinal Dysfunction https://clinicaltrials.gov/study/NCT06510348 RECRUITING Parenteral Nutrition

NCT05717348 A Study of ES014 in Patients With Locally Advanced or Metastatic Solid Tumours https://clinicaltrials.gov/study/NCT05717348 RECRUITING Solid Tumor

NCT05649748 An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH) https://clinicaltrials.gov/study/NCT05649748 RECRUITING Pulmonary Arterial Hypertension DRUG: Treprostinil Palmitil

NCT05942248 The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis https://clinicaltrials.gov/study/NCT05942248 RECRUITING Acne

NCT06325748 SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS https://clinicaltrials.gov/study/NCT06325748 RECRUITING AML/MDS

NCT05110248 Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple Organ Application https://clinicaltrials.gov/study/NCT05110248 RECRUITING Multiple Perspectum

NCT05055648 PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy https://clinicaltrials.gov/study/NCT05055648 RECRUITING Esophageal Cancer

NCT05771948 Effectiveness and Safety of CCoat Intra-Articular Injections in Mild to Moderate Knee Osteoarthritis https://clinicaltrials.gov/study/NCT05771948 RECRUITING Knee Osteoarthritis DEVICE: CCoat Lipo-Sphere

NCT06186648 Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome https://clinicaltrials.gov/study/NCT06186648 RECRUITING Richter Syndrome DRUG: Glofitamab + Obinutuzumab French Innovative Leukemia Organisation Hoffmann-La Roche

NCT06694948 A Study to Evaluate the Relative Bioavailability of Two Different Pimicotinib Capsules in Healthy Subjects https://clinicaltrials.gov/study/NCT06694948 NOT_YET_RECRUITING Pharmacokinetics DRUG: pimicotinib capsules Abbisko Therapeutics Co, Ltd

NCT05346848 Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer https://clinicaltrials.gov/study/NCT05346848 RECRUITING Prostate Cancer DRUG: Association of darolutamide and EBRT

NCT05766748 Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer https://clinicaltrials.gov/study/NCT05766748 RECRUITING Metastatic Pancreatic Cancer DRUG: Azeliragon Cantex Pharmaceuticals

NCT06561048 Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma https://clinicaltrials.gov/study/NCT06561048 RECRUITING Peripheral T-Cell Lymphoma, Not Otherwise Specified

NCT06193148 A Study to Evaluate the Effect of Jaktinib on QT/QTc Interval in Healthy Participants https://clinicaltrials.gov/study/NCT06193148 RECRUITING Healthy Participants DRUG: Jaktinib

NCT05788848 Virtual Reality Cognitive Therapy for Alzheimer's Disease https://clinicaltrials.gov/study/NCT05788848 RECRUITING Alzheimer Disease BEHAVIORAL: VRCT Claritytek, Inc. HealthPartners Institute

NCT06384248 Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma https://clinicaltrials.gov/study/NCT06384248 NOT_YET_RECRUITING Unresectable or Metastatic Sarcoma DRUG: LTC004 Letolab

NCT06011148 Clinical Data Collection on Perceval S Sutureless Prosthetic Aortic Valve in the Chinese Population https://clinicaltrials.gov/study/NCT06011148 NOT_YET_RECRUITING Aortic Valve Disease DEVICE: Perceval S sutureless heart valve Corcym S.r.l

NCT05868148 Shoulder iD‚Ñ¢ Primary Reversed Glenoid Outcomes Clinical Study https://clinicaltrials.gov/study/NCT05868148 RECRUITING Rotator Cuff Tears

NCT05302648 To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects With R/R MM https://clinicaltrials.gov/study/NCT05302648 RECRUITING Multiple Myeloma DRUG: Human Derived anti-BCMA CAR-T Injection Hrain Biotechnology Co., Ltd. Shanghai Changzheng Hospital

NCT05464030 Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) https://clinicaltrials.gov/study/NCT05464030 RECRUITING Colorectal Cancer DRUG: M9140

NCT04967248 A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting https://clinicaltrials.gov/study/NCT04967248 RECRUITING Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation OTHER: Alpelisib

NCT05914948 Minimally Invasive Electrical Stimulation Of The Nerve Hypoglossal for the Treatment of Obstructive Sleep Apnea https://clinicaltrials.gov/study/NCT05914948 NOT_YET_RECRUITING Obstructive Sleep Apnea DEVICE: Medtronic 8-contact Vectris subcompact or compact electrode. Capri Medical Limited

NCT04234048 Phase 1 Trial of ST-001 NanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT04234048 RECRUITING T-cell Lymphoma

NCT05684848 Evaluate the Effect of Nasal Spray in the Prevention of RTI in Children With Pre-school Wheezing https://clinicaltrials.gov/study/NCT05684848 RECRUITING Wheezing

NCT05847348 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients https://clinicaltrials.gov/study/NCT05847348 RECRUITING Biochemical Recurrence of Malignant Neoplasm of Prostate

NCT05565248 An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D https://clinicaltrials.gov/study/NCT05565248 RECRUITING Diabetes Mellitus

NCT06506448 Risk Characterization of Non-culprit Vessels in Patients Undergoing Primary PCI for ST-elevation MI in Multivessel Disease https://clinicaltrials.gov/study/NCT06506448 NOT_YET_RECRUITING ST Elevation Myocardial Infarction DIAGNOSTIC_TEST: CT Coronary Angiography University Hospital Southampton NHS Foundation Trust Boston Scientific Corporation

NCT05836948 The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05836948 NOT_YET_RECRUITING Advanced Solid Tumor DRUG: SHR-9839 Shanghai Hengrui Pharmaceutical Co., Ltd.

NCT05323448 Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion. https://clinicaltrials.gov/study/NCT05323448 RECRUITING Hemostatics

NCT05186948 Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI) https://clinicaltrials.gov/study/NCT05186948 RECRUITING Cancer-related Cognitive Impairment DEVICE: Eye-Tracking Innodem Neurosciences

NCT05501548 Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT05501548 RECRUITING Prostate Cancer

NCT04756648 Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT04756648 RECRUITING Advanced Hepatocellular Carcinoma DRUG: CT0180 Cells Zhejiang University CARsgen Therapeutics Co., Ltd.

NCT05422248 Oxygen Wound Therapy Feasibility Study https://clinicaltrials.gov/study/NCT05422248 RECRUITING Chronic Leg Ulcer DEVICE: Series Topical Oxygen Therapy

NCT06171048 Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects https://clinicaltrials.gov/study/NCT06171048 NOT_YET_RECRUITING Healthy BIOLOGICAL: CM310 Keymed Biosciences Co.Ltd

NCT06021457 Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery https://clinicaltrials.gov/study/NCT06021457 RECRUITING Post-Operative Complications in Cardiac Surgery DRUG: RBT-1

NCT06120348 Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser Epithelial Keratomileusis (LASEK) Surgery https://clinicaltrials.gov/study/NCT06120348 RECRUITING Dry Eye Disease DEVICE: Charge-Balanced, Symmetric Nerve Stimulation

NCT04061148 Near Infrared Spectroscopy (NIRS) for Assessment of Depression https://clinicaltrials.gov/study/NCT04061148 RECRUITING Major Depressive Disorder DEVICE: NIRSIT University of California, San Francisco OBELAB, Inc.

NCT05934448 Pembro Plus CAR T-cell Therapy in R/R in PMBCL https://clinicaltrials.gov/study/NCT05934448 RECRUITING Primary Mediastinal Large B-cell Lymphoma (PMBCL)

NCT04991948 Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer https://clinicaltrials.gov/study/NCT04991948 RECRUITING Unresectable Metastatic Colorectal Cancer DRUG: CYAD-101

NCT02803957 Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair https://clinicaltrials.gov/study/NCT02803957 RECRUITING Mitral Valve Insufficiency DEVICE: NeoChord DS1000

NCT06390657 Radiotherapy Treatment Planning Comparison Using SBRT-PATHY (Photons) Versus CARBON-PATHY for Unresectable Bulky Tumors https://clinicaltrials.gov/study/NCT06390657 NOT_YET_RECRUITING Cancer OTHER: Planning CT, MRI EBG MedAustron GmbH The Princess Margaret Cancer Foundation

NCT04139057 EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC https://clinicaltrials.gov/study/NCT04139057 RECRUITING Head and Neck Squamous Cell Carcinoma DRUG: EBV-specific TCR-T cell with anti-PD1 auto-secreted element Xinqiao Hospital of Chongqing TCRCure Biopharma Ltd.

NCT03019757 Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease https://clinicaltrials.gov/study/NCT03019757 RECRUITING Alzheimer's Disease

NCT06029257 A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO) https://clinicaltrials.gov/study/NCT06029257 RECRUITING Genital Psoriasis DRUG: Tildrakizumab Almirall, S.A.

NCT05957757 RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression https://clinicaltrials.gov/study/NCT05957757 RECRUITING Non-Muscle Invasive Bladder Cancer

NCT05888857 MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors. https://clinicaltrials.gov/study/NCT05888857 NOT_YET_RECRUITING Advanced Solid Tumor DRUG: MEDI5752 Institut Bergoni√© National Cancer Institute, France

NCT05673057 Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome https://clinicaltrials.gov/study/NCT05673057 RECRUITING Leukemia

NCT06541457 A Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7249 Injection in Healthy Subjects https://clinicaltrials.gov/study/NCT06541457 RECRUITING Hyperlipidemia DRUG: HRS-7249 injection

NCT06640257 A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis https://clinicaltrials.gov/study/NCT06640257 RECRUITING Psoriatic Arthritis DRUG: SHR-1314 injection

NCT06044857 PSMA PET Response Guided SabR in High Risk Pca https://clinicaltrials.gov/study/NCT06044857 RECRUITING Prostate Adenocarcinoma DRUG: 68-Ga PSMA11 University of Texas Southwestern Medical Center Once Upon a Time Foundation

NCT05394766 Remote Patient Monitoring and Health Coaching vs. Usual Care for the Treatment of Hypertension https://clinicaltrials.gov/study/NCT05394766 RECRUITING Hypertension OTHER: Omada Hypertension Program Stanford University Omada Health, Inc.

NCT06345066 A Study of LY3841136 in Overweight and Obese Participants https://clinicaltrials.gov/study/NCT06345066 RECRUITING Obesity

NCT05245266 Cell-Based Noninvasive Prenatal Testing https://clinicaltrials.gov/study/NCT05245266 RECRUITING Pregnancy Related DIAGNOSTIC_TEST: Redraw for analysis of blood samples from healthy pregnant women Luna Genetics

NCT06309966 Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy https://clinicaltrials.gov/study/NCT06309966 RECRUITING Focal Epilepsy DRUG: BHV-7000

NCT05276466 Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms https://clinicaltrials.gov/study/NCT05276466 RECRUITING Interstitial Cystitis

NCT03661866 A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC https://clinicaltrials.gov/study/NCT03661866 RECRUITING Atopic Dermatitis

NCT06243666 Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls https://clinicaltrials.gov/study/NCT06243666 NOT_YET_RECRUITING Cervical Intraepithelial Neoplasia

NCT06353126 DEB-TACE Prior to Liver Transplantation in the Treatment of HCC https://clinicaltrials.gov/study/NCT06353126 RECRUITING Liver Cancer PROCEDURE: DEB-TACE RenJi Hospital Boston Scientific Corporation

NCT06593626 A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection https://clinicaltrials.gov/study/NCT06593626 RECRUITING MCI

NCT06308926 MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients https://clinicaltrials.gov/study/NCT06308926 NOT_YET_RECRUITING Acute Respiratory Distress Syndrome

NCT04919226 Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE https://clinicaltrials.gov/study/NCT04919226 RECRUITING Neuroendocrine Tumors DRUG: 177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT

NCT05562466 A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma https://clinicaltrials.gov/study/NCT05562466 RECRUITING Asthma DRUG: QMF149

NCT05847166 A Phase 2/3,PSMA-T4, Prostate Cancer https://clinicaltrials.gov/study/NCT05847166 RECRUITING Prostate Cancer RADIATION: [99mTc]Tc-PSMA-T4 NCBJ Polatom: Narodowe Centrum Bada≈Ñ JƒÖdrowych Polatom

NCT06269666 P200TxE Diseased Eye Image Collection https://clinicaltrials.gov/study/NCT06269666 RECRUITING Retinal Disease DEVICE: P200TxE Optos, PLC

NCT05819866 A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy https://clinicaltrials.gov/study/NCT05819866 RECRUITING Cerebral Adrenoleukodystrophy (cALD) DRUG: Leriglitazone

NCT06072326 Ambrisentan Sotagliflozin and Prevention of Renal Injury; a Randomized Evaluation https://clinicaltrials.gov/study/NCT06072326 NOT_YET_RECRUITING Type 1 Diabetes Mellitus With Diabetic Nephropathy DRUG: Sotagliflozin

NCT05283226 Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination with Paclitaxel in Patients with Recurrent And/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy https://clinicaltrials.gov/study/NCT05283226 RECRUITING Carcinoma

NCT06520826 Vafseo Outcomes In-Center Experience https://clinicaltrials.gov/study/NCT06520826 NOT_YET_RECRUITING Anemia of Chronic Kidney Disease DRUG: Vadadustat

NCT04590326 A Trial to Find Out How Safe REGN5668 is and How Well it Works When Given With Either Cemiplimab or REGN4018 https://clinicaltrials.gov/study/NCT04590326 RECRUITING Ovarian Cancer

NCT06120166 Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research https://clinicaltrials.gov/study/NCT06120166 RECRUITING Diffuse Large B-cell Lymphoma DRUG: Metabolically Armed CD19 CAR-T cells He Huang Leman Biotech Co., Ltd.

NCT06412666 A Study to Evaluate the Effect of Aficamten in Pediatric Patients (Age 12 to <18 Years) With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM). https://clinicaltrials.gov/study/NCT06412666 RECRUITING Pediatric

NCT06694766 VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever) https://clinicaltrials.gov/study/NCT06694766 NOT_YET_RECRUITING Yellow Fever Vaccine PROCEDURE: Blood sample collection Institut Pasteur Cerballiance

NCT05767866 Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR https://clinicaltrials.gov/study/NCT05767866 RECRUITING Treatment

NCT03621566 Belgian Central Sleep Apnea REgistry https://clinicaltrials.gov/study/NCT03621566 RECRUITING Central Sleep Apnea OTHER: No intervention Universitaire Ziekenhuizen KU Leuven Philips Respironics

NCT06046066 A Phase 1 Study of NM6603 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06046066 RECRUITING Cancers DRUG: NM6603 NucMito Pharmaceuticals Co. Ltd.

NCT06097026 Role of Inhaled Nitric Oxide in Vascular Mechanics and Right Ventricular Function https://clinicaltrials.gov/study/NCT06097026 RECRUITING Collapsed Lung

NCT04011566 Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus https://clinicaltrials.gov/study/NCT04011566 RECRUITING Hydrocephalus, Normal Pressure DIAGNOSTIC_TEST: ShuntCheck University of South Florida NeuroDx Development

NCT05532566 Quercus Ilex and Quercus Robur Allergen Extracts Standardisation https://clinicaltrials.gov/study/NCT05532566 RECRUITING Allergic Reaction

NCT06450366 A Study to Evaluate the Efficacy and Safety of Enlicitide Decanoate (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018) CORALreef AddOn https://clinicaltrials.gov/study/NCT06450366 RECRUITING Hypercholesterolemia DRUG: Enlicitide Decanoate

NCT06502366 A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma https://clinicaltrials.gov/study/NCT06502366 RECRUITING Asthma DRUG: BDA MDI HFO 160/180 Œºg

NCT05682066 TVMR With the Innovalve System Trial - Pilot in Georgia https://clinicaltrials.gov/study/NCT05682066 RECRUITING Mitral Valve Regurgitation (Degenerative or Functional) DEVICE: Innovalve MR system Innovalve Bio Medical Ltd.

NCT06421766 Retrospective Study of Outcomes With 3 mm Implant for Percutaneous BAHS Procedures https://clinicaltrials.gov/study/NCT06421766 RECRUITING Hearing Loss DEVICE: BAHS Oticon Medical

NCT05650866 Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction https://clinicaltrials.gov/study/NCT05650866 RECRUITING Erectile Dysfunction Following Radical Prostatectomy DEVICE: Activation of pro-erectile nerves within the pelvic plexus Comphya Australia

NCT05568966 Collection of Blood Samples for New Diagnostic Devices 2 https://clinicaltrials.gov/study/NCT05568966 RECRUITING Embolism and Thrombosis

NCT04093466 A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04093466 RECRUITING Advanced Solid Tumor DRUG: CX1003 Beijing Konruns Pharmaceutical Co., Ltd. National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

NCT04616326 A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine https://clinicaltrials.gov/study/NCT04616326 RECRUITING Chronic Migraine DRUG: Galcanezumab

NCT05144126 Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device - A Canadian, Multicenter, Post-Market Clinical Investigation https://clinicaltrials.gov/study/NCT05144126 NOT_YET_RECRUITING Degenerative Disc Disease OTHER: CT radioraphic assessment CeraPedics, Inc Talosix

NCT06396026 A Study of Efficacy and Safety of TLL-018 in CSU Participants https://clinicaltrials.gov/study/NCT06396026 NOT_YET_RECRUITING Chronic Spontaneous Urticaria DRUG: TLL-018 tablets

NCT05409066 Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma https://clinicaltrials.gov/study/NCT05409066 RECRUITING Follicular Lymphoma (FL) DRUG: Epcoritamab

NCT06666166 SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer https://clinicaltrials.gov/study/NCT06666166 NOT_YET_RECRUITING Advanced Gastric Carcinoma

NCT06072066 Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea https://clinicaltrials.gov/study/NCT06072066 RECRUITING Rosacea

NCT05422066 Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma https://clinicaltrials.gov/study/NCT05422066 RECRUITING DLBCL Germinal Center B-Cell Type DRUG: Selinexor

NCT06530966 Phase I Study of ICP-332 in Healthy Subjects https://clinicaltrials.gov/study/NCT06530966 RECRUITING Healthy Subjects DRUG: ICP-332 Tablets

NCT04062266 AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission https://clinicaltrials.gov/study/NCT04062266 RECRUITING Acute Myeloid Leukemia in Remission

NCT05496166 The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05496166 NOT_YET_RECRUITING Limited Stage Small Cell Lung Cancer COMBINATION_PRODUCT: chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy Shanghai Pulmonary Hospital, Shanghai, China Jiangsu HengRui Medicine Co., Ltd.

NCT05491226 Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation https://clinicaltrials.gov/study/NCT05491226 RECRUITING TNBC - Triple-Negative Breast Cancer

NCT05696366 Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes https://clinicaltrials.gov/study/NCT05696366 RECRUITING Type 1 Diabetes DRUG: Sotagliflozin

NCT05635266 Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives https://clinicaltrials.gov/study/NCT05635266 RECRUITING Age-Related Macular Degeneration

NCT06090266 A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents https://clinicaltrials.gov/study/NCT06090266 RECRUITING Cancer

NCT04172766 Apple Hearing Study https://clinicaltrials.gov/study/NCT04172766 RECRUITING Hearing Loss, Noise-Induced

NCT05353166 REGN5381 in Heart Failure Adult Participants With Elevated Pulmonary Capillary Wedge Pressure https://clinicaltrials.gov/study/NCT05353166 RECRUITING Heart Failure DRUG: REGN5381

NCT06325566 Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain https://clinicaltrials.gov/study/NCT06325566 RECRUITING Degenerative Disc Disease DRUG: Rexlemestrocel-L + HA mixture

NCT04666766 Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers https://clinicaltrials.gov/study/NCT04666766 RECRUITING Brain Injuries, Traumatic

NCT06289166 Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor https://clinicaltrials.gov/study/NCT06289166 RECRUITING Hemophilia DRUG: STSP-0601 for Injection Staidson (Beijing) Biopharmaceuticals Co., Ltd

NCT03728166 Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT) https://clinicaltrials.gov/study/NCT03728166 RECRUITING Venous Thromboembolism BEHAVIORAL: Electronic alert Brigham and Women's Hospital Portola Pharmaceuticals

NCT06516926 SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06516926 NOT_YET_RECRUITING HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors DRUG: SHR-4602 Jiangsu HengRui Medicine Co., Ltd.

NCT06104826 Health-Related Quality of Life Outcomes and Bleeding Rates Among Patients With Severe Hemophilia A on Emicizumab https://clinicaltrials.gov/study/NCT06104826 NOT_YET_RECRUITING Hemophilia A DRUG: Emicizumab Newark Beth Israel Medical Center Genentech, Inc.

NCT06692166 A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer https://clinicaltrials.gov/study/NCT06692166 RECRUITING Cervical Cancer DRUG: 9MW2821

NCT06506266 Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy Participants https://clinicaltrials.gov/study/NCT06506266 NOT_YET_RECRUITING Asthma OTHER: HFA-152a

NCT06504966 Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia¬Æ https://clinicaltrials.gov/study/NCT06504966 NOT_YET_RECRUITING Osteoporosis DRUG: MAB-22

NCT04586166 Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy https://clinicaltrials.gov/study/NCT04586166 RECRUITING Stress Urinary Incontinence

NCT05243966 Myriad‚Ñ¢ Augmented Soft Tissue Reconstruction Registry https://clinicaltrials.gov/study/NCT05243966 RECRUITING Abdominal Wound Dehiscence

NCT06614166 Food Trial to Evaluate the Kinetics of the Medical Foods SBD111 and SBD121 Persistence in Healthy Adults https://clinicaltrials.gov/study/NCT06614166 RECRUITING Product Persistence in GI Tract

NCT06238466 A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia https://clinicaltrials.gov/study/NCT06238466 RECRUITING Cardiovascular DRUG: AZD1705

NCT05437926 A Study to Describe the Effectiveness of Arrhythmia Analysis Software for Screening of Sinus Rhythm, Atrial Fibrillation and Premature Beats in light-and Dark Skin Tone Patients https://clinicaltrials.gov/study/NCT05437926 RECRUITING Arrhythmia, Cardiac DEVICE: Arrhythmia Analysis Software (software) which runs on a mobile application (Huawei Phone) and uses input from a wearable device (smart watch or smart band). Huawei Device Co., Ltd

NCT06507865 Post Market Registry for GORE¬Æ TAG¬Æ Thoracic Branch Endoprosthesis https://clinicaltrials.gov/study/NCT06507865 NOT_YET_RECRUITING Aneurysm

NCT06290765 Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera https://clinicaltrials.gov/study/NCT06290765 NOT_YET_RECRUITING Polycythemia Vera

NCT06594965 A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes https://clinicaltrials.gov/study/NCT06594965 NOT_YET_RECRUITING Myelodysplastic Syndromes

NCT06459765 Mi2000 Totally Implantable Cochlear Implant (Mi2000 TICI) https://clinicaltrials.gov/study/NCT06459765 RECRUITING Hearing Loss, Sensorineural DEVICE: Mi2000 TICI MED-EL Elektromedizinische Ger√§te GesmbH

NCT06111365 Pivotal Observational CHLOE Study https://clinicaltrials.gov/study/NCT06111365 RECRUITING IVF DEVICE: CHLOE Fairtility

NCT06153966 PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717. https://clinicaltrials.gov/study/NCT06153966 RECRUITING Prion Disease DRUG: ION717

NCT05684965 XTX301 in Patients with Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05684965 RECRUITING Advanced Solid Tumor DRUG: XTX301 Xilio Development, Inc.

NCT05813665 A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone https://clinicaltrials.gov/study/NCT05813665 NOT_YET_RECRUITING Giant Cell Tumor of Bone DRUG: Narlumosbart

NCT06635226 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects https://clinicaltrials.gov/study/NCT06635226 NOT_YET_RECRUITING Healthy Adult Subjects DRUG: ID110521156

NCT03448926 The PREDICT Registry: https://clinicaltrials.gov/study/NCT03448926 RECRUITING DCIS OTHER: Treatment Recommendation Surveys

NCT04509726 EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma https://clinicaltrials.gov/study/NCT04509726 RECRUITING Nasopharyngeal Carcinoma DRUG: EBV-specific TCR-T cell with cytokine auto-secreting element Xinqiao Hospital of Chongqing TCRCure Biopharma Ltd.

NCT04464226 Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer https://clinicaltrials.gov/study/NCT04464226 RECRUITING Cancer DRUG: Darolutamide (Nubeqa, BAY1841788) Bayer

NCT04170426 Autologous Adipose-derived Stem Cells (AdMSCs) for Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT04170426 NOT_YET_RECRUITING Rheumatoid Arthritis BIOLOGICAL: autologous adipose derived stem cells Celltex Therapeutics Corporation

NCT06302426 Trial of INI-4001 in Patients With Advanced Solid Tumours https://clinicaltrials.gov/study/NCT06302426 NOT_YET_RECRUITING Advanced Solid Tumor DRUG: INI-4001

NCT04759326 Neurorehabilitation Through Hippotherapy of a Brain Stroke https://clinicaltrials.gov/study/NCT04759326 RECRUITING Cerebrovascular Accident

NCT06003426 A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis https://clinicaltrials.gov/study/NCT06003426 RECRUITING Idiopathic Pulmonary Fibrosis DRUG: BMS-986278

NCT06389526 A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06389526 NOT_YET_RECRUITING Advanced or Metastatic Solid Tumors BIOLOGICAL: CHS-1000

NCT06565026 CS-206 in Patients With Sickle Cell Disease https://clinicaltrials.gov/study/NCT06565026 RECRUITING Sickle Cell Disease GENETIC: CS-206 CorrectSequence Therapeutics Co., Ltd First Affiliated Hospital of Guangxi Medical University

NCT03772457 Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban https://clinicaltrials.gov/study/NCT03772457 RECRUITING Cerebrovascular Stroke

NCT05413057 An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ https://clinicaltrials.gov/study/NCT05413057 RECRUITING Hypertension,Essential Boryung Pharmaceutical Co., Ltd

NCT06360757 Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19) https://clinicaltrials.gov/study/NCT06360757 RECRUITING SARS-CoV-2 Acute Respiratory Disease DIAGNOSTIC_TEST: NeuMoDx SARS-CoV-2 Assay QIAGEN Gaithersburg, Inc

NCT04634357 ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT04634357 RECRUITING Hepatoblastoma

NCT06577857 Inferonasal MIMS¬Æ Procedure: Long-Term Follow-Up Extension Study https://clinicaltrials.gov/study/NCT06577857 RECRUITING Open Angle Glaucoma DEVICE: Inferonasal Minimally Invasive Micro Sclerostomy Sanoculis Ltd

NCT06247657 A Phase I Study to Assess the Safety and Tolerability of BL0006 for Patients With Advanced Solid Tumours https://clinicaltrials.gov/study/NCT06247657 RECRUITING Advanced Solid Tumor DRUG: BL0006 Shanghai Best-Link Bioscience, LLC

NCT06086626 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants https://clinicaltrials.gov/study/NCT06086626 RECRUITING Gram-Negative Bacterial Infections DRUG: Cefiderocol

NCT05583526 A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo https://clinicaltrials.gov/study/NCT05583526 RECRUITING Stable Nonsegmental Vitiligo

NCT05851326 Low-Energy Ultrasound, Electrical and Magnetic Field Stimulation in Therapy-Resistant Myofascial Pain Syndrome https://clinicaltrials.gov/study/NCT05851326 RECRUITING Myofascial Pain Syndrome - Lower Back

NCT06146257 A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes https://clinicaltrials.gov/study/NCT06146257 RECRUITING Acute Myeloid Leukemia

NCT05065957 Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer https://clinicaltrials.gov/study/NCT05065957 RECRUITING Biliary Tract Cancer DRUG: D07001-softgel capsules + Xeloda (or TS-1)

NCT06095557 MCG Discovery Study in Emergency Departments https://clinicaltrials.gov/study/NCT06095557 RECRUITING ACS - Acute Coronary Syndrome

NCT05780957 Multi-Cancer Early Detection (MCED) of Firefighters https://clinicaltrials.gov/study/NCT05780957 RECRUITING Cancer OTHER: MCED Vincere Cancer Center Elypta

NCT05286957 MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLC https://clinicaltrials.gov/study/NCT05286957 RECRUITING NSCLC DRUG: adjuvant tislelizumab and chemotherapy for MRD+ patients

NCT05491057 Treatment Patterns of Neratinib in HER2+ EBC in China https://clinicaltrials.gov/study/NCT05491057 NOT_YET_RECRUITING Breast Cancer DRUG: Neratinib Pierre Fabre Medicament

NCT05181826 Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer https://clinicaltrials.gov/study/NCT05181826 RECRUITING Cancer

NCT06663826 Development of Digital Diagnostic Devices for Parkinson's Disease https://clinicaltrials.gov/study/NCT06663826 RECRUITING Parkinson Disease DIAGNOSTIC_TEST: oculomotor and pupillary function assessment machineMD AG University of Zurich

NCT06063226 Clinical and Microbiological Aspects of Probiotics in Non-surgical Periodontal Therapy. https://clinicaltrials.gov/study/NCT06063226 NOT_YET_RECRUITING Periodontitis

NCT05578326 Study of Trilaciclib and Lurbinectidin https://clinicaltrials.gov/study/NCT05578326 RECRUITING Lung Cancer

NCT06615557 Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4) https://clinicaltrials.gov/study/NCT06615557 RECRUITING Social Anxiety Disorder (SAD) DRUG: Fasedienol Nasal Spray

NCT06659757 A Study to Investigate the Safety and Tolerability of Single and Multiple Ascending Doses of KIT2014 in Healthy Subjects https://clinicaltrials.gov/study/NCT06659757 RECRUITING Cystic Fibrosis DRUG: KIT2014

NCT06607757 Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer https://clinicaltrials.gov/study/NCT06607757 NOT_YET_RECRUITING CCCA Assessed by Ki67 Drop Below <2.7% From Baseline DRUG: Capivasertib

NCT06616766 A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946 https://clinicaltrials.gov/study/NCT06616766 RECRUITING NSCLC (Non-small Cell Lung Cancer)

NCT04812366 Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer https://clinicaltrials.gov/study/NCT04812366 RECRUITING Prostate Cancer DRUG: Apalutamide 60mg Tab

NCT06642766 Fiber Product for Gas, Bloating, and Bowel Regularity https://clinicaltrials.gov/study/NCT06642766 NOT_YET_RECRUITING Bloating

NCT05089266 Study of Œ±PD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05089266 RECRUITING Colorectal Cancer DRUG: CAR T cells Shanghai Cell Therapy Group Co.,Ltd

NCT04140526 Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC https://clinicaltrials.gov/study/NCT04140526 RECRUITING Non Small Cell Lung Cancer

NCT06641726 Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People with Serious Mental Illness https://clinicaltrials.gov/study/NCT06641726 NOT_YET_RECRUITING Bipolar Disorder (BD)

NCT02230826 Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty https://clinicaltrials.gov/study/NCT02230826 RECRUITING Hip Replacement

NCT06385366 Developing & Evaluating Models for Early Predicting Obstetrical Diseases in Pregnant Women by Non-invasive Prenatal Test https://clinicaltrials.gov/study/NCT06385366 NOT_YET_RECRUITING Pregnant With Complication

NCT06104566 Global Trial in APG2575 for Patients With CLL/SLL https://clinicaltrials.gov/study/NCT06104566 RECRUITING CLL/SLL DRUG: lisaftoclax +BTK inhibitor

NCT06507566 Evaluating Technologies for Point-of-Care Blood Collections by Patients https://clinicaltrials.gov/study/NCT06507566 RECRUITING Healthy DEVICE: Tasso+‚Ñ¢ Resilience Government Services, Inc. ICON Government and Public Health Solutions, Inc

NCT04553926 'OLAP' (OLAparib Regulatory Post-marketing Surveillance) https://clinicaltrials.gov/study/NCT04553926 RECRUITING Ovarian Cancer

NCT06050226 A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) https://clinicaltrials.gov/study/NCT06050226 RECRUITING Paroxysmal Nocturnal Hemoglobinuria DRUG: MY008211A tablets Wuhan Createrna Science and Technology Co., Ltd

NCT06328166 The Effect and Safety of Recombinant Fibroblast Growth Factor-1 for Carpal Tunnel Syndrome https://clinicaltrials.gov/study/NCT06328166 NOT_YET_RECRUITING Carpal Tunnel Syndrome PROCEDURE: Sono-guided injection with ES135

NCT06523166 Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics https://clinicaltrials.gov/study/NCT06523166 NOT_YET_RECRUITING Device Related Thrombosis

NCT05435066 Development and Validation of Harbinger Health Test for Early Cancer Detection https://clinicaltrials.gov/study/NCT05435066 RECRUITING Cancer DIAGNOSTIC_TEST: Harbinger Health Test Harbinger Health

NCT02299466 Registry for Patients Receiving Intravenous Nutrition at Home https://clinicaltrials.gov/study/NCT02299466 RECRUITING Parenteral Nutrition, Home University Health Network, Toronto Canadian Nutrition Society

NCT05090566 MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma https://clinicaltrials.gov/study/NCT05090566 RECRUITING Multiple Myeloma DRUG: Elranatamab + Nirogacestat

NCT06018766 LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. https://clinicaltrials.gov/study/NCT06018766 RECRUITING Bronchiolitis Obliterans Syndrome

NCT06246526 Real-World Efficacy of Evoke¬Æ Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA). https://clinicaltrials.gov/study/NCT06246526 RECRUITING Pain

NCT05804526 A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours https://clinicaltrials.gov/study/NCT05804526 RECRUITING Advanced Solid Tumours DRUG: RC88

NCT06198426 A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06198426 RECRUITING Solid Tumor DRUG: IBI3004 Innovent Biologics (Suzhou) Co. Ltd.

NCT05130866 Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas https://clinicaltrials.gov/study/NCT05130866 RECRUITING Neurofibromatosis Type 2 DRUG: REC-2282

NCT06229366 [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT06229366 RECRUITING Prostate Cancer

NCT06572566 Study on Neuropsychiatric Behavior in Cadmium-exposed People https://clinicaltrials.gov/study/NCT06572566 RECRUITING Cadmium Exceeds the Standard OTHER: Non-invasive examination and assessment. Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.

NCT06381466 A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants. https://clinicaltrials.gov/study/NCT06381466 RECRUITING Dilated Cardiomyopathy DRUG: AZD0233

NCT06543966 Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting https://clinicaltrials.gov/study/NCT06543966 NOT_YET_RECRUITING Post-operative Nausea and Vomiting (PONV) DRUG: Aprepitant Injection

NCT06283966 A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease https://clinicaltrials.gov/study/NCT06283966 RECRUITING COPD (Chronic Obstructive Pulmonary Disease) DRUG: BGF MDI 320/14.4/9.6 Œºg

NCT05199766 Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor https://clinicaltrials.gov/study/NCT05199766 RECRUITING Sickle Cell Disease DRUG: Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease Assistance Publique - H√¥pitaux de Paris Pfizer

NCT05170126 A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring https://clinicaltrials.gov/study/NCT05170126 RECRUITING Multiple Sclerosis Bristol-Myers Squibb

NCT06609226 A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia https://clinicaltrials.gov/study/NCT06609226 NOT_YET_RECRUITING Sickle Cell Disease, Thalassemia DRUG: Etavopivat A

NCT06665126 A Study to Evaluate the Effects of a Prebiotic and Probiotic Supplement to Provide Relief From Symptoms Associated With Bacterial Vaginosis and Yeast Infections. https://clinicaltrials.gov/study/NCT06665126 NOT_YET_RECRUITING Bacterial Vaginosis

NCT05573126 Phase 1/2 Study to Evaluate EP0062 in Patients With Relapsed Locally Advanced or Metastatic Androgen Receptor Positive (AR+)/HER2-/ER+ Breast Cancer https://clinicaltrials.gov/study/NCT05573126 RECRUITING Hormone Receptor-positive Breast Cancer

NCT06533826 TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd https://clinicaltrials.gov/study/NCT06533826 NOT_YET_RECRUITING Breast Cancer

NCT05567666 Optilume BPH Catheter System in Benign Prostatic Hyperplasia (BPH) https://clinicaltrials.gov/study/NCT05567666 NOT_YET_RECRUITING Benign Prostatic Hyperplasia DEVICE: Optilume Catheter System Dean Elterman Urotronic Inc.

NCT04198766 Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda¬Æ) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) https://clinicaltrials.gov/study/NCT04198766 RECRUITING Solid Tumor

NCT05661266 Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis https://clinicaltrials.gov/study/NCT05661266 RECRUITING Multiple Sclerosis DEVICE: Eye-Tracking Innodem Neurosciences

NCT05693766 Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort https://clinicaltrials.gov/study/NCT05693766 RECRUITING Invasive Mammary Carcinoma

NCT06091566 Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD) https://clinicaltrials.gov/study/NCT06091566 RECRUITING Urinary Incontinence

NCT05923866 A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy https://clinicaltrials.gov/study/NCT05923866 RECRUITING Multiple System Atrophy (MSA) DRUG: ONO-2808

NCT05168566 Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05168566 RECRUITING Non-small Cell Lung Cancer DRUG: Sutetinib Maleate Capsule Teligene US

NCT06451666 Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia https://clinicaltrials.gov/study/NCT06451666 NOT_YET_RECRUITING Presbyopia DRUG: Pilocarpine HCl Ophthalmic Solution

NCT05791526 An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan https://clinicaltrials.gov/study/NCT05791526 RECRUITING Ulcerative Colitis AbbVie

NCT05946226 A Phase I Trial to Evaluate the Safety of IMC002 in Advanced Digestive System Tumors https://clinicaltrials.gov/study/NCT05946226 RECRUITING Advanced Digestive System Tumor BIOLOGICAL: IMC002 injection Suzhou Immunofoco Biotechnology Co., Ltd

NCT05025826 Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare¬Æ or Placebo During Oxaliplatin Based Chemotherapy https://clinicaltrials.gov/study/NCT05025826 RECRUITING Metastatic Gastric Cancer OTHER: Phycocare

NCT06640166 Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab. https://clinicaltrials.gov/study/NCT06640166 RECRUITING Colorectal Carcinoma

NCT05610566 Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China https://clinicaltrials.gov/study/NCT05610566 RECRUITING Mitral Regurgitation DEVICE: the HighLife Trans-Septal Transcatheter Mitral Valve Replacement System Peijia Medical Technology (Suzhou) Co., Ltd. West China Hospital

NCT06133426 Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients https://clinicaltrials.gov/study/NCT06133426 NOT_YET_RECRUITING Lymphoma, Non-Hodgkin

NCT03793426 Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency https://clinicaltrials.gov/study/NCT03793426 RECRUITING Congenital Fibrinogen Deficiency BIOLOGICAL: Fibryga Octapharma

NCT06575426 A Study to Investigate Safety and Effectiveness of Pancreatic Cells Derived From Pigs (OPF-310) in Patients With Type 1 Diabetes Mellitus https://clinicaltrials.gov/study/NCT06575426 NOT_YET_RECRUITING Diabetes Mellitus, Type 1

NCT06614530 Effectiveness of Chilipad in Enhancing Sleep Quality & Wellbeing https://clinicaltrials.gov/study/NCT06614530 NOT_YET_RECRUITING Sleep

NCT05841030 A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) https://clinicaltrials.gov/study/NCT05841030 RECRUITING Depressive Disorder, Major OTHER: No Intervention Janssen Research & Development, LLC

NCT06717425 A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity https://clinicaltrials.gov/study/NCT06717425 NOT_YET_RECRUITING Obesity DRUG: PF-07976016

NCT04801225 Early Feasibility Study of the Nervive VitalFlow Stimulation for Acute Ischemic Stroke Patients https://clinicaltrials.gov/study/NCT04801225 RECRUITING Acute Stroke DEVICE: Non-invasive electromagnetic stimulation for acute stroke treatment Nervive, Inc. National Institute of Neurological Disorders and Stroke (NINDS)

NCT05967325 SVF Combined With Functional Self-assembling Peptide Nanofiber Hydrogels in the Treatment of Spinal Cord Injury https://clinicaltrials.gov/study/NCT05967325 RECRUITING Safety Issues PROCEDURE: Stromal Vascular Fraction (SVF) combined with Functional self-assembling peptide nanofiber hydrogels Kunming Tongren Hospital

NCT05570825 SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05570825 RECRUITING Metastatic Lung Non-Small Cell Carcinoma

NCT05823025 Withings Study to Analyze the Accuracy of Pulse Wave Velocity Measurement With Bathroom Scales (WIVOP-Scales) https://clinicaltrials.gov/study/NCT05823025 NOT_YET_RECRUITING Vascular Stiffness OTHER: PWV measurement Withings

NCT06694025 Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe. https://clinicaltrials.gov/study/NCT06694025 NOT_YET_RECRUITING Immunization

NCT05453825 A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05453825 RECRUITING Colorectal Cancer

NCT05332925 Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC https://clinicaltrials.gov/study/NCT05332925 RECRUITING Lung Cancer

NCT06170125 QualiTy of Life Evaluation in Patients With ChRonic ObstructIve Pulmonary Disease Who Require Tiotropium as additiOnal treatmeNt. https://clinicaltrials.gov/study/NCT06170125 NOT_YET_RECRUITING COPD OTHER: Tiotropium treated patients Elpen Pharmaceutical Co. Inc.

NCT06614725 A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD) https://clinicaltrials.gov/study/NCT06614725 RECRUITING Respiratory Syncytial Virus Infections BIOLOGICAL: RSVPreF3 OA investigational vaccine

NCT05938725 KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis https://clinicaltrials.gov/study/NCT05938725 RECRUITING Lupus Nephritis

NCT05821725 Effects of Topical Hyaluronic Acid Gel on Postoperative Pain and Wound Healing https://clinicaltrials.gov/study/NCT05821725 RECRUITING Palatal Wound DEVICE: Hyaluronic acid

NCT05825625 NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing https://clinicaltrials.gov/study/NCT05825625 RECRUITING Non-small Cell Lung Cancer DRUG: Atezolizumab

NCT06236425 TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC https://clinicaltrials.gov/study/NCT06236425 RECRUITING Squamous Cell Carcinoma of Head and Neck

NCT06656325 An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis https://clinicaltrials.gov/study/NCT06656325 NOT_YET_RECRUITING Periodontal Diseases

NCT06307925 A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06307925 RECRUITING Advanced Solid Tumor DRUG: HC010 HC Biopharma Inc.

NCT06549530 Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections https://clinicaltrials.gov/study/NCT06549530 NOT_YET_RECRUITING Monkeypox (Mpox) DRUG: MVA-BN Bavarian Nordic Coalition for Epidemic Preparedness Innovations

NCT06409130 Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease https://clinicaltrials.gov/study/NCT06409130 RECRUITING Alcohol-related Liver Disease DRUG: NNC0194-0499

NCT06610825 Castrate Resistant Prostate Cancer Enhertu Therapy https://clinicaltrials.gov/study/NCT06610825 NOT_YET_RECRUITING Prostate Cancer Metastatic

NCT05448625 Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry) https://clinicaltrials.gov/study/NCT05448625 RECRUITING Drug-eluting Stent

NCT06300125 Percutaneous Cryoablation of Low-risk Early Breast Cancer https://clinicaltrials.gov/study/NCT06300125 RECRUITING Breast Cancer PROCEDURE: Cryoablation European Institute of Oncology Fondazione Umberto Veronesi

NCT05533125 Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed https://clinicaltrials.gov/study/NCT05533125 RECRUITING Polymyalgia Rheumatica DRUG: Rituximab

NCT06616025 This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations. https://clinicaltrials.gov/study/NCT06616025 NOT_YET_RECRUITING Peripheral Nerve Injury Upper Limb

NCT06658730 Long-term Characterization of GORE¬Æ TAG¬Æ Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance https://clinicaltrials.gov/study/NCT06658730 NOT_YET_RECRUITING Vascular Disease

NCT05539430 Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma https://clinicaltrials.gov/study/NCT05539430 RECRUITING Gastric Cancer

NCT06627530 COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer https://clinicaltrials.gov/study/NCT06627530 NOT_YET_RECRUITING Prostate Cancer DRUG: Darolutamide Oral Tablet

NCT06381830 Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT06381830 RECRUITING Lymphoma, B-Cell

NCT04302025 A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT04302025 RECRUITING Non-small Cell Lung Cancer DRUG: Alectinib

NCT04621825 Post Market Surveillance Study to Confirm Safety and Performance of Silicone PHMB Foam https://clinicaltrials.gov/study/NCT04621825 RECRUITING Wound DEVICE: ActivHeal Silicone PHMB Foam Adhesive and Non Adhesive dressing. Advanced Medical Solutions Ltd. Imarc Research, Inc.

NCT06138730 Evaluating a Virtual Mentoring Program Plus Mental Health Videos for Teens https://clinicaltrials.gov/study/NCT06138730 RECRUITING Depressive Symptoms

NCT03524430 RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy https://clinicaltrials.gov/study/NCT03524430 RECRUITING Breast Neoplasm Female PROCEDURE: Core needle biopsy Rna Diagnostics Inc.

NCT03521830 Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma https://clinicaltrials.gov/study/NCT03521830 RECRUITING Basal Cell Carcinoma DRUG: Nivolumab

NCT06405230 Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Patient-derived Organoids and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC) https://clinicaltrials.gov/study/NCT06405230 NOT_YET_RECRUITING Lung Cancer, Non-Small Cell BIOLOGICAL: Pembrolizumab

NCT06466330 Efficacy of Microparticle Geniculate Artery Embolization in Total Knee Prosthesis Patients With Pain Resistant to Medical Treatment. A Prospective Randomized Controlled Trial https://clinicaltrials.gov/study/NCT06466330 NOT_YET_RECRUITING Knee Pain Chronic

NCT06500130 Effects of Liraglutide on Body Surface Gastric Mapping https://clinicaltrials.gov/study/NCT06500130 RECRUITING Gastroparesis

NCT05299125 Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small Cell Lung Cancers With Epidermal Growth Factor Receptor Mutations https://clinicaltrials.gov/study/NCT05299125 RECRUITING Metastatic Non-small Cell Lung Cancers DRUG: Amivantamab

NCT05728125 Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients https://clinicaltrials.gov/study/NCT05728125 NOT_YET_RECRUITING Glioblastoma Power Life Sciences Inc.

NCT06428825 A Study to Learn About the Safety of BAY3283142 in People With Mild to Moderate High Blood Pressure https://clinicaltrials.gov/study/NCT06428825 RECRUITING Chronic Kidney Disease

NCT06584825 Enhanced Vitals Monitoring After Major Surgery Trial https://clinicaltrials.gov/study/NCT06584825 NOT_YET_RECRUITING Surgery

NCT06411925 The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients https://clinicaltrials.gov/study/NCT06411925 RECRUITING Acute Bronchitis DRUG: Atock Dry Syrup

NCT06130722 First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study https://clinicaltrials.gov/study/NCT06130722 RECRUITING Locally Advanced/Metastatic Solid Tumors DRUG: FL115 Suzhou Forlong Biotechnology Co.,Ltd,

NCT05856630 Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex¬Æ 10.8mg https://clinicaltrials.gov/study/NCT05856630 NOT_YET_RECRUITING Prostate Cancer DRUG: Goserelin Acetate Sustained-Release Microspheres for Injection

NCT05072730 ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 https://clinicaltrials.gov/study/NCT05072730 RECRUITING Calcified Coronary Artery Disease DEVICE: Super High Pressure Balloon (OPN NC)

NCT05895825 A Study of EOC237 in Patients With Advanced Solid Tumor https://clinicaltrials.gov/study/NCT05895825 RECRUITING Advanced Solid Tumor DRUG: EOC237 Shanghai Yiteng Jingang Bio-pharmaceutical Technology Co., Ltd

NCT06285825 A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia https://clinicaltrials.gov/study/NCT06285825 RECRUITING Cytopenia DRUG: Emapalumab M.D. Anderson Cancer Center Sobi, Inc.

NCT05345925 PV Loops With CNT in Multiple Pacing Sites https://clinicaltrials.gov/study/NCT05345925 NOT_YET_RECRUITING Bradycardia

NCT05537025 Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis https://clinicaltrials.gov/study/NCT05537025 RECRUITING Idiopathic Pulmonary Fibrosis DRUG: ARO-MMP7 Inhalation Solution

NCT05477225 A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions https://clinicaltrials.gov/study/NCT05477225 RECRUITING Hidradenitis Suppurativa DEVICE: NovoSorb¬Æ BTM

NCT06597422 A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects https://clinicaltrials.gov/study/NCT06597422 NOT_YET_RECRUITING Neurotrophic Keratitis DRUG: STSP-0902 ophthalmic solution

NCT06177522 Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer https://clinicaltrials.gov/study/NCT06177522 RECRUITING Pancreatic Cancer

NCT03474822 Plasmodium Immunotherapy for Breast and Liver Cancers https://clinicaltrials.gov/study/NCT03474822 RECRUITING Advanced Breast Cancer

NCT06631430 A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men https://clinicaltrials.gov/study/NCT06631430 RECRUITING Healthy DRUG: BI 3810477

NCT05538130 A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05538130 RECRUITING Melanoma

NCT02686125 Vercise‚Ñ¢ DBS Dystonia Prospective Study https://clinicaltrials.gov/study/NCT02686125 RECRUITING Dystonia DEVICE: Deep Brain Stimulation (DBS) Boston Scientific Corporation

NCT03631225 The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT03631225 RECRUITING Rheumatoid Arthritis (RA) DIAGNOSTIC_TEST: Vectra Sequenom, Inc. Laboratory Corporation of America

NCT06103825 A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients With Obstructive Sleep Apnea (OSA) https://clinicaltrials.gov/study/NCT06103825 RECRUITING Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea DRUG: Solriamfetol

NCT05644925 Effects of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) Therapy on miRNAs Expression and Absolute Microvascular Resistance by Continuous Thermodilution in ST-segment Elevation Myocardial Infarction (STEMI) Patients: PiCSO-STEMI TRIAL https://clinicaltrials.gov/study/NCT05644925 NOT_YET_RECRUITING Anterior Myocardial Infarction DEVICE: PiCSO Impulse System

NCT05881525 NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05881525 RECRUITING Advanced Solid Tumors BIOLOGICAL: TC-N201 cells

NCT06015425 tDCS in Depression in Perinatal Women https://clinicaltrials.gov/study/NCT06015425 NOT_YET_RECRUITING Depression

NCT03587922 FANTOM Post Market Clinical Trial https://clinicaltrials.gov/study/NCT03587922 RECRUITING Coronary Artery Disease DEVICE: Fantom REVA Medical, Inc.

NCT05491525 A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC https://clinicaltrials.gov/study/NCT05491525 RECRUITING Neurogenic Detrusor Overactivity DRUG: Vibegron Urovant Sciences GmbH

NCT05456425 A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium https://clinicaltrials.gov/study/NCT05456425 RECRUITING Pterygium DRUG: CBT-001

NCT06088225 Myopia Preventing With Distance-image Screen https://clinicaltrials.gov/study/NCT06088225 RECRUITING Myopia, Progressive DEVICE: distance-image screen Beijing Airdoc Technology Co., Ltd.

NCT06413225 Multi-Centre Post-Market Data Collection https://clinicaltrials.gov/study/NCT06413225 NOT_YET_RECRUITING Cervical Degenerative Disc Disease DEVICE: Synergy cervical disc system Synergy Spine Solutions MCRA

NCT05884125 Promoting Healing of Injured Nerves With Electrical Stimulation Therapy https://clinicaltrials.gov/study/NCT05884125 RECRUITING Nerve Injury

NCT05148325 Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05148325 RECRUITING Advanced Solid Tumor

NCT05140525 Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH https://clinicaltrials.gov/study/NCT05140525 NOT_YET_RECRUITING CTEPH DRUG: Macitentan Tablets

NCT06420622 INDIcators for Clarifying the bAckground of exTreme Obesity in childRen https://clinicaltrials.gov/study/NCT06420622 RECRUITING Gene Abnormality

NCT04332822 A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma https://clinicaltrials.gov/study/NCT04332822 RECRUITING DLBCL

NCT06034522 Clinical Investigation Evaluating the Safety and Feasibility of Adipearl https://clinicaltrials.gov/study/NCT06034522 RECRUITING Mid-face Volume Deficiency DEVICE: Adipearl Volumina Medical S.A.

NCT04745039 Guo's Entry Tear Repair :The First in Man Study of Endopatch System https://clinicaltrials.gov/study/NCT04745039 RECRUITING Chronic Stanford B Type Aortic Dissection Proximal Tear DEVICE: Endopatch System Hangzhou Endonom Medtech Co., Ltd.

NCT05765539 Performance of the Echopen Probe in Its Clinical Use for Pregnancy Follow-up in Senegal https://clinicaltrials.gov/study/NCT05765539 RECRUITING Pregnancy Related DEVICE: echOpen O1 Handheld Ultrasound device echOpen Factory Institut Pasteur de Dakar

NCT05766839 Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age https://clinicaltrials.gov/study/NCT05766839 RECRUITING Hyperkalemia DRUG: Patiromer Vifor Pharma, Inc.

NCT06302439 PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency https://clinicaltrials.gov/study/NCT06302439 RECRUITING Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency

NCT06157086 Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France https://clinicaltrials.gov/study/NCT06157086 RECRUITING Multiple Sclerosis (MS) OTHER: ofatumumab Novartis Pharmaceuticals

NCT06235086 Phase 3 Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus https://clinicaltrials.gov/study/NCT06235086 NOT_YET_RECRUITING Type 2 Diabetes Mellitus DRUG: TG103

NCT05440786 CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma https://clinicaltrials.gov/study/NCT05440786 RECRUITING Sarcoma, Ewing

NCT05888922 Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia https://clinicaltrials.gov/study/NCT05888922 NOT_YET_RECRUITING Androgenetic Alopecia

NCT04098822 A 3 Years Naturalistic Cohort Survey Of Virtue¬Æ Male Sling System For Male Stress Urinary Incontinence https://clinicaltrials.gov/study/NCT04098822 RECRUITING Urinary Incontinence, Stress DEVICE: Virtue male sling Coloplast A/S

NCT06477939 Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients https://clinicaltrials.gov/study/NCT06477939 NOT_YET_RECRUITING Glioblastoma DRUG: Administration of L-TC

NCT06713239 A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD https://clinicaltrials.gov/study/NCT06713239 NOT_YET_RECRUITING Coronary Artery Disease DEVICE: Cleerly Labs and Cleerly ISCHEMIA Cleerly, Inc.

NCT06490939 Clinical Trial of Efepoetin Alfa in Healthy Subjects https://clinicaltrials.gov/study/NCT06490939 RECRUITING Healthy DRUG: Efepoetin Alfa Genexine, Inc.

NCT03129139 A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide‚Ñ¢ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT03129139 RECRUITING Advanced Cancer

NCT06306339 A Study to Assess the Efficacy and Safety of Burfiralimab (hzVSF-v13) and DMRD (Disease-modifying Antirheumatic Drug) https://clinicaltrials.gov/study/NCT06306339 NOT_YET_RECRUITING Moderate to Severe Rheumatoid Arthritis DRUG: Burfiralimab

NCT05688839 A Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia https://clinicaltrials.gov/study/NCT05688839 NOT_YET_RECRUITING Novel COVID-19-Infected Pneumonia DRUG: Jaktinib hydrochloride tablets

NCT06089122 Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG https://clinicaltrials.gov/study/NCT06089122 NOT_YET_RECRUITING Primary Immunodeficiency Disease BIOLOGICAL: IVIG Azidus Brasil Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

NCT04933422 CM93 Treatment in Subjects With Epidermal Growth Factor Receptor (EGFR)-Modified Recurrent Glioblastoma (rGBM) https://clinicaltrials.gov/study/NCT04933422 NOT_YET_RECRUITING Glioblastoma DRUG: CM93 Crimson Biopharm Inc.

NCT02960022 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study https://clinicaltrials.gov/study/NCT02960022 RECRUITING Prostate Cancer DRUG: enzalutamide

NCT06083922 A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) https://clinicaltrials.gov/study/NCT06083922 RECRUITING Multiple Myeloma

NCT05523622 Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices https://clinicaltrials.gov/study/NCT05523622 RECRUITING Glaucoma DEVICE: Tono-Vera tonometer

NCT06437522 A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors https://clinicaltrials.gov/study/NCT06437522 RECRUITING Head and Neck Squamous Cell Carcinoma DRUG: BL-B01D1

NCT06057922 A Study YL201 in Patients With Selected Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06057922 RECRUITING Advanced Solid Tumor DRUG: YL201 for Injection MediLink Therapeutics (Suzhou) Co., Ltd.

NCT06511739 A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo Patients https://clinicaltrials.gov/study/NCT06511739 RECRUITING Non-segmental Vitiligo DRUG: SYHX1901

NCT04511039 Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer https://clinicaltrials.gov/study/NCT04511039 RECRUITING Advanced Malignant Solid Neoplasm

NCT05320939 Immunological Basis for Mepolizumab Activity in COPD https://clinicaltrials.gov/study/NCT05320939 NOT_YET_RECRUITING COPD DRUG: Mepolizumab 100 MG Temple University GlaxoSmithKline

NCT06190886 A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06190886 RECRUITING Advanced Cancer

NCT04209686 Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma https://clinicaltrials.gov/study/NCT04209686 RECRUITING Advanced Gastric Adenocarcinoma DRUG: Paclitaxel

NCT06218186 Assessing the Performance of Wesper Lab for Sleep Apnea Diagnosis in Pediatric Populations https://clinicaltrials.gov/study/NCT06218186 NOT_YET_RECRUITING Sleep Apnea

NCT05223686 To Evaluate the Safety and Tolerability of Human CD19-CD22 Targeted T Cells Injection for Subjects With R/R B-ALL. https://clinicaltrials.gov/study/NCT05223686 NOT_YET_RECRUITING Acute Lymphoblastic Leukemia DRUG: Human CD19-CD22 Targeted T Cells Injection Hrain Biotechnology Co., Ltd. Ruijin Hospital

NCT06090539 A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas https://clinicaltrials.gov/study/NCT06090539 RECRUITING Relapsed/Refractory Non-Hodgkin Lymphoma DRUG: BMS-986458

NCT06411639 Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases https://clinicaltrials.gov/study/NCT06411639 NOT_YET_RECRUITING Sjogren Disease

NCT06385639 Efficacy and Safety of Probiotic Products for Digestive Health https://clinicaltrials.gov/study/NCT06385639 RECRUITING Healthy Adult DIETARY_SUPPLEMENT: Probiotic Wecare Probiotics Co., Ltd.

NCT06441539 Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions https://clinicaltrials.gov/study/NCT06441539 NOT_YET_RECRUITING Coronary Artery Disease DEVICE: Bingo¬Æ Paclitaxel coated balloon

NCT06630286 Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 https://clinicaltrials.gov/study/NCT06630286 RECRUITING HIV-1-infection DRUG: ISL/LEN

NCT06279286 Phase ‚Ö†b/‚Ö° Study of HS-10506 in Chinese Participants With Insomnia Disorder https://clinicaltrials.gov/study/NCT06279286 NOT_YET_RECRUITING Insomnia Disorder DRUG: HS-10506

NCT05861986 A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy https://clinicaltrials.gov/study/NCT05861986 RECRUITING Muscular Atrophy, Spinal DRUG: risdiplam Hoffmann-La Roche

NCT06040086 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations https://clinicaltrials.gov/study/NCT06040086 RECRUITING Chronic Obstructive Pulmonary Disease (COPD) DRUG: Placebo

NCT04620239 ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study https://clinicaltrials.gov/study/NCT04620239 RECRUITING Transitional Cell Cancer of Renal Pelvis and Ureter DRUG: padeliporfin VTP Steba Biotech S.A. PrimeVigilance

NCT05683886 A Study of KC1036 in Patients with Advanced Thymic Tumors https://clinicaltrials.gov/study/NCT05683886 RECRUITING Thymic Tumors DRUG: KC1036 Beijing Konruns Pharmaceutical Co., Ltd.

NCT06466486 An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian Stimulation https://clinicaltrials.gov/study/NCT06466486 RECRUITING Fertility DRUG: Follitropin delta

NCT05923086 Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy. https://clinicaltrials.gov/study/NCT05923086 RECRUITING Ileus Postoperative DRUG: ORE001

NCT06566586 A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma https://clinicaltrials.gov/study/NCT06566586 RECRUITING B-cell Lymphoma DRUG: TQB3702 tablets+Chemotherapy regimen Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT06435039 A Study of APL-1501 Extended Release Capsules Compared to APL-1202 Immediate Release Tablets in Healthy Volunteers https://clinicaltrials.gov/study/NCT06435039 NOT_YET_RECRUITING Healthy Volunteers DRUG: APL-1202

NCT05571839 A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors https://clinicaltrials.gov/study/NCT05571839 RECRUITING Cutaneous Melanoma

NCT06689839 Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR https://clinicaltrials.gov/study/NCT06689839 NOT_YET_RECRUITING Aortic Stenosis Treated With TAVI

NCT05449639 Study for a Magnetic Endourethral Sphincter Against Stress Urinary Incontinence https://clinicaltrials.gov/study/NCT05449639 RECRUITING Urinary Incontinence DEVICE: Relief implantation Relief srl Donawa Lifescience

NCT06056739 Alio WEAR Study: Long-term Wear of the Alio Platform https://clinicaltrials.gov/study/NCT06056739 RECRUITING End Stage Kidney Disease DEVICE: Alio platform Alio, Inc.

NCT06705686 Novel ACK1 Inhibitor (R)-9b in Patients with Prostate Cancer https://clinicaltrials.gov/study/NCT06705686 NOT_YET_RECRUITING Metastatic Castration-resistant Prostate Cancer (CRPC)

NCT05733286 REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant https://clinicaltrials.gov/study/NCT05733286 RECRUITING Delirium in Old Age DRUG: Suvorexant 20 mg

NCT04977986 Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults with Fragile X Syndrome https://clinicaltrials.gov/study/NCT04977986 RECRUITING Fragile X Syndrome DRUG: ZYN002 - transdermal gel

NCT03513939 A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch‚Ñ¢ for Clinical Islet Transplantation https://clinicaltrials.gov/study/NCT03513939 RECRUITING Type 1 Diabetes Mellitus COMBINATION_PRODUCT: Sernova Cell Pouch Sernova Corp ICON plc

NCT05263739 A First-in-Human Phase I Study of ESG206 in Subjects With B-cell Lymphoid Malignancies https://clinicaltrials.gov/study/NCT05263739 NOT_YET_RECRUITING B-cell Lymphoid Malignancies DRUG: ESG206 Shanghai Escugen Biotechnology Co., Ltd Escugen (Australia) Biotechnology Pty Ltd

NCT05476939 Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 https://clinicaltrials.gov/study/NCT05476939 RECRUITING Diffuse Intrinsic Pontine Glioma

NCT05699486 A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery https://clinicaltrials.gov/study/NCT05699486 RECRUITING Pulmonary Hypertension DRUG: PDNO

NCT06674486 Bioequivalence Study of Iron Sucrose Injection in Healthy Participants https://clinicaltrials.gov/study/NCT06674486 NOT_YET_RECRUITING Bioequivalency

NCT05401786 Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC https://clinicaltrials.gov/study/NCT05401786 RECRUITING Carcinoma, Non-Small-Cell Lung DRUG: Ipilimumab

NCT05023486 NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies https://clinicaltrials.gov/study/NCT05023486 RECRUITING Advanced or Metastatic Solid Tumor Malignancies DRUG: NP-G2-044 Monotherapy

NCT06541639 EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors https://clinicaltrials.gov/study/NCT06541639 NOT_YET_RECRUITING Advanced or Recurrent Solid Tumors BIOLOGICAL: EVM16

NCT05794139 Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy https://clinicaltrials.gov/study/NCT05794139 RECRUITING Spinal Muscular Atrophy DRUG: NMD670

NCT06285539 Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases https://clinicaltrials.gov/study/NCT06285539 RECRUITING Behcet's Disease

NCT03911739 Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study https://clinicaltrials.gov/study/NCT03911739 RECRUITING Opioid-Related Disorders

NCT05934539 ALG.APV-527 First-in-human Study https://clinicaltrials.gov/study/NCT05934539 RECRUITING Solid Tumor DRUG: ALG.APV-527 Aptevo Therapeutics Alligator Bioscience AB

NCT05978739 Evaluating Different Doses of Orelabrutinib in MCL https://clinicaltrials.gov/study/NCT05978739 RECRUITING Mantle Cell Lymphoma DRUG: Orelabrutinib High dose

NCT05461339 TAB014 Compared to Lucentis¬Æ in Patients With Neovascular Age-related Macular Degeneration https://clinicaltrials.gov/study/NCT05461339 RECRUITING Neovascular Age-related Macular Degeneration DRUG: TAB014 Monoclonal Antibody Injection

NCT04701086 3 Month Study of Cationorm Pro Versus Vismed in Adults With Dry Eye Disease Related to Keratitis or Keratoconjunctivitis https://clinicaltrials.gov/study/NCT04701086 RECRUITING Dry Eye Syndromes DEVICE: Cationorm Pro

NCT04069286 EFFICACY OF ORAL AROEIRA (Schinus Terebinthifolia Raddi) COMPARED TO OMEPRAZOLE IN DYSPEPPSIA https://clinicaltrials.gov/study/NCT04069286 NOT_YET_RECRUITING Dyspepsia DRUG: Oral Aroeira

NCT06550986 False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study https://clinicaltrials.gov/study/NCT06550986 NOT_YET_RECRUITING Aortic Dissection DEVICE: False Lumen Embolization System Shape Memory Medical, Inc.

NCT06681766 A Study to Assess Nomlabofusp in Adolescents and Children With Friedreich's Ataxia https://clinicaltrials.gov/study/NCT06681766 NOT_YET_RECRUITING Friedreich Ataxia DRUG: Nomlabofusp

NCT05735366 A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05735366 RECRUITING Solid Tumor DRUG: SAIL66 Chugai Pharmaceutical

NCT05156866 First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer https://clinicaltrials.gov/study/NCT05156866 RECRUITING Advanced Solid Tumor

NCT05918666 National Register of Actionable Mutations https://clinicaltrials.gov/study/NCT05918666 RECRUITING Solid Tumours in Advanced Stages Federation of Italian Cooperative Oncology Groups Roche Pharma AG

NCT04899466 Efficacy Evaluation of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence https://clinicaltrials.gov/study/NCT04899466 RECRUITING Dehiscence Wound DEVICE: ActiGraft RedDress Ltd.

NCT06419166 An Exploratory Clinical Study of GC012F Injection for Refractory gMG https://clinicaltrials.gov/study/NCT06419166 NOT_YET_RECRUITING Refractory Generalized Myasthenia Gravis DRUG: GC012F injection Zhejiang University Gracell Biotechnologies (Shanghai) Co., Ltd.

NCT06544226 The Use of Smart Devices in Capturing Digital Biomarkers in Eating Disorders https://clinicaltrials.gov/study/NCT06544226 RECRUITING Eating Disorders DEVICE: UH100 Univa Health

NCT05504226 Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin https://clinicaltrials.gov/study/NCT05504226 RECRUITING Type 2 Diabetes DRUG: Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral Tablet

NCT03947866 Ezetimibe-Rosuvastatin Evaluation Study https://clinicaltrials.gov/study/NCT03947866 RECRUITING Hypercholesterolemia

NCT04252066 A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding https://clinicaltrials.gov/study/NCT04252066 RECRUITING Fabry Disease DRUG: migalastat Amicus Therapeutics

NCT06315166 Study on Using Radiofrequency to Treat Moderate to Severe Acne https://clinicaltrials.gov/study/NCT06315166 RECRUITING Moderate to Severe Acne Vulgaris DEVICE: triLift/Legend Pro+ Fractional RF System Pollogen Lumenis Be Ltd.

NCT06654466 Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer https://clinicaltrials.gov/study/NCT06654466 NOT_YET_RECRUITING Hereditary Cancer Syndromes

NCT06547866 Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenstr√∂m Macroglobulinemia https://clinicaltrials.gov/study/NCT06547866 NOT_YET_RECRUITING Waldenstrom Macroglobulinemia DRUG: zanubrutinib + BGB-11417 French Innovative Leukemia Organisation BeiGene

NCT05896566 A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer https://clinicaltrials.gov/study/NCT05896566 RECRUITING Breast Cancer DRUG: Giredestrant

NCT05484466 A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB https://clinicaltrials.gov/study/NCT05484466 RECRUITING Hepatitis B, Chronic DRUG: ZM-H1505R

NCT05951166 Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension https://clinicaltrials.gov/study/NCT05951166 RECRUITING Heart Failure Patients With Pulmonary Hypertension DEVICE: Gradient Denervation System Gradient Denervation Technologies

NCT06612866 Determination of the Biological Activity of Enriched Serums on Healthy Volunteers After Consumption of the Kera-Diet¬Æ Ingredient https://clinicaltrials.gov/study/NCT06612866 NOT_YET_RECRUITING Healthy DIETARY_SUPPLEMENT: Keratin hydrolysate BCF Life Sciences Clinic'n'Cell

NCT05630066 Study to Investigate the Pharmacokinetics and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype. https://clinicaltrials.gov/study/NCT05630066 RECRUITING Angelman Syndrome DRUG: 60 mg QD Alogabat

NCT06662266 Induce XT‚Ñ¢ Bone Graft in Foot and Ankle Fusion https://clinicaltrials.gov/study/NCT06662266 NOT_YET_RECRUITING Surgery

NCT03704766 Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis https://clinicaltrials.gov/study/NCT03704766 RECRUITING Joint Infection

NCT05454566 A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis. https://clinicaltrials.gov/study/NCT05454566 NOT_YET_RECRUITING Osteoarthritis, Knee GENETIC: ICM-203 ICM Co. Ltd.

NCT05201066 Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab. https://clinicaltrials.gov/study/NCT05201066 RECRUITING Myelodysplastic Syndromes

NCT06649266 Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis D https://clinicaltrials.gov/study/NCT06649266 RECRUITING Chronic Hepatitis D DRUG: RBD1016

NCT05744466 A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis https://clinicaltrials.gov/study/NCT05744466 RECRUITING Psoriasis DRUG: Deucravacitinib

NCT06473766 Ultrasound RF Data for Discriminating Between Benign and Malignant Ovarian Masses https://clinicaltrials.gov/study/NCT06473766 NOT_YET_RECRUITING Ovarian Cancer DIAGNOSTIC_TEST: RF data extraction Fondazione Policlinico Universitario Agostino Gemelli IRCCS Samsung Medison

NCT05704166 PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients https://clinicaltrials.gov/study/NCT05704166 RECRUITING Acute Lung Injury

NCT06487026 Safety of ArcBlate MRgHIFU in Patients With Painful Bone Metastases: An Extension Study https://clinicaltrials.gov/study/NCT06487026 NOT_YET_RECRUITING Bone Metastases DEVICE: ArcBlate Focused Ultrasound Ablation System EpiSonica

NCT06717126 Study of Roginolisib in UM Patients https://clinicaltrials.gov/study/NCT06717126 NOT_YET_RECRUITING Uveal Melanoma

NCT05267626 Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2RŒ± Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer https://clinicaltrials.gov/study/NCT05267626 RECRUITING Advanced Solid Tumor

NCT04107766 NOLA (NeuWave Observational Liver Ablation) Registry https://clinicaltrials.gov/study/NCT04107766 RECRUITING Cancer of the Liver

NCT05800366 A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma https://clinicaltrials.gov/study/NCT05800366 RECRUITING Lymphoma

NCT04842266 IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures https://clinicaltrials.gov/study/NCT04842266 RECRUITING Cancer Metastatic

NCT05731466 Exercise Right Ventricular Coupling in HFpEF https://clinicaltrials.gov/study/NCT05731466 RECRUITING Heart Failure With Preserved Ejection Fraction

NCT05734066 Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma https://clinicaltrials.gov/study/NCT05734066 RECRUITING Refractory Ewing Sarcoma

NCT05103566 Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage https://clinicaltrials.gov/study/NCT05103566 RECRUITING Subarachnoid Hemorrhage, Aneurysmal DEVICE: gammaCore Massachusetts General Hospital ElectroCore INC

NCT05775666 UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT05775666 NOT_YET_RECRUITING Solid Tumor BIOLOGICAL: UCLM802 Cell Injection Peking University UTC Therapeutics Inc.

NCT06081920 A Study of IBI363 in Subjects With Advanced Melanoma https://clinicaltrials.gov/study/NCT06081920 RECRUITING Melanoma BIOLOGICAL: IBI363 Innovent Biologics (Suzhou) Co. Ltd.

NCT04766320 Study on TIL for the Treatment of r/r Gynecologic Tumors https://clinicaltrials.gov/study/NCT04766320 RECRUITING Gynecologic Cancer BIOLOGICAL: Tumor Infiltrating Lymphocytes (TIL) Shanghai 10th People's Hospital Shanghai Juncell Therapeutics

NCT06273020 Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke https://clinicaltrials.gov/study/NCT06273020 RECRUITING Ischemic Stroke, Acute

NCT04661020 CD19 CAR-T Therapy for Patients With B-cell Non-Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT04661020 RECRUITING Non-hodgkin Lymphoma,B Cell DRUG: CD19 CAR-T cells Zhejiang University Yake Biotechnology Ltd.

NCT06532474 Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies https://clinicaltrials.gov/study/NCT06532474 NOT_YET_RECRUITING Spinal Muscular Atrophy St. Jude Children's Research Hospital Genentech, Inc.

NCT04900974 Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant Women https://clinicaltrials.gov/study/NCT04900974 RECRUITING HIV Infections

NCT06254274 A Study of RAY1225 in Participants With Type 2 Diabetes https://clinicaltrials.gov/study/NCT06254274 RECRUITING T2DM (Type 2 Diabetes Mellitus) DRUG: RAY1225

NCT05284474 Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler https://clinicaltrials.gov/study/NCT05284474 NOT_YET_RECRUITING Fetal Growth Retardation

NCT04786574 A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD) https://clinicaltrials.gov/study/NCT04786574 RECRUITING Autosomal Recessive Polycystic Kidney Disease (ARPKD) DRUG: Tolvaptan (OPC-41061) Otsuka Pharmaceutical Development & Commercialization, Inc.

NCT05531565 A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST) https://clinicaltrials.gov/study/NCT05531565 RECRUITING Subacute Cutaneous Lupus Erythematosus

NCT05753865 A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound) https://clinicaltrials.gov/study/NCT05753865 NOT_YET_RECRUITING Advanced Breast Cancer DRUG: SYHX2011

NCT06344065 Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants https://clinicaltrials.gov/study/NCT06344065 RECRUITING Healthy Volunteers BIOLOGICAL: Diphtheria, tetanus and acellular pertussis (component) combined vaccine (adsorbed)

NCT05894265 Prospective Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft Active Matrix (AM) vs. Standard of Care in Arthroscopic Rotator Cuff Repair https://clinicaltrials.gov/study/NCT05894265 NOT_YET_RECRUITING Rotator Cuff Tears OTHER: ActiveMatrix¬Æ Dosage A

NCT06665165 AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis https://clinicaltrials.gov/study/NCT06665165 NOT_YET_RECRUITING ALS DRUG: AMX0114

NCT06007365 Post Market Clinical FoIIow up (PMCF) Medical Device (MD) of Z-Systems Monotype Zirconia Dental Product: Z5m Dental Implants Registry https://clinicaltrials.gov/study/NCT06007365 RECRUITING Missing Teeth DEVICE: Z5m Dental Implants Z-Systems

NCT04083365 Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer https://clinicaltrials.gov/study/NCT04083365 RECRUITING RECTAL CANCER DRUG: Capecitabine

NCT06206265 Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS) https://clinicaltrials.gov/study/NCT06206265 RECRUITING Irritable Bowel Syndrome DRUG: TRYP-0082

NCT06029465 Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials https://clinicaltrials.gov/study/NCT06029465 NOT_YET_RECRUITING Rhabdomyosarcoma Power Life Sciences Inc.

NCT05868265 A Study of Enfortumab Vedotin in People with Urothelial Carcinoma of the Upper Urinary Tract https://clinicaltrials.gov/study/NCT05868265 RECRUITING Urothelial Carcinoma DRUG: Enfortumab Vedotin

NCT05305365 Study Assessing QBS72S for Treating Brain Metastases https://clinicaltrials.gov/study/NCT05305365 RECRUITING Brain Metastases

NCT06631365 PrEPsmart 2-1-1 Pilot https://clinicaltrials.gov/study/NCT06631365 RECRUITING HIV-1-infection DEVICE: PrEPsmart mobile app

NCT05517265 Acalabrutinib in Patients With Chronic Lymphocytic Leukemia With Direct Oral Anticoagulation (CICERO) https://clinicaltrials.gov/study/NCT05517265 RECRUITING CLL DRUG: Calquence

NCT03090165 Ribociclib and Bicalutamide in AR+ TNBC https://clinicaltrials.gov/study/NCT03090165 RECRUITING Triple Negative Breast Cancer DRUG: ribociclib

NCT05327465 Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy https://clinicaltrials.gov/study/NCT05327465 RECRUITING Androgen Deprivation Therapy

NCT05998265 A Randomised, Controlled, Open-Label, Multi-Centre Study to Evaluate the Efficacy of FeetMe¬Æ Home-Bases Rehabilitation Program in Comparison to Conventional Physiotherapy in Patients With Parkinson's Disease Using Connected Insoles https://clinicaltrials.gov/study/NCT05998265 NOT_YET_RECRUITING Parkinson Disease

NCT06527365 Safety and Efficacy of VDPHL01 in Males With AGA https://clinicaltrials.gov/study/NCT06527365 RECRUITING Androgenetic Alopecia

NCT05851365 Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer https://clinicaltrials.gov/study/NCT05851365 RECRUITING Prostate Cancer

NCT06548139 Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials https://clinicaltrials.gov/study/NCT06548139 NOT_YET_RECRUITING Rabies Virus Infection DRUG: Natural full human monoclonal antibody CBB 1 injection 50.0¬µg/kg

NCT05471986 Multicenter Diagnostic Clinical Performance Study For Automated Detection of Diabetic Retinopathy https://clinicaltrials.gov/study/NCT05471986 NOT_YET_RECRUITING Diabetic Retinopathy DEVICE: Color Fundus Photography/Non-Mydriatic Opthalmic Cameras Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi

NCT06595186 JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM) https://clinicaltrials.gov/study/NCT06595186 RECRUITING Glioblastoma Multiforme (GBM) DRUG: JK-1201I

NCT05361486 Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru https://clinicaltrials.gov/study/NCT05361486 RECRUITING Malaria, Vivax OTHER: Training on revised algorithm

NCT05779839 A Study of Caregiver Connections Via Technology in Dementia https://clinicaltrials.gov/study/NCT05779839 RECRUITING Caregiver Stress

NCT04245839 A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL) https://clinicaltrials.gov/study/NCT04245839 RECRUITING Lymphoma, Non-Hodgkin DRUG: Fludarabine

NCT06578039 Phase 1 Clinical Trial of CordSTEM-ST https://clinicaltrials.gov/study/NCT06578039 RECRUITING Premature Ovarian Insufficiency BIOLOGICAL: umbilical cord-derived mesenchymal stem cell CHABiotech CO., Ltd

NCT05835986 A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT05835986 RECRUITING Systemic Lupus Erythematosus DRUG: RO7507062

NCT05561686 Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer https://clinicaltrials.gov/study/NCT05561686 NOT_YET_RECRUITING HER2-positive Breast Cancer DRUG: Pyrotinib Hunan Cancer Hospital Jiangsu HengRui Medicine Co., Ltd.

NCT06172322 A Phase Ib/‚Ö° Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer https://clinicaltrials.gov/study/NCT06172322 RECRUITING HR Positive/HER-2 Negative Breast Cancer DRUG: NTQ1062 with Fulvestrant Nanjing Chia-tai Tianqing Pharmaceutical

NCT04263922 Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3 https://clinicaltrials.gov/study/NCT04263922 RECRUITING Renal Insufficiency, Chronic DRUG: Huaiqihuang granules

NCT06125522 TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C) https://clinicaltrials.gov/study/NCT06125522 RECRUITING Breast Cancer DRUG: vepdegestrant

NCT04910022 Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma https://clinicaltrials.gov/study/NCT04910022 RECRUITING Glioblastoma

NCT06518122 A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers https://clinicaltrials.gov/study/NCT06518122 NOT_YET_RECRUITING Healthy DRUG: HCP1306

NCT05014139 A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) https://clinicaltrials.gov/study/NCT05014139 RECRUITING Urinary Bladder Neoplasms

NCT05759039 SHould You transFer the Tubercle? https://clinicaltrials.gov/study/NCT05759039 RECRUITING Patellofemoral Dislocation

NCT05404139 Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT) https://clinicaltrials.gov/study/NCT05404139 RECRUITING Metastatic Prostate Cancer DRUG: Enzalutamide

NCT06013839 TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy https://clinicaltrials.gov/study/NCT06013839 RECRUITING DMD-Associated Dilated Cardiomyopathy DRUG: talfirastide Constant Therapeutics LLC

NCT06654739 RCT on the Performance and Safety of LightForce¬Æ Therapy Lasers on Knee Osteoarthritis Pain Reduction (SPARK) https://clinicaltrials.gov/study/NCT06654739 NOT_YET_RECRUITING Osteoarthritis of Knee DEVICE: Laser therapy + physiotherapy/exercise protocol

NCT05044039 Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy https://clinicaltrials.gov/study/NCT05044039 RECRUITING Non-hodgkin Lymphoma

NCT05869539 ACT-TIL and ANV419 for Advanced Melanoma. https://clinicaltrials.gov/study/NCT05869539 RECRUITING Advanced Melanoma DRUG: Combination of Tumor-infiltrating lymphocyte transfer with ANV419 University Hospital, Basel, Switzerland Anaveon AG

NCT06445322 Prescreening Study to Identify Potential Participants for ACDN-01 Clinical Trials https://clinicaltrials.gov/study/NCT06445322 RECRUITING Stargardt Disease

NCT06264622 ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension https://clinicaltrials.gov/study/NCT06264622 RECRUITING Hypertension DIETARY_SUPPLEMENT: Low dose

NCT02445222 CAR-T Long Term Follow Up (LTFU) Study https://clinicaltrials.gov/study/NCT02445222 RECRUITING Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program GENETIC: Previously treated CAR-T patients Novartis Pharmaceuticals University of Pennsylvania

NCT06063122 Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants https://clinicaltrials.gov/study/NCT06063122 RECRUITING Premature Birth DEVICE: smallTalk NICU Active Thrive Neuromedical, LLC National Institute on Deafness and Other Communication Disorders (NIDCD)

NCT06111222 Visual Performance of Patients Implanted With a Multifocal IOL https://clinicaltrials.gov/study/NCT06111222 RECRUITING Cataract

NCT05783622 Study of JANX008 in Subjects with Advanced or Metastatic Solid Tumor Malignancies https://clinicaltrials.gov/study/NCT05783622 RECRUITING Non-Small Cell Lung Cancer

NCT05150639 Vaginal Microbiome and IVF Pregnancy Outcome https://clinicaltrials.gov/study/NCT05150639 RECRUITING Vaginal Flora Imbalance OTHER: IVF Freya Biosciences ApS Boston IVF

NCT05799339 Optimizing CAB-LA as PrEP for Women Who Inject Drugs https://clinicaltrials.gov/study/NCT05799339 RECRUITING HIV Infections

NCT06609239 Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Moderatetosevere Asthma. https://clinicaltrials.gov/study/NCT06609239 RECRUITING Asthma DRUG: Lunsekimig Sanofi

NCT06385522 A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System https://clinicaltrials.gov/study/NCT06385522 NOT_YET_RECRUITING NHL

NCT06600022 Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients With Advanced Malignant Solid Tumours. https://clinicaltrials.gov/study/NCT06600022 NOT_YET_RECRUITING Advanced Malignant Solid Tumours DRUG: SCTB41 Sinocelltech Ltd.

NCT05231122 Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer https://clinicaltrials.gov/study/NCT05231122 RECRUITING Ovarian Clear Cell Adenocarcinoma

NCT05671822 Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2+ Gastric Cancer https://clinicaltrials.gov/study/NCT05671822 RECRUITING HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma DRUG: SHR-A1811ÔºõSHR-1701ÔºõcapecitabineÔºõoxaliplatin

NCT05446922 Variability of Cerebral MRI Diffusion Parameters by Using a Patented Normalization Process vs no Use https://clinicaltrials.gov/study/NCT05446922 NOT_YET_RECRUITING Brain MRI OTHER: Diffusion MRI Braintale

NCT06038539 Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta¬Æ Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy na√Øve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer https://clinicaltrials.gov/study/NCT06038539 NOT_YET_RECRUITING HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients BIOLOGICAL: PERT-IJS plus trastuzumab, carboplatin and docetaxel

NCT05138822 Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections https://clinicaltrials.gov/study/NCT05138822 RECRUITING Uncomplicated Urinary Tract Infections

NCT05406622 MOTIV BTK Randomized Controlled Trial https://clinicaltrials.gov/study/NCT05406622 RECRUITING Critical Limb Ischemia DEVICE: MOTIV Sirolimus-Eluting Bioresorbable Scaffold

NCT05185739 Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) https://clinicaltrials.gov/study/NCT05185739 RECRUITING Hepatocellular Carcinoma DRUG: Pembrolizumab

NCT05060822 Phase ll Study of HEC585 in Patients With IPF https://clinicaltrials.gov/study/NCT05060822 RECRUITING Idiopathic Pulmonary Fibrosis DRUG: HEC585

NCT06427239 Exploratory Clinical Study of HRS-4642 Combined With Adebelimab in the Treatment of Advanced Pancreatic Cancer https://clinicaltrials.gov/study/NCT06427239 RECRUITING Pancreatic Cancer DRUG: HRS-4642

NCT06650839 POC for the Treatment of Subjects With Moderate AS Using Valvosoft¬Æ Non-Invasive Ultrasound Therapy https://clinicaltrials.gov/study/NCT06650839 NOT_YET_RECRUITING Moderate Aortic Valve Stenosis DEVICE: NIUT Cardiawave SA Micro Cro

NCT05652439 PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI) https://clinicaltrials.gov/study/NCT05652439 RECRUITING Chronic Obstructive Pulmonary Disease OTHER: Observational retrospective data collection Chiesi Farmaceutici S.p.A.

NCT06104839 Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia Areata https://clinicaltrials.gov/study/NCT06104839 NOT_YET_RECRUITING Alopecia Areata DRUG: NXC736

NCT04789239 OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure https://clinicaltrials.gov/study/NCT04789239 RECRUITING Heart Failure

NCT04447339 Open Nipple Sparing Mastectomy (NSM) https://clinicaltrials.gov/study/NCT04447339 RECRUITING Nipple Sparing Mastectomy PROCEDURE: Nipple Sparing Mastectomy Intuitive Surgical

NCT06046222 Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis https://clinicaltrials.gov/study/NCT06046222 RECRUITING Eosinophilic Granulomatosis With Polyangiitis

NCT02493322 Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control https://clinicaltrials.gov/study/NCT02493322 NOT_YET_RECRUITING Essential Arterial Hypertension DRUG: Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mg

NCT01892722 Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis https://clinicaltrials.gov/study/NCT01892722 RECRUITING Multiple Sclerosis DRUG: Interferon beta-1a

NCT06137222 Prospective, Multicenter, RCT of the Tenex Ultrasound System https://clinicaltrials.gov/study/NCT06137222 NOT_YET_RECRUITING Diabetic Foot Ulcer DEVICE: Tenex TXB MicroTip Ultrasound system plus SOC

NCT04958239 A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer https://clinicaltrials.gov/study/NCT04958239 RECRUITING Neoplasms DRUG: BI 765179

NCT06197139 A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06197139 RECRUITING Advanced Solid Tumor DRUG: [177Lu]Lu-XT117 Xinlu Wang Sinotau Pharmaceutical Group

NCT04667039 Efficacy, Safety, pharmacokineti—Ås, Immunogenicity of GNR-067 and Lucentis¬Æ https://clinicaltrials.gov/study/NCT04667039 RECRUITING Age Related Macular Degeneration (ARMD) BIOLOGICAL: GNR-067

NCT06027086 DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) https://clinicaltrials.gov/study/NCT06027086 RECRUITING Fibrolamellar Hepatocellular Carcinoma DRUG: Durvalumab

NCT04918186 Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer https://clinicaltrials.gov/study/NCT04918186 RECRUITING Ovarian Cancer DRUG: Durvalumab

NCT05900986 LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer https://clinicaltrials.gov/study/NCT05900986 RECRUITING Breast Cancer

NCT05809986 Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study https://clinicaltrials.gov/study/NCT05809986 RECRUITING Relapsing Multiple Sclerosis OTHER: Ofatumumab Novartis Pharmaceuticals

NCT05192486 A Study of GNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL) https://clinicaltrials.gov/study/NCT05192486 RECRUITING Diffuse Large B-cell Lymphoma DRUG: GNC-038 Sichuan Baili Pharmaceutical Co., Ltd. SystImmune Inc.

NCT06081686 Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer https://clinicaltrials.gov/study/NCT06081686 RECRUITING Prostate Cancer DRUG: Phase I:[177Lu]Lu-XT033 Injection

NCT06480786 SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease https://clinicaltrials.gov/study/NCT06480786 NOT_YET_RECRUITING Peripheral Arterial Disease

NCT06711822 The Safety and Performence of ShockPulse-10 in Patients with Coronary Artery Calcification https://clinicaltrials.gov/study/NCT06711822 RECRUITING Coronary Arterial Disease (CAD)

NCT04919122 Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma https://clinicaltrials.gov/study/NCT04919122 RECRUITING Metastatic Renal Cell Carcinoma Duke University Duke Clinical Research Institute

NCT06058039 Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder https://clinicaltrials.gov/study/NCT06058039 RECRUITING Major Depressive Disorder DRUG: NMRA-335140

NCT06422039 Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects https://clinicaltrials.gov/study/NCT06422039 NOT_YET_RECRUITING Type 2 Diabetes Mellitus DRUG: HRS-7535ÔºàDÔºâTablets

NCT05768139 First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05768139 RECRUITING Breast Cancer

NCT06312722 Safety and Effectiveness of the Optilume¬Æ BPH Catheter System in a Post-Market Study https://clinicaltrials.gov/study/NCT06312722 RECRUITING Benign Prostatic Hyperplasia DEVICE: Optilume¬Æ BPH Catheter System Urotronic Inc.

NCT06315322 A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy https://clinicaltrials.gov/study/NCT06315322 RECRUITING Childhood Absence Epilepsy

NCT06285422 Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID) https://clinicaltrials.gov/study/NCT06285422 RECRUITING Non Hodgkin's Lymphoma

NCT06529822 Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease https://clinicaltrials.gov/study/NCT06529822 NOT_YET_RECRUITING Muscle-Invasive Bladder Carcinoma BIOLOGICAL: Synthetic long peptide personalized cancer vaccine

NCT06507839 Study to Assess the Safety, Tolerability, Pharmacokinetic of Thrv-1268 https://clinicaltrials.gov/study/NCT06507839 RECRUITING Atrial Fibrillation DRUG: THRV-1268

NCT05748639 RCT of an Integrated Digital Intervention for Alcohol Use Disorder https://clinicaltrials.gov/study/NCT05748639 RECRUITING Alcohol Use Disorder OTHER: Mobile health application

NCT06662539 Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities https://clinicaltrials.gov/study/NCT06662539 NOT_YET_RECRUITING Obesity DRUG: Petrelintide

NCT04409639 Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations https://clinicaltrials.gov/study/NCT04409639 RECRUITING Chronic Myelomonocytic Leukemia (CMML) DRUG: Cobimetinib University of Utah Genentech, Inc.

NCT05189639 A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT05189639 RECRUITING Acute Myeloid Leukemia Pfizer

NCT05753930 Imlifidase Prior to Kidney Transplant in Highly Sensitised Children https://clinicaltrials.gov/study/NCT05753930 RECRUITING Kidney Transplantation in Highly Sensitized Patients DRUG: Imlifidase Hansa Biopharma AB

NCT05274230 Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy https://clinicaltrials.gov/study/NCT05274230 RECRUITING Stress Disorders, Post-Traumatic DEVICE: Apollo Wearable Apollo Neuroscience, Inc. The Board of Medicine

NCT06181630 A Lactation Study in Women Receiving Treatment With Ozanimod https://clinicaltrials.gov/study/NCT06181630 NOT_YET_RECRUITING Lactating Women

NCT06297525 Study of STP938 in Advanced Solid Tumours https://clinicaltrials.gov/study/NCT06297525 RECRUITING Solid Tumor DRUG: STP938 Step Pharma, SAS

NCT06465225 Prevention of Pressure Ulcers in Patients at Medium to High Risk of Pressure Ulcers Using the R'GO SOINS Overlay Mattress https://clinicaltrials.gov/study/NCT06465225 NOT_YET_RECRUITING Pressure Ulcer DEVICE: Use of a powered alternating pressure air mattress Nausicaa Medical Clin-Experts

NCT06489925 Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion https://clinicaltrials.gov/study/NCT06489925 NOT_YET_RECRUITING Basilar Artery Occlusion

NCT06515925 Our Whole Lives Gemini: Virtual Integrative Medical Group Visits for Managing Chronic Pain https://clinicaltrials.gov/study/NCT06515925 RECRUITING Chronic Pain BEHAVIORAL: Our Whole Lives (OWL)

NCT06710925 A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants https://clinicaltrials.gov/study/NCT06710925 NOT_YET_RECRUITING Respiratory Syncytial Virus Infections BIOLOGICAL: TNM001

NCT05421325 Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults https://clinicaltrials.gov/study/NCT05421325 RECRUITING Immune Deficiency BIOLOGICAL: QBKPN SSI

NCT06283225 Pilot Study to Investigate the Effect of a Dysmenorrhoea App https://clinicaltrials.gov/study/NCT06283225 NOT_YET_RECRUITING Dysmenorrhea DEVICE: Pia-App Endo Health GmbH

NCT04272125 Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT04272125 RECRUITING Leukemia

NCT06177925 A Phase ‚Ö° Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC https://clinicaltrials.gov/study/NCT06177925 RECRUITING Respiratory Tract Neoplasms

NCT04451525 REal-World Analyses of Stroke - Thrombus Occlusion REtrieval https://clinicaltrials.gov/study/NCT04451525 RECRUITING Acute Ischemic Stroke

NCT05500222 A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) https://clinicaltrials.gov/study/NCT05500222 RECRUITING NASH

NCT05489822 PMCF Study to Evaluate the VERTICALE¬Æ Cervical System in Spine Surgery According to Its Intended Use. https://clinicaltrials.gov/study/NCT05489822 RECRUITING Degenerative Disc Disease (DDD)

NCT05075122 Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab https://clinicaltrials.gov/study/NCT05075122 RECRUITING Head and Neck Squamous Cell Carcinoma BIOLOGICAL: UV1

NCT05929222 Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi https://clinicaltrials.gov/study/NCT05929222 RECRUITING Follicular Lymphoma RADIATION: Radiotherapy

NCT05526222 A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT05526222 RECRUITING Atopic Dermatitis DRUG: Jaktinib Hydrochloride Tablet Suzhou Zelgen Biopharmaceuticals Co.,Ltd

NCT05647122 First in Human Study of AZD9592 in Solid Tumors https://clinicaltrials.gov/study/NCT05647122 RECRUITING Advanced Solid Tumours

NCT05259839 A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-383 in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT05259839 RECRUITING Relapsed/Refractory Multiple Myeloma DRUG: ABBV-383

NCT05660122 A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab https://clinicaltrials.gov/study/NCT05660122 RECRUITING Gastroesophageal Reflux Disease DRUG: Fexuprazan Hydrochloride Daewoong Pharmaceutical Co. LTD.

NCT06165822 A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets https://clinicaltrials.gov/study/NCT06165822 NOT_YET_RECRUITING Advanced Malignant Neoplasm DRUG: TQB3909 tablets

NCT06050122 Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults with Gorlin Syndrome https://clinicaltrials.gov/study/NCT06050122 RECRUITING Gorlin Syndrome DRUG: Patidegib Topical Gel

NCT06191822 Aspire2B Personalization Pilot Study Program https://clinicaltrials.gov/study/NCT06191822 RECRUITING App Proficiency

NCT05943522 Asciminib RMP Study https://clinicaltrials.gov/study/NCT05943522 RECRUITING Chronic Myeloid Leukemia OTHER: Asciminib Novartis Pharmaceuticals

NCT06319222 Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC) https://clinicaltrials.gov/study/NCT06319222 RECRUITING Alcohol Use Disorder

NCT05285839 Dupixent and Narrowband UVB for Atopic Dermatitis https://clinicaltrials.gov/study/NCT05285839 RECRUITING Atopic Dermatitis DRUG: Dupixent Psoriasis Treatment Center of Central New Jersey Regeneron Pharmaceuticals

NCT05570422 A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 https://clinicaltrials.gov/study/NCT05570422 NOT_YET_RECRUITING Cervical Cancer DRUG: KRC-01

NCT03594422 A Study of HQP1351 in Patients With GIST or Other Solid Tumors https://clinicaltrials.gov/study/NCT03594422 RECRUITING Gastrointestinal Stromal Tumor (GIST)

NCT06693622 Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests https://clinicaltrials.gov/study/NCT06693622 RECRUITING Gastro Esophageal Reflux Disease

NCT06217822 First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) https://clinicaltrials.gov/study/NCT06217822 RECRUITING Advanced Metastatic Castration-resistant Prostate Cancer

NCT04752722 LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Na√Øve https://clinicaltrials.gov/study/NCT04752722 RECRUITING Superficial Bladder Cancer

NCT06202339 Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT). https://clinicaltrials.gov/study/NCT06202339 NOT_YET_RECRUITING Carcinoma of the Vulva

NCT05054439 A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC https://clinicaltrials.gov/study/NCT05054439 RECRUITING Head and Neck Squamous Cell Carcinoma DRUG: SI-B001

NCT04855422 Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients. https://clinicaltrials.gov/study/NCT04855422 RECRUITING Transplant; Complication, Rejection DIAGNOSTIC_TEST: Allosure

NCT05553522 Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer https://clinicaltrials.gov/study/NCT05553522 RECRUITING Brain Metastases

NCT04299022 Safety, Efficacy, & Use of ViviGen Cellular Bone Matrix Allograft in Orthopaedic Fracture Care https://clinicaltrials.gov/study/NCT04299022 RECRUITING Fractures, Bone

NCT05484622 Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma https://clinicaltrials.gov/study/NCT05484622 RECRUITING Astrocytoma DRUG: Vorasidenib

NCT05840822 Evaluating Efficacy and Safety of CBD TPM Capsules for Use in Insomnia https://clinicaltrials.gov/study/NCT05840822 NOT_YET_RECRUITING Insomnia DRUG: Cannabidiol Avecho Biotechnology

NCT04837222 A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma https://clinicaltrials.gov/study/NCT04837222 RECRUITING Lymphoma OTHER: No Intervention Takeda

NCT05153239 Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) https://clinicaltrials.gov/study/NCT05153239 RECRUITING Relapsed Small Cell Lung Cancer DRUG: Irinotecan

NCT05686239 A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS) https://clinicaltrials.gov/study/NCT05686239 RECRUITING Cognitive Impairment Associated With Schizophrenia (CIAS)

NCT06307522 MRG-001 in Patients With Alcoholic Hepatitis https://clinicaltrials.gov/study/NCT06307522 NOT_YET_RECRUITING Alcoholic Hepatitis

NCT06077422 Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain https://clinicaltrials.gov/study/NCT06077422 RECRUITING Pain, Postoperative

NCT03805022 Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas https://clinicaltrials.gov/study/NCT03805022 RECRUITING Non-metastatic Soft-tissue Sarcoma

NCT05261139 EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease https://clinicaltrials.gov/study/NCT05261139 RECRUITING COVID-19 DRUG: nirmatrelvir

NCT04617522 Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment https://clinicaltrials.gov/study/NCT04617522 RECRUITING Advanced or Metastatic Solid Tumor

NCT05885022 Feasibility Clinical Evaluation of the Calibreye System https://clinicaltrials.gov/study/NCT05885022 RECRUITING Glaucoma, Open-Angle DEVICE: Calibreye System Myra Vision Inc.

NCT06555822 A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants https://clinicaltrials.gov/study/NCT06555822 RECRUITING Healthy Participants DRUG: AZD5004

NCT03390322 Safety and Initial Performance of the DiaGone Device on Type 2 Diabetes Patients https://clinicaltrials.gov/study/NCT03390322 RECRUITING Diabetes Mellitus, Type 2 DEVICE: DiaGone‚Ñ¢ Digma Medical Ltd.

NCT06593522 A Phase 2 Study of AMG 193 in Participants With MTAP-deleted Advanced NSCLC https://clinicaltrials.gov/study/NCT06593522 NOT_YET_RECRUITING MTAP-deleted NSCLC DRUG: AMG 193 Amgen

NCT05541822 To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation https://clinicaltrials.gov/study/NCT05541822 RECRUITING Advanced Solid Tumors DRUG: ABN401 Abion Inc

NCT04260022 Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL https://clinicaltrials.gov/study/NCT04260022 RECRUITING Leukemia, Myeloid, Chronic

NCT05649722 An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) https://clinicaltrials.gov/study/NCT05649722 RECRUITING Pulmonary Hypertension

NCT06419322 Acceptability, Feasibility, Safety and Efficacy of a Optimized Rehabilitation Program for Treated Patients With Spinal Muscular Atrophy (SMA). https://clinicaltrials.gov/study/NCT06419322 RECRUITING Spinal Muscular Atrophy OTHER: Optimized rehabilitation program University of Oxford Oxford Brookes University

NCT06627322 A Registry-based Randomized Controlled Trial in Type 2 Diabetes with Cardiovascular Risk Factors (REMATCH) https://clinicaltrials.gov/study/NCT06627322 NOT_YET_RECRUITING Type 2 Diabetes DRUG: Dual-combination therapy

NCT05721222 PRO1160 for Advanced Solid and Liquid Tumors (PRO1160-001) https://clinicaltrials.gov/study/NCT05721222 RECRUITING Renal Cell Carcinoma

NCT04877522 Asciminib Roll-over Study https://clinicaltrials.gov/study/NCT04877522 RECRUITING Chronic Myelogenous Leukemia

NCT03110822 A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients https://clinicaltrials.gov/study/NCT03110822 RECRUITING Multiple Myeloma DRUG: Ruxolitinib Oral Tablet [Jakafi]

NCT06260722 Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) https://clinicaltrials.gov/study/NCT06260722 RECRUITING Diabetes Mellitus, Type 2 DRUG: Retatrutide

NCT04301739 to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC) https://clinicaltrials.gov/study/NCT04301739 NOT_YET_RECRUITING Triple Negative Breast Cancer DRUG: HLX10

NCT06129539 A Study to Assess the Efficacy, Safety and Pharmacokinetics of Debio 4326 in Pediatric Participants Receiving Gonadotropin-Releasing Hormone Agonist Therapy for Central Precocious Puberty https://clinicaltrials.gov/study/NCT06129539 RECRUITING Central Precocious Puberty DRUG: Debio 4326 Debiopharm International SA

NCT06568939 A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) https://clinicaltrials.gov/study/NCT06568939 NOT_YET_RECRUITING Non-Small Cell Lung Cancer DRUG: Telisotuzumab Vedotin AbbVie

NCT05632939 ASKB589 in Combination With CAPOX and Sintilimab in Patients With Advanced, and Unresectable G/GEJ Cancer. https://clinicaltrials.gov/study/NCT05632939 RECRUITING Gastric Cancer DRUG: ASKB589 +CAPOX+Sintilimab AskGene Pharma, Inc. Jiangsu Aosaikang Pharmaceutical Co., Ltd.

NCT06115122 PEPPI Study: Identification of Women at Risk for Placental Dysfunction https://clinicaltrials.gov/study/NCT06115122 RECRUITING Pre-Eclampsia

NCT05341739 A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases https://clinicaltrials.gov/study/NCT05341739 RECRUITING Brain Metastases, Adult OTHER: Pre-operative Stereotactic Radiosurgery Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) Elekta Limited

NCT04408625 Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN) https://clinicaltrials.gov/study/NCT04408625 RECRUITING Frontotemporal Dementia BIOLOGICAL: LY3884963

NCT06553625 Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS https://clinicaltrials.gov/study/NCT06553625 RECRUITING Parkinson Disease

NCT06153225 Amino Acid Concentrations in Serum After Intake of Different Protein Sources https://clinicaltrials.gov/study/NCT06153225 RECRUITING Postprandial Amino Acid Concentrations in Healthy Adults DIETARY_SUPPLEMENT: Protein products Nutricia Research

NCT06093425 Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma https://clinicaltrials.gov/study/NCT06093425 NOT_YET_RECRUITING Gastric Cancer

NCT03866525 OH2 Oncolytic Viral Therapy in Solid Tumors https://clinicaltrials.gov/study/NCT03866525 RECRUITING Solid Tumor

NCT06560125 WOUNDCHEK Bacterial Status Performance With Trained vs Untrained Users https://clinicaltrials.gov/study/NCT06560125 RECRUITING Wound OTHER: Standard care Woundchek Laboratories BV Salem VA Heath Care System

NCT06063057 Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial https://clinicaltrials.gov/study/NCT06063057 RECRUITING Hand, Foot and Mouth Disease

NCT05628857 A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor https://clinicaltrials.gov/study/NCT05628857 RECRUITING Digestive Cancer DRUG: RC108 RemeGen Co., Ltd.

NCT06291857 A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine https://clinicaltrials.gov/study/NCT06291857 NOT_YET_RECRUITING COVID-19 BIOLOGICAL: CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant

NCT06371157 A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT06371157 NOT_YET_RECRUITING Hepatocellular Carcinoma DRUG: AK104

NCT05671757 Daratumumab in Primary Antiphospholipid Syndrome https://clinicaltrials.gov/study/NCT05671757 RECRUITING Autoimmune Disorders BIOLOGICAL: Daratumumab

NCT06385457 The Effects of Mindhelper.dk: a Self-guided Digital Mental Health Promotion Service Targeting Young People https://clinicaltrials.gov/study/NCT06385457 NOT_YET_RECRUITING Mental Health Issue

NCT06654557 Effect of Adding Glycerol to Electrolyte Beverages on Fluid Balance in Healthy Euhydrated Men and Women at Rest https://clinicaltrials.gov/study/NCT06654557 RECRUITING Fluid Balance OTHER: Placebo beverage, kiwi-strawberry flavor (Part 1 and Part 2)

NCT02910557 Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC¬Æ to Characterize Risk of Herpetic Infection https://clinicaltrials.gov/study/NCT02910557 RECRUITING Melanoma

NCT06216457 Study on the Performance of a Machine Learning Algorithm Recognizing and Triaging Large Vessel Occlusions Using Non-contrast CT Scans https://clinicaltrials.gov/study/NCT06216457 NOT_YET_RECRUITING Stroke, Ischemic

NCT05038657 Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). https://clinicaltrials.gov/study/NCT05038657 RECRUITING Squamous Cell Carcinoma

NCT06533657 Unique Treatment of Oncology Pain in Advanced Cancer https://clinicaltrials.gov/study/NCT06533657 NOT_YET_RECRUITING Cancer Pain DRUG: Trichomylin¬Æ capsule (5 mg delta-9-tetrahydrocannabinol: 5 mg cannabidiol: 5 mg cannabichromene) ZYUS Life Sciences Inc.

NCT04973657 A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN https://clinicaltrials.gov/study/NCT04973657 RECRUITING Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD) DRUG: VK0214

NCT06433557 A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia https://clinicaltrials.gov/study/NCT06433557 RECRUITING Achondroplasia DRUG: Combination of Navepegritide and Lonapegsomatropin administered as two separate s.c. injections Ascendis Pharma Growth Disorders A/S

NCT05994157 Phase 1, Open-label, Dose-escalation Trial with CD38-SADA:177 Lu-DOTA Drug Complex in Subjects with Relapsed or Refractory Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT05994157 RECRUITING Non-hodgkin Lymphoma DRUG: CD38-SADA:177Lu-DOTA Complex Y-mAbs Therapeutics

NCT04967157 Evaluate the Effects of Citicoline on Cognitive Performance in Healthy Adults https://clinicaltrials.gov/study/NCT04967157 NOT_YET_RECRUITING Healthy

NCT05922657 A Registry to Gather Real World Use Data on the Cerene¬Æ Cryotherapy Device https://clinicaltrials.gov/study/NCT05922657 RECRUITING Heavy Menstrual Bleeding

NCT05940857 US National OCS Liver Perfusion (OLP) Registry https://clinicaltrials.gov/study/NCT05940857 RECRUITING Liver Transplant DEVICE: OCS Liver TransMedics

NCT06685757 A Trial of Felzartamab in Kidney Transplant Recipients With Late Antibody-Mediated Rejection (AMR) https://clinicaltrials.gov/study/NCT06685757 NOT_YET_RECRUITING Antibody-mediated Rejection DRUG: Felzartamab

NCT06381557 Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules https://clinicaltrials.gov/study/NCT06381557 NOT_YET_RECRUITING Cancer-related Fatigue DRUG: Zhengyuan Capsules

NCT06633757 Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance https://clinicaltrials.gov/study/NCT06633757 RECRUITING Primary Ciliary Dyskinesia (PCD) DRUG: RCT1100 ReCode Therapeutics

NCT05943457 Vitamin K2 Supplementation in Adult Episodic Migraine https://clinicaltrials.gov/study/NCT05943457 NOT_YET_RECRUITING Migraine Headache

NCT05281757 Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate¬Æ Complex https://clinicaltrials.gov/study/NCT05281757 RECRUITING Hyperkyphosis

NCT05965557 Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05965557 RECRUITING Lung Cancer Geneplus-Beijing Co. Ltd.

NCT05956457 PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma https://clinicaltrials.gov/study/NCT05956457 RECRUITING Multiple Myeloma

NCT06212557 KIOS Mobile App Evaluation https://clinicaltrials.gov/study/NCT06212557 RECRUITING Opioid Use Disorder DEVICE: KIOS App

NCT06009757 GUIDEX¬Æ Versus Launcher‚Ñ¢ Guiding Catheter in Percutaneous Coronary Intervention (PCI) (GUIDEX_FR) https://clinicaltrials.gov/study/NCT06009757 NOT_YET_RECRUITING Coronary Artery Disease DEVICE: GUIDEX¬Æ guiding catheter

NCT05353257 A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05353257 RECRUITING Limited-Stage Small Cell Lung Cancer DRUG: HLX10

NCT06143657 Clinical Performance Evaluation of AI-Enabled Automated Gram Staining Device https://clinicaltrials.gov/study/NCT06143657 NOT_YET_RECRUITING Infection, Bacterial DIAGNOSTIC_TEST: Automated Gram Staining Machine analysis GramEye

NCT05206357 Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab https://clinicaltrials.gov/study/NCT05206357 RECRUITING Non-hodgkin Lymphoma DRUG: Epcoritamab Genmab AbbVie

NCT05829057 The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 https://clinicaltrials.gov/study/NCT05829057 RECRUITING Esophagus Cancer

NCT06189157 MB-CART19.1 in Refractory SLE https://clinicaltrials.gov/study/NCT06189157 RECRUITING SLE - Systemic Lupus Erythematosus BIOLOGICAL: MB-CART19.1 Miltenyi Biomedicine GmbH

NCT05683457 A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants. https://clinicaltrials.gov/study/NCT05683457 RECRUITING Cytomegalovirus Infection BIOLOGICAL: mRNA-1647

NCT06237257 A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer https://clinicaltrials.gov/study/NCT06237257 RECRUITING Locally Advanced Cervical Cancer BIOLOGICAL: SHR-1316

NCT06102057 PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC https://clinicaltrials.gov/study/NCT06102057 RECRUITING Stage III Non-small Cell Lung Cancer

NCT05463757 Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study https://clinicaltrials.gov/study/NCT05463757 RECRUITING Basal Cell Carcinoma

NCT06357026 Phitys I‚Ñ¢ Percutaneous Left Ventricular Assist System Study https://clinicaltrials.gov/study/NCT06357026 NOT_YET_RECRUITING Coronary Artery Disease DEVICE: Percutaneous Ventricular Assist SystemÔºàPhigine MedicalÔºâ

NCT06163326 A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo https://clinicaltrials.gov/study/NCT06163326 RECRUITING Vitiligo DRUG: Ritlecitinib

NCT06285357 The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection. https://clinicaltrials.gov/study/NCT06285357 RECRUITING HPV Infection DIETARY_SUPPLEMENT: EGCG + folic acid + B12 Lo.Li.Pharma s.r.l

NCT05842057 Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy https://clinicaltrials.gov/study/NCT05842057 RECRUITING Prostate Cancer

NCT06066957 Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients https://clinicaltrials.gov/study/NCT06066957 RECRUITING Cytomegalovirus Infections

NCT05006157 Pericardial Access With ViaOne Device https://clinicaltrials.gov/study/NCT05006157 RECRUITING Pericardial Access DEVICE: ViaOne device CardioVia

NCT04965857 Comparison of the Hologic Genius Digital Diagnostics System With the Liquid-based Cytology (LBC) Manual Microscopy https://clinicaltrials.gov/study/NCT04965857 RECRUITING Cervical Cancer Screening DIAGNOSTIC_TEST: Hologic's Genius Digital Diagnostics System Hologic Deutschland GmbH

NCT05879757 Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency https://clinicaltrials.gov/study/NCT05879757 RECRUITING Multiple Myeloma

NCT06467357 Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer https://clinicaltrials.gov/study/NCT06467357 RECRUITING Biliary Tract Cancer DRUG: Gemcitabine

NCT06453057 Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours https://clinicaltrials.gov/study/NCT06453057 RECRUITING Adult BIOLOGICAL: GT307 injection Grit Biotechnology

NCT06150157 A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms https://clinicaltrials.gov/study/NCT06150157 RECRUITING Myeloproliferative Disorders

NCT06142357 Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis https://clinicaltrials.gov/study/NCT06142357 RECRUITING Moderate-to-severe Plaque Psoriasis OTHER: Secukinumab Novartis Pharmaceuticals

NCT05626257 Regulatory Post-Marketing Surveillance of Xolair¬Æ for Chronic Rhinosinusitis With Nasal Polyps https://clinicaltrials.gov/study/NCT05626257 RECRUITING Chronic Rhinosinusitis With Nasal Polyps OTHER: Xolair Novartis Pharmaceuticals

NCT06603857 Skin Care Regimen for Improving Photoaging Signs on the Face https://clinicaltrials.gov/study/NCT06603857 NOT_YET_RECRUITING Improve Photoaging Signs DRUG: CE Ferulic

NCT05979857 Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT05979857 NOT_YET_RECRUITING Lymphoma, Non-Hodgkin's, Adult DRUG: SP-3164 Salarius Pharmaceuticals, LLC

NCT05701657 Nutrition for Precision Health, Powered by the All of Us https://clinicaltrials.gov/study/NCT05701657 RECRUITING Nutrition

NCT06586957 A Study with NKT3964 for Adults with Advanced/Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT06586957 RECRUITING Solid Tumor

NCT03382457 Clinical Study of Edwards Cardioband FIT Valve Repair System https://clinicaltrials.gov/study/NCT03382457 RECRUITING Tricuspid Regurgitation DEVICE: Transcatheter Tricuspid Valve Repair Edwards Lifesciences

NCT04911257 Interbody Systems: Post Market Clinical Follow-up Study https://clinicaltrials.gov/study/NCT04911257 RECRUITING Degenerative Disc Disease DEVICE: Cervical or Lumbar Spinal fusion K2M, Inc.

NCT05806957 Pivotal Trial to Assess the Clinical Performance of Ophthal-360 for the Detection of Diabetic Retinopathy https://clinicaltrials.gov/study/NCT05806957 NOT_YET_RECRUITING Diabetic Retinopathy DEVICE: Fundus Photography Ophthalytics, Inc.

NCT04807257 Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment https://clinicaltrials.gov/study/NCT04807257 RECRUITING Malignant Fungating Wound COMBINATION_PRODUCT: Auger Molecular Therapy (AMT) NanoRay Biotech Co., Ltd.

NCT03091257 A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT03091257 RECRUITING Multiple Myeloma DRUG: Dabrafenib

NCT04174157 Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) https://clinicaltrials.gov/study/NCT04174157 RECRUITING Spinal Muscular Atrophy (SMA) OTHER: Prospective observational registry

NCT05978622 Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant https://clinicaltrials.gov/study/NCT05978622 RECRUITING Diabetic Macular Edema AbbVie

NCT05479422 Optilume Registry for Treatment of Stricture of the Anterior Urethra https://clinicaltrials.gov/study/NCT05479422 RECRUITING Anterior Urethral Stricture, Male European Association of Urology Research Foundation Laborie Medical Technologies Inc.

NCT06607939 ORB-021 In Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06607939 NOT_YET_RECRUITING Advanced Solid Tumors Cancer DRUG: ORB-021 Orionis Biosciences Inc

NCT06610539 PAS 1ml Magtrace¬Æ for Sentinel Lymph Node Biopsy in Breast Cancer Patients https://clinicaltrials.gov/study/NCT06610539 NOT_YET_RECRUITING Breast Cancer Endomagnetics Ltd. Endomagnetics Inc

NCT06684639 A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma https://clinicaltrials.gov/study/NCT06684639 RECRUITING Neuroblastoma BIOLOGICAL: GD2-CAR-T cell The General Hospital of Western Theater Command Yake Biotechnology Ltd.

NCT05753722 A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies https://clinicaltrials.gov/study/NCT05753722 RECRUITING Advanced or Metastatic Solid Tumors BIOLOGICAL: PRTH-101

NCT06680622 Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy https://clinicaltrials.gov/study/NCT06680622 NOT_YET_RECRUITING Metastatic Gastro-esophageal Adenocarcinoma DRUG: bemarituzumab, paclitaxel, ramucirumab

NCT04821739 RISE - Study of the AGN1 LOEP SV Kit in Patients With Vertebral Compression Fractures https://clinicaltrials.gov/study/NCT04821739 RECRUITING Vertebral Compression Fracture

NCT06055439 A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy https://clinicaltrials.gov/study/NCT06055439 RECRUITING Neuroendocrine Tumors

NCT04589039 A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea https://clinicaltrials.gov/study/NCT04589039 RECRUITING Ovarian Neoplasms Takeda

NCT06208839 Mobile Technologies Extending Reach of Primary Care for Substance Use Disorders https://clinicaltrials.gov/study/NCT06208839 RECRUITING Substance-Related Disorders DEVICE: SBIRT/eIntervention for those with moderate risk drug or alcohol use

NCT06663839 A Study of NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal Cancer https://clinicaltrials.gov/study/NCT06663839 RECRUITING Colorectal Cancer Metastatic DRUG: Biological NILK-2301 Light Chain Bioscience - Novimmune SA

NCT06505239 Assessing the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol Intoxication https://clinicaltrials.gov/study/NCT06505239 RECRUITING Acute Alcohol Intoxication DIETARY_SUPPLEMENT: FSD-F2R6-A-CP

NCT05722886 DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol https://clinicaltrials.gov/study/NCT05722886 RECRUITING Solid Tumor

NCT06118086 Study of REM-422 in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma https://clinicaltrials.gov/study/NCT06118086 RECRUITING Adenoid Cystic Carcinoma

NCT06660186 Sternal Plating High Risk https://clinicaltrials.gov/study/NCT06660186 NOT_YET_RECRUITING Heart Diseases DEVICE: Rigid Sternal Fixation

NCT06440486 Assessment of Probiotics on Inflammation and Metabolism in Type 2 Diabetes. https://clinicaltrials.gov/study/NCT06440486 NOT_YET_RECRUITING Type 2 Diabetes DIETARY_SUPPLEMENT: Probiotics Wecare Probiotics Co., Ltd.

NCT06028386 Use of AC5¬Æ Advanced Wound System in the Treatment of Diabetic Foot Ulcers https://clinicaltrials.gov/study/NCT06028386 RECRUITING Non-healing Wound

NCT06531486 A Study of XS-02 Capsules in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06531486 NOT_YET_RECRUITING Solid Tumor

NCT02476786 Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score https://clinicaltrials.gov/study/NCT02476786 RECRUITING Breast Cancer

NCT05600686 Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma https://clinicaltrials.gov/study/NCT05600686 RECRUITING Double-Expressor Lymphoma

NCT04716686 Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma https://clinicaltrials.gov/study/NCT04716686 RECRUITING Endometrial Carcinoma

NCT05146986 RibFix Blu Thoracic Fixation System Versus Non-surgical Treatment in Non-flail Chest Rib Fractures https://clinicaltrials.gov/study/NCT05146986 RECRUITING Rib; Fracture DEVICE: Non surgical and Surgical Zimmer Biomet

NCT03432286 A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine https://clinicaltrials.gov/study/NCT03432286 RECRUITING Episodic Migraine DRUG: Galcanezumab

NCT04717739 TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study https://clinicaltrials.gov/study/NCT04717739 RECRUITING Glioblastoma DEVICE: TTFields NovoCure Ltd.

NCT05289986 The Effect on Lipid Profile of Switching to Delstrigo in HIV Positive Patients https://clinicaltrials.gov/study/NCT05289986 RECRUITING Hiv DRUG: DELSTRIGO 100Mg-300Mg-300Mg Tablet Chelsea and Westminster NHS Foundation Trust Merck Sharp & Dohme LLC

NCT06313086 DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer https://clinicaltrials.gov/study/NCT06313086 RECRUITING HER2-positive Breast Cancer DRUG: DP303c

NCT06167486 SG2918 For Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT06167486 RECRUITING Advanced Malignant Tumors DRUG: SG2918 Hangzhou Sumgen Biotech Co., Ltd.

NCT06498986 A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT06498986 RECRUITING Non-small Cell Lung Cancer DRUG: BL-B01D1

NCT06345339 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants https://clinicaltrials.gov/study/NCT06345339 RECRUITING Hypothyroidism DRUG: Armour Thyroid

NCT05430386 Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC https://clinicaltrials.gov/study/NCT05430386 RECRUITING Non Small Cell Lung Cancer DRUG: HS-10241 Jiangsu Hansoh Pharmaceutical Co., Ltd.

NCT04564339 Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) https://clinicaltrials.gov/study/NCT04564339 RECRUITING Lupus Nephritis

NCT05961839 Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome https://clinicaltrials.gov/study/NCT05961839 RECRUITING Acute Myeloid Leukemia

NCT06497439 Efficacy and Safety of Silfamin for Common Cold https://clinicaltrials.gov/study/NCT06497439 NOT_YET_RECRUITING Common Cold

NCT06464939 Phase 2 Study of KH001 in Long-term Relief from Dentin Hypersensitivity https://clinicaltrials.gov/study/NCT06464939 RECRUITING Dentin Hypersensitivity DRUG: KH001

NCT06267586 Effects of PeptiSleep in Healthy Males and Females With Mild to Moderate Sleep Impairment https://clinicaltrials.gov/study/NCT06267586 RECRUITING Sleep DIETARY_SUPPLEMENT: PeptiSleep

NCT05729386 A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions https://clinicaltrials.gov/study/NCT05729386 RECRUITING Healthy Volunteers DRUG: GC2129A(Period 1)

NCT06287086 Clinical Study on the Safety and Efficacy of BRL-101 in the Treatment of Sickle Cell Disease https://clinicaltrials.gov/study/NCT06287086 NOT_YET_RECRUITING Sickle Cell Disease DRUG: BRL-101 autologous hematopoietic stem and progenitor cells injection Bioray Laboratories Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College

NCT06339086 Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes https://clinicaltrials.gov/study/NCT06339086 NOT_YET_RECRUITING Type 2 Diabetes Mellitus DRUG: Semaglutide Injection

NCT06004986 DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema https://clinicaltrials.gov/study/NCT06004986 RECRUITING Atopic Dermatitis

NCT06183086 PMCF Study on the Safety of Linovera¬Æ for the Treatment of Category-I Pressure Ulcers/Injuries https://clinicaltrials.gov/study/NCT06183086 RECRUITING Pressure Ulcer DEVICE: Linovera¬Æ B. Braun Medical SA

NCT06636539 Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device https://clinicaltrials.gov/study/NCT06636539 RECRUITING Breast Screening DEVICE: CEM Exam in Investigational Device Hologic, Inc.

NCT06487039 Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration https://clinicaltrials.gov/study/NCT06487039 RECRUITING Neovascular Age-related Macular Degeneration (nAMD) DRUG: EB-203 EyebioKorea, Inc.

NCT05614739 A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3 https://clinicaltrials.gov/study/NCT05614739 RECRUITING Urinary Bladder Neoplasms

NCT06698939 ORKA-001 in Healthy Volunteers https://clinicaltrials.gov/study/NCT06698939 NOT_YET_RECRUITING Healthy Volunteers DRUG: ORKA-001

NCT06396039 A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis https://clinicaltrials.gov/study/NCT06396039 RECRUITING Relapsing Multiple Sclerosis DRUG: BMS-986374 Bristol-Myers Squibb

NCT06602739 A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy https://clinicaltrials.gov/study/NCT06602739 RECRUITING Allergic Conjunctivitis DRUG: REGN5713

NCT06589986 A Study to Assess the Efficacy and Safety of RO7790121 for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis https://clinicaltrials.gov/study/NCT06589986 RECRUITING Moderately to Severely Active Ulcerative Colitis DRUG: RO7790121

NCT05092386 Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine https://clinicaltrials.gov/study/NCT05092386 RECRUITING Pneumococcal Infections BIOLOGICAL: Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

NCT06623786 Cancer Patient Remote Monitoring for Timely Communication Study https://clinicaltrials.gov/study/NCT06623786 NOT_YET_RECRUITING NSCLC Stage IV Asklepios proresearch Q1.6 B.V.

NCT03406286 Samsca PMS in ADPKD Patients https://clinicaltrials.gov/study/NCT03406286 RECRUITING Safety DRUG: Tolvaptan Korea Otsuka Pharmaceutical Co., Ltd.

NCT01804686 A Long-term Extension Study of PCI-32765 (Ibrutinib) https://clinicaltrials.gov/study/NCT01804686 RECRUITING Chronic Lymphocytic Leukemia

NCT06662786 A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer https://clinicaltrials.gov/study/NCT06662786 NOT_YET_RECRUITING Colorectal Neoplasms BIOLOGICAL: Amivantamab

NCT06462586 Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania https://clinicaltrials.gov/study/NCT06462586 RECRUITING Bipolar Disorder, Manic DRUG: Lumateperone

NCT06380686 Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome https://clinicaltrials.gov/study/NCT06380686 RECRUITING Squamous Cell Carcinoma of the Oral Cavity

NCT05954286 PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19 https://clinicaltrials.gov/study/NCT05954286 RECRUITING SARS-CoV-2 DRUG: Upamostat

NCT06041386 REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study https://clinicaltrials.gov/study/NCT06041386 NOT_YET_RECRUITING Asthma DRUG: Mepolizumab

NCT06353386 Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) https://clinicaltrials.gov/study/NCT06353386 RECRUITING Prostatic Neoplasms, Castration-Resistant DRUG: Opevesostat

NCT06561386 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 1-49% https://clinicaltrials.gov/study/NCT06561386 RECRUITING Non-small Cell Lung Cancer DRUG: Nivolumab

NCT06111586 FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS) https://clinicaltrials.gov/study/NCT06111586 RECRUITING Type 1 Diabetes Mellitus DRUG: Frexalimab

NCT06708286 A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) https://clinicaltrials.gov/study/NCT06708286 NOT_YET_RECRUITING Diphtheria

NCT04910386 Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers https://clinicaltrials.gov/study/NCT04910386 NOT_YET_RECRUITING Biliary Tract Neoplasms DRUG: Envafolimab plus Gemcitabine&Cisplatin

NCT05318469 Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer https://clinicaltrials.gov/study/NCT05318469 RECRUITING Anatomic Stage IV Breast Cancer AJCC V8

NCT05789069 A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05789069 RECRUITING Renal Cell Carcinoma

NCT06394869 Study to Assess the Impact of the Urine Test Cxbladder Detect+ on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine. https://clinicaltrials.gov/study/NCT06394869 NOT_YET_RECRUITING Hematuria - Cause Not Known DIAGNOSTIC_TEST: Cxbladder Detect+ Pacific Edge Limited

NCT05418868 A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants https://clinicaltrials.gov/study/NCT05418868 RECRUITING HIV Infections DRUG: Cabotegravir 200 mg/mL

NCT06474468 A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer https://clinicaltrials.gov/study/NCT06474468 RECRUITING Advanced or Metastatic Esophageal Cancer DRUG: SHR-A2102ÔºõAdebrelimabÔºõCisplatin Shanghai Hengrui Pharmaceutical Co., Ltd.

NCT04044768 Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma https://clinicaltrials.gov/study/NCT04044768 RECRUITING Synovial Sarcoma

NCT05118672 Phase 3 Clinical Trial to Evaluate Paracetamol /Fexofenadine /Phenylephrine in Flu and Cold Treatment https://clinicaltrials.gov/study/NCT05118672 NOT_YET_RECRUITING Cold

NCT06513572 Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices https://clinicaltrials.gov/study/NCT06513572 RECRUITING Hydrocephalus DEVICE: FlowSense Rhaeos, Inc.

NCT04707872 Trifecta-Heart cfDNA-MMDx Study https://clinicaltrials.gov/study/NCT04707872 RECRUITING Heart Transplant Rejection DIAGNOSTIC_TEST: MMDx diagnostic test

NCT06120972 Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency https://clinicaltrials.gov/study/NCT06120972 RECRUITING Ovarian Cancer DRUG: Olaparib tablet Alexander B Olawaiye, MD AstraZeneca

NCT05955469 Comparison in New Cochlear Implanted Subjects of a Tonotopy-based Bimodal Fitting and a Conventional Fitting https://clinicaltrials.gov/study/NCT05955469 RECRUITING Sensorineural Hearing Loss, Bilateral

NCT03527069 Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment https://clinicaltrials.gov/study/NCT03527069 RECRUITING Hypertriglyceridemia

NCT06704269 Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis https://clinicaltrials.gov/study/NCT06704269 NOT_YET_RECRUITING Generalized Myasthenia Gravis GENETIC: YTB323 Novartis Pharmaceuticals

NCT05113368 Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer https://clinicaltrials.gov/study/NCT05113368 RECRUITING Ovarian Cancer

NCT06092268 A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06092268 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: SHR-A2009 for injection Ôºõ Almonertinib Mesilate Tablets

NCT05496868 Add-on Reparixin in Adult Patients With ARDS https://clinicaltrials.gov/study/NCT05496868 RECRUITING Acute Respiratory Distress Syndrome, Adult DRUG: Reparixin 600mg

NCT05461768 A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Low Expression Breast Cancer and Other Solid Tumors https://clinicaltrials.gov/study/NCT05461768 RECRUITING Breast Cancer

NCT02332668 A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) https://clinicaltrials.gov/study/NCT02332668 RECRUITING Melanoma

NCT06422468 Combining Accelerometer, Gyroscope, Sound, Electrocardiography and Photoplethysmography Data in Cardiac Monitoring https://clinicaltrials.gov/study/NCT06422468 RECRUITING Atrial Fibrillation DEVICE: FibriCheck recordings Qompium NV

NCT06484972 A Multicenter Cluster Randomized Controlled Study to Evaluate Guideline Adoption Through Lung Cancer Clinical Care Quality Improvement Project (QIP) in Pulmonary and Critical Care Medicine (PCCM) Department https://clinicaltrials.gov/study/NCT06484972 NOT_YET_RECRUITING Lung Cancer AstraZeneca

NCT06418672 Go Sun Smart Georgia Evaluation https://clinicaltrials.gov/study/NCT06418672 RECRUITING Sun Safety BEHAVIORAL: Go Sun Smart Georgia (GSSG) Emory University Centers for Disease Control and Prevention

NCT05689372 Regulatory Post Marketing Surveillance (rPMS) Study of Ozempic (Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea https://clinicaltrials.gov/study/NCT05689372 NOT_YET_RECRUITING Diabetes Mellitus, Type 2 DRUG: Semaglutide Novo Nordisk A/S

NCT05501704 ETHAN - ET for Male BC https://clinicaltrials.gov/study/NCT05501704 RECRUITING Male Breast Cancer

NCT04191304 A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES) https://clinicaltrials.gov/study/NCT04191304 RECRUITING Hypereosinophilic Syndrome BIOLOGICAL: Benralizumab

NCT05510401 Evaluation of Safe Use of SECURIDRAP¬Æ SELFIA¬Æ https://clinicaltrials.gov/study/NCT05510401 RECRUITING Disorientation

NCT06608901 A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension https://clinicaltrials.gov/study/NCT06608901 NOT_YET_RECRUITING Sepsis-Induced Hypotension DRUG: REGN7544

NCT05657301 Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration https://clinicaltrials.gov/study/NCT05657301 RECRUITING Age-Related Macular Degeneration DRUG: KH631 Chengdu Origen Biotechnology Co., Ltd.

NCT06625801 IVUS CHIP Diversity Registry https://clinicaltrials.gov/study/NCT06625801 NOT_YET_RECRUITING Coronary Artery Disease

NCT05704101 NHFT Effects on Symptatheic Drive of Asthma Patients https://clinicaltrials.gov/study/NCT05704101 RECRUITING Asthma RWTH Aachen University ResMed

NCT06589401 Oral Paclitaxel for Patients with Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06589401 RECRUITING Solid Tumor DRUG: INP12 InnoUp Farma S.L.

NCT06417801 Prevalence of Emerging Treatment-induced Mutations in Metastatic ER-positive Breast Cancer. https://clinicaltrials.gov/study/NCT06417801 RECRUITING Metastatic Breast Cancer AstraZeneca

NCT05204667 Different Dosage Regimens of Methocarbamol/Paracetamol in Acute Non-specific Low Back Pain. MioPain Study https://clinicaltrials.gov/study/NCT05204667 RECRUITING Low Back Pain DRUG: 380 mg/300 mg comprimidos metocarbamol/paracetamol - 4 times daily

NCT04800367 Romosozumab/Denosumab Study for Premenopausal IOP https://clinicaltrials.gov/study/NCT04800367 RECRUITING Premenopausal Idiopathic Osteoporosis DRUG: Romosozumab Prefilled Syringe [Evenity]

NCT05780567 Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer https://clinicaltrials.gov/study/NCT05780567 RECRUITING Breast Cancer DRUG: TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen

NCT05775367 Cochlear Implants in Young Children With SSD https://clinicaltrials.gov/study/NCT05775367 RECRUITING Single Sided Deafness

NCT05796167 Pimavanserin for Sleep in Parkinson Disease https://clinicaltrials.gov/study/NCT05796167 RECRUITING Parkinson Disease DRUG: Pimavanserin State University of New York - Downstate Medical Center ACADIA Pharmaceuticals Inc.

NCT03374267 Registry Platform Urologic Cancer https://clinicaltrials.gov/study/NCT03374267 RECRUITING Renal Cell Carcinoma

NCT06060067 A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India https://clinicaltrials.gov/study/NCT06060067 RECRUITING Healthy Volunteers BIOLOGICAL: TDV

NCT06450067 Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia https://clinicaltrials.gov/study/NCT06450067 RECRUITING B-cell Acute Lymphoblastic Leukemia Juventas Cell Therapy Ltd.

NCT06710067 Urine Metabolites in the Diagnosis of Disease https://clinicaltrials.gov/study/NCT06710067 RECRUITING Colorectal Cancer

NCT06369467 Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy https://clinicaltrials.gov/study/NCT06369467 RECRUITING Food Allergy DRUG: linvoseltamab

NCT05280067 Ten Patient Pilot Study to Evaluate Safety of the ZetaFuse‚Ñ¢ Bone Graft Administered Using an Outpatient Local Intratumoral Injection Procedure to Treat Breast Cancer Bone Metastases in the Spine to Control Pain and Prevent Complications Such as Fracture https://clinicaltrials.gov/study/NCT05280067 RECRUITING Metastatic Breast Cancer in the Spine DEVICE: ZetaFuse‚Ñ¢ Bone Graft Zetagen Therapeutics, Inc

NCT05581004 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05581004 RECRUITING Locally Advanced or Metastatic Solid Tumors

NCT05913804 YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT05913804 NOT_YET_RECRUITING Relapsed or Refractory Multiple Myeloma BIOLOGICAL: YTS104 Cells injection Institute of Hematology & Blood Diseases Hospital, China China Immunotech (Beijing) Biotechnology Co., Ltd.

NCT05249101 A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma https://clinicaltrials.gov/study/NCT05249101 RECRUITING Metastatic Pancreatic Adenocarcinoma DRUG: Ivaltinostat

NCT04712201 En Bloc Bladder Tumor Resection: Prospective Randomized Study https://clinicaltrials.gov/study/NCT04712201 RECRUITING Urothelial Carcinoma Bladder

NCT05470101 A PET Study Following a Single Oral Dose of ITI-333 in Healthy Subjects https://clinicaltrials.gov/study/NCT05470101 RECRUITING Healthy Volunteers DRUG: ITI-333 Intra-Cellular Therapies, Inc. National Institute on Drug Abuse (NIDA)

NCT03902067 UC-MSC Transplantation for Left Ventricular Dysfunction After AMI https://clinicaltrials.gov/study/NCT03902067 NOT_YET_RECRUITING Left Ventricular Dysfunction

NCT05936567 Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria https://clinicaltrials.gov/study/NCT05936567 RECRUITING Urticaria

NCT06687967 A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1) https://clinicaltrials.gov/study/NCT06687967 NOT_YET_RECRUITING Lichen Simplex Chronicus DRUG: Dupilumab

NCT05344469 A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis https://clinicaltrials.gov/study/NCT05344469 RECRUITING Relapsing Multiple Sclerosis OTHER: ofatumumab

NCT06388369 Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer https://clinicaltrials.gov/study/NCT06388369 NOT_YET_RECRUITING Very High Risk Prostate Carcinoma RADIATION: [177Lu]Lu-PSMA-617

NCT04840069 Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma https://clinicaltrials.gov/study/NCT04840069 RECRUITING Newly Diagnosed Glioblastoma DRUG: Fluciclovine PET guided Radiotherapy St. Joseph's Hospital and Medical Center, Phoenix Barrow Neurological Foundation

NCT05245968 A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) https://clinicaltrials.gov/study/NCT05245968 RECRUITING Gastrointestinal Stromal Tumors DRUG: Pimitespib

NCT05388968 Metatranscriptomic Next Generation Sequencing in First Trimester Trophoblast With Increased Fetal Nuchal Translucency (METAHCN) https://clinicaltrials.gov/study/NCT05388968 RECRUITING Increased Nuchal Translucency in the First Trimester of Pregnancy BIOLOGICAL: Metatranscriptomic

NCT06516068 A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy https://clinicaltrials.gov/study/NCT06516068 NOT_YET_RECRUITING Obstructive Hypertrophic Cardiomyopathy DRUG: HRS-1893 Shandong Suncadia Medicine Co., Ltd.

NCT05580068 Investigation and Validation of a Study Project on Digital Therapy Management of Patients With Arterial Hypertension https://clinicaltrials.gov/study/NCT05580068 RECRUITING Cardiovascular Diseases

NCT04068168 Open Label, Multicenter, Real World Practice of Durvalumab (Imfinzi PMS) https://clinicaltrials.gov/study/NCT04068168 RECRUITING Lung Cancer, Biliary Tract Cancer AstraZeneca

NCT05609968 Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ‚â•50% (MK-3475-D46) https://clinicaltrials.gov/study/NCT05609968 RECRUITING Carcinoma, Non-Small-Cell Lung BIOLOGICAL: Sacituzumab Govitecan

NCT05879068 A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC https://clinicaltrials.gov/study/NCT05879068 RECRUITING SCLC DRUG: PM8002

NCT06295068 Evaluation of ARi With OpSens SavvyWire https://clinicaltrials.gov/study/NCT06295068 RECRUITING Aortic Valve Insufficiency DEVICE: Transcatheter Aortic Valve Replacement (TAVR)

NCT05106972 Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis https://clinicaltrials.gov/study/NCT05106972 RECRUITING Liver Cirrhosis DRUG: UC-MSC infusion Asia Stem Cell Regenerative Pharmaceutical Co., Ltd.

NCT06109272 A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) https://clinicaltrials.gov/study/NCT06109272 RECRUITING Hepatocellular Carcinoma DRUG: Livmoniplimab

NCT06695572 Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers https://clinicaltrials.gov/study/NCT06695572 RECRUITING Type 2 Diabetes Mellitus (T2DM) DRUG: CKD-383 Chong Kun Dang Pharmaceutical Bumin Hospital

NCT05259072 carDIo-ttranSSfOrm nucLEar Imaging Study https://clinicaltrials.gov/study/NCT05259072 RECRUITING Amyloidosis

NCT05256472 A Study of AK104 Monotherapy or AK104 Plus Axitinib in Advanced/Metastatic Renal Cell Carcinoma https://clinicaltrials.gov/study/NCT05256472 RECRUITING Renal Cell Carcinoma

NCT04697004 SMR Stemless Reverse Vs SMR Reverse Shoulder System https://clinicaltrials.gov/study/NCT04697004 RECRUITING Arthroplasty, Replacement DEVICE: Investigational Arm: SMR Stemless Reverse

NCT05493904 PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment of COMPLEX Lesion (PRECISION-COMPLEX) https://clinicaltrials.gov/study/NCT05493904 RECRUITING Coronary Artery Disease

NCT06376604 Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies https://clinicaltrials.gov/study/NCT06376604 RECRUITING Cancer, Ovarian

NCT05872204 Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer https://clinicaltrials.gov/study/NCT05872204 RECRUITING Low Grade Serous Ovarian Carcinoma

NCT06305104 Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old. https://clinicaltrials.gov/study/NCT06305104 RECRUITING Tuberculosis BIOLOGICAL: 2.5Œºg/ml EEC

NCT06597201 Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition. https://clinicaltrials.gov/study/NCT06597201 RECRUITING End Stage Renal Disease (ESRD) DRUG: amino acid (15) peritoneal dialysis solution

NCT05922501 Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT05922501 NOT_YET_RECRUITING Relapsed Cancer

NCT06130501 TAN for PTSD and OUD in Buprenorphine Therapy https://clinicaltrials.gov/study/NCT06130501 RECRUITING Posttraumatic Stress Disorder

NCT05736601 Early Outcomes of MAKO Medial Unicompartmental Knee Arthroplasty https://clinicaltrials.gov/study/NCT05736601 RECRUITING Knee Osteoarthritis DEVICE: focus motion knee brace Washington University School of Medicine Stryker Nordic

NCT06411301 A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors https://clinicaltrials.gov/study/NCT06411301 NOT_YET_RECRUITING Multiple Myeloma, Refractory

NCT06114667 Nasal High Flow Versus Non-invasive Ventilation for Early Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Hypercapnic Acidosis https://clinicaltrials.gov/study/NCT06114667 NOT_YET_RECRUITING Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT06434467 The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma https://clinicaltrials.gov/study/NCT06434467 NOT_YET_RECRUITING T-lymphoblastic Leukemia

NCT06256367 Observational Study of Oral Cariprazine Capsules to Assess Change in Disease Activity in Adult Participants With Bipolar I Disorder https://clinicaltrials.gov/study/NCT06256367 RECRUITING Bipolar I Disorder AbbVie

NCT04386967 OH2 Injection in Solid Tumors https://clinicaltrials.gov/study/NCT04386967 RECRUITING Solid Tumor

NCT03259867 Combination of TATE and PD-1 Inhibitor in Liver Cancer https://clinicaltrials.gov/study/NCT03259867 RECRUITING Hepatocellular Carcinoma

NCT06198504 Impact of End-tidal Oxygen Monitoring During Preoxygenation Before Intubation for Acute Hypoxemic Respiratory Failure in ICU Setting https://clinicaltrials.gov/study/NCT06198504 NOT_YET_RECRUITING Acute Hypoxemic Respiratory Failure PROCEDURE: Protocol using end-tidal oxygen monitoring during preoxygenation before intubation University Hospital, Grenoble Philips Healthcare

NCT04839601 RNS System RESPONSE Study https://clinicaltrials.gov/study/NCT04839601 RECRUITING Epilepsy

NCT05552001 Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT05552001 RECRUITING Triple Negative Breast Cancer

NCT05661201 NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors https://clinicaltrials.gov/study/NCT05661201 RECRUITING Solid Tumor

NCT05492201 A Study of LY3873862 in Healthy Participants https://clinicaltrials.gov/study/NCT05492201 RECRUITING Healthy DRUG: LY3873862

NCT05853367 Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001) https://clinicaltrials.gov/study/NCT05853367 RECRUITING Metastatic Solid Tumors

NCT04845867 A Prospective, Single-arm, Multi-centre, Blinded, Observational, Diagnostic Accuracy Study With a Diagnostic Medical Product https://clinicaltrials.gov/study/NCT04845867 RECRUITING Thyroid DEVICE: ISAR-M THYRO ISAR-M GmbH CRI-The Clinical Research Institute GmbH

NCT05441267 A Study of Cardiovascular Events iN Diabetes Plus https://clinicaltrials.gov/study/NCT05441267 RECRUITING Diabetes Mellitus, Type 2 DRUG: Semaglutide Oral Tablet

NCT06156904 OSsIRIS Study - A Post-market Clinical Follow-up Investigation. https://clinicaltrials.gov/study/NCT06156904 RECRUITING Surgically Created Bone Defects or Bone Defects/Voids Resulting From Traumatic Injury DEVICE: Bone grafting for the treatment of surgically created bone defects or bone defects/voids resulting from traumatic injury to promote healing in the pelvis, upper and lower extremities. GreenBone Ortho S.p.A.

NCT05753501 Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies https://clinicaltrials.gov/study/NCT05753501 RECRUITING Hematologic Cancer DRUG: ABBV-101 AbbVie

NCT04636801 A 52-week, Placebo-controlled Study to Evaluate the Efficacy and Safety of 2 Doses of CHF6001 DPI (Tanimilast), as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis (PILASTER) https://clinicaltrials.gov/study/NCT04636801 RECRUITING Chronic Obstructive Pulmonary Disease DRUG: Experimental: CHF6001 1600¬µg

NCT05949801 Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure https://clinicaltrials.gov/study/NCT05949801 RECRUITING Chronic Systolic Heart Failure DRUG: Neucardin

NCT04595201 Clinical Follow-up of Pregnant Subjects Undergoing NIPT https://clinicaltrials.gov/study/NCT04595201 RECRUITING Pregnancy DEVICE: NIPT Sequenom, Inc. Integrated Genetics

NCT06194201 A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis https://clinicaltrials.gov/study/NCT06194201 RECRUITING Patients With Candidemia and/or Invasive Candidiasis DRUG: HRS9432

NCT05199701 Prospective Case Collection Study for New Mammography Technologies https://clinicaltrials.gov/study/NCT05199701 RECRUITING Mammography DEVICE: Mammography Hologic, Inc.

NCT06390267 Effect of Transcutaneous Auricular Neurostimulation on Cognitive Performance in a Laboratory Model of Acute Stress Reaction https://clinicaltrials.gov/study/NCT06390267 NOT_YET_RECRUITING Acute Stress Reaction

NCT06248567 Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease https://clinicaltrials.gov/study/NCT06248567 RECRUITING Kidney Impairment DRUG: ZSP1273 Guangdong Raynovent Biotech Co., Ltd

NCT06392269 A Multi-site Clinical Evaluation of Capillary Blood Samples Collected Using the Tasso+SST Device for Downstream Analyte Testing https://clinicaltrials.gov/study/NCT06392269 RECRUITING Serum Analytes DIAGNOSTIC_TEST: Tasso+SST Tasso Inc.

NCT05653869 A Study of APS03118 in Advanced Solid Tumors Harboring RET Mutations or Fusions https://clinicaltrials.gov/study/NCT05653869 RECRUITING RET-altered Solid Tumors DRUG: APS03118 Applied Pharmaceutical Science, Inc.

NCT05834868 Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes https://clinicaltrials.gov/study/NCT05834868 RECRUITING Type 2 Diabetes DRUG: THDB0206 Injection

NCT06361368 Efficacy Assessment of Probiotics in Improving Sleep Indices https://clinicaltrials.gov/study/NCT06361368 RECRUITING Insomnia DIETARY_SUPPLEMENT: PS150

NCT04718168 GORE¬Æ ENFORM Biomaterial Product Study https://clinicaltrials.gov/study/NCT04718168 RECRUITING Hernia, Ventral

NCT05366868 Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus https://clinicaltrials.gov/study/NCT05366868 RECRUITING Diabetes Mellitus, Type 2 DRUG: Imeglimin

NCT04807868 AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL) https://clinicaltrials.gov/study/NCT04807868 RECRUITING Non-Alcoholic Fatty Liver Disease PROCEDURE: Standard of care liver biopsy

NCT05334368 Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial https://clinicaltrials.gov/study/NCT05334368 RECRUITING Hypereosinophilic Syndrome DRUG: Depemokimab

NCT06194968 Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study https://clinicaltrials.gov/study/NCT06194968 RECRUITING Acute Ischemic Stroke DRUG: Urokinase

NCT06382168 DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06382168 RECRUITING Leukemia, Myeloid, Acute DRUG: DFP-10917

NCT06306872 A Clinical Trial to Evaluate the Relative Bioavailability of New and Old ABSK-011 Capsules https://clinicaltrials.gov/study/NCT06306872 RECRUITING Healthy Subjects DRUG: Sequence A ABSK-011

NCT05352672 Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma https://clinicaltrials.gov/study/NCT05352672 RECRUITING Melanoma DRUG: Fianlimab

NCT05959304 Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema. https://clinicaltrials.gov/study/NCT05959304 NOT_YET_RECRUITING Diabetic Macular Edema OTHER: brolucizumab Novartis Pharmaceuticals

NCT06476704 Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas https://clinicaltrials.gov/study/NCT06476704 NOT_YET_RECRUITING Sarcoma DRUG: Administration of L-TC

NCT06637904 TriVerity‚Ñ¢ for Improved Management of Emergency Department (ED) Patients With Suspected Infections https://clinicaltrials.gov/study/NCT06637904 RECRUITING Sepsis

NCT06101004 A Multi-center, Non-interventional Prospective Clinical Trial to Evaluate the Safety and Effectiveness of CVA-FLOW https://clinicaltrials.gov/study/NCT06101004 NOT_YET_RECRUITING Stroke DEVICE: CVA-Flow Cvaid Medical Donawa Lifescience Consulting

NCT05006404 Autus Valve Pivotal Study https://clinicaltrials.gov/study/NCT05006404 RECRUITING Congenital Heart Disease DEVICE: Pulmonary Valve Replacement Surgery Autus Valve Technologies, Inc.

NCT06011304 Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer https://clinicaltrials.gov/study/NCT06011304 RECRUITING Prostate Cancer DRUG: [18F]Florastamin Injection HTA Co., Ltd.

NCT05297201 Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients With Levodopa Induced Dyskinesia https://clinicaltrials.gov/study/NCT05297201 RECRUITING Parkinson Disease

NCT06702501 The PeriCut Catheter System Early Feasibility Study (REIMAGINE-HFpEF) https://clinicaltrials.gov/study/NCT06702501 NOT_YET_RECRUITING Heart Failure With Preserved Ejection Fraction DEVICE: PeriCut Catheter System performs minimally invasive pericardiotomy Heart Failure Solutions, Inc. Mayo Clinic

NCT05945901 A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer https://clinicaltrials.gov/study/NCT05945901 RECRUITING Colorectal Cancer DRUG: HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab

NCT05401201 Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Corticosteroid Treatment in OLP https://clinicaltrials.gov/study/NCT05401201 RECRUITING Oral Lichen Planus

NCT06475001 Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain https://clinicaltrials.gov/study/NCT06475001 RECRUITING Chronic Non-specific Low Back Pain DRUG: VER-01

NCT06115967 A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants https://clinicaltrials.gov/study/NCT06115967 RECRUITING Rheumatoid Arthritis DRUG: AZD6912

NCT04094610 A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations https://clinicaltrials.gov/study/NCT04094610 RECRUITING Locally Advanced Solid Tumors

NCT06226610 Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic https://clinicaltrials.gov/study/NCT06226610 RECRUITING Pruritis DRUG: Dupilumab

NCT06623110 Phase II Study of RP2 As Immunoprevention in High-Risk Oral Precancerous Disease https://clinicaltrials.gov/study/NCT06623110 NOT_YET_RECRUITING High-Risk Oral Precancerous Disease BIOLOGICAL: RP2 Injection Glenn J. Hanna Replimune Inc.

NCT06625710 Evaluation of the Safety, Tolerability and PK Characteristics of GV1001 in Healthy Subjects https://clinicaltrials.gov/study/NCT06625710 RECRUITING Neuro-Degenerative Disease DRUG: GV1001

NCT05588310 Quantification of the Socio-economic Multifacet Burden of Alopecia Areata and Identification of the Associated Factors https://clinicaltrials.gov/study/NCT05588310 RECRUITING Alopecia Areata University Hospital, Toulouse Pfizer

NCT05366010 Oscillation and Lung Expansion (OLE) for Treatment of Neuromuscular Disease Patients https://clinicaltrials.gov/study/NCT05366010 RECRUITING Neuromuscular Diseases DEVICE: Oscillation and Lung Expansion (OLE) therapy Hill-Rom

NCT06647810 A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood https://clinicaltrials.gov/study/NCT06647810 RECRUITING Healthy DRUG: BI 690517 formulation 1

NCT05830110 Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease https://clinicaltrials.gov/study/NCT05830110 RECRUITING Parkinson's Disease DEVICE: Active Vibrotactile Coordinated Reset

NCT04743310 Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System https://clinicaltrials.gov/study/NCT04743310 RECRUITING Central Nervous System Tumor DRUG: tozuleristide

NCT05518110 PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer https://clinicaltrials.gov/study/NCT05518110 RECRUITING Pancreatic Cancer DRUG: Trametinib

NCT06590610 Post-Market Clinical Follow-up HVS on Increased Circulation, RPW2 and Cefar TENS https://clinicaltrials.gov/study/NCT06590610 RECRUITING Healthy DEVICE: Radial pressure wave (RPW) - Intelect RPW2 Chattanooga DJO UK Ltd

NCT06025812 Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells) https://clinicaltrials.gov/study/NCT06025812 NOT_YET_RECRUITING Coronavirus BIOLOGICAL: Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)

NCT04478812 Tbit System Precision and Correlation of Different Blood Samples https://clinicaltrials.gov/study/NCT04478812 NOT_YET_RECRUITING Brain Injuries

NCT06053112 The Trial of a New Infant Formula in Healthy Term Chinese Infants https://clinicaltrials.gov/study/NCT06053112 RECRUITING Healthy Infants OTHER: New infant formula with 6 HMOs blend

NCT06499012 The Efficacy of Nutrilite All-plant Protein Booster to Improve Sarcopenia and Osteoarthritis in Middle-aged and Elderly People https://clinicaltrials.gov/study/NCT06499012 NOT_YET_RECRUITING Osteoarthritis

NCT06441812 A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients https://clinicaltrials.gov/study/NCT06441812 NOT_YET_RECRUITING Eosinophilic Asthma Patients DRUG: SHR-1703 Injection Guangdong Hengrui Pharmaceutical Co., Ltd

NCT05192512 Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers https://clinicaltrials.gov/study/NCT05192512 RECRUITING Advanced Cancer DRUG: TQB2928 injection Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

NCT06617546 SAD and MAD Study of FTX-101 in Healthy Male Subjects https://clinicaltrials.gov/study/NCT06617546 RECRUITING Healthy Volunteers DRUG: FTX-101

NCT05879146 Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study https://clinicaltrials.gov/study/NCT05879146 NOT_YET_RECRUITING Tumor DRUG: Nirogacestat M.D. Anderson Cancer Center SpringWorks Therapeutics, Inc.

NCT06590246 A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/recurrent Hepatocellular Carcinoma (HCC) https://clinicaltrials.gov/study/NCT06590246 NOT_YET_RECRUITING Hepatocellular Carcinoma BIOLOGICAL: Armored and GPC3-targeted autologous CAR T-cell Shanghai AbelZeta Ltd.

NCT05360446 Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events https://clinicaltrials.gov/study/NCT05360446 RECRUITING Coronary Artery Disease DRUG: Inclisiran sodium 300 mg

NCT05713110 A Study of Tazemetostat in Combination With HMPL-689 in Patients With Relapsed/Refractory Lymphoma https://clinicaltrials.gov/study/NCT05713110 RECRUITING Relapsed/Refractory Lymphoma DRUG: tazemetostat

NCT06391710 HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction https://clinicaltrials.gov/study/NCT06391710 RECRUITING Heart Failure With Preserved Ejection Fraction DRUG: HRS9531

NCT06707610 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06707610 NOT_YET_RECRUITING Advanced Cancer

NCT06144710 SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT06144710 RECRUITING Systemic Lupus Erythematosus (SLE) DRUG: SG301 SC Injection

NCT05111210 Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis https://clinicaltrials.gov/study/NCT05111210 RECRUITING Psoriasis OTHER: Blood sample

NCT06389110 Study to Evaluate the Efficacy of Alleance¬Æ (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children. https://clinicaltrials.gov/study/NCT06389110 NOT_YET_RECRUITING Myopia

NCT05858710 Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma https://clinicaltrials.gov/study/NCT05858710 RECRUITING Sarcoma, Soft Tissue DRUG: DPPG2-TSL-DOX Thermosome GmbH

NCT06632912 Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging https://clinicaltrials.gov/study/NCT06632912 NOT_YET_RECRUITING Human Papillomavirus (HPV) Infection

NCT06203912 Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT06203912 RECRUITING Recurrent Multiple Myeloma

NCT06453512 A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema https://clinicaltrials.gov/study/NCT06453512 NOT_YET_RECRUITING Atopic Eczema DEVICE: Doublebase Once Dermal Laboratories Ltd

NCT05555212 To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation https://clinicaltrials.gov/study/NCT05555212 RECRUITING Non-small Cell Lung Cancer DRUG: QLH11811 Qilu Pharmaceutical Co., Ltd.

NCT06547346 Acceptability and Palatability Study of Paediatric Amino Acid Feed https://clinicaltrials.gov/study/NCT06547346 RECRUITING Allergy DIETARY_SUPPLEMENT: Alfamino Junior Soci√©t√© des Produits Nestl√© (SPN)

NCT05457946 Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series https://clinicaltrials.gov/study/NCT05457946 NOT_YET_RECRUITING Diphtheria

NCT04543110 Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC https://clinicaltrials.gov/study/NCT04543110 RECRUITING Bladder Cancer DRUG: Durvalumab

NCT06305910 CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults https://clinicaltrials.gov/study/NCT06305910 RECRUITING Diffuse Midline Glioma, H3 K27M-Mutant

NCT06374212 Anifrolumab for Hidradenitis Suppurativa https://clinicaltrials.gov/study/NCT06374212 RECRUITING Hidradenitis Suppurativa

NCT06120712 A Phase ‚Ö†b Study on Autologous GC101 TIL Injection for the Treatment of Advanced Melanoma (MIZAR-002) https://clinicaltrials.gov/study/NCT06120712 RECRUITING Tumor Infiltrating Lymphocytes

NCT05134012 RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW) https://clinicaltrials.gov/study/NCT05134012 RECRUITING Coronary Artery Disease DRUG: [O-15]-Water PET Myocardial Perfusion Imaging (MPI) MedTrace Pharma A/S

NCT06049212 Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008) https://clinicaltrials.gov/study/NCT06049212 RECRUITING Non-small Cell Lung Cancer

NCT06320912 Efficacy and Safety of Intraparenchymal Portal Vein Covered Stents in Treating Portal Hypertension and Its Complications https://clinicaltrials.gov/study/NCT06320912 NOT_YET_RECRUITING Portal Hypertension DEVICE: The intraparenchymal portal vein covered stent

NCT05587712 Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008) https://clinicaltrials.gov/study/NCT05587712 RECRUITING Pulmonary Arterial Hypertension DRUG: Sotatercept Merck Sharp & Dohme LLC

NCT06263946 Essilor¬Æ Stellest¬Æ Lenses Multicentre European Study (SLOMES) https://clinicaltrials.gov/study/NCT06263946 RECRUITING Myopia DEVICE: Essilor¬Æ Stellest¬Æ spectacle lenses Essilor International

NCT06694246 Improving Outpatient Endometrial Biopsy Results https://clinicaltrials.gov/study/NCT06694246 RECRUITING Histopathology

NCT05784246 A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis https://clinicaltrials.gov/study/NCT05784246 RECRUITING Ulcerative Colitis DRUG: Mirikizumab IV

NCT04989946 Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer https://clinicaltrials.gov/study/NCT04989946 RECRUITING Prostate Cancer DRUG: Degarelix

NCT06663046 Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma https://clinicaltrials.gov/study/NCT06663046 RECRUITING Multiple Myleoma

NCT06241846 A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC https://clinicaltrials.gov/study/NCT06241846 RECRUITING Metastatic Castration-resistant Prostate Cancer (mCRPC) DRUG: YL201 for Injection MediLink Therapeutics (Suzhou) Co., Ltd.

NCT06491446 Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts https://clinicaltrials.gov/study/NCT06491446 RECRUITING Human Papillomavirus Infection DRUG: ABI-2280 Antiva Biosciences

NCT06310746 A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Phase I Clinical Study to Assess the Safety, Pharmacokinetics, and Immunogenicity of HLX6018 in Healthy Subjects https://clinicaltrials.gov/study/NCT06310746 RECRUITING IPF DRUG: GARP/TGF-Œ≤1 monoclonal antibody

NCT06434610 A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. https://clinicaltrials.gov/study/NCT06434610 RECRUITING Platinum-resistant Recurrent Ovarian Cancer DRUG: B013

NCT04821310 Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years https://clinicaltrials.gov/study/NCT04821310 RECRUITING Esophagitis DRUG: Full dose Pantoprazole plus matching placebo

NCT05926310 Safety and Feasibility of TWIICE Rise https://clinicaltrials.gov/study/NCT05926310 RECRUITING Spinal Cord Injuries

NCT06413810 A Randomised, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of a Food Ingredient on Self-reported Stress in Healthy Adults https://clinicaltrials.gov/study/NCT06413810 NOT_YET_RECRUITING Stress OTHER: Calmarell

NCT05708612 Safety and Performance of a Silicone Implant for Fecal Incontinence Treatment (SimplyFI) https://clinicaltrials.gov/study/NCT05708612 RECRUITING Fecal Incontinence PROCEDURE: Medical Device (SimplyFI) A.M.I. Agency for Medical Innovations GmbH

NCT04104412 The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife¬Æ-LDP) for Lumbar Discogenic Pain https://clinicaltrials.gov/study/NCT04104412 RECRUITING Lumbar Discogenic Pain BIOLOGICAL: human umbilical cord mesenchymal stem cell Sclnow Biotechnology Co., Ltd.

NCT04684212 Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF https://clinicaltrials.gov/study/NCT04684212 NOT_YET_RECRUITING Atrial Fibrillation

NCT06298812 REFLECT Scoliosis System Post Approval Study https://clinicaltrials.gov/study/NCT06298812 NOT_YET_RECRUITING Idiopathic Scoliosis DEVICE: REFLECT Scoliosis Correction System Globus Medical Inc

NCT06621212 Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML https://clinicaltrials.gov/study/NCT06621212 RECRUITING Relapsed/Refractory Acute Myeloid Leukaemia

NCT04987112 Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors https://clinicaltrials.gov/study/NCT04987112 RECRUITING Solid Tumor

NCT06122012 To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China https://clinicaltrials.gov/study/NCT06122012 RECRUITING Diabetic Peripheral Neuropathic Pain DRUG: HSK16149 20mg BID Haisco Pharmaceutical Group Co., Ltd.

NCT05480046 Non-interventional Study of Risperidone ISM¬Æ in Schizophrenia Patients Hospitalised Due to a Relapse https://clinicaltrials.gov/study/NCT05480046 RECRUITING Schizophrenia DRUG: Risperidone ISM Rovi Pharmaceuticals Laboratories

NCT05251181 A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent https://clinicaltrials.gov/study/NCT05251181 NOT_YET_RECRUITING Hypovolemic Shock DRUG: Normal Saline

NCT06240481 Clinical Research Study to Assess the Efficacy of Two Brushing Regimens https://clinicaltrials.gov/study/NCT06240481 RECRUITING Dental Plaque

NCT04849910 Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS https://clinicaltrials.gov/study/NCT04849910 RECRUITING Leukemia, Myeloid, Acute

NCT06156410 Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma https://clinicaltrials.gov/study/NCT06156410 RECRUITING Ewing Sarcoma

NCT05203510 A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension https://clinicaltrials.gov/study/NCT05203510 RECRUITING Pulmonary Arterial Hypertension DRUG: Parenteral Treprostinil

NCT05886010 Performance and Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in th Treatment of Brown Spots (Solar and Senile Lentigines, Post-Inflammatory Hyperpigmentation) on the Face and Hands of Asian Ethnicity Skins https://clinicaltrials.gov/study/NCT05886010 NOT_YET_RECRUITING Solar Lentigo

NCT05866510 Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer https://clinicaltrials.gov/study/NCT05866510 RECRUITING Esophageal Cancer DRUG: Utidelone and anlotinib Peking University Beijing Biostar Pharmaceuticals Co., Ltd.

NCT06026410 KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06026410 RECRUITING Solid Tumors with HRAS Alterations

NCT04443010 Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma https://clinicaltrials.gov/study/NCT04443010 RECRUITING Glioblastoma DRUG: Onfekafusp alfa

NCT06653010 Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer https://clinicaltrials.gov/study/NCT06653010 RECRUITING CRC (colorectal Cancer)

NCT06368310 FIH Clinical Investigation of Graphene Electrodes for Brain Mapping https://clinicaltrials.gov/study/NCT06368310 NOT_YET_RECRUITING Brain Tumor

NCT06361810 PSMA Therapy and Immunotherapy in Kidney Cancer https://clinicaltrials.gov/study/NCT06361810 NOT_YET_RECRUITING Metastatic Renal Cell Carcinoma

NCT06676410 Clinical Trial to Evaluate the Efficacy and Safety of Codivir¬Æ in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-na√Øve Participants https://clinicaltrials.gov/study/NCT06676410 RECRUITING HIV

NCT05972512 A Clinical Study to Assess the Safety and Effectiveness of Plant-based Biotin and Plant Based Biotin With Silica in Healthy Human Subjects With Complaints of Hair Fall, Thin, Dry, & Brittle Hair, and Dry Skin https://clinicaltrials.gov/study/NCT05972512 RECRUITING Hair Falling

NCT05751512 A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN https://clinicaltrials.gov/study/NCT05751512 NOT_YET_RECRUITING Squamous Cell Carcinoma of the Head and Neck DRUG: MRG003

NCT06115512 A Phase 3 Study of AGA111 in Patients With Degenerative Disc Disease Undergoing Lumbar Interbody Fusion https://clinicaltrials.gov/study/NCT06115512 RECRUITING Degenerative Disc Disease DRUG: AGA111

NCT06462612 Study of Lumateperone in the Treatment of Patients With Bipolar Mania https://clinicaltrials.gov/study/NCT06462612 RECRUITING Bipolar Disorder, Manic DRUG: Lumateperone

NCT05655312 MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma https://clinicaltrials.gov/study/NCT05655312 RECRUITING Melanoma (Skin)

NCT06560112 An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer https://clinicaltrials.gov/study/NCT06560112 NOT_YET_RECRUITING Recurrent Ovarian Cancer DRUG: AK104

NCT06136312 Clinical Investigation of the Multi4 System https://clinicaltrials.gov/study/NCT06136312 RECRUITING Bladder Cancer DEVICE: Multi4 Multi4 Medical Ab Key2Compliance

NCT06600412 The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease. https://clinicaltrials.gov/study/NCT06600412 RECRUITING Diabetic Kidney Disease DRUG: R3R01

NCT06448312 A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT06448312 RECRUITING Non-Small Cell Lung Cancer DRUG: SKB264

NCT05441410 Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults https://clinicaltrials.gov/study/NCT05441410 NOT_YET_RECRUITING Malaria DRUG: Pyronaridine Tetraphosphate, Artesunate Drug Combination

NCT06341712 Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma https://clinicaltrials.gov/study/NCT06341712 RECRUITING Osteosarcoma

NCT05186012 APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT05186012 RECRUITING NHL, Adult DRUG: APG-1252

NCT06060912 LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs https://clinicaltrials.gov/study/NCT06060912 RECRUITING Left Atrial Appendage Occlusion DEVICE: Left Atrial Appendage Occlusion Deutsches Herzzentrum Muenchen Lifetech Scientific (Shenzhen) Co., Ltd.

NCT05953012 Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration https://clinicaltrials.gov/study/NCT05953012 RECRUITING Neovascular Age-related Macular Degeneration DRUG: PMC-403 PharmAbcine C&R Research, Inc.

NCT04170946 Talazoparib and Thoracic RT for ES-SCLC https://clinicaltrials.gov/study/NCT04170946 RECRUITING Lung Cancer

NCT06527846 Post Marketing Surveillance of JARDIANCE in Chronic Kidney Disease https://clinicaltrials.gov/study/NCT06527846 RECRUITING Kidney Disease, Chronic DRUG: JARDIANCE¬Æ Boehringer Ingelheim

NCT06492746 Personal BP - CAI Study https://clinicaltrials.gov/study/NCT06492746 RECRUITING Blood Pressure DEVICE: HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring Edwards Lifesciences

NCT05652946 IISART (International Industry Society of Advanced Rehabilitation Technology) Advanced Rehabilitation Technology Study https://clinicaltrials.gov/study/NCT05652946 RECRUITING Neurologic Disorder DEVICE: Tyromotion, Fourier Intelligence, Thera-Trainer, EKSO Bionics

NCT05422612 Department of Defense PTSD Adaptive Platform Trial - Master Protocol https://clinicaltrials.gov/study/NCT05422612 RECRUITING Post Traumatic Stress Disorder DRUG: Intervention A Fluoxetine Hydrochloride (HCl)

NCT05235412 A Cohort Study on Milk Composition, Health Outcomes, and Feeding Practices of Chinese Mothers and Infants https://clinicaltrials.gov/study/NCT05235412 RECRUITING Breast Feeding

NCT06547112 A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization https://clinicaltrials.gov/study/NCT06547112 RECRUITING Multiple Myeloma DRUG: Motixafortide

NCT06070012 Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma https://clinicaltrials.gov/study/NCT06070012 NOT_YET_RECRUITING Uveal Melanoma DRUG: Tebentafusp Diwakar Davar Immunocore Ltd

NCT05999812 Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer https://clinicaltrials.gov/study/NCT05999812 RECRUITING Colorectal Cancer DRUG: all trans Retinoic Acid

NCT06198712 A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease https://clinicaltrials.gov/study/NCT06198712 RECRUITING Sickle Cell Disease DRUG: Etavopivat Forma Therapeutics, Inc. Novo Nordisk A/S

NCT06285812 Otitis Treatment with OtoSight‚Ñ¢ - Modification of Antibiotic Treatment Intervention in Children https://clinicaltrials.gov/study/NCT06285812 RECRUITING Otitis Media Acute DEVICE: OtoSight Middle Ear Scope PhotoniCare, Inc. TTi Health Research & Economics

NCT05862012 Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT05862012 RECRUITING Relapsed/Refractory Multiple Myeloma DRUG: ISB 2001

NCT04255446 Structured Light Plethysmography Against Standard of Care in the Diagnosis and Monitoring of Dysfunctional Breathing https://clinicaltrials.gov/study/NCT04255446 NOT_YET_RECRUITING Dysfunctional Breathing DEVICE: Thora3DiTM Pneumacare Ltd

NCT05829746 PROSPECTIVE, MULTI-CENTER, OPEN-LABEL, SINGLE-ARM REGISTRATION TRIAL OF THE TUBRIDGE FOR THE TREATMENT OF WIDE-NECKED SMALL AND MEDIUM-SIZED INTRACRANIAL ANEURYSMS https://clinicaltrials.gov/study/NCT05829746 RECRUITING Brain Diseases

NCT06032546 A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382 https://clinicaltrials.gov/study/NCT06032546 RECRUITING Human Immuno-deficiency Virus (HIV) Disease DRUG: Budigalimab

NCT06250946 Efficacy and Safety of HRS-7535 Tablets in Obese Subjects . https://clinicaltrials.gov/study/NCT06250946 NOT_YET_RECRUITING Overweight and Obesity DRUG: HRS-7535;Placebo

NCT06331312 Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) https://clinicaltrials.gov/study/NCT06331312 RECRUITING Polymyalgia Rheumatica BIOLOGICAL: Secukinumab Novartis Pharmaceuticals

NCT06254612 A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults with Major Depressive Disorder https://clinicaltrials.gov/study/NCT06254612 RECRUITING Major Depressive Disorder DRUG: SP-624

NCT06668012 A Multicenter, Open, Comparative Study on Vaginal Dysbiosis in Premenopausal Women (DISPALOMA) https://clinicaltrials.gov/study/NCT06668012 NOT_YET_RECRUITING Vaginal Dysbiosis DEVICE: Palomacare¬Æ vaginal gel is a medical device with CE class IIa. Procare Health Iberia S.L.

NCT05637112 A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice https://clinicaltrials.gov/study/NCT05637112 RECRUITING Systemic Lupus Erythematosus OTHER: None (Observational study) AstraZeneca Parexel

NCT05743712 Pilot Test of a Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination https://clinicaltrials.gov/study/NCT05743712 RECRUITING Mental Health Services OTHER: SMART-Wrap 3-C Institute for Social Development University of Washington

NCT05010746 TVMR With the Innovalve System Trial - Pilot Study in Italy https://clinicaltrials.gov/study/NCT05010746 RECRUITING Mitral Valve Regurgitation (Degenerative or Functional) DEVICE: Innovalve TMVR system Innovalve Bio Medical Ltd.

NCT02782546 Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation https://clinicaltrials.gov/study/NCT02782546 RECRUITING Acute Myeloid Leukemia PROCEDURE: Graft cell infusion

NCT04716946 Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy https://clinicaltrials.gov/study/NCT04716946 RECRUITING NSCLC

NCT06195046 Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study https://clinicaltrials.gov/study/NCT06195046 RECRUITING Congestive Heart Failure DEVICE: Baroreflex Activation Therapy (BAT) Brian Houston CVRx, Inc.

NCT06594146 Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP) https://clinicaltrials.gov/study/NCT06594146 NOT_YET_RECRUITING Primary Immune Thrombocytopenia BIOLOGICAL: CM313 injection

NCT06279312 The Effect of Adaptogen Elixir on Sleep Improvement https://clinicaltrials.gov/study/NCT06279312 RECRUITING Sleep Disorder

NCT05933512 A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines https://clinicaltrials.gov/study/NCT05933512 NOT_YET_RECRUITING COVID-19

NCT06154512 A Real-world, Multi-center, Prospective, Observational Study for PNH in China https://clinicaltrials.gov/study/NCT06154512 RECRUITING Paroxysmal Nocturnal Hemoglobinuria AstraZeneca

NCT05693012 Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma https://clinicaltrials.gov/study/NCT05693012 RECRUITING Multiple Myeloma DIAGNOSTIC_TEST: cfDNA methylation assessment Qiu Lugui Guangzhou Burning Rock Dx Co., Ltd.

NCT06359912 Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia https://clinicaltrials.gov/study/NCT06359912 RECRUITING Critical Limb Ischemia DRUG: EPCs

NCT04929912 Electroporation for Cancer Treatment Real World Registry https://clinicaltrials.gov/study/NCT04929912 RECRUITING Skin Cancer

NCT06514612 LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis. https://clinicaltrials.gov/study/NCT06514612 NOT_YET_RECRUITING Acquired Blepharophimosis DRUG: STN1013800 (0.1% Oxymetazoline Hydrochloride) eye drops in single dose containers

NCT05570812 Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV https://clinicaltrials.gov/study/NCT05570812 RECRUITING Major Depressive Disorder

NCT06240546 First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors. https://clinicaltrials.gov/study/NCT06240546 RECRUITING Advanced Solid Tumor DRUG: LPM6690176 Luye Pharma Group Ltd.

NCT05703646 Safety and Clinical Performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Stents in Routine Practice https://clinicaltrials.gov/study/NCT05703646 RECRUITING Ischemic Heart Disease Translumina GmbH EVAMED

NCT06386146 JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation https://clinicaltrials.gov/study/NCT06386146 RECRUITING Solid Tumors DRUG: JAB-30355

NCT03028246 A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects https://clinicaltrials.gov/study/NCT03028246 RECRUITING Benign Centrally-Located Intracranial Tumors DEVICE: ExAblate 4000 System InSightec

NCT05699746 CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD https://clinicaltrials.gov/study/NCT05699746 NOT_YET_RECRUITING Colorectal Cancer DRUG: Capecitabine tablets

NCT06059846 A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) https://clinicaltrials.gov/study/NCT06059846 RECRUITING Urinary Tract Infection

NCT05311046 Biomarker-enhanced Artificial Intelligence Based Pediatric Sepsis Screening Tool https://clinicaltrials.gov/study/NCT05311046 RECRUITING Sepsis DIAGNOSTIC_TEST: Pediatric sepsis screening tool (either algorithmic or manual) Computer Technology Associates, Inc. Children's Hospital Medical Center, Cincinnati

NCT04960904 Study Evaluating the Performance and Safety in the Medium and Long Term of Global D Implant-prosthetic Systems https://clinicaltrials.gov/study/NCT04960904 RECRUITING Dental Implants DEVICE: Dental implant surgery with implants Global D

NCT05607004 (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer https://clinicaltrials.gov/study/NCT05607004 RECRUITING Breast Neoplasms

NCT05776004 Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia https://clinicaltrials.gov/study/NCT05776004 RECRUITING Pneumonia, Bacterial DRUG: CAL02

NCT05497401 A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS https://clinicaltrials.gov/study/NCT05497401 NOT_YET_RECRUITING ARDS BIOLOGICAL: MesenCure

NCT06528301 A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies https://clinicaltrials.gov/study/NCT06528301 NOT_YET_RECRUITING Lymphoma, B-Cell

NCT05611801 A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B https://clinicaltrials.gov/study/NCT05611801 RECRUITING Hemophilia A

NCT05520801 Primary Hepatobiliary Cancer Cohort of Central China https://clinicaltrials.gov/study/NCT05520801 RECRUITING Hepatocellular Carcinoma

NCT06329401 A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants with Progressive Pulmonary Fibrosis https://clinicaltrials.gov/study/NCT06329401 RECRUITING Progressive Pulmonary Fibrosis DRUG: AP01

NCT06324201 The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation. https://clinicaltrials.gov/study/NCT06324201 RECRUITING Paroxysmal Atrial Fibrillation DEVICE: Ablation Procedure Heart Rhythm Clinical and Research Solutions, LLC Biosense Webster, Inc.

NCT06200467 A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity https://clinicaltrials.gov/study/NCT06200467 RECRUITING Overweight

NCT05824767 Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock https://clinicaltrials.gov/study/NCT05824767 RECRUITING Septic Shock

NCT06708767 Safety Study of CZ10 in Healthy Volunteers https://clinicaltrials.gov/study/NCT06708767 NOT_YET_RECRUITING Healthy Volunteer Study DRUG: Contrast Media

NCT06239467 First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer https://clinicaltrials.gov/study/NCT06239467 RECRUITING Advanced Cancer

NCT06277804 A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor https://clinicaltrials.gov/study/NCT06277804 NOT_YET_RECRUITING Adult Solid Tumor DRUG: LTC004 in Combination With Cyclophosphamide and Fludarabine Letolab

NCT05813704 Coronary Crossing System in Patients With Coronary Chronic Total Occlusions https://clinicaltrials.gov/study/NCT05813704 RECRUITING Chronic Total Occlusion of Coronary Artery DEVICE: Coronary Crossing System of Shanghai MicroPort Rhythm Shanghai MicroPort Rhythm MedTech Co., Ltd. Shanghai Zhongshan Hospital

NCT06558604 A Phase II Study Evaluating Glofitamab in Combination With Venetoclax Plus Zanubrutinib or Venetoclax Alone in Subjects With Untreated or Relapsed/Refractory High-risk Mantle-cell Lymphoma https://clinicaltrials.gov/study/NCT06558604 NOT_YET_RECRUITING Lymphoma, Mantle-Cell DRUG: Obinutuzumab

NCT06342804 Food Effect on the Bioavailability of 4-MUST, Tablets, 128 mg https://clinicaltrials.gov/study/NCT06342804 RECRUITING Cholecystitis DRUG: 4-MUST, 2 tablets, fasted

NCT05303701 GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD) https://clinicaltrials.gov/study/NCT05303701 NOT_YET_RECRUITING Moderate to Severe Alzheimer's Disease DRUG: GV1001 Placebo

NCT06053801 A Real-world Study to Assess Safety and Effectiveness of Xolair¬Æ in Pediatric Chronic Spontaneous Urticaria in China https://clinicaltrials.gov/study/NCT06053801 RECRUITING Chronic Spontaneous Urticaria OTHER: Xolair Novartis Pharmaceuticals

NCT05750901 Evaluation of Fractional Ablative Laser Treatment for Skin Conditions https://clinicaltrials.gov/study/NCT05750901 RECRUITING Skin Laxity DEVICE: Fractional ablative laser Sciton

NCT06168201 A Participant-mediated Observational Virtual Registry of Children With Achondroplasia in the United States https://clinicaltrials.gov/study/NCT06168201 RECRUITING Achondroplasia BioMarin Pharmaceutical PicnicHealth

NCT03774901 Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma https://clinicaltrials.gov/study/NCT03774901 RECRUITING Penile Cancer

NCT06467201 SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of KSHN001126 in Healthy Post-Menopausal Females https://clinicaltrials.gov/study/NCT06467201 NOT_YET_RECRUITING Healthy Postmenopausal Women DRUG: KSHN001126 150mg

NCT06653101 The Promotion Effect of Probiotics on Weight Loss in Overweight People https://clinicaltrials.gov/study/NCT06653101 RECRUITING Overweight or Obesity DIETARY_SUPPLEMENT: Probiotic

NCT06272201 Incisionless Suture Plications in a POSE2.0 Interventional Randomized Obesity Study https://clinicaltrials.gov/study/NCT06272201 NOT_YET_RECRUITING Obesity DEVICE: POSE2.0 procedure with g-Cath EZ Delivery Catheter with Snowshoe Suture Anchors USGI Medical

NCT06637501 A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia https://clinicaltrials.gov/study/NCT06637501 RECRUITING Chronic Lymphocytic Leukemia DRUG: Sonrotoclax

NCT05432401 TAA05 Injection in the Treatment of Adult Patients With FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT05432401 RECRUITING FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia BIOLOGICAL: T cell injection targeting FLT3 chimeric antigen receptor PersonGen BioTherapeutics (Suzhou) Co., Ltd.

NCT04634201 Effect of Probiotics on the Periodontal Status of Orthodontic Patients https://clinicaltrials.gov/study/NCT04634201 RECRUITING Periodontal Health

NCT06156267 Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino https://clinicaltrials.gov/study/NCT06156267 NOT_YET_RECRUITING Pancreatic Cancer DRUG: Adebrelimab

NCT06157567 Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System https://clinicaltrials.gov/study/NCT06157567 RECRUITING Skin Laxity

NCT02998567 Combination Study of Guadecitabine/ASTX727 and Pembrolizumab https://clinicaltrials.gov/study/NCT02998567 RECRUITING Castration-Resistant Prostatic Cancer

NCT06550167 Neuroprotective Effect of (Nano PSO), in Patients Who Used to Consume Psychoactive Substances https://clinicaltrials.gov/study/NCT06550167 RECRUITING Addiction;Drug(S);LSD

NCT06177067 Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06177067 RECRUITING Refractory Acute Myeloid Leukemia

NCT04936204 Clinical Investigation to Evaluate the Safety and Performance of ConnettivinaBio Plus Cream Compared to ConnettivinaBio Cream in the Management of Wounds in Patients at High Risk of Infection https://clinicaltrials.gov/study/NCT04936204 RECRUITING Wounds DEVICE: ConnettivinaBio Plus cream

NCT05772104 Randomized Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder https://clinicaltrials.gov/study/NCT05772104 NOT_YET_RECRUITING Generalized Anxiety Disorder DRUG: Shugan Jieyu Capsules

NCT06345404 Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD https://clinicaltrials.gov/study/NCT06345404 RECRUITING Atopic Dermatitis DRUG: Soquelitinib

NCT05703204 A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome https://clinicaltrials.gov/study/NCT05703204 NOT_YET_RECRUITING Acute Myeloid Leukemia and Myelodysplastic Syndrome DRUG: QLF32101 Qilu Pharmaceutical Co., Ltd.

NCT06610201 A Study of Bleeding and Treatment in Participants With Von Willebrand Disease https://clinicaltrials.gov/study/NCT06610201 RECRUITING Von Willebrand Disease (VWD)

NCT05795101 TRUDI: TDXD+Durva in HER2+/low IBC https://clinicaltrials.gov/study/NCT05795101 RECRUITING Invasive Breast Cancer

NCT06645301 BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies https://clinicaltrials.gov/study/NCT06645301 NOT_YET_RECRUITING Colorectal Cancer

NCT06430801 A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) https://clinicaltrials.gov/study/NCT06430801 RECRUITING Crohn's Disease DRUG: IV Tulisokibart

NCT05874401 Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan https://clinicaltrials.gov/study/NCT05874401 RECRUITING Extensive-stage Small-cell Lung Cancer DRUG: Trilaciclib

NCT06175767 A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease https://clinicaltrials.gov/study/NCT06175767 NOT_YET_RECRUITING Parkinson's Disease DRUG: MT101-5 Mthera Pharma Co., Ltd.

NCT06421467 Insulin Injection Practices in Spain https://clinicaltrials.gov/study/NCT06421467 NOT_YET_RECRUITING Diabetes Fundaci√≥n para la Investigaci√≥n del Hospital Cl√≠nico de Valencia Novo Nordisk A/S

NCT05170204 A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC) https://clinicaltrials.gov/study/NCT05170204 RECRUITING Non-Small Cell Lung Cancer DRUG: Alectinib

NCT05902104 CGM-Assisted Management of PN https://clinicaltrials.gov/study/NCT05902104 RECRUITING Intestinal Failure

NCT05201404 Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis https://clinicaltrials.gov/study/NCT05201404 RECRUITING Hepatocellular Carcinoma

NCT03212404 Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers https://clinicaltrials.gov/study/NCT03212404 RECRUITING Lung Neoplasms

NCT06111001 NHS Staff Digital Wellbeing Via AirEmail https://clinicaltrials.gov/study/NCT06111001 RECRUITING Communication Research

NCT05662501 Pleiades Safety and Feasibility Study https://clinicaltrials.gov/study/NCT05662501 RECRUITING Elective Cardiac Surgery DEVICE: Pleioflow-RF Pleioflow

NCT05714501 Millipede AspiRation for Revascularization in Stroke (MARRS) Study https://clinicaltrials.gov/study/NCT05714501 RECRUITING Acute Ischemic Stroke DEVICE: Millipede System Perfuze

NCT05618301 Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD) https://clinicaltrials.gov/study/NCT05618301 RECRUITING Sickle Cell Disease DRUG: Motixafortide

NCT06321601 Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV. https://clinicaltrials.gov/study/NCT06321601 RECRUITING Vasculitis DRUG: Avacopan Amgen

NCT05279001 A Safety and Tolerability Study of Jaktinib https://clinicaltrials.gov/study/NCT05279001 RECRUITING Myelofibrosis DRUG: Jaktinib Hydrochloride Tablet Suzhou Zelgen Biopharmaceuticals Co.,Ltd

NCT05526001 Efficacy and Safety of ELIXCYTE Intra-articular Injection in Subject With Knee Osteoarthritis https://clinicaltrials.gov/study/NCT05526001 RECRUITING Knee Osteoarthritis BIOLOGICAL: ELIXCYTE

NCT03073967 Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects https://clinicaltrials.gov/study/NCT03073967 RECRUITING HSV Infection DRUG: Pritelivir

NCT06448767 The Effect of a Multispecies Probiotics on Autism Symptoms and the Quality of Life in Children https://clinicaltrials.gov/study/NCT06448767 RECRUITING Autism Spectrum Disorder DIETARY_SUPPLEMENT: Multispecies probiotics

NCT04611867 Study of PRO in Patients with Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay) https://clinicaltrials.gov/study/NCT04611867 RECRUITING Pancreatic Cancer

NCT05937867 A Phase II Study of HS-10353 in Participants With Postpartum Depression https://clinicaltrials.gov/study/NCT05937867 NOT_YET_RECRUITING Postpartum Depression DRUG: HS-10353 Capsules 30 mg, Oral, QN for 14 days

NCT06333704 Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection. https://clinicaltrials.gov/study/NCT06333704 RECRUITING SARS-CoV-2 BIOLOGICAL: SPIKEVAX Bivalent

NCT04885101 Comparison of Conservative Treatment Options in the Management of Erectile Dysfunction https://clinicaltrials.gov/study/NCT04885101 RECRUITING Erectile Dysfunction PROCEDURE: LISWT Group

NCT06363201 Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours https://clinicaltrials.gov/study/NCT06363201 NOT_YET_RECRUITING Advanced Cancer

NCT06709001 An Observational Study to Assess Malnutrition Risk https://clinicaltrials.gov/study/NCT06709001 NOT_YET_RECRUITING Malnutrition Abbott Nutrition Children International

NCT06576401 A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects https://clinicaltrials.gov/study/NCT06576401 RECRUITING Healthy Adult Subject DRUG: [14C] HDM1002 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

NCT06073301 AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF https://clinicaltrials.gov/study/NCT06073301 RECRUITING Necrotizing Fasciitis DEVICE: Acellular Fish Skin Graft (AFS) with Standard of Care Negative Pressure Wound Therapy (NPWT)

NCT04627701 Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH https://clinicaltrials.gov/study/NCT04627701 RECRUITING Benign Prostatic Hyperplasia

NCT06049667 A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies https://clinicaltrials.gov/study/NCT06049667 RECRUITING Relapsed/Refractory Acute Myeloid Leukemia (AML) DRUG: NTQ2494 tablet Nanjing Chia-tai Tianqing Pharmaceutical

NCT06685367 The Cost-effectiveness of Artificial Intelligence Acute Kidney Injury Prediction Auxiliary Software (Acura AKI) https://clinicaltrials.gov/study/NCT06685367 RECRUITING Acute Kidney Injury

NCT05939167 Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage https://clinicaltrials.gov/study/NCT05939167 RECRUITING AIDS DRUG: mesenchymal stem cell

NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer https://clinicaltrials.gov/study/NCT05633667 RECRUITING Lung Cancer

NCT05597267 The MIRIA Acne Scar Study https://clinicaltrials.gov/study/NCT05597267 RECRUITING Acne Scars - Mixed Atrophic and Hypertrophic DEVICE: MIRIA Laser AVAVA, Inc.

NCT06615167 Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders https://clinicaltrials.gov/study/NCT06615167 RECRUITING Dementia

NCT06228001 Holter of Movement in Patients With Amyotrophic Lateral Sclerosis. https://clinicaltrials.gov/study/NCT06228001 RECRUITING Amyotrophic Lateral Sclerosis DEVICE: Actimyo Laurent Servais SYSNAV

NCT05791201 A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes https://clinicaltrials.gov/study/NCT05791201 RECRUITING Type 1 Diabetes DRUG: VX-264 Vertex Pharmaceuticals Incorporated

NCT03828201 Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB https://clinicaltrials.gov/study/NCT03828201 RECRUITING Tuberculosis, Multidrug-Resistant DRUG: Delamanid

NCT05174767 PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection https://clinicaltrials.gov/study/NCT05174767 RECRUITING Acute Aortic Dissection DEVICE: AMDS Artivion Inc. Syneos Health

NCT05241067 Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS https://clinicaltrials.gov/study/NCT05241067 NOT_YET_RECRUITING COVID-19 Acute Respiratory Distress Syndrome DRUG: Normal Saline

NCT06568367 Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) https://clinicaltrials.gov/study/NCT06568367 RECRUITING Excessive Sleepiness

NCT05837767 A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue https://clinicaltrials.gov/study/NCT05837767 RECRUITING Invasive Ductal Breast Carcinoma

NCT05520567 A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT05520567 RECRUITING Acute Myeloid Leukemia (AML)

NCT05246267 Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis https://clinicaltrials.gov/study/NCT05246267 RECRUITING Chronic Rhinosinusitis With Nasal Polyps BIOLOGICAL: Dupilumab Montefiore Medical Center Regeneron Pharmaceuticals

NCT05147467 Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL https://clinicaltrials.gov/study/NCT05147467 RECRUITING Chronic Lymphocytic Leukemia

NCT05957367 A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies https://clinicaltrials.gov/study/NCT05957367 RECRUITING GIST DRUG: DCC-3116

NCT06144840 INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP https://clinicaltrials.gov/study/NCT06144840 RECRUITING Erythropoietic Protoporphyria (EPP)

NCT05508867 A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008) https://clinicaltrials.gov/study/NCT05508867 RECRUITING Hodgkin Lymphoma BIOLOGICAL: favezelimab/pembrolizumab

NCT06082167 Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT06082167 RECRUITING Head and Neck Squamous Cell Carcinoma DRUG: Zanzalintinib

NCT06590467 Abbott Structural Heart Device Registry https://clinicaltrials.gov/study/NCT06590467 RECRUITING Heart Diseases

NCT05997667 Study on the Efficacy and Safety of Rechargeable Implantable DBS System in the Treatment of Parkinson's Disease https://clinicaltrials.gov/study/NCT05997667 RECRUITING Parkinson Disease DEVICE: Rechargeable implantable deep brain stimulation system

NCT06134167 A Study to Evaluate the Safety and Effectiveness Transdermal Compress Device in Participants with Transfemoral Amputations https://clinicaltrials.gov/study/NCT06134167 RECRUITING Prosthesis and Implants DEVICE: Transdermal Compress Device Balmoral Medical company

NCT06072040 Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia https://clinicaltrials.gov/study/NCT06072040 RECRUITING Microtia COMBINATION_PRODUCT: AUR-201 Auregen Biotherapeutics, SA

NCT05463601 Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer https://clinicaltrials.gov/study/NCT05463601 RECRUITING Metastatic Breast Cancer DRUG: Mecapegfilgrastim

NCT04961567 A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT04961567 RECRUITING Lupus Erythematosus, Systemic DRUG: Litifilimab

NCT06047067 Bioaerosol Sampling Device (BSD) Clinical Study https://clinicaltrials.gov/study/NCT06047067 RECRUITING COVID-19 Cantor BioConnect, Inc. 3M

NCT04580667 Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From Plasma https://clinicaltrials.gov/study/NCT04580667 RECRUITING Prostate Cancer OTHER: Collection of plasma samples DiaCarta, Inc.

NCT05442567 A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD) https://clinicaltrials.gov/study/NCT05442567 RECRUITING Ulcerative Colitis

NCT06082440 Study on the Safety and Tolerance of Mesenchymal Stem Cells Mediated by Arthroscopy in Patients With Osteoarthritis https://clinicaltrials.gov/study/NCT06082440 RECRUITING Osteoarthritis, Knee BIOLOGICAL: Human Umbilical Mesenchymal Stem Cells First Affiliated Hospital of Wannan Medical College

NCT05255601 A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT05255601 RECRUITING Lymphoma, Non-Hodgkin

NCT06108401 Effect Of a Goat Milk-Based Infant Formula On Gastrointestinal And Other Symptoms And Health-Related Quality Of Life. https://clinicaltrials.gov/study/NCT06108401 NOT_YET_RECRUITING Infant Nutrition Disorders

NCT06697301 Safety and Efficacy of EIK1001-006 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. https://clinicaltrials.gov/study/NCT06697301 NOT_YET_RECRUITING Advanced Melanoma DRUG: EIK1001

NCT06618001 A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms https://clinicaltrials.gov/study/NCT06618001 NOT_YET_RECRUITING Leukemia, Myeloid, Acute

NCT06045767 T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer https://clinicaltrials.gov/study/NCT06045767 NOT_YET_RECRUITING Non-small Cell Lung Cancer Metastatic DRUG: Pembrolizumab 50 MG Injection [Keytruda] Ari Raphael Bar-Ilan University, Israel

NCT03510767 A Study of TQ-B3525 on Tolerance and Pharmacokinetics https://clinicaltrials.gov/study/NCT03510767 RECRUITING Relapsed or Refractory Lymphoma or Advanced Cancer DRUG: TQ-B3525 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT05456867 A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in Russia https://clinicaltrials.gov/study/NCT05456867 RECRUITING NSCLC, Non-small-cell Lung Carcinoma AstraZeneca

NCT05654467 Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama https://clinicaltrials.gov/study/NCT05654467 RECRUITING Poliomyelitis BIOLOGICAL: Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)

NCT06322667 A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab https://clinicaltrials.gov/study/NCT06322667 RECRUITING Alzheimer's Disease OTHER: No Intervention Eisai Co., Ltd.

NCT04786067 Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression https://clinicaltrials.gov/study/NCT04786067 RECRUITING Kidney Transplant Immunosuppression DRUG: Belatacept University of Texas Southwestern Medical Center CareDx

NCT05833867 Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer https://clinicaltrials.gov/study/NCT05833867 RECRUITING Localized Muscle Invasive Bladder Urothelial Carcinoma

NCT05870267 Biomechanical Assessment of Load Applied on Residuum of Individuals With Limb Loss Fitted With a Prosthetic Limb https://clinicaltrials.gov/study/NCT05870267 RECRUITING Prosthesis User

NCT05785767 A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) https://clinicaltrials.gov/study/NCT05785767 RECRUITING Advanced Non-Small Cell Lung Cancer DRUG: fianlimab

NCT06440967 A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy https://clinicaltrials.gov/study/NCT06440967 RECRUITING Hot Flashes DRUG: Fezolinetant

NCT05963867 A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine Cancer https://clinicaltrials.gov/study/NCT05963867 RECRUITING Small Cell Lung Carcinoma (SCLC)

NCT05980767 Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial https://clinicaltrials.gov/study/NCT05980767 RECRUITING Neuropathy;Peripheral DEVICE: Temporary Peripheral Nerve Stimulation System Epineuron Technologies Inc. Federal Economic Development Agency for Southern Ontario (FedDev Ontario)

NCT05792410 A Phase ‚Ö†b/‚Ö° Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer. https://clinicaltrials.gov/study/NCT05792410 NOT_YET_RECRUITING HER2 Low Advanced or Metastatic Breast Cancer DRUG: SHR-A1811 & Dalpiciclib Isethionate Tablets

NCT06246110 A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC https://clinicaltrials.gov/study/NCT06246110 RECRUITING NSCLC DRUG: EIK1001

NCT05536310 TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease https://clinicaltrials.gov/study/NCT05536310 NOT_YET_RECRUITING Aortic Valve Stenosis

NCT05655910 Enhanced Nutritional Optimization in LVAD Trial https://clinicaltrials.gov/study/NCT05655910 RECRUITING Heart Failure

NCT06094010 A Surveillance Study of Susceptibility to Baloxavir Marboxil in Participants With Influenza https://clinicaltrials.gov/study/NCT06094010 RECRUITING Influenza DRUG: Baloxavir Marboxil Hoffmann-La Roche

NCT05954312 A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05954312 RECRUITING Advanced Solid Tumors DRUG: VVD-130037 Vividion Therapeutics, Inc.

NCT06471712 Clinical Study of 18F-LNC1007 Injection PET/CT https://clinicaltrials.gov/study/NCT06471712 NOT_YET_RECRUITING Healthy Volunteers

NCT05430412 CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis https://clinicaltrials.gov/study/NCT05430412 RECRUITING Ulcerative Colitis DEVICE: Adacolumn Adacyte Therapeutics SL Adknoma Health Research

NCT06473246 A Study to Determine Safety, Pharmakokinetics and Efficacy of the Different Doses of VL-SE-01 in Healthy Participants. https://clinicaltrials.gov/study/NCT06473246 NOT_YET_RECRUITING Healthy Population DIETARY_SUPPLEMENT: CBD Isolate (25 mg/0.5 ml)

NCT05660746 Precise Infliximab Exposure and Pharmacodynamic Control https://clinicaltrials.gov/study/NCT05660746 RECRUITING Crohn Disease DEVICE: RoadMAB

NCT05486546 Contoura With Phorcides Compared to Wavefront Optimized LASIK https://clinicaltrials.gov/study/NCT05486546 RECRUITING Myopia

NCT05930210 A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer https://clinicaltrials.gov/study/NCT05930210 RECRUITING Diabetic Foot Ulcer

NCT05475210 177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors https://clinicaltrials.gov/study/NCT05475210 RECRUITING Neuroendocrine Tumors DRUG: 177Lu-DOTA-EB-TATE

NCT06014710 Modelling of Pharyngeal Laryngeal Effectiveness https://clinicaltrials.gov/study/NCT06014710 RECRUITING Swallowing Disorders OTHER: Swallowing evaluation University Hospital, Toulouse National Research Agency, France

NCT03854110 Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine https://clinicaltrials.gov/study/NCT03854110 RECRUITING Pancreatic Cancer, Adult DRUG: GP-2250 Geistlich Pharma AG Translational Drug Development

NCT06126510 Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma https://clinicaltrials.gov/study/NCT06126510 RECRUITING Sarcoma DRUG: Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell) CNBG-Virogin Biotech (Shanghai) Ltd.

NCT06080412 Blueprint¬Æ Mixed Reality Pilot Study https://clinicaltrials.gov/study/NCT06080412 RECRUITING Orthopedic Disorder

NCT06393712 A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy https://clinicaltrials.gov/study/NCT06393712 RECRUITING Cerebral Amyloid Angiopathy DRUG: Placebo

NCT03791112 A Phase I Study of BPI-16350 in Patients With Advanced Solid Tumor https://clinicaltrials.gov/study/NCT03791112 RECRUITING Advanced Solid Cancer DRUG: BPI-16350 Betta Pharmaceuticals Co., Ltd.

NCT06324812 Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06324812 NOT_YET_RECRUITING Dermatitis, Atopic DRUG: Recombinant Anti-interleukin-4 Receptor Alpha Monoclonal Antibody Injection (611) Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

NCT06513312 Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP) https://clinicaltrials.gov/study/NCT06513312 RECRUITING Pre-Exposure Prophylaxis of HIV Infection DRUG: Lenacapavir Injection

NCT05369312 Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients https://clinicaltrials.gov/study/NCT05369312 NOT_YET_RECRUITING Solid Tumor

NCT06024746 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF) https://clinicaltrials.gov/study/NCT06024746 RECRUITING Heart Failure DRUG: Finerenone

NCT06062355 Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer https://clinicaltrials.gov/study/NCT06062355 NOT_YET_RECRUITING Prostate Cancer DRUG: HRS-9815 injection Jiangsu HengRui Medicine Co., Ltd.

NCT06650514 A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma https://clinicaltrials.gov/study/NCT06650514 NOT_YET_RECRUITING Osteosarcoma

NCT06186414 A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination With BCG in NMIBC https://clinicaltrials.gov/study/NCT06186414 RECRUITING Non-Muscle-Invasive Bladder Cancer (NMIBC) DRUG: SIM0237

NCT05793814 Assess the Effects of a Limosilactobacillus Supplement on Recurrence of UTI in Healthy Women During a 6-month Period https://clinicaltrials.gov/study/NCT05793814 RECRUITING Uncomplicated Symptomatic Urinary Tract Infections DIETARY_SUPPLEMENT: Limosilactobacillus reuteri 3613

NCT06159114 Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS https://clinicaltrials.gov/study/NCT06159114 NOT_YET_RECRUITING Chronic Prostatitis DRUG: Ningmitai capsule

NCT06367114 Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration) https://clinicaltrials.gov/study/NCT06367114 NOT_YET_RECRUITING Relapsed or Refractory Acute Lymphoblastic Leukemia BIOLOGICAL: ssCART-19

NCT06542614 Treatment of Moderate to Severe Plaque Psoriasis https://clinicaltrials.gov/study/NCT06542614 RECRUITING Plaque Psoriasis DRUG: TQH3906 capsules

NCT06051695 A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Participants with Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression https://clinicaltrials.gov/study/NCT06051695 RECRUITING Solid Tumor, Adult

NCT06162195 The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement https://clinicaltrials.gov/study/NCT06162195 NOT_YET_RECRUITING Osteoarthritis, Hip

NCT05257395 A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer https://clinicaltrials.gov/study/NCT05257395 NOT_YET_RECRUITING Advanced Breast Cancer DRUG: XZP-3287+ Letrozole/Anastrozole

NCT05469295 CETIC-I (CEra Traction Improves Cervical Kyphosis -I) https://clinicaltrials.gov/study/NCT05469295 NOT_YET_RECRUITING Cervical Kyphosis

NCT06057610 A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT06057610 NOT_YET_RECRUITING HER2-PositiveRecurrent or Metastatic Breast Cancer DRUG: SHR-A1811 Injection

NCT05797610 A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression https://clinicaltrials.gov/study/NCT05797610 RECRUITING Primary IgA Nephropathy DRUG: RO7434656

NCT06580210 Performance and Safety Assessment of the Mechanical Decongestant Seawater Spray Enriched with Essential Oils from Laboratoires Gilbert in Patient with Acute Rhinitis Associated with Nasal Obstruction https://clinicaltrials.gov/study/NCT06580210 NOT_YET_RECRUITING Acute Rhinitis

NCT05960110 Randomized Clinical Trial: Oral Health Package Law and Fluor Varnish Impact on Schoolchildren in Merida, Mexico https://clinicaltrials.gov/study/NCT05960110 RECRUITING Caries

NCT05541510 Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19 https://clinicaltrials.gov/study/NCT05541510 RECRUITING COVID-19 BIOLOGICAL: AD17002 + Formulation buffer

NCT06251310 SW-682 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06251310 RECRUITING Advanced Solid Tumor

NCT06283212 A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome https://clinicaltrials.gov/study/NCT06283212 RECRUITING Dravet Syndrome DRUG: ETX101 Encoded Therapeutics

NCT06340412 Effects of Intact and Disrupted Milk Fat Globule Membrane on Postprandial Metabolic Response to High-fat Dairy in Healthy Individuals https://clinicaltrials.gov/study/NCT06340412 RECRUITING Postprandial Lipid Metabolism DIETARY_SUPPLEMENT: Sandwich with butter-like dairy product (40g milk fat) with intact MFGM. One sandwich for breakfast and one sandwich for lunch.

NCT05360212 Anatomy-based Fitting in Cochear Implant Users https://clinicaltrials.gov/study/NCT05360212 RECRUITING Cochlear Implant

NCT05942612 A Phase I Study of SHR -2001 in Healthy Subjects https://clinicaltrials.gov/study/NCT05942612 RECRUITING Healthy DRUG: SHR-2001

NCT05427812 Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT05427812 RECRUITING Relapsed/Refractory Multiple Myeloma DRUG: ISB 1442 SC injection escalating doses

NCT06531512 Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers https://clinicaltrials.gov/study/NCT06531512 RECRUITING Diabetic Foot Ulcer DRUG: Xianglei Tangzu Gao

NCT05326412 Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD https://clinicaltrials.gov/study/NCT05326412 RECRUITING Chronic Obstructive Pulmonary Disease DRUG: Itepekimab SAR440340 Sanofi Regeneron Pharmaceuticals

NCT05890612 A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19 https://clinicaltrials.gov/study/NCT05890612 RECRUITING COVID-19 Pfizer

NCT05853146 Fetal Heart Rate Characterization Using Innovative Advanced Non-invasive Technology https://clinicaltrials.gov/study/NCT05853146 NOT_YET_RECRUITING Fetus Pulse Monitoring DEVICE: Oxitone 1000M Oxitone Medical Ltd.

NCT05910255 A Detailed Look At What Patients Experience When They Take Part In Hypertension Clinical Trials https://clinicaltrials.gov/study/NCT05910255 NOT_YET_RECRUITING Hypertension Power Life Sciences Inc.

NCT06596655 Single Use Bronchoscopes for Interventional Pulmonology https://clinicaltrials.gov/study/NCT06596655 NOT_YET_RECRUITING Bronchoscopic Interventions DEVICE: Single use bronchoscope Beth Israel Deaconess Medical Center Olympus

NCT06452355 Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage https://clinicaltrials.gov/study/NCT06452355 RECRUITING Postpartum Hemorrhage

NCT05648214 A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Non-Alcoholic Fatty Liver Disease (NAFLD) https://clinicaltrials.gov/study/NCT05648214 RECRUITING Healthy Volunteers

NCT05516914 A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors https://clinicaltrials.gov/study/NCT05516914 RECRUITING Malignant Tumors DRUG: LBL-007 Injection

NCT04603014 Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients https://clinicaltrials.gov/study/NCT04603014 RECRUITING End Stage Renal Disease on Dialysis

NCT06306014 Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients https://clinicaltrials.gov/study/NCT06306014 RECRUITING Clostridioides Difficile Infection

NCT06308614 Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women https://clinicaltrials.gov/study/NCT06308614 RECRUITING Sexual Dysfunction, Physiological DRUG: 20 mg estetrol monohydrate

NCT06324214 Oral Supplementation During PR Participation in COPD https://clinicaltrials.gov/study/NCT06324214 RECRUITING Copd DIETARY_SUPPLEMENT: Urolithin A (Mitopure)

NCT06361914 Digital CBT-I for Patients With Chronic Pain and Insomnia https://clinicaltrials.gov/study/NCT06361914 RECRUITING Chronic Pain

NCT05250414 Single-Sided Deafness in the Medicare Population https://clinicaltrials.gov/study/NCT05250414 RECRUITING Hearing Loss, Unilateral DEVICE: MED-EL Cochlear Implant System Med-El Corporation

NCT05822895 Review of the Impact of a Computer-aided Real-time Polyp Detection System on Adult Colonoscopy https://clinicaltrials.gov/study/NCT05822895 RECRUITING Colonic Polyp DEVICE: CADe enabled programme (GI Genius) Sengkang General Hospital Medtronic

NCT05630495 Validation of an Innovative Neonatal Jaundice Detection System (Picterus) in Indonesia https://clinicaltrials.gov/study/NCT05630495 RECRUITING Jaundice, Neonatal DEVICE: Picterus Jaundice Pro Picterus AS Airlangga University

NCT05566795 DAY101 Vs. Standard of Care Chemotherapy in Pediatric Patients with Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) https://clinicaltrials.gov/study/NCT05566795 RECRUITING Low-grade Glioma DRUG: Tovorafenib

NCT04309695 The Zenflow Spring System Safety and Performance Study (ZEST CAN) https://clinicaltrials.gov/study/NCT04309695 RECRUITING Benign Prostatic Hyperplasia DEVICE: Zenflow Spring System Zenflow, Inc.

NCT05802810 The Mass Balance Study of [14C]JT001 https://clinicaltrials.gov/study/NCT05802810 RECRUITING Healthy Subjects DRUG: [14C]JT001 Shanghai Vinnerna Biosciences Co., Ltd. Sponsor GmbH

NCT02975310 In-clinic Endoscopic Polypectomy for Chronic Sinusitis With Nasal Polyps https://clinicaltrials.gov/study/NCT02975310 RECRUITING Sinusitis

NCT04977310 TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading vs. Standard of Care https://clinicaltrials.gov/study/NCT04977310 NOT_YET_RECRUITING Heart Failure DEVICE: CardioMEMS STAVROS G DRAKOS Abbott

NCT05780710 Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake https://clinicaltrials.gov/study/NCT05780710 RECRUITING Hypertension OTHER: Aktiia Optical Blood Pressure Monitoring (OBPM) device and antihypertensive drugs (monotherapy and bitherapy)

NCT03591510 A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML https://clinicaltrials.gov/study/NCT03591510 RECRUITING FLT3-mutated Acute Myeloid Leukemia DRUG: Midostaurin

NCT06233110 Ruxolitinib Plus Fostamatinib for Steroid Refractory CGvHD https://clinicaltrials.gov/study/NCT06233110 NOT_YET_RECRUITING Chronic Graft Versus Host Disease DRUG: Fostamatinib

NCT06664710 Evaluation of the Automated Integration of a Robotics and ECochG System for Use with Cochlear Implant Surgery https://clinicaltrials.gov/study/NCT06664710 NOT_YET_RECRUITING Hearing Loss, Sensorineural

NCT05456412 JAK Inhibition in Ulcerative Colitis https://clinicaltrials.gov/study/NCT05456412 RECRUITING Colitis, Ulcerative OTHER: JAK inhibitor treatment Leiden University Medical Center Galapagos NV

NCT06422312 A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients. https://clinicaltrials.gov/study/NCT06422312 NOT_YET_RECRUITING Bladder Cancer

NCT05842512 Study of ADI-PEG 20 Versus Placebo in Subjects With NASH https://clinicaltrials.gov/study/NCT05842512 RECRUITING Nonalcoholic Steatohepatitis (NASH) DRUG: ADI-PEG20

NCT05877612 Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex Regional Pain Syndromes Type 1 of the Upper Limbs https://clinicaltrials.gov/study/NCT05877612 RECRUITING Complex Regional Pain Syndrome Type I DEVICE: Implantable spinal cord stimulator Elsan Abbott

NCT05266612 Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT05266612 RECRUITING Solid Tumor DRUG: VG2025

NCT06395012 A First-In-Human Study of LY3985297 in Healthy Participants https://clinicaltrials.gov/study/NCT06395012 RECRUITING Healthy DRUG: LY3985297

NCT04679012 Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation https://clinicaltrials.gov/study/NCT04679012 RECRUITING Richter Syndrome

NCT05885412 A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM) https://clinicaltrials.gov/study/NCT05885412 RECRUITING PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) GENETIC: RP-A601 Rocket Pharmaceuticals Inc.

NCT04581512 Study to Evaluate the Safety and Tolerability of EP0042 https://clinicaltrials.gov/study/NCT04581512 RECRUITING Acute Myeloid Leukemia

NCT05357612 Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases https://clinicaltrials.gov/study/NCT05357612 RECRUITING Neurodegenerative Diseases

NCT05845710 Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III) https://clinicaltrials.gov/study/NCT05845710 RECRUITING Carotid Stenosis

NCT06682910 Assessment of Safety and Accuracy of the Microtech System in Patients Undergoing Left Ventricular Assist Device Implantation https://clinicaltrials.gov/study/NCT06682910 NOT_YET_RECRUITING Heart Failure DEVICE: Microtech sensor pressure Microtech Medical Technologies, Ltd

NCT06606210 INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone https://clinicaltrials.gov/study/NCT06606210 RECRUITING Wound Heal

NCT06321510 A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer. https://clinicaltrials.gov/study/NCT06321510 RECRUITING Lung Cancer Pfizer

NCT05689710 The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis https://clinicaltrials.gov/study/NCT05689710 RECRUITING Metabolic Syndrome

NCT05102110 Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer. https://clinicaltrials.gov/study/NCT05102110 RECRUITING Non Small Cell Lung Cancer

NCT04697810 Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH) https://clinicaltrials.gov/study/NCT04697810 RECRUITING NASH - Nonalcoholic Steatohepatitis DRUG: Namodenoson

NCT06229210 Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia or Bipolar Disorder https://clinicaltrials.gov/study/NCT06229210 RECRUITING Schizophrenia

NCT06229912 A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes https://clinicaltrials.gov/study/NCT06229912 RECRUITING Leukemia

NCT02483312 A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML) https://clinicaltrials.gov/study/NCT02483312 RECRUITING Acute Myeloid Leukemia BIOLOGICAL: IL-12 University Health Network, Toronto Ozmosis Research Inc.

NCT05339412 Technology-based Training Tool for PHAT Life https://clinicaltrials.gov/study/NCT05339412 RECRUITING HIV Infection

NCT04994912 First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers https://clinicaltrials.gov/study/NCT04994912 RECRUITING Healthy DRUG: EI-001

NCT05479812 Dose Escalation Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05479812 RECRUITING Metastatic Solid Tumor

NCT05293912 SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma. https://clinicaltrials.gov/study/NCT05293912 RECRUITING Hematological Malignancy

NCT06305481 Glaucoma Evaluation With the P200TE https://clinicaltrials.gov/study/NCT06305481 RECRUITING Glaucoma DEVICE: P200TE Optos, PLC

NCT06299410 PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects https://clinicaltrials.gov/study/NCT06299410 RECRUITING Healthy Volunteers DRUG: ITI-1284 10 mg

NCT03739710 Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) https://clinicaltrials.gov/study/NCT03739710 RECRUITING Neoplasms DRUG: Docetaxel

NCT06549010 Perimetric Testing With Virtual Reality https://clinicaltrials.gov/study/NCT06549010 RECRUITING Glaucoma DIAGNOSTIC_TEST: Perimetric test Envision Health Technologies, Inc. Illinois College of Optometry

NCT06227910 A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease https://clinicaltrials.gov/study/NCT06227910 NOT_YET_RECRUITING Crohn's Disease DRUG: Vedolizumab

NCT05625412 A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05625412 RECRUITING Advanced Solid Tumors DRUG: BMS-986360

NCT05592912 Safety and Efficacy of HydroLenz for Vitrectomy-Induced Lens Opacities https://clinicaltrials.gov/study/NCT05592912 NOT_YET_RECRUITING Pars Plana Vitrectomy DRUG: HydroLenz Injection

NCT06692712 Phase 3, Open-label Study to Assess the Efficacy and Safety of a Single Lumbar Intrathecal Administration of MELPIDA in Individuals with Hereditary Spastic Paraplegia Type 50 (SPG50) Versus Matched Prospective Concurrent Controls. https://clinicaltrials.gov/study/NCT06692712 NOT_YET_RECRUITING Hereditary Spastic Paraplegia Type 50 GENETIC: MELPIDA Elpida Therapeutics SPC

NCT05737212 Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas https://clinicaltrials.gov/study/NCT05737212 RECRUITING Recurrent High-grade Glioma

NCT04763512 Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL) https://clinicaltrials.gov/study/NCT04763512 RECRUITING Atopic Dermatitis

NCT05784012 Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT05784012 RECRUITING Head and Neck Squamous Cell Carcinoma DRUG: Dostarlimab

NCT05451212 Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis https://clinicaltrials.gov/study/NCT05451212 RECRUITING MuSK Myasthenia Gravis BIOLOGICAL: MuSK-CAART Cabaletta Bio

NCT05048212 A Phase II Study of Nivolumab with Ipilimumab and Cabozantinib in Patients with Untreated Renal Cell Carcinoma Brain Metastases https://clinicaltrials.gov/study/NCT05048212 RECRUITING Brain Metastases

NCT06101914 Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients https://clinicaltrials.gov/study/NCT06101914 NOT_YET_RECRUITING Treatment Resistant Depression Power Life Sciences Inc.

NCT05561114 Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus https://clinicaltrials.gov/study/NCT05561114 RECRUITING Esophageal Stricture COMBINATION_PRODUCT: GIE Medical ProTractX3 TTS DCB

NCT05827614 Study of the CHK1 Inhibitor BBI-355, an EcDNA-directed Therapy (ecDTx), in Subjects with Tumors with Oncogene Amplifications https://clinicaltrials.gov/study/NCT05827614 RECRUITING Non-small Cell Lung Cancer

NCT05709314 A Study of AMDX-2011P in Participants With CAA https://clinicaltrials.gov/study/NCT05709314 RECRUITING Cerebral Amyloid Angiopathy DRUG: AMDX-2011P Amydis Inc. National Institutes of Health (NIH)

NCT06539195 DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9) https://clinicaltrials.gov/study/NCT06539195 RECRUITING Diffuse Large B Cell Lymphoma DRUG: DZD8586

NCT03205995 Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome https://clinicaltrials.gov/study/NCT03205995 RECRUITING Thrombotic Microangiopathies

NCT04801095 A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04801095 RECRUITING Advanced Solid Tumor

NCT06285695 Clareon Toric Study (T2-T9) https://clinicaltrials.gov/study/NCT06285695 RECRUITING Aphakia

NCT04494295 The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation https://clinicaltrials.gov/study/NCT04494295 RECRUITING Supratentorial Hemorrhage DEVICE: Aurora Surgiscope System Integra LifeSciences Corporation Icahn School of Medicine at Mount Sinai

NCT06555081 A Study to Evaluate the Bioequivalence of Ruxolitinib Extended Release (XR) Tablets With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants https://clinicaltrials.gov/study/NCT06555081 RECRUITING Healthy Participants DRUG: Ruxolitinib IR

NCT04541810 A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis https://clinicaltrials.gov/study/NCT04541810 RECRUITING Rheumatoid Arthritis (RA)

NCT04794010 A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT04794010 RECRUITING Carcinoma, Non-Small-Cell Lung Bristol-Myers Squibb

NCT06672510 Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE) https://clinicaltrials.gov/study/NCT06672510 NOT_YET_RECRUITING Pulmonary Embolism Acute DEVICE: ATC Akura Medical

NCT06075810 A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer https://clinicaltrials.gov/study/NCT06075810 RECRUITING Breast Cancer

NCT06009510 Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer https://clinicaltrials.gov/study/NCT06009510 NOT_YET_RECRUITING Bladder Cancer Power Life Sciences Inc.

NCT06530810 Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML) https://clinicaltrials.gov/study/NCT06530810 NOT_YET_RECRUITING Chronic Myelogenous Leukemia

NCT04004312 Single Fractions SBRT for Prostate Cancer https://clinicaltrials.gov/study/NCT04004312 RECRUITING Prostate Cancer RADIATION: Stereotactic Body Radiation Therapy (SBRT) Fabio Cury Boston Scientific Corporation

NCT06681012 Gelsectan¬Æ in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome https://clinicaltrials.gov/study/NCT06681012 RECRUITING Irritable Bowel Syndrome (IBS)

NCT06103812 Evaluate Performance and Safety of Hyalo4 Skin in Acute and Chronic Wounds https://clinicaltrials.gov/study/NCT06103812 RECRUITING Wound Heal DEVICE: Hyalo4 Skin Gel Fidia Farmaceutici s.p.a.

NCT04807712 Pediatric Pertussis in Ambulatory Settings https://clinicaltrials.gov/study/NCT04807712 RECRUITING Pertussis/Whooping Cough

NCT05283512 Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease https://clinicaltrials.gov/study/NCT05283512 RECRUITING Contrast-induced Nephropathy

NCT05898412 Retrospective Study on Characteristics and Outcomes in Hospitalised Patients Treated With Ondexxya https://clinicaltrials.gov/study/NCT05898412 RECRUITING Hemorrhage DRUG: Andexanet alfa AstraZeneca LOGEX Healthcare Analytics Amsterdam The Netherlands

NCT05669612 Promephy - Metabolic Fate of Plant-based Proteins https://clinicaltrials.gov/study/NCT05669612 RECRUITING Amino Acid Change

NCT06265012 Study to Evaluate the Recombinant Vesicular Stomatitis Virus (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects https://clinicaltrials.gov/study/NCT06265012 RECRUITING Marburg Virus Disease BIOLOGICAL: PHV01

NCT04928612 A Study of CBP-1018 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04928612 RECRUITING Solid Tumor DRUG: CBP-1018 Coherent Biopharma (Suzhou) Co., Ltd.

NCT04005469 Safety and Efficacy of Treprostinil (Remodulin¬Æ) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation https://clinicaltrials.gov/study/NCT04005469 RECRUITING Ischemia Reperfusion Injury

NCT06687369 A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda¬Æ in Non-small Cell Lung Cancer (BENITO Study) https://clinicaltrials.gov/study/NCT06687369 NOT_YET_RECRUITING Non Squamous Non Small Cell Lung Cancer DRUG: MB12 (Proposed Pembrolizumab Biosimilar)

NCT06084169 Investigation for Assessing the Visual Performance of Hanita Lenses Intensity SL IOL in Comparison to Alcon Panoptix IOL https://clinicaltrials.gov/study/NCT06084169 RECRUITING Cataract DEVICE: Intra Ocular Lens (IOL) Implant Hanita Lenses

NCT06447168 A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment https://clinicaltrials.gov/study/NCT06447168 RECRUITING Primary Biliary Cholangitis Ipsen

NCT05702268 Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT05702268 RECRUITING Moderate to Severe Atopic Dermatitis DRUG: ICP-332

NCT04532268 A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL https://clinicaltrials.gov/study/NCT04532268 RECRUITING Acute Lymphoblastic Leukemia

NCT02977468 Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer https://clinicaltrials.gov/study/NCT02977468 RECRUITING Triple Negative Breast Cancer DRUG: Merck 3475 Pembrolizumab

NCT02168868 Proteomic Biomarker Tests in Blood Samples from Children with Autism Spectrum Disorder (ASD) https://clinicaltrials.gov/study/NCT02168868 RECRUITING Autistic Disorder DIAGNOSTIC_TEST: Blood draw

NCT06648668 A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Cocaine Use Disorder https://clinicaltrials.gov/study/NCT06648668 NOT_YET_RECRUITING Cocaine Use Disorder DRUG: TMP-301

NCT05580172 Phase 1 Study of Oral RH324 in Advanced Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05580172 RECRUITING Safety Issues DRUG: RH324 ReHeva Biosciences,Inc.

NCT05862272 A Phase 3B Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Women with Uterine Fibroids or Endometriosis https://clinicaltrials.gov/study/NCT05862272 RECRUITING Uterine Fibroids

NCT03860272 Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer https://clinicaltrials.gov/study/NCT03860272 RECRUITING Advanced Cancer

NCT03934372 Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors https://clinicaltrials.gov/study/NCT03934372 RECRUITING Acute Myeloid Leukemia

NCT06445972 Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06) https://clinicaltrials.gov/study/NCT06445972 RECRUITING Gastroesophageal Junction

NCT06525272 A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of OsrhCT in Patients With Pleurisy https://clinicaltrials.gov/study/NCT06525272 NOT_YET_RECRUITING Pleurisy DRUG: Recombinant Human Chymotrypsin(OsrhCT)

NCT05675072 Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19 https://clinicaltrials.gov/study/NCT05675072 RECRUITING Mild to Moderate COVID-19 DRUG: FB2001

NCT02332369 EyeKon Medical Inc. Capsular Tension Ring Study https://clinicaltrials.gov/study/NCT02332369 RECRUITING Cataract Extraction DEVICE: Capsular Tension Ring EyeKon Medical, Inc.

NCT06340269 Feasibility Pilot Study to Evaluate the Safety and Performance of the MEX-CD1 Medical Device in ACLF https://clinicaltrials.gov/study/NCT06340269 RECRUITING Acute on Chronic Liver Failure

NCT06128369 Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery https://clinicaltrials.gov/study/NCT06128369 RECRUITING Inflammation Eye

NCT06717269 Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets https://clinicaltrials.gov/study/NCT06717269 RECRUITING Healthy Volunteer DRUG: NX-5948 capsule

NCT06179069 A Study of ZL-1310 in Subjects With Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT06179069 RECRUITING SCLC DRUG: ZL-1310

NCT06446869 Menopausal Symptoms Probiotic Study https://clinicaltrials.gov/study/NCT06446869 NOT_YET_RECRUITING Menopause DIETARY_SUPPLEMENT: Gyntima Menopause

NCT05333068 COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events https://clinicaltrials.gov/study/NCT05333068 RECRUITING Multivessel Coronary Artery Disease

NCT06566768 Study to Evaluate Drug Levels of Various Solid Gastro-retentive Formulations of Deucravacitinib (BMS-986165) in Healthy Participants https://clinicaltrials.gov/study/NCT06566768 RECRUITING Healthy Participants DRUG: Deucravacitinib Bristol-Myers Squibb

NCT05027568 A Study to Assess an ATX Inhibitor (IOA-289) in Healthy Volunteers https://clinicaltrials.gov/study/NCT05027568 RECRUITING Healthy DRUG: IOA-289

NCT06613568 Moda-flx Hemodialysis System‚Ñ¢ Under Professional Care Settings by Trained Individuals and At Home by Participants https://clinicaltrials.gov/study/NCT06613568 NOT_YET_RECRUITING End Stage Kidney Disease DEVICE: Moda-flx Hemodialysis System‚Ñ¢ Diality Inc.

NCT06301568 Retrospective Analysis of Long-term Speech Performance in Cochlear Implant Recipients Using Electro-acoustic Stimulation https://clinicaltrials.gov/study/NCT06301568 RECRUITING Cochlear Hearing Loss Advanced Bionics AG

NCT03721068 Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma https://clinicaltrials.gov/study/NCT03721068 RECRUITING Neuroblastoma

NCT05491668 Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI https://clinicaltrials.gov/study/NCT05491668 RECRUITING Coronary Artery Disease DIAGNOSTIC_TEST: Non-hyperemic pressure ratio assessment pre and post PCI Beth Israel Deaconess Medical Center Opsens, Inc.

NCT05148572 Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT05148572 RECRUITING Hepatocellular Carcinoma National Cancer Centre, Singapore Duke-NUS Graduate Medical School

NCT05160272 Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients With Type 2 Diabetes https://clinicaltrials.gov/study/NCT05160272 RECRUITING Type2 Diabetes DRUG: AP-325

NCT03263572 Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia https://clinicaltrials.gov/study/NCT03263572 RECRUITING Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

NCT06093672 Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera https://clinicaltrials.gov/study/NCT06093672 RECRUITING Polycythemia Vera DRUG: Givinostat

NCT05467072 PMCFU of an Annular Closure System https://clinicaltrials.gov/study/NCT05467072 RECRUITING Lumbar Disc Herniation DEVICE: Annular closure Intrinsic Therapeutics

NCT06254469 Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease https://clinicaltrials.gov/study/NCT06254469 NOT_YET_RECRUITING Alzheimer Disease

NCT03571568 A Study of BI-1206 in Combination With Rituximab in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT03571568 RECRUITING Indolent B-Cell Non-Hodgkin Lymphoma BIOLOGICAL: BI-1206 BioInvent International AB

NCT06376968 Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis https://clinicaltrials.gov/study/NCT06376968 RECRUITING Renal Dialysis DEVICE: BioLogic Fusion B.Braun Avitum AG

NCT06525168 Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414 https://clinicaltrials.gov/study/NCT06525168 RECRUITING Ischemic Stroke DRUG: DA414 Granules

NCT05838768 Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. https://clinicaltrials.gov/study/NCT05838768 RECRUITING MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers DRUG: HRO761

NCT05892068 A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain https://clinicaltrials.gov/study/NCT05892068 RECRUITING Metastatic Breast Cancer DRUG: Tucatinib Memorial Sloan Kettering Cancer Center Pfizer

NCT06438172 A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients With Essential Hypertension https://clinicaltrials.gov/study/NCT06438172 RECRUITING Hypertension DRUG: HCP1803-3

NCT05047172 Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis https://clinicaltrials.gov/study/NCT05047172 RECRUITING Intracranial Arteriosclerosis

NCT03803969 ConfirmRxTM: Posture and Activity https://clinicaltrials.gov/study/NCT03803969 RECRUITING Syncope

NCT05048069 Post-Marketing Surveillance of Safety and Effectiveness of Mucosta¬ÆSR Tab. https://clinicaltrials.gov/study/NCT05048069 RECRUITING Acute Gastritis

NCT03562169 The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd) https://clinicaltrials.gov/study/NCT03562169 RECRUITING Multiple Myeloma DRUG: Ixazomib, thalidomide, & dexamethasone (ITD) re-induction

NCT02208869 Russian Familial Hypercholesterolemia Registry https://clinicaltrials.gov/study/NCT02208869 RECRUITING Familial Hypercholesterolemia Russian Cardiology Research and Production Center Pfizer

NCT03957369 Primary Resistance in HIV Patients in Colombia https://clinicaltrials.gov/study/NCT03957369 RECRUITING HIV Infection DIAGNOSTIC_TEST: HIV-1 plasma RNA Genotyping secuencing by Sanger technique

NCT06052969 Pulse Endovascular ReperFUSION for Acute Ischemic Stroke https://clinicaltrials.gov/study/NCT06052969 RECRUITING Acute Ischemic Stroke AIS

NCT04541368 A Study of CS1-targeted CAR-T Cells Therapy for Relapsed Multiple Myeloma After BCMA CAR-T Cells Therapy https://clinicaltrials.gov/study/NCT04541368 NOT_YET_RECRUITING Relapse Multiple Myeloma DRUG: CS1 Targeted CAR T-cells Zhejiang University Yake Biotechnology Ltd.

NCT05483868 A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer https://clinicaltrials.gov/study/NCT05483868 RECRUITING Non-muscle-invasive Bladder Cancer

NCT06657768 A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) https://clinicaltrials.gov/study/NCT06657768 RECRUITING Alzheimer Disease

NCT06553768 Evaluation of Maralixibat in Pruritus Associated with General Cholestatic Liver Disease (EXPAND) https://clinicaltrials.gov/study/NCT06553768 RECRUITING Cholestatic Liver Disease (except ALGS, PFIC, PBC and PSC) DRUG: Maralixibat

NCT03611868 A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors https://clinicaltrials.gov/study/NCT03611868 RECRUITING Unresectable or Metastatic Melanoma or Advanced Solid Tumors

NCT02934568 Ribociclib (LEE011) Rollover Study for Continued Access https://clinicaltrials.gov/study/NCT02934568 RECRUITING Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies DRUG: LEE011 Novartis Pharmaceuticals

NCT05429268 Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND) https://clinicaltrials.gov/study/NCT05429268 RECRUITING Large B-Cell Lymphoma

NCT06594068 Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users https://clinicaltrials.gov/study/NCT06594068 RECRUITING Systemic Lupus Erythematosus DRUG: Anifrolumab AstraZeneca PPD DEVELOPMENT, LP

NCT06057168 Performance of Elucirem¬Æ in DSC-MRI Perfusion of Brain Gliomas https://clinicaltrials.gov/study/NCT06057168 RECRUITING Brain Tumor, Primary

NCT04434768 Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke https://clinicaltrials.gov/study/NCT04434768 RECRUITING Acute Stroke BIOLOGICAL: UMSC01 Ever Supreme Bio Technology Co., Ltd.

NCT03527472 Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT03527472 RECRUITING Lupus Erythematosus, Systemic DRUG: Memantine

NCT06210672 Natural History Study in Patients With LGMDR5/2c https://clinicaltrials.gov/study/NCT06210672 NOT_YET_RECRUITING Gamma-sarcoglycanopathy Atamyo Therapeutics

NCT06182072 ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC) https://clinicaltrials.gov/study/NCT06182072 RECRUITING Pancreatic Ductal Carcinoma DRUG: ProAgio Dose Levels (DL) 1,2,3,4

NCT06564272 A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma https://clinicaltrials.gov/study/NCT06564272 RECRUITING Ewing Sarcoma DRUG: KC1036 Beijing Konruns Pharmaceutical Co., Ltd.

NCT06569472 Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis https://clinicaltrials.gov/study/NCT06569472 RECRUITING Juvenile Dermatomyositis BIOLOGICAL: CD19-targetd CAR-T Chongqing Precision Biotech Co., Ltd

NCT06142669 EVOLUTION¬Æ Revision STEMMED CS Post Market Clinical Follow-up Study Protocol https://clinicaltrials.gov/study/NCT06142669 RECRUITING Joint Diseases DEVICE: EVOLUTION¬Æ Revision Tibial System and EVOLUTION¬Æ Stemmed CS Femur with the EVOLUTION¬Æ MP CS Tibial Insert MicroPort Orthopedics Inc.

NCT06570369 A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression https://clinicaltrials.gov/study/NCT06570369 RECRUITING Major Depressive Disorder

NCT05204368 Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40) https://clinicaltrials.gov/study/NCT05204368 NOT_YET_RECRUITING Complicated Urinary Tract Infection Including Acute Pyelonephritis DRUG: Combination of Imipenem/Cilastatin and XNW4107

NCT02710968 Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH) https://clinicaltrials.gov/study/NCT02710968 RECRUITING Congenital Diaphragmatic Hernia DEVICE: 11540KE and Balt Goldbal 2 balloon Johns Hopkins University KARL STORZ Endoscopy-America, Inc.

NCT05552768 Supracrestal Tissue Attachment Dimensions & Peri-implant Health https://clinicaltrials.gov/study/NCT05552768 RECRUITING Dental Implant Placement PROCEDURE: Bone level-driven placement

NCT06427668 Study of SPG302 in Adult Participants With Mild-to-Moderate Alzheimer's Disease (AD) https://clinicaltrials.gov/study/NCT06427668 RECRUITING Alzheimer Disease DRUG: SPG302

NCT03953768 VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems https://clinicaltrials.gov/study/NCT03953768 RECRUITING Autoimmune Diseases

NCT04465968 Efficacy and Safety of CRT, Durvalumab and Surgery for SST https://clinicaltrials.gov/study/NCT04465968 NOT_YET_RECRUITING Superior Sulcus Tumor

NCT05875168 First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05875168 RECRUITING Advanced Solid Tumor

NCT06596668 Drug-Drug Interaction Study of Bomedemstat and Carbamazepine in Healthy Adult Participants (MK-3543-020) https://clinicaltrials.gov/study/NCT06596668 RECRUITING Healthy DRUG: bomedemstat

NCT06439368 Effect of Dezocine Combined With Sufentanil on the Quality of Postoperative Recovery and Analgesic Effect in Patients Undergoing Thoracic Surgery https://clinicaltrials.gov/study/NCT06439368 RECRUITING Rehabilitation

NCT05066672 Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression https://clinicaltrials.gov/study/NCT05066672 RECRUITING Treatment Resistant Depression DRUG: NV-5138

NCT06716372 A Clinical Trial to Evaluate the Vision Correction Safety and Efficacy of DSiHy Silicone Hydrogel Soft Contact Lens https://clinicaltrials.gov/study/NCT06716372 RECRUITING Myopia

NCT06593769 Glycemic and Appetite Effects of a Pre-meal Whey-Protein Microgel https://clinicaltrials.gov/study/NCT06593769 NOT_YET_RECRUITING Glucose Metabolism

NCT05345769 Safety and Efficacy of AM712 in Patients With nAMD https://clinicaltrials.gov/study/NCT05345769 RECRUITING Neovascular Age-related Macular Degeneration BIOLOGICAL: AM712(ASKG712) AffaMed Therapeutics (US) Inc.

NCT06505369 Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients https://clinicaltrials.gov/study/NCT06505369 RECRUITING Multiple Myeloma DRUG: Daratumumab

NCT06388668 Lipid Testing After Myocardial Infarction at the Montreal Heart Institute https://clinicaltrials.gov/study/NCT06388668 NOT_YET_RECRUITING Dyslipidemias

NCT05624268 Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD https://clinicaltrials.gov/study/NCT05624268 RECRUITING Treatment Resistant Depression DRUG: Psilocybin COMPASS Pathways

NCT06482268 Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II) https://clinicaltrials.gov/study/NCT06482268 RECRUITING PD - Parkinson's Disease COMBINATION_PRODUCT: Human induced pluripotent stem cell-derived dopaminergic progenitors (CT1-DAP001) University of California, San Diego Sumitomo Pharma America, Inc.

NCT06347068 Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells https://clinicaltrials.gov/study/NCT06347068 RECRUITING Breast Cancer

NCT05270668 Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) https://clinicaltrials.gov/study/NCT05270668 RECRUITING Diffuse Cutaneous Systemic Sclerosis

NCT03142568 Safety of Sildenafil in Premature Infants https://clinicaltrials.gov/study/NCT03142568 RECRUITING Bronchopulmonary Dysplasia DRUG: Sildenafil

NCT06089668 An Observational Study to Evaluate Clinical Characteristics of Adult Patients With Suspected or Confirmed Melioidosis https://clinicaltrials.gov/study/NCT06089668 RECRUITING Melioidosis OTHER: Observational Study AN2 Therapeutics, Inc Mahidol Oxford Tropical Medicine Research Unit

NCT05907668 A Proof-of-Concept Study to Assess Batoclimab in Participants With Graves' Disease https://clinicaltrials.gov/study/NCT05907668 RECRUITING Graves Disease DRUG: IMVT-1401 (batoclimab) Immunovant Sciences GmbH

NCT06195072 Platform Clinical Study for Conquering Scleroderma https://clinicaltrials.gov/study/NCT06195072 RECRUITING Interstitial Lung Disease Due to Systemic Disease

NCT05820672 A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA https://clinicaltrials.gov/study/NCT05820672 RECRUITING Growth Hormone Deficiency OTHER: No intervention Ascendis Pharma Endocrinology Division A/S

NCT06245772 CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity https://clinicaltrials.gov/study/NCT06245772 RECRUITING Upper Limb Injury Ipsen

NCT06310772 Assessing Comorbidities in Epilepsy Using Eye Movement Recordings https://clinicaltrials.gov/study/NCT06310772 RECRUITING Childhood Absence Epilepsy

NCT06691672 Feasibility Study of Dialysis Clinic Semi-Autonomous Ultrasound Scanning Using the Vexev Ultrasound Imaging System for Arteriovenous Fistula Mapping Examinations. the CANSCAN Trial. https://clinicaltrials.gov/study/NCT06691672 RECRUITING Feasibility Assessment of the VxWave Device for Vascular Access Imaging DIAGNOSTIC_TEST: Robotic Tomographic ultrasound imaging of the arm vasculature. Vexev Pty Ltd USRC Kidney Research

NCT03152669 The Extended Salford Lung Study ("Ex-SLS") Data Access Project https://clinicaltrials.gov/study/NCT03152669 RECRUITING Asthma GlaxoSmithKline

NCT06660069 A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation https://clinicaltrials.gov/study/NCT06660069 RECRUITING Dental Plaque

NCT06462469 Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease https://clinicaltrials.gov/study/NCT06462469 RECRUITING Steroid-refractory Acute Graft Versus Host Disease DRUG: Ruxolitinib Novartis Pharmaceuticals

NCT04065269 ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss https://clinicaltrials.gov/study/NCT04065269 RECRUITING Gynaecological Cancers DRUG: Ceralasertib

NCT05914168 Clinical Data Collection in Breast Tomosynthesis (COBRIS) https://clinicaltrials.gov/study/NCT05914168 RECRUITING Breast Cancer DEVICE: Breast Tomosynthesis GE Healthcare

NCT04768868 The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04768868 RECRUITING Advanced Solid Tumors DRUG: IMP7068 Impact Therapeutics, Inc. Covance

NCT05886868 Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05886868 RECRUITING Advanced Solid Tumor DRUG: BL0020 Shanghai Best-Link Bioscience, LLC

NCT06191068 Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia https://clinicaltrials.gov/study/NCT06191068 NOT_YET_RECRUITING Hemophilia The Hospital for Sick Children Roche Pharma AG

NCT04644068 Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies https://clinicaltrials.gov/study/NCT04644068 RECRUITING Ovarian Cancer

NCT03890068 Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma https://clinicaltrials.gov/study/NCT03890068 RECRUITING Soft Tissue Sarcoma DRUG: Anlotinib Hydrochloride Sun Yat-sen University Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT06496568 A Study Evaluating Single-agent Inavolisib and Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers https://clinicaltrials.gov/study/NCT06496568 RECRUITING PIK3CA-Mutated Cancers DRUG: Inavolisib

NCT05149768 Open Label Extension Study of Brentuximab Vedotin in Early dcSSc https://clinicaltrials.gov/study/NCT05149768 RECRUITING Diffuse Cutaneous Systemic Sclerosis DRUG: Brentuximab vedotin Lawson Health Research Institute Seattle Genetics (now a wholly owned subsidiary of Pfizer)

NCT04680468 Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma https://clinicaltrials.gov/study/NCT04680468 RECRUITING Myeloma DRUG: Belantamab mafodotin University of Pennsylvania GlaxoSmithKline

NCT04892472 EF-36/Keynote B36: A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT04892472 RECRUITING Non-small Cell Lung Cancer DEVICE: NovoTTF-200T

NCT06459869 NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer https://clinicaltrials.gov/study/NCT06459869 NOT_YET_RECRUITING Locally Advanced Rectal Cancer (LARC) DRUG: NG-350A IV administration

NCT05129969 Registry Platform Ovarian and Endometrial Cancer https://clinicaltrials.gov/study/NCT05129969 RECRUITING Ovarian Cancer

NCT05482568 A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05482568 RECRUITING Advanced Non-small Cell Lung Cancer DRUG: SHR-A1811 & Pyrotinib/SHR-A1811 & SHR-1316 Jiangsu HengRui Medicine Co., Ltd.

NCT03315468 French Clinical Datbase of Melanoma Patients (RIC-Mel) https://clinicaltrials.gov/study/NCT03315468 RECRUITING Melanoma (Skin) Nantes University Hospital CENGEPS

NCT06241768 Feasibility of a Colorectal Cancer Screening Web App in Primary Care Patients https://clinicaltrials.gov/study/NCT06241768 NOT_YET_RECRUITING Colorectal Cancer Screening OTHER: mPATH-CRC Web app Digital Health Navigation Solutions, Inc Wake Forest University Health Sciences

NCT05652868 Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05652868 RECRUITING NSCLC

NCT05539768 Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor https://clinicaltrials.gov/study/NCT05539768 NOT_YET_RECRUITING Advanced Solid Tumor BIOLOGICAL: HS-IT101 The Affiliated Hospital of Qingdao University Qingdao Sino-Cell Biomedicine Co., Ltd.

NCT04681768 Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients https://clinicaltrials.gov/study/NCT04681768 RECRUITING Breast Cancer/ Metastatic Breast Cancer DRUG: Abemaciclib Technical University of Munich Eli Lilly and Company

NCT03965468 Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC https://clinicaltrials.gov/study/NCT03965468 RECRUITING Non-small Cell Lung Cancer

NCT06340568 A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients with Recurring Uterine Cancer https://clinicaltrials.gov/study/NCT06340568 NOT_YET_RECRUITING Endometrial Cancer DRUG: BNT323/DB-1303

NCT06045468 Early Rehabilitation After Transfemoral Amputation in Moderately Active Patients https://clinicaltrials.gov/study/NCT06045468 RECRUITING Transfemoral Amputation OTHER: Amputation-specialized rehabilitation

NCT06448572 EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy. https://clinicaltrials.gov/study/NCT06448572 RECRUITING Non-Small Cell Lung Cancer DRUG: EXL01 University Hospital, Lille Exeliom Biosciences

NCT05757869 A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation https://clinicaltrials.gov/study/NCT05757869 RECRUITING Atrial Fibrillation DRUG: Milvexian

NCT06422169 Interventistic Clinical Investigation on the Use of Medical Device in Subjects With Mild-moderate Osteoarticular Pain https://clinicaltrials.gov/study/NCT06422169 RECRUITING Osteoarthritis, Knee DEVICE: ArToFILL PromoPharma spa

NCT05657769 Preventive Care System Application Effectiveness Study on the Treatment of Diabetic Patients in Bandung https://clinicaltrials.gov/study/NCT05657769 RECRUITING Diabetes Mellitus, Type 2 DEVICE: Medwell Preventive Care Application

NCT05574868 Rigicon Infla10¬Æ Three-Piece Inflatable Penile Prosthesis (ERASE ED) https://clinicaltrials.gov/study/NCT05574868 RECRUITING Erectile Dysfunction DEVICE: Rigicon Infla 10¬Æ Three-Piece Inflatable Penile Prosthesis Rigicon, Inc.

NCT06686368 Comparative Efficacy Study to Demonstrate the Non-inferiority of I-DROP¬Æ MGD Versus 2 Competitor Eye Drops in Managing Evaporative Dry Eye https://clinicaltrials.gov/study/NCT06686368 NOT_YET_RECRUITING Evaporative Dry Eye Disease DEVICE: I-DROP MGD

NCT04984668 A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors https://clinicaltrials.gov/study/NCT04984668 RECRUITING Solid Tumor DRUG: GT90001+KN046

NCT06661668 Laparoscopic Implantation of a Gastric Pacemaker in the Treatment of Gastroparesis https://clinicaltrials.gov/study/NCT06661668 RECRUITING Gastroparesis

NCT05841472 Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05841472 RECRUITING Non Squamous Non Small Cell Lung Cancer DRUG: Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin CrystalGenomics, Inc.

NCT06477172 Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures https://clinicaltrials.gov/study/NCT06477172 RECRUITING Post Procedural Erythema Acorn Biolabs Inc.

NCT04666272 Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection https://clinicaltrials.gov/study/NCT04666272 RECRUITING Melanoma DRUG: dabrafenib

NCT05191940 Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial) https://clinicaltrials.gov/study/NCT05191940 RECRUITING Pancreas Cancer RADIATION: Particle-therapy using protons or carbon ions

NCT04380740 Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis https://clinicaltrials.gov/study/NCT04380740 RECRUITING Graft Vs Host Disease DRUG: Placebo

NCT05544240 Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05544240 RECRUITING Metastatic Cancer

NCT04973540 A Clinical Trial to Evaluate the Safety and Efficacy of IBS Angel in Patients With Pulmonary Artery Stenosis https://clinicaltrials.gov/study/NCT04973540 RECRUITING Pulmonary Artery Stenosis DEVICE: Iron Bioresorbable Scaffold System (IBS Angel) Biotyx Medical (Shenzhen) Co., Ltd.

NCT06542744 Comparison of the Flexibility of the Perineum in Primiparous Women Using the Medical Device Emagina During 90 Days of Their Pregnancy Compared to Those Having a Standard Pregnancy Follow-up https://clinicaltrials.gov/study/NCT06542744 NOT_YET_RECRUITING Pregnancy

NCT03828344 Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT03828344 NOT_YET_RECRUITING Rheumatoid Arthritis BIOLOGICAL: hUC-MSC suspension

NCT05422144 Cleanser for Acute Wounds https://clinicaltrials.gov/study/NCT05422144 NOT_YET_RECRUITING Acute Wound DEVICE: Antimicrobial Skin & Wound Cleanser (AWC)

NCT05641844 A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas https://clinicaltrials.gov/study/NCT05641844 RECRUITING Anal Fistula DEVICE: RD2 Ver.02

NCT06619392 A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects https://clinicaltrials.gov/study/NCT06619392 RECRUITING Pain DRUG: HRS-2129

NCT06168292 Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma https://clinicaltrials.gov/study/NCT06168292 NOT_YET_RECRUITING Biliary Tract Carcinoma

NCT04838392 Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus https://clinicaltrials.gov/study/NCT04838392 NOT_YET_RECRUITING Diabetes Mellitus

NCT05966701 The MAD Study of SSGJ-613 in Healthy Subjects https://clinicaltrials.gov/study/NCT05966701 NOT_YET_RECRUITING Arthritis, Gouty DRUG: SSGJ-613

NCT05669001 A Study of TCD601 in de Novo Renal Transplant Recipients https://clinicaltrials.gov/study/NCT05669001 RECRUITING Renal Transplantation BIOLOGICAL: TCD601

NCT06632301 DEXA Bone Density Analysis of the CoreHip¬Æ Prosthesis System https://clinicaltrials.gov/study/NCT06632301 NOT_YET_RECRUITING Primary Osteoarthritis

NCT03934567 A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma https://clinicaltrials.gov/study/NCT03934567 RECRUITING Lymphoma, Follicular DRUG: Abexinostat Xynomic Pharmaceuticals, Inc.

NCT05954767 IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery https://clinicaltrials.gov/study/NCT05954767 RECRUITING Ureter Injury DRUG: IS-001 Intuitive Surgical

NCT05974267 Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2) https://clinicaltrials.gov/study/NCT05974267 RECRUITING Malaria Infection DRUG: M5717 60 mg

NCT06173167 Clinical Evaluation of Full Contour Zirconia Chairside CAD/CAM Crowns https://clinicaltrials.gov/study/NCT06173167 RECRUITING Dental Disorders Hard Tissues of Teeth

NCT05044767 Study to Evaluate the Performance and Safety of ATF Implants and Lap√© M√©dical Devices Implanted During Hip Arthroplasty https://clinicaltrials.gov/study/NCT05044767 RECRUITING Arthroplasty, Hip, Replacement DEVICE: total hip arthroplasty ATF Implants

NCT05304767 An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia https://clinicaltrials.gov/study/NCT05304767 RECRUITING Schizophrenia DRUG: Xanomeline and Trospium Chloride Capsules Karuna Therapeutics

NCT05523440 Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation https://clinicaltrials.gov/study/NCT05523440 RECRUITING Recurrent Endometrial Carcinoma

NCT04627740 Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04627740 RECRUITING Solid Tumors DRUG: Retroviral vector-transduced autologous T cells to express anti-ALPP CARs Xinqiao Hospital of Chongqing TCRCure Biopharma Ltd.

NCT06580444 Brexanolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study https://clinicaltrials.gov/study/NCT06580444 NOT_YET_RECRUITING Alcohol Use Disorder (AUD)

NCT06615544 Clinical Evaluation of a New Dual-cure Universal Adhesive https://clinicaltrials.gov/study/NCT06615544 NOT_YET_RECRUITING Class I Dental Restorations

NCT02584244 Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers https://clinicaltrials.gov/study/NCT02584244 RECRUITING Colorectal Cancer

NCT04525144 EGb 761 in the Syndrome of MCI With Concomitant CVD https://clinicaltrials.gov/study/NCT04525144 RECRUITING Mild Cognitive Impairment

NCT06144892 The Comfort of Proactive Sleep Apnea Therapy https://clinicaltrials.gov/study/NCT06144892 NOT_YET_RECRUITING Obstructive Sleep Apnea

NCT06354192 Precision Nudging for Hypertension Management: Observational Study https://clinicaltrials.gov/study/NCT06354192 RECRUITING Hypertension BEHAVIORAL: Precision Nudging for Hypertension Management Lirio Cone Health

NCT05474092 Aeson TAH System - Post-Market Clinical Follow-up Study https://clinicaltrials.gov/study/NCT05474092 RECRUITING Heart Failure DEVICE: Aeson Total Artificial Heart Carmat SA

NCT03836040 Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine https://clinicaltrials.gov/study/NCT03836040 RECRUITING Migraine DRUG: Erenumab Dose 1

NCT06004440 Real World Registry for Use of the Ion Endoluminal System https://clinicaltrials.gov/study/NCT06004440 RECRUITING Lung Cancer

NCT05866640 Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR https://clinicaltrials.gov/study/NCT05866640 RECRUITING Aortic Stenosis DEVICE: F2 filter and delivery system EnCompass Technologies, Inc.

NCT06399640 Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06399640 RECRUITING Relapsed Myelodysplastic Syndrome

NCT05737940 A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2 https://clinicaltrials.gov/study/NCT05737940 RECRUITING Pulmonary Hypertension (World Health Organization Group 2)

NCT05692544 Image Data Collection of Tanned Skin During Phototherapy Treatment Using a Multi-spectral Camera https://clinicaltrials.gov/study/NCT05692544 NOT_YET_RECRUITING Pigment; Lesion

NCT06128044 CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06128044 RECRUITING Acute Myeloid Leukemia, in Relapse

NCT03587844 Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients https://clinicaltrials.gov/study/NCT03587844 RECRUITING Mycosis Fungoides

NCT04835844 RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation https://clinicaltrials.gov/study/NCT04835844 RECRUITING Paroxysmal Atrial Fibrillation DEVICE: CARTO

NCT06161844 Efficacy and Safety of Semaglutide Injection (HD1916) in Patients with Type 2 Diabetes Mellitus https://clinicaltrials.gov/study/NCT06161844 RECRUITING Type 2 Diabetes Mellitus DRUG: semaglutide injection (HD1916)

NCT06332092 FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT06332092 RECRUITING Head and Neck Squamous Cell Carcinoma DRUG: FID007 Fulgent Pharma LLC.

NCT05631392 Study to Evaluate the Clinical and Radiographic Outcomes of the BEE¬Æ HA Cage for Anterior Cervical Discectomy and Fusion https://clinicaltrials.gov/study/NCT05631392 RECRUITING Cervical Disc Degeneration Invibio Ltd NGMedical GmbH

NCT03829540 CD4CAR for CD4+ Leukemia and Lymphoma https://clinicaltrials.gov/study/NCT03829540 RECRUITING T-cell Lymphoma

NCT06233240 Sitagliptin and Metformin Hydrochloride Tablets 50 mg/1000 mg Relative to Originator https://clinicaltrials.gov/study/NCT06233240 NOT_YET_RECRUITING Healthy Subjects DRUG: Sitagliptin and Metformin Hydrochloride Tablets Test product

NCT06489340 P2a Open Label Study to Evaluate 2-HPŒ≤CD in Subjects With Diabetic Kidney Disease https://clinicaltrials.gov/study/NCT06489340 NOT_YET_RECRUITING Diabetic Kidney Disease DRUG: 2HPŒ≤CD ZyVersa Therapeutics, Inc.

NCT06689540 Mts105 for Advanced Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT06689540 NOT_YET_RECRUITING Liver Cancer, Adult

NCT05999240 Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder https://clinicaltrials.gov/study/NCT05999240 NOT_YET_RECRUITING Autism Spectrum Disorder DRUG: Pimavanserin Tartrate 34 Mg ORAL CAPSULE [NUPLAZID]

NCT06569940 Sleepiz One+ vs. Capnography and Electrocardiography https://clinicaltrials.gov/study/NCT06569940 RECRUITING Sleep Apnea

NCT06005740 A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer https://clinicaltrials.gov/study/NCT06005740 RECRUITING Advanced Solid Tumor

NCT05067140 A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer https://clinicaltrials.gov/study/NCT05067140 RECRUITING Prostate Cancer Metastatic DRUG: ARV-766 Part A&B

NCT05634967 Kesimpta (Ofatumumab) Pregnancy Registry https://clinicaltrials.gov/study/NCT05634967 RECRUITING Multiple Sclerosis

NCT06368440 A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants https://clinicaltrials.gov/study/NCT06368440 RECRUITING Healthy Participants DRUG: AZD6793

NCT05046444 Solving Riddles Through Sequencing https://clinicaltrials.gov/study/NCT05046444 RECRUITING Leukemia

NCT04050644 Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery https://clinicaltrials.gov/study/NCT04050644 RECRUITING Age-related Cataract DRUG: Preservative Free drop treatment

NCT05822544 Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects with Obesity, with or Without Diabetes https://clinicaltrials.gov/study/NCT05822544 RECRUITING Healthy Subjects

NCT06467344 Study to Evaluate ACDN-01 in ABCA4-related Retinopathy (STELLAR) https://clinicaltrials.gov/study/NCT06467344 RECRUITING Stargardt Disease

NCT04956744 A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis https://clinicaltrials.gov/study/NCT04956744 RECRUITING Multiple Sclerosis BIOLOGICAL: IMS001 ImStem Biotechnology Rho, Inc.

NCT06460844 Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa Patients (ENVISION) https://clinicaltrials.gov/study/NCT06460844 RECRUITING Retinitis Pigmentosa GENETIC: RTx-015 Ray Therapeutics, Inc.

NCT05887492 Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors https://clinicaltrials.gov/study/NCT05887492 RECRUITING Non Small Cell Lung Cancer

NCT06555692 Evaluation of the Clinical Effectiveness and Safety of Acellular Dermal Matrix(SC DERM¬Æ Recon) in Breast Reconstruction https://clinicaltrials.gov/study/NCT06555692 RECRUITING Breast Cancer Female

NCT05295992 Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach https://clinicaltrials.gov/study/NCT05295992 RECRUITING Muscle-Invasive Bladder Carcinoma DEVICE: Varian Ethos Adaptive Radiation Therapy Varian, a Siemens Healthineers Company Herlev Hospital

NCT06438367 TGRX-326 Pharmacokinetic Mass Balance https://clinicaltrials.gov/study/NCT06438367 NOT_YET_RECRUITING Non Small Cell Lung Cancer DRUG: [14C]TGRX-326 Shenzhen TargetRx, Inc. The First Affiliated Hospital of Soochow University

NCT06181240 Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE) https://clinicaltrials.gov/study/NCT06181240 RECRUITING Coronary Artery Disease

NCT05727267 A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate https://clinicaltrials.gov/study/NCT05727267 RECRUITING Chronic Hepatitis B BIOLOGICAL: HEPLISAV B; TherVacB

NCT06378567 A Study to Assess the Effects of Dietary Supplement Drinks on Sleep, Stress and Mood https://clinicaltrials.gov/study/NCT06378567 RECRUITING Sleep

NCT05523167 A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy. https://clinicaltrials.gov/study/NCT05523167 RECRUITING Active Idiopathic Inflammatory Myopathy

NCT04228367 JuggerStitch Post Market Clinical Follow-up Study https://clinicaltrials.gov/study/NCT04228367 RECRUITING Meniscus Tear, Tibial

NCT06505967 Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels https://clinicaltrials.gov/study/NCT06505967 RECRUITING NAD+ Levels in the Blood DIETARY_SUPPLEMENT: Qualia NAD+

NCT05127772 A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing https://clinicaltrials.gov/study/NCT05127772 RECRUITING Gout DRUG: HEC93077

NCT04508244 Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status https://clinicaltrials.gov/study/NCT04508244 RECRUITING Trauma

NCT05121844 Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform https://clinicaltrials.gov/study/NCT05121844 RECRUITING Weight Loss

NCT04314544 Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) https://clinicaltrials.gov/study/NCT04314544 RECRUITING Active Psoriatic Arthritis DRUG: TILD

NCT06719544 A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034) https://clinicaltrials.gov/study/NCT06719544 NOT_YET_RECRUITING Healthy DRUG: lithium carbonate

NCT06397144 A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants https://clinicaltrials.gov/study/NCT06397144 NOT_YET_RECRUITING Biological Availability

NCT04445844 INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study https://clinicaltrials.gov/study/NCT04445844 RECRUITING Anatomic Stage IV Breast Cancer AJCC v8

NCT06191744 Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma https://clinicaltrials.gov/study/NCT06191744 RECRUITING Follicular Lymphoma (FL) DRUG: Epcoritamab

NCT06302140 A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers https://clinicaltrials.gov/study/NCT06302140 RECRUITING Advanced Cancer DRUG: [14C]-Nanatinostat

NCT05490940 Sensory Recovery of Digital Nerves After Microsurgical Epineural Neurorrhaphy Alone or in Combination With Tisseel - RET https://clinicaltrials.gov/study/NCT05490940 NOT_YET_RECRUITING Digital Nerve Injuries DRUG: Tisseel¬Æ Insel Gruppe AG, University Hospital Bern Baxter Healthcare Corporation

NCT05032040 A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies https://clinicaltrials.gov/study/NCT05032040 RECRUITING Ovarian Cancer

NCT05537740 A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05537740 RECRUITING Advanced Solid Tumors DRUG: BAY3375968

NCT06421740 An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China https://clinicaltrials.gov/study/NCT06421740 RECRUITING Atopic Dermatitis AbbVie

NCT06451640 A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps https://clinicaltrials.gov/study/NCT06451640 RECRUITING Chronic Rhinosinusitis With Nasal Polyps DRUG: 210mg of TQC2731 injection

NCT05059444 ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation https://clinicaltrials.gov/study/NCT05059444 RECRUITING Bladder Carcinoma

NCT06047444 A Study to Evaluate the Effectiveness and Safety of Dysport¬Æ for the Prevention of Chronic Migraine in Adults https://clinicaltrials.gov/study/NCT06047444 RECRUITING Chronic Migraine BIOLOGICAL: Botulinum toxin type A

NCT05013944 AnovaOS Network Powered Patient Registry https://clinicaltrials.gov/study/NCT05013944 RECRUITING Infectious Disease

NCT05940844 Study of OB-002 in Patients With Refractory Metastatic Cancer https://clinicaltrials.gov/study/NCT05940844 NOT_YET_RECRUITING Metastatic Cancer

NCT06401044 A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease https://clinicaltrials.gov/study/NCT06401044 RECRUITING Thyroid Eye Disease DRUG: AMG 732

NCT05972044 A Study to Access the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS) https://clinicaltrials.gov/study/NCT05972044 RECRUITING ADHD DRUG: Solriamfetol 150 mg

NCT04734444 SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue https://clinicaltrials.gov/study/NCT04734444 RECRUITING Brain Tumour

NCT06129240 An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH https://clinicaltrials.gov/study/NCT06129240 RECRUITING Pulmonary Hypertension

NCT06268340 Hearing and Structure Preservation Via ECochG https://clinicaltrials.gov/study/NCT06268340 RECRUITING Hearing Loss, Sensorineural

NCT05390840 A Study to Investigate the Effect on Central Macular Thickness of Treatment With MG-O-1002 Eye Drops in Participants Aged Over 45 With Neovascular Age-related Macular Degeneration (nAMD) https://clinicaltrials.gov/study/NCT05390840 RECRUITING Age-Related Macular Degeneration DRUG: MG-O-1002

NCT05864040 HYbrid RObotic Surgery in Urology https://clinicaltrials.gov/study/NCT05864040 RECRUITING Nephrectomy DEVICE: Bitrack System-assisted laparoscopic radical/simple nephrectomy Rob Surgical Systems S.L.

NCT05966740 A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot https://clinicaltrials.gov/study/NCT05966740 RECRUITING Venous Thromboembolism Boehringer Ingelheim Children's Hospital Acquired Thrombosis consortium

NCT06254040 Effect of Consuming a Mixture of Extracts and DHA on the Mild Cognitive Impairment https://clinicaltrials.gov/study/NCT06254040 RECRUITING Mild Cognitive Impairment DIETARY_SUPPLEMENT: Placebo

NCT04622644 Clinical Investigation to Evaluate the Suitability of StrokeWave in Distinguishing Haemorragic From Ischaemic Strokes https://clinicaltrials.gov/study/NCT04622644 RECRUITING Stroke, Ischemic

NCT06137144 AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haematologic Malignancies. https://clinicaltrials.gov/study/NCT06137144 RECRUITING Lymphoma

NCT05071144 Spine Procedures Assisted With RoboTics And Navigation https://clinicaltrials.gov/study/NCT05071144 RECRUITING Spine Deformity

NCT06215144 Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD https://clinicaltrials.gov/study/NCT06215144 RECRUITING Attention-Deficit/Hyperactivity Disorder (ADHD) DRUG: NRCT-101SR Neurocentria, Inc.

NCT05743244 Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D) https://clinicaltrials.gov/study/NCT05743244 RECRUITING Diabetes Mellitus, Type 1 DRUG: Abrocitinib 200 MG Oral Tablet

NCT06216444 A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures https://clinicaltrials.gov/study/NCT06216444 NOT_YET_RECRUITING Sedation in Non-intubated Diagnostic and Therapeutic Procedures DRUG: Remimazolam Tosilate for Injection

NCT06541444 Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06541444 RECRUITING Relapsed/Refractory Acute Myeloid Leukemia DRUG: NK520 Base Therapeutics (Shanghai) Co., Ltd. Shanghai Pudong Hospital

NCT06601504 Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL https://clinicaltrials.gov/study/NCT06601504 RECRUITING Relapsed/Refractory Diffuse Large B-Cell Lymphoma DRUG: HMPL-760 planned dose 1

NCT04733404 Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation https://clinicaltrials.gov/study/NCT04733404 RECRUITING Mitral Regurgitation Functional DEVICE: Dragonfly Transcatheter Mitral Valve Repair System Hangzhou Valgen Medtech Co., Ltd

NCT04278404 Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) https://clinicaltrials.gov/study/NCT04278404 RECRUITING Coronavirus Infection (COVID-19)

NCT05431504 The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis https://clinicaltrials.gov/study/NCT05431504 NOT_YET_RECRUITING Advanced Breast Cancer DRUG: Dalpiciclib in combination with endocrine therapy by Physicians choice Cancer Institute and Hospital, Chinese Academy of Medical Sciences Jiangsu HengRui Medicine Co., Ltd.

NCT06099704 Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent¬Æ for Moderate to Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06099704 RECRUITING Moderate to Severe Atopic Dermatitis Sanofi Regeneron Pharmaceuticals

NCT06364501 Phase 1 Trial of KH801 https://clinicaltrials.gov/study/NCT06364501 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: KH801 Beijing Kanghong Biopharmaceutical Co., Ltd.

NCT03319901 Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL https://clinicaltrials.gov/study/NCT03319901 RECRUITING Leukemia DRUG: Venetoclax

NCT04268901 VR to Reduce Pain/Anxiety During Painful Procedures https://clinicaltrials.gov/study/NCT04268901 RECRUITING Phlebotomy

NCT06134401 Nebulised Hypertonic Saline to Decrease Respiratory Exacerbations in Neuromuscular Disease or Neurodisability https://clinicaltrials.gov/study/NCT06134401 NOT_YET_RECRUITING Neuromuscular Diseases

NCT06449001 Study of Danicopan as Add-on Treatment to Ravulizumab or Eculizumab in Pediatric Participants With PNH Who Have Clinically Significant Extravascular Hemolysis https://clinicaltrials.gov/study/NCT06449001 NOT_YET_RECRUITING Paroxysmal Nocturnal Hemoglobinuria

NCT06580301 Study of YK012 in B-cell Acute Lymphoblastic Leukemia https://clinicaltrials.gov/study/NCT06580301 RECRUITING B-cell Acute Lymphoblastic Leukemia DRUG: YK012 Excyte Biopharma Ltd

NCT06679101 A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM) https://clinicaltrials.gov/study/NCT06679101 NOT_YET_RECRUITING Multiple Myeloma

NCT06359301 H-34 DELTA Revision Cup https://clinicaltrials.gov/study/NCT06359301 RECRUITING Hip, Osteoarthritis DEVICE: DELTA Revision acetabular cup Limacorporate S.p.a

NCT06689501 12-Week Trial Investigating L-carnitine Tartrate, Dihydrocapsiate and Protein Yeast Hydrolysate on Energy Intake and Expenditure in Overweight Adults https://clinicaltrials.gov/study/NCT06689501 RECRUITING Overweight and Obesity COMBINATION_PRODUCT: SPICE BLEND CAPSULE

NCT05754567 CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes https://clinicaltrials.gov/study/NCT05754567 RECRUITING Neurocognitive Disorders University of Manitoba Canadian Institutes of Health Research (CIHR)

NCT04339504 Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial https://clinicaltrials.gov/study/NCT04339504 RECRUITING Knee Osteoarthritis BIOLOGICAL: SMUP-IA-01(low-dose)

NCT05081804 The Effect of Enhanced Recovery After Surgery (ERAS) for Cesarean Section on Neonatal Blood Glucose https://clinicaltrials.gov/study/NCT05081804 RECRUITING Enhanced Recovery After Surgery

NCT06695104 YMCA Produce Prescription Project (YPRx) https://clinicaltrials.gov/study/NCT06695104 NOT_YET_RECRUITING Pre-diabetes BEHAVIORAL: YMCA Produce Rx (YPRx) Program Only (Control)

NCT03755804 Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 https://clinicaltrials.gov/study/NCT03755804 RECRUITING Hodgkin Lymphoma DRUG: bendamustine

NCT05721404 Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis https://clinicaltrials.gov/study/NCT05721404 RECRUITING Peritoneal Dialysis DRUG: Icodextrin Peritoneal Dialysis Solution

NCT06606704 Effects of Resistance-band Training and Creatine Supplementation Strategies in Healthy Older Adults https://clinicaltrials.gov/study/NCT06606704 RECRUITING Aging DIETARY_SUPPLEMENT: Creatine Bolus 5

NCT06059001 Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered Iv in Patients with PDAC https://clinicaltrials.gov/study/NCT06059001 RECRUITING Metastatic Pancreatic Cancer DRUG: OMO-103

NCT06238401 An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients with Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06238401 RECRUITING Advanced Solid Tumors DRUG: ACR246 for injection Hangzhou Adcoris Biopharmacy Co., Ltd

NCT06718101 A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06718101 NOT_YET_RECRUITING Atopic Dermatitis DRUG: Lutikizumab

NCT06649201 Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation https://clinicaltrials.gov/study/NCT06649201 RECRUITING Graft Vs Host Disease

NCT06333301 Translational Initiative to Map Epigenetics in Sleep https://clinicaltrials.gov/study/NCT06333301 NOT_YET_RECRUITING Biological Aging OTHER: Surveys Elysium Health University of Oxford

NCT06082401 Evaluating the Addition of Hemodiafiltration to EVLP - Impact on the Regeneration of Marginal Donor Lungs https://clinicaltrials.gov/study/NCT06082401 RECRUITING Lung Diseases DEVICE: hemodiafiltration (HDF)

NCT06294301 A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants https://clinicaltrials.gov/study/NCT06294301 RECRUITING Paroxysmal Nocturnal Hemoglobinuria (PNH) BIOLOGICAL: LP-005 Dose 1 (Single)

NCT06139367 A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects https://clinicaltrials.gov/study/NCT06139367 NOT_YET_RECRUITING Biliary Carcinoma DRUG: TQB3454 tablets Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NCT06091267 PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes https://clinicaltrials.gov/study/NCT06091267 RECRUITING Myelodysplastic Syndromes DRUG: IV Decitabine

NCT06595004 A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients https://clinicaltrials.gov/study/NCT06595004 RECRUITING Chronic Low-back Pain DRUG: HCP1004

NCT05938504 Usefulness of Balanced High Protein Supplementation on Recovery and Clinical Outcomes After Chemotherapy https://clinicaltrials.gov/study/NCT05938504 RECRUITING Colorectal Neoplasms OTHER: ONS_320275

NCT05549804 A Study of Intratumoral KL340399 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05549804 RECRUITING Advanced Solid Tumors DRUG: KL340399 Intratumoral Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

NCT05285904 Kesimpta¬Æ (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study https://clinicaltrials.gov/study/NCT05285904 RECRUITING Multiple Sclerosis OTHER: Ofatumumab Novartis Pharmaceuticals

NCT05884801 Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05884801 RECRUITING Advanced Solid Tumor DRUG: QLS1103 Qilu Pharmaceutical Co., Ltd.

NCT06124001 Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT06124001 NOT_YET_RECRUITING Primary Hepatocellular Carcinoma DRUG: Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))

NCT06555601 A First-in-human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UCB3101 in Healthy Participants https://clinicaltrials.gov/study/NCT06555601 RECRUITING Healthy Participants DRUG: UCB3101

NCT04748601 Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old https://clinicaltrials.gov/study/NCT04748601 RECRUITING Migraine Disorders DRUG: Qudexy XR

NCT05602467 Long Term Transcranial Pulse Stimulation (TPS) on Older Adults With Mild Neurocognitive Disorder (NCD) https://clinicaltrials.gov/study/NCT05602467 RECRUITING Mild Neurocognitive Disorder DEVICE: Transcranial Pulse Stimulation (TPS)

NCT06403267 NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis with or Without Endovascular Thrombectomy https://clinicaltrials.gov/study/NCT06403267 RECRUITING Acute Ischemic Stroke DRUG: NoNO-42

NCT06604767 Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older https://clinicaltrials.gov/study/NCT06604767 RECRUITING Respiratory Syncytial Virus Infection

NCT04868604 64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) https://clinicaltrials.gov/study/NCT04868604 RECRUITING Prostatic Neoplasms, Castration-Resistant DRUG: 64Cu-SAR-bisPSMA

NCT05425004 Cabozantinib for Patients With Recurrent or Progressive Meningioma https://clinicaltrials.gov/study/NCT05425004 RECRUITING Meningioma DRUG: Cabozantinib Baptist Health South Florida Exelixis

NCT04658004 NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT04658004 NOT_YET_RECRUITING Acute Myeloid Leukemia DRUG: NKG2D CAR T-cells Zhejiang University Yake Biotechnology Ltd.

NCT06286904 Sleep Position Pattern Recording https://clinicaltrials.gov/study/NCT06286904 NOT_YET_RECRUITING Pregnant Women DEVICE: Skiin Garment system Myant Medical Corp. McMaster University

NCT04338204 Observational Study To Assess The Effectiveness and Treatment Adherence Of Tofacitinib of Ulcerative Colitis In Clinical Practice In Sweden https://clinicaltrials.gov/study/NCT04338204 RECRUITING Ulcerative Colitis DRUG: tofacitinib Pfizer

NCT06549504 Bioequivalence Study of AG2202 https://clinicaltrials.gov/study/NCT06549504 NOT_YET_RECRUITING Bioequivalence Study DRUG: AG2202T

NCT06146101 RePOSA-Revealing the Efficacy of IHL-42X Use in Patients with OSA https://clinicaltrials.gov/study/NCT06146101 RECRUITING Obstructive Sleep Apnea DRUG: IHL-42X Low Dose

NCT06345001 A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers https://clinicaltrials.gov/study/NCT06345001 RECRUITING Hepatocellular Carcinoma (HCC)

NCT06320301 Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC) https://clinicaltrials.gov/study/NCT06320301 RECRUITING Biliary Tract Cancer

NCT06101901 Revealing Engagement Dynamics Among Diabetic Kidney Disease Patients https://clinicaltrials.gov/study/NCT06101901 NOT_YET_RECRUITING Diabetic Kidney Disease Power Life Sciences Inc.

NCT05978401 Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05978401 NOT_YET_RECRUITING Advanced Non-Small Cell Lung Cancer DRUG: GLS-012+GLS-010

NCT04253301 Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency https://clinicaltrials.gov/study/NCT04253301 RECRUITING Chronic Venous Insufficiency DEVICE: InnoVein Valve Treatment InnoVein

NCT05126901 Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years https://clinicaltrials.gov/study/NCT05126901 RECRUITING Anemia

NCT06346704 Prospective Longitudinal Monocentric Study to Evaluate the Syde¬Æ Digital Endpoint in Patients With Multiple Sclerosis https://clinicaltrials.gov/study/NCT06346704 RECRUITING Multiple Sclerosis OTHER: Digital HealthTechnology SYSNAV

NCT06154304 BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma https://clinicaltrials.gov/study/NCT06154304 NOT_YET_RECRUITING Bronchial Asthma DRUG: Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation)

NCT05727904 Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. https://clinicaltrials.gov/study/NCT05727904 RECRUITING Metastatic Melanoma

NCT04805801 The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII Inhibitors https://clinicaltrials.gov/study/NCT04805801 RECRUITING Hemophilia A With Inhibitor

NCT06026501 A Phase Ib/II Clinical Trial of PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor https://clinicaltrials.gov/study/NCT06026501 NOT_YET_RECRUITING Advanced Solid Tumors DRUG: PE0116,PE0105 Shanghai YingLi Pharmaceutical Co. Ltd. Shanghai HyaMab Biotech Co.,Ltd.

NCT05672901 Silicone Gel Vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause https://clinicaltrials.gov/study/NCT05672901 RECRUITING Genitourinary Syndrome of Menopause DEVICE: StrataMGT

NCT06233201 Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator https://clinicaltrials.gov/study/NCT06233201 NOT_YET_RECRUITING Healthy Subjects DRUG: Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Test product

NCT04042701 DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT04042701 RECRUITING Breast Cancer

NCT06514001 A Study of AMDX-2011P in Participants With Alzheimer's Disease https://clinicaltrials.gov/study/NCT06514001 RECRUITING Alzheimer Disease DRUG: AMDX-2011P Amydis Inc.

NCT06046001 AirWaze - Easy and Advanced Tools for CBCT Guided Lung Interventions https://clinicaltrials.gov/study/NCT06046001 RECRUITING Lung Diseases DEVICE: AirWaze Philips Clinical & Medical Affairs Global

NCT02156401 VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE https://clinicaltrials.gov/study/NCT02156401 RECRUITING Venous Thromboembolism (VTE)

NCT05900401 Delayed Tolerance Through Mixed Chimerism https://clinicaltrials.gov/study/NCT05900401 RECRUITING Kidney Failure

NCT06139601 A Single Session Community-Based Body Empowerment Session https://clinicaltrials.gov/study/NCT06139601 RECRUITING Body Image BEHAVIORAL: Virtual single session intervention Equip Health

NCT04428801 Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 https://clinicaltrials.gov/study/NCT04428801 NOT_YET_RECRUITING COVID-19 BIOLOGICAL: autologous adipose-derived stem cells Celltex Therapeutics Corporation

NCT06644404 Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults https://clinicaltrials.gov/study/NCT06644404 NOT_YET_RECRUITING Healthy DRUG: DWP16001 0.3mg

NCT06216301 LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC https://clinicaltrials.gov/study/NCT06216301 RECRUITING Metastatic Non-small Cell Lung Cancer DEVICE: NovoTTF-200T

NCT06536101 The Purpose of the Study is to Evaluate the Safety, Tolerability and Pharmacokinetics of Single-ascending and Multiple-ascending Doses of GIM-407 https://clinicaltrials.gov/study/NCT06536101 RECRUITING Healthy Volunteers DRUG: GIM-407

NCT05130801 A Study of Multiparametric MRI and pHLIP¬Æ ICG in Breast Cancer Imaging During Surgery https://clinicaltrials.gov/study/NCT05130801 RECRUITING Breast Cancer DIAGNOSTIC_TEST: pHLIP¬Æ ICG NIRF imaging Memorial Sloan Kettering Cancer Center Stryker Instruments

NCT05251701 Personal KinetiGraph¬Æ Clinical Validation Study https://clinicaltrials.gov/study/NCT05251701 RECRUITING Movement Disorders

NCT05355701 A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. https://clinicaltrials.gov/study/NCT05355701 RECRUITING Melanoma

NCT03048201 Physica System Total Knee Replacement Registry Study https://clinicaltrials.gov/study/NCT03048201 RECRUITING Osteoarthritis, Knee

NCT06248801 Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets https://clinicaltrials.gov/study/NCT06248801 NOT_YET_RECRUITING Healthy Subjects DRUG: Vildagliptin and Metformin-Test product

NCT05945004 ChatGPT v.s. Human in Writing a Preoperative Visit Sheet https://clinicaltrials.gov/study/NCT05945004 NOT_YET_RECRUITING Preoperative Care OTHER: ChatGPT-4

NCT06344104 A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension https://clinicaltrials.gov/study/NCT06344104 RECRUITING Uncontrolled Hypertension

NCT06701604 Changes in Amino Acid Absorption After Adding a Probiotic to an Acute Protein Feeding https://clinicaltrials.gov/study/NCT06701604 NOT_YET_RECRUITING Amino Acid Absorption

NCT05312801 Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT05312801 RECRUITING Lymphoma, Non-Hodgkin Lymphoma, B-Cell DRUG: BAFF CAR-T Luminary Therapeutics Case Comprehensive Cancer Center

NCT03587701 Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease https://clinicaltrials.gov/study/NCT03587701 RECRUITING Autoimmune Inner Ear Disease

NCT06330701 Stone Access and Removal (STAR) Study https://clinicaltrials.gov/study/NCT06330701 RECRUITING Kidney Calculi DEVICE: Robotic-assisted mini-PCNL Auris Health, Inc.

NCT05922904 PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT05922904 RECRUITING Hodgkin Lymphoma DRUG: Brentuximab vedotin

NCT06192004 Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD https://clinicaltrials.gov/study/NCT06192004 RECRUITING Non-Small Cell Lung Cancer OTHER: None (Observational Study) AstraZeneca

NCT06462404 A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1 https://clinicaltrials.gov/study/NCT06462404 RECRUITING Narcolepsy Type 1 (NT1) DRUG: E2086

NCT05763004 A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05763004 RECRUITING Solid Tumor, Adult DRUG: IOS-1002

NCT05719701 Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients With Relapsed and/or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT05719701 RECRUITING Relapsed and/or Refractory Multiple Myeloma DRUG: ICP-490

NCT06072001 Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis https://clinicaltrials.gov/study/NCT06072001 RECRUITING Pain

NCT06117501 Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome Decompression https://clinicaltrials.gov/study/NCT06117501 RECRUITING Recurrent Cubital Tunnel Syndrome

NCT05721001 French Registry Conducted on E-vita OPEN NEO https://clinicaltrials.gov/study/NCT05721001 RECRUITING Vascular Aneurysm DEVICE: Surgical Repair JOTEC GmbH ICON plc

NCT04362501 Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) https://clinicaltrials.gov/study/NCT04362501 RECRUITING Chronic Sinusitis BIOLOGICAL: dupilumab

NCT05541601 Prospective Cohort for Early Detection of Liver Cancer https://clinicaltrials.gov/study/NCT05541601 RECRUITING Cirrhosis

NCT05666804 Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy https://clinicaltrials.gov/study/NCT05666804 RECRUITING Macular Polypoidal Choroidal Vasculopathy (PCV) DRUG: Brolucizumab 6mg

NCT05369104 Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR. https://clinicaltrials.gov/study/NCT05369104 RECRUITING Infection of Total Hip Joint Prosthesis

NCT06394804 A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer https://clinicaltrials.gov/study/NCT06394804 RECRUITING Low-Grade Serous Ovarian Cancer DRUG: Avutometinib

NCT03320304 A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients with Difficult to Treat Depression. https://clinicaltrials.gov/study/NCT03320304 RECRUITING Treatment Resistant Depression DEVICE: Vagal Nerve Simulation (VNS) Therapy LivaNova

NCT05930704 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-2017 Injection in Postmenopausal Women https://clinicaltrials.gov/study/NCT05930704 RECRUITING Osteoporosis DRUG: SHR-2017 injection

NCT05271604 A Phase 2 Open Label Study of BA3021 in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck https://clinicaltrials.gov/study/NCT05271604 RECRUITING Head and Neck Cancer

NCT04351204 The MR-Linac Technical Feasibility Protocol https://clinicaltrials.gov/study/NCT04351204 RECRUITING Tumors at All Sites Which Will Receive Radiotherapy RADIATION: radiotherapy The Netherlands Cancer Institute Elekta Limited

NCT05658601 A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) https://clinicaltrials.gov/study/NCT05658601 RECRUITING Multiple Sclerosis, Relapsing-Remitting Bristol-Myers Squibb

NCT06592001 Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study https://clinicaltrials.gov/study/NCT06592001 NOT_YET_RECRUITING Ventricular Arrythmia

NCT06701201 A Long-Term Follow-Up Basket Study for Participants Treated with SynKIR Chimeric Antigen Receptor (CAR) T Cell Product https://clinicaltrials.gov/study/NCT06701201 NOT_YET_RECRUITING Cancer DRUG: SynKIR-110

NCT02134301 Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections https://clinicaltrials.gov/study/NCT02134301 RECRUITING Gram Positive Bacterial Infections DRUG: Oritavancin Melinta Therapeutics, LLC

NCT06485401 To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects https://clinicaltrials.gov/study/NCT06485401 RECRUITING Influenza Type A

NCT05909501 Assessment of Geriatric Evaluations Impact on New AML Guidance https://clinicaltrials.gov/study/NCT05909501 RECRUITING AML, Adult Abramson Cancer Center at Penn Medicine Bristol-Myers Squibb

NCT04175704 Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria https://clinicaltrials.gov/study/NCT04175704 NOT_YET_RECRUITING Chronic Idiopathic Urticaria DRUG: UB-221 United BioPharma

NCT06112704 HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06112704 RECRUITING Advanced Solid Tumor DRUG: HS-20093 Hansoh BioMedical R&D Company

NCT05618704 Growth, Safety and Tolerance of a Hydrolyzed Protein Infant Formula https://clinicaltrials.gov/study/NCT05618704 RECRUITING Cow Milk Allergy DIETARY_SUPPLEMENT: Hydrolyzed protein infant formula Nutricia Research

NCT06605404 Pan-tumor MRD Study https://clinicaltrials.gov/study/NCT06605404 NOT_YET_RECRUITING Muscle Invasive Bladder Urothelial Carcinoma

NCT05848804 Hearing Screener Study https://clinicaltrials.gov/study/NCT05848804 RECRUITING Hearing Screener Linus Health, Inc.

NCT05631704 A Study to Investigate Safety, Tolerability, and Pharmacokinetics (PK) of VH4524184 and the Potential for Changes in Cytochrome P450 3A (CYP3A) Activity https://clinicaltrials.gov/study/NCT05631704 RECRUITING HIV Infections DRUG: VH4524184

NCT05137301 Performance of the Diagnostic Value of Bone Age Assessment Software Based on Deep Learning in Chinese Children https://clinicaltrials.gov/study/NCT05137301 RECRUITING Endocrine Diseases DEVICE: X-ray bone age instrument Tongji Hospital Changchun GeneScience Pharmaceutical Co., Ltd.

NCT06402201 First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors https://clinicaltrials.gov/study/NCT06402201 RECRUITING Select Advanced Solid Tumors BIOLOGICAL: CDR404 CDR-Life AG

NCT06220201 A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis or Progressive Forms of Multiple Sclerosis https://clinicaltrials.gov/study/NCT06220201 RECRUITING Multiple Sclerosis DRUG: CC-97540

NCT05534269 Stress Urinary Incontinence Study to Assess Safety and Efficacy of Muvon's Muscle Precursor Cell Therapy https://clinicaltrials.gov/study/NCT05534269 RECRUITING Female Stress Urinary Incontinence BIOLOGICAL: autologous muscle precursor cells University of Zurich GCP-Service International Ltd. & Co. KG

NCT05639569 Ankura‚Ñ¢ TAA Stent Graft System Post-Market Clinical Follow-up Study https://clinicaltrials.gov/study/NCT05639569 RECRUITING Aneurysm Thoracic

NCT05464368 R21 Roche: 3-Way Tau Tracers in AD https://clinicaltrials.gov/study/NCT05464368 RECRUITING Alzheimer Disease DRUG: [18F]RO-948

NCT06644768 A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations https://clinicaltrials.gov/study/NCT06644768 RECRUITING Non-small Cell Lung Cancer

NCT05403268 The EARLY DELTA Trial https://clinicaltrials.gov/study/NCT05403268 RECRUITING Delirium

NCT06027268 Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer https://clinicaltrials.gov/study/NCT06027268 RECRUITING Metastatic Triple-Negative Breast Cancer DRUG: Trilaciclib

NCT06175468 Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease https://clinicaltrials.gov/study/NCT06175468 NOT_YET_RECRUITING Influenza Viral Infections

NCT06041568 A Study of Imvotamab in Severe Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT06041568 RECRUITING Systemic Lupus Erythematosus

NCT05498272 Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations https://clinicaltrials.gov/study/NCT05498272 RECRUITING Prostate Cancer

NCT06099769 A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT06099769 RECRUITING Metastatic Breast Cancer DRUG: Enzalutamide

NCT04674969 Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature https://clinicaltrials.gov/study/NCT04674969 RECRUITING Peripheral Vascular Diseases DEVICE: Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device. Boston Scientific Corporation

NCT06669169 Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure https://clinicaltrials.gov/study/NCT06669169 NOT_YET_RECRUITING Heart Failure DRUG: Jia Shen Tablet Placebo

NCT06137768 A Trial of HRS-5965 Tablets in Primary IgA Nephropathy https://clinicaltrials.gov/study/NCT06137768 NOT_YET_RECRUITING Primary IgA Nephropathy DRUG: HRS-5965

NCT06075368 Prospective Registry of Patients With Acute Coronary Syndrome Treated With GENOSS Stent https://clinicaltrials.gov/study/NCT06075368 RECRUITING Acute Coronary Syndrome

NCT06484868 Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy https://clinicaltrials.gov/study/NCT06484868 RECRUITING Partial Lipodystrophy DRUG: Metreleptin Amryt Pharma

NCT06480968 CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction https://clinicaltrials.gov/study/NCT06480968 RECRUITING Fragile X Syndrome DRUG: CTH120

NCT06660368 BCL2i CLAG-M in R/R Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06660368 NOT_YET_RECRUITING Relapsed or Refractory Acute Myeloid Leukemia (AML) DRUG: Cladribine, Cytarabine, Mitoxantrone, G-CSF (CLAG-M) regimen

NCT06504368 Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors https://clinicaltrials.gov/study/NCT06504368 RECRUITING Solid Tumors, Adult DRUG: DCR-PDL1 Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

NCT03810768 Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness https://clinicaltrials.gov/study/NCT03810768 RECRUITING Metabolomics

NCT05020769 SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer. https://clinicaltrials.gov/study/NCT05020769 RECRUITING Non-small Cell Lung Cancer DRUG: SI-B001

NCT06172569 Spartan Stem, World Cup and World Liner Post Market Clinical Follow-up Study https://clinicaltrials.gov/study/NCT06172569 RECRUITING Hip Replacement DEVICE: Spartan Stem, World Acetabular Cup and World Liner Signature Orthopaedics The Cleveland Clinic

NCT06617169 Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors https://clinicaltrials.gov/study/NCT06617169 RECRUITING Solid Tumor, Adult

NCT06216769 Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation https://clinicaltrials.gov/study/NCT06216769 RECRUITING Atrial Fibrillation DRUG: Rivaroxaban Seoul National University Hospital Samjin Pharmaceutical Co., Ltd.

NCT06552169 REgulatory T Cell Therapy to Achieve Immunosuppression REduction https://clinicaltrials.gov/study/NCT06552169 NOT_YET_RECRUITING Kidney Transplantation DRUG: Arm 1: SOC (mTOR + CNI)

NCT06465069 A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors https://clinicaltrials.gov/study/NCT06465069 RECRUITING Metastatic Solid Tumor

NCT04998669 Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma https://clinicaltrials.gov/study/NCT04998669 RECRUITING Follicular Lymphoma DRUG: Loncastuximab tesirine

NCT06684769 A Chitosan Brush and Enamel Matrix Derivative for Non-surgical Treatment of Furcations https://clinicaltrials.gov/study/NCT06684769 RECRUITING Periodontitis, Adult

NCT06258668 Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea https://clinicaltrials.gov/study/NCT06258668 RECRUITING Moderate-to-severe Plaque Psoriasis DRUG: Deucravacitinib Bristol-Myers Squibb

NCT05048368 Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function https://clinicaltrials.gov/study/NCT05048368 NOT_YET_RECRUITING Esophageal Cancer

NCT05275868 Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05275868 RECRUITING Non-small Cell Lung Cancer DRUG: MGY825 Novartis Pharmaceuticals

NCT05642468 Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis https://clinicaltrials.gov/study/NCT05642468 RECRUITING Primary Sclerosing Cholangitis DRUG: Ritivixibat Albireo, an Ipsen Company

NCT06239168 Citrus Extract, Sleep and Mental Wellbeing https://clinicaltrials.gov/study/NCT06239168 RECRUITING Sleep Disturbance DIETARY_SUPPLEMENT: Citrus extract

NCT06556368 A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK https://clinicaltrials.gov/study/NCT06556368 RECRUITING Wet Age-related Macular Degeneration DRUG: Tarcocimab tedromer

NCT06397768 Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers https://clinicaltrials.gov/study/NCT06397768 RECRUITING RSV Immunization BIOLOGICAL: RSVt vaccine

NCT06400368 Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease https://clinicaltrials.gov/study/NCT06400368 RECRUITING Mild Cognitive Impairment

NCT06176768 A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis https://clinicaltrials.gov/study/NCT06176768 RECRUITING Plaque Psoriasis DRUG: LY3972406

NCT06071468 Registry of the Patient Experience for Carpal Tunnel Release https://clinicaltrials.gov/study/NCT06071468 RECRUITING Carpal Tunnel Syndrome

NCT05854368 Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer https://clinicaltrials.gov/study/NCT05854368 RECRUITING Gastric Lesion

NCT05196269 Comparing Decision on Aesthetics After Breast Cancer Locoregional Treatment. https://clinicaltrials.gov/study/NCT05196269 RECRUITING Breast Cancer DEVICE: Artificial Intelligence and Digital Health Arm Fundacao Champalimaud European Commission

NCT06029569 Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula https://clinicaltrials.gov/study/NCT06029569 NOT_YET_RECRUITING Peripheral Arterial Disease PROCEDURE: Rapamycin drug balloon angioplasty

NCT04901169 Angiotensin II in Liver Transplantation https://clinicaltrials.gov/study/NCT04901169 RECRUITING Liver Transplant; Complications

NCT06318169 A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants with MASH and Fibrosis (ENLIGHTEN-Fibrosis) https://clinicaltrials.gov/study/NCT06318169 RECRUITING Metabolic Dysfunction-associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) with Fibrosis BIOLOGICAL: Pegozafermin

NCT06015269 Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery https://clinicaltrials.gov/study/NCT06015269 RECRUITING Solid Tumor DRUG: DC cells Shanghai Cell Therapy Group Co.,Ltd

NCT03883269 Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients https://clinicaltrials.gov/study/NCT03883269 RECRUITING Acne Vulgaris DRUG: Erythromycin 4% topical gel formulation

NCT04838769 REZ≈™M vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men https://clinicaltrials.gov/study/NCT04838769 RECRUITING Benign Prostatic Hyperplasia (BPH) DEVICE: REZ≈™M

NCT05571969 Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05571969 RECRUITING Advanced Solid Tumors DRUG: 2X-121 and dovitinib Allarity Therapeutics Amarex Clinical Research

NCT06672068 A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC https://clinicaltrials.gov/study/NCT06672068 NOT_YET_RECRUITING NSCLC DRUG: TY-9591 80mg QD+pemetrexed+Cisplatin/Carboplatin

NCT05630768 Efficacy and Safety of Actonel¬Æ After Denosumab Discontinuation in Postmenopausal Osteoporosis Women https://clinicaltrials.gov/study/NCT05630768 RECRUITING Postmenopausal Osteoporosis DRUG: Risedronate Sodium 35 MG [Actonel]

NCT05797168 Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors https://clinicaltrials.gov/study/NCT05797168 RECRUITING Ovarian Cancer

NCT06184568 A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity https://clinicaltrials.gov/study/NCT06184568 RECRUITING Type 2 Diabetes

NCT05863468 Quantification of the Airflow Into Sinuses Before and After ArchSinus Implantation https://clinicaltrials.gov/study/NCT05863468 NOT_YET_RECRUITING Chronic Sinusitis, Ethmoidal DEVICE: ArchSinus implantation STS Medical

NCT06068868 Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) https://clinicaltrials.gov/study/NCT06068868 RECRUITING Acute Myeloid Leukemia DRUG: ABBV-787 AbbVie

NCT04107168 Microbiome Immunotherapy Toxicity and Response Evaluation https://clinicaltrials.gov/study/NCT04107168 RECRUITING Melanoma

NCT06574568 A Study of YKST02 in Participants with Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT06574568 RECRUITING Relapsed or Refractory Multiple Myeloma DRUG: YKST02 Excyte Biopharma Ltd

NCT05258669 Immuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults https://clinicaltrials.gov/study/NCT05258669 RECRUITING COVID-19 BIOLOGICAL: BBV152 Ocugen

NCT06622668 NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease https://clinicaltrials.gov/study/NCT06622668 RECRUITING Lung Disease

NCT06362668 EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU) https://clinicaltrials.gov/study/NCT06362668 RECRUITING Acute Decompensated Heart Failure DEVICE: Reprieve Decongestion Management System

NCT06015568 Study of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive Mutation https://clinicaltrials.gov/study/NCT06015568 NOT_YET_RECRUITING Non-Small Cell Lung Cancer„ÄÅEGFR Sensitive Mutation DRUG: MCLA-129: 1500mg or 2000mg IV Q2W

NCT02551068 High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib https://clinicaltrials.gov/study/NCT02551068 RECRUITING Idiopathic Pulmonary Fibrosis OTHER: 60% Oxygen

NCT06612268 A Research Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease https://clinicaltrials.gov/study/NCT06612268 NOT_YET_RECRUITING Sickle Cell Disease DRUG: Etavopivat

NCT06253468 Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins https://clinicaltrials.gov/study/NCT06253468 RECRUITING Hyperpigmentation OTHER: tested product Cosmetique Active International

NCT06574269 A Study on TLC590 for Managing Postsurgical Pain https://clinicaltrials.gov/study/NCT06574269 RECRUITING Postsurgical Pain Management DRUG: TLC590

NCT04873869 Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE) https://clinicaltrials.gov/study/NCT04873869 RECRUITING SCN8A Developmental and Epileptic Encephalopathy Syndrome DRUG: NBI-921352

NCT06673069 Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) and Pharmacodynamics (PD) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer's Disease (AD) https://clinicaltrials.gov/study/NCT06673069 RECRUITING Alzheimer Disease

NCT05614869 Continuous Treatment With PREVENA Therapy for 14 Days https://clinicaltrials.gov/study/NCT05614869 RECRUITING Abdominal Surgery

NCT05872269 A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities https://clinicaltrials.gov/study/NCT05872269 RECRUITING NAFLD

NCT06073769 A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06073769 RECRUITING Acute Myeloid Leukemia DRUG: Oral azacitidine Bristol-Myers Squibb

NCT04101669 RESET System Pivotal Trial (Rev F) https://clinicaltrials.gov/study/NCT04101669 RECRUITING Diabetes type2

NCT03215069 Empagliflozin and the Preservation of Beta-cell Function in Women With Recent Gestational Diabetes https://clinicaltrials.gov/study/NCT03215069 RECRUITING Gestational Diabetes DRUG: Empagliflozin 10 MG

NCT06567769 Phase 1 Study of GC1130A in Pediatric Patients With Sanfilippo Syndrome Type A (MPS IIIA) https://clinicaltrials.gov/study/NCT06567769 RECRUITING Sanfilippo Syndrome Type A DRUG: GC1130A GC Biopharma Corp Novel Pharma Inc.

NCT05906368 Hypotension Prediction Index to Predict Epidural-labor Analgesia Induced Hypotension https://clinicaltrials.gov/study/NCT05906368 RECRUITING Anesthesia, Epidural

NCT05546268 Study of Oral MRT-2359 in Selected Cancer Patients https://clinicaltrials.gov/study/NCT05546268 RECRUITING NSCLC

NCT06287268 Revolade Tablets Specified Drug-use Survey https://clinicaltrials.gov/study/NCT06287268 RECRUITING Aplastic Anemia OTHER: eltrombopag Novartis Pharmaceuticals

NCT06257368 TFL Driven Urinary System Treatment Study https://clinicaltrials.gov/study/NCT06257368 RECRUITING Urologic Diseases DEVICE: Coloplast TFL Drive Coloplast A/S

NCT06116968 An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM https://clinicaltrials.gov/study/NCT06116968 RECRUITING Obstructive Hypertrophic Cardiomyopathy DRUG: Aficamten Corxel Pharmaceuticals

NCT05227846 Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1) https://clinicaltrials.gov/study/NCT05227846 RECRUITING Decompensated Cirrhosis BIOLOGICAL: Human Umbilical Cord-derived Mesenchymal Stem Cells Beijing 302 Hospital Vcanbio Cell and Gene Engineering Corp., Ltd.

NCT04606446 Study of PF-07248144 in Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT04606446 RECRUITING Locally Advanced or Metastatic ER+ HER2- Breast Cancer

NCT05684146 Protect the Head to Head Study https://clinicaltrials.gov/study/NCT05684146 RECRUITING Embolism DEVICE: Emboliner Embolic Protection

NCT06223646 A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT06223646 RECRUITING Multiple Myeloma BIOLOGICAL: KQ-2003 CAR T-cells Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

NCT06084546 Geko‚Ñ¢ KM40C Hydrogel Skin Adhesion Trial (XW-3) https://clinicaltrials.gov/study/NCT06084546 NOT_YET_RECRUITING Leg Ulcer DEVICE: geko‚Ñ¢ X-W3 Firstkind Ltd

NCT06373146 A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity https://clinicaltrials.gov/study/NCT06373146 RECRUITING Obesity DRUG: Tirzepatide

NCT06706869 A Study to Learn if the Study Medicine Called Itraconazole Changes How the Body Processes the Other Study Medicine Called PF-07258669 In Older Adults https://clinicaltrials.gov/study/NCT06706869 NOT_YET_RECRUITING Healthy DRUG: PF-07258669

NCT05521269 Dose Study of ANX1502 in Healthy Volunteers https://clinicaltrials.gov/study/NCT05521269 RECRUITING Healthy DRUG: ANX1502

NCT06519669 Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer https://clinicaltrials.gov/study/NCT06519669 RECRUITING Adult

NCT04430569 Pulmonary Embolism International THrOmbolysis Study-3 https://clinicaltrials.gov/study/NCT04430569 RECRUITING Pulmonary Embolism DRUG: Alteplase

NCT04167969 The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer https://clinicaltrials.gov/study/NCT04167969 RECRUITING Prostate Cancer DRUG: (64Cu)-labeled PSMA-targeting particle tracer, or 64Cu-NOTA-PSMAi-PEG-Cy5.5-C' dots

NCT05618769 Towards Life-Long Healthy Lungs: A Multidisciplinary Follow-up Framework for Preterm Infants https://clinicaltrials.gov/study/NCT05618769 RECRUITING Premature Birth

NCT04331769 Clinical Evaluation of the AccuCinch¬Æ Ventricular Restoration System in Patients Who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): the CORCINCH-HF Study https://clinicaltrials.gov/study/NCT04331769 RECRUITING Heart Failure with Reduced Ejection Fraction (HFrEF)

NCT05552469 Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases https://clinicaltrials.gov/study/NCT05552469 RECRUITING Myeloid Diseases DRUG: DFV890 Novartis Pharmaceuticals

NCT04666168 A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT04666168 RECRUITING Non-hodgkin's Lymphoma BIOLOGICAL: Auto CAR-T

NCT05858268 NeuralNET Cerebral Palsy Pilot Study https://clinicaltrials.gov/study/NCT05858268 RECRUITING Cerebral Palsy GENETIC: Whole-genome sequencing University of Cambridge Rosetrees Trust

NCT02397668 CorMatrix Cor TRICUSPID ECM Valve Replacement Study https://clinicaltrials.gov/study/NCT02397668 RECRUITING Tricuspid Valve Disease DEVICE: CorMatrix Cor TRICUSPID ECM Valve CorMatrix Cardiovascular, Inc.

NCT06548568 A Real-world Study to Assess Safety of OZURDEX¬Æ (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China https://clinicaltrials.gov/study/NCT06548568 RECRUITING Diabetic Macular Edema AbbVie

NCT05190068 HMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma https://clinicaltrials.gov/study/NCT05190068 RECRUITING B-Cell Non-Hodgkin's Lymphoma DRUG: HMPL-760 Hutchison Medipharma Limited

NCT03900468 Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS) https://clinicaltrials.gov/study/NCT03900468 RECRUITING Epilepsy DEVICE: Activa‚Ñ¢ PC and Percept‚Ñ¢ PC Neurostimulation Systems MedtronicNeuro

NCT05522868 SB17170 Phase 1 Clinical Trial in Solid Tumors https://clinicaltrials.gov/study/NCT05522868 RECRUITING Solid Tumor DRUG: SB17170 SPARK Biopharma

NCT06113068 Fistura¬Æ Procedure for the Treatment of Complex Anal Fistulas https://clinicaltrials.gov/study/NCT06113068 NOT_YET_RECRUITING Complex Anal Fistulas DEVICE: Fistura¬Æ procedure F Care Systems NV

NCT05092269 A Long-term Extension Study of Ustekinumab in Pediatric Participants https://clinicaltrials.gov/study/NCT05092269 RECRUITING Crohn Disease

NCT05140369 CLL Therapy Approaches in Russia https://clinicaltrials.gov/study/NCT05140369 RECRUITING Chronic Lymphocytic Leukemia AstraZeneca

NCT05174169 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease https://clinicaltrials.gov/study/NCT05174169 RECRUITING Stage III Colon Cancer DEVICE: Signatera test

NCT06647069 DR-0201 in Subjects With Autoimmune Diseases https://clinicaltrials.gov/study/NCT06647069 NOT_YET_RECRUITING SLE

NCT05948969 Transform CV Risk in Diabetes https://clinicaltrials.gov/study/NCT05948969 RECRUITING Type 2 Diabetes OTHER: Decision support

NCT06127368 Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics From Single Dose of Intramuscular (IM) and Subcutaneous (SC) Donepezil (GB-5001) Injections Versus Donepezil Oral Tablet (Aricept¬Æ) in Healthy Male Volunteers https://clinicaltrials.gov/study/NCT06127368 RECRUITING Alzheimer Disease DRUG: GB-5001A

NCT06592768 A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants with Allergic Asthma https://clinicaltrials.gov/study/NCT06592768 NOT_YET_RECRUITING Allergic Asthma DRUG: Briquilimab

NCT04827368 Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease https://clinicaltrials.gov/study/NCT04827368 RECRUITING IBD

NCT06173869 A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 Œºg or 15 Œºg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China https://clinicaltrials.gov/study/NCT06173869 RECRUITING Infertility, Female DRUG: FE 999049

NCT06555068 A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients https://clinicaltrials.gov/study/NCT06555068 RECRUITING Advanced Unresectable or Metastatic Breast Cancer DRUG: HRS-6209 in Combination with Fulvestrant

NCT06547268 Advancing the Science of Pediatric Interstage Home Monitoring https://clinicaltrials.gov/study/NCT06547268 RECRUITING Heart Defects, Congenital DEVICE: Wireless sensor and platform Ann & Robert H Lurie Children's Hospital of Chicago Sibel Health Inc.

NCT06383468 A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis https://clinicaltrials.gov/study/NCT06383468 RECRUITING Atopic Dermatitis DRUG: AK120 Akeso

NCT05764668 Efficacy and Safety of Zihua Wenfei Granules in Treatment of Postinfectious Cough (Wind-cold Invading Lungs Syndrome) https://clinicaltrials.gov/study/NCT05764668 RECRUITING Cough DRUG: Zihua Wenfei Zhisou Granule

NCT06093568 Delving Into Participation Trends in Renal Cell Carcinoma Studies https://clinicaltrials.gov/study/NCT06093568 NOT_YET_RECRUITING Renal Cell Carcinoma Power Life Sciences Inc.

NCT05795140 Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS https://clinicaltrials.gov/study/NCT05795140 RECRUITING Atypical Hemolytic Uremic Syndrome DRUG: Iptcaopan 200 mg Novartis Pharmaceuticals

NCT06432140 A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Severe AADC Deficiency https://clinicaltrials.gov/study/NCT06432140 NOT_YET_RECRUITING Aromatic L-amino Acid Decarboxylase Deficiency GENETIC: VGN-R09b injection Shanghai Vitalgen BioPharma Co., Ltd.

NCT05221840 A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05221840 RECRUITING Non-Small Cell Lung Cancer DRUG: Durvalumab

NCT06612840 A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors https://clinicaltrials.gov/study/NCT06612840 RECRUITING Non-small Cell Lung Cancer

NCT05488340 A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial) https://clinicaltrials.gov/study/NCT05488340 RECRUITING Urinary Tract Infections DRUG: LBP-EC01 0.1 x IV dose

NCT05888740 Feasibility Study to Evaluate Therapeutic Ultrasound (TUS) to Acutely Increase the Perfusion in Peripheral Arterial Disease (PAD) https://clinicaltrials.gov/study/NCT05888740 RECRUITING Peripheral Arterial Disease DEVICE: VibratoSleeve Therapeutic Ultrasound Device Vibrato Medical, Inc.

NCT06299644 Endoscopic Sleeve Gastroplasty Technique Comparison for Weight Loss https://clinicaltrials.gov/study/NCT06299644 NOT_YET_RECRUITING Obesity

NCT04679844 Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed with Autograft in Patients Undergoing Posterolateral Lumbar Fusion https://clinicaltrials.gov/study/NCT04679844 NOT_YET_RECRUITING Degenerative Disc Disease

NCT05159544 The FuSion Program: A Prospective and Multicenter Cohort Study of Pan-Cancer Screening in Chinese Population https://clinicaltrials.gov/study/NCT05159544 RECRUITING Cancer Singlera Genomics Inc. Fudan University

NCT03721744 A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer https://clinicaltrials.gov/study/NCT03721744 RECRUITING Metastatic Pancreatic Cancer DRUG: GB201

NCT04098744 Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) https://clinicaltrials.gov/study/NCT04098744 RECRUITING CIN 2/3

NCT04029844 Colibri Transcatheter Aortic Heart Valve System Study https://clinicaltrials.gov/study/NCT04029844 RECRUITING Severe Aortic Stenosis DEVICE: Colibri TAVI System Colibri Heart Valve LLC

NCT06085144 Emgality for Migraine in Breastmilk https://clinicaltrials.gov/study/NCT06085144 RECRUITING Migraine DRUG: Galcanezumab University of California, San Francisco Eli Lilly and Company

NCT04961944 HypErsensitiVity PneumonITis: DiseAse Progression Characterization https://clinicaltrials.gov/study/NCT04961944 RECRUITING Hypersensitivity Pneumonitis OTHER: Disease assessment Hospital do Coracao Boehringer Ingelheim

NCT04522544 Durvalumab and Tremelimumab in Combination With Either Y-90 SIRT or DEB-TACE for Intermediate Stage HCC https://clinicaltrials.gov/study/NCT04522544 RECRUITING Hepatocellular Carcinoma Non-resectable

NCT05979844 MDMA-assisted Brief Cognitive Behavioral Conjoint Therapy for PTSD https://clinicaltrials.gov/study/NCT05979844 RECRUITING PTSD

NCT05823844 Efficacy of Suvorexant on Post-operative Sleep Disturbance https://clinicaltrials.gov/study/NCT05823844 RECRUITING Postoperative Insomnia

NCT06020144 A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs https://clinicaltrials.gov/study/NCT06020144 RECRUITING Rheumatoid Arthritis DRUG: TLL-018

NCT06664801 A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024) https://clinicaltrials.gov/study/NCT06664801 RECRUITING Pulmonary Arterial Hypertension BIOLOGICAL: Sotatercept

NCT06223867 Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part a https://clinicaltrials.gov/study/NCT06223867 RECRUITING Suicidal Ideation

NCT06660667 A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration https://clinicaltrials.gov/study/NCT06660667 NOT_YET_RECRUITING Neovascular Age-related Macular Degeneration BIOLOGICAL: SAR402663

NCT06004167 Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T) https://clinicaltrials.gov/study/NCT06004167 RECRUITING Lymphoma, B-Cell

NCT05007067 H-29 DELTA Multihole TT Study. https://clinicaltrials.gov/study/NCT05007067 RECRUITING Osteoarthritis, Hip DEVICE: DELTA Multihole TT Limacorporate S.p.a

NCT05205967 REFLECTION: A Clinical Practice Learning Program for Galleri¬Æ https://clinicaltrials.gov/study/NCT05205967 RECRUITING Early Detection of Cancer

NCT05406167 Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System https://clinicaltrials.gov/study/NCT05406167 RECRUITING Cancer

NCT05742867 A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder https://clinicaltrials.gov/study/NCT05742867 RECRUITING Urinary Bladder Neoplasms Bristol-Myers Squibb Ono Pharmaceutical Co. Ltd

NCT05315167 A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05315167 RECRUITING Advanced Solid Tumor

NCT06623240 HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis https://clinicaltrials.gov/study/NCT06623240 NOT_YET_RECRUITING Juvenile Idiopathic Arthritis (JIA) BIOLOGICAL: allogeneic Hope Biosciences adipose-derived mesenchymal stem cells

NCT06715540 Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Single Ascending and Extension Doses of BCD-261 in Healthy Subjects https://clinicaltrials.gov/study/NCT06715540 RECRUITING Healthy DRUG: BCD-261, dose 1

NCT06601140 Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients with Mild to Moderate Depressive Episode https://clinicaltrials.gov/study/NCT06601140 NOT_YET_RECRUITING Major Depressive Disorder (MDD) DEVICE: EMOCARE software Emobot Rumb

NCT05960240 Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects. https://clinicaltrials.gov/study/NCT05960240 RECRUITING Chronic Hepatitis b DRUG: AB-101

NCT04948840 Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis https://clinicaltrials.gov/study/NCT04948840 RECRUITING Radiation Toxicity

NCT05869240 BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05869240 RECRUITING Solid Tumor DRUG: BPB-101 Betta Pharmaceuticals Co., Ltd.

NCT06644040 A Study of TeriQ Patch in Healthy Adult Female Participants https://clinicaltrials.gov/study/NCT06644040 RECRUITING Osteoporosis DRUG: TeriQ Patch

NCT06146140 Effects of an Oral Herbal Supplement on Skin Aging, Hydration, and Elasticity https://clinicaltrials.gov/study/NCT06146140 NOT_YET_RECRUITING Photoaging DIETARY_SUPPLEMENT: Oral herbal supplement

NCT03734640 Optimal Post Tpa-Iv Monitoring in Ischemic Stroke https://clinicaltrials.gov/study/NCT03734640 RECRUITING Acute Ischemic Stroke Patients Receiving Reperfusion Therapy OTHER: Low-intensity monitoring strategy

NCT06313944 German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation https://clinicaltrials.gov/study/NCT06313944 NOT_YET_RECRUITING Alzheimer Disease DIAGNOSTIC_TEST: Registry Heinrich-Heine University, Duesseldorf Storz Medical AG

NCT06533644 A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT06533644 NOT_YET_RECRUITING Metastatic Castration-resistant Prostate Cancer DRUG: SV-102 Syncromune, Inc.

NCT06417840 To Evaluate the Impact of Consumption of a Bioactive Compound on Fasting Blood Glucose Levels in Asian Indians With Pre-diabetes https://clinicaltrials.gov/study/NCT06417840 RECRUITING PreDiabetes DIETARY_SUPPLEMENT: N-trans-caffeoyltyramine (NCT) and N-trans-feruloyltyramine (NFT)

NCT05711940 Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD https://clinicaltrials.gov/study/NCT05711940 RECRUITING Treatment Resistant Depression DRUG: Psilocybin COMPASS Pathways

NCT05277740 Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis https://clinicaltrials.gov/study/NCT05277740 RECRUITING Clinically Isolated Syndrome

NCT05238740 Comparison of Standalone Anterior Lumbar Interbody Fusion (ALIF) L5/S1 Performed With Either rhBMP-2 or ViviGen¬Æ https://clinicaltrials.gov/study/NCT05238740 RECRUITING Spondylosis

NCT06632444 LIVERAGE‚Ñ¢: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis https://clinicaltrials.gov/study/NCT06632444 RECRUITING Metabolic Dysfunction Associated Steatohepatitis (MASH)

NCT06664944 Technology Exposure and Child Health: Wellness Impact and Social Effects: an Observational Product Registry Study https://clinicaltrials.gov/study/NCT06664944 NOT_YET_RECRUITING Mood

NCT06651944 Invisalign¬Æ System with Mandibular Advancement https://clinicaltrials.gov/study/NCT06651944 RECRUITING Class II Malocclusion

NCT02952144 Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis https://clinicaltrials.gov/study/NCT02952144 RECRUITING Dialysis Amyloidosis DEVICE: Lixelle¬Æ treatment Kaneka Medical America LLC

NCT05948540 Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant https://clinicaltrials.gov/study/NCT05948540 RECRUITING Post Traumatic Stress Disorder DRUG: Intervention C Daridorexant

NCT05039840 Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus https://clinicaltrials.gov/study/NCT05039840 RECRUITING Systemic Lupus Erythematosus DRUG: SAR441344 IV

NCT06365840 A Study of Phase2, IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor https://clinicaltrials.gov/study/NCT06365840 NOT_YET_RECRUITING TMB-H

NCT06480240 A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06480240 RECRUITING Advanced Solid Tumor DRUG: OBI-992 OBI Pharma, Inc

NCT04956640 Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) https://clinicaltrials.gov/study/NCT04956640 RECRUITING Carcinoma, Non-Small-Cell Lung

NCT04908644 MS-20 on Patients With Ulcerative Colitis(UC) https://clinicaltrials.gov/study/NCT04908644 RECRUITING Ulcerative Colitis DRUG: MS-20 oral solution

NCT06117540 A Study of WX390 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06117540 RECRUITING Solid Tumor DRUG: WX390 Shanghai Jiatan Pharmatech Co., Ltd

NCT06589440 Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) https://clinicaltrials.gov/study/NCT06589440 NOT_YET_RECRUITING Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) DRUG: SR-8541A Stingray Therapeutics

NCT06363240 Evaluation of Broadband Light Treatment for Solar Lentigines https://clinicaltrials.gov/study/NCT06363240 RECRUITING Solar Lentigo DEVICE: Broadband Light Sciton

NCT06597240 Home Monitoring During Chemoradiation https://clinicaltrials.gov/study/NCT06597240 NOT_YET_RECRUITING Locally Advanced Head and Neck Carcinoma DEVICE: AMCOR University Medical Center Groningen Siemens Corporation, Corporate Technology

NCT06494540 NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations https://clinicaltrials.gov/study/NCT06494540 RECRUITING Non-squamous Metastatic Non-Small-Cell Lung Carcinoma AstraZeneca

NCT06153940 Everglade Stem, World Cup and World Liner Post Market Clinical Follow-up https://clinicaltrials.gov/study/NCT06153940 RECRUITING Hip Disease DEVICE: Treatment Signature Orthopaedics The Cleveland Clinic

NCT03960840 Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL https://clinicaltrials.gov/study/NCT03960840 RECRUITING Chronic Lymphocytic Leukemia

NCT05301140 Vivistim Registry for Paired VNS Therapy (GRASP) https://clinicaltrials.gov/study/NCT05301140 RECRUITING Upper Extremity Problem DEVICE: Vivistim System MicroTransponder Inc.

NCT05919940 Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPRO ) https://clinicaltrials.gov/study/NCT05919940 RECRUITING ICU Acquired Weakness

NCT06703840 Phase 2a Trial to Investigate the Efficacy of LIB-01 in Treatment of Erectile Dysfunction https://clinicaltrials.gov/study/NCT06703840 RECRUITING Erectile Dysfunction DRUG: LIB-01

NCT03902444 AcandiS Stenting of Intracranial STENosis - regisTry https://clinicaltrials.gov/study/NCT03902444 RECRUITING Intracranial Stenosis DEVICE: Credo¬Æ Stent, NeuroSpeed¬Æ PTA balloon catheter Acandis GmbH

NCT06623344 Brain Volume and Cardiac Function in Heart Failure https://clinicaltrials.gov/study/NCT06623344 NOT_YET_RECRUITING Heart Failure OTHER: Magnetic Resonance Imaging with or without Contrast Johns Hopkins University Canon Medical Systems, USA

NCT06657144 A Study of CHS-114 in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06657144 NOT_YET_RECRUITING Metastatic Solid Tumor

NCT06120140 Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib https://clinicaltrials.gov/study/NCT06120140 RECRUITING Carcinoma, Non-Small-Cell Lung DRUG: Amivantamab

NCT06533540 Safety Study of TPX-121 on Nasolabial Folds https://clinicaltrials.gov/study/NCT06533540 RECRUITING Nasolabial Fold, Hypoplastic BIOLOGICAL: TPX-115(allogeneic fibroblasts) Tego Science, Inc.

NCT03026140 Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer https://clinicaltrials.gov/study/NCT03026140 RECRUITING Colon Carcinoma DRUG: Nivolumab

NCT05693844 Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05693844 RECRUITING Advanced or Metastatic Solid Tumors BIOLOGICAL: Pan-T booster co-expressing MSLN CAR T cell

NCT06007144 Performance of the SPIRION Laryngeal Pacemaker in BVFP Patients With Single-sided Glottal Enlargement https://clinicaltrials.gov/study/NCT06007144 RECRUITING Bilateral Vocal Cord Paralysis DEVICE: SPIRION Laryngeal Pacemaker System Implantation and follow-up MED-EL Elektromedizinische Ger√§te GesmbH

NCT05307744 Effects of Lactobacillus Plantarum PS128 in Children With ASD https://clinicaltrials.gov/study/NCT05307744 RECRUITING Autism Spectrum Disorder DIETARY_SUPPLEMENT: PS128

NCT05849844 Tympanoseal Clinical Study https://clinicaltrials.gov/study/NCT05849844 RECRUITING Tympanic Membrane Perforation DEVICE: Tympanoseal Grace Medical, Inc.

NCT03671044 A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients https://clinicaltrials.gov/study/NCT03671044 RECRUITING Triple Negative Breast Cancer DRUG: Nanosomal Docetaxel Lipid Suspension (75 mg/m2)

NCT06031844 A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Elevated hsCRP https://clinicaltrials.gov/study/NCT06031844 RECRUITING Coronary Heart Disease DRUG: DFV890

NCT06469944 Substudy 06C: A Study of Sacituzumab Tirumotecan (MK-2870) With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06) https://clinicaltrials.gov/study/NCT06469944 RECRUITING Gastroesophageal Junction

NCT05723640 The Safety and Dosimetry Study of 177Lu-LNC1004 Injection https://clinicaltrials.gov/study/NCT05723640 RECRUITING Solid Tumor, Unspecified, Adult DRUG: 177Lu-LNC1004 Injection group 1 radionuclide therapy

NCT06087640 A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ‚â•65 Years of Age https://clinicaltrials.gov/study/NCT06087640 RECRUITING Influenza, Human BIOLOGICAL: aQIV or aTIV

NCT06555640 A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia https://clinicaltrials.gov/study/NCT06555640 RECRUITING Severe Hypertriglyceridemia DRUG: DR10624 Injection

NCT06044844 Effectiveness of Tofacitinib in Systemic Sclerosis https://clinicaltrials.gov/study/NCT06044844 RECRUITING Efficacy of Tofacitinib in the Systemic Sclerosis DRUG: Tofacitinib Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Aristopharma Ltd

NCT06144944 Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer https://clinicaltrials.gov/study/NCT06144944 RECRUITING Breast Cancer Invasive

NCT05765344 Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function https://clinicaltrials.gov/study/NCT05765344 RECRUITING Chronic Hepatitis D Infection DRUG: Bulevirtide Gilead Sciences

NCT06355544 Individual Factors Related to Chronic Low-grade Inflammation and Cardiometabolic Disease Risk https://clinicaltrials.gov/study/NCT06355544 NOT_YET_RECRUITING Overweight

NCT06213844 A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics https://clinicaltrials.gov/study/NCT06213844 RECRUITING Healthy Participants

NCT06280144 Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine https://clinicaltrials.gov/study/NCT06280144 RECRUITING Influenza Prevention BIOLOGICAL: Influenza Vaccine, Live, Nasal, Freeze-dried

NCT05283044 Implementing Precision Medicine in cOmmunity HospiTALs https://clinicaltrials.gov/study/NCT05283044 RECRUITING Metastatic Cancer BIOLOGICAL: biopsy liquid Gustave Roussy, Cancer Campus, Grand Paris Roche Pharma AG

NCT06558344 A Study to Test Different Doses of BI 1569912 in People With Depression https://clinicaltrials.gov/study/NCT06558344 RECRUITING Depressive Disorder, Major DRUG: BI 1569912

NCT04730544 Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. https://clinicaltrials.gov/study/NCT04730544 RECRUITING Colorectal Cancer Metastatic

NCT06386744 Dusquetide for the Treatment of Behcet's Disease https://clinicaltrials.gov/study/NCT06386744 RECRUITING Beh√ßet Disease DRUG: Dusquetide Soligenix

NCT06200844 The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants https://clinicaltrials.gov/study/NCT06200844 RECRUITING Rotavirus Infection of Children BIOLOGICAL: ROTAVAC 5D

NCT06714240 Enhanced Protein Intake to Support Muscle Protein Synthesis in ICU https://clinicaltrials.gov/study/NCT06714240 NOT_YET_RECRUITING Critical Illness

NCT05527340 Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients. https://clinicaltrials.gov/study/NCT05527340 NOT_YET_RECRUITING Multiple Myeloma DRUG: Iberdomide

NCT06547840 A Study of MOv18 IgE in Folate Receptor Alpha-expressing Platinum Resistant Ovarian Cancer https://clinicaltrials.gov/study/NCT06547840 RECRUITING Advanced Ovarian Cancer

NCT06313840 Central Sleep Apnea Prevalence and Impact on Cognitive Function in Patients With Heart Failure With Reduced or Mildly Reduced Left Ventricular Ejection Fraction https://clinicaltrials.gov/study/NCT06313840 RECRUITING Heart Failure

NCT06659640 A Study to Evaluate ALN-6400 in Adult Healthy Volunteers https://clinicaltrials.gov/study/NCT06659640 NOT_YET_RECRUITING Healthy Volunteers DRUG: ALN-6400

NCT06336044 Pre-marketing Clinical Trial to Evaluate the Safety and Efficacy of the Filler of Hyaluronic Acid Recombinant Collagen https://clinicaltrials.gov/study/NCT06336044 NOT_YET_RECRUITING Wrinkle

NCT06100744 A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab https://clinicaltrials.gov/study/NCT06100744 RECRUITING Juvenile Psoriatic Arthritis DRUG: Adalimumab

NCT06620744 Magnetocardiography (MCG) Device Use in Patients with Elevated Troponin https://clinicaltrials.gov/study/NCT06620744 NOT_YET_RECRUITING ACS - Acute Coronary Syndrome DEVICE: Sponsor MCG deivce SB Technology, Inc.

NCT06495944 Impact of Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Participants https://clinicaltrials.gov/study/NCT06495944 RECRUITING Healthy Adults DRUG: Dazucorilant

NCT06520540 HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects https://clinicaltrials.gov/study/NCT06520540 NOT_YET_RECRUITING Glucagon-Like Peptide-1 Receptor Agonists DRUG: HDM1002 100 mg QD 12weeks

NCT06375044 Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT06375044 RECRUITING Relapsed or Refractory Multiple Myeloma DRUG: SIM0500 Jiangsu Simcere Pharmaceutical Co., Ltd. Shanghai Xianxiang Medical Technology Co., Ltd.

NCT06039644 To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer https://clinicaltrials.gov/study/NCT06039644 RECRUITING Breast Cancer DIETARY_SUPPLEMENT: Probiotic

NCT04192344 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor https://clinicaltrials.gov/study/NCT04192344 RECRUITING Neoplasms

NCT04834544 A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care https://clinicaltrials.gov/study/NCT04834544 RECRUITING Epithelial Ovarian Carcinoma

NCT05906992 A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis https://clinicaltrials.gov/study/NCT05906992 RECRUITING Relapsing-remitting Multiple Sclerosis BIOLOGICAL: CT-P53

NCT06620692 A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis https://clinicaltrials.gov/study/NCT06620692 NOT_YET_RECRUITING Psoriasis DRUG: 5% GM-XANTHO [GM-XAN003]

NCT06649292 SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma https://clinicaltrials.gov/study/NCT06649292 NOT_YET_RECRUITING Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma DRUG: SHR-A1904

NCT05888792 Effectiveness of the Defocus Incorporated Spectacle Lenses on Fast Progressing Myope https://clinicaltrials.gov/study/NCT05888792 RECRUITING Myopia OTHER: Variant of Defocus Incorporated Spectacle lens (DG2) The Hong Kong Polytechnic University HOYA Lens Thailand LTD.

NCT06721689 PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors https://clinicaltrials.gov/study/NCT06721689 NOT_YET_RECRUITING Refractory Solid Tumors

NCT05529901 Japan Post Marketing Surveillance of the GORE¬Æ CARDIOFORM Septal Occluder https://clinicaltrials.gov/study/NCT05529901 RECRUITING Stroke

NCT06075667 A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities https://clinicaltrials.gov/study/NCT06075667 RECRUITING Obesity

NCT04472767 Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT04472767 RECRUITING Hepatocellular Carcinoma

NCT05879367 Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma https://clinicaltrials.gov/study/NCT05879367 RECRUITING Glioblastoma, IDH-wildtype

NCT03392467 PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants https://clinicaltrials.gov/study/NCT03392467 RECRUITING Severe Bronchopulmonary Dysplasia BIOLOGICAL: PNEUMOSTEM

NCT05636267 Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients https://clinicaltrials.gov/study/NCT05636267 RECRUITING NSCLC DRUG: AK119

NCT06320067 A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer https://clinicaltrials.gov/study/NCT06320067 RECRUITING Prostate Cancer Metastatic RADIATION: Stereotactic Ablative Body Radiotherapy (SABR)

NCT06504667 To Validate Point Mini User Needs https://clinicaltrials.gov/study/NCT06504667 NOT_YET_RECRUITING Amputation; Traumatic, Hand

NCT06704867 High Flow Nasal Cannula Compared to Standard Oxygen for Endoscopic Ultrasound https://clinicaltrials.gov/study/NCT06704867 NOT_YET_RECRUITING Endoscopic Ultrasound OTHER: High flow nasal cannula Mayo Clinic Fisher and Paykel Healthcare

NCT02628067 Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) https://clinicaltrials.gov/study/NCT02628067 RECRUITING Advanced Cancer

NCT06703892 A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects with Relapsed or Refractory B-Cell Hematological Malignancies https://clinicaltrials.gov/study/NCT06703892 NOT_YET_RECRUITING Diffuse Large B Cell Lymphoma Relapsed

NCT06277492 A First-In-Human Study of Single and Multiple Ascending Doses of Oral SUL-238 in Healthy Subjects https://clinicaltrials.gov/study/NCT06277492 RECRUITING Healthy Subjects DRUG: Single ascending doses SUL-238

NCT05978492 A Study of TXN10128 in Subjects With Solid Tumors https://clinicaltrials.gov/study/NCT05978492 RECRUITING Locally Advanced (Unresectable) or Metastatic Solid Tumors DRUG: TXN10128 Txinno Bioscience Inc.

NCT05710692 Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients with Fabry Disease https://clinicaltrials.gov/study/NCT05710692 RECRUITING Fabry Disease DRUG: PRX-102 1 mg/kg every 2 weeks

NCT05796492 Ultrasound Treatment on Wound Healing Time https://clinicaltrials.gov/study/NCT05796492 RECRUITING Burn Wound

NCT04393389 Acotec DCB Post Market Clinical Follow-up https://clinicaltrials.gov/study/NCT04393389 RECRUITING Peripheral Artery Disease DEVICE: AcoArt Orchid (0.035"), AcoArt Tulip (0.018") and AcoArt Litos (0.014") percutaneous transluminal angioplasty (PTA) paclitaxel drug coated balloon catheter manufactured by Acotec Scientific Co., Ltd. Acotec Scientific Co., Ltd

NCT05590689 Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor https://clinicaltrials.gov/study/NCT05590689 RECRUITING Glioblastoma DRUG: Gliolan

NCT06324344 Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN) https://clinicaltrials.gov/study/NCT06324344 RECRUITING Chemotherapy-induced Peripheral Neuropathy

NCT05578092 A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway https://clinicaltrials.gov/study/NCT05578092 RECRUITING Solid Tumor

NCT01633489 Lysosomal Acid Lipase (LAL) Deficiency Registry https://clinicaltrials.gov/study/NCT01633489 RECRUITING Lysosomal Acid Lipase Deficiency

NCT05851092 Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT05851092 RECRUITING Advanced Malignant Tumor DRUG: HRS-2189 Tablets Shandong Suncadia Medicine Co., Ltd.

NCT05696392 The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance. https://clinicaltrials.gov/study/NCT05696392 RECRUITING Atopic Dermatitis DRUG: ruxolitinib cream Incyte Corporation

NCT06671392 A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients with Hypertension https://clinicaltrials.gov/study/NCT06671392 NOT_YET_RECRUITING Essential Hypertension DRUG: DWC202405

NCT06710392 Efficacy of Two Enzyme Cocktails in Healthy Adults https://clinicaltrials.gov/study/NCT06710392 NOT_YET_RECRUITING Digestive

NCT06222892 A Study of Camlipixant in Male and Female Healthy Participants and Participants With Hepatic Impairment Aged 18-75 Years of Age https://clinicaltrials.gov/study/NCT06222892 RECRUITING Cough DRUG: Camlipixant Bellus Health Inc. - a GSK company

NCT05980689 Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer https://clinicaltrials.gov/study/NCT05980689 RECRUITING Locally Advanced Rectal Cancer DRUG: AK104

NCT05337189 A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China https://clinicaltrials.gov/study/NCT05337189 RECRUITING Bladder Cancer

NCT06634589 A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies https://clinicaltrials.gov/study/NCT06634589 NOT_YET_RECRUITING B-cell Malignancy

NCT06690489 An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients with Early Breast Cancer Treated with Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events) https://clinicaltrials.gov/study/NCT06690489 NOT_YET_RECRUITING Early Breast Cancer

NCT06681389 A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis https://clinicaltrials.gov/study/NCT06681389 NOT_YET_RECRUITING Healthy Adult Volunteers

NCT05536089 ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation https://clinicaltrials.gov/study/NCT05536089 RECRUITING Cancer Colorectal DIAGNOSTIC_TEST: a multi-locus blood-based assay Singlera Genomics Inc. Second Affiliated Hospital, School of Medicine, Zhejiang University

NCT06390592 Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep‚Ä¢Safe Harmony https://clinicaltrials.gov/study/NCT06390592 NOT_YET_RECRUITING Renal Failure

NCT04310592 Natural Killer Cell (CYNK-001) Infusions in Adults With AML https://clinicaltrials.gov/study/NCT04310592 RECRUITING Leukemia

NCT05044689 Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria https://clinicaltrials.gov/study/NCT05044689 RECRUITING Colorectal Cancer

NCT06659289 Hemoperfusion Efferon LPS During Cardiac Surgery Using Cardiopulmonary Bypass https://clinicaltrials.gov/study/NCT06659289 RECRUITING Cardiac Disease

NCT05728489 A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis https://clinicaltrials.gov/study/NCT05728489 RECRUITING Psoriasis DRUG: BI 765250

NCT03254589 Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT03254589 RECRUITING Rheumatoid Arthritis

NCT06443489 A Trial of SHR-4849 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06443489 RECRUITING Advanced Solid Tumors DRUG: SHR-4849 Suzhou Suncadia Biopharmaceuticals Co., Ltd.

NCT06597292 The VIS Opti-K Low Vision Aid Device Provides Vision Improvement. https://clinicaltrials.gov/study/NCT06597292 NOT_YET_RECRUITING Hyperopia

NCT04811092 Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) https://clinicaltrials.gov/study/NCT04811092 RECRUITING Pulmonary Arterial Hypertension DRUG: Sotatercept

NCT06389292 A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacytidine in the Treatment of Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06389292 RECRUITING Acute Myeloid Leukemia DRUG: Lisaftoclax (APG-2575)

NCT04307992 AneuFix - Prophylactic Sac Filling https://clinicaltrials.gov/study/NCT04307992 RECRUITING Abdominal Aortic Aneurysm

NCT06267092 A Study of How CagriSema Works on Appetite in People With Excess Body Weight https://clinicaltrials.gov/study/NCT06267092 RECRUITING Overweight

NCT06379789 A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B https://clinicaltrials.gov/study/NCT06379789 RECRUITING Hemophilia B DRUG: REGV131

NCT05118789 A Study of NVL-520 in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1) https://clinicaltrials.gov/study/NCT05118789 RECRUITING Locally Advanced Solid Tumor

NCT04562389 Study of Selinexor in Combination with Ruxolitinib in Myelofibrosis https://clinicaltrials.gov/study/NCT04562389 RECRUITING Myelofibrosis DRUG: Selinexor

NCT05656092 A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients with Gastric Ulcer https://clinicaltrials.gov/study/NCT05656092 RECRUITING Gastric Ulcer DRUG: HIP0612

NCT06642792 A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma https://clinicaltrials.gov/study/NCT06642792 NOT_YET_RECRUITING Classic Hodgkin Lymphoma DRUG: AK129

NCT05353192 A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia https://clinicaltrials.gov/study/NCT05353192 RECRUITING Achondroplasia DRUG: Recombinant human growth hormone Changchun GeneScience Pharmaceutical Co., Ltd. Children's Hospital of Fudan University

NCT05972889 Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients with Non-Specific CLBP https://clinicaltrials.gov/study/NCT05972889 RECRUITING Non-Specific Chronic Lower Back Pain DEVICE: NexWave

NCT05675189 Exploring Clinical Trial Experiences of Patients With Migraine https://clinicaltrials.gov/study/NCT05675189 NOT_YET_RECRUITING Migraine

NCT04381689 Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants https://clinicaltrials.gov/study/NCT04381689 RECRUITING Healthy BIOLOGICAL: IL-YANG FLU Vaccine Prefilled Syringe INJ.

NCT05329792 L19IL2/L19TNF in Skin Cancer Patients https://clinicaltrials.gov/study/NCT05329792 RECRUITING BCC - Basal Cell Carcinoma

NCT06360289 Observational Study of Neurofilament Light Chain (NfL) as a Biomarker in Asymptomatic Carriers of the Transthyretin (TTR) Variants and Patients With Hereditary Transthyretin-mediated (hATTR) Amyloidosis With Polyneuropathy https://clinicaltrials.gov/study/NCT06360289 RECRUITING Hereditary Amyloidosis, Transthyretin-Related

NCT05723289 Evaluation of the Feasibility of Remote Monitoring of Mechanical In-exsufflation Devices in Paralytic and Neuromuscular Patients Treated at Home. https://clinicaltrials.gov/study/NCT05723289 RECRUITING Neuromuscular Diseases

NCT05468489 To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC https://clinicaltrials.gov/study/NCT05468489 RECRUITING Extensive Stage Small Cell Lung Cancer DRUG: Serplulimab + chemotherapy (carboplatin-etoposide)

NCT03519269 Navio Robotic Versus Conventional Total Knee Arthroplasty https://clinicaltrials.gov/study/NCT03519269 RECRUITING Osteoarthritis, Knee DEVICE: Navio‚Ñ¢ Robotics-assisted Surgical System Columbia University Smith & Nephew, Inc.

NCT04248569 DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT04248569 RECRUITING Fibrolamellar Hepatocellular Carcinoma (FLC) DRUG: DNAJB1-PRKACA peptide vaccine

NCT05756569 Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology https://clinicaltrials.gov/study/NCT05756569 RECRUITING Bladder Squamous Cell Carcinoma

NCT05109169 METformin and FINGER Intervention to Prevent Cognitive Impairment and Disability in Older Adults at Risk for Dementia https://clinicaltrials.gov/study/NCT05109169 RECRUITING Cognitive Decline

NCT06539169 FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases https://clinicaltrials.gov/study/NCT06539169 RECRUITING Alpha-Thalassemia

NCT04512469 Study on the Efficacy of Prophylactic on Lay Mesh in Preventing Post-operative Hernia in Liver Transplant Patients https://clinicaltrials.gov/study/NCT04512469 NOT_YET_RECRUITING Incisional Hernia of Anterior Abdominal Wall DEVICE: Low molecular weight mesh Lawson Health Research Institute Ethicon, Inc.

NCT04924569 Continence Care Registry https://clinicaltrials.gov/study/NCT04924569 RECRUITING Neurogenic Bladder

NCT06197568 Open-Label Study of Vaginal AZU-101 in Postmenopausal Women https://clinicaltrials.gov/study/NCT06197568 NOT_YET_RECRUITING Postmenopausal Symptoms DRUG: Lasofoxifene Tartrate (AZU-101)

NCT06135168 A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations https://clinicaltrials.gov/study/NCT06135168 NOT_YET_RECRUITING Pediatric Growth Hormone Deficiency (PGHD) DRUG: PEG-rhGH with new preparation

NCT06673368 A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR with NRCT-202XR Compared to NRCT-202XR Alone in Subjects with Attention-Deficit/Hyperactivity Disorder https://clinicaltrials.gov/study/NCT06673368 RECRUITING ADHD DRUG: NRCT-101SR, NRCT-202XR Neurocentria, Inc.

NCT05648968 A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia https://clinicaltrials.gov/study/NCT05648968 RECRUITING Warm Autoimmune Hemolytic Anemia (wAIHA) BIOLOGICAL: Ianalumab

NCT05508568 A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer https://clinicaltrials.gov/study/NCT05508568 RECRUITING Bladder Cancer DIAGNOSTIC_TEST: ADXBLADDER Arquer Diagnostics Ltd

NCT05287568 CC-486 and Venetoclax for Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT05287568 RECRUITING AML DRUG: Venetoclax

NCT05776069 Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease https://clinicaltrials.gov/study/NCT05776069 RECRUITING Von Willebrand Diseases DRUG: VGA039

NCT06695169 Evaluation of the Integrated Smart Pump-EHR Technology in Eight Adult Acute and Intensive Care Units https://clinicaltrials.gov/study/NCT06695169 NOT_YET_RECRUITING Nurse's Role The University of Texas Health Science Center at San Antonio Baxter Healthcare Corporation

NCT06713369 AZD5305 hADME in Patients With Advanced Solid Malignancies https://clinicaltrials.gov/study/NCT06713369 NOT_YET_RECRUITING Locally Advanced or Metastatic Solid Tumor DRUG: Saruparib (AZD5305)

NCT04556669 Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors https://clinicaltrials.gov/study/NCT04556669 RECRUITING Solid Tumor, Adult

NCT05001269 Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function https://clinicaltrials.gov/study/NCT05001269 RECRUITING Primary Hyperoxaluria

NCT04944069 Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal Metastasis https://clinicaltrials.gov/study/NCT04944069 NOT_YET_RECRUITING NSCLC

NCT06387069 A Study to Evaluate HMPL-306 in Patients With IDH1- and IDH2-mutated Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06387069 RECRUITING Acute Myeloid Leukemia DRUG: HMPL-306 Regimen

NCT05847868 Clinical Evaluation of Moment Tumor Hip Replacement Products https://clinicaltrials.gov/study/NCT05847868 RECRUITING Primary and Secondary Bone Tumor in the Proximal Femur Region DEVICE: Moment Tumour Hip Prothesis Estas Tƒ±bbi Mam√ºlleri Medikal Klinar CRO

NCT06465368 A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause https://clinicaltrials.gov/study/NCT06465368 RECRUITING Breast Cancer DRUG: PF-07220060

NCT03896568 MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma https://clinicaltrials.gov/study/NCT03896568 RECRUITING IDH1 wt Allele

NCT05613868 TPN-101 in Aicardi-Gouti√®res Syndrome (AGS) https://clinicaltrials.gov/study/NCT05613868 RECRUITING Aicardi-Gouti√®res Syndrome (AGS) DRUG: TPN-101 Transposon Therapeutics, Inc.

NCT03737669 Mirasol Evaluation of Reduction in Infections Trial https://clinicaltrials.gov/study/NCT03737669 RECRUITING Transfusion-Transmitted Infectious Disease BIOLOGICAL: Mirasol-treated Fresh Whole Blood

NCT06220669 A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis https://clinicaltrials.gov/study/NCT06220669 RECRUITING Multiple Sclerosis DRUG: LY3541860

NCT06163469 Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life https://clinicaltrials.gov/study/NCT06163469 RECRUITING Neurogenic Bladder

NCT04426669 A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering https://clinicaltrials.gov/study/NCT04426669 RECRUITING Gastrointestinal Epithelial Cancer

NCT05992168 Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME) https://clinicaltrials.gov/study/NCT05992168 NOT_YET_RECRUITING PE - Pulmonary Embolism

NCT05976568 A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT05976568 NOT_YET_RECRUITING Hepatocellular Carcinoma DRUG: QL1706

NCT06671769 Natural Heart Health Supplement Trial https://clinicaltrials.gov/study/NCT06671769 NOT_YET_RECRUITING Cholesterol

NCT06106269 Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids https://clinicaltrials.gov/study/NCT06106269 RECRUITING Internal Hemorrhoid DEVICE: Rectal Artery Embolization Mayo Clinic Terumo Corporation

NCT05843669 A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis. https://clinicaltrials.gov/study/NCT05843669 RECRUITING Chronic Bronchitis DRUG: Guafenesin tablets American Health Research Vitaccess Ltd

NCT05881369 Examining Clinical Research Participation for Substance Abuse Disorder Patient https://clinicaltrials.gov/study/NCT05881369 NOT_YET_RECRUITING Substance Abuse Disorder Power Life Sciences Inc.

NCT05723068 Burden of Hepatitis D Virus (HDV) Infection in Italy https://clinicaltrials.gov/study/NCT05723068 RECRUITING Chronic Hepatitis D University of Turin, Italy Gilead Sciences

NCT02991469 A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS) https://clinicaltrials.gov/study/NCT02991469 RECRUITING Juvenile Idiopathic Arthritis DRUG: Sarilumab SAR153191 (REGN88) Sanofi Regeneron Pharmaceuticals

NCT03922269 Trans People Living With HIV Throughout Europe https://clinicaltrials.gov/study/NCT03922269 RECRUITING HIV Infections

NCT06701669 JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart https://clinicaltrials.gov/study/NCT06701669 NOT_YET_RECRUITING Acute Respiratory Distress Syndrome (ARDS)

NCT06536569 Comparison of Efficacy Between ILM Forceps https://clinicaltrials.gov/study/NCT06536569 NOT_YET_RECRUITING Macular Holes

NCT06685068 Trial to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Antitumor Activity of GEN1286 in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06685068 RECRUITING Advanced Solid Tumor DRUG: GEN1286 Genmab

NCT05277168 A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS https://clinicaltrials.gov/study/NCT05277168 RECRUITING Advanced Solid Tumors DRUG: SHR-A1904 Jiangsu HengRui Medicine Co., Ltd.

NCT03789669 A Prospective, Multi-Center Evaluation of Corneal Flap Creation Using Cheetah Femtosecond Laser System and Cheetah Patient Interface https://clinicaltrials.gov/study/NCT03789669 RECRUITING Refractive Error DEVICE: Cheetah femtosecond laser and Cheetah patient interface

NCT05986669 Safety and Effectiveness of DSP Dental Implant Systems: Prospective Study Multicenter Involving Real-world Data https://clinicaltrials.gov/study/NCT05986669 RECRUITING Dental Implant DSP Industrial Ltda

NCT03801369 Olaparib in Combination With Either Durvalumab, Selumetinib, or Capivasertib or Ceralasertib Alone in Treating Patients With Metastatic Triple Negative Breast Cancer https://clinicaltrials.gov/study/NCT03801369 RECRUITING Anatomic Stage IV Breast Cancer AJCC v8

NCT06229769 Natural History Study for Patients With Angelman Syndrome https://clinicaltrials.gov/study/NCT06229769 RECRUITING Angelman Syndrome Centre Hospitalier Universitaire de Liege Centre Hospitalier R√©gional de la Citadelle

NCT05878769 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) https://clinicaltrials.gov/study/NCT05878769 RECRUITING Chronic Obstructive Pulmonary Disease DRUG: Astegolimab Hoffmann-La Roche

NCT05428969 A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies https://clinicaltrials.gov/study/NCT05428969 RECRUITING Acute Myeloid Leukemia

NCT05830968 Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne https://clinicaltrials.gov/study/NCT05830968 RECRUITING Inflammatory Acne Vulgaris DEVICE: Morpheus8 Applicator Radiofrequency device InMode MD Ltd.

NCT02873468 Efficacy and Safety of Three Doses of Florence Oral Suspension in Adults With Eosinophilic Esophagitis https://clinicaltrials.gov/study/NCT02873468 RECRUITING Eosinophilic Esophagitis DRUG: Florence 30 Œºg/mL

NCT06354868 A Study to Assess utiLity of BIoEP as an Early Prognostic Indicator for Predicting Anti-Seizure Medication (ASM) Efficacy https://clinicaltrials.gov/study/NCT06354868 NOT_YET_RECRUITING Epilepsy Neuronostics Ltd Cornwall Partnership NHS Foundation Trust

NCT05426369 A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT) https://clinicaltrials.gov/study/NCT05426369 RECRUITING Chemotherapy-induced Thrombocytopenia (CIT) BIOLOGICAL: Recombinant Human Tumor Necrosis Factor Receptor II -Fc-TPO Mimetic Peptide Fusion Protein Sichuan Clover Biopharmaceuticals, Inc.

NCT05180669 Reward-based Technology to Improve OUD Treatment https://clinicaltrials.gov/study/NCT05180669 RECRUITING Opioid Use Disorder OTHER: OARSCM Software Application

NCT04905069 Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy https://clinicaltrials.gov/study/NCT04905069 RECRUITING Prostate Cancer DEVICE: SpaceOAR Vue System Boston Scientific Corporation

NCT05768269 A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product https://clinicaltrials.gov/study/NCT05768269 RECRUITING Hematological Malignancy

NCT04832269 Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour https://clinicaltrials.gov/study/NCT04832269 RECRUITING Multiple Sclerosis OTHER: Exposure to methylprednisolone during pregnancy Jena University Hospital Ruhr University of Bochum

NCT06051669 Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US https://clinicaltrials.gov/study/NCT06051669 RECRUITING Liver Fibrosis

NCT05804669 A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome https://clinicaltrials.gov/study/NCT05804669 RECRUITING Cushing Syndrome

NCT04278469 Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy https://clinicaltrials.gov/study/NCT04278469 RECRUITING Early Hormone Receptor-positive Breast Cancer DRUG: Chemotherapy Drugs, Cancer Gencurix, Inc.

NCT05118269 A Randomized Controlled Trial of InterVapor¬Æ in France - The TARGET Trial https://clinicaltrials.gov/study/NCT05118269 NOT_YET_RECRUITING Emphysema DEVICE: Treatment plus Optimal Medical Therapy

NCT06452069 Efficacy and Safety Study of Essential Oil-Based Preparation Administered to COVID-19 Patients https://clinicaltrials.gov/study/NCT06452069 NOT_YET_RECRUITING COVID-19 Respiratory Infection

NCT05772169 Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym¬Æ (Mifepristone) (CATALYST) https://clinicaltrials.gov/study/NCT05772169 RECRUITING Hypercortisolism

NCT04910568 A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/study/NCT04910568 RECRUITING Multiple Myeloma DRUG: Cevostamab

NCT05509569 A Survey of Icatibant in Pediatric Participants with Hereditary Angioedema https://clinicaltrials.gov/study/NCT05509569 RECRUITING Hereditary Angioedema (HAE) DRUG: Icatibant Takeda

NCT05860569 Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis https://clinicaltrials.gov/study/NCT05860569 RECRUITING Hypertriglyceridemia, Familial GENETIC: GC304 GeneCradle Inc

NCT04664569 National Bacterial Meningitis Study https://clinicaltrials.gov/study/NCT04664569 RECRUITING Meningitis

NCT06682169 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease https://clinicaltrials.gov/study/NCT06682169 RECRUITING Graft-versus-host Disease DRUG: Rovadicitinib

NCT06362369 A Study of Oral 7HP349 (Alintegimod) in Combination with Ipilimumab Followed by Nivolumab Monotherapy https://clinicaltrials.gov/study/NCT06362369 RECRUITING Advanced Cancer

NCT05651269 Milciclib in Combination With Gemcitabine in Advanced NSCLC https://clinicaltrials.gov/study/NCT05651269 NOT_YET_RECRUITING NSCLC DRUG: Milciclib Dose: 150 mg/day Mode of administration: oral Tiziana Life Sciences LTD

NCT03884569 Cultivated Limbal Epithelial Transplantation (CLET) for Limbal Stem Cell Deficiency (LSCD) https://clinicaltrials.gov/study/NCT03884569 NOT_YET_RECRUITING Limbal Stem-cell Deficiency Instituto Universitario de Oftalmobiolog√≠a Aplicada (Institute of Applied Ophthalmobiology) - IOBA Citospin

NCT05694169 A Study of Participants With Chronic Kidney Disease Previously Treated With REACT https://clinicaltrials.gov/study/NCT05694169 RECRUITING Diabetic Kidney Disease

NCT05037968 MagnetOs Flex Matrix Compared to Trinity Elite Mixed with Local Autograft in Patients Undergoing Up to Four-level Instrumented Posterolateral Fusion https://clinicaltrials.gov/study/NCT05037968 RECRUITING Degenerative Disc Disease

NCT05517668 Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose https://clinicaltrials.gov/study/NCT05517668 RECRUITING Acetaminophen

NCT06588868 Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma https://clinicaltrials.gov/study/NCT06588868 NOT_YET_RECRUITING Cutaneous T Cell Lymphoma

NCT04755569 Optimizer System With ODOCOR II CCM‚Ñ¢ Leads https://clinicaltrials.gov/study/NCT04755569 RECRUITING Evaluate the Safety and Useability of the ODOCOR II Intra-cardiac Lead DEVICE: ODOCOR II CCM LEADS Impulse Dynamics

NCT06268769 Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs https://clinicaltrials.gov/study/NCT06268769 RECRUITING Immunosuppression DRUG: Tacrolimus Pill

NCT06571669 BOOM-IBD2 to Evaluate the Sacral Neuromodulation in IBD Patients https://clinicaltrials.gov/study/NCT06571669 NOT_YET_RECRUITING Ulcerative Colitis

NCT03064269 CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia https://clinicaltrials.gov/study/NCT03064269 RECRUITING B-cell Acute Lymphocytic Leukemia BIOLOGICAL: CD19 CAR-T cells Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd The First Affiliated Hospital of Soochow University

NCT06662669 YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer https://clinicaltrials.gov/study/NCT06662669 NOT_YET_RECRUITING Metastatic Pancreatic Cancer DRUG: YL-13027

NCT06705569 A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults https://clinicaltrials.gov/study/NCT06705569 NOT_YET_RECRUITING Healthy DRUG: Tafamidis 61 mg free acid tablet (Test)

NCT05973669 MED-EL Remote Care Multi-Center Feasibility Study https://clinicaltrials.gov/study/NCT05973669 RECRUITING Hearing Loss, Sensorineural

NCT05816369 Oral Nutritional Supplement Preferences in Patients With Cancer https://clinicaltrials.gov/study/NCT05816369 RECRUITING Neoplasms

NCT06557369 A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD https://clinicaltrials.gov/study/NCT06557369 RECRUITING Intermediate AMD DEVICE: reSEES Oculox Technologies SA Latis S.r.l.

NCT05564169 Masitinib in Patients With Mild to Moderate Alzheimer's Disease https://clinicaltrials.gov/study/NCT05564169 NOT_YET_RECRUITING Alzheimer Disease DRUG: Placebo

NCT05705869 Targeted Assessment in High-Risk paTients With dIAbetes to ideNtify Undiagnosed Heart Failure https://clinicaltrials.gov/study/NCT05705869 RECRUITING Heart Failure

NCT05245669 Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia¬Æ in Healthy Adult Male Volunteers https://clinicaltrials.gov/study/NCT05245669 RECRUITING Healthy Male Subjects BIOLOGICAL: ENZ215

NCT05300269 SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer https://clinicaltrials.gov/study/NCT05300269 RECRUITING Locally Advanced Rectal Cancer DRUG: SHR-1701ÔºõCapecitabineÔºõOxaliplatin Suzhou Suncadia Biopharmaceuticals Co., Ltd.

NCT06218069 Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor https://clinicaltrials.gov/study/NCT06218069 NOT_YET_RECRUITING NSCLC DRUG: Sasanlimab

NCT06288568 Night Shift Work and Biomarkers of Obesity Risk in Hospital and Industry Workers https://clinicaltrials.gov/study/NCT06288568 NOT_YET_RECRUITING Obesity

NCT06588855 A Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Participants With Moderately to Severely Active Ulcerative Colitis https://clinicaltrials.gov/study/NCT06588855 RECRUITING Moderately to Severely Active Ulcerative Colitis DRUG: RO7790121

NCT05778955 Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma https://clinicaltrials.gov/study/NCT05778955 RECRUITING Pediatric Soft Tissue Sarcoma GENETIC: detection and monitoring of cirulating tumor DNA Sun Yat-sen University Nanjing Geneseeq Technology Inc.

NCT05648955 Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer Treatment https://clinicaltrials.gov/study/NCT05648955 RECRUITING Colorectal Cancer (CRC)

NCT05886855 Evaluation of PerioMonitor for Detection of Oral Inflammatory Load (OIL) in Human Subjects. https://clinicaltrials.gov/study/NCT05886855 NOT_YET_RECRUITING Oral Inflammation Oral Science International Inc. Advarra

NCT05122455 Effects of Edoxaban on Platelet Aggregation https://clinicaltrials.gov/study/NCT05122455 RECRUITING SCAD

NCT06137755 Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above https://clinicaltrials.gov/study/NCT06137755 RECRUITING Vaccine-Preventable Diseases

NCT05555355 Prevena Spine for Use in Spine Surgery https://clinicaltrials.gov/study/NCT05555355 RECRUITING Surgery

NCT06143514 A Study Evaluating the Presence and Concentration of BRIUMVI‚Ñ¢ (Ublituximab) in Breast Milk https://clinicaltrials.gov/study/NCT06143514 RECRUITING Relapsing Multiple Sclerosis OTHER: No intervention TG Therapeutics, Inc.

NCT06641414 Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4). https://clinicaltrials.gov/study/NCT06641414 NOT_YET_RECRUITING Higher-risk Myelodysplastic Syndrome DRUG: Lisaftoclax (APG-2575)

NCT05939414 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. https://clinicaltrials.gov/study/NCT05939414 RECRUITING Oligometastatic Prostate Cancer (OMPC) DRUG: AAA617 Novartis Pharmaceuticals

NCT05749055 ENCALM: a Study of ENX-102 As a Monotherapy Treatment in Patients with Generalized Anxiety Disorder https://clinicaltrials.gov/study/NCT05749055 RECRUITING Generalized Anxiety Disorder DRUG: ENX-102

NCT04988555 A Study of DSP-5336 in Relapsed/refractory AML/ ALL with or Without MLL Rearrangement or NPM1 Mutation https://clinicaltrials.gov/study/NCT04988555 RECRUITING Leukemia, Myeloid, Acute

NCT05485155 Zemaira Eosinophilic Esophagitis Pilot Study https://clinicaltrials.gov/study/NCT05485155 RECRUITING Eosinophilic Esophagitis DRUG: Alpha-proteinase inhibitor Children's Hospital Medical Center, Cincinnati CSL Behring

NCT05864014 Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors. https://clinicaltrials.gov/study/NCT05864014 NOT_YET_RECRUITING Chemotherapy-Induced Thrombocytopenia DRUG: Hetrombopag

NCT05975814 The Effect of Concave Healing Abutment on Soft Tissue Healing https://clinicaltrials.gov/study/NCT05975814 RECRUITING Dental Implant Therapy DEVICE: dental implant MIS Implant Technologies, Ltd Charite University, Berlin, Germany

NCT04692714 Evaluation of Two Surgical Strategies for Robotic Implantation of Total Knee Prostheses (Stryker), Cemented Versus Uncemented https://clinicaltrials.gov/study/NCT04692714 RECRUITING Total Knee Arthroplasty DEVICE: Knee prosthesis implementation with additional cement

NCT06649214 A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia https://clinicaltrials.gov/study/NCT06649214 NOT_YET_RECRUITING Schizophrenia DRUG: Olanzapine-samidorphanÔºõ

NCT06135155 A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations https://clinicaltrials.gov/study/NCT06135155 NOT_YET_RECRUITING Pediatric Growth Hormone Deficiency (PGHD) DRUG: PEG-rhGH with new preparation

NCT06464055 A Study of GQ1010 in Subjects With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06464055 RECRUITING Advanced Malignant Solid Tumors DRUG: Dose Escalation

NCT06660355 Ruxolitinib Vs Prednisone As First-line Therapy for CGVHD Needing Systemic Therapy https://clinicaltrials.gov/study/NCT06660355 NOT_YET_RECRUITING Chronic Graft-versus-host Disease (cGVHD) DRUG: Ruxolitinib

NCT06712355 Safety and Effectiveness of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer https://clinicaltrials.gov/study/NCT06712355 NOT_YET_RECRUITING Extensive-stage Small-cell Lung Cancer DRUG: BNT327

NCT06331455 Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection https://clinicaltrials.gov/study/NCT06331455 RECRUITING Lung Cancer Patients

NCT05821855 A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China https://clinicaltrials.gov/study/NCT05821855 RECRUITING Open-angle Glaucoma

NCT06022055 Multimodal Study of the Human Brain Epilepsy Tissue https://clinicaltrials.gov/study/NCT06022055 RECRUITING Focal Drug-resistant Epilepsy OTHER: Blood and tissue collection Assistance Publique - H√¥pitaux de Paris ICM Co. Ltd.

NCT06294314 Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace https://clinicaltrials.gov/study/NCT06294314 RECRUITING Anterior Cruciate Ligament Rupture PROCEDURE: Fertilized ACL Marshall University Arthrex, Inc.

NCT05193214 A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma https://clinicaltrials.gov/study/NCT05193214 NOT_YET_RECRUITING Sarcoma, Soft Tissue DRUG: Recombinant anti-PD-1 humanized monoclonal antibody injection Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

NCT05115214 Safety and Performance of the Affera SpherePVI‚Ñ¢ Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation https://clinicaltrials.gov/study/NCT05115214 RECRUITING Atrial Fibrillation DEVICE: SpherePVI‚Ñ¢ Catheter Affera, Inc.

NCT06645314 Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma https://clinicaltrials.gov/study/NCT06645314 NOT_YET_RECRUITING Hepatocellular Carcinoma BIOLOGICAL: Group A

NCT06537414 A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) https://clinicaltrials.gov/study/NCT06537414 NOT_YET_RECRUITING Chronic Hepatitis B Virus Infection DRUG: Daplusiran/Tomligisiran Dose Level 1

NCT03364114 Endorotor Resection In Refractory Barrett's Dysplasia Patients https://clinicaltrials.gov/study/NCT03364114 RECRUITING Barrett's Esophagus With Dysplasia DEVICE: EndoRotor Mucosal Resection System

NCT06200714 A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib https://clinicaltrials.gov/study/NCT06200714 RECRUITING Idiopathic Pulmonary Fibrosis

NCT06697314 Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System https://clinicaltrials.gov/study/NCT06697314 NOT_YET_RECRUITING Acute Pulmonary Embolism (PE)

NCT06038955 Effect of Immersive Virtual Reality-based Cognitive Remediation in Patients With Mood - or Psychosis Spectrum Disorders https://clinicaltrials.gov/study/NCT06038955 RECRUITING Bipolar Disorder

NCT04068155 Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors https://clinicaltrials.gov/study/NCT04068155 RECRUITING Skin Cancer

NCT05720455 Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above https://clinicaltrials.gov/study/NCT05720455 NOT_YET_RECRUITING Rhinitis Allergic DRUG: Fexofenadine HCL and pseudoephedrine HCL Sanofi

NCT05197855 Sleep Quality Evolution: Dreem Under CPAP https://clinicaltrials.gov/study/NCT05197855 RECRUITING Sleep Apnea

NCT06256055 Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT06256055 RECRUITING Malignant Mesothelioma

NCT06648655 A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder https://clinicaltrials.gov/study/NCT06648655 RECRUITING Alcohol Use Disorder (AUD) DRUG: TMP-301

NCT06503614 A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer https://clinicaltrials.gov/study/NCT06503614 NOT_YET_RECRUITING Non-muscle Invasive Bladder Cancer

NCT05669755 REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels https://clinicaltrials.gov/study/NCT05669755 RECRUITING Cardiovascular Disease DRUG: Cagrilintide

NCT06249555 VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study https://clinicaltrials.gov/study/NCT06249555 RECRUITING Crohn's Disease DRUG: Vedolizumab (VDZ)

NCT06492655 To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers https://clinicaltrials.gov/study/NCT06492655 NOT_YET_RECRUITING Type 2 Diabetes Mellitus DRUG: CKD-383(Fed)

NCT04350255 A Register Based Prospective Study During Implementation of a New Cup https://clinicaltrials.gov/study/NCT04350255 RECRUITING Prospective DEVICE: Total hip arthroplasty

NCT05637255 A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD) https://clinicaltrials.gov/study/NCT05637255 RECRUITING Wet Macular Degeneration

NCT06309355 Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis https://clinicaltrials.gov/study/NCT06309355 RECRUITING Atopic Dermatitis DRUG: YR001 ointment

NCT06491914 A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) https://clinicaltrials.gov/study/NCT06491914 RECRUITING Neovascular Age-Related Macular Degeneration

NCT02523014 Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas https://clinicaltrials.gov/study/NCT02523014 RECRUITING Intracranial Meningioma

NCT06452914 Clinical Outcomes Related to Treatment of Distal Symmetric Polyneuropathy Using Semiconductor Embedded Therapeutic Socks https://clinicaltrials.gov/study/NCT06452914 NOT_YET_RECRUITING Diabetic Neuropathy DEVICE: Semiconductor Embedded Therapeutic Socks

NCT05905055 P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales https://clinicaltrials.gov/study/NCT05905055 RECRUITING Complicated Urinary Tract Infection

NCT06419855 Study to Evaluate the Effectivity and Safety of BIOSCAFF¬ÆH Compared to DuraGen¬Æ, in Patients Undergoing Dural Repair https://clinicaltrials.gov/study/NCT06419855 NOT_YET_RECRUITING Cerebrospinal Fluid Leakage DEVICE: Human collagen matrix graft

NCT06006455 Effect of the Erchonia¬Æ LunulaLaser‚Ñ¢ for the Treatment of Toenail Onychomycosis https://clinicaltrials.gov/study/NCT06006455 RECRUITING Onychomycosis of Toenail DEVICE: Erchonia LunulaLaser Erchonia Corporation

NCT06665555 Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ‚â§55 Years of Age https://clinicaltrials.gov/study/NCT06665555 RECRUITING Pharmacokinetics

NCT05738655 Effectiveness of Pumpkin Seed Extract on Improving Blood Sugar Level in Subhealth Subjects https://clinicaltrials.gov/study/NCT05738655 RECRUITING Diabetes

NCT06708455 Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma https://clinicaltrials.gov/study/NCT06708455 NOT_YET_RECRUITING Malignant Melanoma with Metastasis

NCT04645355 Guselkumab Immunogenetics https://clinicaltrials.gov/study/NCT04645355 RECRUITING Psoriasis Guttate

NCT06345755 A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of VX-407 in Healthy Participants https://clinicaltrials.gov/study/NCT06345755 RECRUITING Autosomal Dominant Polycystic Kidney Disease (ADPKD) DRUG: VX-407

NCT06271655 Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE) https://clinicaltrials.gov/study/NCT06271655 RECRUITING Acute Respiratory Infection

NCT06544655 A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06544655 RECRUITING Advanced Solid Tumors DRUG: BMS-986484

NCT05003414 The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study https://clinicaltrials.gov/study/NCT05003414 RECRUITING Arthritis

NCT04617314 A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors https://clinicaltrials.gov/study/NCT04617314 RECRUITING Solid Tumor DRUG: RC108 RemeGen Co., Ltd.

NCT06524414 A Study to Learn About How a New Pneumococcal Vaccine Works in Infants https://clinicaltrials.gov/study/NCT06524414 RECRUITING Pneumococcal Disease BIOLOGICAL: PG4

NCT05606614 Safety and Efficacy of TSHA-102 in Adolescent and Adult Females with Rett Syndrome (REVEAL Adult Study) https://clinicaltrials.gov/study/NCT05606614 RECRUITING Rett Syndrome GENETIC: TSHA-102 Taysha Gene Therapies, Inc.

NCT06415214 Efficacy and Safety of HRS-7535 Tablets in Adults With Type 2 Diabetic Kidney Disease https://clinicaltrials.gov/study/NCT06415214 NOT_YET_RECRUITING Type 2 Diabetic Kidney Disease DRUG: Placebo

NCT06606314 Specified Drug-use Surveillance of Fabhalta Capsules https://clinicaltrials.gov/study/NCT06606314 RECRUITING Paroxysmal Nocturnal Hemoglobinuria Novartis Pharmaceuticals

NCT05149755 Evolut‚Ñ¢ EXPAND TAVR II Pivotal Trial https://clinicaltrials.gov/study/NCT05149755 RECRUITING Moderate Aortic Valve Stenosis DEVICE: Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT) Medtronic Cardiovascular

NCT04225455 The Use of the Dexcom G6¬Æ in Commercial Pilots With Insulin-treated Diabetes https://clinicaltrials.gov/study/NCT04225455 RECRUITING Insulin Dependent Diabetes DEVICE: Glucose monitoring University of Surrey DexCom, Inc.

NCT06165614 Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in Kenya https://clinicaltrials.gov/study/NCT06165614 RECRUITING Cervix Cancer

NCT06118255 A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome https://clinicaltrials.gov/study/NCT06118255 RECRUITING Dravet Syndrome DRUG: fenfluramine UCB BIOSCIENCES, Inc.

NCT06341855 Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer https://clinicaltrials.gov/study/NCT06341855 RECRUITING Endometrial Cancer DIAGNOSTIC_TEST: MRD-ctDNA The First Hospital of Jilin University Geneplus-Beijing Co. Ltd.

NCT05370755 A Study of ICP-189 and ICP-189 in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05370755 NOT_YET_RECRUITING Patients With Advanced Solid Tumors DRUG: ICP-189 Beijing InnoCare Pharma Tech Co., Ltd.

NCT06241755 Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC) https://clinicaltrials.gov/study/NCT06241755 RECRUITING Non-Muscle Invasive Bladder Cancer DRUG: BCG for Therapeutic Use

NCT02944955 A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML) https://clinicaltrials.gov/study/NCT02944955 NOT_YET_RECRUITING Myelodysplastic Syndrome (MDS) DRUG: BLEX 404 Oral Liquid BioLite, Inc.

NCT06096155 Ambispective Study to Assess the Safety and the Performance of SAGITTA EVL R Stem https://clinicaltrials.gov/study/NCT06096155 RECRUITING Hip Arthropathy Societe dEtude, de Recherche et de Fabrication

NCT05790655 Ovarian PRP for Diminished Ovarian Reserve https://clinicaltrials.gov/study/NCT05790655 NOT_YET_RECRUITING Diminished Ovarian Reserve OTHER: oPRP Generation Next Fertility Igenomix

NCT05413655 A Study of Oral EX039 in Subjects With Mild Alzheimer's Disease https://clinicaltrials.gov/study/NCT05413655 RECRUITING Alzheimer Disease DRUG: EX039

NCT04550455 A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets https://clinicaltrials.gov/study/NCT04550455 RECRUITING Multiple Sclerosis DRUG: Cladribine Tablets Keith Edwards, M.D. EMD Serono

NCT06716814 Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa https://clinicaltrials.gov/study/NCT06716814 NOT_YET_RECRUITING Severe Haemophilia A DRUG: Efanesoctocog alfa Swedish Orphan Biovitrum PSI CRO

NCT05772455 A Study of XZB-0004 in Patients With Solid Tumors https://clinicaltrials.gov/study/NCT05772455 RECRUITING Advanced Solid Tumor

NCT04042155 Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD) https://clinicaltrials.gov/study/NCT04042155 RECRUITING Atrial Fibrillation

NCT04789655 Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT04789655 RECRUITING Leukemia, Myeloid DRUG: CC-96191 Celgene

NCT01842555 Photodynamic Therapy (PDT) Oncology Registry https://clinicaltrials.gov/study/NCT01842555 RECRUITING Lung Cancer

NCT06257355 Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars https://clinicaltrials.gov/study/NCT06257355 RECRUITING Corneal Scar BIOLOGICAL: CSB-001 Ophthalmic Solution 0.1% Claris Biotherapeutics, Inc.

NCT04322955 CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition https://clinicaltrials.gov/study/NCT04322955 RECRUITING Kidney Cancer

NCT05985655 Study to Assess GTAEXS617 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05985655 RECRUITING Advanced Solid Tumor DRUG: GTAEXS617 Exscientia AI Limited GT Apeiron LLC

NCT06001255 ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06001255 RECRUITING Metastasis Castration Resistant Prostate Cancer(mCRPC) DRUG: HS-20093 Hansoh BioMedical R&D Company

NCT06167655 A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM https://clinicaltrials.gov/study/NCT06167655 RECRUITING Headache Migraine Chronic DEVICE: Neurostimulator ShiraTronics

NCT06260514 Study of APR-1051 in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06260514 RECRUITING Advanced Solid Tumor DRUG: APR-1051 Aprea Therapeutics

NCT05346614 Digital, Blended Lifestyle Intervention for Type 2 Diabetes Remission https://clinicaltrials.gov/study/NCT05346614 NOT_YET_RECRUITING Diabetes Mellitus, Type 2 BEHAVIORAL: Lifestyle intervention Ancora Health B.V. University of Groningen

NCT06239714 A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) https://clinicaltrials.gov/study/NCT06239714 NOT_YET_RECRUITING Hyperlipidemias DRUG: SGB-3403

NCT05327114 Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) https://clinicaltrials.gov/study/NCT05327114 RECRUITING Polyradiculoneuropathy, Chronic Inflammatory Demyelinating DRUG: Nipocalimab

NCT06053814 NS-050/NCNP-03 in Boys With DMD (Meteor50) https://clinicaltrials.gov/study/NCT06053814 NOT_YET_RECRUITING Duchenne Muscular Dystrophy DRUG: NS-050/NCNP-03

NCT06074510 PYLARIFY¬Æ PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer https://clinicaltrials.gov/study/NCT06074510 RECRUITING Prostate Cancer DRUG: Piflufolastat F 18 Intravenous Solution [PYLARIFY] Lantheus Medical Imaging

NCT05100810 Angelman Syndrome Natural History Study-FAST UK https://clinicaltrials.gov/study/NCT05100810 RECRUITING Angelman Syndrome OTHER: Natural History Study University of Oxford Foundation for Angelman Syndrome Therapeutics UK

NCT05466110 Spinal Cord Stimulation Versus Instrumentation for FBSS https://clinicaltrials.gov/study/NCT05466110 RECRUITING Failed Back Surgery Syndrome

NCT06416410 JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation https://clinicaltrials.gov/study/NCT06416410 RECRUITING Advanced Non-squamous Non-small-cell Lung Cancer

NCT04608110 A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome https://clinicaltrials.gov/study/NCT04608110 RECRUITING Myelodysplastic Syndrome (MDS) DRUG: ASTX030 Otsuka Pharmaceutical Co., Ltd.

NCT06706310 Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection https://clinicaltrials.gov/study/NCT06706310 NOT_YET_RECRUITING Chronic Hepatitis B DRUG: Placebo

NCT05082610 A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05082610 RECRUITING Cancer

NCT05902910 Efficacy and Acceptability of the Luna EMG Rehabilitation Robot on Motor Recovery of the Upper Limb in the Chronic Phase of Stroke https://clinicaltrials.gov/study/NCT05902910 RECRUITING Stroke DEVICE: LUNA-EMG Robot University Hospital, Brest EGZOTech

NCT04995081 Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD) https://clinicaltrials.gov/study/NCT04995081 RECRUITING Parkinson Disease BIOLOGICAL: Biological/Vaccine: Allogeneic HB-adMSCs

NCT05980481 A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer https://clinicaltrials.gov/study/NCT05980481 RECRUITING Gastric Cancer DRUG: RC48-ADC

NCT06329310 Xeltis Hemodialysis Access (aXess) Conduit: aXess-E Study https://clinicaltrials.gov/study/NCT06329310 NOT_YET_RECRUITING End Stage Renal Disease DEVICE: aXess-E conduit Xeltis

NCT06036810 Spanish Decision Tool for Ovarian Cancer Maintenance Therapy https://clinicaltrials.gov/study/NCT06036810 RECRUITING Ovarian Cancer OTHER: Shared Medical Decision Tool

NCT05217810 A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura¬Æ https://clinicaltrials.gov/study/NCT05217810 RECRUITING Asthma OTHER: Atectura inhalation capsule (150/80ug)

NCT05874310 Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa https://clinicaltrials.gov/study/NCT05874310 RECRUITING X-Linked Retinitis Pigmentosa GENETIC: FT-002 Frontera Therapeutics Eye & ENT Hospital of Fudan University

NCT06472310 Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR) https://clinicaltrials.gov/study/NCT06472310 RECRUITING Severe Asthma AstraZeneca

NCT06666010 PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study https://clinicaltrials.gov/study/NCT06666010 NOT_YET_RECRUITING Stimulant Use Disorder DRUG: PEX010-Assisted Therapy

NCT05849610 Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma https://clinicaltrials.gov/study/NCT05849610 RECRUITING High-Risk de Novo Multiple Myeloma DRUG: Daratumumab

NCT06497010 An Exploratory Study of Individualized Neo-antigen MRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment https://clinicaltrials.gov/study/NCT06497010 RECRUITING Advanced Solid Tumor DRUG: Biological: PD-1

NCT06556810 IC14 for Treatment of Acute Decompensated Heart Failure https://clinicaltrials.gov/study/NCT06556810 RECRUITING Acute Decompensated Heart Failure DRUG: Atibuclimab (IC14) Implicit Bioscience University of Virginia

NCT05246410 A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries. https://clinicaltrials.gov/study/NCT05246410 RECRUITING Peripheral Vascular Disease (PVD)

NCT06454110 Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN) https://clinicaltrials.gov/study/NCT06454110 NOT_YET_RECRUITING IgA Nephropathy DRUG: NM8074 NovelMed Therapeutics

NCT06116110 Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU https://clinicaltrials.gov/study/NCT06116110 RECRUITING Non Hodgkin Lymphoma OTHER: Long-term Follow-Up Miltenyi Biomedicine GmbH

NCT05455112 Safety and Efficacy of RUTI¬Æ With the Standard of Treatment for Tuberculosis https://clinicaltrials.gov/study/NCT05455112 RECRUITING Tuberculosis, Pulmonary BIOLOGICAL: RUTI¬Æ Vaccine

NCT04793581 Assessment of the Utility of the Pantheris Small Vessel (SV) System https://clinicaltrials.gov/study/NCT04793581 RECRUITING Peripheral Arterial Disease DEVICE: Atherectomy Avinger, Inc.

NCT05491681 AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial https://clinicaltrials.gov/study/NCT05491681 NOT_YET_RECRUITING ARDS, Human BIOLOGICAL: intravenous delivery of allogeneic bone marrow-derived MSCs BioCardia, Inc.

NCT06301581 Retrospective Analysis of Speech Performance Using the HiRes Ultra and HiRes Ultra 3D Cochlear Implant https://clinicaltrials.gov/study/NCT06301581 RECRUITING Cochlear Hearing Loss Advanced Bionics AG

NCT06072781 A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer https://clinicaltrials.gov/study/NCT06072781 RECRUITING Low Grade Serous Ovarian Cancer DRUG: avutometinib

NCT05582681 HCV Test and Treat Utilizing Simplified HCV Patient Education https://clinicaltrials.gov/study/NCT05582681 RECRUITING Hepatitis C DIAGNOSTIC_TEST: Cepheid POC HCV Viremia (RNA) test

NCT05381181 Safety and Efficacy Evaluation of Next-generation CD19-UCART https://clinicaltrials.gov/study/NCT05381181 NOT_YET_RECRUITING Acute Lymphoblastic Leukemia

NCT05157581 Extracorporeal Photopheresis in Sezary Syndrome https://clinicaltrials.gov/study/NCT05157581 RECRUITING Sezary Syndrome DEVICE: Extracorporeal photopheresis (ECP)

NCT06118281 ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack https://clinicaltrials.gov/study/NCT06118281 RECRUITING Cardiovascular Risk

NCT06298981 Pulse Rate and Breathing Rate Accuracy https://clinicaltrials.gov/study/NCT06298981 RECRUITING Pulse Rate and Breathing Rate DEVICE: noninvasive and investigational NuraLogix AMC-SDK Nuralogix Corporation

NCT04356781 Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing https://clinicaltrials.gov/study/NCT04356781 RECRUITING Multifocal Motor Neuropathy (MMN)

NCT06285981 Retrospective Study Chimaera Long Nail in Adult Patient https://clinicaltrials.gov/study/NCT06285981 RECRUITING Pertrochanteric Fracture of Femur

NCT03807310 Targeted Nutrient Supplement in COPD (NUTRECOVER-trial) https://clinicaltrials.gov/study/NCT03807310 RECRUITING Pulmonary Disease, Chronic Obstructive DIETARY_SUPPLEMENT: Targeted nutrient supplementation (Long-drink)

NCT05332210 Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis https://clinicaltrials.gov/study/NCT05332210 RECRUITING Myasthenia Gravis DRUG: HBM9161 Injection (680mg) Harbour BioMed (Guangzhou) Co. Ltd.

NCT05451810 A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma https://clinicaltrials.gov/study/NCT05451810 RECRUITING Diffuse Large B-Cell Lymphoma

NCT04810910 Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy https://clinicaltrials.gov/study/NCT04810910 RECRUITING Resectable Pancreatic Cancer BIOLOGICAL: iNeo-Vac-P01

NCT06701110 Pharmacokinetic Study of SudapyridineÔºàWX-081Ôºâin Healthy Chinese Subjects https://clinicaltrials.gov/study/NCT06701110 RECRUITING TB DRUG: [U-14C] WX-081 Shanghai Jiatan Pharmatech Co., Ltd

NCT05758610 A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients https://clinicaltrials.gov/study/NCT05758610 RECRUITING NHL, Adult

NCT05442710 Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy https://clinicaltrials.gov/study/NCT05442710 RECRUITING Sepsis, Severe BIOLOGICAL: ARTICE Artcline GmbH Zentrum f√ºr Klinische Studien Jena

NCT06496581 Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders) https://clinicaltrials.gov/study/NCT06496581 NOT_YET_RECRUITING Prostate Cancer Metastatic DRUG: 177Lu-PMSA-617

NCT05970510 A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder. https://clinicaltrials.gov/study/NCT05970510 RECRUITING Generalized Anxiety Disorder DRUG: Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg

NCT05117710 IMPase in Treatment-resistant Depression https://clinicaltrials.gov/study/NCT05117710 RECRUITING Depressive Disorder, Treatment-Resistant DRUG: Ebselen

NCT06149910 Evaluating the Uptake and Utility of Clinical Pathways for Newly Diagnosed Patients With Multiple Myeloma https://clinicaltrials.gov/study/NCT06149910 RECRUITING Multiple Myeloma

NCT04983810 A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma https://clinicaltrials.gov/study/NCT04983810 RECRUITING Solid Tumor, Adult

NCT05775510 Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain https://clinicaltrials.gov/study/NCT05775510 RECRUITING Pain, Intractable

NCT06151210 Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic Gastritis https://clinicaltrials.gov/study/NCT06151210 RECRUITING Gastritis Acute

NCT06701981 Study on the Effect of Filters on Discomfort Glare on Healthy Adults https://clinicaltrials.gov/study/NCT06701981 NOT_YET_RECRUITING Glare OTHER: Filter comparison Essilor International

NCT04371081 Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance https://clinicaltrials.gov/study/NCT04371081 RECRUITING Patent Ductus Arteriosus DEVICE: Amplatzer Piccolo Occluder Abbott Medical Devices Japanese society of Congenital Interventional Cardiology

NCT04807881 Phase Ib Clinical Study of Keynatinib https://clinicaltrials.gov/study/NCT04807881 RECRUITING Lymphoma, B-Cell DRUG: Keynatinib Medolution Ltd.

NCT06620510 Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea https://clinicaltrials.gov/study/NCT06620510 NOT_YET_RECRUITING Hepatocellular Carcinoma BIOLOGICAL: Immuncell-LC

NCT05195710 Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases https://clinicaltrials.gov/study/NCT05195710 RECRUITING Metastases DRUG: Yttrium-90 (Y-90) resin microspheres M.D. Anderson Cancer Center Sirtex Medical

NCT06446310 Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus https://clinicaltrials.gov/study/NCT06446310 RECRUITING Uremic Pruritus DRUG: QLG2198

NCT05671510 ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors https://clinicaltrials.gov/study/NCT05671510 RECRUITING Non Small Cell Lung Cancer DRUG: Gotistobart

NCT06519110 Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations https://clinicaltrials.gov/study/NCT06519110 NOT_YET_RECRUITING Advanced Solid Tumor DRUG: Neratinib tablets Convalife (Shanghai) Co., Ltd.

NCT05835310 An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants https://clinicaltrials.gov/study/NCT05835310 RECRUITING Systemic Lupus Erythematosus BIOLOGICAL: Anifrolumab

NCT05416710 Universal Germline Testing in the Community https://clinicaltrials.gov/study/NCT05416710 RECRUITING Cancer

NCT06411210 Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment https://clinicaltrials.gov/study/NCT06411210 RECRUITING Diabetes type1

NCT06039410 A Novel Device for the Treatment of Postural Hypotension - a Signal of Effectiveness Study. https://clinicaltrials.gov/study/NCT06039410 RECRUITING Orthostatic Hypotension DEVICE: ISO-101 Isotech Ltd Newcastle-upon-Tyne Hospitals NHS Trust

NCT05954910 A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma https://clinicaltrials.gov/study/NCT05954910 RECRUITING Diffuse Large B-Cell Lymphoma DRUG: Polatuzumab Vedotin Hoffmann-La Roche

NCT05956210 Surgical Ward Innovation: Telemonitoring Controlled by Healthdot https://clinicaltrials.gov/study/NCT05956210 RECRUITING Monitoring DEVICE: Evaluation of implementation regarding Philips Healthdot as monitoring device of hospitalized patients at one surgical ward Catharina Ziekenhuis Eindhoven Philips Electronics Nederland B.V. acting through Philips CTO organization

NCT06585410 Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT06585410 NOT_YET_RECRUITING Cutaneous Squamous Cell Carcinoma (CSCC) DRUG: Cemiplimab

NCT06612710 The Safety and Efficacy of NouvSoma001 in Ischemic Stroke https://clinicaltrials.gov/study/NCT06612710 NOT_YET_RECRUITING Ischemic Stroke DRUG: extracellular vesicles derived from human induced neural stem cell for intravenous injection

NCT06148610 Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support https://clinicaltrials.gov/study/NCT06148610 RECRUITING Hematologic Diseases

NCT03922555 ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas https://clinicaltrials.gov/study/NCT03922555 RECRUITING Neurological Cancer DRUG: ASTX727 Massachusetts General Hospital Astex Pharmaceuticals, Inc.

NCT05729555 Comparative Pharmacokinetic (PK) Study of Ibuprofen and Diphenhydramine Hydrochloride MR Tablets in Healthy Adults Under Fasting Condition https://clinicaltrials.gov/study/NCT05729555 NOT_YET_RECRUITING Pain

NCT01719055 RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain https://clinicaltrials.gov/study/NCT01719055 RECRUITING Pain DEVICE: neurostimulation system Boston Scientific Corporation

NCT05840055 ACT With NMOSD Patients and Caregivers Pilot Study https://clinicaltrials.gov/study/NCT05840055 RECRUITING NMO Spectrum Disorder BEHAVIORAL: Acceptance and Commitment Therapy Thomas Jefferson University Alexion Pharmaceuticals, Inc.

NCT06646055 AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer https://clinicaltrials.gov/study/NCT06646055 NOT_YET_RECRUITING Metastatic Pancreatic Ductal Adenocarcinoma DRUG: AK112, Cadonilimab, nab-paclitaxel, gemcitabine

NCT06568055 A Study of Cytomegalovirus (CMV) Infection After Kidney Transplant in Adults in the United Kingdom https://clinicaltrials.gov/study/NCT06568055 RECRUITING Cytomegalovirus (CMV) OTHER: No Intervention Takeda

NCT05938855 Performance and Safety of the PHENIX LIBERTY, a Medical Device for Electrostimulation and Biofeedback, in the Treatment of Pelvic Static Disorders in Women with Urinary Incontinence. https://clinicaltrials.gov/study/NCT05938855 RECRUITING Urinary Incontinence

NCT06480955 BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe https://clinicaltrials.gov/study/NCT06480955 NOT_YET_RECRUITING Bone Metastases DEVICE: Cryoablation system Cardiovascular and Interventional Radiological Society of Europe Boston Scientific Corporation

NCT06332755 Study to Evaluate LB-LR1109 for the Treatment of Solid Tumors https://clinicaltrials.gov/study/NCT06332755 RECRUITING Non-small Cell Lung Cancer(NSCLC)

NCT06703255 a Phase 2 Study of HX301 in Patients With High-grade Giloma https://clinicaltrials.gov/study/NCT06703255 NOT_YET_RECRUITING Glioma DRUG: HX301+/Temozolomide Hangzhou Hanx Biopharmaceuticals, Ltd.

NCT06428955 Evaluation of a Monofocal Intraocular Lens https://clinicaltrials.gov/study/NCT06428955 RECRUITING Cataract DEVICE: CT LUCIA 621P Carl Zeiss Meditec AG

NCT04291755 Development and Analysis of a Stool Bank for Cancer Patients https://clinicaltrials.gov/study/NCT04291755 RECRUITING Carcinoma, Non-Small-Cell Lung

NCT06700395 A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma https://clinicaltrials.gov/study/NCT06700395 RECRUITING Multiple Myeloma DRUG: TQB2029 injection Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

NCT06692881 Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada https://clinicaltrials.gov/study/NCT06692881 NOT_YET_RECRUITING Migraine AbbVie

NCT05659381 Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer https://clinicaltrials.gov/study/NCT05659381 RECRUITING Stage III Ovarian Cancer

NCT05041010 Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz https://clinicaltrials.gov/study/NCT05041010 RECRUITING Ischemic Stroke DRUG: Neu2000KWL group

NCT04905810 Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure https://clinicaltrials.gov/study/NCT04905810 RECRUITING Acute Myeloid Leukemia

NCT05366881 cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease https://clinicaltrials.gov/study/NCT05366881 RECRUITING Brain Cancer

NCT05003310 ConsideRAte Study - Splenic Stimulation for RA https://clinicaltrials.gov/study/NCT05003310 RECRUITING Rheumatoid Arthritis DEVICE: Active Stimulation

NCT05658510 Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) https://clinicaltrials.gov/study/NCT05658510 RECRUITING Agitation,Psychomotor

NCT05156710 BIVV020 (SAR445088) n Prevention and Treatment of Antibody-mediated Rejection (AMR) https://clinicaltrials.gov/study/NCT05156710 RECRUITING Transplant Rejection DRUG: BIVV020 (SAR445088)

NCT04939610 A Study of 177Lu-FAP-2286 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT04939610 RECRUITING Solid Tumor DRUG: 68Ga-FAP-2286

NCT06208410 A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors https://clinicaltrials.gov/study/NCT06208410 RECRUITING Advanced Solid Tumors DRUG: JS105

NCT05521438 Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome https://clinicaltrials.gov/study/NCT05521438 RECRUITING Netherton Syndrome DRUG: QRX003-2% Lotion

NCT05923008 A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT05923008 RECRUITING Solid Tumor DRUG: IBI130 Innovent Biologics (Suzhou) Co. Ltd.

NCT05422508 Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination https://clinicaltrials.gov/study/NCT05422508 RECRUITING Varicella BIOLOGICAL: MG1111 (BARICELA)

NCT05971108 Real-world Elecsys¬Æ GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC https://clinicaltrials.gov/study/NCT05971108 RECRUITING Liver Cirrhosis

NCT05707208 A Randomized, Controlled Study of Repeat Dose Sustained Release Lidocaine for Treatment of Chronic Scrotal Pain https://clinicaltrials.gov/study/NCT05707208 RECRUITING Chronic Pain DRUG: ST-01

NCT06645808 PET-imaging of Two Vartumabs in Patients with Solid Tumors https://clinicaltrials.gov/study/NCT06645808 NOT_YET_RECRUITING Solid Tumor

NCT05881408 A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) https://clinicaltrials.gov/study/NCT05881408 RECRUITING Duchenne Muscular Dystrophy GENETIC: delandistrogene moxeparvovec

NCT05358808 ACHIEVE - Efficacy and Effectiveness of Adoptive Cellular tHerapy wIth Ex-Vivo Expanded Allogeneic Œ≥Œ¥ T-lymphocytes (TCB008) for Patients With Refractory or Relapsed Acute Myeloid Leukaemia (AML) https://clinicaltrials.gov/study/NCT05358808 RECRUITING Acute Myeloid Leukemia

NCT04006808 A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant https://clinicaltrials.gov/study/NCT04006808 RECRUITING Herpes Zoster BIOLOGICAL: PED-HZ/su GlaxoSmithKline

NCT03516708 Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer https://clinicaltrials.gov/study/NCT03516708 RECRUITING Rectal Cancer DRUG: Epacadostat

NCT05990738 DAREONTM-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy https://clinicaltrials.gov/study/NCT05990738 RECRUITING Small Cell Lung Carcinoma (SCLC) DRUG: BI 764532

NCT06328608 A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease https://clinicaltrials.gov/study/NCT06328608 NOT_YET_RECRUITING Fabry Disease DRUG: PRX-102 1 mg/kg every two weeks Chiesi Farmaceutici S.p.A. ICON plc

NCT05834738 Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy https://clinicaltrials.gov/study/NCT05834738 RECRUITING IgA Nephropathy

NCT02427308 Treatment of Leishmaniasis With Impavido¬Æ (Miltefosine): Pregnancy Registry https://clinicaltrials.gov/study/NCT02427308 RECRUITING Leishmaniasis or Other Uses of Miltefosine DRUG: Miltefosine Knight Therapeutics (USA) Inc

NCT05635708 A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05635708 RECRUITING Non-small Cell Lung Cancer

NCT06339008 A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1) https://clinicaltrials.gov/study/NCT06339008 RECRUITING Perennial Allergic Rhinitis (PAR) DRUG: LY3650150

NCT06717438 Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS]) https://clinicaltrials.gov/study/NCT06717438 NOT_YET_RECRUITING Jordan's Syndrome

NCT06153238 A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda¬Æ in Participants With Stage II and III Melanoma https://clinicaltrials.gov/study/NCT06153238 RECRUITING Melanoma DRUG: GME751

NCT04541108 Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies https://clinicaltrials.gov/study/NCT04541108 RECRUITING Solid Tumor BIOLOGICAL: Rilvegostomig

NCT06690138 A Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Divarasib in Healthy Participants https://clinicaltrials.gov/study/NCT06690138 NOT_YET_RECRUITING Healthy Participants DRUG: Divarasib

NCT06608238 The Purpose of This Study is to Evaluate the Safety and Efficacy of D-MNA in Adult Patients With Nodular Basal Cell Carcinoma https://clinicaltrials.gov/study/NCT06608238 RECRUITING Nodular Basal Cell Carcinoma DRUG: D-MNA 200 mcg

NCT06059508 Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT06059508 RECRUITING Advanced Malignant Tumor DRUG: SHR-5495 for injection Suzhou Suncadia Biopharmaceuticals Co., Ltd.

NCT05843708 A Phase 1, Open-Label Study to Evaluate the Effect of a Low-Fat Meal and Multiple Doses of Ciprofloxacin on the Pharmacokinetics of Vorasidenib in Healthy Subjects https://clinicaltrials.gov/study/NCT05843708 RECRUITING Healthy Subjects DRUG: Vorasidenib 40 mg Oral Tablet

NCT05188508 Pembrolizumab, Olaparib, and Temozolomide for People With Glioma https://clinicaltrials.gov/study/NCT05188508 RECRUITING Glioma DRUG: Pembrolizumab

NCT03633708 A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis https://clinicaltrials.gov/study/NCT03633708 RECRUITING Secondary Hyperparathyroidism

NCT05911308 Abequolixron (RGX-104) and Durvalumab in Lung Cancer https://clinicaltrials.gov/study/NCT05911308 RECRUITING Non-Small Cell Lung Cancer DRUG: Durvalumab

NCT05900908 Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy https://clinicaltrials.gov/study/NCT05900908 NOT_YET_RECRUITING Glioblastoma DEVICE: Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)

NCT06333808 Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy https://clinicaltrials.gov/study/NCT06333808 RECRUITING HIV-1-infection DRUG: Bictegravir

NCT06578338 Assessing a Height Artificial Intelligence Algorithm to Estimate Height of Children https://clinicaltrials.gov/study/NCT06578338 RECRUITING Growth; Stunting, Nutritional OTHER: Physical height measurement Danone Asia Pacific Holdings Pte, Ltd. KK Women's and Children's Hospital

NCT06192108 A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin https://clinicaltrials.gov/study/NCT06192108 RECRUITING Type 2 Diabetes DRUG: Orforglipron

NCT06720038 A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants https://clinicaltrials.gov/study/NCT06720038 RECRUITING Pneumococcal Vaccines BIOLOGICAL: 0.5 mL of the low dose VAX-31

NCT06036108 Food Effect Study of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia https://clinicaltrials.gov/study/NCT06036108 RECRUITING Schizophrenia DRUG: OPC-34712FUM/ Brexpiprazole fumarate

NCT06693908 A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis https://clinicaltrials.gov/study/NCT06693908 NOT_YET_RECRUITING Moderate to Severe Ulcerative Colitis DRUG: Vixarelimab Genentech, Inc.

NCT06465108 Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism https://clinicaltrials.gov/study/NCT06465108 RECRUITING Hypoparathyroidism DRUG: MBX 2109

NCT05869708 PRISM Neurofeedback Training for MDD Anhedonic Patients https://clinicaltrials.gov/study/NCT05869708 RECRUITING Depression

NCT04095208 Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study https://clinicaltrials.gov/study/NCT04095208 RECRUITING Soft Tissue Sarcoma Adult

NCT06669208 Trial of an Inactivated Chikungunya Virus Vaccine https://clinicaltrials.gov/study/NCT06669208 RECRUITING Chikungunya Fever

NCT06015308 A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo https://clinicaltrials.gov/study/NCT06015308 RECRUITING Dermatitis Atopic DRUG: Amlitelimab

NCT06024408 A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor https://clinicaltrials.gov/study/NCT06024408 RECRUITING Nonalcoholic Fatty Liver Disease (NAFLD)

NCT06614608 The Safety and Pharmacokinetics of ASKC200 in Osteoarthritic Knee Pain https://clinicaltrials.gov/study/NCT06614608 NOT_YET_RECRUITING Osteoarthritis, Knee

NCT06328738 ELVN-002 with Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer https://clinicaltrials.gov/study/NCT06328738 RECRUITING HER2-positive Breast Cancer

NCT06649708 HX044,FIH Study in Patients With Advanced Solid Tumor Malignancies https://clinicaltrials.gov/study/NCT06649708 RECRUITING Advanced Solid Tumor Malignancies DRUG: HX044 Hanx Biopharmaceuticals Pty Ltd

NCT06112808 A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo¬Æ as Monotherapy in Subjects With Advanced Melanoma of the Skin https://clinicaltrials.gov/study/NCT06112808 RECRUITING Advanced Melanoma DRUG: BCD-263

NCT06361108 MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP https://clinicaltrials.gov/study/NCT06361108 RECRUITING Diabetic Peripheral Neuropathic Pain DRUG: YJ001 for Spray Use

NCT06249308 Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC ) https://clinicaltrials.gov/study/NCT06249308 RECRUITING Ovarian Cancer OTHER: Blood collection Fudan University Shanghai Weihe Medical Laboratory Co., Ltd.

NCT06292208 A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors https://clinicaltrials.gov/study/NCT06292208 NOT_YET_RECRUITING MTD BIOLOGICAL: IBD0333 SUNHOÔºàChinaÔºâBioPharmaceutical CO., Ltd.

NCT05479708 ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma https://clinicaltrials.gov/study/NCT05479708 NOT_YET_RECRUITING Pancreatic Cancer Resectable DEVICE: ctDNA-based MRD detection BAIYONG SHEN GeneCast Biotechnology Co., Ltd.

NCT06717308 Evaluation of a Switchable Acrylic Adhesive Drape for Safer Removal in Negative Pressure Wound Therapy Applications. https://clinicaltrials.gov/study/NCT06717308 NOT_YET_RECRUITING Measure of Type and Frequency of Medical Adhesive-Related Skin Injury (MARSI)

NCT06563908 Lipiodol Prior to FET (LIFE) https://clinicaltrials.gov/study/NCT06563908 NOT_YET_RECRUITING IVF

NCT02557308 An Observational Study to Evaluate Safety and Efficacy of Remsima‚Ñ¢ in Patients With Ankylosing Spondylitis https://clinicaltrials.gov/study/NCT02557308 RECRUITING Ankylosing Spondylitis Celltrion

NCT05354843 SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05354843 RECRUITING Advanced Solid Tumor DRUG: ET0038 Etern BioPharma (Shanghai) Co., Ltd

NCT05854238 The Study for Evaluate of Safety and Efficacy of Vein of Marshall RF Ablation https://clinicaltrials.gov/study/NCT05854238 RECRUITING Persistent Atrial Fibrillation DEVICE: TIRA-VoM Tau Pnu Medical Co., Ltd.

NCT06016738 OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer https://clinicaltrials.gov/study/NCT06016738 RECRUITING Breast Cancer

NCT06402838 A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD) https://clinicaltrials.gov/study/NCT06402838 RECRUITING Alzheimer's Disease DRUG: RO7269162

NCT06631638 EMPHASYS Cup Position in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)) https://clinicaltrials.gov/study/NCT06631638 NOT_YET_RECRUITING Osteoarthritis

NCT05806138 A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction https://clinicaltrials.gov/study/NCT05806138 RECRUITING Breast Cancer

NCT05326308 Zanubrutinib in Patients With Waldenstr√∂m's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma https://clinicaltrials.gov/study/NCT05326308 RECRUITING Waldenstr√∂m's Macroglobulinemia

NCT05934838 A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas https://clinicaltrials.gov/study/NCT05934838 RECRUITING Follicular Lymphoma

NCT06110208 Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML https://clinicaltrials.gov/study/NCT06110208 RECRUITING Acute Myeloid Leukemia DRUG: CLL1 and CD38 dual-target CAR-T injection 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China Gracell Biotechnologies (Shanghai) Co., Ltd.

NCT06706908 Innovative Spinopelvic Solutions With Real-World Evidence https://clinicaltrials.gov/study/NCT06706908 NOT_YET_RECRUITING Sacro Iliac Joint Pain OTHER: Health questionnaires SI-BONE, Inc.

NCT05796908 Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders. https://clinicaltrials.gov/study/NCT05796908 NOT_YET_RECRUITING Arthritis

NCT06445608 PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm https://clinicaltrials.gov/study/NCT06445608 RECRUITING Coronary Artery Disease DEVICE: Percutaneous Mechanical Circulatory Support Kardion Inc

NCT06322108 Assessment of the Safety and Efficacy of Balstilimab in Combination With Botensilimab for the Treatment of Non-Small Cell Lung Cancer (IMMONC0008) https://clinicaltrials.gov/study/NCT06322108 RECRUITING Non-small Cell Lung Cancer DRUG: Botensilimab + Balstilimab Immune Oncology Research Institute Agenus Inc.

NCT05766943 Reduction of Myopotential Interference With Smart Pass in S-ICD Patients https://clinicaltrials.gov/study/NCT05766943 RECRUITING Subcutaneous ICD

NCT06567743 Brief Title: Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC https://clinicaltrials.gov/study/NCT06567743 RECRUITING High-Risk Non-Muscle-Invasive Bladder Cancer DRUG: Cretostimogene Grenadenorepvec

NCT05313243 Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma https://clinicaltrials.gov/study/NCT05313243 RECRUITING T-Cell Lymphoma DRUG: Brentuximab vedotin

NCT05643638 A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD https://clinicaltrials.gov/study/NCT05643638 RECRUITING Graft Versus Host Disease, Acute BIOLOGICAL: CYP-001: Cymerus induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells (MSCs)

NCT04757038 An Open Label, Randomized-controlled Trial to Assess Efficacy Safety of HYALODISC With Physical Exercise Program https://clinicaltrials.gov/study/NCT04757038 RECRUITING Degenerative Disc Disease(DDD) DEVICE: Intradiscal injection Fidia Farmaceutici s.p.a.

NCT03992404 Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury https://clinicaltrials.gov/study/NCT03992404 RECRUITING Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury DRUG: NT 201

NCT06670404 Prospective Evaluation of Therapeutic Combination in Treating Vertebral Compression Fractures https://clinicaltrials.gov/study/NCT06670404 NOT_YET_RECRUITING Vertebral Compression Fractures

NCT04816604 Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) https://clinicaltrials.gov/study/NCT04816604 RECRUITING Pulmonary Arterial Hypertension DRUG: GB002 (seralutinib)

NCT04485104 Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures https://clinicaltrials.gov/study/NCT04485104 RECRUITING Seizure in Participants With Tuberous Sclerosis Complex

NCT05176704 Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease https://clinicaltrials.gov/study/NCT05176704 RECRUITING Alzheimer's Disease DEVICE: Eye-Tracking Innodem Neurosciences

NCT05077904 A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures https://clinicaltrials.gov/study/NCT05077904 RECRUITING Stereotypical Prolonged Seizures DRUG: Staccato alprazolam

NCT06084104 DZD9008 PK Study in Hepatic Impairment Subjects https://clinicaltrials.gov/study/NCT06084104 RECRUITING Hepatic Impairment DRUG: DZD9008

NCT04840004 Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT04840004 RECRUITING Non Small Cell Lung Cancer

NCT04110301 MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) https://clinicaltrials.gov/study/NCT04110301 RECRUITING Follicular Lymphoma and Marginal Zone Lymphoma DRUG: Recombinant Humanized Monoclonal Antibody MIL62 Injection

NCT05735704 Early Detection and Screening of Hematological Malignancies - SANGUINE https://clinicaltrials.gov/study/NCT05735704 RECRUITING Hematologic Malignancy DIAGNOSTIC_TEST: Blood sampling for HemaChip screening/diagnostic testing

NCT06006104 Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer https://clinicaltrials.gov/study/NCT06006104 NOT_YET_RECRUITING Advanced Prostate Cancer DRUG: HRS-4357 injection Jiangsu HengRui Medicine Co., Ltd.

NCT06510504 Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1 https://clinicaltrials.gov/study/NCT06510504 RECRUITING Social Anxiety Disorder DRUG: 225 mg BNC210

NCT06541704 A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy https://clinicaltrials.gov/study/NCT06541704 RECRUITING Age-related Macular Degeneration (AMD)

NCT05899504 The Use of Novel Over-The-Scope-Clip to Prevent Esophageal Stent Migration https://clinicaltrials.gov/study/NCT05899504 NOT_YET_RECRUITING Migration of Implant DEVICE: Over-The-Scope-Clip (OTSC) Stent Fix Asian Institute of Gastroenterology, India Ovesco Endoscopy AG

NCT05276804 The POUR (Postoperative Urinary Retention) Study https://clinicaltrials.gov/study/NCT05276804 RECRUITING Postoperative Urinary Retention DRUG: Sugammadex Wake Forest University Health Sciences Merck Sharp & Dohme LLC

NCT05378204 Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer. https://clinicaltrials.gov/study/NCT05378204 RECRUITING Breast Cancer OTHER: Main study:

NCT05646004 621 Real World Study https://clinicaltrials.gov/study/NCT05646004 RECRUITING Senile Cataract DEVICE: Cataract surgery Carl Zeiss Meditec AG

NCT05181501 A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2) https://clinicaltrials.gov/study/NCT05181501 NOT_YET_RECRUITING Multiple Myeloma DRUG: Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A) Nanjing IASO Biotechnology Co., Ltd.

NCT04703101 Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer https://clinicaltrials.gov/study/NCT04703101 RECRUITING Locally Advanced Rectal Carcinoma

NCT04081701 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors. https://clinicaltrials.gov/study/NCT04081701 RECRUITING CNS Tumors

NCT04590001 Effect of the MobiusHD¬Æ in Patients With Heart Failure https://clinicaltrials.gov/study/NCT04590001 RECRUITING Heart Failure With Reduced Ejection Fraction DEVICE: MobiusHD Vascular Dynamics, Inc.

NCT05821101 Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach https://clinicaltrials.gov/study/NCT05821101 RECRUITING Aphakia, Postcataract DEVICE: Clareon Vivity and Clareon Vivity Toric IOLs targeted for mini-monovision with dominant eye set at emmetropia and non-dominant eye at -0.50. Debbie S. Kuo, MD Alcon Research

NCT06228404 Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC https://clinicaltrials.gov/study/NCT06228404 RECRUITING Metastatic Castration-resistant Prostate Cancer

NCT06507904 A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults https://clinicaltrials.gov/study/NCT06507904 NOT_YET_RECRUITING Healthy DRUG: Osivelotor

NCT05103904 Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant https://clinicaltrials.gov/study/NCT05103904 RECRUITING Recurrent Hepatocellular Carcinoma

NCT04504604 TCF-001 TRACK (Target Rare Cancer Knowledge) Study https://clinicaltrials.gov/study/NCT04504604 RECRUITING Rare Cancers

NCT06526104 Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis https://clinicaltrials.gov/study/NCT06526104 NOT_YET_RECRUITING Hepatocellular Carcinoma

NCT06487104 Use of TrachPhone in Tracheostomized Patients https://clinicaltrials.gov/study/NCT06487104 NOT_YET_RECRUITING Tracheostomy DEVICE: TrachPhone HME

NCT06203704 Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients https://clinicaltrials.gov/study/NCT06203704 RECRUITING Chronic Kidney Disease (CKD) AstraZeneca

NCT06164704 A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants with Chronic Rhinosinusitis with Nasal Polyps https://clinicaltrials.gov/study/NCT06164704 RECRUITING Chronic Rhinosinusitis with Nasal Polyps DRUG: Verekitug (UPB-101)

NCT04080804 Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer https://clinicaltrials.gov/study/NCT04080804 RECRUITING Head and Neck Squamous Cell Carcinoma (HNSCC) DRUG: Nivolumab

NCT05200104 Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD) https://clinicaltrials.gov/study/NCT05200104 NOT_YET_RECRUITING ALD (Adrenoleukodystrophy) DRUG: PXL065 Poxel SA

NCT05357404 Age and Sex-Specific PREValence of AcqUirEd VALVular Heart DiseasE https://clinicaltrials.gov/study/NCT05357404 RECRUITING Valvular Heart Disease Cardiovascular Research Foundation, New York CVS Caremark

NCT05061004 Cephea Early Feasibility Study https://clinicaltrials.gov/study/NCT05061004 RECRUITING Mitral Regurgitation DEVICE: Cephea Mitral Valve System Abbott Medical Devices

NCT05527301 HEM1036 Phase 2 Study in Low Anterior Resection Syndrome https://clinicaltrials.gov/study/NCT05527301 NOT_YET_RECRUITING LARS - Low Anterior Resection Syndrome DRUG: Lactobacillus Fermentum

NCT04755101 Efficacy of a Right-sided Ablation of the Anterior Ganglionated Plexus for Neurally Mediated Syncope https://clinicaltrials.gov/study/NCT04755101 RECRUITING Syncope, Neurogenic

NCT05282901 Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME) https://clinicaltrials.gov/study/NCT05282901 RECRUITING Metastatic Uveal Melanoma DRUG: Pembrolizumab 25 MG/1 ML Intravenous Solution Institut Curie Merck Sharp & Dohme LLC

NCT06010901 A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ¬±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. https://clinicaltrials.gov/study/NCT06010901 RECRUITING Colorectal Cancer DRUG: TQB2618 injection

NCT06277401 Exercise in Patients With Hypermobile Joints and Knee Pain https://clinicaltrials.gov/study/NCT06277401 RECRUITING Hypermobility, Joint

NCT06494904 Standard Versus High Dose ED-Initiated Buprenorphine Induction https://clinicaltrials.gov/study/NCT06494904 NOT_YET_RECRUITING Opioid Use Disorder DRUG: Buprenorphine Yale University National Drug Abuse Treatment Clinical Trials Network

NCT06474104 Collection of Blood and Skin Samples From Patients With Primary Mitochondrial Diseases and Healthy Volunteers https://clinicaltrials.gov/study/NCT06474104 RECRUITING Primary Mitochondrial Diseases Minovia Therapeutics Ltd.

NCT04612504 SynOV1.1 Intratumoral Injection Study https://clinicaltrials.gov/study/NCT04612504 RECRUITING Hepatocellular Carcinoma BIOLOGICAL: SynOV1.1 Beijing Syngentech Co., Ltd.

NCT05651204 GABA Biomarkers in Dravet Syndrome https://clinicaltrials.gov/study/NCT05651204 RECRUITING Dravet Syndrome DIAGNOSTIC_TEST: GABA Blood Level Cook Children's Health Care System Encoded Therapeutics

NCT05564104 A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body https://clinicaltrials.gov/study/NCT05564104 RECRUITING Hepatic Impairment

NCT05730504 Evaluating the Effectiveness of Mobile Self-guided Psychological Interventions to Reduce Relapse in Substance Use Disorder https://clinicaltrials.gov/study/NCT05730504 RECRUITING Substance Use Disorders

NCT05951101 Zenith LAA Occlusion System https://clinicaltrials.gov/study/NCT05951101 RECRUITING Atrial Fibrillation

NCT05637801 A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011) https://clinicaltrials.gov/study/NCT05637801 RECRUITING Alzheimer Disease

NCT06225804 A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT06225804 RECRUITING Non-Small Cell Lung Cancer DRUG: ABSK112 Abbisko Therapeutics Co, Ltd

NCT06481904 Registry for Stage 2 Type 1 Diabetes https://clinicaltrials.gov/study/NCT06481904 RECRUITING Type 1 Diabetes DRUG: TZIELD (teplizumab-mzwv) Sanofi

NCT04886804 Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) https://clinicaltrials.gov/study/NCT04886804 RECRUITING Neoplasm Metastasis

NCT06245304 Physiologic Pacing for Symptomatic First-Degree Heart Block https://clinicaltrials.gov/study/NCT06245304 RECRUITING Symptomatic First-degree Heart Block DEVICE: Dual chamber Medtronic pacemaker implantation.

NCT05989204 TmCD19-IL18 in CD19+ Cancers https://clinicaltrials.gov/study/NCT05989204 RECRUITING Non Hodgkin Lymphoma BIOLOGICAL: TmCD19-IL18 University of Pennsylvania Kite, A Gilead Company

NCT05907304 A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations https://clinicaltrials.gov/study/NCT05907304 RECRUITING Advanced or Metastatic Solid Tumors DRUG: Naporafenib

NCT06258304 A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies https://clinicaltrials.gov/study/NCT06258304 RECRUITING Advanced or Metastatic Solid Tumor Malignancies DRUG: GIGA-564

NCT05906004 Retrospective Data Collection and Prospective Clinical Investigation for the Augmentation or Reinforcement of the Rotator Cuff Using the Pitch-Patch https://clinicaltrials.gov/study/NCT05906004 NOT_YET_RECRUITING Rotator Cuff Tear

NCT06400004 Lumason¬Æ Infusion vs. Bolus Administrations https://clinicaltrials.gov/study/NCT06400004 NOT_YET_RECRUITING Heart Diseases DRUG: Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]

NCT05815901 A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients https://clinicaltrials.gov/study/NCT05815901 RECRUITING Gout DRUG: Epaminurad 6 mg

NCT06104501 Validation of the Blood Pressure Monitoring Function https://clinicaltrials.gov/study/NCT06104501 NOT_YET_RECRUITING Blood Pressure DEVICE: RadiHeart RadiRad Co., Ltd. Hualien Tzu Chi General Hospital

NCT05915104 Efficacy and Safety of Budesonide MMX¬Æ vs. Budesonide CR for Induction of Remission in Microscopic Colitis https://clinicaltrials.gov/study/NCT05915104 NOT_YET_RECRUITING Microscopic Colitis DRUG: Budesonide MMX¬Æ

NCT05731804 Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir https://clinicaltrials.gov/study/NCT05731804 NOT_YET_RECRUITING Renal Impairment

NCT04711304 Evaluation of Safety and Efficacy of Wharton's Jelly Compared to Hyaluronic Acid and Saline for Knee Osteoarthritis. https://clinicaltrials.gov/study/NCT04711304 NOT_YET_RECRUITING Osteoarthritis, Knee BIOLOGICAL: Umbilical Cord-derived Wharton's Jelly

NCT06497504 Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus) https://clinicaltrials.gov/study/NCT06497504 RECRUITING Hepatitis B DRUG: Bepirovirsen

NCT05467904 Double-Blind Randomized Placebo-Controlled Trial of a Proprietary Full Hemp Flower Formulation for Long COVID https://clinicaltrials.gov/study/NCT05467904 NOT_YET_RECRUITING Post-acute COVID-19 Syndrome OTHER: Xltranplus, Xltran LUCINDA BATEMAN, MD Endourage, LLC

NCT06121401 First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients https://clinicaltrials.gov/study/NCT06121401 RECRUITING Carcinoma, Ovarian Epithelial DRUG: Olaparib

NCT06403501 Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris https://clinicaltrials.gov/study/NCT06403501 RECRUITING Acne Vulgaris DRUG: Clascoterone

NCT04404101 Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies https://clinicaltrials.gov/study/NCT04404101 RECRUITING Pancreatic Cyst PROCEDURE: 1). EUS-FNA plus MFB

NCT05536804 A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes https://clinicaltrials.gov/study/NCT05536804 RECRUITING Overweight

NCT06693804 Ophthalmoscope and Otoscope Training in Family Medicine Residency https://clinicaltrials.gov/study/NCT06693804 NOT_YET_RECRUITING Resident Education

NCT06276101 NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL https://clinicaltrials.gov/study/NCT06276101 RECRUITING High-grade Squamous Intraepithelial Lesion (HSIL) BIOLOGICAL: NWRD08 administered by electroporation Newish Technology (Beijing) Co., Ltd.

NCT06079372 Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa https://clinicaltrials.gov/study/NCT06079372 RECRUITING Hypophosphatasia DRUG: ALXN1850

NCT06465472 Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria Type 1, 2 or 3 https://clinicaltrials.gov/study/NCT06465472 NOT_YET_RECRUITING Primary Hyperoxaluria Type 1

NCT05958472 Navigating the Clinical Research Process for Glioma https://clinicaltrials.gov/study/NCT05958472 NOT_YET_RECRUITING Glioma Power Life Sciences Inc.

NCT06480604 Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis https://clinicaltrials.gov/study/NCT06480604 RECRUITING Vulvovaginal Candidiasis DIETARY_SUPPLEMENT: Probiotic

NCT06313372 Interpreting Respiratory Oscillometry in Adult Asthma and COPD: a Delphi Study https://clinicaltrials.gov/study/NCT06313372 NOT_YET_RECRUITING Asthma

NCT04603872 CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies https://clinicaltrials.gov/study/NCT04603872 RECRUITING Multiple Myeloma in Relapse

NCT04433572 Temsirolimus Adventitial Delivery to Improve ANGioplasty And/or Atherectomy Revascularization Outcomes Below the Knee https://clinicaltrials.gov/study/NCT04433572 NOT_YET_RECRUITING Peripheral Artery Disease

NCT06207968 FH ORTHO SAS Knee Observatory https://clinicaltrials.gov/study/NCT06207968 NOT_YET_RECRUITING Knee Surgery DEVICE: Knee surgery with FH Ortho devices FH ORTHO

NCT06387368 Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer https://clinicaltrials.gov/study/NCT06387368 NOT_YET_RECRUITING Pancreatic Cancer Non-resectable DRUG: Huaier Granule

NCT05521672 Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease https://clinicaltrials.gov/study/NCT05521672 RECRUITING Stenosis; Bowel

NCT06133972 Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). https://clinicaltrials.gov/study/NCT06133972 RECRUITING Systemic Lupus Erythematosus DRUG: Placebo

NCT05776472 A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) https://clinicaltrials.gov/study/NCT05776472 RECRUITING Paroxysmal Nocturnal Hemoglobinuria DRUG: Pegcetacoplan Swedish Orphan Biovitrum

NCT05563272 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors https://clinicaltrials.gov/study/NCT05563272 RECRUITING Cervical Cancer

NCT05415072 A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas https://clinicaltrials.gov/study/NCT05415072 RECRUITING Metastatic Uveal Melanoma DRUG: DYP688 Novartis Pharmaceuticals

NCT06032572 Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) https://clinicaltrials.gov/study/NCT06032572 NOT_YET_RECRUITING Coronary Artery Disease

NCT06700304 Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices https://clinicaltrials.gov/study/NCT06700304 RECRUITING Tetraplegia/Tetraparesis

NCT05733104 A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea https://clinicaltrials.gov/study/NCT05733104 RECRUITING Complicated Intra-abdominal Infection

NCT06163404 Open-Label Study to Evaluate the Safety and Effectiveness of the Spirair Implant https://clinicaltrials.gov/study/NCT06163404 RECRUITING Nasal Septal Deviation

NCT06513104 A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After Menopause https://clinicaltrials.gov/study/NCT06513104 RECRUITING Healthy Volunteers DRUG: NNC0519-0130

NCT05023304 In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery https://clinicaltrials.gov/study/NCT05023304 NOT_YET_RECRUITING Cataract DRUG: Dextenza 0.4Mg Ophthalmic Insert

NCT04970901 A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7) https://clinicaltrials.gov/study/NCT04970901 RECRUITING B-Cell Non-Hodgkin Lymphoma

NCT06234904 Study of IBR733 Cell Injection in Acute Myeloid Leukemia https://clinicaltrials.gov/study/NCT06234904 NOT_YET_RECRUITING Acute Myeloid Leukemia BIOLOGICAL: IBR733 Cell Injection Imbioray (Hangzhou) Biomedicine Co., Ltd. The First Affiliated Hospital of Soochow University

NCT05685004 Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) https://clinicaltrials.gov/study/NCT05685004 RECRUITING Glioblastoma Multiforme of Brain BIOLOGICAL: TVI-Brain-1

NCT06602804 Trima Non-DEHP Leukoreduced Red Blood Cell in Vivo Recovery Study https://clinicaltrials.gov/study/NCT06602804 RECRUITING Device Validation of In-vivo Performance DEVICE: Trima Accel Auto RBC Collection Terumo BCT

NCT06336304 NXT Post-Market Clinical Follow-up https://clinicaltrials.gov/study/NCT06336304 RECRUITING Urinary Incontinence

NCT06367504 A Study to Assess the Effect of Doctor's Biome Medical Food in Individuals With Clostridium Difficile Infection https://clinicaltrials.gov/study/NCT06367504 NOT_YET_RECRUITING Clostridium Difficile Infection DIETARY_SUPPLEMENT: DBMF

NCT06358001 EchoTip AcuCore Post-Market Clinical Study https://clinicaltrials.gov/study/NCT06358001 RECRUITING Adenocarcinoma

NCT05942001 Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) https://clinicaltrials.gov/study/NCT05942001 RECRUITING Advanced Prostate Cancer DRUG: HRS-5041 Jiangsu HengRui Medicine Co., Ltd.

NCT06652568 Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Diagnosis https://clinicaltrials.gov/study/NCT06652568 RECRUITING Deep Vein Thrombosis

NCT05840172 A Clinical Investigation to Assess the Effectiveness of Benzocaine in NRL Condoms in Healthy Adult Men Who Feel They Ejaculate Too Quickly During Vaginal Sex https://clinicaltrials.gov/study/NCT05840172 RECRUITING Ejaculation Delayed DEVICE: Test condom A (NRL condom with 5% benzocaine paste)

NCT06070272 Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients https://clinicaltrials.gov/study/NCT06070272 NOT_YET_RECRUITING Recurrent Prostate Cancer Power Life Sciences Inc.

NCT06584604 Calibration of Esophageal Balloon Catheter in Spontaneous and Mandatory Mechanical Ventilation. https://clinicaltrials.gov/study/NCT06584604 NOT_YET_RECRUITING Intensive Care Unit

NCT06588504 Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents https://clinicaltrials.gov/study/NCT06588504 RECRUITING Diabetes Mellitus, Type 1 DRUG: Dasiglucagon

NCT04882904 Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part. https://clinicaltrials.gov/study/NCT04882904 RECRUITING Amyotrophic Lateral Sclerosis DEVICE: Actimyo¬∞ Centre Hospitalier Universitaire de Liege SYSNAV

NCT06088004 Phase ‚Ö†/‚Ö° Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06088004 RECRUITING Solid Tumor, Adult DRUG: ABO2011 Injection

NCT03943004 Trial of DFP-14927 in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT03943004 RECRUITING Solid Tumor

NCT06288672 IBS Skin Patch Test Food Allergy Study https://clinicaltrials.gov/study/NCT06288672 RECRUITING Irritable Bowel Syndrome OTHER: True avoidance diet

NCT04768972 FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS) https://clinicaltrials.gov/study/NCT04768972 RECRUITING Amyotrophic Lateral Sclerosis DRUG: ION363

NCT06566872 Collecting Recorded Videos of Colonoscopy and Gastroscopy Tests for the Evaluation of the (ME-APDS). https://clinicaltrials.gov/study/NCT06566872 RECRUITING Colon Polyp DEVICE: ME-APDS Magentiq Eye LTD

NCT05812768 Suture-Tight‚Ñ¢ First-in-Human Safety and Performance Study https://clinicaltrials.gov/study/NCT05812768 RECRUITING Aortic Aneurysm, Abdominal DEVICE: Suture-Tight Suture Delivery System Vesteck, Inc. Prince of Wales Hospital, Sydney

NCT04657068 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors https://clinicaltrials.gov/study/NCT04657068 RECRUITING Advanced Cancer

NCT06280768 Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation https://clinicaltrials.gov/study/NCT06280768 NOT_YET_RECRUITING Atrial Fibrillation DRUG: SHR-2004 injection Beijing Suncadia Pharmaceuticals Co., Ltd

NCT05860972 Evaluation of Safety and Efficacy of Morpheus8 Applicator for the Treatment of Focal Hyperhidrosis of the Axillae Using Radio Frequency https://clinicaltrials.gov/study/NCT05860972 RECRUITING Hyperhidrosis Primary Focal Axilla DEVICE: Morpheus8 Applicator (with the 24 pin tip) in the treatment of primary axillary hyperhidrosis. InMode MD Ltd.

NCT05490472 JAB-2485 Activity in Adult Patients With Advanced Solid Tumors https://clinicaltrials.gov/study/NCT05490472 RECRUITING Solid Tumors

NCT05433272 Immunogenicity and Safety Study of One Booster Dose of Trivalent COVID-19 Vaccine (Vero Cell), Inactivated https://clinicaltrials.gov/study/NCT05433272 NOT_YET_RECRUITING COVID-19 BIOLOGICAL: Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain

NCT02106572 Therapeutic Instillation of Mistletoe https://clinicaltrials.gov/study/NCT02106572 RECRUITING Superficial Bladder Cancer DRUG: abnobaVISCUM 900

NCT06607172 Clinical Efficacy of the Combined Effect of Oral Irrigator and Chemicals (0.075% CPC) https://clinicaltrials.gov/study/NCT06607172 NOT_YET_RECRUITING Dental Plaque

NCT06686472 Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis https://clinicaltrials.gov/study/NCT06686472 RECRUITING Allergic Conjunctivitis DRUG: TL-925

NCT06640972 Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists https://clinicaltrials.gov/study/NCT06640972 RECRUITING Triglycerides

NCT06364072 Safety, Tolerability, Analgesic Effect, and Feasibility of Intranasal CT001 in Pediatric Patients https://clinicaltrials.gov/study/NCT06364072 RECRUITING Pain DRUG: CT001 Cessatech A/S

NCT06152172 CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101 https://clinicaltrials.gov/study/NCT06152172 RECRUITING Idiopathic Inflammatory Myopathies

NCT03244072 Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery https://clinicaltrials.gov/study/NCT03244072 NOT_YET_RECRUITING Endophthalmitis DRUG: Moxifloxacin

NCT05183204 Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma https://clinicaltrials.gov/study/NCT05183204 RECRUITING Glioblastoma DRUG: Paxalisib

NCT06712472 Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for P53abn Endometrial Cancer https://clinicaltrials.gov/study/NCT06712472 RECRUITING Endometrial Cancer

NCT05094804 A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents https://clinicaltrials.gov/study/NCT05094804 RECRUITING Cancer

NCT06469372 Cardiac Amyloidosis Discovery Trial https://clinicaltrials.gov/study/NCT06469372 RECRUITING Cardiac Amyloidosis DEVICE: Cardiac amyloidosis deep learning model Pierre Elias Pfizer

NCT05769504 Examining Clinical Trial Participation for Small Cell Lung Cancer Patients https://clinicaltrials.gov/study/NCT05769504 NOT_YET_RECRUITING Small Cell Lung Cancer Power Life Sciences Inc.

NCT05065346 Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC https://clinicaltrials.gov/study/NCT05065346 NOT_YET_RECRUITING Squamous Cell Carcinoma

NCT04294446 Post-market Study of the Biodesign Hernia Graft https://clinicaltrials.gov/study/NCT04294446 RECRUITING Ventral Hernia DEVICE: Biodesign Hernia Graft Cook Biotech Incorporated

NCT04250246 A Study of NIVO Plus IPI and Guadecitabine or NIVO Plus IPI in Melanoma and NSCLC Resistant to Anti-PD1/PDL1 https://clinicaltrials.gov/study/NCT04250246 NOT_YET_RECRUITING Melanoma

NCT05724446 Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population https://clinicaltrials.gov/study/NCT05724446 RECRUITING Cataracts Infantile DRUG: Clobetasol Propionate

NCT05305846 Data Collection for Development of a Bladder Sensor During Urodynamics https://clinicaltrials.gov/study/NCT05305846 RECRUITING Urinary Incontinence DEVICE: TENA-PROTO2 Essity Hygiene and Health AB

NCT06475846 A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults https://clinicaltrials.gov/study/NCT06475846 NOT_YET_RECRUITING Preventing of Postoperative Nausea and Vomiting in Adults DRUG: HRS5580

NCT05176210 Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects https://clinicaltrials.gov/study/NCT05176210 RECRUITING Type II Diabetes DRUG: PS1

NCT06344910 PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC https://clinicaltrials.gov/study/NCT06344910 RECRUITING Heart Failure With Reduced Ejection Fraction OTHER: Best practice alert for the notification of patients with HFrEF and recommended evidence-based therapies Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) AstraZeneca

NCT05900310 Linus Health CDS Retrospective Validation Study https://clinicaltrials.gov/study/NCT05900310 NOT_YET_RECRUITING Cognitive Impairment

NCT06000410 A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee https://clinicaltrials.gov/study/NCT06000410 RECRUITING Knee Osteoarthritis BIOLOGICAL: Amniotic Suspension Allograft

NCT06517810 QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry https://clinicaltrials.gov/study/NCT06517810 RECRUITING Acute Kidney Injury

NCT06127810 MRI Gadopiclenol Enhanced Imaging of CNS Tumors https://clinicaltrials.gov/study/NCT06127810 NOT_YET_RECRUITING Image DEVICE: CE MRI on 0.064T Scanner

NCT06589310 Falcon Real World Evidence Registry https://clinicaltrials.gov/study/NCT06589310 RECRUITING Cancer DEVICE: Exact Sciences Multicancer Early Detection (MCED) Test Exact Sciences Corporation

NCT06528210 Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer https://clinicaltrials.gov/study/NCT06528210 NOT_YET_RECRUITING High Risk Prostate Carcinoma

NCT05262010 A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years https://clinicaltrials.gov/study/NCT05262010 RECRUITING HPV InfectioN

NCT06546410 OASIS: RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS https://clinicaltrials.gov/study/NCT06546410 NOT_YET_RECRUITING Epilepsy

NCT06354010 Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis https://clinicaltrials.gov/study/NCT06354010 RECRUITING Sensorineural Hearing Loss, Bilateral GENETIC: Genotyping

NCT05397210 Post-market Clinical Follow-up (PMCF) Study of the Infinity-Lock Button System for Acromioclavicular Joint Stabilisation https://clinicaltrials.gov/study/NCT05397210 RECRUITING Acromioclavicular; Dislocation DEVICE: Infinity-Lock Button System Xiros Ltd

NCT06053710 Detecting Fluid Accumulation With a Wearable Bioimpedance Sensor https://clinicaltrials.gov/study/NCT06053710 RECRUITING Overhydration

NCT05637710 Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil https://clinicaltrials.gov/study/NCT05637710 NOT_YET_RECRUITING Allergic Rhinitis DRUG: Administration of investigation of Eurofarma drug

NCT01973881 Quantitative MRI for Myelofibrosis https://clinicaltrials.gov/study/NCT01973881 RECRUITING Myelofibrosis PROCEDURE: T1 Weighted MRI (magnetic resonance imaging) University of Michigan Sanofi

NCT05750381 Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults. https://clinicaltrials.gov/study/NCT05750381 RECRUITING Microbial Colonization OTHER: Micrococcus luteus Blis Q24 balm

NCT06079281 Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa https://clinicaltrials.gov/study/NCT06079281 RECRUITING Hypophosphatasia DRUG: ALXN1850

NCT06569381 Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions https://clinicaltrials.gov/study/NCT06569381 NOT_YET_RECRUITING Idiopathic Pulmonary Fibrosis DRUG: Pirfenidone Modified-Release Tablets

NCT06079112 9MW2821 Combined With Toripalimab Injection in Subjects With Local Advanced or Metastatic Urothelial Cancer https://clinicaltrials.gov/study/NCT06079112 RECRUITING Advanced Urothelial Carcinoma DRUG: 9MW2821

NCT05833412 Molecular Early Sepsis Identification Study https://clinicaltrials.gov/study/NCT05833412 RECRUITING Sepsis

NCT02987946 Leiden Trial In Prevention of Post-Operative ThromboEmbolic Events https://clinicaltrials.gov/study/NCT02987946 RECRUITING Deep-Venous Thrombosis DEVICE: IPD Device delivered by Converis

NCT05712746 Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload in Heart Failure. https://clinicaltrials.gov/study/NCT05712746 RECRUITING Heart Failure DRUG: Samtasu for I.V. infusion Otsuka Pharmaceutical Co., Ltd.

NCT06709612 Postsurgical Analgesia After Hernia Repair https://clinicaltrials.gov/study/NCT06709612 NOT_YET_RECRUITING Hernia

NCT06424912 Vivifi's Treatment, BPH Treatment Via Vasculature Anastomosis https://clinicaltrials.gov/study/NCT06424912 NOT_YET_RECRUITING Benign Prostatic Hyperplasia

NCT03889912 Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma https://clinicaltrials.gov/study/NCT03889912 RECRUITING Cutaneous Squamous Cell Carcinoma

NCT05626712 Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes https://clinicaltrials.gov/study/NCT05626712 RECRUITING Type 1 Diabetes

NCT06286046 A Study of Mitapivat in Participants With Sickle Cell Disease and Nephropathy https://clinicaltrials.gov/study/NCT06286046 NOT_YET_RECRUITING Sickle Cell Disease

NCT06655246 A Study of Ziftomenib, an Oral Menin Inhibitor, in Combination with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors (GIST) https://clinicaltrials.gov/study/NCT06655246 NOT_YET_RECRUITING Gastrointestinal Stromal Tumor (GIST)

NCT06119646 Warm Pads Applied to the Breast During Episiotomy Repair https://clinicaltrials.gov/study/NCT06119646 RECRUITING Breastfeeding OTHER: Warm Pads Applied to the Breast Selcuk University Lansinoh Laboratories

NCT06458946 Monitoring Postprandial Blood Glucose and Insulin in Fruit Snacks https://clinicaltrials.gov/study/NCT06458946 RECRUITING Blood Glucose

NCT06375512 A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants https://clinicaltrials.gov/study/NCT06375512 RECRUITING Herpes Zoster BIOLOGICAL: HZ Vaccine (IN001)

NCT06440746 Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases https://clinicaltrials.gov/study/NCT06440746 RECRUITING Lung Diseases, Interstitial DRUG: Subcutaneous (SC) injections of OKZ 64 milligrams (mg) every 4 weeks (q4w), one injection of 0.4 millilitre (mL)

NCT03613246 NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population https://clinicaltrials.gov/study/NCT03613246 RECRUITING Transcatheter Aortic Valve Implantation NVT GmbH

NCT04422912 A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV) https://clinicaltrials.gov/study/NCT04422912 RECRUITING Pemphigus Vulgaris BIOLOGICAL: DSG3-CAART or CABA-201 Cabaletta Bio

NCT05490446 A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) https://clinicaltrials.gov/study/NCT05490446 RECRUITING Myelodysplastic Syndromes DRUG: Tebapivat Agios Pharmaceuticals, Inc.

NCT05846581 Registry of GORE¬Æ ACUSEAL Vascular Graft in Dialysis Access https://clinicaltrials.gov/study/NCT05846581 RECRUITING Chronic Kidney Diseases

NCT03597581 A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer https://clinicaltrials.gov/study/NCT03597581 RECRUITING Gastrointestinal Cancer

NCT05765981 An Early Clinical Trial to Evaluate VGN-R09b for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency. https://clinicaltrials.gov/study/NCT05765981 RECRUITING Aromatic L-amino Acid Decarboxylase (AADC) Deficiency DRUG: VGN-R09b Shanghai Jiao Tong University School of Medicine Shanghai Vitalgen BioPharma Co., Ltd.

NCT05608681 A Trial to Evaluate EP-104IAR in Adults With Eosinophilic Esophagitis (EoE). https://clinicaltrials.gov/study/NCT05608681 RECRUITING Eosinophilic Esophagitis DRUG: EP-104IAR Eupraxia Pharmaceuticals Inc.

NCT06591481 Retrospective Case-Control Study for Developing an Artificial Intelligence (AI) Tool for Lesion Detection Using Magnetic Resonance Imaging (MRI) and Clinical Variables for Early Diagnosis of Axial Spondyloarthritis (axSpA) https://clinicaltrials.gov/study/NCT06591481 RECRUITING Axial Spondyloarthritis (AxSpA) √Ångel Alberich Bayarri

NCT05733481 Evaluating the Use of the CapBuster System for the Crossing of CTO's in Coronary Arteries https://clinicaltrials.gov/study/NCT05733481 NOT_YET_RECRUITING Chronic Total Occlusion of Coronary Artery DEVICE: CapBuster System Medical Device for the Crossing of Chronic Total Occlusions in Coronary Arteries Praxis Medical Devices Ltd

NCT05486481 Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE) https://clinicaltrials.gov/study/NCT05486481 RECRUITING AL Amyloidosis

NCT06096168 Ambispective Study Evaluating the Clinical Results of SAGITTA EVL R Revision Stems https://clinicaltrials.gov/study/NCT06096168 RECRUITING Hip Arthropathy Societe dEtude, de Recherche et de Fabrication

NCT05574972 Timing Carotid Stent Clinical Study for the Treatment of Carotid Artery StenosisÔºàTiming TrialÔºâ https://clinicaltrials.gov/study/NCT05574972 RECRUITING Carotid Artery Diseases

NCT05533372 MAD Study of IA-14069 https://clinicaltrials.gov/study/NCT05533372 RECRUITING Healthy

NCT05691868 Vantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US) https://clinicaltrials.gov/study/NCT05691868 RECRUITING Rheumatoid Arthritis

NCT06500468 PillSense for Suspected Upper Gastrointestinal Bleeding https://clinicaltrials.gov/study/NCT06500468 NOT_YET_RECRUITING Bleeding Ugi DEVICE: PillSense System Tan Tock Seng Hospital EnteraSense Limited

NCT05983068 A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis https://clinicaltrials.gov/study/NCT05983068 RECRUITING Dermatitis Atopic DRUG: dupilumab Sanofi Regeneron Pharmaceuticals

NCT06672172 A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise https://clinicaltrials.gov/study/NCT06672172 NOT_YET_RECRUITING Type 2 Diabetes DRUG: HRS-7535 tablet

NCT06648772 Efficacy and Safety of Roflumilast Cream 0.3% in Subjects with Plaque Psoriasis: a Phase 3 Study https://clinicaltrials.gov/study/NCT06648772 NOT_YET_RECRUITING Plaque Psoriasis DRUG: Roflumilast Cream 0.3%

NCT01357668 An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis https://clinicaltrials.gov/study/NCT01357668 RECRUITING Juvenile Idiopathic Arthritis Bristol-Myers Squibb

NCT05296772 Phase 1 First-in-human Study of JS014 https://clinicaltrials.gov/study/NCT05296772 RECRUITING Neoplasm Malignant

NCT06162572 Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) https://clinicaltrials.gov/study/NCT06162572 RECRUITING Non-small Cell Lung Cancer (NSCLC) DRUG: S095018

NCT06557772 A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease https://clinicaltrials.gov/study/NCT06557772 RECRUITING Coeliac Disease

NCT03744468 Study of BGB-A425 and LBL-007 in Combination with Tislelizumab in Advanced Solid Tumors https://clinicaltrials.gov/study/NCT03744468 RECRUITING Locally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2 DRUG: BGB-A425

NCT06544772 Study of a Smartphone-Based Switch Program https://clinicaltrials.gov/study/NCT06544772 NOT_YET_RECRUITING Smoking Cessation DEVICE: Pivot cigarette smoking cessation program Pivot Health Technologies Inc.

NCT06553872 Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL https://clinicaltrials.gov/study/NCT06553872 RECRUITING Mantle Cell Lymphoma DRUG: Pirtobrutinib

NCT04104672 A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies https://clinicaltrials.gov/study/NCT04104672 RECRUITING Advanced Pancreatic Cancer DRUG: AB680

NCT05023772 Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases https://clinicaltrials.gov/study/NCT05023772 RECRUITING Neoplasm Metastasis

NCT05378672 A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D https://clinicaltrials.gov/study/NCT05378672 RECRUITING Hypoglycemia

NCT06635772 A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy https://clinicaltrials.gov/study/NCT06635772 NOT_YET_RECRUITING Immunoglobulin a Nephropathy DRUG: HS-10390

NCT05902169 Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM https://clinicaltrials.gov/study/NCT05902169 RECRUITING Glioblastoma

NCT06259669 Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population https://clinicaltrials.gov/study/NCT06259669 RECRUITING Pregnancy Related

NCT04095572 Alternative Prophylaxis in Female Recurrent Urinary Tract Infections https://clinicaltrials.gov/study/NCT04095572 RECRUITING Urinary Tract Infections

NCT05069272 Double-blinded, Vehicle Controlled Study to Evaluate Efficacy & Tolerance of Bakuchiol and Ethyl Linoleate on Acne https://clinicaltrials.gov/study/NCT05069272 RECRUITING Acne Vulgaris OTHER: Bakuchiol and Ethyl Linoleate

NCT06052072 Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study) https://clinicaltrials.gov/study/NCT06052072 RECRUITING Group 2 Pulmonary Hypertension

NCT04857372 A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors https://clinicaltrials.gov/study/NCT04857372 RECRUITING Mesothelioma DRUG: IAG933 Novartis Pharmaceuticals

NCT05093972 Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014) https://clinicaltrials.gov/study/NCT05093972 NOT_YET_RECRUITING Hepatic Insufficiency DRUG: Ulonivirine Merck Sharp & Dohme LLC

NCT05402072 AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the Hip https://clinicaltrials.gov/study/NCT05402072 RECRUITING Hip Arthroscopy

NCT05099172 First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2) https://clinicaltrials.gov/study/NCT05099172 RECRUITING Advanced Non-small Cell Lung Cancer

NCT04278768 Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) https://clinicaltrials.gov/study/NCT04278768 RECRUITING Acute Myelogenous Leukemia

NCT06024772 Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer https://clinicaltrials.gov/study/NCT06024772 NOT_YET_RECRUITING Prostate Carcinoma PROCEDURE: ultiparametric Magnetic Resonance Imaging

NCT06159972 Can EndoFLIP Improve Quality of Life Before and After Fundoplication? https://clinicaltrials.gov/study/NCT06159972 RECRUITING GERD

NCT05119972 Tolerability, Pharmacokinetics and Efficacy of ZSP1603 in Patients With Idiopathic Pulmonary Fibrosis ÔºàIPFÔºâ https://clinicaltrials.gov/study/NCT05119972 RECRUITING Idiopathic Pulmonary Fibrosis (IPF) DRUG: ZSP1603

NCT05937672 Cold Atmospheric Plasma Device Extension Study https://clinicaltrials.gov/study/NCT05937672 RECRUITING Verruca Vulgaris

NCT05379972 Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers https://clinicaltrials.gov/study/NCT05379972 RECRUITING Gastric Cancer

NCT04960072 Study on TIL for the Treatment of r/r Gastrointestinal Tumors https://clinicaltrials.gov/study/NCT04960072 RECRUITING Gastrointestinal Tumor BIOLOGICAL: Tumor Infiltrating Lymphocytes (TIL) Shanghai Juncell Therapeutics Shanghai 10th People's Hospital

NCT05008081 The CATALINA Study https://clinicaltrials.gov/study/NCT05008081 RECRUITING Chronic Obstructive Pulmonary Disease Exacerbation Wim Janssens European Respiratory Society

NCT03997981 Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY) https://clinicaltrials.gov/study/NCT03997981 RECRUITING Chemotherapy-induced Peripheral Neuropathy Disarm Therapeutics Eli Lilly and Company

NCT06318481 TADCLOT- a Double Blind Randomized Controlled Trial https://clinicaltrials.gov/study/NCT06318481 RECRUITING Stent Thrombosis

NCT06380881 PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases https://clinicaltrials.gov/study/NCT06380881 RECRUITING Patients With Bone Metastases DRUG: SHR-2017 Suzhou Suncadia Biopharmaceuticals Co., Ltd.

NCT06062069 A Study of CT-868 in Type 1 Diabetes Mellitus https://clinicaltrials.gov/study/NCT06062069 RECRUITING Overweight

NCT05277272 INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH) https://clinicaltrials.gov/study/NCT05277272 RECRUITING Hemophagocytic Lymphohistiocytoses Children's Hospital Medical Center, Cincinnati Sobi, Inc.

NCT04689204 A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies https://clinicaltrials.gov/study/NCT04689204 RECRUITING Acute Lymphoblastic Leukemia

NCT05164172 A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine https://clinicaltrials.gov/study/NCT05164172 RECRUITING Migraine DRUG: Eptinezumab H. Lundbeck A/S

NCT05970172 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease https://clinicaltrials.gov/study/NCT05970172 RECRUITING Chronic Kidney Disease

NCT06131372 A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo https://clinicaltrials.gov/study/NCT06131372 RECRUITING Chronic Kidney Disease

NCT05486104 Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis https://clinicaltrials.gov/study/NCT05486104 RECRUITING Moderate to Severe Ulcerative Colitis DRUG: Hemay005 tablets

NCT06608472 Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension https://clinicaltrials.gov/study/NCT06608472 NOT_YET_RECRUITING Essential Arterial Hypertension DRUG: N0877

NCT06655272 OM 85 to Prevent Respiratory Infections in Older At Risk Patients https://clinicaltrials.gov/study/NCT06655272 NOT_YET_RECRUITING Respiratory Tract Infections (RTI) DRUG: Bacterial Lysate

NCT05645172 Retention Rate of Acalabrutinib in a Non-interventional Setting https://clinicaltrials.gov/study/NCT05645172 RECRUITING Chronic Lymphocytic Leukaemia (CLL) AstraZeneca

NCT04670172 Real-Life Chronic Rhinosinusitis Outcome Registry https://clinicaltrials.gov/study/NCT04670172 RECRUITING Chronic Rhinosinusitis (Diagnosis) Change Accelerator in Respiratory Care

NCT04980404 Inqovi Maintenance Therapy in Myeloid Neoplasms https://clinicaltrials.gov/study/NCT04980404 RECRUITING Myelodysplastic Syndromes

NCT06377072 Efficacy and Safety of Shenqi Sherong Pill in Participants With Cervical Spondylotic Myelopathy https://clinicaltrials.gov/study/NCT06377072 RECRUITING Cervical Spondylotic Myelopathy DRUG: Shenqi Sherong Pill

NCT05132504 Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer https://clinicaltrials.gov/study/NCT05132504 RECRUITING Pancreatic Ductal Adenocarcinoma DRUG: Pembrolizumab

NCT06400472 A Study of LY4170156 in Participants With Selected Advanced Solid Tumors https://clinicaltrials.gov/study/NCT06400472 RECRUITING Ovarian Neoplasms

NCT06492304 A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies https://clinicaltrials.gov/study/NCT06492304 RECRUITING T Cell Lymphoma

NCT06563804 A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML https://clinicaltrials.gov/study/NCT06563804 NOT_YET_RECRUITING Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

NCT04691804 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer https://clinicaltrials.gov/study/NCT04691804 RECRUITING Metastatic Castration-Resistant Prostate Cancer (mCRPC) DRUG: Fuzuloparib , Abiraterone acetate and Prednisone

NCT04889872 PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR https://clinicaltrials.gov/study/NCT04889872 RECRUITING Aortic Stenosis, Calcific

NCT06570772 Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio https://clinicaltrials.gov/study/NCT06570772 NOT_YET_RECRUITING Ulcerative Colitis BIOLOGICAL: AVT16

NCT06166472 A Study to Evaluate the Safety, Tolerance, Pharmacokinetics, and Preliminary Antineoplastic Activity of AK132 in Advanced Malignant Solid Tumor https://clinicaltrials.gov/study/NCT06166472 NOT_YET_RECRUITING Advanced Malignant Solid Tumor DRUG: AK132 Akeso

NCT05459272 Clinical Trial on a Food Supplement With Melatonin and Herbal Products to Improve Sleep Quality https://clinicaltrials.gov/study/NCT05459272 RECRUITING Sleep Disorders DIETARY_SUPPLEMENT: Aquilea Sueno Forte

NCT06527404 A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis https://clinicaltrials.gov/study/NCT06527404 RECRUITING Prurigo Nodularis DRUG: Rocatinlimab

NCT05478304 Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial https://clinicaltrials.gov/study/NCT05478304 RECRUITING Ischemic Stroke

NCT05741372 A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis https://clinicaltrials.gov/study/NCT05741372 RECRUITING Liver Cirrhosis DRUG: Rosuvastatin

NCT06578104 PULSED AF Post-Approval Study https://clinicaltrials.gov/study/NCT06578104 NOT_YET_RECRUITING Atrial Fibrillation DEVICE: PulseSelect‚Ñ¢ PFA system Medtronic Cardiac Rhythm and Heart Failure

NCT06110572 Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation https://clinicaltrials.gov/study/NCT06110572 RECRUITING Extensive Stage Lung Small Cell Carcinoma

NCT06466772 Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops https://clinicaltrials.gov/study/NCT06466772 RECRUITING Stroke BEHAVIORAL: Hyper-personalized feedback (HPF intervention)

NCT04121572 EtCO2 for Monitoring and Predicting Severity of DKA in Pediatric Emergency, Doha, Qatar. https://clinicaltrials.gov/study/NCT04121572 RECRUITING Diabetes Mellitus DEVICE: Nasal cannula capnography Hamad Medical Corporation

NCT06095804 Clinical Pilot Study of the Percutaneous Ultrasound Jejunostomy Procedure https://clinicaltrials.gov/study/NCT06095804 NOT_YET_RECRUITING Jejunostomy; Complications

NCT06414304 Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy https://clinicaltrials.gov/study/NCT06414304 RECRUITING Colorectal Cancer

NCT05716672 Impact of Lazertinib Dose Modification on Effectiveness and Safety https://clinicaltrials.gov/study/NCT05716672 NOT_YET_RECRUITING Non-small Cell Lung Cancer DRUG: Lazertinib Pusan National University Hospital Yuhan Corporation

NCT06596772 A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel¬Æ [EU-sourced] in Rheumatoid Arthritis https://clinicaltrials.gov/study/NCT06596772 RECRUITING Rheumatoid Arthritis (RA) DRUG: MB04 (proposed biosimilar to etanercept)

NCT06226272 Clinical Outcome Measure at Stryker Spine https://clinicaltrials.gov/study/NCT06226272 NOT_YET_RECRUITING Degenerative Disc Disease

NCT03973372 ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement https://clinicaltrials.gov/study/NCT03973372 RECRUITING Cirrhosis, Liver

NCT06215846 A Clinical Study Evaluating the Safety and Efficacy of BioTTT001 in Patients With Malignant Solid Tumors https://clinicaltrials.gov/study/NCT06215846 NOT_YET_RECRUITING Solid Tumor BIOLOGICAL: BioTTT001 injection Beijing Bio-Targeting Therapeutics Technology Co., Ltd

NCT05494346 Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction https://clinicaltrials.gov/study/NCT05494346 RECRUITING Acute Rhinitis

NCT06711146 Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research https://clinicaltrials.gov/study/NCT06711146 RECRUITING Systemic Lupus Erythematosus DRUG: Metabolically Armed CD19 CAR-T cells Zhejiang University Leman Biotech Co., Ltd.

NCT06070246 Navigating the Clinical Research Process for Lymphoma https://clinicaltrials.gov/study/NCT06070246 NOT_YET_RECRUITING Lymphoma Power Life Sciences Inc.

NCT06353646 XH001 Combination With Ipilimumab and Chemotherapy for Patients With Resected Pancreatic Cancer https://clinicaltrials.gov/study/NCT06353646 NOT_YET_RECRUITING Pancreatic Cancer BIOLOGICAL: XH001

NCT04836546 Eversense¬Æ Non-adjunctive Use Post Approval Study https://clinicaltrials.gov/study/NCT04836546 RECRUITING Diabetes DEVICE: Blood glucose meter

NCT03641469 Green Sun Medical Dynamic Scoliosis Brace https://clinicaltrials.gov/study/NCT03641469 RECRUITING Adolescent Idiopathic Scoliosis DEVICE: Green Sun Dynamic Brace Green Sun medical Children's Healthcare of Atlanta

NCT06678269 A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer https://clinicaltrials.gov/study/NCT06678269 RECRUITING Metastatic Breast Cancer

NCT06348446 Tacrolimus Exposure in Kidney Transplantation https://clinicaltrials.gov/study/NCT06348446 RECRUITING Kidney Transplant Rejection Seoul National University Hospital Astellas Pharma Inc

NCT04607746 Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference https://clinicaltrials.gov/study/NCT04607746 RECRUITING Colonic Polyp DEVICE: Capsule Endoscope Capso Vision, Inc.

NCT06080269 To Compare the Effect of Receiving the Technology-based Training Along With the Conventional Therapy to the Conventional Therapy Alone on Executive Functions Among People With Traumatic Brain Injury With Mild to Moderate Cognitive Deficit https://clinicaltrials.gov/study/NCT06080269 RECRUITING Traumatic Brain Injury DEVICE: technology based intervention along with conventional therapy

NCT05979246 Effect of the Superhydrophilic Surface of Lance CLEAR Implants on the Marginal Bone Loss and Survival in Diabetic and Non Diabetic Patients https://clinicaltrials.gov/study/NCT05979246 NOT_YET_RECRUITING Diabetes DEVICE: Lance CLEAR dental implant MIS Implant Technologies, Ltd Rambam Health Care Campus

NCT04354246 COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies https://clinicaltrials.gov/study/NCT04354246 RECRUITING Advanced Cancer

NCT06168669 A Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection https://clinicaltrials.gov/study/NCT06168669 RECRUITING Colorectal Surgery

NCT06017869 Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-201 in Pediatric Patients With Pearson Syndrome https://clinicaltrials.gov/study/NCT06017869 RECRUITING Mitochondrial Diseases

NCT05824169 Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients https://clinicaltrials.gov/study/NCT05824169 RECRUITING Spinal Muscular Atrophy GENETIC: GC101 GeneCradle Inc

NCT05690581 Safety, Tolerability, Pharmacokinetic Characteristics, and Efficacy of CM369 in Advanced Solid Tumors & Hematologic Malignancies https://clinicaltrials.gov/study/NCT05690581 RECRUITING Advanced Solid Tumors and Hematologic Malignancies DRUG: CM369 Beijing InnoCare Pharma Tech Co., Ltd.

NCT06019481 A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations https://clinicaltrials.gov/study/NCT06019481 RECRUITING Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)

NCT03297281 Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) https://clinicaltrials.gov/study/NCT03297281 RECRUITING Benign Prostatic Hyperplasia

NCT05576181 Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia https://clinicaltrials.gov/study/NCT05576181 NOT_YET_RECRUITING Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited DRUG: ThisCART19A

NCT03047369 The Myelin Disorders Biorepository Project https://clinicaltrials.gov/study/NCT03047369 RECRUITING Leukodystrophy

NCT05148546 Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer https://clinicaltrials.gov/study/NCT05148546 RECRUITING Renal Cell Carcinoma DRUG: Neoadjuvant nivolumab

NCT06182969 A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus. https://clinicaltrials.gov/study/NCT06182969 RECRUITING SLE DRUG: APG-2575

NCT05100069 Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer https://clinicaltrials.gov/study/NCT05100069 RECRUITING Non-small Cell Lung Cancer (NSCLC) DRUG: Brigatinib Takeda

NCT05945069 Feasibility of Dynamic Muscle Stimulation + Radiofrequency for Improving Blink Quality in Subjects With Dry Eye Disease https://clinicaltrials.gov/study/NCT05945069 RECRUITING Eyelid Diseases

NCT05936346 Evaluation of Safety and Tolerability of Salvia Haenkei Extract as a Dietary Supplement Ingredient https://clinicaltrials.gov/study/NCT05936346 RECRUITING Aging DIETARY_SUPPLEMENT: Salvia haenkei 175mg

NCT05352646 NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection https://clinicaltrials.gov/study/NCT05352646 RECRUITING Hepatocellular Carcinoma DRUG: Autologous memory lymphocyte Injection (NewishT), low-dose group

NCT06384846 AI Algorithms in Prediction of ACS Based on Leukocyte Properties https://clinicaltrials.gov/study/NCT06384846 RECRUITING Acute Coronary Syndrome

NCT06482346 MT-3534 Clinical Pharmacology Study in Healthy Adult Male Volunteers https://clinicaltrials.gov/study/NCT06482346 RECRUITING Healthy Adult Male Volunteers BIOLOGICAL: MT-3534

NCT06603246 A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-Obstructive Disease https://clinicaltrials.gov/study/NCT06603246 RECRUITING Non Cystic Fibrosis Bronchiectasis

NCT05876546 Evaluation of Skin Irritancy and Sensitization of a Liquid Bandage https://clinicaltrials.gov/study/NCT05876546 NOT_YET_RECRUITING Skin Care DEVICE: Liquid bandage

NCT06362746 Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism https://clinicaltrials.gov/study/NCT06362746 RECRUITING Pulmonary Embolism DRUG: Non-immunogenic recombinant staphylokinase

NCT06513546 A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients https://clinicaltrials.gov/study/NCT06513546 NOT_YET_RECRUITING Amyotrophic Lateral Sclerosis

NCT05739669 DigitalEPI - A Prospective Pilot Study https://clinicaltrials.gov/study/NCT05739669 RECRUITING Epilepsy DEVICE: EEG recording with the comparator device Micromed Brain Quick

NCT06006169 A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors https://clinicaltrials.gov/study/NCT06006169 RECRUITING Head and Neck Squamous Cell Carcinoma DRUG: BL-B01D1

NCT06329869 Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma https://clinicaltrials.gov/study/NCT06329869 RECRUITING Esophageal Squamous Cell Carcinoma DRUG: Sacituzumab govitecan National Taiwan University Hospital Gilead Sciences

NCT06206746 The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System https://clinicaltrials.gov/study/NCT06206746 RECRUITING Polycystic Ovary Syndrome

NCT04653246 Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM https://clinicaltrials.gov/study/NCT04653246 RECRUITING Multiple Myeloma

NCT05587569 Outcomes Following Combined Adductoplasty‚Ñ¢ and Lapiplasty¬Æ (MTA3D) https://clinicaltrials.gov/study/NCT05587569 RECRUITING Metatarsus Adductus

NCT06130358 Investigating the Effects of a Museum Intervention on the Psychological and Cardiac Health of Older Adults https://clinicaltrials.gov/study/NCT06130358 NOT_YET_RECRUITING Atrial Fibrillation Recurrent

NCT06009458 Acuity 200‚Ñ¢ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear https://clinicaltrials.gov/study/NCT06009458 NOT_YET_RECRUITING Myopia DEVICE: Acuity 200‚Ñ¢ (fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear Acuity Polymers, Inc.

NCT06603558 Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine https://clinicaltrials.gov/study/NCT06603558 RECRUITING Chronic Migraine

NCT06680258 A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy https://clinicaltrials.gov/study/NCT06680258 NOT_YET_RECRUITING Hepatocellular Carcinoma (HCC) DRUG: TPST-1120

NCT04829058 GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study https://clinicaltrials.gov/study/NCT04829058 RECRUITING Pelvic Organ Prolapse DEVICE: Intervention Ethicon, Inc.

NCT05317858 Blood-brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets https://clinicaltrials.gov/study/NCT05317858 RECRUITING Brain Tumor DEVICE: Blood Brain Barrier Disruption - Oncology

NCT06038058 A Phase I Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies https://clinicaltrials.gov/study/NCT06038058 NOT_YET_RECRUITING Advanced Malignancies DRUG: BRY812 for injection BioRay Pharmaceutical Co., Ltd.

NCT05556096 Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis https://clinicaltrials.gov/study/NCT05556096 RECRUITING Generalized Myasthenia Gravis COMBINATION_PRODUCT: ALXN1720

NCT06537596 89Zr-olaratumab Dosimetry in Participants With Soft Tissue Sarcoma https://clinicaltrials.gov/study/NCT06537596 NOT_YET_RECRUITING Soft Tissue Sarcoma DRUG: 89Zr-DFOsq-olaratumab (89Zr-TLX300-CDx) Telix Pharmaceuticals (Innovations) Pty Ltd

NCT05514158 To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG) https://clinicaltrials.gov/study/NCT05514158 RECRUITING Gastric Cancer DRUG: RC48-ADC

NCT05560958 Post-market Clinical Follow-up Data Collection From Procedures With BIOTRONIK EP Products https://clinicaltrials.gov/study/NCT05560958 RECRUITING Cardiac Arrhythmia DEVICE: BIOTRONIK EP catheters (AlCath, MultiCath, ViaCath), external devices (Qubic RF, Qubic Stim, Qiona) and transseptal sheaths (Senovo bi-flex) Biotronik SE & Co. KG

About Us

TrialWire News

Contact us